Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cytoplasmic translation (GO:0002181),0.9552712277676996,2.7111164141762765,0.0,0.0,0.0,75/91,2.42%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL27A;RPL17;RPL23;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;RPS29;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPS13;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPS10;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.9623710414202663,2.707378548226465,0.0,0.0,0.0,77/87,2.42%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL27A;RPL17;RPL23;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;RPS29;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPS13;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPS10;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;RPL35;RPL4;SEC61B;RPL10;RPS6;RPL10A
prerank,cotranslational protein targeting to membrane (GO:0006613),0.9518977831441687,2.6810060366173807,0.0,0.0,0.0,77/91,2.42%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL27A;RPL17;RPL23;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;RPS29;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPS13;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPS10;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;SSR2;RPS6;RPL10A
prerank,protein targeting to ER (GO:0045047),0.9440063716180067,2.6755097829602765,0.0,0.0,0.0,76/99,2.42%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL27A;RPL17;RPL23;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;RPS29;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPS13;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPS10;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.933127115493444,2.6666877914913854,0.0,0.0,0.0,78/110,2.85%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL27A;RPL17;RPL23;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;RPS29;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPS13;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPS10;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A;MAGOHB;MAGOH
prerank,peptide biosynthetic process (GO:0043043),0.8959340610504116,2.5968575308653516,0.0,0.0,0.0,82/153,2.42%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL27A;MRPL23;RPL17;RPL23;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;RPS29;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL21;RPS13;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPS10;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.8691968039346569,2.545747758320703,0.0,0.0,0.0,79/168,2.99%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL27A;RPL17;RPL23;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;RPS29;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPS13;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPS10;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A;MAGOHB;MAGOH;POLR2D
prerank,rRNA metabolic process (GO:0016072),0.8498758352264976,2.497594088401571,0.0,0.0,0.0,59/160,2.42%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL27A;RPL17;RPL23;RPL13;RPL8;RPL32;RPL37A;RPL28;RPS9;RPL35A;RPL11;RPS15;RPS16;RPS14;RPL38;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,translation (GO:0006412),0.8445271054109973,2.4858328292520633,0.0,0.0,0.0,87/208,2.42%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL27A;MRPL23;RPL17;RPL23;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;RPS29;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL21;RPS13;LARS2;RPL34;EEF2;RPS20;RPS18;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPS10;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL14;RPL7A;EEF1B2;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;RPL10;MRPS34;RPS6;RPL10A;EEF1G
prerank,rRNA processing (GO:0006364),0.832840843953787,2.4564816105687006,0.0,0.0,0.0,59/172,2.42%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL27A;RPL17;RPL23;RPL13;RPL8;RPL32;RPL37A;RPL28;RPS9;RPL35A;RPL11;RPS15;RPS16;RPS14;RPL38;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,ribosome biogenesis (GO:0042254),0.8080761491361766,2.4029098593894522,0.0,0.0,0.0,59/187,2.42%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL27A;RPL17;RPL23;RPL13;RPL8;RPL32;RPL37A;RPL28;RPS9;RPL35A;RPL11;RPS15;RPS16;RPS14;RPL38;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,ncRNA processing (GO:0034470),0.8007670515959784,2.361528107290491,0.0,0.0,0.0,59/200,2.42%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL27A;RPL17;RPL23;RPL13;RPL8;RPL32;RPL37A;RPL28;RPS9;RPL35A;RPL11;RPS15;RPS16;RPS14;RPL38;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.7920344758233147,2.3427541030953325,0.0,0.0,0.0,93/306,3.51%,RPLP1;APOE;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL27A;MRPL23;RPL17;RPL23;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;RPS29;PTMA;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL21;RPS13;RPL34;EEF2;RPS20;RPS18;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPS10;PTMS;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL14;RPL7A;EEF1B2;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;POLR2E;RPL10;RPS6;RPL10A;EEF1G;EIF4G2;POLR2D;MRPL43;POLR2F
prerank,ribosome assembly (GO:0042255),0.8476914836578995,2.2564746871518184,0.0,0.0,0.0,18/47,3.09%,RPSA;RPL11;RPS15;RPS14;RPS5;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;RPS28;RPL10;NPM1;RPS27L
prerank,cellular protein metabolic process (GO:0044267),0.7520200609325227,2.231177419867707,0.0,0.0,0.0,135/396,8.92%,RPLP1;APOE;RPL41;CST3;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL27A;MRPL23;RPL17;RPL23;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;SFTPA2;SFTPA1;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;RPS29;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL21;RPS13;RPL34;IGFBP6;RPS20;RPS18;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPS10;RPLP2;RPLP0;RPL12;RPL3;SPP1;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;RPL23A;SPARCL1;C3;RPL14;RPL7A;RPL31;RPL36A;LGALS1;RPS28;MRPL34;RPL35;RPL4;RPL10;LAMC1;LAMB2;RPS6;LGMN;RPL10A;CKAP4;PNPLA2;RPN1;IGFBP3;IGFBP4;MFGE8;MRPL43;HSP90B1;IGFBP5;CHEK2;SHISA5;RPN2;MRPL35;UBE2G2;UBL5;MRPL55;PDIA6;PSENEN;EEF1A2;LOX;CPE;CDC34;MRPL28;PENK;FN1;OMA1;SFTPB;UBA52;SPCS1;MRPL27;MRPL41;P4HB;MRPS14;MRPS11;MRPL11;APLP2;UBE2M;TIMP1;MRPL52;VWA1;NEDD8
prerank,gene expression (GO:0010467),0.7444366582282254,2.2143457239919195,0.0,0.0,0.0,91/348,3.51%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL27A;MRPL23;RPL17;RPL23;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;RPS29;PTMA;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL21;RPS13;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL6;RPL27;RPL29;RPL9;RPS10;RPLP2;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL14;RPL7A;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;POLR2E;RPL10;RPS6;RPL10A;MAGOHB;MAGOH;HNRNPK;POLR2D;DDX39B;MRPL43;POLR2F
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.6524838624599882,-2.1833607474467844,0.0,0.027348458950322962,0.024,16/26,18.92%,SETD5;TET2;SETD2;OGT;TET3;KMT5C;KMT2A;KMT5B;WDR82;KMT2D;SETD4;PRDM9;SETD1B;SETD3;VCPKMT;BEND3
prerank,ribosomal small subunit biogenesis (GO:0042274),0.8368528893458562,2.1750530508860275,0.0,0.0,0.0,19/39,7.65%,RPS24;RPSA;RPS15;RPS16;RPS14;RPS5;RPS7;RPS19;RPS27;RPS25;RPS17;RPS28;RPS6;NPM1;RPS27L;LSM6;EMG1;SRFBP1;MRPS11
prerank,response to cadmium ion (GO:0046686),0.8874668781603504,2.1735773761668447,0.0,0.0,0.0,12/26,2.13%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;MT3;MAPK3;MT2A;AKT1
prerank,response to copper ion (GO:0046688),0.9273370922305334,2.1675820979027005,0.0,0.0,0.0,12/20,2.50%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;ATP5F1D;MT3;MT2A;PRNP
prerank,cellular response to cadmium ion (GO:0071276),0.8877703440050009,2.1620753980302823,0.0,0.0,0.0,12/24,2.13%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;MT3;MAPK3;MT2A;AKT1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.7840589443815087,2.1524718309461126,0.0,0.0,0.0,19/57,5.09%,RPL26;RPS24;RPL35A;RPL11;RPS15;RPS16;RPL38;RPS7;RPS19;RPL5;RPS25;RPL7;RPS17;RPL14;RPS28;RPS6;NPM1;LTO1;EMG1
prerank,cellular response to copper ion (GO:0071280),0.9350184696752619,2.1267782815930656,0.0,0.0,0.0,11/16,2.50%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;MT3;MT2A;PRNP
prerank,ribosomal large subunit biogenesis (GO:0042273),0.7745457004719392,2.115056686305001,0.0,0.0,0.0,17/54,4.88%,RPL26;RPL35A;RPL11;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL7;RPL23A;RPL14;RPL7A;RPL10;RPL10A;NPM1;LTO1
prerank,ribosomal large subunit assembly (GO:0000027),0.8735060284981508,2.1131378843432675,0.0,0.0,0.0,10/24,4.22%,RPL11;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;RPL10;DDX28
prerank,response to zinc ion (GO:0010043),0.8660182120591774,2.111848337442698,0.0,0.0,0.0,11/25,1.91%,CRIP1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;MT3;MT2A
prerank,negative regulation of peptidase activity (GO:0010466),0.7784948765099896,2.0770791298514233,0.0,0.0,0.0,18/47,8.73%,CST3;VTN;GAPDH;PARK7;UBXN1;TIMP2;SERPINH1;AKT1;SPOCK2;SERPINE2;SERPINF1;AGT;ECM1;SPOCK1;CSTB;TIMP1;SERPING1;SPOCK3
prerank,aerobic electron transport chain (GO:0019646),0.7500196570757942,2.0694676851948985,0.0,0.0,0.0,45/68,15.93%,COX4I1;UQCR11;COX6C;UQCR10;NDUFA2;COX6B1;COX7C;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;CYC1;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;UQCRC1;NDUFS2;NDUFB9;UQCRB;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX7B;COX5A
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.7477203473773544,2.06194639155648,0.0,0.0,0.0,45/69,15.93%,COX4I1;UQCR11;COX6C;UQCR10;NDUFA2;COX6B1;COX7C;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;CYC1;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;UQCRC1;NDUFS2;NDUFB9;UQCRB;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX7B;COX5A
prerank,cellular zinc ion homeostasis (GO:0006882),0.8406646917471623,2.0603615274480935,0.0,0.0,0.0,11/26,1.91%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;MT3;SLC30A1;MT2A
prerank,histone H3-K4 trimethylation (GO:0080182),-0.7602259733269544,-2.0388635769632186,0.0034602076124567475,0.13617253519014977,0.199,10/11,21.77%,TET2;OGT;TET3;KMT2A;WDR82;KMT2D;PRDM9;SETD1B;BEND3;CTR9
prerank,androgen receptor signaling pathway (GO:0030521),-0.7803224556910329,-2.0341673717383837,0.0,0.09382040778791349,0.204,8/11,13.29%,ZMIZ1;ARID1A;KDM3A;PMEPA1;AR;RNF14;DDX17;PLPP1
prerank,ribosomal small subunit assembly (GO:0000028),0.8938747830769805,2.0263531503607184,0.0,6.466170144091524e-05,0.002,8/16,3.09%,RPSA;RPS15;RPS14;RPS5;RPS19;RPS27;RPS28;RPS27L
prerank,zinc ion homeostasis (GO:0055069),0.8244557898558794,2.0205527532394894,0.0,6.257584010411152e-05,0.002,11/28,1.91%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;MT3;SLC30A1;MT2A
prerank,retina homeostasis (GO:0001895),0.8400457660906722,2.0080171380371077,0.0,0.00015155086275214509,0.004,6/23,1.79%,POTEF;ACTB;ACTG1;B2M;HSPB1;SOD1
prerank,cellular response to zinc ion (GO:0071294),0.895393465144219,2.0072778761054675,0.0,0.00017635009483885975,0.005,10/15,1.91%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;MT3;MT2A
prerank,regulation of complement activation (GO:0030449),0.7574847543297732,1.9926130443963483,0.0,0.00019969054856753234,0.006,11/40,8.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C3;C4B;C5AR1;C6;SERPING1
prerank,regulation of immune effector process (GO:0002697),0.750105219278602,1.9878422680933217,0.0,0.00019398510432274568,0.006,11/41,8.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C3;C4B;C5AR1;C6;SERPING1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.6156714981334023,-1.985562381498377,0.0,0.1401608521204052,0.37,11/24,13.00%,SMAD6;PARVA;ACVR1;BMPR1A;ROBO1;NRP1;ZFPM2;FGFR2;NRP2;SMAD4;BMP4
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.8625488691319096,1.9827946809307742,0.0,0.00018859662920266943,0.006,9/17,3.24%,COX4I1;COX6C;COX6B1;COX7C;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L
prerank,regulation of humoral immune response (GO:0002920),0.7455841834429129,1.9787634339369669,0.0,0.00020971362629486023,0.007,11/44,8.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C3;C4B;C5AR1;C6;SERPING1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.8962599207603039,1.9782953179420806,0.0,0.00022971920248746205,0.008,11/16,2.65%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A
prerank,ATP synthesis coupled proton transport (GO:0015986),0.8854055881084494,1.9750602209169004,0.0,0.0002486988516958278,0.009,11/17,2.65%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A
prerank,cellular transition metal ion homeostasis (GO:0046916),0.7017876204808045,1.9736423350647905,0.0,0.0002424813804034321,0.009,27/91,7.14%,FTH1;FTL;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;ATOX1;MT3;BOLA2;SLC30A1;HMOX1;SOD1;TMPRSS6;MT2A;PRNP;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;SLC39A10;TFRC;HEPH;SLC39A7
prerank,inner mitochondrial membrane organization (GO:0007007),0.7461277073207946,1.954899929130077,0.0,0.0004258209607084662,0.015,18/47,5.60%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;TIMM8B;ATP5MC1;TIMM13;ATP5MG;NDUFA13;ATP5PF;ATP5ME;ATP5F1A;MICOS13;ROMO1;GHITM;TIMM10B
prerank,regulation of viral entry into host cell (GO:0046596),0.7792108788052023,1.9532705251475444,0.0,0.00041568236640588367,0.015,7/30,1.44%,IFITM3;CD74;IFITM2;LY6E;GSN;IFITM1;LGALS1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.7764342262930947,1.9532584461825118,0.0,0.00040601533462900264,0.015,5/29,0.51%,RPS8;RPS16;RPS14;RPS21;RPS19
prerank,negative regulation of viral life cycle (GO:1903901),0.898776473183366,1.953052058157021,0.0,0.0003967877133874344,0.015,6/15,0.99%,IFITM3;PPIA;IFITM2;LY6E;GSN;IFITM1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.6638000376986879,1.9471615232494486,0.0,0.00043107800960610155,0.017,33/132,7.65%,RPSA;RPL11;RPS15;RPS14;RPL38;RPS5;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;HSP90AA1;HSP90AB1;SNRPG;RPS28;RPL10;GEMIN7;POLR2D;RPS27L;DDX39B;SNRPD2;LSM4;PUF60;SNRPE;SNRPF;SRSF9;STRAP;XAB2;MRPS11
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.7570918260291256,1.9461558819114608,0.0,0.0004638774233804789,0.018,27/38,13.93%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9
prerank,cristae formation (GO:0042407),0.8007343451695493,1.9421004610159212,0.0,0.0004746444041939522,0.019,12/27,3.36%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A;MICOS13
prerank,negative regulation of endopeptidase activity (GO:0010951),0.7222028617295322,1.9323868711394365,0.0,0.0007072373595100104,0.03,17/47,13.02%,VTN;GAPDH;MT3;TIMP2;SERPINH1;AKT1;SPOCK2;SERPINE2;SERPINF1;AGT;SORL1;SPOCK1;TIMP1;SERPING1;SPOCK3;TIMP3;SERPINA9
prerank,negative regulation of viral entry into host cell (GO:0046597),0.9125855714863274,1.9283190539895034,0.0,0.0008115703344114872,0.036,5/12,0.99%,IFITM3;IFITM2;LY6E;GSN;IFITM1
prerank,limb morphogenesis (GO:0035108),-0.64325610365576,-1.924606341561504,0.0,0.24135015023660014,0.604,7/20,7.99%,FBXW4;GLI3;NIPBL;SKI;LRP6;PCSK5;IQCE
prerank,glycolytic process (GO:0006096),0.789976643382184,1.9142827398849014,0.0,0.001222106157233298,0.055,11/28,6.50%,ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;PKM;ENO1;LDHA;PGK1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.7386455944433323,-1.9080965981111466,0.0,0.24157805406118615,0.67,3/11,6.17%,AFDN;RAPGEF2;RAPGEF6
prerank,negative regulation of cell activation (GO:0050866),0.8763915570836536,1.9079635956068657,0.0,0.0012932340288183046,0.059,6/14,4.03%,APOE;THBD;TREM2;GPER1;NR1D1;PDGFB
prerank,substantia nigra development (GO:0021762),0.7480052472004844,1.9038681187538717,0.001160092807424594,0.0013243213852802832,0.061,15/37,5.38%,ACTB;CALM1;S100A1;MBP;PLP1;COX6B1;CKB;DYNLL1;ATP5PF;HSPA5;CNP;CALM3;NDRG2;YWHAH;YWHAE
prerank,translational elongation (GO:0006414),0.6706480671520202,1.9002113951841235,0.0,0.0014640385231905334,0.069,51/101,19.97%,EEF1A1;MRPL23;MRPL13;MRPS12;EEF2;RACK1;EEF1B2;MRPL34;AURKAIP1;MRPS34;EEF1G;MRPL43;EEF1D;MRPL35;MRPL55;MRPL4;EEF1A2;MRPL30;MRPL28;MRPL14;MRPL27;MRPL41;MRPS14;MRPS11;MRPL11;MRPL52;MRPL36;MRPL51;MRPL57;MRPL54;MRPL58;MRPL50;MRPL2;MRPL37;MRPL44;MRPL17;CHCHD1;MRPS24;TUFM;MRPL32;TSFM;MRPS2;MRPL12;MRPS6;MRPL46;MRPS16;MRPL18;MRPS21;MRPL39;MRPS31;MRPL49
prerank,pyruvate metabolic process (GO:0006090),0.7036641708491649,1.899545172114048,0.0,0.0014728498661541803,0.071,14/52,6.82%,BSG;ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;GLO1;PKM;ENO1;LDHA;PGK1;SDS
prerank,negative regulation of hippo signaling (GO:0035331),-0.7448046501896658,-1.8953902080224232,0.007407407407407408,0.2402757464921232,0.722,6/12,17.09%,WWC2;VGLL4;DLG5;MARK3;LIMD1;MAPK14
prerank,embryonic limb morphogenesis (GO:0030326),-0.5649169290256197,-1.8917476462535134,0.0,0.21949987105441504,0.74,10/34,5.87%,CACNA1C;AFF3;CREBBP;FBXW4;GLI3;NIPBL;SKI;LRP6;RARG;WDPCP
prerank,cellular component disassembly (GO:0022411),0.7027727639138147,1.8876185863242838,0.0,0.002010391081163001,0.096,15/53,8.48%,BSG;GSN;CTSL;CAPNS1;CTSS;MMP3;LAMC1;TMPRSS6;TIMP2;A2M;ADAM15;FLOT1;ADAMTS4;LCP1;TIMP1
prerank,extracellular matrix disassembly (GO:0022617),0.7007431471647279,1.8821875617425263,0.0,0.00221697262083138,0.107,15/53,8.48%,BSG;GSN;CTSL;CAPNS1;CTSS;MMP3;LAMC1;TMPRSS6;TIMP2;A2M;ADAM15;FLOT1;ADAMTS4;LCP1;TIMP1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.8008784447365157,1.8788275348187433,0.0,0.002331224499317207,0.112,7/22,3.47%,RPL23;RPS15;RPL37;RPS7;RPS20;UBB;EIF5A
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.8452443620467118,1.8743387321345566,0.0,0.0026087651960645113,0.125,4/16,1.59%,TPT1;RPS3;CLU;CXCL12
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.8255613720417275,1.8703547457202385,0.0,0.0027289429930148976,0.135,7/17,7.50%,PPIA;HSPB1;SOD1;AKT1;TREM2;BAG5;P4HB
prerank,eye morphogenesis (GO:0048592),-0.6096268290926863,-1.869502571822224,0.0,0.2458829040811444,0.816,14/19,19.83%,COL5A2;FBN1;COL5A1;SHROOM2;NIPBL;SKI;RARG;EFEMP1;STAT3;IFT122;MFAP5;NKD1;NF1;AGTPBP1
prerank,cellular response to interleukin-12 (GO:0071349),0.7026653291757761,1.8637024489520666,0.0,0.0033139121988469055,0.162,15/48,7.82%,PPIA;RPLP0;BOLA2;CFL1;SOD1;TALDO1;PSME2;CNN2;MIF;SIRPA;AIP;MSN;GSTO1;P4HB;LCP1
prerank,negative regulation of hemostasis (GO:1900047),0.8791714621442965,1.8586919193450981,0.0,0.00367299664742248,0.181,5/12,3.06%,APOE;VTN;THBD;SERPINE2;CD34
prerank,catecholamine metabolic process (GO:0006584),-0.6914912802813579,-1.8569594530995392,0.0,0.25194767807985036,0.849,3/14,6.86%,SNCAIP;PRKN;ATP7A
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.6967646274007456,-1.8521034458608452,0.0,0.2427175731841163,0.867,8/13,14.52%,BMP6;RBPMS;BMPR1A;DAB2;TGFBR1;SMAD4;BMP4;TGFB3
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.6130453438332536,-1.8504669987762357,0.00909090909090909,0.22666934553618373,0.875,11/18,18.18%,ASH1L;SETD2;EHMT1;KMT2A;KMT2D;SETD7;EHMT2;SETD4;PRDM9;SETD1B;SETD3
prerank,response to interferon-beta (GO:0035456),0.7912943641201575,1.8498754195500777,0.0,0.004708831967834392,0.224,7/22,6.21%,IFITM3;IFITM2;IFITM1;NDUFA13;SHFL;UBE2G2;CDC34
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.8777899501591431,1.8468145361516328,0.0,0.0051421448288727824,0.244,6/12,3.44%,APOE;CLU;PFDN5;TREM2;CRYAB;PFDN6
prerank,mitochondrial translational elongation (GO:0070125),0.6587142649315822,1.8441873701479539,0.0,0.005395210713976364,0.263,49/88,22.99%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL27;MRPL41;MRPS14;MRPS11;MRPL11;MRPL52;MRPL36;MRPL51;MRPL57;MRPL54;MRPL58;MRPL50;MRPL2;MRPL37;MRPL44;MRPL17;CHCHD1;MRPS24;TUFM;MRPL32;TSFM;MRPS2;MRPL12;MRPS6;MRPL46;MRPS16;MRPL18;MRPS21;MRPL39;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.7402008784455071,1.843659914706853,0.0,0.005386817127731631,0.267,8/32,4.97%,RPL39;RPL30;RPS19;GAPDH;PGLYRP1;ROMO1;ANG;S100A9
prerank,platelet aggregation (GO:0070527),0.7265018151478188,1.8429257046522762,0.0,0.005393373733821794,0.27,13/33,12.34%,ACTB;ACTG1;PPIA;MYL9;HSPB1;MYL12A;METAP1;FLNA;FN1;CSRP1;P2RY12;ACTN1;CLIC1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.6964443141305261,1.8419966828968655,0.001128668171557562,0.005428687620972361,0.275,14/46,7.82%,PPIA;RPLP0;BOLA2;CFL1;SOD1;TALDO1;PSME2;CNN2;MIF;AIP;MSN;GSTO1;P4HB;LCP1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.6833154302782947,1.8392262925477045,0.0,0.005619862581114838,0.283,14/56,6.98%,SFTPA2;SFTPA1;RPS27A;CTSB;UBC;UBB;CTSL;S100A1;CTSS;LGMN;HSP90B1;S100A8;S100A9;UBA52
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.685983025913624,1.8381335362150464,0.0,0.005597855867599233,0.286,38/56,22.31%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFB4;NDUFAF8;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;DMAC1;TMEM126A;NDUFS3;NDUFB2;NDUFV1;NDUFA12;NDUFAF3;NDUFAB1;NDUFAF2;NDUFA10
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.685983025913624,1.8381335362150464,0.0,0.005597855867599233,0.286,38/56,22.31%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFB4;NDUFAF8;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;DMAC1;TMEM126A;NDUFS3;NDUFB2;NDUFV1;NDUFA12;NDUFAF3;NDUFAB1;NDUFAF2;NDUFA10
prerank,regulation of amyloid fibril formation (GO:1905906),0.8316915090295551,1.8369031251021668,0.0,0.005682943901286072,0.292,6/15,3.44%,APOE;CLU;PFDN5;TREM2;CRYAB;PFDN6
prerank,regulation of glucose import (GO:0046324),-0.5472648511751712,-1.836337864638621,0.0,0.2427175731841163,0.911,15/30,16.62%,PRKAG2;SORBS1;PID1;OSBPL8;APPL2;IRS1;GRB10;INSR;IGF1;ENPP1;CREBL2;PRKCI;OCLN;RHOQ;APPL1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5968647762535391,-1.8322159838111371,0.0045045045045045045,0.23376420864680822,0.918,10/21,15.39%,SAMD4A;CNOT4;PAN3;CNOT1;PARN;TUT7;CNOT10;CNOT7;TNKS1BP1;TUT4
prerank,negative regulation of interleukin-2 production (GO:0032703),0.7983768004683278,1.8321540313624503,0.0,0.006439227768491143,0.326,8/18,10.29%,LAPTM5;PRNP;CD34;PTPRC;HOMER2;TNFAIP3;NAV3;ZFP36
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.8422423440669305,1.8307747502624334,0.0,0.006523745631675901,0.334,5/15,6.78%,APOE;PLTP;APOC1;ABCG1;LIPG
prerank,reverse cholesterol transport (GO:0043691),0.8518713871085849,1.8292801007309623,0.0,0.006632193431574954,0.342,4/13,6.78%,APOE;CLU;ABCG1;LIPG
prerank,aggrephagy (GO:0035973),0.7529029619154833,1.8288588832488002,0.0,0.006647222908126087,0.345,7/27,1.81%,RPS27A;UBC;VIM;UBB;DYNLL2;PARK7;DYNLL1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.7618456048839434,1.8275694689284157,0.0,0.006661856872136399,0.348,7/24,5.09%,APOE;UBB;GPX1;PSME1;PSME2;PINK1;ATP5IF1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.767802292433742,1.8243967044604572,0.0,0.007142178840973818,0.372,4/21,0.53%,RPL23;RPL11;RPS7;RPL5
prerank,eye development (GO:0001654),-0.47787106685305836,-1.8214737077904006,0.0,0.23998272728908404,0.935,14/54,7.62%,PBX1;CACNA1C;COL5A2;FBN1;SMOC1;COL5A1;PBX3;SHROOM2;NIPBL;SKI;LAMA1;EFEMP1;SIPA1L3;CEP290
prerank,amyloid fibril formation (GO:1990000),0.6854374436904209,1.8209154674292891,0.0,0.00768479451740108,0.394,16/51,8.71%,CST3;RPS27A;UBC;B2M;UBB;GSN;H3-3A;ITM2B;MFGE8;FKBP1A;SORL1;PSENEN;TTR;UBA52;CALB1;MAPT
prerank,mitochondrial translational termination (GO:0070126),0.6507329984724005,1.819457632080044,0.0,0.00785762447889603,0.406,47/88,22.99%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL27;MRPL41;MRPS14;MRPS11;MRPL11;MRPL52;MRPL36;MRPL51;MRPL57;MRPL54;MRPL58;MRPL50;MRPL2;MRPL37;MRPL44;MRPL17;CHCHD1;MRPS24;MRPL32;MRPS2;MRPL12;MRPS6;MRPL46;MRPS16;MRPL18;MRPS21;MRPL39;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,regulation of endopeptidase activity (GO:0052548),0.6684871078576795,1.8176588659944863,0.0,0.007989761484293088,0.414,22/59,13.02%,VTN;GAPDH;TIMP2;SERPINH1;PSME1;AKT1;SPOCK2;SERPINE2;PSMB8;PSME2;SERPINF1;AGT;PSENEN;SPOCK1;TIMP1;SERPING1;SPOCK3;VSIR;ATP13A2;PSMB9;TIMP3;SERPINA9
prerank,neutrophil degranulation (GO:0043312),0.6102519505090436,1.8161097318666344,0.0,0.008130610236737305,0.422,158/425,18.00%,FTH1;CST3;FTL;EEF1A1;PSAP;CTSD;HSPA8;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;CTSZ;PRG2;TYROBP;ATP6V0C;HSP90AA1;C3;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;PGLYRP1;S100A11;NPC2;TIMP2;VAT1;CKAP4;CYBA;PSMD2;ITGB2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;SRP14;TMEM30A;PRDX4;RAC1;CYB5R3;PTPRC;TOLLIP;LGALS3;PKM;FCER1G;PSMD1;ORMDL3;C5AR1;FABP5;DNAJC5;CD93;ATP8B4;S100A8;S100A9;MIF;HSPA1B;SIRPA;PSMC3;ACTR1B;PSMD6;VCP;NDUFC2;LRG1;DDOST;ARHGAP9;CYBB;MGST1;IQGAP2;RHOG;HP;APRT;TTR;SELL;SYNGR1;CD53;HVCN1;SURF4;RAB14;CREG1;CSTB;TRAPPC1;GUSB;CD68;COTL1;SLC15A4;CCT8;SLCO4C1;VAMP2;PTPRN2;TICAM2;HMGB1;ALAD;GAA;RAB3D;ATP6AP2;FGL2;PSMD13;FUCA1;PECAM1;ATP8A1;LCN2;CTSA;PNP;TRPM2;CMTM6;SVIP;VAMP8;ARPC5;RHOA;PTPRB;SLC11A1;BST2;HSPA1A;LAMTOR3;NME2;ARHGAP45;LILRB3;CTSH;SDCBP;CLEC4D;CAT;LRRC7;NFASC;HPSE;CAP1;GOLGA7;YPEL5;DEGS1;PSMB1;NEU1;OSCAR;PLAU;MLEC;RAB5C;BRI3;ATP11B;CD300A;SLC2A3;MAGT1;TMBIM1;LAMP2;CTSC
prerank,neutrophil activation involved in immune response (GO:0002283),0.6097696329396667,1.8148314517187452,0.0,0.00831533709383477,0.434,161/428,18.42%,FTH1;CST3;FTL;EEF1A1;PSAP;CTSD;HSPA8;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;CTSZ;PRG2;TYROBP;ATP6V0C;HSP90AA1;C3;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;PGLYRP1;S100A11;NPC2;TIMP2;VAT1;CKAP4;CYBA;PSMD2;ITGB2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;SRP14;TMEM30A;PRDX4;RAC1;CYB5R3;PTPRC;TOLLIP;LGALS3;PKM;FCER1G;PSMD1;ORMDL3;C5AR1;FABP5;DNAJC5;CD93;ATP8B4;S100A8;S100A9;MIF;HSPA1B;SIRPA;PSMC3;ACTR1B;PSMD6;VCP;NDUFC2;LRG1;DDOST;ARHGAP9;CYBB;MGST1;IQGAP2;RHOG;HP;APRT;TTR;SELL;SYNGR1;CD53;HVCN1;SURF4;RAB14;CREG1;CSTB;TRAPPC1;GUSB;CD68;COTL1;SLC15A4;CCT8;SLCO4C1;VAMP2;PTPRN2;TICAM2;HMGB1;ALAD;GAA;RAB3D;ATP6AP2;FGL2;PSMD13;FUCA1;PECAM1;ATP8A1;LCN2;CTSA;PNP;TRPM2;CMTM6;SVIP;VAMP8;ARPC5;RHOA;PTPRB;SLC11A1;BST2;HSPA1A;LAMTOR3;NME2;ARHGAP45;LILRB3;CTSH;SDCBP;CLEC4D;CAT;LRRC7;NFASC;HPSE;CAP1;GOLGA7;YPEL5;DEGS1;PSMB1;NEU1;OSCAR;PLAU;MLEC;RAB5C;BRI3;ATP11B;CD300A;SLC2A3;MAGT1;TMBIM1;LAMP2;CTSC;SYK;CD14;GCA
prerank,neutrophil mediated immunity (GO:0002446),0.6073700782574635,1.8084738068037352,0.0,0.009535653320925333,0.494,159/432,18.00%,FTH1;CST3;FTL;EEF1A1;PSAP;CTSD;HSPA8;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;CTSZ;PRG2;TYROBP;ATP6V0C;HSP90AA1;C3;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;PGLYRP1;S100A11;NPC2;TIMP2;VAT1;CKAP4;CYBA;PSMD2;ITGB2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;SRP14;TMEM30A;PRDX4;RAC1;CYB5R3;PTPRC;TOLLIP;LGALS3;PKM;FCER1G;PSMD1;ORMDL3;C5AR1;FABP5;DNAJC5;CD93;ATP8B4;S100A8;S100A9;MIF;HSPA1B;SIRPA;PSMC3;ACTR1B;PSMD6;VCP;NDUFC2;LRG1;DDOST;ARHGAP9;CYBB;MGST1;IQGAP2;RHOG;HP;APRT;TTR;SELL;SYNGR1;CD53;HVCN1;SURF4;RAB14;CREG1;CSTB;TRAPPC1;GUSB;CD68;COTL1;SLC15A4;CCT8;SLCO4C1;VAMP2;PTPRN2;TICAM2;HMGB1;ALAD;GAA;RAB3D;ATP6AP2;FGL2;PSMD13;FUCA1;PECAM1;ATP8A1;LCN2;CTSA;PNP;TRPM2;CMTM6;SVIP;VAMP8;ARPC5;RHOA;PTPRB;SLC11A1;BST2;HSPA1A;LAMTOR3;NME2;ARHGAP45;LILRB3;CTSH;SDCBP;CLEC4D;CAT;LRRC7;NFASC;HPSE;CAP1;GOLGA7;YPEL5;DEGS1;PSMB1;NEU1;OSCAR;PLAU;MLEC;RAB5C;BRI3;ATP11B;ADAM17;CD300A;SLC2A3;MAGT1;TMBIM1;LAMP2;CTSC
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.5791240757617586,-1.8071830078121673,0.004545454545454545,0.25696156222074285,0.955,8/21,14.52%,BMP6;RBPMS;BMPR1A;DAB2;TGFBR1;SMAD4;BMP4;TGFB3
prerank,modulation by symbiont of host process (GO:0044003),0.8958631319709889,1.8041905967729999,0.0,0.010368965695346764,0.52,8/10,6.98%,RPS27A;UBC;B2M;UBB;MRC1;ENO1;PGK1;UBA52
prerank,regulation of membrane depolarization (GO:0003254),-0.6143012951517327,-1.803875776805375,0.0043859649122807015,0.25009093221484063,0.964,10/18,26.46%,LRRK2;CAMK2D;FHL1;PTPN3;SMAD7;HCN4;RANGRF;SCN5A;GPD1L;NEDD4L
prerank,alcohol catabolic process (GO:0046164),0.8812869170704293,1.803005000820852,0.0,0.010452373856449121,0.529,3/10,2.30%,APOE;MT3;SNX17
prerank,protein localization to vacuole (GO:0072665),0.8320580733113878,1.7982532697372207,0.001402524544179523,0.011492489610748715,0.564,8/13,10.24%,CD81;LAMTOR4;LAMTOR5;GLMP;RTN4;ATP13A2;MFSD1;RNF128
prerank,negative regulation of lipid catabolic process (GO:0050995),0.8018568769110577,1.795454163749651,0.0012919896640826874,0.012051603320280926,0.588,7/17,9.00%,AKT1;APOC1;TNF;SORL1;BSCL2;PDE3B;MFSD2A
prerank,platelet degranulation (GO:0002576),0.6207299099076123,1.7941997195265162,0.0,0.012267353472228178,0.596,46/118,20.40%,TMSB4X;PSAP;SPARC;CLU;ALDOA;CD63;CALM1;SELENOP;F13A1;TAGLN2;ISLR;SOD1;A2M;ANXA5;PDGFB;TUBA4A;LGALS3BP;ECM1;FLNA;RARRES2;ENDOD1;MANF;FN1;LEFTY2;APLP2;TIMP1;SERPING1;CLEC3B;SRGN;PECAM1;ITIH3;ACTN1;TIMP3;TEX264;GAS6;PF4;PDGFA;IGF2;SCCPDH;SCG3;LAMP2;TGFB1;HGF;MAGED2;QSOX1;CYB5R1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.647668841032713,1.7934742930218972,0.0,0.012216702356505503,0.599,30/70,16.15%,B2M;PSMB4;CALR;PSME1;PSMB6;PSMB8;PSME2;CYBA;PSMD2;FCER1G;TAPBP;PSMD1;PSMC3;PSMD6;PSMA7;CYBB;TAP2;PDIA3;PSMD5;VAMP3;FCGR1A;PSMB9;PSMD13;PSMB3;VAMP8;PSMB11;PSMB10;PSMB1;NCF1;PSMB5
prerank,postsynaptic membrane organization (GO:0001941),0.794186292863927,1.7934047798278663,0.0,0.01209173816945115,0.599,8/17,6.66%,APOE;NRXN1;NLGN1;SHISA7;LRP4;LHFPL4;MUSK;GPHN
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.726402780487947,1.7932135011326569,0.0,0.012012154536908484,0.6,7/30,4.99%,TPT1;RPS3;CD74;CLU;CXCL12;DDX39B;MIF
prerank,vascular process in circulatory system (GO:0003018),-0.6660773666835189,-1.791990147661589,0.007662835249042145,0.25123397926075197,0.973,3/13,4.96%,ROCK2;ROCK1;AGTR1
prerank,regulation of tube diameter (GO:0035296),-0.6660773666835189,-1.791990147661589,0.007662835249042145,0.25123397926075197,0.973,3/13,4.96%,ROCK2;ROCK1;AGTR1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.6508394164338321,1.7908049262895838,0.0,0.012545775768699316,0.625,29/67,16.15%,B2M;PSMB4;CALR;PSME1;PSMB6;PSMB8;PSME2;CYBA;PSMD2;TAPBP;PSMD1;PSMC3;PSMD6;PSMA7;CYBB;TAP2;PDIA3;PSMD5;VAMP3;FCGR1A;PSMB9;PSMD13;PSMB3;VAMP8;PSMB11;PSMB10;PSMB1;NCF1;PSMB5
prerank,regulation of tau-protein kinase activity (GO:1902947),0.8825288100693557,1.7896666677652957,0.0,0.01269246623445062,0.632,6/10,9.42%,CLU;HSP90AA1;HSP90AB1;C5AR1;SORL1;EGR1
prerank,canonical glycolysis (GO:0061621),0.7552349942831229,1.7891459307933897,0.0,0.012537563584649037,0.634,9/24,6.50%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.7552349942831229,1.7891459307933897,0.0,0.012537563584649037,0.634,9/24,6.50%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.8060275259165713,1.7846386345102057,0.0,0.013801231901295346,0.683,6/15,6.02%,RPL23;RPL11;RPS7;RPL5;PARK7;BAG5
prerank,negative regulation of platelet activation (GO:0010544),0.8021912724539444,1.78225630685536,0.0,0.014438891270208497,0.7,4/16,4.03%,APOE;THBD;SERPINE2;PDGFB
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.7492766261529373,1.781213305234231,0.0,0.014618163218606909,0.707,9/25,6.50%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6842195774879828,-1.7809230601132449,0.011111111111111112,0.2654509796865723,0.976,5/11,7.27%,MLLT3;DAB2;PLEKHA4;WNT5B;RSPO3
prerank,negative regulation of lipid metabolic process (GO:0045833),0.7606813540207009,1.7782925155000477,0.0,0.015371849933453937,0.72,6/22,5.63%,APOD;APOC1;GPER1;TNF;BSCL2;PDE3B
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.7356536409254476,1.7753555273701989,0.0012121212121212121,0.01604256812749107,0.74,7/25,6.50%,RPL23;RPL11;RPS7;RPL5;HSP90AB1;GABARAPL2;HIPK2
prerank,regulation of hippo signaling (GO:0035330),-0.6216310545768046,-1.7750326175370763,0.0,0.2639343339967677,0.981,8/17,17.09%,WWC2;VGLL4;DLG5;MOB3B;MARK3;NF2;LIMD1;MAPK14
prerank,maturation of SSU-rRNA (GO:0030490),0.6954584059610566,1.7745331284686017,0.0,0.0162198436238177,0.746,9/34,10.27%,RPS8;RPS16;RPS14;RPS19;RPS28;LSM6;SRFBP1;MRPS11;WDR3
prerank,translational termination (GO:0006415),0.6299210132568502,1.7740037278796965,0.0,0.01619395258145274,0.749,48/95,22.99%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;TRMT112;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL27;MRPL41;MRPS14;MRPS11;MRPL11;MRPL52;MRPL36;MRPL51;MRPL57;MRPL54;MRPL58;MRPL50;MRPL2;MRPL37;MRPL44;MRPL17;CHCHD1;MRPS24;MRPL32;MRPS2;MRPL12;MRPS6;MRPL46;MRPS16;MRPL18;MRPS21;MRPL39;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.7017686334389056,1.7698607558610986,0.0,0.01743982588377306,0.771,11/35,6.53%,CLU;B2M;VTN;C3;CCL19;APOC1;HNRNPK;RAC1;FLOT1;SNAP91;LRPAP1
prerank,carbohydrate catabolic process (GO:0016052),0.6979229884861143,1.7681356321850517,0.0,0.01766383594169617,0.777,12/38,6.50%,ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;PKM;ENO1;LDHA;MAN2B2;PGK1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.7112230978672054,1.7636000026714698,0.0024242424242424242,0.019047489767309602,0.812,5/26,3.62%,APOE;S100A1;PARK7;AKT1;TNF
prerank,negative regulation of coagulation (GO:0050819),0.8104920620989519,1.7623086449199565,0.0,0.019508313321513857,0.821,7/14,10.76%,APOE;VTN;THBD;SERPINE2;CD34;HS3ST5;PROCR
prerank,neutrophil chemotaxis (GO:0030593),0.6590765207852637,1.7621547009881695,0.0,0.01936225153427032,0.821,18/53,18.30%,BSG;PPIA;PPIB;CCL19;PDE4B;ITGB2;LGALS3;FCER1G;S100A8;S100A9;CXCL10;CCL2;PF4;EDN3;CCL3;PIK3CD;CCL8;SYK
prerank,positive regulation of lipid transport (GO:0032370),0.8495693289558366,1.7610621234062502,0.0,0.01956914547774365,0.824,3/12,1.04%,APOE;SPP1;DBI
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.834398960721558,1.7588854697396743,0.0,0.020306147158922278,0.84,2/12,0.25%,ACTB;ACTG1
prerank,mitochondrial translation (GO:0032543),0.6200693135752126,1.7576239277301413,0.0,0.020624143591404645,0.85,51/104,22.99%,MRPL23;MRPL13;MRPS12;LARS2;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL27;MRPL41;MRPS14;MRPS11;MRPL11;MRPL52;MRPL36;MRPL51;MRPL57;MRPL54;MRPL58;MRPL50;NDUFA7;MRPL2;MRPL37;MRPL44;MRPL17;CHCHD1;MRPS24;TUFM;MRPL32;TSFM;MRPS2;MRPL12;MRPS6;MRPL46;MRPS16;MRPL18;MRPS21;MRPL39;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,regulation of protein-containing complex assembly (GO:0043254),0.6097306762875183,1.753791100031086,0.0,0.02184516940571461,0.868,29/110,12.50%,APOE;RPS3;HSPA8;GFAP;CLU;RACK1;GSN;HSP90AA1;MMP3;PARK7;HSPA5;NRG1;CRYAB;PINK1;TNF;RHOC;LGALS3;SORL1;TIRAP;VCP;TFRC;SAR1A;MTLN;PIH1D1;HCK;BAX;WARS1;SVIP;NCLN
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6578859292154535,1.752916754075953,0.0,0.022031165419511837,0.873,14/54,9.90%,APOE;TMSB4X;ATP5F1B;HSPB1;AKT1;ATP5F1A;CSNK2B;TNF;PDGFB;ACVRL1;VASH1;KDR;GATA2;HMGB1
prerank,regulation of peptidase activity (GO:0052547),0.7592433863122057,1.7523042412527117,0.0012953367875647669,0.022016450999462065,0.873,8/19,9.82%,CST3;NDUFA13;RCN3;PSMB8;PINK1;ECM1;CSTB;ATP13A2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.6866072322242288,1.7508738249012639,0.0011574074074074073,0.02245292501349675,0.884,17/37,17.12%,RPS3;RPS7;RACK1;UBB;SOD1;EIF5A;S100A8;S100A9;NUPR1;BAX;MSX1;PMAIP1;BBC3;BAD;CAV1;DNM1L;BCAP31
prerank,nerve growth factor signaling pathway (GO:0038180),-0.7062053633163974,-1.747907147980248,0.02702702702702703,0.3130051845393971,0.991,5/10,15.02%,RAPGEF2;RAPGEF1;NGF;KIDINS220;BDNF
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.6714918818716407,1.7467822109959779,0.0,0.023952943316373817,0.898,7/40,2.94%,CLU;CD63;B2M;VTN;C3;CCL19;HNRNPK
prerank,microglial cell activation (GO:0001774),0.7606853824513531,1.746237354499024,0.0,0.02403910236758163,0.904,12/21,14.77%,CLU;C1QA;TYROBP;GRN;TREM2;ITGB2;TNF;C5AR1;MAPT;AIF1;CX3CR1;IFNGR1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6095462641496145,-1.7458399308767765,0.007272727272727273,0.3047470489192691,0.993,10/16,25.09%,PARP9;KMT5C;KMT5B;SHLD1;PARP3;SMCHD1;KDM4D;SHLD2;SHLD3;PRKDC
prerank,neutrophil migration (GO:1990266),0.6463155788933106,1.7455640063759388,0.0,0.024090628767602523,0.904,19/58,18.30%,BSG;PPIA;PPIB;CCL19;PDE4B;ITGB2;LGALS3;FCER1G;S100A8;S100A9;CXCL10;PECAM1;CCL2;PF4;EDN3;CCL3;PIK3CD;CCL8;SYK
prerank,response to metal ion (GO:0010038),0.6259730251340515,1.744673208994203,0.0,0.024248138040343217,0.906,24/67,20.78%,CRIP1;MT1A;MT1X;CALM1;ATP5F1D;PPP1CA;MT3;MT2A;CALM3;SLC25A13;GPHN;HVCN1;NDRG1;MAPT;PDCD6;TRPC1;CAV1;KCNMA1;CALM2;PPP3CA;SNCA;D2HGDH;CAPN3;KHK
prerank,positive regulation of cellular component movement (GO:0051272),0.7238607609517377,1.742569778978885,0.0012531328320802004,0.02497354452289466,0.915,12/24,17.68%,RPS19;CAVIN1;CCL19;SPOCK2;TUBB2B;NTN1;PHPT1;CSF1R;STK11;TWIST1;TRIM32;ADAM17
prerank,cholesterol efflux (GO:0033344),0.7361617596610164,1.742558843801515,0.0012903225806451613,0.02476543165187053,0.915,4/20,5.34%,APOE;NPC2;APOC1;ABCG1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.7203095236219552,1.7384249286423676,0.0,0.02646854605263249,0.932,9/26,6.02%,PPIA;HSPB1;PARK7;ATF4;AKT1;TXN;PINK1;GPR37L1;BAG5
prerank,pre-replicative complex assembly (GO:0036388),0.6435404104442018,1.738085068201747,0.002171552660152009,0.026434445568570882,0.933,22/64,13.37%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;PSMC3;MCM5;PSMD6;PSMA7;UBA52;GMNN;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10
prerank,positive regulation of endocytosis (GO:0045807),0.653535917479256,1.7344018252195916,0.002257336343115124,0.028151496846837484,0.944,11/45,5.06%,APOE;CLU;B2M;VTN;C3;CD151;CCL19;NLGN1;TREM2;HNRNPK;FLOT1
prerank,granulocyte chemotaxis (GO:0071621),0.6434608002638635,1.7327553640496436,0.0,0.02886310624802144,0.947,18/55,18.30%,BSG;PPIA;PPIB;CCL19;PDE4B;ITGB2;LGALS3;FCER1G;S100A8;S100A9;CXCL10;CCL2;PF4;EDN3;CCL3;PIK3CD;CCL8;SYK
prerank,positive regulation of peptidase activity (GO:0010952),0.7565957246965781,1.7321741675915818,0.0024813895781637717,0.02890378054408911,0.948,13/20,18.91%,GRN;NDUFA13;PSME1;RCN3;PSME2;PINK1;PSENEN;VCP;VSIR;CTSH;APH1B;PRELID1;DDRGK1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.6729641319988446,1.729923997417899,0.0,0.029852152165222533,0.955,10/37,6.50%,RPL23;RPL11;RPS7;RPL5;HSP90AB1;PARK7;UBXN1;MAP1A;BAG5;HIPK2
prerank,immunoglobulin mediated immune response (GO:0016064),0.8511134828162646,1.729422893341509,0.0,0.02978511444325623,0.955,3/10,4.22%,CD74;CD81;FCER1G
prerank,regulation of phagocytosis (GO:0050764),0.6539421512848862,1.7289752947759573,0.0,0.029741856815108474,0.955,20/53,14.04%,RACK1;CALR;TREM2;CYBA;DOCK2;TGM2;TNF;PTPRC;LMAN2;FCER1G;CAMK1D;SIRPA;IL2RB;SPACA3;SYT11;GATA2;HCK;IL2RG;SLC11A1;GAS6
prerank,neuron cell-cell adhesion (GO:0007158),0.7987094750615562,1.7287426709999973,0.002770083102493075,0.02967671344038284,0.955,8/14,12.77%,NRXN1;NLGN1;CNTN4;NINJ2;NRXN3;CDK5R1;NCAM2;NRXN2
prerank,pteridine-containing compound metabolic process (GO:0042558),0.8041944376676722,1.727525707714262,0.0013679890560875513,0.030157222756636085,0.96,5/13,12.23%,CALM1;HSP90AA1;AKT1;SPR;QDPR
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5560140476768495,-1.7243443167253603,0.004694835680751174,0.33447165296244985,0.997,7/20,11.60%,ZBTB20;ARNT;INSR;PRKAA2;IGF1;ENTPD5;PSEN1
prerank,positive regulation of glycolytic process (GO:0045821),-0.5560140476768495,-1.7243443167253603,0.004694835680751174,0.33447165296244985,0.997,7/20,11.60%,ZBTB20;ARNT;INSR;PRKAA2;IGF1;ENTPD5;PSEN1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.7218833858766992,1.723816988882116,0.0012077294685990338,0.03200754221325304,0.965,5/24,4.99%,TPT1;CD74;CLU;CXCL12;MIF
prerank,negative regulation of blood coagulation (GO:0030195),0.6734464423146973,1.7235144528363513,0.0011547344110854503,0.03188997548336047,0.965,12/38,17.43%,APOE;VTN;THBD;A2M;SERPINE2;CD34;PDGFB;SERPING1;PLAT;PDGFA;PLAU;F10
prerank,toll-like receptor signaling pathway (GO:0002224),0.6150201199799588,1.7226889203112514,0.0,0.032146103002055004,0.966,26/84,15.81%,SFTPA2;SFTPA1;RPS27A;CTSB;UBC;UBB;CTSL;S100A1;CTSS;LGMN;ITGB2;HSP90B1;S100A8;S100A9;TIRAP;UBA52;HSPD1;TICAM2;HMGB1;RIPK2;TLR6;UNC93B1;TRIL;TLR5;TRAF3;TLR1
prerank,homotypic cell-cell adhesion (GO:0034109),0.6677757172921256,1.7226351465818588,0.0011273957158962795,0.03191344496115618,0.966,13/39,12.34%,ACTB;ACTG1;PPIA;MYL9;HSPB1;MYL12A;METAP1;FLNA;FN1;CSRP1;P2RY12;ACTN1;CLIC1
prerank,DNA alkylation (GO:0006305),-0.5743127279232599,-1.7209662160717574,0.00425531914893617,0.3177992220616233,0.998,8/19,15.15%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,DNA methylation or demethylation (GO:0044728),-0.5743127279232599,-1.7209662160717574,0.00425531914893617,0.3177992220616233,0.998,8/19,15.15%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.6017958488830732,1.7208349299519397,0.0,0.0328194057980112,0.972,23/107,9.82%,TPT1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;CALR;MT3;CXCL12;SLC30A1;MT2A;CCL19;SLC24A4;SLC24A2;SLC39A10;DRD5;SLC39A7;TMCO1;HTR2C;ATP13A2
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.76615099216773,1.716122222384743,0.0012755102040816326,0.03535235890175921,0.978,7/17,4.90%,APOE;CLU;PRNP;NTRK2;PIN1;RTN4;SORL1
prerank,gluconeogenesis (GO:0006094),0.6762326954540133,1.7120507711175668,0.0,0.037671340879610576,0.988,12/39,9.40%,ALDOA;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;SLC25A11
prerank,negative regulation of secretion by cell (GO:1903531),0.6618925071309538,1.7106346436863835,0.0011668611435239206,0.03822068830822794,0.988,14/38,13.71%,APOE;SLC30A1;TRH;IL1RAPL1;GRM7;SYT11;VAMP3;DPH3;SYT4;CHGA;IL11;VAMP8;TNFRSF1A;LILRB1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.6414555435761589,1.7106250342515354,0.0,0.037959675090494124,0.988,18/46,17.12%,TSPO;TIMM8B;TIMM13;AKT1;TOMM5;TOMM7;PINK1;ROMO1;AIP;TIMM10B;DNLZ;HSPD1;TOMM40L;GDAP1;TIMM50;TOMM20L;MFF;BCAP31
prerank,cellular glucan metabolic process (GO:0006073),-0.691382428490254,-1.7099974236812663,0.006993006993006993,0.33489653080685666,0.998,5/11,13.98%,PRKAG2;PHKB;PHKA1;GBE1;GSK3B
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.7086036575230389,1.7083071388353526,0.0012578616352201257,0.039039502244952576,0.993,9/23,9.84%,RPS27A;UBC;UBB;COPS7A;COPS6;PARP1;UBA52;RBX1;DDB1
prerank,regulated exocytosis (GO:0045055),0.5842589952142864,1.70826176170964,0.0,0.03877638415132331,0.993,66/173,20.40%,TMSB4X;PSAP;SPARC;CLU;ALDOA;CD63;CALM1;SELENOP;F13A1;TAGLN2;ISLR;SOD1;A2M;SNAP25;ANXA5;PDGFB;TUBA4A;LGALS3BP;DNAJC5;ECM1;SYNGR2;FLNA;RARRES2;ENDOD1;MANF;SYT1;FN1;RIMS2;LEFTY2;SYNGR1;RIMS1;APLP2;TIMP1;SERPING1;CLEC3B;SDF4;SYT12;SYT11;VAMP2;SYT6;SYT4;SRGN;PECAM1;ITIH3;ACTN1;TIMP3;TEX264;GAS6;SYT10;PF4;RAB26;CDK5;PDGFA;IGF2;SYT2;SCCPDH;SCG3;LAMP2;SCIN;RAB31;SNCA;TGFB1;HGF;MAGED2;QSOX1;CYB5R1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.7438604208836108,1.7074519836037385,0.007731958762886598,0.039063408859921926,0.995,6/18,6.02%,PPIA;HSPB1;PARK7;AKT1;PINK1;BAG5
prerank,hydrogen peroxide metabolic process (GO:0042743),0.7414070296149067,1.7044400490607108,0.0,0.04085217773901739,0.997,9/19,9.91%,GPX1;PARK7;SOD1;CYBA;PRDX5;PRDX4;PRDX2;PRDX1;GPX3
prerank,mitochondrial transport (GO:0006839),0.6321581509899732,1.7036819059038584,0.0011273957158962795,0.041019766851580604,0.997,19/53,15.38%,TSPO;HSP90AA1;TIMM8B;TIMM13;TOMM5;TOMM7;SLC25A5;SLC25A4;SLC25A13;AIP;TIMM10B;TMEM14A;GDAP1;PMAIP1;TMEM14C;SPG7;ABCB10;BAD;MFF
prerank,protein localization to lysosome (GO:0061462),0.6914709753013336,1.7018338015858523,0.0,0.04212821334567767,0.997,14/28,19.33%,CD81;LAPTM5;LAMTOR4;LAMTOR5;GLMP;RTN4;SORL1;ATP13A2;MFSD1;RNF128;M6PR;VPS4A;NCOA4;SNX16
prerank,intermediate filament organization (GO:0045109),0.746976746231652,1.701450167787733,0.003861003861003861,0.042038963703915584,0.997,6/17,13.67%,GFAP;VIM;NEFL;KRT9;EPPK1;DES
prerank,negative regulation of protein binding (GO:0032091),0.6171701302935751,1.701380203002832,0.0,0.04185855448379247,0.997,21/71,12.24%,ACTB;RACK1;B2M;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;ADAM15;PDGFB;PIN1;SORL1;TLE5;LRPAP1;IFIT1;MAP2;CAMK1;BAX;DDX11;DNAJB2
prerank,cellular response to metal ion (GO:0071248),0.5873243098452293,1.6996255610027275,0.0,0.04282090106908177,0.998,41/123,16.59%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;B2M;MT3;MAPK3;MT2A;AKT1;LGMN;NLGN1;PRNP;ANK3;DLG2;SYT1;HVCN1;AQP1;SYT12;SYT11;ATP13A2;JUN;SYT6;SYT4;SMPD1;WNT5A;GLRA2;TRPM2;GLRA1;ALOX5AP;SYT10;CPNE5;SYT2;CPNE6;KCNA1;DMTN;NCF1;ADCY8
prerank,histone H3-K9 demethylation (GO:0033169),-0.6645738767814141,-1.6963132548960032,0.014184397163120567,0.35792688588863775,0.999,7/11,14.55%,KDM3B;KDM7A;JMJD1C;KDM3A;KDM4C;PHF8;KDM4D
prerank,response to unfolded protein (GO:0006986),0.6357224308296914,1.6946035026353308,0.0022727272727272726,0.046061697925763374,0.999,26/48,23.22%,HSPA8;HSP90AA1;HSP90AB1;HSPB1;HSPA5;SERPINH1;TMBIM6;HSPE1;HSPA1B;HSPD1;HSPB8;BAX;HSPB2;DNAJA1;DNAJB2;HSPA1A;DNAJB1;DAB2IP;HERPUD1;HSPA4L;HSPA2;BAK1;HSPA9;DDIT3;PTPN1;HSPH1
prerank,protein targeting to mitochondrion (GO:0006626),0.6267126446058942,1.6935966651724599,0.0,0.04644003397486532,0.999,19/52,15.38%,TSPO;HSP90AA1;TIMM8B;TIMM13;NDUFA13;TOMM5;TOMM7;ROMO1;AIP;TIMM10B;DNLZ;HSPD1;TOMM40L;PMPCB;GDAP1;TIMM50;TOMM20L;TIMM29;MFF
prerank,positive regulation of locomotion (GO:0040017),0.698354785733283,1.6933215621452289,0.0025031289111389237,0.04631876116792448,0.999,16/27,19.62%,CAVIN1;CCL19;SPOCK2;TREM2;PDGFB;RARRES2;P2RY12;NTN1;PHPT1;CSF1R;AIF1;F2RL1;TWIST1;TRIM32;STX4;TGFB1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.8513369573154752,1.693222243403333,0.0013869625520110957,0.04605231900977815,0.999,7/10,8.25%,ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5F1A;ATP5MC2
prerank,negative regulation of mitochondrion organization (GO:0010823),0.6612170349436228,1.6898106772753667,0.005889281507656066,0.048160288808493434,0.999,14/33,13.35%,CLU;GPX1;AKT1;VAT1;SLC25A5;PINK1;FZD9;GHITM;TMEM14A;TFRC;OMA1;MAPT;ACAA2;HSPA1A
prerank,lipoprotein catabolic process (GO:0042159),0.8148353177318833,1.6852726761144095,0.0013831258644536654,0.05142494729854606,0.999,3/11,3.44%,APOE;CTSD;LYPLA2
prerank,regulation of B cell proliferation (GO:0030888),0.6316932972386977,1.6835694985098881,0.002188183807439825,0.052551190519432855,0.999,15/44,20.51%,CD74;CD81;TYROBP;PTPRC;MIF;TIRAP;TFRC;IL2;CD22;CTLA4;VAV3;IKZF3;CD300A;GPR183;MEF2C
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.495587227791346,-1.6833694815211706,0.0,0.3804854351463683,0.999,11/28,14.78%,PID1;APPL2;TNS2;IRS1;GRB10;KANK1;NCK1;ENPP1;PTPN2;PIP4K2C;PRKCB
prerank,positive regulation of transport (GO:0051050),0.599971337509815,1.6831644154240504,0.0,0.05248789265040446,0.999,26/85,14.04%,APOE;ACTB;CHCHD10;CALR;CD151;CCL19;TREM2;CYBA;DOCK2;TNF;LMAN2;FCER1G;CAMK1D;FLOT1;SIRPA;IL2RB;MLC1;SPACA3;SGK1;GATA2;SMPD1;BAX;IL2RG;SLC11A1;CLIP3;GAS6
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.604232462893464,1.6825725867114494,0.0,0.052579847862767155,0.999,35/87,15.21%,UQCC2;NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFB4;NDUFAF8;NDUFA6;NDUFS6;COX17;NDUFA3;COA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;OMA1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;DMAC1;UQCRFS1;TMEM126A
prerank,skeletal system morphogenesis (GO:0048705),-0.46766637200616157,-1.6817765432843068,0.0,0.37243895979122615,0.999,11/42,8.34%,WWOX;HOXB3;ANKRD11;HOXA3;LRP5;SKI;HOXB4;LRP6;HOXC4;TGFBR1;FGFR2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.7623925549058569,1.6804446734516962,0.002631578947368421,0.05385542152605849,0.999,3/15,2.18%,TMSB4X;HSPB1;LGMN
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.6037173388137107,1.679091859767213,0.0,0.05462693739654679,0.999,32/86,16.50%,RPS27A;UBC;UBB;PSMB4;ELOB;HMOX1;ATF4;PSME1;KLF2;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;EPAS1;PSMC3;PSMD6;PSMA7;UBA52;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;HSPA1A;PSMB10;DNAJB1;EGLN2;PSMB1;PSMB5;VHL
prerank,response to interferon-alpha (GO:0035455),0.7561397184902529,1.6760015587707053,0.006544502617801047,0.05689825591166535,1.0,7/16,14.30%,IFITM3;IFITM2;IFITM1;BST2;GAS6;PDE12;RO60
prerank,cellular iron ion homeostasis (GO:0006879),0.621903741911212,1.67022434761744,0.0,0.06163545348838544,1.0,18/55,13.12%,FTH1;FTL;BOLA2;HMOX1;SOD1;TMPRSS6;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;TFRC;HEPH;NEDD8;ATP13A2;LCN2;SLC40A1;ISCU;SLC11A1
prerank,positive regulation of B cell proliferation (GO:0030890),0.6716404942879002,1.6697121216462127,0.0035419126328217238,0.061680078541139695,1.0,7/29,8.83%,CD74;CD81;PTPRC;MIF;TIRAP;TFRC;IL2
prerank,response to interferon-gamma (GO:0034341),0.6102657342946987,1.6692362569069688,0.0,0.06174200743720274,1.0,18/67,14.17%,IFITM3;CD74;IFITM2;GAPDH;IFITM1;RPL13A;CCL19;AQP4;SHFL;SIRPA;CXCL16;WNT5A;IRF8;AIF1;SLC11A1;BST2;CCL2;PDE12
prerank,negative regulation of transposition (GO:0010529),-0.5698583949968452,-1.6682065362459395,0.024489795918367346,0.39762095395742997,1.0,7/16,16.25%,UBR2;TUT7;MYBL1;MOV10;TEX15;TUT4;SIRT7
prerank,positive regulation of phospholipid transport (GO:2001140),0.8259657496855333,1.6678792306989576,0.0041841004184100415,0.06266073720425276,1.0,3/10,3.82%,APOE;DBI;TMEM30A
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.8058650893301863,1.6668136099633337,0.00425531914893617,0.06338022408508619,1.0,5/11,12.23%,CALM1;HSP90AA1;AKT1;SPR;QDPR
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.7270642224933026,1.6662878685166134,0.007462686567164179,0.0636236084629632,1.0,7/19,4.90%,APOE;CLU;PRNP;NTRK2;PIN1;RTN4;SORL1
prerank,positive regulation of phagocytosis (GO:0050766),0.6310562495524876,1.6662751971871461,0.0011074197120708748,0.06326005258333371,1.0,21/47,15.58%,C3;CALR;C4B;TREM2;CYBA;DOCK2;TNF;PTPRC;LMAN2;FCER1G;CAMK1D;SIRPA;IL2RB;SPACA3;GATA2;IL2RG;SLC11A1;CCL2;GAS6;F2RL1;CD300LF
prerank,iron ion homeostasis (GO:0055072),0.6164401721522648,1.6647021386719913,0.0,0.06433839293371066,1.0,19/58,13.12%,FTH1;FTL;B2M;BOLA2;HMOX1;SOD1;TMPRSS6;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;TFRC;HEPH;NEDD8;ATP13A2;LCN2;SLC40A1;ISCU;SLC11A1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.6609944011007353,1.6642389447737853,0.005841121495327103,0.06436517588697022,1.0,8/33,10.08%,RPS3;CD81;LAPTM5;PRNP;LGALS3;DUSP3;THY1;PHPT1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.7252051481690766,1.663862397755455,0.001321003963011889,0.06432888385996935,1.0,7/18,10.24%,APOE;CD81;HSP90AA1;ATP5IF1;MSN;PTTG1IP;RNF128
prerank,chondroitin sulfate catabolic process (GO:0030207),0.7696324014366397,1.6638215675633112,0.009358288770053475,0.06396970779391596,1.0,5/13,8.04%,BGN;HEXB;BCAN;HEXA;DCN
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.6263745259712862,1.6629872688914369,0.0022026431718061676,0.06437034784430647,1.0,15/53,10.51%,APOE;UBB;GPX1;HSP90AB1;PSME1;PSME2;TREM2;PINK1;GABARAPL2;PSMC3;FOXF2;NUPR1;XPO1;ALAD;ECSCR
prerank,negative regulation of lymphocyte migration (GO:2000402),0.8201733530775573,1.662382682905151,0.004335260115606936,0.0645925545347501,1.0,2/10,2.13%,APOD;AKT1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.550096856949616,-1.6611222191109687,0.0091324200913242,0.40601411658825426,1.0,10/20,19.01%,TNRC6B;TNRC6A;TNRC6C;CNOT1;MOV10;CNOT7;LIMD1;AGO2;CELF1;AGO4
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6732418104753282,-1.660044220294243,0.015432098765432098,0.3972899906827554,1.0,6/11,14.55%,PARP4;PARP9;PARP12;PARP16;PARP3;PARP10
prerank,DNA methylation (GO:0006306),-0.5164584165462252,-1.6581918051838764,0.009852216748768473,0.3911806360572981,1.0,8/23,15.15%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.7484948768855618,1.657853012985336,0.0026702269692923898,0.0686194435118678,1.0,4/16,3.62%,APOE;S100A1;AKT1;TNF
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7543389026689299,1.6572900183666215,0.0025806451612903226,0.06883699987681433,1.0,5/16,6.53%,APOE;CLU;TREM2;TNF;LRPAP1
prerank,hexose biosynthetic process (GO:0019319),0.645410632495782,1.6551636949797812,0.0011402508551881414,0.07056759263786247,1.0,12/42,9.40%,ALDOA;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;SLC25A11
prerank,regulation of leukocyte migration (GO:0002685),0.7533979813557486,1.6544901839308814,0.003911342894393742,0.07086484093507761,1.0,4/16,6.60%,CD81;HMOX1;RAC1;RHOG
prerank,regulation of plasminogen activation (GO:0010755),0.7781801397519391,1.653955806786958,0.006963788300835654,0.07097348269111695,1.0,4/12,8.57%,CTSZ;SERPINE2;ENO1;CLEC3B
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.6184430589434108,1.6534586474966586,0.0011025358324145535,0.07111884062111837,1.0,24/53,20.33%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;BCKDK;PSMB9;PSMD13;PSMB3;PSMB11;ODC1;PSMB10;PSMB1;PSMB5;PSMA6;PSMA4;OAZ2
prerank,response to reactive oxygen species (GO:0000302),0.6187096412894368,1.6531254611239847,0.0032967032967032967,0.07104165598308554,1.0,15/54,9.86%,APOE;RPS3;APOD;GPX1;HMOX1;SOD1;MAPK3;AKT1;PTPRN;PRDX5;ROMO1;HYAL2;HP;MAPT;JUN
prerank,histone lysine demethylation (GO:0070076),-0.5081198816860376,-1.65282919275142,0.020618556701030927,0.3938621235172091,1.0,10/25,14.55%,KDM3B;KDM2A;KDM7A;JMJD1C;KDM5B;KDM3A;KDM5C;KDM4C;PHF8;KDM4D
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7916552377072547,1.652294803225875,0.014084507042253521,0.07139937928166475,1.0,3/11,1.43%,ITM2A;ITM2C;ITM2B
prerank,maintenance of blood-brain barrier (GO:0035633),0.6625542881162167,1.6495592648924389,0.002398081534772182,0.07397014417581621,1.0,12/30,14.62%,ACTB;ACTG1;CLDN5;MBP;LAMC1;ESAM;MFSD2A;PECAM1;SLC1A1;LSR;GJA1;JAM3
prerank,glucose metabolic process (GO:0006006),0.6175702515101328,1.6493382989231915,0.001088139281828074,0.07379384173457892,1.0,23/58,20.56%,ALDOA;APOD;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;OMA1;SLC25A11;GAA;DCXR;ENO3;SLC25A1;G6PC3;PPARGC1A;AKR1A1;TFAP2B;GOT1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.820053519476111,1.6476431499351916,0.002894356005788712,0.07540116663675421,1.0,6/10,8.92%,RPS27A;UBC;UBB;UBA52;ISG15;NEDD8
prerank,positive regulation of cation channel activity (GO:2001259),0.6324788239149305,1.6474657175626988,0.0,0.07517184934539264,1.0,15/40,19.25%,TMSB4X;CALM1;CTSS;CALM3;AKAP6;ANK3;GSTO1;P2RY6;GSTM2;HAP1;CCL2;LRRC55;CCR2;CALM2;STAC3
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.6300724392756162,1.6464756803813023,0.0033975084937712344,0.075742839792685,1.0,8/40,7.02%,RPL23;RPL11;RPS7;RPL5;CLU;LAPTM5;HIPK2;FOXF2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.7882560885773585,1.645511664256557,0.008426966292134831,0.07633884399524522,1.0,8/11,14.87%,UQCR11;UQCR10;CYC1;UQCRH;UQCRQ;UQCRC1;UQCRB;UQCRFS1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.6459661244988912,1.6451141668294513,0.00477326968973747,0.07642806743183923,1.0,12/30,16.32%,HSPA8;HSPA5;SDF2L1;HSPE1;CCT2;HSPA1B;BAG1;SDF2;HSPA1A;DNAJB1;PTGES3;ERO1A
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.4891170836095192,-1.6442682482258029,0.017857142857142856,0.4072086984697863,1.0,11/29,15.64%,FER;GHR;STAT5B;IL31RA;PIAS1;IL15;STAT3;STAT2;PKD1;NMI;STAT5A
prerank,regulation of oxidative phosphorylation (GO:0002082),0.7324786074600712,1.6439562865853197,0.006631299734748011,0.07737337084322851,1.0,9/16,14.17%,UQCC2;PINK1;COX7A2L;COX7A2;VCP;NUPR1;MLXIPL;AK4;PDE12
prerank,cellular response to interferon-beta (GO:0035458),0.7642782186633612,1.6423385303950577,0.007802340702210663,0.07882942055136419,1.0,4/14,6.21%,IFITM2;NDUFA13;UBE2G2;CDC34
prerank,positive regulation of protein sumoylation (GO:0033235),-0.6661105444376962,-1.6407628950264603,0.03169014084507042,0.40542890900040185,1.0,3/10,5.61%,HDAC4;PIAS1;SAE1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.6660407229910079,1.6398086399670686,0.0037313432835820895,0.0812553836195878,1.0,13/25,21.18%,HSPA8;HSPA5;SDF2L1;HSPE1;HSPA1B;BAG1;SDF2;HSPA1A;DNAJB1;PTGES3;ERO1A;HSPA2;HSPA9
prerank,chemical synaptic transmission (GO:0007268),0.5504333487781023,1.6391382262187801,0.0,0.08158993281032983,1.0,122/284,23.65%,APOE;HSPA8;CALM1;GABARAP;MBP;PLP1;MTNR1B;MPZ;SLC17A8;ASIC2;NRXN1;CNP;GABRB1;NLGN1;NSG1;SNAP25;CHRNA9;DLGAP2;GRM5;GRIA2;SLC1A4;SLC1A2;DLGAP1;GRID2;KCNQ3;KCNQ2;DLG2;KCND2;PMP22;GABRG3;DNAJC5;GRIK5;GRIK2;CACNA1A;GRIN1;SYT1;PENK;DRD5;AMPH;GABRA2;SYPL1;RIMS1;RAPSN;SLC12A5;GRIN2A;GRIA4;GRM7;PDYN;PRKAR1A;SYN2;HTR2C;ERC2;SLC6A2;SLC6A5;CRH;VAMP2;PTPRN2;KIF5A;GRID1;CAMK1;GRM1;PRKAR1B;SLC17A7;HAP1;SLC17A6;CHRM3;GLRA2;GABRA3;GABRB3;GRIA1;GLRA1;SYN1;HCRT;CHRM2;CHRNA4;NRXN2;SLC1A1;CHAT;CBLN2;SDCBP;SYT10;LIN7C;PPFIA3;NAAA;CDK5;KCNK3;CPNE6;KCNA1;DOC2A;NAPA;GABRB2;DTNA;HTR7;PRKAR2B;HCRTR1;CHRM5;PCDHB14;CAMKK1;APBA2;GRM4;GRIN2B;PTCHD1;SNCA;STAC3;GLRA3;UNC119;GABBR2;UTS2;SST;GAD1;GRIA3;CACNB4;NPY5R;RIMBP2;GRIK1;CHRNA3;SLC32A1;CACNA1E;HTR3B;SLC5A7;UNC13A;SYT5
prerank,regulation of neuron death (GO:1901214),0.5844731109563028,1.6377828859869275,0.0,0.0829462214209046,1.0,34/82,20.51%,CLU;UBB;C1QA;CTSZ;TYROBP;GPNMB;PARK7;DCC;AKT1;PRNP;ITGB2;CD34;GRID2;NENF;SORL1;FAIM2;MAPT;DHCR24;EGR1;TRIM2;ATP13A2;WNT5A;CHGA;EGLN2;CDK5;EPHB1;PPARGC1A;GRM4;GRIN2B;AKT1S1;NSMF;SNCA;DDIT4;MEF2C
prerank,hydrogen peroxide catabolic process (GO:0042744),0.7823392242182355,1.6375350924903933,0.00846262341325811,0.0827886428474316,1.0,7/11,14.44%,GPX1;PRDX5;PRDX4;PRDX2;PRDX1;GPX3;CAT
prerank,kinetochore organization (GO:0051383),-0.6025191338747496,-1.6363577418414255,0.048034934497816595,0.4075972247403903,1.0,8/13,26.27%,POGZ;CENPC;CENPT;CENPE;CENPH;NDC80;MIS12;NUF2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.6342954290626497,1.635441984570891,0.005656108597285068,0.08452776571437796,1.0,8/40,5.74%,RPL39;MBL2;MPEG1;PGLYRP1;ROMO1;ANG;TIRAP;RARRES2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.5830001509885305,1.633320589113632,0.0,0.08676379678802808,1.0,16/84,4.90%,APOE;MRPL13;RPS3;CLU;RACK1;GAPDH;RPL13A;CALR;PRNP;IGFBP5;NTRK2;ORMDL3;NCL;PIN1;RTN4;SORL1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.6941847856734429,1.6315130732825702,0.009913258983890954,0.08822875810821328,1.0,9/20,15.09%,CLU;HSP90AA1;HSP90AB1;PFDN6;CCT2;HSPD1;PSMG3;HSPA1A;PTGES3
prerank,protein targeting to lysosome (GO:0006622),0.7038756756698189,1.6309251607600281,0.0050062578222778474,0.0884297753341971,1.0,9/20,19.33%,HSPA8;CLU;LAPTM5;SORL1;M6PR;LAMP2;VPS4A;NCOA4;SNX16
prerank,regulation of interleukin-2 production (GO:0032663),0.6201752124522604,1.6304361727034533,0.0022271714922048997,0.08849230035386359,1.0,11/43,11.59%,RPS3;LAPTM5;PDE4B;PRNP;CD34;PTPRC;HOMER2;TNFAIP3;NAV3;ZFP36;PNP
prerank,defense response to bacterium (GO:0042742),0.5664720816220891,1.6290468671276963,0.0,0.08980055441860706,1.0,30/105,19.80%,RPL39;RPL30;RPS19;MBL2;MPEG1;PGLYRP1;TREM2;ROMO1;FCER1G;ANG;S100A8;S100A9;TIRAP;RARRES2;ISG15;CEBPB;AQP1;ADGRB1;STAB1;CHGA;LCN2;LYZL4;SLC11A1;TLR6;ADAM17;NOS2;OAS3;SYK;RNASE7;IL6
prerank,inositol lipid-mediated signaling (GO:0048017),-0.4443462204779484,-1.6289510948072556,0.0125,0.41831747002764835,1.0,13/50,10.31%,GAB2;PLCE1;PITPNM2;PI4KA;OGT;ADAP2;IRS1;PLCD3;PLCL1;IGF1;PDGFRB;TNFAIP8L3;NGF
prerank,regulation of neuron apoptotic process (GO:0043523),0.571687570452349,1.6288797200891596,0.0010319917440660474,0.08956610749588267,1.0,43/96,22.15%,APOE;MDK;GRN;MT3;PARK7;SOD1;ATF4;LGMN;PRNP;FOXQ1;TREM2;PINK1;TNF;GRID2;FZD9;NTRK2;CTNNB1;FAIM2;NUPR1;TRIM2;CDK5R1;SET;BAX;WFS1;CCL2;PTPRZ1;EGLN2;CDK5;TYRO3;CCL3;BACE1;PPARGC1A;GRM4;AGAP2;ERBB3;AKT1S1;NSMF;TFAP2B;POU4F1;MEF2C;CRLF1;DDIT3;MAG
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7304533918060252,1.6287165528605847,0.007832898172323759,0.0893964027792297,1.0,3/15,2.18%,TMSB4X;HSPB1;LGMN
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.46136303527942096,-1.6286102861971905,0.0,0.40897619253455525,1.0,14/35,13.29%,NR3C2;RBFOX2;ZMIZ1;UBR5;YAP1;ARID1A;KDM3A;PMEPA1;ESR1;AR;RNF14;DDX17;PPARGC1B;PLPP1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.6153019618390292,1.6284383571915,0.002224694104560623,0.08922837003022847,1.0,23/50,20.33%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;ODC1;PSMB10;PSMB1;PSMB5;PSMA6;PSMA4;OAZ2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7776032069070593,1.6281870122876696,0.012413793103448275,0.08870323745958136,1.0,8/11,18.67%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;FKBP1B;SRI;CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7776032069070593,1.6281870122876696,0.012413793103448275,0.08870323745958136,1.0,8/11,18.67%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;FKBP1B;SRI;CALM2
prerank,negative regulation of viral process (GO:0048525),0.6020473207054224,1.6281481499556636,0.002185792349726776,0.08830559785371592,1.0,15/57,13.41%,IFITM3;PPIA;IFITM2;IFITM1;MBL2;SHFL;TNF;ISG15;TRIM28;PROX1;IFIT1;ZFP36;BANF1;BST2;HEXIM1
prerank,aerobic respiration (GO:0009060),0.6958229191934155,1.6245802063040913,0.010062893081761006,0.09220852338085296,1.0,9/20,13.89%,ATP5F1D;UQCR10;NDUFS7;UQCRH;UQCRC1;SDHB;BLOC1S1;UQCRB;NDUFS8
prerank,error-free translesion synthesis (GO:0070987),0.687542086453144,1.624104151083294,0.008674101610904586,0.09234810110595328,1.0,8/22,13.50%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;PCNA;RFC2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.6540895251757486,1.623835400079853,0.01061320754716981,0.0922682259364792,1.0,17/32,20.98%,PPIA;CALM1;HSP90AB1;CALM3;PPP1R15B;PIN1;DLC1;DUSP26;SMPD1;CDH5;CD300A;PPP1R15A;CALM2;NSMF;TGFB1;PPP2R5A;CAMTA1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6396339200590019,1.6237975170242416,0.007151370679380214,0.09187042166866037,1.0,15/32,20.66%,CALM1;CALM3;AKAP6;GPER1;APLNR;GSTO1;P2RY6;THY1;CXCL10;GSTM2;HAP1;TRPC1;CALM2;SNCA;CAPN3
prerank,negative regulation of protein metabolic process (GO:0051248),0.6139935327526169,1.6192243668384527,0.0021953896816684962,0.09711206905029209,1.0,11/48,5.39%,APOE;CLU;PFDN5;HSP90AB1;PRNP;TREM2;CRYAB;PFDN6;CD84;PIN1;FLNA
prerank,actin filament bundle organization (GO:0061572),-0.4604620951567661,-1.6181317379089624,0.022222222222222223,0.42799795629101667,1.0,9/33,4.63%,CALD1;PAWR;DPYSL3;LIMA1;BAIAP2L1;SHROOM2;BAIAP2;MYO1B;EPS8
prerank,negative regulation of wound healing (GO:0061045),0.6559427109674046,1.6181002536168723,0.010948905109489052,0.09820495906339,1.0,8/28,9.99%,APOE;VTN;THBD;SERPINE2;CD34;TNF;CLASP1;EPPK1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.5465659427309896,1.6179927933958747,0.0,0.097848636659323,1.0,91/224,21.93%,CALM1;GABARAP;MBP;PLP1;MTNR1B;MPZ;ASIC2;NRXN1;CNP;GABRB1;NLGN1;SNAP25;CHRNA9;GRM5;GRIA2;SLC1A2;DLGAP1;KCNQ3;KCNQ2;DLG2;KCND2;PMP22;GABRG3;GRIK2;CACNA1A;GRIN1;SYT1;PENK;DRD5;AMPH;GABRA2;SYPL1;RAPSN;SLC12A5;GRIN2A;GRIA4;GRM7;PDYN;PRKAR1A;SYN2;HTR2C;SLC6A2;SLC6A5;CRH;KIF5A;CAMK1;GRM1;PRKAR1B;HAP1;CHRM3;GLRA2;GABRA3;GABRB3;GRIA1;GLRA1;SYN1;HCRT;CHRM2;CHRNA4;NRXN2;SLC1A1;SDCBP;SYT10;CDK5;KCNK3;CPNE6;KCNA1;DOC2A;GABRB2;DTNA;HTR7;PRKAR2B;HCRTR1;CHRM5;PCDHB14;CAMKK1;APBA2;GRM4;GRIN2B;PTCHD1;SNCA;GLRA3;UNC119;GABBR2;UTS2;SST;GAD1;GRIA3;CACNB4;NPY5R;GRIK1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5919007854791658,1.6171346094484795,0.003257328990228013,0.0984836993417977,1.0,23/62,19.26%,TPT1;PPIA;CLU;HSPB1;CXCL12;PARK7;NDUFA13;AKT1;TMBIM6;PINK1;ENO1;BAG5;CREB3;PTTG1IP;SYVN1;DNAJA1;HSPA1A;YBX3;HERPUD1;NDUFS3;TRIM32;CCAR2;RTKN2
prerank,error-prone translesion synthesis (GO:0042276),0.689193832649782,1.616131904311341,0.008827238335435058,0.09951886979906442,1.0,7/21,13.50%,RPS27A;UBC;UBB;RPA2;UBA52;PCNA;RFC2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.5770793448303649,1.6160045588626004,0.0010526315789473684,0.09875361509001715,1.0,22/78,15.34%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CLTC;CAPZA2;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5770793448303649,1.6160045588626004,0.0010526315789473684,0.09875361509001715,1.0,22/78,15.34%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CLTC;CAPZA2;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,neurotransmitter transport (GO:0006836),0.578299768370406,1.6151543255751426,0.0,0.09932838197259858,1.0,30/73,15.59%,HSPA8;SLC17A8;NRXN1;SNAP25;SLC1A2;DNAJC5;SYT1;GLUL;PPFIA4;GABRA2;RIMS1;PPFIA2;SYN2;SLC6A2;VAMP2;PTPRN2;SLC6A16;SLC29A1;SLC17A7;SLC17A6;SYN1;NRXN2;SLC1A1;CHAT;GLS2;GLS;SLC29A2;LIN7C;PPFIA3;NAAA
prerank,regulation of calcium ion import (GO:0090279),0.6715420409930024,1.6147136824690094,0.007425742574257425,0.09949930031312339,1.0,11/21,19.74%,CXCL12;SLC30A1;PRNP;PDGFB;LGALS3;CTNNB1;PLN;CCL2;CCL3;PSEN2;SPHK2
prerank,B cell mediated immunity (GO:0019724),0.7952642100988125,1.6131986524767943,0.011220196353436185,0.10107946560926342,1.0,2/10,4.22%,CD74;FCER1G
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4113986281390749,-1.6111716774759557,0.010101010101010102,0.437363339647413,1.0,16/51,11.29%,FBN1;SMAD6;BMPR1A;CRIM1;SMURF2;SKI;BMPER;SMAD9;SMURF1;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4;CHRDL1
prerank,glutamate receptor signaling pathway (GO:0007215),0.6323233698321413,1.6111470465880724,0.006896551724137931,0.10328609604369904,1.0,13/37,10.49%,GRM5;GRIA2;GRID2;HOMER2;GRIK2;GRIN1;GRIN3A;GRM8;GRIN2A;GRIA4;GRM7;CDK5R1;GRM1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.6745056057398985,1.6111106667521822,0.013597033374536464,0.10287327176539124,1.0,10/23,15.33%,HSP90AA1;TIMM8B;TIMM13;NDUFA13;ROMO1;TIMM10B;BAX;PMAIP1;TIMM29;BAD
prerank,negative regulation of receptor binding (GO:1900121),0.7908321096965927,1.6104421561066704,0.0028776978417266188,0.10328184500555873,1.0,2/10,3.50%,B2M;ADAM15
prerank,regulation of protein neddylation (GO:2000434),0.7936561978391854,1.6103326748585576,0.015299026425591099,0.10299396632635781,1.0,4/10,4.70%,RPL11;RPL5;COPS9;EPAS1
prerank,acylglycerol homeostasis (GO:0055090),0.6888587018863623,1.6089475944947564,0.007614213197969543,0.10445882328775054,1.0,4/20,9.38%,APOE;LPL;MTLN;MLXIPL
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5842612043855581,1.6086019593138503,0.0021119324181626186,0.10441720327815052,1.0,32/74,20.78%,RPS27A;UBC;UBB;PSMB4;ELOB;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;EPAS1;PSMC3;PSMD6;PSMA7;UBA52;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;EGLN2;PSMB1;PSMB5;VHL;PSMA6;NOTCH1;PSMA4;CITED2;SIRT2
prerank,cellular respiration (GO:0045333),0.6063803768678968,1.6081920377903582,0.005688282138794084,0.10448704275569215,1.0,20/41,24.25%,ATP5F1D;UQCR10;NDUFS7;UQCRH;ETFB;SLC25A13;NDUFA5;MTLN;UQCRC1;SDHB;BLOC1S1;UQCRB;NDUFS8;UQCRFS1;PPARGC1A;CYCS;SDHA;COQ10A;MTFR1L;SLC25A14
prerank,zymogen activation (GO:0031638),0.6252910994907145,1.608109415512656,0.005701254275940707,0.10409257714195755,1.0,18/39,18.94%,CTSL;LGMN;CD5L;PGK1;HP;HPR;OMA1;F9;KLK1;GRIN2A;VSIR;PLAT;RIPK2;CTSH;BAD;MMP14;PLAU;PRSS12
prerank,keratan sulfate catabolic process (GO:0042340),0.7794123117813266,1.6077463503028844,0.012640449438202247,0.1041589887664839,1.0,4/11,2.90%,HEXB;LUM;FMOD;HEXA
prerank,nuclear migration (GO:0007097),-0.6135592976202129,-1.6075807327890812,0.029850746268656716,0.43648762040600686,1.0,7/13,11.67%,SYNE2;SYNE3;PAFAH1B1;DOCK7;PCM1;FBXW11;CLMN
prerank,regulation of ATP biosynthetic process (GO:2001169),0.7031448023324633,1.604582686257653,0.01045751633986928,0.10804548604028408,1.0,8/16,9.88%,TMSB4X;TREM2;PINK1;ENO1;PARP1;VCP;AK4;DNAJC30
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5648771525416321,-1.6043345076246074,0.02100840336134454,0.43585340319718413,1.0,4/15,3.28%,EDA;ANKRD11;GLI2;LRP6
prerank,regulation of mRNA catabolic process (GO:0061013),0.5549113360492747,1.6037456759946505,0.0,0.10874082752706642,1.0,37/121,13.46%,RPS27A;HSPA8;UBC;VIM;UBB;PSMB4;HSPB1;PSME1;AKT1;PSMB6;PSMB8;PSME2;PSMD2;ZFP36L1;YWHAB;PSMD1;ZFP36L2;PSMC3;PRR5L;PCBP4;PSMD6;PSMA7;UBA52;PSMD5;XPO1;SET;EXOSC2;ZFP36;PSMB9;PSMD13;APEX1;PSMB3;PABPC1;PSMB11;HSPA1A;PSMB10;YWHAZ
prerank,histone H3-K36 demethylation (GO:0070544),-0.6321977353358044,-1.603732358891822,0.033783783783783786,0.42808760789903183,1.0,4/10,12.93%,KDM2A;KDM7A;KDM4C;PHF8
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.7291642439568163,1.6020941582141994,0.015810276679841896,0.11052970232941274,1.0,2/14,1.12%,RPS3;CD81
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5709502993797342,1.6019990206803536,0.0010482180293501049,0.11020102289133146,1.0,22/79,15.34%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CLTC;CAPZA2;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7231886584197755,1.6016859673002624,0.017310252996005325,0.11019431620555971,1.0,6/17,10.08%,LAPTM5;PRNP;LGALS3;DUSP3;THY1;PHPT1
prerank,digestive tract development (GO:0048565),-0.4552843408969862,-1.601630378111864,0.018518518518518517,0.42455573109849776,1.0,13/32,16.62%,RARB;SMO;GLI3;COBL;NIPBL;GLI2;CLMP;PCSK5;FGFR2;PKD1;KIT;CCDC39;PKDCC
prerank,embryonic appendage morphogenesis (GO:0035113),-0.6280412427373662,-1.601294436868492,0.046511627906976744,0.4166129393395987,1.0,3/12,3.28%,FBXW4;SKI;LRP6
prerank,negative regulation of RNA splicing (GO:0033119),0.6968658387450849,1.5994049527717265,0.008706467661691543,0.11300251428196711,1.0,5/19,7.09%,RPS13;RPS26;TMBIM6;PCBP4;SRSF9
prerank,defense response to fungus (GO:0050832),0.7061848711188683,1.5984843875516375,0.011627906976744186,0.11377719550997653,1.0,8/17,19.19%,GAPDH;S100A8;S100A9;RARRES2;CLEC6A;CLEC4D;CX3CR1;RNASE7
prerank,regulation of lipid catabolic process (GO:0050994),0.6910004639556935,1.598009835785908,0.015209125475285171,0.11394373996949127,1.0,5/19,5.74%,APOC1;TNF;BSCL2;PDE3B;RARRES2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.6909858595743001,1.5977050875099705,0.020887728459530026,0.11386029053935279,1.0,6/18,12.29%,RPS27A;UBC;UBB;UBA52;SYVN1;MAN1B1
prerank,ATP transport (GO:0015867),0.7834953871242114,1.596584122203996,0.017316017316017316,0.1149260286467748,1.0,2/10,4.43%,SLC25A5;SLC25A4
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5738179067026415,-1.5958126006999858,0.03404255319148936,0.4213895205610987,1.0,6/17,11.86%,PBX1;CREBBP;MAML2;KAT2B;MAML1;RBPJ
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.6594254407437183,1.5956431245247529,0.009828009828009828,0.11577273507361867,1.0,7/24,7.14%,B2M;CALR;CANX;FCER1G;TAPBP;TAP2;PDIA3
prerank,triglyceride catabolic process (GO:0019433),0.6831631880309645,1.5955765006311273,0.013994910941475827,0.11542516165926031,1.0,7/19,23.84%,PNPLA2;FABP5;LIPG;LPL;FABP7;FABP4;FABP3
prerank,cellular response to heat (GO:0034605),0.6209290146630541,1.5953270946389433,0.007017543859649123,0.1153008983710072,1.0,11/35,13.35%,HSP90AA1;HSP90AB1;HSBP1;HMOX1;POLR2D;HSPA1B;YWHAE;VCP;MAPT;PDCD6;HSPA1A
prerank,regulation of blood coagulation (GO:0030193),0.6540123482087633,1.5948533724085387,0.006060606060606061,0.11547302609170851,1.0,5/27,3.06%,APOE;VTN;THBD;SERPINE2;CD34
prerank,high-density lipoprotein particle assembly (GO:0034380),0.7947331513609563,1.5945841976055988,0.014450867052023121,0.11535753539848524,1.0,1/10,0.01%,APOE
prerank,negative regulation of neuron death (GO:1901215),0.5607221239705562,1.5940998423384867,0.001034126163391934,0.11555178010147553,1.0,17/93,4.90%,APOE;MDK;GRN;GPNMB;MT3;PARK7;SOD1;ATF4;AKT1;LGMN;FOXQ1;CD34;PINK1;FZD9;NTRK2;NENF;SORL1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6379460582377753,-1.5934384003106832,0.043333333333333335,0.41868211614698597,1.0,4/10,5.14%,ROCK2;ROCK1;IL18;IL15
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5914055621418385,1.593283587891674,0.005611672278338945,0.11617815211329319,1.0,15/53,17.29%,MTNR1A;MTNR1B;NPY1R;AGT;SSTR4;VIPR1;HTR2C;MC1R;CHRM3;CHRM2;CCL2;MC5R;HTR7;PTGIR;CHRM5
prerank,transition metal ion transport (GO:0000041),0.6106853433685185,1.5928398854207628,0.004624277456647399,0.11637928212172499,1.0,12/35,15.19%,FTH1;ATOX1;MT3;SLC30A1;COX17;TFRC;HEPH;TTYH1;TRPC7;SLC11A1;TRPC1;SLC31A1
prerank,cellular response to hypoxia (GO:0071456),0.5528648607197975,1.5914573590640302,0.0,0.11793981463622419,1.0,55/126,22.48%,RPS27A;UBC;UBB;PSMB4;ELOB;MT3;HMOX1;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PINK1;ZFP36L1;KCND2;PSMD1;EPAS1;PSMC3;PSMD6;PSMA7;HIPK2;PGK1;UBA52;P4HB;NDRG1;BNIP3L;FMN2;AQP1;PSMD5;RBX1;AK4;PSMB9;PSMD13;ACAA2;PSMB3;PMAIP1;PSMB11;PSMB10;EGLN2;BAD;PSMB1;PSMB5;VHL;TWIST1;LMNA;SFRP1;NOP53;PSMA6;PSMA4;MYC;SIRT2;STUB1;HYOU1;ELOC;TBL2
prerank,positive regulation of chemokine production (GO:0032722),0.6150306993691643,1.5911292649991664,0.012600229095074456,0.1179842334303543,1.0,24/44,26.22%,CD74;MBP;HMOX1;TNF;TIRAP;LPL;EGR1;HMGB1;WNT5A;CSF1R;AIF1;F2RL1;TWIST1;ADCYAP1;ADAM17;OAS3;SYK;IL6;PYCARD;APP;IL33;AGER;TLR7;TLR2
prerank,regulation of platelet activation (GO:0010543),0.6922867107778795,1.5907458361879088,0.008928571428571428,0.11805157508665014,1.0,4/21,4.22%,APOE;THBD;PDGFB;FCER1G
prerank,positive regulation of cellular component organization (GO:0051130),0.5562548681708568,1.5900773299577275,0.0030959752321981426,0.11857822532366086,1.0,30/107,11.37%,APOE;RPS3;CLU;RACK1;GPX1;CD151;MMP3;PARK7;CCL19;NRXN1;TREM2;NRG1;TNF;RHOC;TMEM30A;LGALS3;LRP4;FLOT1;TIRAP;VCP;LMAN1;TFRC;SURF4;MTLN;CAMK1;PIH1D1;SMPD1;BAX;TMED9;WARS1
prerank,sulfur compound catabolic process (GO:0044273),0.613889983844249,1.5898161794005818,0.00576036866359447,0.1185310569984777,1.0,22/38,30.15%,BGN;HEXB;BCAN;LUM;FMOD;HEXA;MPST;DCN;ACAT1;VCAN;TXN2;TST;ACAN;PRELP;ADO;CSPG5;CHAC2;GLB1;GGT5;GGT7;IDS;GNS
prerank,heme biosynthetic process (GO:0006783),0.6739813367916265,1.5891340400944864,0.01486988847583643,0.11898264224823589,1.0,10/22,16.22%,TSPO;PGRMC1;NFE2L1;ATP5IF1;ABCB6;ALAD;PPOX;UROD;ABCB10;HMBS
prerank,actin filament bundle assembly (GO:0051017),-0.452720023969505,-1.5891139643220662,0.022727272727272728,0.4215103579230741,1.0,9/33,4.63%,CALD1;PAWR;DPYSL3;LIMA1;BAIAP2L1;SHROOM2;BAIAP2;MYO1B;EPS8
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.5696993975936067,1.5889248584900875,0.003125,0.11880060198001853,1.0,24/84,13.37%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;PSMC3;ECRG4;PSMD6;PSMA7;UBA52;PSMD5;PSMB9;PSMD13;BUB3;PSMB3;PSMB11;FBXO5;FBXO31;PSMB10
prerank,receptor signaling pathway via STAT (GO:0097696),-0.4809200995800786,-1.5888605326530139,0.02,0.4141275458679514,1.0,12/25,21.77%,GHR;STAT5B;IL31RA;PIAS1;STAT3;STAT2;PKD1;NMI;STAT5A;STAT6;PKD2;CTR9
prerank,response to nitric oxide (GO:0071731),0.7444719260597572,1.5883934727942035,0.021505376344086023,0.11916771212611027,1.0,5/13,8.63%,MT3;MMP3;CCL19;TXN;AQP1
prerank,lipid catabolic process (GO:0016042),0.7023393651133693,1.5880700523227935,0.01403061224489796,0.11921748618397493,1.0,5/18,8.95%,MT3;PLAAT3;LIPG;LPL;LIPE
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.5584890624293476,-1.5879610062334175,0.01293103448275862,0.40794784600898426,1.0,4/16,8.01%,PDS5A;NIPBL;PDS5B;POGZ
prerank,protein-containing complex disassembly (GO:0032984),0.5853498235881605,1.587904612009195,0.0066298342541436465,0.11903665710980006,1.0,10/54,5.76%,RPL23;HSPA8;GABARAP;PPP1CA;MAP1LC3B;MAP1LC3A;GABARAPL2;GABARAPL1;CTNNB1;VCP
prerank,positive regulation of chemotaxis (GO:0050921),0.6137101479700553,1.5864667533643442,0.007963594994311717,0.12077452444714203,1.0,21/43,21.90%,TMSB4X;MDK;HSPB1;LGMN;CCL19;TREM2;PDGFB;DSCAM;RARRES2;KDR;P2RY12;AIF1;F2RL1;EDN3;ADAM17;CCR2;STX4;TGFB1;IL6;PTN;PPM1F
prerank,positive regulation of leukocyte migration (GO:0002687),0.6606070786623681,1.5856755872745278,0.0035671819262782403,0.12151781177931999,1.0,12/27,21.57%,MDK;TNF;LGALS3;THY1;AIF1;JAM3;F2RL1;PLVAP;EDN3;ADAM17;IL6;PTN
prerank,negative regulation of translational initiation (GO:0045947),-0.5900949160756968,-1.5854176746739235,0.02857142857142857,0.40691383791595503,1.0,7/13,21.36%,EIF2AK4;LARP1;RBM4;PAIP2;AGO2;FMR1;TPR
prerank,positive regulation of translation (GO:0045727),0.5597983716516776,1.5843687786258667,0.003134796238244514,0.12303132193392603,1.0,17/94,6.59%,RPL26;RPS9;RPS4X;RPL5;EEF2;VIM;UQCC2;EIF3D;POLR2D;NPM1;RPS27L;EIF5A;EIF5AL1;COA3;PKM;UHMK1;EIF3C
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.693017673291428,1.5835687688640179,0.02295918367346939,0.12386060396699453,1.0,8/18,20.32%,GNA11;CDK5R1;RGS10;CHRM3;CHRM2;CHRM5;GRK2;AGRN
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6943394479367468,1.5824929214754482,0.015463917525773196,0.12489456993390215,1.0,10/18,18.16%,APOE;NSG1;PSENEN;ABCG1;KLK6;ACHE;BACE1;PSEN2;ADAM17;APH1B
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.625773274996364,1.5819504751474518,0.005753739930955121,0.12520152674245047,1.0,8/33,5.49%,APOD;HMOX1;IGFBP3;GPER1;IGFBP5;ANG;NDRG4;TNFAIP3
prerank,cholesterol transport (GO:0030301),0.5932708024761207,1.5800283600442293,0.007909604519774011,0.1278501447978642,1.0,12/45,18.07%,APOE;CLU;NPC2;APOC1;ABCG1;LIPG;TSPO2;STARD4;MSR1;CAV1;SOAT2;VPS4A
prerank,protein stabilization (GO:0050821),0.543586034636128,1.579480845323101,0.0,0.12824245443887478,1.0,52/168,16.69%,RPL23;RPL11;RPS7;RPL5;CLU;GAPDH;LAMP1;TYROBP;HSP90AA1;HSP90AB1;GRN;CALR;MT3;PPIB;PARK7;CRYAB;PINK1;CCT2;CHEK2;GLMP;PIN1;RTN4;FLOT1;HSPA1B;FLNA;DNLZ;BAG5;BAG1;PFN1;CCT7;ATP1B2;HSPD1;CCT8;TSPAN1;MFSD1;TAF9;MTMR9;CDC37;SYVN1;MSX1;SOX17;WFS1;NCLN;FBXW7;HSPA1A;WNT10B;PTGES3;GOLGA7;PEX6;ATP1B1;VHL;PFN2
prerank,regulation of cellular component biogenesis (GO:0044087),0.608074159372632,1.5793375383937163,0.006818181818181818,0.12797912014134827,1.0,9/39,6.25%,APOE;HSPA8;GFAP;HSP90AA1;CCL19;AGT;PINK1;BAG5;MSN
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.70108083613686,1.578622494901264,0.013020833333333334,0.12859686691058422,1.0,5/17,4.01%,CALM1;HSP90AB1;CALM3;PPP1R15B;PTPRC
prerank,response to ethanol (GO:0045471),0.7248361548773197,1.5779833443881028,0.015584415584415584,0.12905076212575495,1.0,7/14,11.99%,SOD1;GRIN1;GRIN3A;GRIN2A;SDF4;GLRA2;GLRA1
prerank,T cell activation involved in immune response (GO:0002286),0.7530933218408351,1.577873411790742,0.021136063408190225,0.12870442934573248,1.0,7/12,14.82%,CD74;MDK;FCER1G;LCP1;SLC11A1;LILRB1;F2RL1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.6091080699496388,1.5778005183129917,0.014722536806342015,0.12831755419274957,1.0,20/38,19.71%,PRNP;GRM5;AGT;PTPRC;PDGFB;HYAL2;PTK6;THY1;LILRA5;FCGR1A;CSF1R;DOK7;SRCIN1;GAS6;LRP8;CASS4;CAV1;ERBB3;UNC119;EFNA1
prerank,regulation of leukocyte activation (GO:0002694),0.712736836192668,1.5776920844496272,0.01694915254237288,0.12800869448722,1.0,4/14,9.18%,CD74;GPER1;MIF;GPR137B
prerank,epithelial cell differentiation (GO:0030855),0.5606663037722599,1.5773459676873265,0.0010438413361169101,0.12804443246362415,1.0,18/88,12.19%,CTSB;TAGLN;ALDOC;TAGLN2;ACADVL;AKT1;ERBB4;TOLLIP;LGALS3;PGK1;EDF1;BASP1;PROX1;KDR;PIH1D1;DNPH1;KDM6B;PCNA
prerank,selective autophagy (GO:0061912),0.5869144793490968,1.5761954140363126,0.004429678848283499,0.12938735401512366,1.0,11/56,7.85%,RPS27A;UBC;VIM;UBB;DYNLL2;PARK7;DYNLL1;MAP1LC3B;AUP1;UBA52;UFC1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7603839724577601,1.574922367723024,0.015006821282401092,0.1307735713320291,1.0,4/11,10.07%,GSN;PARK7;ST18;PIH1D1
prerank,cell-cell junction assembly (GO:0007043),0.5769274260988411,1.574724354313947,0.004371584699453552,0.13058019122438208,1.0,23/63,18.37%,ACTB;ACTG1;CLDN5;RAMP2;GJA4;GJB2;RHOC;CDH20;CTNNB1;CLDN11;CDH18;RHOA;CDH12;GJA1;JAM3;DCHS1;CDH19;CDH24;CDH7;EPB41L3;CDH10;CDH5;CTNND2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.733984074480366,1.573604802516847,0.023225806451612905,0.13174821668586478,1.0,3/14,5.39%,TYROBP;TNF;ATP6AP1
prerank,positive regulation of neuron death (GO:1901216),0.6021763473379311,1.5726719201040287,0.007803790412486065,0.1326241843200057,1.0,25/46,22.30%,CLU;C1QA;TYROBP;GRN;ATF4;PRNP;ITGB2;TNF;CTNNB1;MAPT;NUPR1;EGR1;CDK5R1;WNT5A;BAX;TLR6;CDK5;CCL3;BACE1;GRIN2B;SNCA;TFAP2B;DDIT4;DDIT3;REST
prerank,neuron maturation (GO:0042551),0.6901819540728003,1.5721521097608806,0.014267185473411154,0.13294259739413494,1.0,6/18,12.98%,MTCH1;C1QA;C3;ADGRB3;B4GALT6;CLN5
prerank,regulation of cholesterol esterification (GO:0010872),0.7859810650615406,1.5716498359240472,0.014450867052023121,0.1333108744706869,1.0,6/10,14.20%,APOE;APOC1;AGT;ABCG1;STARD4;ABCA2
prerank,autophagosome maturation (GO:0097352),0.6139704485852766,1.5710973243873354,0.014319809069212411,0.13369037707557227,1.0,9/32,12.44%,CALM1;GABARAP;MAP1LC3B;MAP1LC3A;GABARAPL2;GABARAPL1;VCP;VAMP8;VMP1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.7456805761706254,1.5703724348293218,0.030942334739803096,0.13441234781907546,1.0,5/11,5.60%,TIMM8B;TIMM13;NDUFA13;ROMO1;TIMM10B
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.6138600300970378,1.568309929854439,0.012850467289719626,0.137192869525278,1.0,8/36,8.91%,APOE;CALM1;S100A1;HSP90AA1;AKT1;TNF;CYGB;SPR
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.6807494828833573,1.5680175220127015,0.016352201257861635,0.1372873025416294,1.0,11/20,22.68%,GNA11;LY6H;CDK5R1;RGS10;CHRM3;CHRM2;LYPD1;CHRM5;GRK2;AGRN;CHRNA3
prerank,protein K63-linked ubiquitination (GO:0070534),-0.4270855542600223,-1.5678143258340287,0.015873015873015872,0.44600778471485036,1.0,13/41,10.79%,UBE2E2;HECTD1;RNF152;PRKN;TRAF3IP2;ARIH2;TRAF5;RNF135;TRIM5;RNF8;ZFP91;ITCH;RNF115
prerank,positive regulation of superoxide anion generation (GO:0032930),0.727132272206634,1.5658239301780268,0.02656042496679947,0.14038647356145748,1.0,7/13,19.62%,TYROBP;SOD1;ITGB2;MAPT;F2RL1;SYK;TGFB1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.6470782413781009,1.5654348268233227,0.010948905109489052,0.14041458630266956,1.0,10/25,16.42%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;TNF;KLF4;DDAH1;TLR6;DDAH2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.7644757281921463,1.56517716763711,0.0182328190743338,0.14040519762353137,1.0,4/11,3.16%,RACK1;PARK7;ATF4;PINK1
prerank,cellular response to peptide (GO:1901653),0.5737732599792996,1.5650425762554063,0.006472491909385114,0.14012213232455892,1.0,20/56,16.92%,RPL23;VIM;LGMN;PRNP;TREM2;GRM5;GPER1;ZFP36L1;CACNA1A;GRIN1;ATP1A3;GRIN2A;CHMP5;DDX11;GJA1;RIPK2;TLR6;CDK5;CAV1;VCAM1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.6524613831161497,1.5644860848194937,0.02278481012658228,0.14047081078648826,1.0,8/24,14.38%,RPS27A;UBC;UBB;TNFAIP3;UBA52;AAMP;RIPK2;UBE2V1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.6055841466341043,1.5640543380523626,0.011273957158962795,0.1407063235074587,1.0,15/42,21.99%,RPL30;RPS19;MPEG1;TREM2;ROMO1;RARRES2;AQP1;ADGRB1;CHGA;SLC11A1;NOS2;RNASE7;IL6;PYCARD;LBP
prerank,pulmonary valve morphogenesis (GO:0003184),-0.5298550323400912,-1.563924600122355,0.04504504504504504,0.4490519286575352,1.0,8/17,14.58%,NOTCH2;SMAD6;ROBO1;SLIT2;NFATC1;BMP4;JAG1;HEY2
prerank,regulation of superoxide anion generation (GO:0032928),0.7139542085345205,1.5636701176303993,0.01971090670170828,0.14088000972901196,1.0,7/14,19.62%,TYROBP;SOD1;ITGB2;MAPT;F2RL1;SYK;TGFB1
prerank,negative regulation of axonogenesis (GO:0050771),0.6420580218452028,1.562504556255918,0.009489916963226572,0.1422724085569828,1.0,10/27,16.08%,ARHGDIA;MT3;DCC;RTN4;LRP4;THY1;MAP2;GDI1;RHOA;FGF13
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4379747334771713,-1.5619029517959746,0.02,0.44679145400640935,1.0,13/39,14.41%,TSPAN5;CREBBP;ZMIZ1;MAML2;ROBO1;YAP1;KAT2B;STAT3;MAML1;AAK1;RBPJ;JAG1;PRKCI
prerank,transition metal ion homeostasis (GO:0055076),0.6382688944270523,1.561723399682655,0.010935601458080195,0.1429710078811579,1.0,9/28,13.12%,FTL;B2M;MT3;HMOX1;TMPRSS6;HEPH;ATP13A2;SLC40A1;SLC11A1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5925336754915496,1.561208814964752,0.011299435028248588,0.14341325383232614,1.0,11/48,9.90%,TMSB4X;ATP5F1B;HSPB1;HMOX1;AKT1;ATP5F1A;PDGFB;KDR;JCAD;GATA2;HMGB1
prerank,embryonic eye morphogenesis (GO:0048048),-0.6031522492457273,-1.5594359132271554,0.06666666666666667,0.4464164398485908,1.0,4/11,5.68%,FBN1;LRP6;RARG;EFEMP1
prerank,mitochondrial gene expression (GO:0140053),0.6006225699390666,1.5586344121833042,0.008018327605956471,0.14726702503168446,1.0,16/42,19.56%,MRPL23;MRPS12;LARS2;MRPS34;MRPS14;MRPS11;MRPL51;MRPL57;NDUFA7;MRPL2;MRPS24;MRPS2;MRPL12;MRPS6;MRPS16;MRPS21
prerank,anterograde axonal transport (GO:0008089),0.6016306061143761,1.5575992551845992,0.016055045871559634,0.14862875662558847,1.0,12/37,12.92%,HSPB1;SOD1;BLOC1S4;MAP1A;DLG2;NEFL;AP3B2;KIF5A;BLOC1S1;BLOC1S3;HAP1;BLOC1S5
prerank,protein catabolic process (GO:0030163),0.572155081537487,1.556912706747358,0.004366812227074236,0.1492833341678319,1.0,15/59,12.98%,APOE;CTSD;HSPA8;HSP90AA1;USE1;NR1D1;CHEK2;UBE2G2;VCP;PRPF19;FBXO27;DDB1;PMAIP1;CLN6;CLN5
prerank,protein autoubiquitination (GO:0051865),-0.3793638151704136,-1.5557797365402586,0.01639344262295082,0.4485456289987998,1.0,19/61,15.53%,RNF220;CNOT4;PRKN;RNF146;SH3RF1;SH3RF3;RNF213;UHRF2;RNF8;DDB2;RNF41;SH3RF2;NFX1;ITCH;RNF115;ERCC8;WWP2;RNF185;MDM2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.5522746194362205,1.5553664900755673,0.003131524008350731,0.15140635364665214,1.0,36/94,20.69%,RPS27A;UBC;UBB;PSMB4;MAPK3;PSME1;PSMB6;PSMB8;PSME2;PSMD2;TOLLIP;PSMD1;PSMC3;ST18;PSMD6;PSMA7;UBA52;PSMD5;RBX1;EGR1;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;RIPK2;UBE2V1;PSMB1;PSMB5;SQSTM1;PSMA6;TAB1;SKP1;PSMA4;IL1RAP;NFKBIA
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.4750147623200598,-1.5552089611625237,0.012269938650306749,0.44258922734606,1.0,15/29,19.01%,SMAD3;DICER1;DROSHA;ZC3H7A;SMAD1;TUT7;ZC3H7B;SMAD2;SRRT;PUM2;TUT4;TARBP2;AGO2;ADAR;AGO4
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.5588514980404938,1.5550795136361824,0.012738853503184714,0.15140602488062893,1.0,24/69,21.10%,APOE;MDK;GRN;MT3;PARK7;SOD1;LGMN;FOXQ1;PINK1;FZD9;NTRK2;SET;WFS1;CCL2;PTPRZ1;NONO;CX3CR1;TYRO3;PPARGC1A;AGAP2;ERBB3;POU4F1;MEF2C;CRLF1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.7327174200078217,1.5547535713056533,0.02710027100271003,0.15150950305180874,1.0,3/12,1.63%,CTSB;CTSL;CTSS
prerank,positive regulation of phosphatase activity (GO:0010922),0.6712042822238891,1.554157398008519,0.017743979721166033,0.1519549983861508,1.0,10/21,20.51%,CALM1;HSP90AB1;CALM3;PPP1R15B;MTMR9;BMP2;CD300A;PPP1R15A;CALM2;MEF2C
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5423598861823281,-1.5540974355574733,0.04035874439461883,0.4382665269354693,1.0,5/17,9.95%,PRKAG2;PPARA;NCOR1;PRKAA2;PPARG
prerank,dendrite self-avoidance (GO:0070593),0.6929121831007167,1.5531715558028643,0.02621231979030144,0.15311289397009276,1.0,8/16,15.73%,BSG;DSCAM;CNTN4;ROBO4;EMB;TNN;IGSF9;DSCAML1
prerank,ganglioside metabolic process (GO:0001573),0.6727464193133255,1.552003931160693,0.017654476670870115,0.15466136893652555,1.0,9/20,16.27%,GM2A;HEXB;HEXA;B4GALNT1;CLN6;ST8SIA4;ABCA2;NEU1;ST6GALNAC3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.6624471460968773,1.5515705563276163,0.020151133501259445,0.15487437817397826,1.0,13/22,20.10%,PSMB4;PSMB6;PSMB8;PSMA7;PSMB9;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;ENC1;PSMA6;PSMA4
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.5509177858554412,1.5512410094310352,0.0020876826722338203,0.15493922098883514,1.0,26/88,17.78%,APOE;CST3;MRPL13;RPS3;RACK1;GAPDH;RPL13A;CALR;AKT1;SERPINE2;IGFBP5;NCL;CSTB;NELL1;YBX1;PLAT;PCIF1;ATRAID;CAMK2N1;CDK5;ENC1;EIF4A3;DAB2IP;EIF4ENIF1;CLN8;NANOS2
prerank,peptide cross-linking (GO:0018149),0.6441573888923499,1.5494941662811494,0.013414634146341463,0.15726467809955316,1.0,6/25,13.98%,F13A1;TGM2;FN1;COL3A1;EPB42;EVPL
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7188398291628034,1.5489363307300783,0.026595744680851064,0.15781258781079843,1.0,5/13,5.76%,TMSB4X;TREM2;PINK1;ENO1;VCP
prerank,muscle filament sliding (GO:0030049),0.6073666156717134,1.5487440124184102,0.011682242990654205,0.15709644341305992,1.0,8/38,15.36%,MYL6;VIM;TPM2;MYL1;MYL6B;TNNI1;DES;TMOD1
prerank,actin-myosin filament sliding (GO:0033275),0.6073666156717134,1.5487440124184102,0.011682242990654205,0.15709644341305992,1.0,8/38,15.36%,MYL6;VIM;TPM2;MYL1;MYL6B;TNNI1;DES;TMOD1
prerank,positive regulation of response to wounding (GO:1903036),0.6438267080385439,1.5487378780752978,0.027127003699136867,0.1566068741888419,1.0,4/24,1.33%,ACTG1;VTN;MDK;GRN
prerank,proton transmembrane transport (GO:1902600),0.6078002725600427,1.5482512228650747,0.012865497076023392,0.15695897973314293,1.0,11/36,13.28%,ATP5MF;ATP6V0C;ATP5F1B;ATP6V1F;UCP2;ATP6V0E2;ATP1A3;HVCN1;ATP1A4;ATP1A1;SLC25A27
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.6472233106673011,1.5474208830272844,0.012391573729863693,0.1578234116439316,1.0,10/24,16.22%,TSPO;PGRMC1;NFE2L1;ATP5IF1;ABCB6;ALAD;PPOX;UROD;ABCB10;HMBS
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.6878694699559114,1.5472054034552016,0.02346805736636245,0.15766885450386248,1.0,5/17,8.39%,APOE;SOD1;RAN;ABCG1;SEC14L2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.6318411020752105,1.5468404119125614,0.021013597033374538,0.15781277009336217,1.0,9/28,14.38%,RPS27A;UBC;UBB;TNFAIP3;UBA52;OTULIN;AAMP;RIPK2;UBE2V1
prerank,regulation of aerobic respiration (GO:1903715),0.7052801433332523,1.54677005703578,0.01790633608815427,0.15742756117529833,1.0,6/15,9.48%,UQCC2;PINK1;COX7A2L;COX7A2;VCP;AK4
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.635635631495126,1.5462035469257356,0.03026634382566586,0.15798393226335614,1.0,5/27,6.98%,RPS27A;UBC;UBB;MAPK3;UBA52
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.4510611350928928,-1.5460932045958382,0.012987012987012988,0.4526464025729529,1.0,9/31,10.75%,RANBP3L;SMAD6;CRIM1;SUFU;LRP5;SKI;CDK6;PPARG;TRPM4
prerank,positive regulation of dephosphorylation (GO:0035306),0.6368395115269526,1.545471948789875,0.022673031026252982,0.15870866755088944,1.0,14/27,20.98%,PPIA;CALM1;CALM3;PIN1;DLC1;SMPD1;MTMR9;BMP2;CDH5;CALM2;NSMF;TGFB1;PPP2R5A;CAMTA1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.6515617709801845,1.545460702735296,0.01591187270501836,0.1582202481014748,1.0,12/24,25.21%,RPS27A;UBC;UBB;RPA2;UBA52;PCNA;RFC2;POLD4;RFC4;LIG1;POLD1;RPA3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.48379697652069414,-1.5452787078006616,0.015789473684210527,0.44739691278851756,1.0,8/23,11.60%,ZBTB20;ARNT;NFKB1;INSR;PRKAA2;IGF1;ENTPD5;PSEN1
prerank,response to thyroid hormone (GO:0097066),0.7211719813342103,1.5442821858192604,0.033647375504710635,0.15971135247880397,1.0,3/13,1.63%,CTSB;CTSL;CTSS
prerank,mitochondrion localization (GO:0051646),-0.5116539335698663,-1.5436155675208116,0.03827751196172249,0.4450712424356922,1.0,6/19,8.10%,LRRK2;TRAK1;MFN1;MARK1;BRAT1;MEF2A
prerank,macrophage migration (GO:1905517),0.7204240380496079,1.5409833067337935,0.021798365122615803,0.16513058018445642,1.0,6/13,19.23%,LGALS3;P2RY12;CCL2;CCL3;CCR2;CXCL17
prerank,negative regulation of growth (GO:0045926),0.5351708025685679,1.5407295172181859,0.0020325203252032522,0.16508132377865659,1.0,44/121,20.34%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;RACK1;MT3;NDUFA13;MT2A;CCDC85B;ADAM15;ACVRL1;ENO1;RTN4;HSPA1B;PPP2R1A;HYAL2;BTG1;WFDC1;JADE1;APBB1;MSX1;SOX17;DNAJB2;BST2;HSPA1A;GJA1;STK11;DACT3;ING1;NDUFS3;SLIT3;CCAR2;SFRP1;SCGB3A1;INHBA;TGFB1;SPHK2;ING5;NOTCH1;OSGIN1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6303579746003095,1.54035918816368,0.010856453558504222,0.1652680571033785,1.0,6/26,3.62%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;TNF
prerank,glycine transport (GO:0015816),0.7536205897510719,1.539705167203651,0.031609195402298854,0.16587834953337394,1.0,3/10,9.30%,SLC38A5;SLC6A17;SLC6A5
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.630915570662559,1.5395541857710806,0.0171990171990172,0.1655930120414522,1.0,19/25,31.25%,TMEM50A;CHMP2B;VCP;LEPROT;CHMP5;CHMP6;SORT1;UBXN6;CHMP1B;CHMP7;LYST;CHMP1A;LAPTM4B;CHMP4C;LEPROTL1;MVB12A;CHMP4A;CHMP4B;TMEM50B
prerank,cellular response to purine-containing compound (GO:0071415),0.7432814303886063,1.538593477275882,0.029085872576177285,0.1668930488579178,1.0,6/10,16.06%,P2RY6;P2RY1;GSTM2;TRPM2;SLC8A1;RYR2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.48252562986783215,-1.5383667372393122,0.02976190476190476,0.451530069695204,1.0,8/27,7.82%,PHLDB2;ARHGAP28;ARHGAP6;CGNL1;PRKN;ARHGEF18;PPFIA1;MET
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.7102461741811665,1.5366562133360098,0.027851458885941646,0.16979963839302986,1.0,5/14,8.98%,GRN;TREM2;NR1D1;PTPRC;SYT11
prerank,dopamine metabolic process (GO:0042417),-0.5140657538519469,-1.5355309480110386,0.043859649122807015,0.4521819065081808,1.0,4/18,6.86%,SNCAIP;MOXD1;PRKN;ATP7A
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.7438777405322295,1.5349541378091986,0.02699055330634278,0.17229864074286086,1.0,4/12,10.38%,RPL26;CD74;MIF;TAF9
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.6469410490586037,1.5346385034809238,0.02987012987012987,0.17233529887241358,1.0,7/22,9.84%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6995372326890552,1.5343826235590823,0.03208556149732621,0.17223570733655982,1.0,2/16,7.13%,CLDN5;CLDN11
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.6277088046937249,1.5340734291177158,0.019925280199252802,0.17229591872240466,1.0,8/26,14.38%,RPS27A;UBC;UBB;TNFAIP3;UBA52;AAMP;RIPK2;UBE2V1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.7095667205677247,1.5340728877626113,0.024691358024691357,0.17177674904603862,1.0,4/13,3.75%,RACK1;PARK7;TXN;GPR37L1
prerank,regulation of receptor binding (GO:1900120),0.7428929850516819,1.5332722878783138,0.024495677233429394,0.17276981496781096,1.0,2/10,3.50%,B2M;ADAM15
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.562112293740095,-1.5325340484617673,0.05693950177935943,0.4527122390172243,1.0,9/13,29.54%,RANBP2;CBLB;KPNA4;KPNA2;NUP35;KPNA6;KPNA3;NUP54;IPO5
prerank,neuron remodeling (GO:0016322),0.748577005702138,1.532516809613605,0.034139402560455195,0.1737335268654374,1.0,3/10,4.27%,C1QA;C3;ADGRB3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.45939601408184777,-1.5314797079051843,0.005847953216374269,0.44861862411709313,1.0,10/27,14.78%,PID1;TNS2;IRS1;GRB10;KANK1;NCK1;ENPP1;PTPN2;PIP4K2C;PRKCB
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.6037617794952643,1.5314544569025967,0.017584994138335287,0.17519243325532297,1.0,13/34,19.80%,LAPTM5;RBP4;SLC7A5;PTPRC;IL2;VAMP3;WNT5A;F2RL1;STX4;DNAJB9;CD86;SPHK2;IL6
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5853697846807764,1.53106643178103,0.020713463751438434,0.17538808923168486,1.0,22/41,22.63%,PRNP;GRM5;AGT;PDGFB;NTRK2;DOCK3;LILRA5;FCGR1A;CSF1R;DOK7;FBXW7;SRCIN1;GAS6;LRP8;NCF1;CASS4;ADAM17;ERBB3;UNC119;EFNA1;PTPN1;TGFA
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5656006765005199,1.5308525699714077,0.011086474501108648,0.17522355990466523,1.0,20/54,16.92%,RPS3;RPL11;RPL5;PARK7;UBXN1;AKT1;COPS9;HSPA1B;CTNNB1;TNFAIP3;BAG5;ISG15;ADGRB1;DNAJA1;VPS28;HSPA1A;IVNS1ABP;ARRB2;SQSTM1;CAV1
prerank,regulation of B cell activation (GO:0050864),0.6307747865520025,1.5305183174732007,0.027127003699136867,0.17541795862328288,1.0,9/25,21.68%,LAPTM5;ZFP36L1;ZFP36L2;TNFAIP3;CD22;IKZF3;SH3KBP1;IL6;BANK1
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6889886828577625,1.5303292406378117,0.019815059445178335,0.17516221734543477,1.0,6/16,17.79%,APOE;AGT;DDAH1;MAFA;DDAH2;NOS2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.6368228587520558,1.5300351223439077,0.022031823745410038,0.175192079940946,1.0,16/26,26.22%,CYBA;RTN4;FLOT1;TIRAP;SLC15A4;TICAM2;HMGB1;NINJ1;F2RL1;TLR5;TLR1;CAV1;RSAD2;LBP;MFHAS1;TLR2
prerank,negative regulation of proteolysis (GO:0045861),0.5957760941673799,1.5296299304868697,0.016241299303944315,0.17539343458986661,1.0,13/34,12.61%,CST3;TIMP2;AKT1;SERPINE2;PRNP;TMEM59;ECM1;CSTB;TIMP1;GAS1;PLAT;CAMK2N1;TIMP3
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.626610822760184,1.5291855764513533,0.013349514563106795,0.17572768273942846,1.0,11/26,18.67%,CALM1;CALM3;FKBP1A;YWHAE;GSTO1;PLN;GSTM2;CBARP;FKBP1B;SRI;CALM2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6278568671986149,1.5290179501756493,0.018115942028985508,0.1755280758484012,1.0,11/24,18.67%,CALM1;CALM3;AKAP6;FKBP1A;GSTO1;GSTM2;JPH4;FKBP1B;SRI;SELENON;CALM2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.6402970877786955,1.5287302525451503,0.017412935323383085,0.17564160059819134,1.0,11/24,16.94%,CLU;RACK1;PARK7;UBXN1;TMBIM6;CREB3;SYVN1;WFS1;HSPA1A;NR1H2;HERPUD1
prerank,negative regulation of bone remodeling (GO:0046851),0.7296370581739056,1.5283290787297288,0.0297029702970297,0.17586757424408925,1.0,6/11,19.80%,TNFAIP3;P2RX7;GPR137B;TMEM119;SFRP1;IL6
prerank,negative regulation of actin filament polymerization (GO:0030837),0.643938374266727,1.5271441893660023,0.03194103194103194,0.1774568967422234,1.0,5/22,6.43%,TMSB4X;TMSB10;GSN;MYADM;PFN1
prerank,receptor-mediated endocytosis (GO:0006898),0.52100373202697,1.526916030576088,0.0,0.17737548118740104,1.0,44/132,19.29%,APOE;SPARC;CTSL;CD81;RAMP2;HSP90AA1;CALR;MRC1;ITGB2;LRP1B;CANX;HSP90B1;FCER1G;SORL1;CAV2;SNAP91;DNM3;AP2M1;TFRC;HP;HPR;CD163;CXCL16;CLTC;AP2S1;FCGR1A;STAB1;LRP3;FCHO1;FNBP1L;RAMP3;MSR1;LILRB1;CLTA;M6PR;ARRB2;DLL1;CAV1;TMEM108;HSPG2;SYK;RAB31;SNCA;GRK2
prerank,myelin maintenance (GO:0043217),0.7534006774399671,1.5268503270617142,0.024745269286754003,0.1769805719120264,1.0,7/10,16.89%,CLU;SOD1;MYRF;CXCR4;EPB41L3;DEGS1;PRX
prerank,neurotransmitter secretion (GO:0007269),0.5810665325180508,1.5262284512391253,0.011235955056179775,0.17752432219945105,1.0,22/44,23.64%,HSPA8;NRXN1;SNAP25;DNAJC5;SYT1;RIMS2;RIMS1;SYN2;VAMP2;PTPRN2;SYN1;NRXN2;SYT10;LIN7C;PPFIA3;NAAA;CDK5;GRM4;SNCA;GAD1;SLC32A1;UNC13A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.6739066178175238,1.5260667007557682,0.032175032175032175,0.17733750334401352,1.0,5/18,10.31%,LAPTM5;GPNMB;AKT1;DUSP3;FGL1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6162451758721029,1.5252092799650978,0.0186799501867995,0.17849408753914994,1.0,11/28,14.89%,RPS3;RAC1;HSPA1B;NAV3;PAK1;CLASP1;MAPT;CDK5R1;DCTN1;HSPA1A;ARL2
prerank,regulation of fibroblast proliferation (GO:0048145),0.5827472800013878,1.523877617348687,0.007891770011273957,0.18049205470921073,1.0,17/45,18.46%,FTH1;CD74;S100A6;AGT;PDGFB;MIF;CTNNB1;FN1;AQP1;WNT5A;GAS6;PDGFA;DAB2IP;TRIM32;CD300A;DDR2;SFRP1
prerank,natural killer cell mediated immunity (GO:0002228),0.6966110171208348,1.5237192352376738,0.03225806451612903,0.18030114083832638,1.0,2/15,1.47%,TUBB;TUBB4B
prerank,axon development (GO:0061564),0.5501632395927513,1.5236133796816336,0.007407407407407408,0.17996527178305635,1.0,25/78,16.57%,ACTB;S100A6;PLP1;DCC;S100B;ANK3;CTNNA2;MAP1A;CNTN4;RTN4;NEFH;NRCAM;GRM7;MAPT;CDK5R1;PAK3;ADGRB1;APBB1;SHTN1;CCK;SPTBN4;CDK5;DSCAML1;GAP43;BRSK2
prerank,negative regulation of neuron projection development (GO:0010977),0.5609509256699732,1.5224334959688466,0.014238773274917854,0.18176624088190646,1.0,12/56,8.18%,APOE;ARHGDIA;ITM2C;MT3;DCC;NLGN1;RTN4;LRP4;SPOCK1;BAG5;CRMP1;THY1
prerank,positive regulation of DNA replication (GO:0045740),-0.5202941141811511,-1.5216434708885622,0.03375527426160337,0.4668560302335023,1.0,7/16,13.21%,EGFR;GLI2;KAT7;BRPF3;BCAR3;ATAD5;STN1
prerank,negative regulation of axon extension (GO:0030517),0.6076048466237941,1.521264663159474,0.023474178403755867,0.1835488153062861,1.0,9/30,13.77%,MT3;SEMA3F;RTN4;SEMA7A;SEMA4C;SEMA6D;MAP2;SEMA4A;SEMA4G
prerank,long-term memory (GO:0007616),0.6582294316177745,1.5212474427695892,0.031047865459249677,0.18305090168190585,1.0,4/19,7.91%,APOE;PRNP;CALB1;SGK1
prerank,regulation of mRNA stability (GO:0043488),0.522831044231213,1.520391370594798,0.00101010101010101,0.18411692949329367,1.0,53/145,18.86%,RPS27A;HSPA8;UBC;VIM;UBB;PSMB4;HSPB1;PSME1;AKT1;PSMB6;PSMB8;PSME2;PSMD2;NPM1;ZFP36L1;YWHAB;PSMD1;MEX3D;ZFP36L2;PSMC3;PCBP4;PSMD6;PSMA7;UBA52;YBX1;PSMD5;XPO1;SET;EXOSC2;ZFP36;PSMB9;PSMD13;APEX1;PSMB3;PABPC1;PSMB11;SLC11A1;HSPA1A;PSMB10;YWHAZ;HNRNPU;PDE12;PSMB1;CIRBP;YTHDF1;PSMB5;PCID2;EIF4ENIF1;ANP32A;TBRG4;EXOSC9;CARHSP1;PSMA6
prerank,innate immune response (GO:0045087),0.5145574558299201,1.519979454808036,0.0,0.18448689809428184,1.0,58/217,19.19%,IFITM3;RPL39;CD74;IFITM2;B2M;IFITM1;MBL2;TYROBP;C3;PGLYRP1;S100B;TREM2;CYBA;SHFL;ADAM15;SERINC3;FCER1G;ANG;RARRES2;CYBB;MFAP4;RNF187;PPP1R14B;ISG15;CXCL16;CORO1A;TRIM28;CLEC6A;PTK6;OTULIN;CXCL10;CAPZA2;IFIT1;HMGB1;TRIM59;HCK;SMPD1;CHGA;LCN2;IRF7;MSRB1;SLC11A1;BST2;RIPK2;CLEC4D;CX3CR1;SERINC5;NCF1;ATAD3A;TRIM32;PIK3CD;NOS2;SRMS;SYK;SLA;TRIM13;SNCA;RNASE7
prerank,acylglycerol catabolic process (GO:0046464),0.6033913404280231,1.5191703705534172,0.027744270205066344,0.18539665766488111,1.0,12/30,25.18%,PNPLA2;LYPLA2;FABP5;LIPG;LPL;LIPE;FAAH;FABP7;FABP4;ABHD16A;FABP3;ABHD12
prerank,intraciliary retrograde transport (GO:0035721),-0.5706797332707156,-1.5178204647443825,0.03676470588235294,0.47076790737166063,1.0,7/12,17.55%,DYNC2H1;WDR35;IFT140;IFT122;WDR19;DYNC2I2;DYNC2LI1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6920348356287365,1.5165753058030085,0.032679738562091505,0.1898163157994867,1.0,6/16,13.57%,IGFBP6;IGFBP3;IGFBP4;IGFBP5;IGFBP2;BMP2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5512272349964173,1.5153196396398703,0.0075675675675675675,0.19168691968403317,1.0,18/71,9.84%,RPS27A;CTSB;UBC;UBB;CTSL;CTSZ;CTSS;LGMN;NR1D1;TNFAIP3;VCP;OMA1;UBA52;ISG15;PRPF19;NEDD8;OTUD7A;DDB1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.5995304317103903,1.5144625419769737,0.016374269005847954,0.1927545616942164,1.0,13/30,18.91%,RPL11;HSP90AB1;PARK7;UBXN1;MAP1A;BAG5;TAF9;SVIP;SDCBP;SGTA;CCAR2;NOP53;DDRGK1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.574828729579102,1.5108058716517085,0.021939953810623556,0.19967872789575447,1.0,13/41,17.14%,GPX4;SCD5;GPX1;SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4;GSTM2;SCD;FADS3;DEGS1;FAAH
prerank,negative regulation of inclusion body assembly (GO:0090084),0.7414412408298915,1.5103247714734904,0.039473684210526314,0.20007719850808814,1.0,8/10,20.99%,SORL1;HSPA1B;DNAJB2;HSPA1A;DNAJB1;SACS;DNAJA4;HSPA2
prerank,limb development (GO:0060173),-0.449421058870762,-1.5094004302105621,0.016666666666666666,0.4870080037491784,1.0,8/28,12.88%,SMOC1;GLI3;KREMEN1;KAT2B;PCSK5;IQCE;INTU;IFT122
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.7561188043380133,1.5088684518126814,0.02545968882602546,0.2024559648535425,1.0,3/10,2.56%,CALM1;PDE4B;CALM3
prerank,regulation of interleukin-8 production (GO:0032677),0.5458116209619517,1.508710398950036,0.012903225806451613,0.20220422661959847,1.0,23/69,21.99%,TMSB4X;CD74;PARK7;TNF;LAMTOR5;PTPRC;HSPA1B;TIRAP;HYAL2;HMGB1;KLF4;HSPA1A;TLR6;F2RL1;TLR5;TLR1;NOS2;SYK;CD14;IL6;PYCARD;DDIT3;LBP
prerank,positive regulation of inflammatory response (GO:0050729),0.5401852645191001,1.5081037660052972,0.007368421052631579,0.20296089050226948,1.0,37/86,26.22%,RPS19;CD81;MDK;GRN;AGT;TNF;S100A8;S100A9;DDT;HYAL2;LPL;FEM1A;CEBPA;IL2;NUPR1;LILRA5;KARS1;PLA2G7;NINJ1;WNT5A;VAMP8;TNFRSF1A;GPSM3;CCL3;CCR2;SNCA;IL6;NFKBIA;LBP;TNIP1;APP;IL33;PLA2G3;TLR7;PDE2A;CX3CL1;TLR2
prerank,positive regulation of ATPase activity (GO:0032781),0.580697813310573,1.5079955635870996,0.019744483159117306,0.2026113629127926,1.0,16/41,18.81%,DYNLL2;DYNLL1;GABARAPL2;PFN1;ATP1B2;DNAJB2;VMP1;DNAJB1;HNRNPU;ATP1B1;RYR2;PFN2;DNAJB11;AHSA1;ATP1B3;DNAJC10
prerank,dendritic cell differentiation (GO:0097028),0.6381739898310432,1.507957901378852,0.046740467404674045,0.20215567257547004,1.0,10/22,20.25%,CCL19;TREM2;IRF8;TRPM2;LILRB1;GAS6;F2RL1;BATF3;FLT3;BATF2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.5841631248976769,1.5075315961456408,0.014857142857142857,0.20248575239022212,1.0,15/38,16.92%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;CD34;TNF;RAC1;SIRPA;KLF4;DDAH1;CX3CR1;TLR6;DDAH2;CAV1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.6335258155872441,1.5075210510098418,0.046153846153846156,0.20194373644063565,1.0,6/22,12.29%,RPS27A;UBC;UBB;UBA52;SYVN1;MAN1B1
prerank,response to axon injury (GO:0048678),0.6616440884092005,1.506311549655856,0.045103092783505154,0.2038595212907647,1.0,4/18,2.59%,APOD;TYROBP;SOD1;TREM2
prerank,protein insertion into ER membrane (GO:0045048),0.5928769574269391,1.5062566518397522,0.02424942263279446,0.2034105902384275,1.0,17/37,22.12%,HMOX1;SEC61B;PRNP;WDR83OS;EMC6;SEC61G;EMC3;EMC10;VAMP2;EMC4;SERP1;SGTA;TRAM1L1;EMC8;VAPA;TRAM1;CYB5A
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.6606235583921528,1.5062348554009655,0.039440203562340966,0.20289125690056614,1.0,6/19,5.43%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,signal release from synapse (GO:0099643),0.5756723317526519,1.5059726792376724,0.016891891891891893,0.20286744365837944,1.0,26/43,29.39%,HSPA8;NRXN1;SNAP25;DNAJC5;SYT1;RIMS1;SYN2;VAMP2;PTPRN2;SYN1;NRXN2;SYT10;LIN7C;PPFIA3;NAAA;CDK5;GRM4;SNCA;GAD1;SLC32A1;UNC13A;STXBP2;PIP5K1C;CPLX1;PCLO;SNPH
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6855414926975149,1.5056268875101455,0.040207522697795074,0.2030584342689349,1.0,5/14,13.71%,CD74;LAPTM5;SEMA7A;WNT5A;LILRB1
prerank,epiboly involved in wound healing (GO:0090505),0.6725238499523933,1.504678548633666,0.04118404118404118,0.2044685546414643,1.0,6/16,13.05%,CD151;RHOC;FLNA;MRTFA;LCP1;RHOA
prerank,negative regulation of immune system process (GO:0002683),0.6638096088152003,1.5044305010693029,0.04387096774193548,0.20438929214610357,1.0,4/16,13.22%,HMOX1;GPER1;COL3A1;SOX9
prerank,spliceosomal snRNP assembly (GO:0000387),0.5833270740664688,1.5039490645119566,0.03244495944380069,0.20492114287596716,1.0,12/38,15.95%,SNRPG;GEMIN7;SNRPD2;LSM4;SNRPE;SNRPF;STRAP;CD2BP2;PRPF19;PRPF8;SNRPB;PRPF31
prerank,respiratory electron transport chain (GO:0022904),0.6854158440062756,1.5035687705681728,0.035422343324250684,0.2051251723849741,1.0,11/14,27.77%,ETFB;SLC25A13;NDUFA5;SDHB;SLC25A22;UQCRFS1;PPARGC1A;SLC25A18;SDHA;GPD2;SLC25A12
prerank,acylglycerol metabolic process (GO:0006639),0.5852101312467232,1.5032088246618038,0.02962085308056872,0.20526942203604648,1.0,8/37,9.45%,APOE;PNPLA2;APOC1;LYPLA2;PLAAT3;LPL;DGKH;DGKI
prerank,lipoprotein biosynthetic process (GO:0042158),0.7267295497752434,1.5016698906385522,0.029829545454545456,0.20787209571487927,1.0,1/11,0.01%,APOE
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.6368778140371382,1.5007789229107353,0.03125,0.20910781742937232,1.0,5/21,5.80%,RPS3;CD81;NFAM1;PTPRC;SLC39A10
prerank,iron ion transport (GO:0006826),0.558733205851468,1.499684831318267,0.0208105147864184,0.21076000420569438,1.0,13/47,13.12%,FTH1;ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;ATP6AP1;TFRC;HEPH;TTYH1;CLTC;ATP6V0D2;SLC40A1;SLC11A1
prerank,morphogenesis of an epithelium (GO:0002009),0.6190808849859653,1.4993830044418712,0.02176541717049577,0.21083756026078423,1.0,2/25,0.25%,ACTB;ACTG1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7266523045380138,1.4990610197682446,0.0480225988700565,0.2109676184557279,1.0,7/11,15.81%,TREM2;CYBA;TIRAP;TNFAIP3;TLR6;F2RL1;TLR1
prerank,lipid droplet organization (GO:0034389),0.6295284536432029,1.498761544568004,0.03821656050955414,0.21102915824270924,1.0,6/22,7.48%,PPIA;AUP1;CDS1;BSCL2;TSPO2;HSD17B13
prerank,response to hydrogen peroxide (GO:0042542),0.5722071935112032,1.498499151276549,0.014689265536723164,0.2110302295746707,1.0,12/45,11.69%,RPS3;GPX1;HMOX1;PARK7;SOD1;RHOB;SIRPA;TNFAIP3;HP;AQP1;NET1;TRPM2
prerank,cellular response to interleukin-1 (GO:0071347),0.5195757797194194,1.4983780220538152,0.0010162601626016261,0.21073881784299112,1.0,48/143,20.93%,RPS27A;UBC;UBB;PSMB4;MAPK3;PSME1;CCL19;PSMB6;PSMB8;PSME2;PSMD2;NR1D1;TOLLIP;PSMD1;SIRPA;PSMC3;ST18;PSMD6;HYAL2;PSMA7;UBA52;PSMD5;RBX1;EGR1;PSMB9;PSMD13;PSMB3;PSMB11;SOX9;PSMB10;CCL2;RIPK2;UBE2V1;MAPK11;PSMB1;PSMB5;DAB2IP;SQSTM1;CCL3;CCL8;SFRP1;PSMA6;TAB1;SKP1;PSMA4;IL1RAP;NFKBIA;PYCARD
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5557336925476506,-1.4980451009596147,0.07058823529411765,0.5140180843683965,1.0,7/14,19.57%,GHR;STAT5B;PXN;STAT3;PTK2;STAT5A;STAT6
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6507562759375416,1.4978540618328569,0.029339853300733496,0.21130164094898568,1.0,3/21,2.59%,APOE;PLTP;TREM2
prerank,gene silencing by miRNA (GO:0035195),-0.4489128498001751,-1.4978509855088635,0.039473684210526314,0.5076011347868734,1.0,16/32,19.01%,TNRC6B;TNRC6A;TNRC6C;CNOT1;DICER1;ZC3H7A;MOV10;RBM4;ZC3H7B;CNOT7;PUM2;TARBP2;LIMD1;AGO2;ADAR;AGO4
prerank,regulation of microtubule-based movement (GO:0060632),0.718734799402108,1.4972608954388968,0.05342465753424658,0.2119809532314558,1.0,4/11,11.30%,LAMP1;NEFH;MAP2;HAP1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.6686566830775591,1.4971066757574008,0.043941411451398134,0.21171167152850454,1.0,10/15,27.30%,CCT2;NOP10;CCT7;NHP2;CCT8;DKC1;CCT4;NAF1;CCT3;RUVBL2
prerank,regulation of stress fiber assembly (GO:0051492),-0.37079458676188587,-1.4968667986783122,0.03389830508474576,0.503282479658449,1.0,20/74,6.16%,ROCK2;PHLDB2;ARHGAP28;ARHGAP6;CGNL1;ABL1;ASAP3;ALMS1;SLC9A1;LPAR1;ROCK1;PPM1E;SORBS3;NRP1;ARHGEF18;ARHGEF10L;CARMIL1;PPFIA1;TGFBR1;PXN
prerank,hemidesmosome assembly (GO:0031581),0.7259359483537192,1.4967189437933683,0.039942938659058486,0.21192625217279967,1.0,4/11,9.72%,CD151;LAMC1;PLEC;LAMC2
prerank,cellular copper ion homeostasis (GO:0006878),0.6837824350456384,1.4961492838155361,0.050870147255689425,0.21249019735343208,1.0,6/14,15.19%,ATOX1;MT2A;PRNP;ABCB6;ARF1;SLC31A1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6735526495359869,1.495788588711659,0.04736129905277402,0.21264263104434583,1.0,4/15,5.46%,CLU;GPX1;AKT1;GHITM
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5079243207075727,-1.4957441139815122,0.03827751196172249,0.49979308731715216,1.0,9/18,21.22%,BIRC2;BIRC3;SEC14L1;ANKRD17;DDX60;NPLOC4;PUM2;DHX58;GPATCH3
prerank,synaptic vesicle cycle (GO:0099504),0.5993446983754699,1.4956223890417446,0.03106332138590203,0.21244069981755273,1.0,17/30,28.90%,SLC17A8;NLGN1;SNAP25;DNAJC5;RIMS1;VAMP2;SLC17A7;SLC17A6;SYNDIG1;SYT10;CDK5;SNCA;SLC32A1;WNT7A;PIP5K1C;CPLX1;PCLO
prerank,cellular response to chemical stress (GO:0062197),0.5288191389614258,1.4952336757166946,0.005192107995846314,0.212717403285629,1.0,35/96,21.08%,PPIA;GPX1;MT3;CHCHD2;PARK7;SOD1;ATF4;CYBA;PRDX5;PRDX6;PINK1;PRDX2;PARP1;HSPA1B;PRR5L;PYCR2;CYBB;PRDX1;ATP13A2;GPX3;GPX7;AIF1;ERMP1;HSPA1A;CAT;NCF1;ERO1A;CAV1;PPARGC1A;STX4;SNCA;SOD3;SIRT2;SELENOS;CYCS
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6465262752602362,1.4950558483702467,0.03482587064676617,0.21253828923744258,1.0,4/20,8.39%,APOE;ACADVL;RAN;SEC14L2
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.4817070619394082,-1.4946803245822466,0.04090909090909091,0.4962755717087389,1.0,9/20,19.42%,ST3GAL4;B4GALT1;ST3GAL3;FUT8;B3GALT1;ST6GALNAC6;ST3GAL6;ST3GAL2;ST6GALNAC5
prerank,positive regulation of cellular respiration (GO:1901857),0.7175149494953585,1.4938241969631876,0.036684782608695655,0.21460455115283053,1.0,7/11,19.91%,PARK7;PINK1;VCP;NUPR1;ISCU;PRELID1;IL10RB
prerank,energy reserve metabolic process (GO:0006112),-0.4999244410549424,-1.4929154354190306,0.05217391304347826,0.49481768044534563,1.0,5/19,4.43%,PRKAG2;PID1;PHKB;PHKA1;LEPR
prerank,apoptotic cell clearance (GO:0043277),0.5961523150262373,1.4927358593854323,0.03146853146853147,0.2163177002301776,1.0,12/30,19.95%,TYROBP;TREM2;TGM2;RAC1;RHOG;XKR4;HMGB1;ADGRB1;GAS6;TYRO3;RAC2;XKR6
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.7049054275612122,1.4924626336781592,0.0310391363022942,0.21630066576127355,1.0,8/13,18.67%,CALM1;CALM3;ANK3;IRX3;SLC8A1;CAV1;SRI;CALM2
prerank,regulation of T cell migration (GO:2000404),0.6531435742868008,1.4922083591763755,0.03880983182406209,0.21630306638740876,1.0,7/18,16.79%,APOD;CXCL12;CXCL10;AIF1;RHOA;DOCK8;TMEM102
prerank,positive regulation of interleukin-6 production (GO:0032755),0.552376879241129,1.4918684568622083,0.014989293361884369,0.21656844482599075,1.0,32/68,27.21%,CD74;MBP;TYROBP;CYBA;TNF;TIRAP;HYAL2;HSPD1;LPL;LILRA5;HMGB1;WNT5A;AIF1;C1QTNF4;TLR6;F2RL1;TLR1;TWIST1;NOS2;SYK;SPHK2;IL6;TMEM106A;PYCARD;LBP;APP;IL33;AGER;TLR7;TLR2;POU2F2;XBP1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.5349222960127714,1.4916047037691722,0.007322175732217573,0.21654369468027793,1.0,43/85,26.48%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;RAC1;PSMD1;PSMC3;PSMD6;PSMA7;AP2M1;PFN1;CLTC;PSMD5;AP2S1;WNT5A;PSMB9;PSMD13;PSMB3;PSMB11;RHOA;PSMB10;TIAM1;PSMB1;PRICKLE2;ARRB2;PSMB5;ARHGEF19;PSMA6;PSMA4;FZD1;FZD2;AP2A1;PSMD9;PARD6A;WNT7A;PSMC1;PSMD4;CELSR3;FZD3;PSMB2;PSMD10
prerank,regulation of supramolecular fiber organization (GO:1902903),0.6223026776059241,1.490794151666137,0.0416141235813367,0.21769786268160413,1.0,8/22,10.83%,APOE;HSPA8;GPX1;PARK7;MAP1A;MAPT;MAP2;AEBP1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.5822850549064807,1.4907605022046906,0.020713463751438434,0.2172393680631637,1.0,8/35,4.70%,CALM1;HSP90AB1;CALM3;CSNK2B;PPP1R15B;HSP90B1;FKBP1A;PPP1R1B
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4739693174182573,-1.4901815072437588,0.037037037037037035,0.4962021411579698,1.0,7/24,7.82%,PHLDB2;ARHGAP28;ARHGAP6;CGNL1;ARHGEF18;PPFIA1;MET
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.7494973736266477,1.4901580413790263,0.027298850574712645,0.21794178691078137,1.0,5/10,13.71%,TYROBP;HSP90AB1;FN1;CD24;LILRB1
prerank,regulation of translation (GO:0006417),0.5104931836047207,1.489403233627478,0.0,0.21895532450817237,1.0,24/173,4.61%,RPL26;MRPL13;RPS3;RPS4X;RPL5;EEF2;VIM;RACK1;GAPDH;RPL13A;HSPB1;CALR;EIF1;RPL10;EIF4G2;EIF3D;SHFL;GRM5;NPM1;RPS27L;EIF1B;METAP1;IGFBP5;NCL
prerank,regulation of protein binding (GO:0043393),0.5250556644986715,1.4892736419685249,0.002044989775051125,0.21868967790267185,1.0,31/114,14.60%,ACTB;RPL11;RACK1;B2M;CLDN5;VTN;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;RAN;PDGFB;FKBP1A;PIN1;SORL1;FLOT1;TLE5;ADD2;HIPK2;LRPAP1;IFIT1;CAMK1;BAX;DDX11;DNAJB2;HDAC5;BMP2;RIPK2;TIAM1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.7223354568838818,1.4891863410763073,0.04929577464788732,0.21836604390150058,1.0,6/11,14.04%,CXCL12;CCL19;HCLS1;IRF7;LILRB1;GAS6
prerank,regulation of transport (GO:0051049),0.5782704062681469,1.4891450449652652,0.027522935779816515,0.21791387664255757,1.0,15/36,20.46%,ACTB;ACTG1;PINK1;REEP5;REEP6;VAMP2;DNAJA1;RSC1A1;CDK5;EPB41;ICA1L;TMEM102;ICA1;SNCA;TRAT1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.6008680272455141,-1.4885291975429908,0.06818181818181818,0.49430608637585316,1.0,5/10,16.90%,RAPGEF2;ATP7A;GIPC1;APPL1;CTNS
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6669272250361804,1.4884704597774039,0.04203821656050955,0.21873118466250618,1.0,4/16,9.35%,TUBB;TUBB4B;CORO1A;VAMP2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5879708902350649,-1.4881597887105222,0.07801418439716312,0.4891528275067922,1.0,8/11,38.90%,SMAD7;RC3H2;SOCS5;ANXA1;JAK3;IL4;FOXP3;TBX21
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.593891683090382,1.4866296329215485,0.03659976387249114,0.22206350649819945,1.0,9/30,15.58%,RPS27A;UBC;UBB;UBA52;TICAM2;IRF7;TLR6;TRAF3;CD300LF
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5442720429299014,1.4852844757583252,0.010559662090813094,0.22441915961231546,1.0,32/69,24.85%,CLU;TYROBP;HSPB1;CCL19;CYBA;PTPRC;MIF;DDT;TIRAP;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;IFNGR1;PF4;TLR1;RASGRP1;CCL3;TWIST1;OAS3;SYK;CD14;CCR2;SPHK2;IL6;TMEM106A;PYCARD;LBP;APP;IL33;AGER
prerank,central nervous system myelination (GO:0022010),0.7237407095285008,1.4851134181880175,0.044444444444444446,0.2242800485739223,1.0,6/11,14.20%,CLU;PLP1;B4GALT6;MYRF;TENM4;ABCA2
prerank,negative regulation of viral genome replication (GO:0045071),0.5687264010997944,1.4847998933112212,0.023728813559322035,0.2244197311720324,1.0,10/40,13.29%,IFITM3;IFITM2;IFITM1;SHFL;TNF;ISG15;PROX1;IFIT1;BANF1;BST2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5773703312005427,1.4846349381119262,0.023755656108597284,0.22423465652807387,1.0,13/36,18.91%,RPL11;HSP90AB1;PARK7;UBXN1;MAP1A;GABARAPL2;BAG5;ALAD;TAF9;SDCBP;CCAR2;NOP53;DDRGK1
prerank,phospholipid transport (GO:0015914),0.5601824723712125,1.4845895941205125,0.023076923076923078,0.22377833215571993,1.0,11/52,11.39%,APOE;PLTP;NPC2;APOC1;TMEM30A;SCP2;ATP8B4;ABCG1;ATP8A2;MFSD2A;ATP8A1
prerank,copper ion homeostasis (GO:0055070),0.6583676456980525,1.4844895278792416,0.04432855280312908,0.22346805570462136,1.0,6/17,15.19%,ATOX1;MT2A;PRNP;ABCB6;ARF1;SLC31A1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.5501172485548468,1.4843690640321474,0.018743109151047408,0.2232032425895917,1.0,24/55,21.63%,RPS3;RACK1;AGT;GPER1;TNF;S100A8;S100A9;HYAL2;TNFSF12;NUPR1;BAX;PMAIP1;BBC3;BAD;DAB2IP;CAV1;DNM1L;BCAP31;TNFRSF12A;LTBR;ING5;PYCARD;FIS1;DDIT3
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.3965951357062041,-1.4843590977381043,0.0,0.4934821209153441,1.0,22/43,27.20%,BABAM2;FOXN3;RINT1;UIMC1;TAOK3;MRNIP;PABIR1;RAD17;ATM;ORC1;NAE1;CHFR;CLSPN;TAOK1;INTS3;CDC14B;ABRAXAS1;HUS1B;BRCC3;CDK1;PLK1;TICRR
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.6663245670237034,1.4835720828060435,0.045572916666666664,0.2242721834083744,1.0,6/17,5.43%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5581949107686969,-1.4833870274067114,0.07462686567164178,0.4901877749053314,1.0,10/13,25.19%,RNF152;SESN1;ATM;ITFG2;SPAAR;CASTOR2;SESN2;CASTOR1;KPTN;SESN3
prerank,positive regulation of macrophage activation (GO:0043032),0.6572870312185316,1.4832537241231243,0.03617571059431524,0.22446518662903936,1.0,10/17,24.81%,TREM2;SPACA3;HSPD1;CEBPA;KARS1;WNT5A;TLR6;CCL3;LBP;IL33
prerank,histone modification (GO:0016570),-0.335556601261106,-1.483216714236975,0.0,0.4847075016270844,1.0,29/109,13.14%,EYA2;NSD1;EYA1;PRDM5;KAT6B;CREBBP;USP3;MIDEAS;BAZ2A;HDAC4;MTA3;EHMT1;TBL1X;HUWE1;UFL1;EYA4;BAZ1B;RCOR1;USP16;MIER1;NSD3;USP36;TBL1XR1;EYA3;RCOR3;PHF20L1;BRD8;KAT6A;SIRT1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5978719984412765,1.4830769928004315,0.034606205250596656,0.22425965164666994,1.0,9/29,15.58%,RPS27A;UBC;UBB;UBA52;TICAM2;IRF7;TLR6;TRAF3;CD300LF
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.581572334629924,-1.4826082552347861,0.06020066889632107,0.4807414128380681,1.0,4/11,8.79%,TGFBR3;ACVR1;TGFBR1;SMAD7
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6586999408473444,1.4824041542843778,0.0431266846361186,0.22530704906327417,1.0,1/17,0.02%,TMSB4X
prerank,negative regulation of macrophage activation (GO:0043031),0.6665974551386156,1.4823752521338875,0.028,0.22483742863879372,1.0,5/16,8.98%,GRN;NR1D1;PTPRC;LRFN5;SYT11
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.54013918761505,1.4815247616800962,0.013626834381551363,0.22615239897485281,1.0,30/73,21.99%,CLU;TYROBP;HSPB1;CCL19;CYBA;PTPRC;MIF;DDT;TIRAP;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;IFNGR1;PF4;TLR1;RASGRP1;CCL3;TWIST1;OAS3;SYK;CD14;CCR2;CD86;SPHK2;IL6;TMEM106A;PYCARD;LBP
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6388394152810163,1.4815136525335453,0.04768041237113402,0.22565567710595455,1.0,7/22,10.08%,LAPTM5;PRNP;LGALS3;DUSP3;THY1;CD22;PHPT1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.398158532263422,-1.4810837974825337,0.009615384615384616,0.47904043317249534,1.0,15/47,10.52%,GOLGA4;VAMP5;MACF1;EXOC4;SPTBN1;RABEP1;EXOC2;BLZF1;ARL3;RAB10;ARFGEF2;GGA2;OPTN;KIF13A;EXOC6B
prerank,protein-DNA complex assembly (GO:0065004),0.5153318236593396,1.4809746258626675,0.00508130081300813,0.22626522513692063,1.0,30/116,13.37%,RPS27A;UBC;UBB;PSMB4;H3-3A;PSME1;PSMB6;PSMB8;PSME2;PSMD2;NPM1;PSMD1;PARP1;PSMC3;MCM5;PSMD6;PSMA7;RPA2;UBA52;BRD2;GMNN;PSMD5;RBX1;DDB1;PSMB9;PSMD13;PSMB3;PSMB11;SOX9;PSMB10
prerank,global genome nucleotide-excision repair (GO:0070911),0.6030696595791382,1.4801706818205336,0.04150943396226415,0.2275427144256805,1.0,7/26,9.84%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1
prerank,gastrulation (GO:0007369),-0.5351829092357026,-1.479943328890297,0.06967213114754098,0.4765442471649057,1.0,5/15,14.85%,GPC3;LRP5;TASOR;NPHP3;SMAD2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6145987310031007,1.4799346256929649,0.026537997587454766,0.22755718840303066,1.0,11/27,17.88%,CD74;S100A6;AGT;PDGFB;MIF;FN1;AQP1;WNT5A;GAS6;PDGFA;DDR2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.629614401915787,1.4782230443863553,0.045743329097839895,0.23057836417655855,1.0,6/21,10.91%,MDK;MAPK3;MIF;DDT;RARRES2;CSF1R
prerank,hexose metabolic process (GO:0019318),0.57221961586936,1.4778265757566083,0.029646522234891677,0.23088953269616458,1.0,11/39,11.22%,ALDOA;APOD;ALDOC;GALT;OMA1;FUOM;PMM1;CHST1;GAA;DCXR;FUCA1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6528019665741193,1.477120247240959,0.03911342894393742,0.23189976238638232,1.0,9/18,11.36%,SLC17A8;GRIA2;SLC1A4;GRID2;GRIK5;GRIK2;GRID1;SLC17A7;SLC17A6
prerank,cardiac conduction system development (GO:0003161),-0.4564152406568525,-1.4769929972178597,0.04736842105263158,0.47830987736968106,1.0,9/24,14.58%,NOTCH2;BMPR1A;SMAD1;MAML1;SMAD4;GJB6;BMP4;CACNA1G;HEY2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.4619881935992184,-1.4764211346083351,0.049773755656108594,0.4744413766481454,1.0,9/21,19.42%,ST3GAL4;B4GALT1;ST3GAL3;FUT8;B3GALT1;ST6GALNAC6;ST3GAL6;ST3GAL2;ST6GALNAC5
prerank,response to UV-B (GO:0010224),0.7072808894301227,1.4761864587613545,0.04788732394366197,0.2332592479034697,1.0,4/12,13.95%,CRIP1;HYAL2;MFAP4;STK11
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.5252734374084659,1.4753136075425592,0.016094420600858368,0.23455883207596517,1.0,20/72,14.83%,RPS27A;UBC;UBB;POLR2E;COPS7A;POLR2D;COPS6;POLR2F;RPA2;HMGN1;UBA52;XAB2;PRPF19;RBX1;DDB1;POLR2G;PCNA;POLR2K;RFC2;COPS8
prerank,cellular protein-containing complex assembly (GO:0034622),0.5053223248784534,1.4752058006633357,0.0010131712259371835,0.23424035804047963,1.0,46/159,15.55%,RPL38;CLU;GPX4;HSP90AA1;HSP90AB1;FMOD;NSG1;CYBA;NRG1;HIGD2A;COX7A2L;CSNK2B;PFDN6;CCT2;MID1IP1;FKBP1A;RTN4;COX7A2;POMP;AP2M1;EID2;DNAAF3;OMA1;HSPD1;CLTC;MAPT;VAMP3;VAMP2;AP2S1;PSMG3;HIGD1B;PSMD13;FCHO1;VAMP8;ANLN;HSPA1A;NSG2;VBP1;OTUD6B;TIAM1;ARL2;PDE4DIP;PTGES3;MAPK8IP2;CLTA;TBCA
prerank,regulation of dendritic spine development (GO:0060998),0.6488251456038774,1.4748076308547613,0.042746113989637305,0.23452398684652317,1.0,6/19,9.92%,APOE;NLGN1;GRIN3A;PPFIA2;ARF6;CAMK1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5226800461682721,1.4742129705899973,0.005268703898840885,0.23532790224288053,1.0,22/84,11.92%,TMSB4X;SPARC;ATP5F1B;HSPB1;GRN;CALR;RHOB;AKT1;LGMN;ATP5F1A;AGT;RAC1;PDGFB;EMC10;PROX1;KDR;GATA2;HMGB1;WNT5A;PDCD6;AAMP;FLT4
prerank,protein kinase B signaling (GO:0043491),0.6239927931308205,1.474209874688244,0.041212121212121214,0.23479726725274802,1.0,12/23,20.78%,MT3;AKT1;TNF;ZFP36L1;KDR;CCL2;GAS6;TYRO3;CCL3;TGFB1;THEM4;SIRT2
prerank,positive regulation of cell death (GO:0010942),0.5415203312953571,1.4739106455084314,0.019845644983461964,0.2349164032143538,1.0,15/59,11.56%,CLU;C1QA;TYROBP;MT3;MMP3;PRNP;ITGB2;TNF;HP;HPR;SLC6A6;MAPT;EGR1;WNT5A;RAMP3
prerank,triglyceride homeostasis (GO:0070328),0.5976293593003588,1.4737811654924096,0.035108958837772396,0.23467347995444165,1.0,4/26,9.38%,APOE;LPL;MTLN;MLXIPL
prerank,regulation of proteolysis (GO:0030162),0.5528454526289774,1.4734753408018781,0.0244173140954495,0.23478135942572317,1.0,21/48,21.15%,CST3;AURKAIP1;AKT1;SERPINE2;LTBP4;PRSS37;CSTB;GSAP;NEDD8;PLAT;CLN6;CAMK2N1;BAD;TRAF3;CDK5;CAV1;TRIM32;CLN8;CAPN3;STUB1;BAK1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6086252793744219,1.4733263999460111,0.05542168674698795,0.23458811773093308,1.0,7/23,18.10%,TUBB;TUBA1A;TUBA1B;KIF5A;CCDC88A;HOOK1;KIF5C
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5625101269149607,-1.4723640282408774,0.04198473282442748,0.4793278360127532,1.0,5/12,10.89%,NFIB;PAFAH1B1;GLI2;EPHA4;EPHB2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5841538137805273,-1.4717040575465976,0.05970149253731343,0.47590116970638396,1.0,5/11,18.43%,PDK1;STK24;PRODH;MAP3K5;GSKIP
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5929981187838507,1.47162209157278,0.038686987104337635,0.23786821319340923,1.0,13/29,19.23%,CALR;CXCL12;LGMN;TNF;LGALS3;CREB3;CXCL10;PLA2G7;HMGB1;AIF1;GAS6;CCR2;CXCL17
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.4538563348089802,-1.4714925160750827,0.047337278106508875,0.4712349849901803,1.0,12/25,16.55%,SULF1;ZNF423;BMPR1A;FOXD1;SMAD4;RBPJ;BMP4;NUMA1;SMAD2;ACVR2A;BMPR2;ACVR2B
prerank,cell junction assembly (GO:0034329),0.5153574813618829,1.4713282740549893,0.011410788381742738,0.23801841229384466,1.0,33/100,18.75%,ACTB;ACTG1;CLDN5;GJA4;NRXN1;SPOCK2;NLGN1;DSCAM;CDH20;ADGRL3;FLNA;DNM3;FN1;KIRREL3;CDH18;NRCAM;DNER;VMP1;NRXN2;RHOA;CDH12;DCHS1;CDH19;CDH24;CDH7;CDK5;ACHE;CDH10;CDH5;PCDHB14;GPM6A;CTNND2;FBLIM1
prerank,positive regulation of neutrophil migration (GO:1902624),0.657771263934903,1.4712154226417786,0.044386422976501305,0.23777342730975654,1.0,6/18,5.43%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,positive regulation of leukocyte activation (GO:0002696),0.6482075408610526,1.4691956075037005,0.0391644908616188,0.2415766965088328,1.0,10/18,24.81%,SPACA3;HSPD1;CEBPA;KARS1;WNT5A;CLEC4D;TLR6;CRLF2;LBP;IL33
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.7302169668979868,1.4691546229224595,0.043909348441926344,0.24058699461903033,1.0,3/10,13.04%,MBP;MYADM;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.7302169668979868,1.4691546229224595,0.043909348441926344,0.24058699461903033,1.0,3/10,13.04%,MBP;MYADM;KLF4
prerank,cellular response to unfolded protein (GO:0034620),0.6042240529856863,1.469021003269503,0.05025125628140704,0.24037951507485716,1.0,14/26,22.26%,HSPA8;HSPA5;TMBIM6;HSPA1B;HSPD1;HSPB8;BAX;HSPA1A;ABCB10;DAB2IP;HSPA2;BAK1;HSPA9;PTPN1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5602737519388816,1.4684457619965166,0.026106696935300794,0.24106097836178,1.0,16/40,20.93%,CLU;GPX1;AKT1;PINK1;GPER1;GHITM;BAX;PMAIP1;BBC3;BAD;MFF;DNM1L;PDCD5;PRELID1;HGF;PYCARD
prerank,positive regulation of nervous system development (GO:0051962),0.553176512569993,1.4682552646236051,0.038288288288288286,0.24098025398638914,1.0,21/42,24.43%,NRXN1;NLGN1;SERPINF1;TGM2;GPER1;GRID2;IL1RAPL1;PTPRD;SNW1;SYNDIG1;LRRC4B;CX3CR1;EPHB1;CLSTN2;TRIM32;CLSTN1;SOX11;IL1RAP;CLSTN3;WNT7A;NAP1L1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6717983213960784,1.4682179189603897,0.03674540682414698,0.2405200708309654,1.0,9/15,18.91%,TYROBP;TREM2;FLOT1;CD53;CAMK1;ADGRB1;EHD1;EHD2;SCGB3A1
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.4077118186883284,-1.4681141434322005,0.0410958904109589,0.47443630961647226,1.0,11/36,17.92%,MGA;YAF2;EPC1;EHMT1;PHC3;APAF1;RBBP8;TFDP1;EHMT2;EZH2;L3MBTL2
prerank,muscle organ development (GO:0007517),-0.37106135945205576,-1.4679578863192455,0.010416666666666666,0.46983721256726435,1.0,11/54,8.31%,LAMA2;LARGE1;VAMP5;TCF12;MRAS;ITGA11;CHD2;FHL1;UTRN;MEF2A;IGF1
prerank,histone mRNA catabolic process (GO:0071044),-0.5116936083975594,-1.4674298271001334,0.06694560669456066,0.4662694045240568,1.0,8/15,21.23%,TENT4B;XRN1;TUT7;TUT1;ATM;TUT4;TENT2;LSM1
prerank,regulation of microglial cell activation (GO:1903978),0.6601820922648977,1.4664852061704503,0.05167958656330749,0.24372108653370664,1.0,5/15,8.98%,GRN;TREM2;NR1D1;PTPRC;SYT11
prerank,regulation of interleukin-6 production (GO:0032675),0.5234461797439376,1.4657719642662101,0.009365244536940686,0.24477160101834386,1.0,39/96,26.29%,CD74;MBP;TYROBP;TREM2;CYBA;TNF;SIRPA;TIRAP;TNFAIP3;HYAL2;HSPD1;LPL;SYT11;LILRA5;HMGB1;WNT5A;AIF1;C1QTNF4;GAS6;TLR6;F2RL1;TLR1;TWIST1;NOS2;SYK;PTPN6;SPHK2;IL6;TMEM106A;SELENOS;PYCARD;LBP;APP;IL33;AGER;TLR7;CX3CL1;TLR2;POU2F2
prerank,carbohydrate derivative transport (GO:1901264),0.6420306124340004,1.4655225946241237,0.05099502487562189,0.24476017245311363,1.0,9/18,15.37%,PLTP;NPC2;ABCG1;MFSD2A;SLC15A4;SLC29A1;SLC25A19;SLC29A2;SLC15A2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.6320773287211249,1.4653953757517173,0.05223880597014925,0.24448078827693412,1.0,11/19,21.01%,PRNP;GRM5;PTPRC;KDR;TRPM2;RYR2;DMTN;VCAM1;FKBP1B;BCAP31;FIS1
prerank,atrial septum development (GO:0003283),-0.5296491073191821,-1.465284847002662,0.0703125,0.4663991795462315,1.0,7/13,19.21%,NOTCH2;ANK2;MDM4;NPHP3;HEY2;BMPR2;DAND5
prerank,gas transport (GO:0015669),0.7187823569118404,1.4652029123317258,0.055632823365785816,0.24438515106620565,1.0,6/10,22.51%,CA2;CYGB;IPCEF1;AQP1;MYC;MB
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.5854784495289912,-1.465199684437789,0.0903010033444816,0.4616951646405217,1.0,5/10,14.78%,PID1;APPL2;GRB10;ENPP1;PRKCB
prerank,release of cytochrome c from mitochondria (GO:0001836),0.6459027553653863,1.4647203634931227,0.05533596837944664,0.24495066677505137,1.0,10/17,21.15%,CLU;FZD9;BAX;BBC3;TIMM50;BAD;MFF;DNM1L;FIS1;BAK1
prerank,negative regulation of binding (GO:0051100),0.5303275570507999,1.4645675112698784,0.009483667017913594,0.24468114612892208,1.0,21/81,12.24%,ACTB;RACK1;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;PDGFB;PIN1;SORL1;TLE5;LRPAP1;PLN;IFIT1;JUN;CAMK1;BAX;SUMO3;DDX11;DNAJB2
prerank,steroid catabolic process (GO:0006706),0.7334300451518854,1.4645048284409117,0.05649717514124294,0.24427574261841756,1.0,3/10,6.71%,SPP1;YWHAH;HSD17B6
prerank,heart process (GO:0003015),0.6761099779560166,1.464456319123228,0.04563758389261745,0.2438405385096414,1.0,6/14,20.79%,GPX1;SOD1;SGCZ;RAMP3;SGCG;PPCS
prerank,cellular response to ATP (GO:0071318),0.6705984384493359,1.4639765435809329,0.05812417437252312,0.24429526709320326,1.0,4/14,9.44%,HSP90B1;P2RX7;P2RY12;P2RY1
prerank,glutathione derivative metabolic process (GO:1901685),0.6260558151103223,1.4630905851762552,0.05815423514538559,0.24514031416095944,1.0,9/20,20.52%,GSTM1;MGST1;GSTO1;GSTM5;GSTM2;MGST3;HPGDS;AKR1A1;ESD
prerank,glutathione derivative biosynthetic process (GO:1901687),0.6260558151103223,1.4630905851762552,0.05815423514538559,0.24514031416095944,1.0,9/20,20.52%,GSTM1;MGST1;GSTO1;GSTM5;GSTM2;MGST3;HPGDS;AKR1A1;ESD
prerank,protein localization to cell-cell junction (GO:0150105),0.6683142606942953,1.4620747119877353,0.06572164948453608,0.2469576388322129,1.0,2/15,0.25%,ACTB;ACTG1
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.4141641929152379,-1.4617910961462959,0.040983606557377046,0.4653937069484512,1.0,11/36,10.23%,AFDN;GOLGA4;VAMP5;MACF1;SPTBN1;GORASP2;BLZF1;RAB10;GGA2;OPTN;KIF13A
prerank,regulation of steroid metabolic process (GO:0019218),0.6190144558317746,1.4612224169667951,0.044226044226044224,0.2482780382954798,1.0,3/23,5.34%,APOE;ACADVL;ABCG1
prerank,endothelial cell differentiation (GO:0045446),0.6864811352581105,1.4603460242591628,0.05345501955671447,0.24970286014358403,1.0,7/12,13.78%,SOX18;ACVRL1;EDF1;PROX1;KDR;KDM6B;TIE1
prerank,histone H3 deacetylation (GO:0070932),-0.5064544296609982,-1.4602187947711582,0.06910569105691057,0.46478426920166216,1.0,7/15,20.69%,HDAC4;PER2;HDAC8;SMARCAD1;SIRT1;SIRT7;SIRT6
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5754899291089621,1.460057307995997,0.037037037037037035,0.24982628649018226,1.0,13/35,18.00%,NLGN1;PCDHGB4;CDH20;SELL;CDH18;CDH12;DCHS1;CDH19;CDH24;CDH7;CDH10;CDH5;PCDHB14
prerank,negative regulation of T cell activation (GO:0050868),0.5811046864743799,1.4597309711685358,0.027186761229314422,0.25004224971477496,1.0,8/35,13.71%,LAPTM5;GPNMB;LGALS3;DUSP3;CEBPB;FGL1;SDC4;LILRB1
prerank,water transport (GO:0006833),0.7020764551766538,1.459655568941732,0.06555090655509066,0.2496835933192447,1.0,2/12,8.63%,AQP4;AQP1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4424434810697637,-1.4594066292960661,0.05583756345177665,0.46225341390781577,1.0,7/26,5.55%,FOXP1;STRN3;DAB2;KANK2;PIAS2;CNOT1;NCOR1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7106413674432239,1.4590423639711076,0.06515580736543909,0.25048172148935427,1.0,4/10,14.49%,AKT1;TREM2;CD68;TLR6
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5842071164739427,1.458761272996341,0.042131350681536554,0.25061889113561514,1.0,8/29,9.84%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1
prerank,positive regulation of cholesterol transport (GO:0032376),0.6061317808178388,1.458151286746794,0.03769140164899882,0.2513419473778358,1.0,5/27,6.78%,APOE;PLTP;TREM2;SCP2;LIPG
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5891929209256089,-1.45795923894739,0.0903010033444816,0.4610836227112159,1.0,5/10,13.14%,CREBBP;KAT7;KAT2B;ESCO1;SIRT1
prerank,regulation of macrophage activation (GO:0043030),0.5800104420703673,1.4579528432326998,0.03694874851013111,0.25124549645632577,1.0,9/30,10.49%,CD74;LRFN5;MIF;SPACA3;HSPD1;CEBPA;GPR137B;KARS1;WNT5A
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.5042363722049873,1.4569919764244699,0.003076923076923077,0.25288919173746405,1.0,28/113,11.37%,RPS3;CLU;RACK1;HSP90AA1;MMP3;PARK7;TPPP3;NRG1;IL5;TERF1;TNF;RASIP1;RHOC;LGALS3;PARP1;PSMC3;TIRAP;VCP;RPA2;TFRC;ISG15;LCP1;MTLN;RBX1;DDB1;PIH1D1;BAX;WARS1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6868789855096283,1.4561218520109631,0.06657789613848203,0.25427331106221085,1.0,2/13,1.79%,APOE;SOD1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6093438330277379,1.455883291347071,0.04590570719602978,0.25424248987306275,1.0,12/22,19.25%,CALM1;CALM3;AKAP6;GSTO1;P2RY6;GSTM2;HAP1;VMP1;ATP1B1;RYR2;CALM2;STAC3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6751524598954058,1.4557431111915815,0.0664819944598338,0.2539601851644549,1.0,4/13,7.00%,CD81;TMEM30A;SORL1;SAR1A
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5467423062870522,1.4557313624129806,0.01762114537444934,0.25346644502713667,1.0,23/51,24.85%,TYROBP;HSPB1;CCL19;S100A13;TNF;LPL;P2RX7;EGR1;LILRA5;HMGB1;WNT5A;RIPK2;TLR6;F2RL1;CCL3;NLRP3;IL6;TMEM106A;PYCARD;TMED10;CASP1;APP;AGER
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.523313541234843,1.454798897937054,0.008359456635318705,0.2550661640463702,1.0,14/80,7.62%,RPL26;RPS4X;RPL5;CLU;EEF2;VIM;RACK1;EIF3D;NPM1;RPS27L;TNF;ABCG1;EIF3C;GSAP
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.61438010687092,1.4547537517855418,0.03916768665850673,0.2546488036828859,1.0,5/24,7.24%,MT3;HSPA5;ATF4;KLF2;CEBPB
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6856273812365901,1.4539767578934253,0.056910569105691054,0.25590136651057316,1.0,4/13,3.87%,TYROBP;HSP90AB1;TNF;MAP1A
prerank,cell junction maintenance (GO:0034331),0.6841796277029409,1.4539342539806286,0.05184174624829468,0.2554779807675813,1.0,6/14,14.82%,CHCHD10;MYADM;CSF1R;DCTN1;CBLN2;F2RL1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.5801383274644477,1.4537186335544314,0.04491725768321513,0.2554631521575927,1.0,8/31,14.84%,MDK;LAPTM5;CCL19;TIRAP;HSPD1;HMGB1;RIPK2;MAPK11
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.4960669950698491,-1.4534858913173532,0.06299212598425197,0.4677443940439313,1.0,9/16,23.23%,SHLD1;FBH1;FANCB;SMCHD1;CGAS;RMI2;SHLD2;POLQ;SHLD3
prerank,fatty acid biosynthetic process (GO:0006633),0.5285632140367937,1.4524792709745815,0.0203862660944206,0.25767821347300474,1.0,25/63,28.33%,GPX4;SCD5;FADS1;LIPG;ELOVL1;LPL;ELOVL2;TECRL;OXSM;SCD;ELOVL7;ACOT7;FADS3;DEGS1;LTC4S;ASAH2;NDUFAB1;ACSM5;ELOVL6;CYP2E1;ACLY;HACD4;XBP1;HSD17B8;GSTM4
prerank,cellular response to BMP stimulus (GO:0071773),-0.3422540585522168,-1.4524344612931026,0.0273972602739726,0.4656499663024557,1.0,22/66,16.55%,BMP6;TGFBR3;SMAD3;ADAMTS12;SMAD6;ACVR1;BMPR1A;SMAD9;SMURF1;SMAD1;SMAD7;GDF1;PDCD4;RGMA;SMAD4;HIVEP1;BMP4;TGFB3;SMAD2;ACVR2A;BMPR2;ACVR2B
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3643627866147973,-1.4524267222086895,0.03488372093023256,0.4611401561356641,1.0,16/63,9.88%,AUTS2;MCU;SIPA1L1;PHACTR1;FER;PARVA;GAB1;PTK7;NRP1;RICTOR;MYH9;MKLN1;CDC42BPB;PDLIM4;NRK;PIP5K1A
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6635001884432398,1.4524003588913317,0.06149732620320856,0.2573156528358495,1.0,2/15,3.62%,APOE;TNF
prerank,cellular response to oxidative stress (GO:0034599),0.5085285749122642,1.4523311105787147,0.009221311475409836,0.25691474848379087,1.0,30/118,11.77%,RPS3;PPIA;GPX1;MT3;CHCHD2;HMOX1;PARK7;SOD1;MAPK3;ATF4;AKT1;CYBA;PRDX5;PRDX6;PINK1;PRDX2;ROMO1;PARP1;HSPA1B;PRR5L;PYCR2;CYBB;MAPT;PRDX1;ATP13A2;JUN;GPX3;GPX7;AIF1;ERMP1
prerank,negative regulation of MAPK cascade (GO:0043409),0.5172951097739353,1.4521926738326034,0.012448132780082987,0.2567261677259846,1.0,21/87,13.51%,APOE;PPIA;AGT;PEBP1;GPER1;PTPRC;PIN1;SORL1;UCHL1;SIRPA;DUSP3;RGS2;HYAL2;DUSP26;P2RX7;SMPD1;CAMK2N1;TIMP3;PTPRR;SPRY1;CNKSR3
prerank,negative regulation of interferon-gamma production (GO:0032689),0.615663493942224,1.4515657014788224,0.05223880597014925,0.2576768802420472,1.0,10/23,25.24%,LAPTM5;PRNP;VSIR;HMGB1;LILRB1;GAS6;INHBA;DDIT3;C1QBP;INHA
prerank,protein O-linked glycosylation (GO:0006493),-0.3422955377315413,-1.451383467433146,0.0,0.4594891724922851,1.0,18/96,7.43%,TMTC1;GXYLT2;LARGE1;ST3GAL4;TMTC4;PLOD2;OGA;TET2;TRAK1;OGT;GALNT11;TET3;ST3GAL3;B3GNT2;PGM3;ST6GAL1;GALNT12;CRPPA
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.608909458992343,1.4513279599984936,0.07151515151515152,0.25765180733740684,1.0,13/21,32.05%,MDK;NES;FZD9;CTNNB1;PROX1;CX3CR1;TOX;NAP1L1;FZD3;CX3CL1;DLL4;DRD2;DISP3
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5873805769700511,-1.4510233031758555,0.09060402684563758,0.45610066837508856,1.0,5/10,16.16%,CAMK2D;PRKCE;ATP1A2;HECW2;STK39
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.5452762321794272,1.4510224632922009,0.03745743473325766,0.257940926497422,1.0,22/50,27.64%,ACTB;HSP90AB1;CCNI;CCND2;SERTAD1;CDKN1C;CCND1;CDK5R1;CDC37;CAMK2N1;CCNG1;CDK5R2;CCNJL;CDC25A;GADD45A;BLM;CDKN2B;CCNG2;CCNA2;CCNH;CDKN1A;CNPPD1
prerank,regulation of tissue remodeling (GO:0034103),0.6389237177923485,1.450462277573688,0.0546875,0.25867440527037355,1.0,3/18,1.41%,CST3;MDK;GPNMB
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.6911889266012786,1.4496780615401514,0.08175182481751825,0.2598397026695537,1.0,7/11,24.60%,TERF1;CCT2;CCT7;CCT8;DKC1;CCT4;CCT3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.599514640146457,1.449609842433599,0.035578144853875476,0.25946685750359477,1.0,9/26,14.89%,RPS3;RAC1;NAV3;PAK1;CLASP1;MAPT;CDK5R1;DCTN1;ARL2
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.5312442769350924,1.4493717471075314,0.02188183807439825,0.2594560567544215,1.0,25/61,20.33%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;NCOR2;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;ODC1;PSMB10;PSMB1;PSMB5;CAV1;PSMA6;PSMA4;OAZ2
prerank,maintenance of protein localization in organelle (GO:0072595),0.6252586731639355,1.449159493568207,0.06979695431472081,0.25947463198170495,1.0,5/19,4.37%,CHCHD10;HSPA5;AKT1;PINK1;ARL2BP
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5903100094882042,1.448937878358017,0.05043050430504305,0.2595126480636394,1.0,11/27,18.96%,RPS27A;UBC;UBB;TIRAP;UBA52;HSPD1;TLR6;TLR5;TLR1;CD14;TAB1
prerank,regulation of establishment of planar polarity (GO:0090175),0.5169040416462538,1.4486541594646536,0.017653167185877467,0.259626469493323,1.0,43/88,26.48%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;RAC1;PSMD1;PSMC3;PSMD6;PSMA7;AP2M1;PFN1;CLTC;PSMD5;AP2S1;WNT5A;PSMB9;PSMD13;PSMB3;PSMB11;RHOA;PSMB10;TIAM1;PSMB1;PRICKLE2;ARRB2;PSMB5;ARHGEF19;PSMA6;PSMA4;FZD1;FZD2;AP2A1;PSMD9;PARD6A;WNT7A;PSMC1;PSMD4;CELSR3;FZD3;PSMB2;PSMD10
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5337726521340286,1.4480443028134065,0.024891774891774892,0.2604181994684652,1.0,16/57,18.25%,PSAP;MTNR1A;GNAI2;NPY1R;GPR37L1;FLNA;GRM8;GRM7;P2RY12;GNAI1;CHRM3;CHRM2;ADCY4;ADCY8;CHRM5;GRM4
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.6161832686539348,1.4480300814415625,0.0468557336621455,0.2599361600903928,1.0,13/24,16.77%,TYROBP;GRN;ATF4;PRNP;TNF;CTNNB1;NUPR1;CDK5R1;BAX;FBXW7;CDK5;CCL3;BACE1
prerank,positive regulation of T cell migration (GO:2000406),0.623496077921443,1.446383705530259,0.06148055207026349,0.26316344496909977,1.0,12/20,26.60%,CXCL12;CXCL10;WNT5A;AIF1;RHOA;DOCK8;TMEM102;ADAM17;CCR2;PYCARD;APP;OXSR1
prerank,regulation of B cell differentiation (GO:0045577),0.636786420995637,1.4463690242076528,0.05151915455746367,0.2626836538177611,1.0,11/17,27.21%,ZFP36L1;ZFP36L2;IKZF3;MMP14;SYK;SFRP1;INHBA;ID2;PPP2R3C;INHA;XBP1
prerank,DNA-dependent DNA replication (GO:0006261),0.5045453771123817,1.4460264744083493,0.0020325203252032522,0.2629635849572711,1.0,51/128,27.80%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;PSMC3;MCM5;PSMD6;PSMA7;RPA2;CDC34;UBA52;GMNN;PSMD5;PSMB9;PSMD13;PSMB3;POLE4;PSMB11;PSMB10;RFC2;RECQL5;PSMB1;PSMB5;POLD4;PSMA6;PSMA4;RFC4;POLG;GINS3;BLM;CDC45;PSMD9;PSMC1;PNKP;POLD1;PSMD4;RPAIN;RPA3;RAD51;PSMB2;PSMD10;POLE3;PSMC5;MCM7;MCM2
prerank,regulation of viral genome replication (GO:0045069),0.5326407352847641,1.4457995157585217,0.024838012958963283,0.2629979994231225,1.0,23/56,24.37%,IFITM3;PPIA;IFITM2;IFITM1;SHFL;TNF;ISG15;PROX1;IFIT1;DDB1;BANF1;PABPC1;BST2;PDE12;OAS3;RAD23A;FAM111A;RSAD2;ISG20;TNIP1;VAPB;CD28;BTBD17
prerank,fatty acid transport (GO:0015908),0.6448566123119278,1.4448143893459373,0.056338028169014086,0.2647262861288385,1.0,3/17,9.00%,APOE;FABP5;MFSD2A
prerank,ribosomal subunit export from nucleus (GO:0000054),0.672076234808125,1.4445894387284743,0.056451612903225805,0.2647379124814104,1.0,5/13,14.95%,RPS15;NPM1;RAN;XPO1;NUP88
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.668699688259962,1.4443139922657475,0.07493188010899182,0.264843233307067,1.0,5/12,9.21%,SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5501228661151432,-1.444248669074078,0.09293680297397769,0.46004919257406707,1.0,4/12,14.46%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5501228661151432,-1.444248669074078,0.09293680297397769,0.46004919257406707,1.0,4/12,14.46%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5501228661151432,-1.444248669074078,0.09293680297397769,0.46004919257406707,1.0,4/12,14.46%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,macrophage chemotaxis (GO:0048246),0.7055283559571955,1.4441662386356864,0.0618705035971223,0.264652197641579,1.0,4/10,19.23%,LGALS3;CCL2;CCL3;CXCL17
prerank,regulation of activated T cell proliferation (GO:0046006),0.5860511369364757,1.4436505217982647,0.042704626334519574,0.2653651438396979,1.0,9/30,15.76%,RPS3;PRNP;IL2;PRKAR1A;CD24;HMGB1;ICOSLG;IGFBP2;IGF2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.5725639669770589,1.4432978455681311,0.052443384982121574,0.2656093495570489,1.0,13/31,22.26%,HSPA8;HSPA5;TMBIM6;HSPA1B;HSPB8;BAX;HSPA1A;DAB2IP;HSPA2;STUB1;BAK1;HSPA9;PTPN1
prerank,monocyte chemotaxis (GO:0002548),0.5758795311057658,1.4429576950164547,0.023837902264600714,0.2658772746879934,1.0,13/32,25.58%,RPS19;CCL19;PDGFB;LGALS3;CCL2;FOLR2;CCL3;FLT1;CCL8;IL6;PTPRO;TNFRSF11A;CX3CL1
prerank,peptide hormone secretion (GO:0030072),0.5878478334233452,1.4429234273495657,0.05066344993968637,0.26542618102410687,1.0,8/26,19.80%,PARK7;PTPRN;LTBP4;RIMS2;MAFA;EDN3;ADCYAP1;IL6
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5735157880980164,1.4427679994719027,0.03981264637002342,0.26530393590323587,1.0,14/32,25.58%,AKAP6;GPER1;GRIN1;APLNR;P2RX7;THY1;CXCL10;RAMP3;TRPC1;CAV1;SNCA;CAPN3;F2RL3;CX3CL1
prerank,positive regulation of ERAD pathway (GO:1904294),0.6824152834794551,1.4405493088301144,0.06545961002785515,0.26992046018900656,1.0,8/13,21.59%,UBQLN2;RNFT1;SGTA;CAV1;HERPUD1;BCAP31;TMEM259;USP13
prerank,negative regulation of cartilage development (GO:0061037),-0.530425507753677,-1.4402977958546883,0.07905138339920949,0.46592741532797927,1.0,8/13,21.58%,ADAMTS12;EFEMP1;TGFBR1;WNT11;CHADL;WNT9A;PTPN11;ADAMTS7
prerank,positive regulation of calcium ion import (GO:0090280),0.6769952080105684,1.4402549152832977,0.07133058984910837,0.27000089830987833,1.0,7/12,19.74%,CXCL12;PDGFB;LGALS3;RAMP3;CCL2;CCL3;SPHK2
prerank,negative regulation of viral transcription (GO:0032897),0.6600324107803143,1.4400190999286357,0.09115281501340483,0.270015235133273,1.0,5/13,19.05%,IFITM3;ZFP36;HEXIM1;TRIM32;TRIM13
prerank,positive regulation of cellular senescence (GO:2000774),0.7076942261022268,1.4398191441404262,0.06114130434782609,0.2699169526047458,1.0,2/10,2.32%,B2M;YPEL3
prerank,myeloid cell activation involved in immune response (GO:0002275),0.639177811882558,1.4389231048126088,0.0697084917617237,0.2714462025923178,1.0,7/18,21.99%,TYROBP;DOCK2;FCER1G;KARS1;SYK;PYCARD;LBP
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.49197364359647244,-1.4384533118934517,0.05855855855855856,0.4663326621620221,1.0,8/17,14.58%,NOTCH2;ACVR1;BMPR1A;GALNT11;RBPJ;BMP4;JAG1;HEY2
prerank,macrophage activation involved in immune response (GO:0002281),0.6880049241690724,1.438125245750163,0.06873315363881402,0.27273782393893553,1.0,3/13,2.59%,TYROBP;GRN;TREM2
prerank,regulation of protein metabolic process (GO:0051246),0.5518683906517423,1.4372262082308587,0.030751708428246014,0.2742968027537501,1.0,12/44,13.04%,APOE;HSP90AB1;KLF2;LTBP4;FKBP1A;CHEK2;GSAP;NEDD8;CHMP6;WFS1;ODC1;KLF4
prerank,regulation of macrophage migration (GO:1905521),0.7110448561511631,1.4362501839014554,0.06433566433566433,0.2760247931643461,1.0,3/10,14.47%,CD81;P2RY12;CX3CR1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5360025531814406,1.435490949256123,0.03303964757709251,0.2772147477894962,1.0,24/55,20.10%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;GPR132;PSMD5;RBX1;PSMB9;PSMD13;ATF5;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;PSMA6;SKP1;PSMA4
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6371647329054929,1.4354019131972744,0.07040417209908735,0.2769257909444107,1.0,11/17,21.57%,MDK;SERPINE2;HES1;TENM4;CXCR4;BMP2;PTPRZ1;TGFB1;NOTCH1;ID2;PTN
prerank,type I interferon signaling pathway (GO:0060337),0.5555542893434392,1.4353736895325975,0.04288939051918736,0.2759244123886735,1.0,16/41,22.44%,IFITM3;IFITM2;IFITM1;PSMB8;ISG15;IFIT1;EGR1;IRF8;IRF7;BST2;OAS3;IRF9;IFI27;RSAD2;IRF5;ISG20
prerank,cellular response to type I interferon (GO:0071357),0.5555542893434392,1.4353736895325975,0.04288939051918736,0.2759244123886735,1.0,16/41,22.44%,IFITM3;IFITM2;IFITM1;PSMB8;ISG15;IFIT1;EGR1;IRF8;IRF7;BST2;OAS3;IRF9;IFI27;RSAD2;IRF5;ISG20
prerank,myeloid cell differentiation (GO:0030099),0.5443995192918061,1.4349946300729253,0.033632286995515695,0.27624068924317385,1.0,11/47,11.33%,RPS14;RPS19;SLC25A5;HCLS1;SPI1;ATP5IF1;TIRAP;HIPK2;CEBPA;IKZF1;IL11
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6281248372090864,1.4346465463278686,0.054707379134860054,0.2764619020458501,1.0,4/19,15.87%,APOE;RAPSN;CHRNA4;ACHE
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.5923721910061139,1.4346451675739207,0.05368289637952559,0.27594564787926035,1.0,9/23,23.63%,GPX4;GSTM1;FADS1;GSTM2;ACOT7;LTC4S;ASAH2;ELOVL6;CYP2E1
prerank,negative regulation of chemokine production (GO:0032682),0.6582994119928041,1.4344232569274968,0.057971014492753624,0.27592455906928165,1.0,7/14,19.80%,APOD;SIRPA;KLF4;F2RL1;SIGIRR;OAS3;IL6
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5368460066959085,1.4342041442258828,0.03066812705366922,0.27585230849140635,1.0,19/51,19.80%,MDK;CALR;CXCL12;MAPK3;LGMN;RARRES2;CREB3;CXCL10;PLA2G7;HMGB1;CSF1R;AIF1;GAS6;F2RL1;EDN3;ADAM17;CCR2;CXCL17;IL6
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.4295329091683973,-1.4336884936404908,0.05521472392638037,0.4738449023160874,1.0,7/27,12.90%,KAT6B;CREBBP;KAT7;KAT2B;PHF20L1;BRD8;KAT6A
prerank,positive regulation of protein binding (GO:0032092),0.5319802426744562,1.4335659842771529,0.02258064516129032,0.27676669498100215,1.0,11/56,6.50%,APOE;RPL11;B2M;CLDN5;VTN;RAN;FKBP1A;PIN1;FLOT1;ADD2;HIPK2
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5045908906323154,1.4335254723267778,0.008238928939237899,0.27634308475104824,1.0,41/112,20.93%,CLU;TYROBP;HSPB1;CCL19;CYBA;CD34;POMC;PTPRC;MIF;SIRPA;DDT;TIRAP;TNFAIP3;LPL;SYT11;VSIR;LILRA5;HMGB1;ZFP36;MC1R;WNT5A;C1QTNF4;LILRB1;GAS6;CX3CR1;IFNGR1;PF4;TLR1;RASGRP1;CCL3;TWIST1;OAS3;SYK;CD14;CCR2;PTPN6;SPHK2;IL6;TMEM106A;SELENOS;PYCARD
prerank,activation of protein kinase B activity (GO:0032148),0.58299647225278,1.4332346709358839,0.05548854041013269,0.27651248205389806,1.0,9/29,4.47%,PPIA;MT3;PARK7;AKT1;TXN;NRG1;PINK1;PDGFB;ANG
prerank,activin receptor signaling pathway (GO:0032924),-0.5084165849256398,-1.4331351388009979,0.06741573033707865,0.47104871744123983,1.0,6/15,16.55%,SMAD3;ACVR1;TGFBR1;SMAD2;ACVR2A;ACVR2B
prerank,negative regulation of immune effector process (GO:0002698),0.6614432998079365,1.4327940670573502,0.07212205270457697,0.277031798516047,1.0,3/13,4.11%,RPS19;GRN;LGALS3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6805347249084543,1.4322866604278215,0.07909604519774012,0.27766520208185763,1.0,4/13,7.00%,CD81;TMEM30A;SORL1;SAR1A
prerank,regulation of autophagosome maturation (GO:1901096),-0.528276899028924,-1.431977480947985,0.07364341085271318,0.4696734792077035,1.0,7/13,23.75%,CLEC16A;UVRAG;CLN3;RUBCN;TMEM39A;ADRB2;PHF23
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.49023460099631033,-1.4319757568351017,0.0611353711790393,0.46555353640763597,1.0,6/16,13.15%,RBFOX2;ARID1A;ESR1;AR;DDX17;PPARGC1B
prerank,negative regulation of neurogenesis (GO:0050768),0.565221762117657,1.4317042160544287,0.04088785046728972,0.2785351044568499,1.0,16/34,23.39%,ARHGDIA;B2M;TNF;YWHAH;RTN4;SORL1;LRP4;THY1;GDI1;RHOA;IL6;NOTCH1;PTN;MAG;REST;WNT7A
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5309356634609926,1.4305990285054397,0.03296703296703297,0.28055411796413193,1.0,18/48,20.66%,CALM1;CALM3;AKAP6;GPER1;FKBP1A;APLNR;GSTO1;THY1;CXCL10;GSTM2;JPH4;TRPC1;FKBP1B;SRI;SELENON;CALM2;SNCA;CAPN3
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.6436933841240651,1.4304078333835362,0.06744487678339818,0.2804851536294868,1.0,4/16,10.91%,C3;GPER1;KLK6;CHGA
prerank,regulation of mononuclear cell migration (GO:0071675),0.6011919085370337,1.4303702535689533,0.06511056511056511,0.2800457500948729,1.0,8/23,11.69%,MDK;MAPK3;TNF;LGALS3;RARRES2;MSN;CSF1R;AIF1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.3859067654604147,-1.430166530050821,0.018018018018018018,0.46587505290158854,1.0,14/43,14.78%,SORBS1;PID1;SIK2;TNS2;OGT;IRS1;GRB10;KANK1;NCK1;ENPP1;PTPN2;PIP4K2C;SIRT1;PRKCB
prerank,positive regulation of synapse assembly (GO:0051965),0.5808913342141496,1.4300597900390344,0.05090909090909091,0.28026896026215364,1.0,15/27,23.39%,NRXN1;NLGN1;GRID2;IL1RAPL1;SEMA4A;PTPRD;SYNDIG1;LRRC4B;EPHB1;CLSTN2;CLSTN1;AGRN;IL1RAP;CLSTN3;WNT7A
prerank,cellular response to superoxide (GO:0071451),0.706073287253951,1.4293197894072251,0.06610407876230662,0.2814038999491512,1.0,4/10,9.77%,MT3;SOD1;PRDX2;PRDX1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5163280953006011,1.4287874176193238,0.023529411764705882,0.28204789937553465,1.0,16/71,13.25%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;RAC1;FCER1G;ELMO1;PAK1;ARPC1B;FCGR1A;HCK;ARPC3;VAV1;ARPC5;VAV3
prerank,antibacterial humoral response (GO:0019731),0.6508396613912131,1.4286028724078454,0.0728476821192053,0.28199289520655496,1.0,2/16,4.47%,RPL39;ANG
prerank,positive regulation of synaptic transmission (GO:0050806),0.5124100360408878,1.428262009115933,0.029946524064171122,0.28232499369663433,1.0,32/72,21.91%,LGMN;NRXN1;NLGN1;GPER1;SLC24A2;TNF;MPP2;SHISA7;GRIK2;FLOT1;SYT1;LGI1;RIMS2;RIMS1;GRIN2A;VAMP2;HAP1;CCL2;ADRA1A;SQSTM1;ADCY8;CLSTN2;CACNG8;CLSTN1;GRIN2B;CCR2;CACNG5;STX4;KCTD13;ZDHHC12;CLSTN3;STX1B
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.5502037105664727,1.4282442800837787,0.05128205128205128,0.2818461191421001,1.0,10/39,13.50%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1;PCNA;RFC2
prerank,positive regulation of viral life cycle (GO:1903902),0.6023503194247638,1.4279111215041378,0.05808080808080808,0.28208134327488493,1.0,7/22,18.07%,CD74;LGALS1;CHMP2B;P4HB;DDB1;TYRO3;VPS4A
prerank,phospholipid homeostasis (GO:0055091),0.687135126879697,1.4271388414724313,0.07053941908713693,0.2833636524808108,1.0,3/11,6.78%,RCN3;ABCG1;LIPG
prerank,triglyceride metabolic process (GO:0006641),0.5291266201052732,1.4271148544509316,0.04161979752530934,0.28288727407664344,1.0,7/48,7.81%,APOE;PNPLA2;APOC1;FABP5;PLAAT3;LIPG;LPL
prerank,heart contraction (GO:0060047),0.5517696919403343,1.42685792316773,0.03534777651083238,0.2829691457564773,1.0,12/41,19.29%,GPX1;SOD1;SGCZ;SCN4B;GAA;TNNI1;KCNE5;SLC8A1;ATP1B1;RYR2;SGCG;GRK2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5793179674574309,1.4264453420460343,0.058682634730538925,0.283355805385183,1.0,7/28,7.63%,APOE;TYROBP;LGMN;NSG1;SHISA7;FAM107A;CALB1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.6033372888737981,1.4263229598046734,0.05875,0.28307214737782593,1.0,9/22,19.74%,LAPTM5;SLC7A5;TNF;WNT5A;LILRB1;F2RL1;TRIL;CCR2;SPHK2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5037714962770167,1.4261236746794996,0.02415966386554622,0.28304078405453664,1.0,32/88,21.15%,RPS3;CLU;RACK1;MMP3;PARK7;NRG1;TNF;RHOC;LGALS3;FLOT1;TIRAP;VCP;PFN1;TFRC;MTLN;ATP13A2;PIH1D1;SDC4;BAX;CHGA;WARS1;SDCBP;DAB2IP;PFN2;CDH5;CRB3;VPS4A;SYK;TGFB1;CDC42EP2;ERCC1;BAK1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.5536855723376076,1.426073556771257,0.05889281507656066,0.2826324383433625,1.0,10/37,13.50%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1;PCNA;RFC2
prerank,camera-type eye development (GO:0043010),-0.4388390037118676,-1.4260024727300014,0.049079754601226995,0.47199667947022905,1.0,7/25,7.62%,CACNA1C;FBN1;SHROOM2;SKI;LAMA1;EFEMP1;CEP290
prerank,regulation of immune response (GO:0050776),0.4948261044409414,1.4258012892601177,0.0061162079510703364,0.2827875633611781,1.0,33/135,18.30%,B2M;IFITM1;CD81;TYROBP;COL1A1;C3;TREM2;ITGB2;CD34;FKBP1A;TIRAP;SPPL2B;SELL;CD3D;COL3A1;CD22;NPDC1;FCGR1A;FGL1;COL1A2;CD300LG;ELMOD2;IRF7;LILRB1;NCR1;TRAF3;CD300LF;LRP8;PIANP;OSCAR;VCAM1;CD300A;SYK
prerank,lipoxygenase pathway (GO:0019372),0.6497585517707143,1.4240536125234888,0.06477732793522267,0.2864268707935201,1.0,2/14,1.19%,GPX4;GPX1
prerank,positive regulation of binding (GO:0051099),0.5108683625619262,1.423702404435012,0.015608740894901144,0.28668974833281186,1.0,24/84,14.60%,APOE;RPL11;B2M;CLDN5;VTN;TXN;NME1;RAN;FKBP1A;PIN1;FLOT1;ADD2;HES1;HIPK2;GMNN;EDF1;DPH3;HMGB1;DDX11;CLN5;BMP2;RIPK2;STMN1;TIAM1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.6319669872982543,1.4232462459424606,0.07114624505928854,0.28724770950513007,1.0,8/18,16.79%,CHCHD10;SLC25A5;FZD9;TMEM14A;BAX;ACAA2;HSPA1A;TMEM102
prerank,translesion synthesis (GO:0019985),0.5509715729679462,1.4229990216618644,0.03530751708428246,0.28726308508682724,1.0,7/42,6.99%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.6910242406642841,1.422576850292435,0.07777777777777778,0.28770003696653657,1.0,5/11,18.82%,TYROBP;ITGB2;SPI1;F2RL1;STX4
prerank,peptidyl-proline modification (GO:0018208),0.5811055195522505,1.4221675974996466,0.07343941248470012,0.2881371603136783,1.0,6/25,5.59%,PPIA;PPIB;FKBP1A;PIN1;FKBP10;FKBP7
prerank,cellular response to leucine (GO:0071233),-0.5722229533166219,-1.4221441422754832,0.09897610921501707,0.47285215130740244,1.0,8/10,25.19%,UBR1;UBR2;SESN1;LARS1;KLHL22;RPTOR;SESN2;SESN3
prerank,response to leucine (GO:0043201),-0.5722229533166219,-1.4221441422754832,0.09897610921501707,0.47285215130740244,1.0,8/10,25.19%,UBR1;UBR2;SESN1;LARS1;KLHL22;RPTOR;SESN2;SESN3
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6713251713494984,1.4220565410422021,0.0955137481910275,0.28787251167695593,1.0,7/12,24.60%,CCT2;CCT7;CCT8;DKC1;GNL3L;CCT4;CCT3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.512752483058687,1.4202686414216588,0.029946524064171122,0.2915195721670131,1.0,16/73,13.25%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;RAC1;FCER1G;ELMO1;PAK1;ARPC1B;FCGR1A;HCK;ARPC3;VAV1;ARPC5;VAV3
prerank,pulmonary valve development (GO:0003177),-0.47453623318635896,-1.4199992775718075,0.0970873786407767,0.47417401621221733,1.0,9/18,16.38%,NOTCH2;SMAD6;ROBO1;SLIT2;NFATC1;BMP4;JAG1;HEY2;BMPR2
prerank,macrophage activation (GO:0042116),0.5717417913066034,1.4194091815827088,0.05293440736478711,0.29304843885886045,1.0,19/34,25.58%,CLU;C1QA;TREM2;ITGB2;TNF;C5AR1;CD93;MAPT;AIF1;SLC11A1;IFNGR1;TLR1;SYK;SNCA;TMEM106A;LBP;APP;AGER;CX3CL1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4633717151880034,-1.4183852222229332,0.09313725490196079,0.4742108830073709,1.0,7/19,16.80%,NFAT5;PLCE1;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,negative regulation of lymphocyte activation (GO:0051250),0.6063481003465406,1.4182644714883021,0.0695322376738306,0.2953853144839341,1.0,6/21,10.31%,LAPTM5;GPNMB;LGALS3;DUSP3;TNFAIP3;FGL1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6755933213975969,1.4181536585630357,0.07417582417582418,0.2950959774157138,1.0,7/12,23.93%,APOC1;P4HB;MFSD2A;SOAT2;ACSL3;DGAT1;MTTP
prerank,BMP signaling pathway (GO:0030509),-0.3443998218351904,-1.4175599441346518,0.0,0.47241072531854367,1.0,21/62,16.55%,BMP6;TGFBR3;SMAD3;SMAD6;ACVR1;BMPR1A;SMAD9;SMURF1;SMAD1;SMAD7;GDF1;PDCD4;RGMA;SMAD4;HIVEP1;BMP4;TGFB3;SMAD2;ACVR2A;BMPR2;ACVR2B
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4966587487315142,1.4172434047866822,0.014373716632443531,0.2967817867698177,1.0,24/108,11.91%,RPS3;MTCH1;CTSD;RACK1;GSN;LAPTM5;NDUFA13;RPS27L;HSPE1;GPER1;TNF;S100A8;S100A9;ST18;VCP;BEX3;DLC1;HSPD1;FOXL2;MAPT;HMGB1;BAX;PDCD6;PMAIP1
prerank,positive regulation of T cell proliferation (GO:0042102),0.5280535417231229,1.4172233985118736,0.03862660944206009,0.29630454903139397,1.0,22/55,24.85%,RPS3;CCL19;PTPRC;TFRC;IL2;CD24;HMGB1;ICOSLG;PNP;AIF1;IGFBP2;IGF2;VCAM1;SYK;CCR2;CD86;IL6;PYCARD;CD276;IL12RB1;CD28;AGER
prerank,stem cell differentiation (GO:0048863),-0.38265110448868633,-1.4171742898950521,0.04032258064516129,0.4695472608919692,1.0,13/39,18.23%,MLLT3;FBXL17;SETD2;HOXB4;LRP6;JARID2;UFL1;FGFR2;KIT;TP53;BATF;PSMD11;METTL5
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5626711947816232,1.4168675418762657,0.05503512880562061,0.2966025414633362,1.0,12/33,15.61%,NRG3;NLGN1;GRID2;FABP5;GRIK5;GRIK2;CACNA1A;LRRC4C;GRID1;ABR;CX3CR1;LRP8
prerank,regulation of immunoglobulin production (GO:0002637),0.5927694745808494,1.4167260188425435,0.06748466257668712,0.2964136714022665,1.0,9/23,19.80%,RBP4;PTPRC;IL2;VAMP3;CD22;STX4;DNAJB9;CD86;IL6
prerank,regulation of amyloid-beta formation (GO:1902003),0.5626010726020882,1.416519750244692,0.045507584597432905,0.2963547874460473,1.0,10/34,7.62%,APOE;CLU;PRNP;TNF;NTRK2;PIN1;RTN4;SORL1;ABCG1;GSAP
prerank,negative regulation of RNA metabolic process (GO:0051253),0.6286703202806829,1.4163798103144432,0.06566347469220246,0.2961687114649444,1.0,5/18,6.89%,RPS13;RPS26;TMBIM6;TNF;NCOR2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.533381397708411,1.4161607359369879,0.03867403314917127,0.29610876597433383,1.0,14/50,14.04%,GPX1;MT3;PARK7;AKT1;ARL6IP1;TNF;LAMTOR5;YWHAE;BEX3;AQP1;DHCR24;PIH1D1;KLF4;GAS6
prerank,protein deneddylation (GO:0000338),0.6845421386929287,1.4160305551617003,0.09857142857142857,0.29595423769449264,1.0,3/10,14.83%,COPS7A;COPS6;COPS8
prerank,cellular response to tumor necrosis factor (GO:0071356),0.48224548659196453,1.4157643251280339,0.00101010101010101,0.29611792379552787,1.0,48/175,18.86%,TMSB4X;RPS3;PSMB4;PSME1;AKT1;CCL19;PSMB6;PSMB8;PSME2;PSMD2;GPER1;EIF5A;TNF;ZFP36L1;NR1D1;PSMD1;ZFP36L2;PSMC3;ST18;PSMD6;HYAL2;PSMA7;TNFSF12;PSMD5;ZFP36;PSMB9;TXNDC17;PSMD13;PSMB3;PSMB11;PSMB10;TNFRSF1A;CCL2;ERBIN;TRAF3;YBX3;PSMB1;PLVAP;PSMB5;DAB2IP;CCL3;ADAM17;CCL8;COMMD7;TNFRSF12A;SFRP1;LTBR;PSMA6
prerank,postreplication repair (GO:0006301),0.5427962603699892,1.4156704329628995,0.041666666666666664,0.29582897091918137,1.0,12/45,16.51%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15;PCNA;NSMCE1;RFC2;UBE2V1;POLD4
prerank,regulation of BMP signaling pathway (GO:0030510),-0.3489755122723073,-1.415560609451363,0.02,0.46965790192636264,1.0,25/73,16.55%,SULF1;SMAD6;ZNF423;BMPR1A;FOXD1;CRIM1;SMURF2;SKI;BMPER;SMAD9;SMURF1;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4;RBPJ;ITGA3;BMP4;NUMA1;SMAD2;ACVR2A;BMPR2;ACVR2B
prerank,negative regulation of protein processing (GO:0010955),0.6801622988973297,1.4150292241007618,0.07649513212795549,0.29682751978635136,1.0,5/12,10.39%,CTSZ;SERPINE2;PRNP;TMEM59;GAS1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6057004091699185,1.4148524980697368,0.07528230865746549,0.29676190903155847,1.0,6/20,13.77%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6715064686234106,1.4147683685461974,0.088,0.2964448145280935,1.0,8/12,14.82%,CD74;MBP;TNF;TIRAP;LPL;HMGB1;KLF4;F2RL1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5624210529886065,1.4146268265658113,0.052508751458576426,0.2962712050994888,1.0,13/33,20.75%,APOE;CSNK2B;TNF;ACVRL1;VASH1;HMGB1;KLF4;RHOA;HDAC5;TGFB1;NOTCH1;MEF2C;GADD45A
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5339788454594527,1.4141595174532466,0.04601571268237935,0.29687246245599513,1.0,22/49,26.22%,CD74;PARK7;TNF;LAMTOR5;HSPA1B;TIRAP;HYAL2;HMGB1;HSPA1A;F2RL1;TLR5;TLR1;NOS2;SYK;CD14;IL6;PYCARD;DDIT3;LBP;RELA;TLR7;TLR2
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5726298674343355,-1.413866522085409,0.10583941605839416,0.4695921546913654,1.0,5/10,16.59%,MLLT3;HOXB4;UFL1;TP53;BATF
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.5376294886539235,1.4131763746878954,0.05632183908045977,0.2986302186030124,1.0,12/40,11.91%,UBB;PARK7;SOD1;AKT1;PINK1;ATP5IF1;VCP;MTLN;MAPT;TUSC2;BAX;PMAIP1
prerank,regulation of telomere maintenance (GO:0032204),-0.4405204877811262,-1.413032280990281,0.040697674418604654,0.46763129959157235,1.0,9/26,16.69%,SMG6;DHX36;SMG1;HDAC8;PML;YLPM1;TERF2;TINF2;RTEL1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4896052312800853,1.4130013709445943,0.009249743062692703,0.29849374600727646,1.0,42/114,24.75%,TMSB4X;PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;EIF5A;TNF;PSMD1;PSMC3;ST18;PSMD6;PSMA7;TNFSF12;PSMD5;PSMB9;TXNDC17;PSMD13;PSMB3;PSMB11;PSMB10;TNFRSF1A;TRAF3;PSMB1;PLVAP;PSMB5;ADAM17;COMMD7;TNFRSF12A;LTBR;PSMA6;PSMA4;NFKBIA;PYCARD;TNFRSF9;PSMD9;PSMC1;RELA;TNFRSF13B;PSMD4;TNFRSF11A
prerank,T cell migration (GO:0072678),0.6547757471661879,1.4127125075743459,0.09336941813261164,0.2987071144145086,1.0,8/13,24.69%,S1PR1;MSN;CXCL16;CXCL10;CCL3;PIK3CD;GPR183;MYO1G
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.5623836944772117,1.4126184997904536,0.06563245823389022,0.2984215026962294,1.0,10/31,19.63%,TYROBP;GPNMB;CEBPB;SDC4;CTLA4;LILRB1;CD300A;SOX11;LST1;CD86
prerank,detection of calcium ion (GO:0005513),0.6616404674264861,1.411110851579209,0.07260273972602739,0.3015523316582252,1.0,5/13,18.67%,CALM1;CALM3;SYT1;RYR2;CALM2
prerank,positive regulation of cell communication (GO:0010647),0.5719429667658076,1.4105583840234275,0.06038647342995169,0.30238503992261995,1.0,15/28,21.23%,ANK3;TNF;GRIK2;SYT1;LGI1;RIMS2;RIMS1;HCRT;EDN3;CLSTN2;CLSTN1;NMB;SOX11;KCTD13;CLSTN3
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.5925704414013636,1.4101476807591582,0.06731946144430845,0.3028497431498675,1.0,8/23,11.45%,SEC61B;HSP90B1;AUP1;VCP;LMAN1;SURF4;TMED9;SYVN1
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5166846304496853,-1.409463760997432,0.0992063492063492,0.47236685166478803,1.0,7/13,18.91%,LARGE1;OGA;PGM3;MGAT3;RENBP;CHST3;NAGK
prerank,relaxation of cardiac muscle (GO:0055119),0.6598811906520397,1.4091146389562539,0.08333333333333333,0.3049046652919157,1.0,8/13,15.84%,GSN;RGS2;PLN;CHGA;GSTM2;ATP1A1;SLC8A1;ATP1B1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.678469415235803,1.4082463066002948,0.09612625538020086,0.306448709583543,1.0,2/10,2.56%,CALM1;CALM3
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5977397854750527,1.4081524919100856,0.08990147783251232,0.30617096440065095,1.0,10/21,20.73%,MT3;MAPK3;ZFP36L1;ZFP36L2;KDR;KARS1;SOX9;CTSH;MAP2K2;MYC
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6021435425468783,1.4080407751046566,0.06832298136645963,0.3058892356539702,1.0,7/22,17.21%,MBP;TNF;FLOT1;MYADM;THY1;KLF4;SKAP1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.5594353833512132,1.4073696442682286,0.05995203836930456,0.3069470214489311,1.0,15/34,22.68%,AKT1;GRID2;MPP2;GABRG3;GRIN1;GABRA2;GRIN2A;GABRA3;GLRA1;CHRNA4;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,negative regulation of leukocyte activation (GO:0002695),0.6408685860291548,1.4071753262804385,0.08198924731182795,0.30691354916048036,1.0,4/15,4.56%,GRN;GPER1;CD84;LRFN5
prerank,prostanoid biosynthetic process (GO:0046457),0.6346943173395445,1.4067776231428035,0.08650065530799476,0.3073553551066534,1.0,4/15,8.30%,CD74;PTGDS;MIF;PRXL2B
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.5429358516167301,1.4064514008989992,0.048943270300333706,0.3076196222826976,1.0,7/42,6.99%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6523969301886309,1.406214121414899,0.10014306151645208,0.3077300278255476,1.0,1/13,0.02%,TMSB4X
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.43190301299740874,-1.4062081994870554,0.08602150537634409,0.47678556814378664,1.0,12/25,21.55%,SF3B1;TRA2B;MPHOSPH10;SRRM1;SCAF11;PRPF3;SF3B3;PRPF4;SLU7;DDX23;LSM1;PRPF6
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6465529863859569,1.4058437745798924,0.07848443843031123,0.30810650870249967,1.0,9/15,22.30%,GPER1;ZFP36L1;ZFP36L2;FAM107A;SSTR4;ZFP36;HNRNPU;SSTR2;REST
prerank,regulation of viral transcription (GO:0046782),0.535812691375138,1.4057614840770405,0.06417736289381563,0.3077453655851934,1.0,15/39,21.65%,IFITM3;POLR2E;POLR2D;POLR2F;NELFCD;ZFP36;POLR2G;SUPT4H1;POLR2K;HEXIM1;NELFE;TRIM32;TRIM13;CDK9;POLR2H
prerank,connective tissue development (GO:0061448),-0.3876703138749844,-1.4055680420630248,0.03816793893129771,0.47476105708391064,1.0,11/35,11.54%,SULF1;SOX5;ZBTB16;LRP5;SLC39A13;ATP7A;ARID5B;ITGB8;PKD1;SPTLC2;CREB3L2
prerank,central nervous system neuron differentiation (GO:0021953),0.5589730571499593,1.4047839460902751,0.055944055944055944,0.30958921565845615,1.0,10/33,9.19%,MDGA2;GRID2;NTRK2;KNDC1;CTNNB1;SPOCK1;PROX1;FAIM2;MAPT;MAP2
prerank,glycosphingolipid metabolic process (GO:0006687),0.5338506678907,1.4044440635538897,0.05061867266591676,0.30985240713472173,1.0,13/42,16.27%,PSAP;GM2A;HEXB;HEXA;B4GALNT1;SMPD1;B4GALT6;CTSA;CLN6;GLTP;ABCA2;NEU1;ST6GALNAC3
prerank,cGMP-mediated signaling (GO:0019934),0.6556490950486864,1.4027135491685505,0.09054593874833555,0.31340375473427556,1.0,3/13,9.16%,APOE;AQP1;HTR2C
prerank,DNA dealkylation (GO:0035510),-0.5757765165697633,-1.401973694694675,0.09574468085106383,0.47608232402849077,1.0,6/10,18.72%,FTO;ASCC3;ASCC1;MGMT;ALKBH3;MPG
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.5757765165697633,-1.401973694694675,0.09574468085106383,0.47608232402849077,1.0,6/10,18.72%,FTO;ASCC3;ASCC1;MGMT;ALKBH3;MPG
prerank,"phagocytosis, engulfment (GO:0006911)",0.5446473929291381,1.4017275656787014,0.07142857142857142,0.31527574085530896,1.0,11/36,12.09%,GSN;ITGB2;RAC1;ARHGAP25;ELMO1;RHOG;XKR4;FCGR1A;ADGRB1;AIF1;MSR1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.5076568436915166,1.4016467806519857,0.035751840168243953,0.314945915518225,1.0,25/75,16.57%,ACTB;S100A6;DCC;S100B;ANK3;CTNNA2;MAP1A;CNTN4;LRP4;NEFH;NRCAM;MFSD2A;MAP2;PAK3;ADGRB1;APBB1;TMEM106B;SHTN1;CCK;MAPK8IP2;CDHR1;SPTBN4;CDK5;DSCAML1;BRSK2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.6720316710169938,1.401214693410774,0.0993006993006993,0.3154345533287826,1.0,4/11,7.50%,MMP3;PARK7;PINK1;P4HB
prerank,cellular response to dsRNA (GO:0071359),0.6289803744868909,1.400628071513758,0.09630606860158311,0.3163416096699877,1.0,7/15,21.26%,NPM1;FLOT1;PQBP1;IFIT1;PDE12;CAV1;RALB
prerank,response to glucocorticoid (GO:0051384),0.5768602876040791,1.4001865918567906,0.06934306569343066,0.31685994296929276,1.0,14/26,22.30%,TNF;ZFP36L1;ZFP36L2;FAM107A;SSTR4;ZFP36;HSD3B2;HNRNPU;PDCD7;SLIT3;IL6;GOT1;SSTR2;REST
prerank,positive regulation of macrophage migration (GO:1905523),0.6111056784525867,1.4001562293196088,0.0792838874680307,0.3164002512928079,1.0,8/19,19.23%,MDK;MAPK3;TREM2;RARRES2;P2RY12;CSF1R;CCL3;CXCL17
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.49188675840280394,1.3997999174691538,0.022540983606557378,0.3162020906570549,1.0,33/104,20.10%,PSMB4;TYROBP;PSME1;PSMB6;PSMB8;PSME2;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;PSMA6;TAB1;MUC1;SKP1;PSMA4
prerank,cellular response to lectin (GO:1990858),0.49188675840280394,1.3997999174691538,0.022540983606557378,0.3162020906570549,1.0,33/104,20.10%,PSMB4;TYROBP;PSME1;PSMB6;PSMB8;PSME2;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;PSMA6;TAB1;MUC1;SKP1;PSMA4
prerank,apoptotic mitochondrial changes (GO:0008637),0.5575601241057752,1.3996501779133743,0.07048984468339307,0.3160653366153012,1.0,14/32,21.15%,CLU;ERBB4;FZD9;HSPD1;BAX;BBC3;TIMM50;BAD;MFF;DNM1L;CCAR2;THEM4;FIS1;BAK1
prerank,phospholipid catabolic process (GO:0009395),0.5795112693652522,1.3992057504563282,0.07035175879396985,0.31661639150798654,1.0,13/24,25.18%,PRDX6;LIPG;ENPP2;SMPD1;PLA2G4F;GDE1;SMPDL3A;PLBD2;GPCPD1;GDPD1;ENPP6;GDPD3;ABHD12
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4760241568976299,-1.3991821075409108,0.11946902654867257,0.4755247830869918,1.0,4/17,7.18%,BRWD1;STAT5B;IRS1;STAT3
prerank,cellular response to interleukin-7 (GO:0098761),-0.4760241568976299,-1.3991821075409108,0.11946902654867257,0.4755247830869918,1.0,4/17,7.18%,BRWD1;STAT5B;IRS1;STAT3
prerank,fluid transport (GO:0042044),0.6620268082372502,1.399066196776734,0.09349593495934959,0.3164350317352318,1.0,2/12,8.63%,AQP4;AQP1
prerank,innate immune response in mucosa (GO:0002227),0.6910653156302079,1.3990604297289433,0.0912863070539419,0.3159393938886507,1.0,1/10,0.47%,RPL39
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5266150465641495,1.398818157884754,0.06002265005662514,0.3160456501363796,1.0,21/49,22.02%,RACK1;NDUFA13;PINK1;S100A8;S100A9;P4HB;NUPR1;BAX;PMAIP1;BBC3;BAD;CAV1;HERPUD1;DNM1L;BCAP31;NDUFS3;RTKN2;PYCARD;FIS1;DDIT3;PTPMT1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.5025673827158855,1.398207153219347,0.0322234156820623,0.31695431220200426,1.0,22/72,16.15%,PSMB4;PSME1;AKT1;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;PSMC3;TIRAP;PSMD6;PSMA7;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;TLR6;COPS8;PSMB1;PSMB5
prerank,spermatid development (GO:0007286),-0.4014780475257717,-1.3979908357809177,0.06369426751592357,0.47468254111050856,1.0,18/32,32.32%,CDYL;RNF8;ING2;NECTIN2;RFX2;JAM2;SYCP3;CIB1;ZMYND15;MKKS;YTHDC2;DPY19L2;TDRD5;CCDC63;ACRBP;RSPH1;SOX30;TTC21A
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5912430957852972,1.397897692169038,0.07868020304568528,0.31718768932954405,1.0,4/22,4.03%,CALM1;GPNMB;CALM3;PDGFB
prerank,prostaglandin metabolic process (GO:0006693),0.5721974525776469,1.3976345845359137,0.07367149758454106,0.31730398178471036,1.0,7/26,15.09%,CD74;PTGDS;GSTM1;MIF;PRXL2B;HPGDS;PTGES3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.569764625773846,1.397378819258431,0.07496977025392987,0.31744657868802717,1.0,10/27,12.80%,SLC38A5;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC25A29;SLC6A5;SLC3A2;SLC25A22;SLC1A1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5288835789745444,1.3971539789539915,0.060335195530726256,0.3174476917613734,1.0,21/52,24.83%,CXXC1;ACADVL;HSPA5;CTDSP2;PDIA6;SSR1;SYVN1;DDX11;SERP1;WFS1;KLHDC3;DCTN1;DNAJB11;LMNA;DNAJB9;YIF1A;HYOU1;MYDGF;TLN1;VAPB;DNAJC3
prerank,glycolipid metabolic process (GO:0006664),0.5261751847485489,1.3969648289728112,0.04638009049773756,0.317367452652025,1.0,13/47,16.74%,PSAP;GM2A;HEXB;HEXA;B4GALNT1;SMPD1;FUCA1;CTSA;GLTP;ABCA2;NEU1;ST6GALNAC3;SCCPDH
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.48113456583331315,1.3969383424601884,0.005060728744939271,0.31693292591757577,1.0,38/152,17.62%,PSAP;MTNR1A;RAMP2;GNAI2;NPY1R;GPER1;GPR37L1;ADGRB3;GNA11;SCTR;ADGRL3;S1PR5;S1PR1;DRD5;GPR6;ADGRG1;GRM8;RXFP1;CXCL10;VIPR1;P2RY12;GNAI1;MC1R;ADGRB1;GNAO1;CALCB;ADGRB2;RAMP3;CHRM2;ADCY4;PF4;MC5R;ADGRL4;ADRA1D;ADCY8;ADGRE1;PTGIR;ADCYAP1
prerank,glutathione metabolic process (GO:0006749),0.5424754724430741,1.3968774914974402,0.05862068965517241,0.31657620529892716,1.0,8/38,15.73%,GPX1;PARK7;SOD1;GSTM1;GSTM5;GSTM2;HPGDS;GLRX2
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5347948483206263,-1.3967702452099817,0.08992805755395683,0.4740399551389314,1.0,2/12,1.15%,PLEKHH2;LIMA1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.49083262301177555,1.396431461593808,0.020512820512820513,0.3171547475281205,1.0,33/105,20.10%,PSMB4;TYROBP;PSME1;PSMB6;PSMB8;PSME2;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;PSMA6;TAB1;MUC1;SKP1;PSMA4
prerank,divalent inorganic cation homeostasis (GO:0072507),0.581943540546719,1.3964167981005047,0.08560794044665013,0.3166853459103517,1.0,12/25,19.75%,MT3;ANK3;TMTC2;GRIN1;ATP13A2;WFS1;SLC8A1;KCNA1;CAV1;SELENON;SNCA;TFAP2B
prerank,amide transport (GO:0042886),0.5790234571551149,1.3949929355422224,0.06634499396863691,0.31959123531214084,1.0,7/26,15.35%,SLC38A5;PLTP;TAP2;GLTP;SLC14A1;SLC19A1;FOLR2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5359657307824846,1.3944342060146975,0.04853273137697517,0.3204782665983764,1.0,20/45,24.85%,TYROBP;HSPB1;CCL19;TNF;LPL;P2RX7;EGR1;LILRA5;WNT5A;RIPK2;TLR6;F2RL1;CCL3;NLRP3;IL6;TMEM106A;PYCARD;CASP1;APP;AGER
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5053849921882253,1.394044428678653,0.048283261802575105,0.3209478910227858,1.0,15/70,13.25%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;RAC1;ELMO1;PAK1;ARPC1B;FCGR1A;HCK;ARPC3;VAV1;ARPC5;VAV3
prerank,negative regulation of secretion (GO:0051048),0.6859225601121631,1.393767585489864,0.08131241084165478,0.321145738034566,1.0,4/10,12.01%,CD74;NRG1;VAMP3;VAMP8
prerank,negative regulation of cell projection organization (GO:0031345),0.5240997274159597,1.3936282935223312,0.048152295632698766,0.32099754528344454,1.0,9/48,7.15%,APOE;ITM2C;MT3;DCC;PRNP;YWHAH;SPOCK1;BAG5;CRMP1
prerank,ceramide catabolic process (GO:0046514),0.6400278914803713,1.3933480418109885,0.102880658436214,0.3211839084429461,1.0,3/14,2.90%,GM2A;HEXB;HEXA
prerank,regulation of interleukin-4 production (GO:0032673),0.5956000483399155,1.3931447824534149,0.07398273736128237,0.3212052085958998,1.0,11/21,28.35%,SLC7A5;FCER1G;CEBPB;SYK;CD86;NLRP3;DDIT3;CD28;PRKCQ;LEF1;ZFPM1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5710883386676977,1.3929511047463132,0.07509386733416772,0.32113435980644417,1.0,14/27,25.67%,BGN;BCAN;DCN;CHPF2;B3GAT3;CHPF;UGDH;XYLT1;VCAN;CHSY3;CSGALNACT2;B3GAT1;CHST9;CSPG5
prerank,protein targeting (GO:0006605),0.4791588831897962,1.392748189019563,0.029774127310061602,0.3210959124917638,1.0,32/118,18.45%,RPL11;GABARAP;TSPO;NACA;TIMM8B;TIMM13;TOMM5;NLGN1;TOMM7;AKAP6;SRP14;SEC61G;SORL1;AIP;TIMM10B;SPCS1;ICMT;CDC37;HAP1;GDAP1;SEC61A1;GOLGA7B;YIF1B;SDCBP;SPCS2;MFF;GOLGA7;PEX6;NCF1;BCAP31;LAMP2;VPS37C
prerank,adherens junction organization (GO:0034332),0.5267028943297146,1.3925008220463009,0.06284454244762955,0.3211509073717961,1.0,16/48,17.22%,ACTB;RAMP2;CADM2;ANG;CDH20;CTNNB1;CDH18;CADM3;CDH12;JAM3;DCHS1;CDH19;CDH24;CDH7;CDH10;CDH5
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.5636554636865292,1.392276386237703,0.06855791962174941,0.3211537960195529,1.0,6/29,8.86%,PPIA;HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2
prerank,insulin secretion (GO:0030073),0.6028958971664584,1.3922547400435559,0.08513341804320203,0.32069611346475807,1.0,6/19,17.62%,PARK7;PTPRN;RIMS2;PTPRN2;MAFA;ADCYAP1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.6602820311402615,1.3922317896006036,0.08916323731138547,0.3202368226117942,1.0,8/12,24.54%,CXCL12;CXCL10;AIF1;RHOA;DOCK8;TMEM102;PYCARD;APP
prerank,negative regulation of cation channel activity (GO:2001258),0.5693935916882726,1.391987271993935,0.07290400972053462,0.3203201839020912,1.0,9/26,18.67%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;CBARP;FKBP1B;SRI;CALM2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5531740964166643,1.3918293730318394,0.06227967097532315,0.32019381679714054,1.0,8/33,11.69%,RPS3;PARK7;RHOB;SIRPA;TNFAIP3;AQP1;NET1;TRPM2
prerank,interstrand cross-link repair (GO:0036297),0.5111348493508142,1.3918253820563198,0.05043859649122807,0.3197010915015326,1.0,8/53,7.87%,RPS27A;UBC;UBB;VCP;NUCKS1;RPA2;UBA52;CENPX
prerank,regulation of macrophage cytokine production (GO:0010935),0.654517850172687,1.3914373158728015,0.08904109589041095,0.3201404873391286,1.0,6/13,13.71%,CD74;LAPTM5;SEMA7A;CUEDC2;WNT5A;LILRB1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.48245229948459356,-1.390896007587529,0.0967741935483871,0.48403395989114817,1.0,6/16,14.92%,FTO;RREB1;SIX1;SIRT1;SOX13;NAPEPLD
prerank,protein K48-linked ubiquitination (GO:0070936),-0.3498444619929895,-1.3908576007794944,0.04807692307692308,0.4805921900957796,1.0,15/54,10.79%,UBE2E2;TTC3;RNF216;RNF152;UBR5;PRKN;RNF146;ARIH2;UBE2Q2;UBE2R2;RNF8;ZNRF1;TOPORS;ITCH;RNF115
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.5101170559659196,-1.3907846083413704,0.11440677966101695,0.477325429982416,1.0,6/15,8.31%,ROCK2;SLC9A1;ROCK1;CAMK2D;MEF2A;IGF1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.5048530111413003,1.3905760820086177,0.05075593952483801,0.32174182065330914,1.0,17/63,12.61%,CST3;MT3;TIMP2;AKT1;TREM2;EIF4G2;APOC1;RASIP1;SORL1;HP;NELL1;TIMP1;NUPR1;MFSD2A;MTMR9;ATRAID;TIMP3
prerank,leukocyte tethering or rolling (GO:0050901),0.6269056852741417,1.390384054499157,0.08036890645586298,0.3217316868646173,1.0,8/17,16.92%,TNF;ADD2;SELL;PODXL2;SELPLG;GCNT1;CX3CR1;VCAM1
prerank,negative regulation of cytokine production (GO:0001818),0.47698979979240796,1.3890647920359476,0.009155645981688708,0.32440996506918307,1.0,45/163,21.63%,TMSB4X;APOD;TYROBP;LAPTM5;GPNMB;PRNP;TREM2;CD34;CD84;TNF;RAC1;PTPRC;HOMER2;PIN1;SIRPA;TNFAIP3;CUEDC2;FN1;ISG15;NAV3;SYT11;VSIR;SARS1;LILRA5;HMGB1;ZFP36;SRGN;ATP2B1;KLF4;SLC11A1;LILRB1;GAS6;TLR6;F2RL1;SIGIRR;DLL1;HDAC9;INHBA;PTPN6;IL6;INHBB;SELENOS;PYCARD;TWSG1;DDIT3
prerank,receptor clustering (GO:0043113),0.571476960884335,1.3886157018773488,0.07579462102689487,0.32509196715594657,1.0,10/27,14.81%,NRXN1;NLGN1;ITGB2;DLG2;LRP4;FLNA;MUSK;THY1;NRXN2;LRRC7
prerank,myoblast fusion (GO:0007520),0.6557532570599399,1.3884843360921004,0.09530386740331492,0.3249160411444231,1.0,3/12,5.61%,CD81;ADGRB3;ADAM12
prerank,positive regulation of cellular process (GO:0048522),0.4634730086246352,1.3877876873006385,0.0,0.32611534473930276,1.0,169/565,20.93%,RPL23;RPS9;RPS4X;RPS15A;RPS19;CLDN5;CD81;MDK;HSP90AB1;GRN;CALR;H3-3A;GNAI2;CAPNS1;MT3;CXCL12;TSPAN31;AKT1;RPS6;LGMN;S100B;TREM2;AKAP6;CYBA;SLC25A5;NRG1;EIF4G2;CCND2;DOCK2;TGM2;ERBB4;NPM1;COPS9;S100A13;GPER1;COX17;TNF;EMP2;ZFP36L1;MAP1A;RAC1;PDGFB;ROMO1;HCLS1;LMAN2;FCER1G;NTRK2;CAMK1D;S100A8;S100A9;FLOT1;SSR1;SIRPA;GRIN1;SERTAD1;HES1;IL2RB;MATK;FN1;MLC1;LGI1;FRMD5;RHOG;RNF187;HP;HPR;SPACA3;ADGRG1;DUSP26;CCND1;CXCL16;P4HB;PAK1;NAMPT;PTK6;P2RX7;SLC6A6;DDX49;MTLN;PROX1;TIMP1;KDR;MAPT;IL2;CCN2;NUPR1;MFSD2A;VIPR1;FASN;MLXIPL;LILRA5;LAMC2;GATA2;EXOSC2;HCK;DNPH1;ZFP36;MYRF;WNT5A;KITLG;TENM4;CSF1R;IL11;RAMP3;AIF1;CEP131;FLT4;IL2RG;HRAS;NSMCE1;PRMT1;FBXO5;SLC11A1;SOX9;RIPK2;CTSH;SDCBP;GAS6;TIAM1;FOLR2;PDF;MMP14;PDGFA;IGF2;EDN3;RYR2;DLL1;IER5;EPB41L4B;ADRA1D;VHL;CCKBR;TMEM102;CAV1;FKBP1B;CIAO1;TRIM32;FLT1;LMNA;ADAM17;TBRG4;CNBP;SFRP1;ERBB3;MAZ;EXOSC9;PPP3CA;SOX11;STX4;DDRGK1;TRIM13;HMGN5;RAD23A;RTKN2;PTPN6;TGFB1;CD86;TFAP2B;IL6;NOTCH1;FLT3;MAPK15;THPO;CITED2;EXOSC4;MYC;SIRT2;CRLF2;PYCARD
prerank,protein processing (GO:0016485),0.48871955688677904,1.3876554046029943,0.025826446280991736,0.3259353888256134,1.0,35/102,18.94%,CTSL;CTSS;LGMN;CD5L;RCE1;CPXM1;CPD;PSENEN;CPE;HP;HPR;OMA1;F9;SPCS1;KLK1;KLK6;VSIR;METAP2;PCSK2;MYRF;AEBP1;CPXM2;SRGN;TMEM208;CLN5;CTSH;SPCS2;SPG7;MMP14;BACE1;PSEN2;ADAM17;APH1B;SEC11C;PRSS12
prerank,regulation of protein dephosphorylation (GO:0035304),0.5449647676570865,1.3864510299571624,0.08135593220338982,0.32836836006694425,1.0,16/37,20.98%,PPIA;CALM1;CALM3;HSP90B1;YWHAB;PIN1;DLC1;SMPD1;ARPP19;CDH5;PPP1R15A;CALM2;NSMF;TGFB1;PPP2R5A;CAMTA1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5329459706795332,1.3864235341442679,0.04269662921348315,0.32793927982315246,1.0,11/46,5.49%,APOD;HMOX1;AKT1;IGFBP3;TNF;IGFBP5;PDGFB;ANG;NDRG4;CTNNB1;TNFAIP3
prerank,activation of GTPase activity (GO:0090630),-0.3294487758368211,-1.3860108401631834,0.022727272727272728,0.48531128559400105,1.0,23/89,11.68%,ARHGAP29;SIPA1L1;BCAS3;ARHGAP42;TIAM2;SGSM2;USP6NL;TBC1D12;NTRK3;RALGAPB;DOCK7;SIPA1L3;TBC1D2B;RABGAP1;TBC1D9B;BCR;TBC1D4;SYDE2;PIP5K1A;TBCK;TBC1D8B;RALGAPA1;SIPA1
prerank,regulation of mitochondrial translation (GO:0070129),0.589127221555531,1.3856212243934185,0.08767471410419314,0.32947520725674084,1.0,10/21,27.61%,UQCC2;COA3;TRUB2;TSFM;SHMT2;RPUSD4;MTG2;C1QBP;TRMT10C;RCC1L
prerank,diol metabolic process (GO:0034311),0.6068680385240033,1.3856066623331404,0.1,0.3290011171167058,1.0,9/19,21.50%,CALM1;HSP90AA1;AKT1;SPR;NAAA;SPHK2;SGPP1;SGPP2;ASAH2
prerank,regulation of cholesterol efflux (GO:0010874),0.5688291688849134,1.385526074861183,0.0689252336448598,0.32868443947291814,1.0,3/30,2.59%,APOE;PLTP;TREM2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.6490637595575797,1.3855099437261027,0.07152496626180836,0.32820559294214274,1.0,8/13,22.26%,RACK1;HSPA5;PPP1R15B;WFS1;PPP1R15A;DDRGK1;DNAJB9;PTPN1
prerank,regulation of protein targeting to membrane (GO:0090313),0.5695168607161474,1.385496325620741,0.07833537331701346,0.32774745896837887,1.0,11/28,21.46%,PRNP;ITGB2;ANK3;GDI1;HRAS;MTCL1;MIEF2;MFF;DMTN;FIS1;C2CD5
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.605338068962687,1.3850763054641584,0.1011378002528445,0.3282828254411856,1.0,10/18,24.85%,RPS3;IL2;CD24;HMGB1;ICOSLG;IGFBP2;IGF2;PYCARD;IL12RB1;AGER
prerank,positive regulation of telomerase activity (GO:0051973),0.5516241533626396,1.385073427305469,0.07220216606498195,0.32778610858517654,1.0,16/33,23.79%,HSP90AA1;HSP90AB1;MAPK3;CCT2;CTNNB1;KLF4;PARM1;PTGES3;MAPK15;DKC1;MYC;MAP2K7;CCT4;GRHL2;NAF1;PNKP
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.6339341905195225,1.3849291309698926,0.0948509485094851,0.3276682585486889,1.0,4/14,8.48%,CD63;EMP2;FLNA;TIMP1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5778738501698397,1.384749949711701,0.0880893300248139,0.3276243568826925,1.0,7/24,13.77%,SEMA3F;DSCAM;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,mesonephric tubule development (GO:0072164),-0.49294337056161225,-1.3847069864487431,0.12062256809338522,0.48495146558943486,1.0,6/15,13.33%,SLIT2;FGFR2;PKD1;SIX1;BMP4;WNT11
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4893154124172188,1.3845591567027384,0.024640657084188913,0.32759234492503686,1.0,33/101,21.15%,RPL26;RPS4X;RPL5;EEF2;VIM;HSP90AA1;AURKAIP1;AKT1;EIF3D;NPM1;RPS27L;AGT;MSN;EIF3C;PTTG1IP;PCIF1;CLN6;ZCCHC4;KLF4;BAD;NR1H2;CIRBP;YTHDF1;EIF4A3;ASPSCR1;TRIM32;INHBA;TGFB1;IL6;CAPN3;NFKBIA;STUB1;BAK1
prerank,endothelial tube morphogenesis (GO:0061154),0.6707972286991096,1.3844337194855212,0.10428571428571429,0.32740342221564533,1.0,5/10,13.05%,RHOB;CSNK2B;ACVRL1;CTNNB1;RHOA
prerank,vasodilation (GO:0042311),0.6555847903201328,1.3842101416835644,0.10453920220082531,0.32743044648071906,1.0,5/13,17.91%,SOD1;KLF2;GPER1;F2RL1;KCNMA1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6765140768548381,1.3841317653152072,0.09732016925246827,0.327126766045318,1.0,4/10,8.70%,RACK1;FZD9;DCN;KDR
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5933955617055737,1.3832524555113934,0.09722222222222222,0.32887778838741644,1.0,7/20,5.08%,VTN;S100A11;IGFBP3;IGFBP5;PDGFB;SORL1;NDRG4
prerank,cellular response to decreased oxygen levels (GO:0036294),0.5012311860318076,1.3832153428109752,0.035331905781584586,0.32847804007240516,1.0,27/65,22.48%,MT3;HMOX1;PINK1;ZFP36L1;KCND2;EPAS1;HIPK2;PGK1;P4HB;NDRG1;BNIP3L;FMN2;AQP1;AK4;ACAA2;PMAIP1;EGLN2;BAD;TWIST1;LMNA;SFRP1;NOP53;MYC;SIRT2;STUB1;HYOU1;TBL2
prerank,Rap protein signal transduction (GO:0032486),-0.5582668661005995,-1.3831449281700445,0.12758620689655173,0.48509329063135365,1.0,5/10,18.44%,RAPGEF2;RAPGEF1;RAPGEF3;SGSM3;PLK2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6534803793158733,1.3829612195962,0.10174029451137885,0.3285848437883698,1.0,6/12,18.67%,CALM1;CALM3;IRX3;CAV1;SRI;CALM2
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6806715568328963,1.3826191317113978,0.10198300283286119,0.32839384026625057,1.0,6/10,23.17%,AP2M1;CLTC;AP2S1;CLTA;AP2A1;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6806715568328963,1.3826191317113978,0.10198300283286119,0.32839384026625057,1.0,6/10,23.17%,AP2M1;CLTC;AP2S1;CLTA;AP2A1;VLDLR
prerank,action potential (GO:0001508),0.5287198479020183,1.382507875299893,0.0622876557191393,0.3281508857429766,1.0,15/44,21.14%,AKAP6;ANK3;GPER1;SCN1A;KCND2;GNA11;YWHAH;KCNE4;KCNA2;CHRNA4;KCNE5;KCNA1;SRI;MYH14;SCN9A
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5033367704200347,1.3824429569672005,0.028938906752411574,0.3278189021550854,1.0,22/72,17.22%,APOE;HSPA8;CLU;PFDN5;TREM2;CRYAB;PFDN6;MID1IP1;MYADM;PFN1;NAV3;CORO1A;CLASP1;TUBB4A;MAP2;CLIP3;VBP1;STMN1;PFDN1;FGF13;PFN2;CDH5
prerank,response to alcohol (GO:0097305),0.5607023937500858,1.3822858054386709,0.07801418439716312,0.3276917225399562,1.0,14/27,19.62%,SOD1;CCL19;GRIN1;GRIN3A;CCR5;GRIN2A;SDF4;GLRA1;HSD3B2;ABCA2;CCL3;SLIT3;GRIN2B;TGFB1
prerank,retrograde axonal transport (GO:0008090),0.6193627317028045,1.381426889658499,0.09681697612732096,0.32918435065470936,1.0,6/16,11.30%,SOD1;MAP1A;DLG2;NEFL;KIF5A;HAP1
prerank,regulation of transmembrane transport (GO:0034762),0.5536294076034005,1.3813409770942469,0.07099879663056559,0.32889698842940657,1.0,3/31,5.65%,ACTB;SLC2A1;KCNJ10
prerank,cellular response to organonitrogen compound (GO:0071417),0.4826698005255299,1.3810773482613554,0.015479876160990712,0.32906953861633725,1.0,30/99,19.03%,ACTB;GABRB1;AKAP6;LAMTOR2;LAMTOR4;LAMTOR5;ZFP36L1;HSP90B1;IGFBP5;CTNNB1;P2RX7;P2RY6;AQP1;P2RY12;EGR1;P2RY1;GLRA2;TRPM2;GABRB3;GLRA1;SOX9;LAMTOR3;RRAGC;HCN1;DMTN;RRAGD;GABRB2;HCN3;SFRP1;NSMF
prerank,protein localization to chromatin (GO:0071168),-0.46631901283852895,-1.380896474438776,0.12844036697247707,0.4870918940292303,1.0,7/18,12.38%,NIPBL;WAPL;TASOR;ESR1;PPHLN1;MRNIP;LRWD1
prerank,negative regulation of B cell activation (GO:0050869),0.5876339127802566,1.3806997425898462,0.08603491271820449,0.3294901658623277,1.0,11/21,25.24%,TYROBP;LAPTM5;TNFAIP3;CTLA4;CD300A;SFRP1;INHBA;ID2;BANK1;TNFRSF13B;INHA
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.6339386412092217,1.380505699149099,0.10597826086956522,0.32950349994691475,1.0,1/13,0.37%,RPS21
prerank,protein K11-linked ubiquitination (GO:0070979),-0.4204647336620598,-1.3804727659499356,0.09146341463414634,0.484736990285874,1.0,6/27,9.87%,UBE2E2;ANAPC5;ANAPC1;PRKN;ANAPC7;CDC26
prerank,cAMP biosynthetic process (GO:0006171),-0.5648483960930718,-1.38039497370055,0.11267605633802817,0.481530500422528,1.0,3/10,2.13%,ADCY9;ADCY1;ADCY5
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.4553614277590306,-1.3801938070957382,0.07725321888412018,0.4787167315392904,1.0,7/18,14.90%,SARNP;DDX19A;PABPN1;IWS1;DDX19B;MCM3AP;THOC2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4775485048195699,1.3801318586873452,0.015120967741935484,0.3299508971997142,1.0,43/151,17.83%,APOE;CD74;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;TNF;PTPRC;PDGFB;NTRK2;C5AR1;SEMA7A;MIF;NDRG4;DDT;ATP6AP1;TIRAP;P2RY6;KDR;CCN2;HTR2C;P2RY1;HMGB1;CSF1R;RAMP3;FLT4;HRAS;FBXW7;BMP2;CCL2;GAS6;F2RL1;PDGFA;RASGRP1;ARRB2;ADRA1A;CCL3;GATA4;ADCYAP1;CCL8
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.5791457457415969,1.3799930374700666,0.10643564356435643,0.3298147332699143,1.0,12/25,22.68%,AKT1;GRID2;MPP2;GRIN1;GRIN2A;GLRA1;CHRNA4;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,regulation of RNA export from nucleus (GO:0046831),-0.5334688312205614,-1.3797120238136176,0.13268608414239483,0.47670407226081624,1.0,6/11,21.36%,SETD2;IWS1;AKAP8L;CPSF6;KHDRBS1;TPR
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.4750527303214238,-1.3797056508723564,0.10576923076923077,0.4734545857264673,1.0,6/17,4.54%,ABL1;BAIAP2L1;BCAS3;NRP1;BAIAP2;NTRK3
prerank,negative regulation of neuron differentiation (GO:0045665),0.5803732581273322,1.3796620365853511,0.08030112923462986,0.3301632189420093,1.0,7/22,16.23%,B2M;CALR;CNTN4;HES1;SOX9;HEY1;DLL1
prerank,regulation of chemokine production (GO:0032642),0.5462069148415274,1.379604031844278,0.07459207459207459,0.3298245999858096,1.0,20/36,26.39%,CD74;HMOX1;TREM2;TNF;LPL;EGR1;WNT5A;CSF1R;AIF1;F2RL1;SIGIRR;ADAM17;IL6;PYCARD;APP;IL33;AGER;TLR7;TLR2;ACKR1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.49745269951371185,-1.3794549092940245,0.10546875,0.47076868255473747,1.0,4/13,5.61%,ATG10;SENP6;UBA3;SAE1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5218291756958384,1.3788739348996628,0.05790645879732739,0.33112630630610007,1.0,12/49,14.62%,CLU;RPL13A;PARK7;HSPA5;TREM2;CRYAB;SORL1;HMGB1;SVIP;THRA;NLRP2B;JAM3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.6715061965779654,1.3777004601544487,0.12426900584795321,0.33345954102388936,1.0,6/10,24.60%,CCT2;CCT7;CCT8;DKC1;CCT4;CCT3
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4952194739065682,-1.3774522189141578,0.10687022900763359,0.47204579667380364,1.0,7/13,22.11%,SNX6;CBLB;ERRFI1;SOCS5;GPRC5A;CBL;TSG101
prerank,dendritic cell chemotaxis (GO:0002407),0.6447476873769197,1.377153856207863,0.108,0.3342976828923569,1.0,7/14,19.50%,CCL19;CCR5;HMGB1;TRPM2;CXCR4;CCR2;GPR183
prerank,response to nutrient levels (GO:0031667),0.6062678139850719,1.376625366999547,0.11011523687580026,0.3350922514803219,1.0,4/17,8.74%,ATF4;SCTR;FAM107A;CD68
prerank,glutamine family amino acid catabolic process (GO:0009065),0.6354929249022141,1.375255752127604,0.1,0.33794612287455505,1.0,8/13,21.47%,GLUL;DDAH1;GLS2;GLS;NOS2;GLUD1;GAD1;ALDH4A1
prerank,central nervous system neuron development (GO:0021954),0.6270034851186519,1.374777859482997,0.10949868073878628,0.33866377611599346,1.0,6/15,10.44%,HSP90AA1;HSP90AB1;NTRK2;MAPT;MAP2;B4GALT6
prerank,angiogenesis involved in wound healing (GO:0060055),0.6634848712769592,1.3745033719590884,0.11261872455902307,0.3389120252029385,1.0,7/11,25.15%,CD34;KDR;GATA2;MCAM;HPSE;PRCP;SRF
prerank,regulation of protein ubiquitination (GO:0031396),0.47773862684782864,1.3744879123612892,0.03199174406604747,0.33845607467729755,1.0,32/108,16.92%,RPS3;UBB;HSP90AA1;HSP90AB1;LAPTM5;PARK7;UBXN1;AKT1;PINK1;FKBP1A;HSPA1B;TNFAIP3;BAG5;FAM107A;ISG15;FOXF2;CENPX;PTTG1IP;ADGRB1;DNAJA1;WFS1;DNAJB2;VPS28;NSMCE3;FBXW7;HSPA1A;IVNS1ABP;RIPK2;HSPBP1;ARRB2;SQSTM1;CAV1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.600140107875234,1.3740991630223265,0.10326797385620914,0.33896433454038677,1.0,9/18,21.15%,SLC25A5;SLC25A4;ALKBH7;PMAIP1;SPG7;BAD;TMEM102;THEM4;BAK1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4574126076214873,1.373877764802214,0.0,0.33900443238477745,1.0,155/532,21.40%,TMSB4X;RPS27A;IFITM3;HSPA8;PPIA;UBC;VIM;IFITM2;B2M;UBB;RPLP0;IFITM1;PSMB4;HSP90AA1;F13A1;MT3;BOLA2;CFL1;CXCL12;MMP3;HMOX1;SOD1;TALDO1;MAPK3;MT2A;PSME1;AKT1;CCL19;PSMB6;PSMB8;PSME2;PSMD2;ITGB2;IL5;POMC;CNN2;CSNK2B;EIF5A;CANX;TNF;HSP90B1;PDGFB;TOLLIP;FCER1G;SPI1;PSMD1;JUNB;MIF;PSMC3;AIP;ST18;PSMD6;IL2RB;CSF3R;S1PR1;PSMA7;MSN;FN1;UBA52;ISG15;CCND1;CCR5;GSTO1;P4HB;LCP1;CEBPA;TIMP1;CXCL10;TNFSF12;IL2;PSMD5;IFIT1;RBX1;EGR1;FCGR1A;HCK;PSMB9;COL1A2;IRF8;CSF1R;TXNDC17;PSMD13;IL3RA;IL11;LCN2;PSMB3;IL2RG;PSMB11;MAOA;VAV1;IRF7;BST2;PSMB10;YWHAZ;TNFRSF1A;CCL2;PTPRZ1;RIPK2;RHOU;UBE2V1;ARF1;NDN;IFNGR1;PF4;TRAF3;CD300LF;LRP8;PSMB1;PLVAP;CSF2RB;IL17RB;PSMB5;SQSTM1;CCL3;TWIST1;VCAM1;PIK3CD;ADAM17;NOS2;CCL8;COMMD7;TNFRSF12A;NCAM1;OAS3;SYK;SLA;CCR2;LTBR;STX4;PSMA6;TAB1;IL20RA;IFNGR2;MUC1;PTPN6;SKP1;SOS1;TGFB1;CD86;CSF2RA;HGF;IL6;FLT3;IL10RB;PSMA4;IL1RAP;NFKBIA;MYC;CRLF2;IRF9;PYCARD;CRLF1;HSPA9;HNRNPF;IFI27
prerank,positive regulation of ruffle assembly (GO:1900029),0.6383467617089053,1.3732600573371931,0.11413043478260869,0.340039605481173,1.0,5/13,12.19%,NLGN1;PFN1;P2RY12;DEF8;HRAS
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5954947994061839,1.3732261685088554,0.10050251256281408,0.33962390659777125,1.0,6/19,14.62%,MDK;MAPK3;CAMK1D;RARRES2;CSF1R;JAM3
prerank,positive regulation of glucose import (GO:0046326),-0.451877882859287,-1.3731644800000504,0.06965174129353234,0.4789880683774266,1.0,10/21,16.62%,SORBS1;OSBPL8;IRS1;INSR;IGF1;CREBL2;PRKCI;OCLN;RHOQ;APPL1
prerank,protein autoprocessing (GO:0016540),0.61141631388051,1.3729645848696748,0.10860927152317881,0.33980143988379147,1.0,4/17,10.45%,CTSL;OMA1;KLK6;MYRF
prerank,positive regulation of lymphocyte activation (GO:0051251),0.5647180291498346,1.3728100152227758,0.09938650306748466,0.3396835706458454,1.0,9/28,20.93%,TYROBP;SIRPA;HSPD1;THY1;CCL2;SH3KBP1;CCR2;IL6;PYCARD
prerank,regulation of interferon-gamma production (GO:0032649),0.5034173017532995,1.3719230720186153,0.05157894736842105,0.3414179703369027,1.0,28/71,28.65%,LAPTM5;PDE4B;PRNP;SLC7A5;SIRPA;ISG15;HSPD1;VSIR;HMGB1;SLC11A1;LILRB1;GAS6;F2RL1;RASGRP1;CD14;CCR2;INHBA;PYCARD;DDIT3;CD276;IL12RB1;C1QBP;TLR7;INHA;CEBPG;IL12RB2;ZFPM1;FZD5
prerank,prostaglandin biosynthetic process (GO:0001516),0.6001093448828778,1.3714334374209733,0.10473815461346633,0.3420562199089864,1.0,6/18,15.09%,CD74;PTGDS;MIF;PRXL2B;HPGDS;PTGES3
prerank,regulation of primary metabolic process (GO:0080090),0.476802932645244,1.3713247708716882,0.021538461538461538,0.34186882757584836,1.0,29/126,13.37%,APOE;PSAP;PSMB4;PSME1;PSMB6;PSMB8;PSME2;OAZ1;PSMD2;CERS2;NR1D1;PSMD1;PSMC3;PSMD6;PSMA7;NCOR2;EDF1;LSS;PSMD5;FASN;SIN3B;PSMB9;PSMD13;SCD;SC5D;PSMB3;PSMB11;ODC1;PSMB10
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6116431411916811,1.3709017690798089,0.0967741935483871,0.342432344363538,1.0,8/17,26.18%,SLC7A5;FCER1G;CEBPB;SYK;CD86;NLRP3;CD28;PRKCQ
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4886198677744804,1.370691367258516,0.04811715481171548,0.34246141417858805,1.0,27/87,13.65%,PSMB4;GPNMB;PSME1;PSMB6;PSMB8;PSME2;PSMD2;ZFP36L1;PSMD1;ZFP36L2;PSMC3;PSMD6;PSMA7;GPR132;FAM107A;PSMD5;JADE1;RBX1;CDK2AP2;PSMB9;PSMD13;PSMB3;PSMB11;FBXO5;KLF4;PSMB10;CCL2
prerank,positive regulation of signaling (GO:0023056),0.5316189707580367,1.3706549918756692,0.06651376146788991,0.34207194735484175,1.0,17/37,21.23%,TNF;GRIK2;SYT1;LGI1;RIMS2;RIMS1;VAMP3;RAMP3;HCRT;EDN3;CLSTN2;CLSTN1;NMB;SOX11;SNCA;KCTD13;CLSTN3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.594996422475883,1.3698873123255804,0.09746835443037975,0.34345187247156594,1.0,6/20,14.20%,ACADVL;APOC1;GPER1;FBXW7;BMP2;ABCA2
prerank,regulation of cation channel activity (GO:2001257),0.4882424624258403,1.3695290538063012,0.032157676348547715,0.3438372157517796,1.0,40/89,25.91%,CALM1;CTSS;NLGN1;GRIA2;ANK3;FKBP1A;DLG2;NEFL;SHISA7;FGF14;GRIN1;AHNAK;GRIN2A;GRIA4;CRH;VAMP2;FGF11;FGF12;GRIA1;JPH4;KCNE5;LRRC7;MAPK8IP2;FGF13;CACNG8;FKBP1B;SELENON;GRIN2B;CACNG5;CALM2;MEF2C;GRIA3;CACNB4;KCNAB1;APP;CACNG2;PRKACA;PRRT1;SHISA6;ITGB1
prerank,basement membrane organization (GO:0071711),0.6248050927453561,1.3695233384163836,0.10353866317169069,0.34336329251562875,1.0,4/14,5.90%,RAMP2;CTSS;LAMB2;COL4A1
prerank,positive regulation of cytokinesis (GO:0032467),-0.3972773973219956,-1.3690791494369476,0.075,0.485526307898067,1.0,11/32,21.16%,SVIL;PRKCE;CDC14A;PKP4;CDC25B;CSPP1;GIPC1;CDC14B;RACGAP1;KIF23;PKN2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.6168810519202588,1.3682244930526968,0.11788079470198676,0.34607328377010294,1.0,8/15,27.42%,RACK1;TNF;ORMDL3;TNFRSF1A;SPHK2;ORMDL2;PLA2G6;SAMD8
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.6201536314043066,1.3677231499579658,0.11740890688259109,0.3467696985805746,1.0,1/14,0.02%,TMSB4X
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5405938564119575,1.3668157662995857,0.0735632183908046,0.3485755707810811,1.0,6/35,7.86%,APOE;SPARC;ATP5F1A;ATP5IF1;CAV2;VASH1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5737416186077312,1.3658394555787092,0.10159118727050184,0.35055879566896186,1.0,9/22,16.42%,TREM2;NR1D1;FLOT1;TIRAP;TNFAIP3;TICAM2;NINJ1;F2RL1;DAB2IP
prerank,erythrocyte differentiation (GO:0030218),0.5205072948973812,1.3654203593722918,0.058426966292134834,0.35110344916505776,1.0,8/44,9.24%,RPS14;RPS19;SLC25A5;HCLS1;ATP5IF1;HIPK2;TSPO2;IKZF1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6583423621379217,1.365118348451417,0.1306179775280899,0.3514331552868744,1.0,2/11,2.62%,TREM2;AKAP6
prerank,positive regulation of immune response (GO:0050778),0.4988143158691705,1.3646678473900475,0.05139186295503212,0.35211301837603065,1.0,20/64,23.54%,CD74;CD81;GRN;CYBA;ITGB2;PTPRC;IL2;SLC15A4;KARS1;LILRB1;F2RL1;SKAP1;STX4;NLRP3;SPHK2;POLR3D;PYCARD;RSAD2;AKIRIN2;IL12RB1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.4191248308107767,-1.3646291255001297,0.09392265193370165,0.49267222477147754,1.0,12/27,18.10%,EGFR;TNRC6B;DDX6;STAT3;RIPK1;EIF4G1;BMP4;PUM2;LIMD1;TP53;AGO2;FMR1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5264211791596678,1.3644608391086566,0.07796610169491526,0.3521634504298555,1.0,15/44,22.74%,APOE;AGT;SORL1;UCHL1;RGS2;HYAL2;SMPD1;DNAJA1;MAPK8IP1;SPRY1;DAB2IP;CD300A;SPRY3;PTPN1;DUSP1
prerank,androgen metabolic process (GO:0008209),0.5908953101420559,1.3642559383114947,0.11153846153846154,0.35215243934803386,1.0,4/18,12.96%,SPP1;HSD17B6;HSD17B4;HSD3B2
prerank,positive regulation of cell division (GO:0051781),-0.3833410886296758,-1.363442868620093,0.028985507246376812,0.4918299477620444,1.0,9/38,12.31%,SVIL;FGF1;PRKCE;CDC14A;FGFR2;PKP4;CDC25B;CSPP1;GIPC1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.6358458141072991,1.3631487092373957,0.10405405405405406,0.3543955497409354,1.0,4/13,14.04%,CD74;TAF9;WNT5A;GAS6
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6779063290857003,1.3624811709391313,0.11412268188302425,0.35507413326208875,1.0,4/10,19.74%,RACK1;TNF;TNFRSF1A;SPHK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6779063290857003,1.3624811709391313,0.11412268188302425,0.35507413326208875,1.0,4/10,19.74%,RACK1;TNF;TNFRSF1A;SPHK2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6020909977366485,1.3623422922137265,0.1010230179028133,0.35490197972354626,1.0,9/18,22.30%,ZFP36L1;ZFP36L2;FAM107A;SSTR4;AQP1;ZFP36;HNRNPU;SSTR2;REST
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4824002261553995,1.3622543090475334,0.029015544041450778,0.3546450828087352,1.0,28/98,20.75%,APOE;CD63;MT3;CHCHD2;AKT1;APOC1;AGT;SLCO1C1;PDGFB;ROMO1;GHITM;VAMP3;FASN;STARD4;DCXR;RAMP3;SFRP4;KLF4;NR1H2;ARRB2;PRELID1;SNCA;INHBA;CBR1;TGFB1;IL10RB;NFKBIA;GADD45A
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.36382069564244723,-1.3620430303037392,0.02,0.4922052305691704,1.0,21/50,15.44%,FBXL17;CREBBP;SMO;DCDC2;GLI3;SUFU;GPC3;TTC23;HERC4;DLG5;FGFR2;BTRC;ZIC1;TULP3;INTU;IFT122;GAS8;WDR11;EVC;UCHL5;KIF7
prerank,positive regulation of proteolysis (GO:0045862),0.5046513191772041,1.3619407792992395,0.058305830583058306,0.3549360043202238,1.0,19/55,23.16%,APOE;AURKAIP1;NDUFA13;RCN3;PINK1;TNF;ATP5IF1;CLN6;CTSH;BAD;SNX33;TRIM32;CTSC;WDR48;CAPN3;STUB1;BAK1;TNIP1;NKD2
prerank,positive regulation of bone resorption (GO:0045780),0.6518394663852921,1.3618754562860185,0.11049723756906077,0.3546177210288324,1.0,6/11,25.31%,SPP1;ATP6AP1;DEF8;SYK;TNFRSF11A;PRKCA
prerank,positive regulation of type 2 immune response (GO:0002830),0.6271720902967521,1.3614775053792494,0.10666666666666667,0.35512610566984654,1.0,2/14,1.12%,CD74;CD81
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5894441148771906,1.3614161186965519,0.11948051948051948,0.35480440585788414,1.0,10/18,27.30%,CCT2;NOP10;CCT7;NHP2;CCT8;DKC1;CCT4;NAF1;CCT3;RUVBL2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3232231628320607,-1.361378460895244,0.023809523809523808,0.4904593897738791,1.0,19/79,10.54%,SULF1;ADAMTS12;SMAD6;BMPR1A;CRIM1;SMURF2;SLIT2;SKI;NIBAN2;BMPER;SMAD9;SMURF1;CASK;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5346453944043864,1.361348073251356,0.07084785133565621,0.35445672943815393,1.0,14/36,22.02%,RPS3;PPIA;TMBIM6;TNF;CX3CR1;MAPK8IP2;DAB2IP;GATA4;MAZ;QARS1;ING5;PYCARD;ASAH2;PTPMT1
prerank,regulation of chemotaxis (GO:0050920),0.558125998384557,1.3613357268736772,0.08757396449704143,0.35400940009825554,1.0,15/30,21.90%,CCL19;TREM2;PDGFB;DUSP3;RARRES2;P2RY12;AIF1;ZSWIM8;CXCR4;F2RL1;YTHDF1;STX4;GPR183;TGFB1;PPM1F
prerank,histone methylation (GO:0016571),-0.39942748531424976,-1.3613282493701067,0.07386363636363637,0.4873980599541832,1.0,12/26,20.52%,NSD1;CREBBP;SMYD3;EHMT1;NSD3;EHMT2;EZH2;CARM1;SIRT7;PRMT6;SETD6;PRMT8
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5550016266561776,1.3612720260971056,0.08913308913308914,0.3536811979746304,1.0,16/27,25.72%,SYT1;RIMS2;RIMS1;SDF4;SYT12;SYT11;VAMP2;SYT6;SYT4;SYT10;SYT2;DOC2B;SCIN;SYT3;SYT5;SYT17
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.6345882142862638,1.3612492650647308,0.1115702479338843,0.35325088845663694,1.0,4/12,13.02%,RPS27L;RPA2;CCND1;FBXO31
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5252678546607383,1.3611544867831964,0.07972665148063782,0.35298475460348216,1.0,11/36,17.68%,CD74;LAPTM5;HSPA1B;TICAM2;WNT5A;C1QTNF4;CXCR4;HSPA1A;GAS6;CD300LF;ADAM17
prerank,regulation of cellular response to heat (GO:1900034),0.48273423453893466,1.3610480116149677,0.048025613660619,0.3527593773299075,1.0,24/77,19.20%,HSPA8;HSP90AA1;HSP90AB1;HSBP1;MAPK3;CRYAB;CD34;HSPA1B;YWHAE;BAG5;RPA2;BAG1;MAPT;HSPB8;HSPA1A;DNAJB1;NUP85;NUP88;PTGES3;IER5;CCAR2;NUP50;AKT1S1;RAE1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6228845045490677,1.3607902816802622,0.11950549450549451,0.35284371636891726,1.0,5/15,10.49%,GRM5;HOMER2;GRM8;GRM7;GRM1
prerank,adenine nucleotide transport (GO:0051503),0.6011583230321952,1.3605548745186242,0.10191082802547771,0.3529850349955147,1.0,4/17,13.83%,SLC25A5;LRRC8A;SLC25A4;SLC19A1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5006192467887002,1.359998640819373,0.04983748645720477,0.3539098788556724,1.0,16/63,20.51%,CD74;CD81;CCL19;PTPRC;MIF;TIRAP;TFRC;IL2;PNP;AIF1;VAV3;VCAM1;GPR183;CD86;IL6;MEF2C
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5463777665192416,1.3599092542495583,0.10684273709483794,0.35363537591936495,1.0,5/30,8.69%,GPX1;HMOX1;PARK7;TNFAIP3;FAIM2
prerank,cAMP metabolic process (GO:0046058),-0.5072331414608632,-1.3586494961529685,0.1391941391941392,0.49047532710426966,1.0,3/13,2.13%,ADCY9;ADCY1;ADCY5
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.4679931948296624,1.3586028629487679,0.007,0.3564489542279108,1.0,47/184,17.04%,RPS27A;TUBB;UBC;UBB;TUBA1A;PSMB4;HSP90AA1;TUBB4B;DYNLL1;PSME1;PSMB6;PSMB8;PSME2;PSMD2;ZFP36L1;TUBA4A;PSMD1;DCTN3;ZFP36L2;PSMC3;PPP2R1A;YWHAE;PSMD6;PSMA7;UBA52;CLASP1;YWHAG;PSMD5;TUBB4A;DDB1;PSMB9;PSMD13;BUB3;PSMB3;CEP131;PSMB11;FBXO5;DCTN1;ANLN;PSMB10;SSNA1;HAUS2;DCTN2;PSMB1;PSMB5;CETN2;PRKAR2B
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.546991983450918,1.3582924728395587,0.0881316098707403,0.3567182291509852,1.0,11/31,15.33%,CHCHD10;YWHAB;YWHAH;YWHAE;YWHAG;BAX;PMAIP1;YWHAQ;BBC3;YWHAZ;BAD
prerank,regulation of feeding behavior (GO:0060259),-0.5303177990345469,-1.3579820283132154,0.1353135313531353,0.48899886540873383,1.0,4/11,7.18%,AGRP;EIF2AK4;LEPR;STAT3
prerank,peptidyl-amino acid modification (GO:0018193),0.6692981537896742,1.3577796022855917,0.11904761904761904,0.3575140186970538,1.0,5/10,15.54%,METAP1;FKBP10;FKBP7;METAP2;PDF
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5660353679892534,1.357458267959376,0.1116564417177914,0.35783389689434486,1.0,8/24,10.51%,PEX5L;SCTR;APLNR;PDE3B;CDC34;PRKAR1A;GNAI1;PRKAR1B
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.6589565424210959,1.3573513783474294,0.12429378531073447,0.3571642159590136,1.0,7/11,24.60%,CCT2;CCT7;CCT8;MEPCE;DKC1;CCT4;CCT3
prerank,regulation of protein localization to Cajal body (GO:1904869),0.6589565424210959,1.3573513783474294,0.12429378531073447,0.3571642159590136,1.0,7/11,24.60%,CCT2;CCT7;CCT8;MEPCE;DKC1;CCT4;CCT3
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6197901761336604,1.357297526567046,0.11080711354309165,0.3568156226158797,1.0,2/14,1.65%,RPL7;RPL35
prerank,negative regulation of innate immune response (GO:0045824),0.5270733880065596,1.356615178660075,0.08886255924170616,0.35806395298176963,1.0,6/34,8.49%,RPS19;GRN;A2M;TNFAIP3;ISG15;SERPING1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6436651529826631,1.3563905615203031,0.10664819944598337,0.35815941666767703,1.0,4/13,7.81%,CD81;ITGB2;FCER1G;LPL
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.603341179078567,1.3563547249821555,0.10855683269476372,0.35776376969504603,1.0,9/17,19.23%,CXCL12;LGMN;CREB3;CXCL10;PLA2G7;HMGB1;AIF1;CCR2;CXCL17
prerank,positive regulation of B cell activation (GO:0050871),0.5010821450400229,1.355650082456498,0.07456140350877193,0.3589900889498359,1.0,14/50,20.51%,CD74;CD81;PTPRC;MIF;TIRAP;TFRC;IL2;VAV3;SH3KBP1;MMP14;SYK;GPR183;IL6;MEF2C
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.6670933134518601,1.355311443632579,0.13006993006993006,0.35932020134689585,1.0,5/10,16.99%,EMC6;EMC3;EMC10;EMC4;EMC8
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.6508129166568913,1.3552820804224235,0.12648809523809523,0.3589206785404932,1.0,8/10,33.47%,GABRG3;GABRA2;GABRA3;GABRB2;GABRA4;GABRG2;GABRA1;GABRG1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.6083835562104124,1.3552108128610596,0.10209424083769633,0.358600343085647,1.0,6/17,16.99%,EMC6;EMC3;EMC10;EMC4;SGTA;EMC8
prerank,receptor internalization (GO:0031623),0.511400813615377,1.353984085032318,0.0834272829763247,0.36124525007073244,1.0,16/44,19.29%,CD81;RAMP2;ITGB2;FCER1G;DNM3;AP2M1;TFRC;CLTC;RAMP3;LILRB1;ARRB2;CAV1;SYK;RAB31;SNCA;GRK2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.6305001058903644,1.3535609461945954,0.11650485436893204,0.36177572742322184,1.0,8/14,26.02%,TIRAP;HNRNPA0;ZFP36;TARDBP;ELAVL4;YBX3;ELAVL1;HNRNPC
prerank,membrane repolarization during action potential (GO:0086011),0.6305041001787753,1.3532707959157304,0.1411451398135819,0.361976723342993,1.0,5/13,15.84%,YWHAE;KCNE4;ATP1A1;KCNE5;ATP1B1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6428362881973655,1.3532286340726911,0.11528150134048257,0.36162164444218764,1.0,2/13,1.15%,LAMP1;TYROBP
prerank,negative regulation of inflammatory response (GO:0050728),0.46287923276126913,1.3531584501785747,0.010050251256281407,0.36131018914140206,1.0,46/182,20.07%,APOE;RPS19;RAMP2;MDK;GRN;TREM2;POMC;GPER1;NR1D1;LRFN5;SCTR;SIRPA;TNFAIP3;DRD5;CD163;FEM1A;RXFP1;OTULIN;PRKAR1A;VIPR1;CRH;FCGR1A;HCK;MC1R;PRKAR1B;CALCB;RAMP3;KLF4;TNFRSF1A;ADCY4;MC5R;TYRO3;FNDC4;ADCY8;HTR7;PRKAR2B;CDH5;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;CXCL17;NLRP3;IL6;GIT1
prerank,maturation of LSU-rRNA (GO:0000470),0.5511117680290588,1.3530407079699927,0.09926470588235294,0.36113000599545614,1.0,4/26,2.42%,RPL7;RPL7A;RPL35;RPL10A
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.6757380263894841,1.3528183368946929,0.11748251748251748,0.3611785957000654,1.0,6/10,25.47%,APLNR;PDE3B;CDC34;PDE11A;RNF157;PDE2A
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.42366300862142137,-1.3525169182315786,0.09090909090909091,0.4990661029653081,1.0,9/23,19.90%,HDAC4;CLK2;PPARA;NCOR1;SIK1;C1QTNF3;CRY1;TIGAR;PFKFB1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.547935504659156,1.3524754303726065,0.09101941747572816,0.36152202705811465,1.0,11/28,18.91%,CLU;LAPTM5;TREM2;ATP5IF1;PSMC3;NUPR1;ECSCR;FBXW7;DAB2IP;CTSC;DDRGK1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3743411751753343,-1.3514835310496445,0.056910569105691054,0.4982135274763106,1.0,10/38,15.23%,MGA;YAF2;EPC1;EHMT1;PHC3;APAF1;RBBP8;TFDP1;EHMT2;EZH2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5037866831035307,1.3508412546190867,0.0625,0.3652682913968984,1.0,25/57,22.30%,CTSD;NDUFA13;LGMN;GPER1;TNF;GRIN1;FOXL2;GRIN2A;HMGB1;PDCD6;PMAIP1;RIPK2;BAD;BCAP31;PDCD5;SYK;GRIN2B;NLRP3;MYC;PYCARD;FIS1;CYCS;BAK1;PPM1F;REST
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.6038269828524443,1.349957298060113,0.10144927536231885,0.3669440218742969,1.0,8/18,16.92%,TNF;ADD2;SELL;PODXL2;SELPLG;GCNT1;CX3CR1;VCAM1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.656404754906855,1.349596769938997,0.12236286919831224,0.367354159430133,1.0,3/11,7.24%,HSPA5;ATF4;CEBPB
prerank,organic substance transport (GO:0071702),0.4647937606858669,1.3493145187660847,0.02566735112936345,0.367582553559735,1.0,33/121,19.38%,RAMP2;PLTP;GM2A;RCN3;SLC18A1;LRP1B;TXNIP;HSP90B1;ABCG1;ABCB6;CHMP2B;TAP2;RD3;ARRDC1;SCAMP3;MFSD2A;SLC50A1;SLC6A2;VAMP2;SLC48A1;ATP8A1;RAMP3;CMTM6;NME4;SLC19A1;ABCA2;ARRDC3;SCAMP2;CHMP1B;MFSD2B;CLN8;SLC19A2;SLCO1B1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.5116195471439674,1.3491474735016962,0.09572072072072071,0.36756722389333985,1.0,10/47,13.42%,APOE;RPL10;AKT1;GRM5;AGT;METAP1;PCIF1;RBM4B;KLF4;METTL18
prerank,mitochondrion disassembly (GO:0061726),0.5316885312425675,1.3488637051057517,0.09905660377358491,0.3678432956475781,1.0,7/34,5.61%,GABARAP;MAP1LC3B;MAP1LC3A;PINK1;GABARAPL2;GABARAPL1;ATG9A
prerank,ceramide transport (GO:0035627),0.6443574092855767,1.3486533612618243,0.12757201646090535,0.36792593201066875,1.0,4/12,14.20%,PSAP;PLTP;GLTP;ABCA2
prerank,positive regulation of mitochondrial translation (GO:0070131),0.6093458095141198,1.3485539228701855,0.11924119241192412,0.3676999123304523,1.0,7/14,27.61%,UQCC2;COA3;TRUB2;RPUSD4;C1QBP;TRMT10C;RCC1L
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.668556709789131,1.3485224299351863,0.12222222222222222,0.3672848285250915,1.0,2/10,5.06%,ACADVL;ETFB
prerank,cholesterol metabolic process (GO:0008203),0.48300895667365296,1.348418420747582,0.053304904051172705,0.36707549593413513,1.0,19/68,25.22%,APOE;MT3;SNX17;ABCG1;LSS;DHCR24;PIP4P1;ACAA2;CLN6;SOAT2;CLN8;CH25H;PLPP6;OSBPL1A;FDPS;PMVK;NSDHL;ACLY;INSIG2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.5718514062291721,1.3481081510087836,0.0971709717097171,0.3673504045590383,1.0,6/23,5.43%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4927392724043176,1.3477091568797441,0.0748663101604278,0.3678337940908911,1.0,24/65,20.10%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;GPR132;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;VPS4A;PSMA6;SKP1;PSMA4
prerank,transferrin transport (GO:0033572),0.528275107607558,1.3473722191821698,0.08284714119019837,0.3681627087308654,1.0,8/33,11.39%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;ATP6AP1;TFRC;CLTC;ATP6V0D2
prerank,MAPK cascade (GO:0000165),0.45353578528078753,1.347306233593513,0.003,0.3678534222076411,1.0,92/295,20.10%,RPS27A;UBC;CALM1;UBB;PSMB4;MBP;MT3;MAPK3;PSME1;PSMB6;PSMB8;PSME2;NRG1;PSMD2;ERBB4;IL5;RCE1;LAMTOR2;PEBP1;TNF;ZFP36L1;PDGFB;YWHAB;DLG2;PSMD1;NEFL;ZFP36L2;PSMC3;YWHAE;GRIN1;PSMD6;IL2RB;PSMA7;SHC3;UBA52;CCR5;PAK1;KDR;IL2;PSMD5;RBX1;ABHD17A;KARS1;ZFP36;ICMT;KITLG;PSMB9;RASGRP3;PSMD13;IL3RA;PSMB3;IL2RG;HRAS;GFRA1;PSMB11;SOX9;PSMB10;LAMTOR3;CCL2;CTSH;KBTBD7;LRRC7;MAPK11;ARL2;SPTBN4;GOLGA7;PDGFA;PSMB1;PLVAP;CSF2RB;RASGRP1;GFRA2;FGF13;PSMB5;DAB2IP;CCL3;SPTBN2;NCAM1;MAP2K2;RASGRF1;GRIN2B;ERBB3;KLB;PSMA6;SKP1;SOS1;TGFB1;BRAP;CSF2RA;HGF;FLT3;PSMA4
prerank,positive regulation of cell aging (GO:0090343),0.6531943312701418,1.346739622589177,0.11659807956104253,0.3688230200606142,1.0,2/11,2.32%,B2M;YPEL3
prerank,positive regulation of cell junction assembly (GO:1901890),0.5033245796459794,1.3466636636373275,0.06535947712418301,0.3685262920769644,1.0,26/56,21.90%,CLDN5;NRXN1;NLGN1;S100A10;AGT;GRID2;CNTNAP2;RAC1;FLOT1;IL1RAPL1;THY1;KDR;PTPRD;SYNDIG1;IRX3;LRRC4B;EPHB1;CLSTN2;CAV1;CRB3;CLSTN1;SFRP1;IL1RAP;CLSTN3;COL16A1;PPM1F
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.536064316382054,1.3459938489060277,0.09928229665071771,0.3696915213154436,1.0,13/30,18.35%,OST4;RPN1;RPN2;DAD1;DDOST;LMAN1;MGAT2;DPM3;MCFD2;ASGR2;DPM2;MAGT1;STT3A
prerank,negative regulation of calcium ion transport (GO:0051926),0.6104686690526099,1.34592719650571,0.112,0.3693717924178165,1.0,5/15,14.72%,SLC30A1;TMBIM6;PLN;LILRB1;CBARP
prerank,relaxation of muscle (GO:0090075),0.6310831594317597,1.3457005634482702,0.1270718232044199,0.3694725228233166,1.0,7/13,15.84%,GSN;RGS2;PLN;GSTM2;ATP1A1;SLC8A1;ATP1B1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6207967895666328,1.3452812302102213,0.12844036697247707,0.3700510542157816,1.0,8/15,17.07%,MAGEL2;IQGAP2;ARPC1B;ARPC3;ARPC5;ARPC5L;ARPC4;ARPC2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4354795656991307,-1.3448295645118176,0.08866995073891626,0.5104262251329938,1.0,9/23,14.85%,TGFBR3;SMAD3;SMURF2;DKK3;SMAD7;SMAD4;LATS2;ITGA3;SMAD2
prerank,presynapse organization (GO:0099172),0.6569966787954679,1.3433432189981942,0.13629842180774748,0.37439626387789465,1.0,6/10,23.39%,NLGN1;C5AR1;WNT5A;LRRTM3;FZD1;WNT7A
prerank,regulation of endothelial cell proliferation (GO:0001936),0.47459585559338235,1.3430423742474873,0.04583333333333333,0.3747103881274302,1.0,20/88,13.78%,APOE;SPARC;AKT1;ATP5F1A;PDGFB;ACVRL1;ANG;ECM1;ATP5IF1;CAV2;EMC10;VASH1;PROX1;TNFSF12;KDR;WNT5A;PDCD6;FLT4;BMP2;TIE1
prerank,positive regulation of cell development (GO:0010720),0.5344310697820075,1.3425965549548702,0.10179640718562874,0.37535742715244486,1.0,10/31,18.81%,TYROBP;SERPINF1;TGM2;GPER1;ATP6AP1;SNW1;CX3CR1;BAD;TRIM32;SOX11
prerank,autophagy of mitochondrion (GO:0000422),0.5182712478833056,1.342162015164284,0.09595375722543352,0.3760152836512898,1.0,7/38,5.61%,GABARAP;MAP1LC3B;MAP1LC3A;PINK1;GABARAPL2;GABARAPL1;ATG9A
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.46458943980089473,1.34199501133001,0.020242914979757085,0.3760119495152615,1.0,41/145,17.04%,TUBB;TUBA1A;PSMB4;HSP90AA1;TUBB4B;DYNLL1;PSME1;PSMB6;PSMB8;PSME2;PSMD2;TUBA4A;PSMD1;DCTN3;PSMC3;PPP2R1A;YWHAE;PSMD6;PSMA7;GPR132;CCND1;CLASP1;YWHAG;PSMD5;TUBB4A;RBX1;PSMB9;PSMD13;PSMB3;CEP131;PSMB11;FBXO5;DCTN1;PSMB10;SSNA1;HAUS2;DCTN2;PSMB1;PSMB5;CETN2;PRKAR2B
prerank,regulation of monooxygenase activity (GO:0032768),0.561799661116921,1.341587771712019,0.10732323232323232,0.3765963066686732,1.0,9/23,19.16%,CALM1;HSP90AA1;AKT1;CYGB;SPR;DDAH1;DDAH2;CAV1;SNCA
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6277385636552768,1.3414960022510658,0.14522821576763487,0.3763634332368471,1.0,3/13,11.91%,RPL26;MSX1;PMAIP1
prerank,response to amyloid-beta (GO:1904645),0.506067535145325,1.3414271495006667,0.08229988726042842,0.3760566420272577,1.0,14/44,16.92%,MMP3;LGMN;PRNP;TREM2;GRM5;CACNA1A;GRIN1;ATP1A3;GRIN2A;RAMP3;GJA1;TLR6;CDK5;VCAM1
prerank,regulation of ion transport (GO:0043269),0.4820788793063837,1.3414223346283924,0.06441393875395987,0.3755893946343044,1.0,21/76,15.82%,B2M;NKAIN2;ANK3;CA2;YWHAH;KCNJ10;SYT1;NKAIN3;P2RX7;SYT12;SYT11;VAMP3;VAMP2;SYT6;SYT4;KCNA2;ATP1A1;CHRNA4;SYT10;SPTBN4;SYT2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5370690391614739,-1.3412680034148392,0.17049180327868851,0.5159827521729929,1.0,5/10,19.57%,GHR;STAT5B;STAT3;STAT5A;STAT6
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4853133408990758,1.341194157279544,0.04656084656084656,0.375715453619534,1.0,32/80,22.30%,CTSD;GPX1;MT3;NDUFA13;AKT1;ARL6IP1;GPER1;TNF;LAMTOR5;YWHAE;BEX3;FOXL2;AQP1;DHCR24;HMGB1;PDCD6;PMAIP1;KLF4;GAS6;BAD;BCAP31;PDCD5;SYK;SNCA;NLRP3;HGF;MYC;PYCARD;FIS1;CYCS;PPM1F;REST
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.46760736341110193,1.3409094821405225,0.027522935779816515,0.3759005742209206,1.0,42/124,20.23%,APOE;PLP1;NLGN1;BLOC1S4;CNTNAP2;RAC1;GPM6B;CNTN4;SH3GL2;GPRIN1;UHMK1;STMN3;MANF;LGI1;PQBP1;ATP1B2;PRDM12;MAPT;STMN4;MAP2;CDK5R1;HMGB1;BLOC1S1;CSF1R;BLOC1S3;BLOC1S5;PRMT1;STMN1;EHD1;GPRIN2;CDK5;NCDN;TMEM108;ADCYAP1;GPM6A;ERCC6;ATCAY;RASGRF1;VAPA;IL6;CTTN;POU4F1
prerank,positive regulation of calcium ion transport (GO:0051928),0.5253803524139945,1.340753204015148,0.10562571756601608,0.37585293528184066,1.0,13/36,19.74%,CXCL12;PDGFB;LGALS3;GRIN1;P2RX7;LILRA5;ATP2B1;WFS1;CCL2;CCL3;ORAI1;CAV1;SPHK2
prerank,cellular response to virus (GO:0098586),0.5385896373715098,1.3401668062101046,0.11191335740072202,0.37681483114499764,1.0,8/30,14.84%,HSP90AA1;CCL19;EIF5A;CXCL10;RRP1B;BAX;ARF1;MAPK11
prerank,negative regulation of T cell proliferation (GO:0042130),0.5499564747804137,1.3399157078916404,0.11515151515151516,0.37700401132488287,1.0,6/28,13.71%,GPNMB;PRNP;CEBPB;PRKAR1A;SDC4;LILRB1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5360193992760588,1.3393691695896,0.10869565217391304,0.37796446681148377,1.0,9/30,15.53%,BGN;HEXB;BCAN;HEXA;DCN;CHPF2;CHPF;UGDH;VCAN
prerank,synapse organization (GO:0050808),0.46146080730857997,1.339062550585397,0.031794871794871796,0.37827832928883404,1.0,45/125,20.70%,C1QB;C1QA;CHCHD10;C1QC;NRXN1;SPOCK2;NLGN1;GRM5;ANK3;DSCAM;C5AR1;LRFN5;PIN1;LRP4;ADGRL3;DNM3;LRRC4C;MUSK;GPHN;PPFIA4;KIRREL3;NRCAM;PPFIA2;MAPT;PAK3;DNER;PTPRD;DOK7;NRXN2;DCTN1;CBLN2;LRRC4B;CX3CR1;ELFN1;PPFIA3;CDK5;ACHE;RAB39B;PCDHB14;GPM6A;CTNND2;SNCA;POU4F1;AGRN;PLXND1
prerank,epithelium development (GO:0060429),0.46857162875943287,1.3382968591780013,0.033707865168539325,0.3798142399871623,1.0,22/107,13.57%,CTSB;TAGLN;ALDOC;TAGLN2;ACADVL;RCN3;SOX18;CD34;TOLLIP;LGALS3;NDRG4;PGK1;PROX1;KDR;MFSD2A;PIH1D1;DNPH1;SOX17;PCNA;SOX8;SOX9;BMP2
prerank,regulation of intracellular transport (GO:0032386),0.5230249755795676,1.337995059427288,0.0859465737514518,0.3801826018341528,1.0,12/38,11.30%,LAMP1;CRYAB;NEFH;REEP5;MLC1;REEP6;LCP1;MAP2;ATP13A2;DNAJC30;GAS1;HAP1
prerank,regulation of axon extension (GO:0030516),0.5222276465224751,1.3374742318442325,0.10332950631458095,0.38105459069024805,1.0,8/37,9.30%,APOE;MT3;RTN4;SEMA7A;NRCAM;MAPT;MAP2;NTN1
prerank,regulation of glycolytic process (GO:0006110),-0.33039800269137826,-1.3371098192697635,0.0410958904109589,0.5226946080605837,1.0,25/68,21.53%,ZBTB20;PRKAG2;ARNT;RANBP2;HDAC4;OGT;PPARA;NUP98;NCOR1;INSR;PRKAA2;IGF1;ENTPD5;PSEN1;PRKAG1;AAAS;NUP214;NUP35;TIGAR;NDC1;JMJD8;PFKFB1;NUP62;TPR;NUP93
prerank,UV protection (GO:0009650),0.6626190430697756,1.3368474645376602,0.12797619047619047,0.3821653328250895,1.0,5/10,14.44%,GPX1;MFAP4;SDF4;MC1R;CAT
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6614169665468285,1.3366203875420803,0.13304721030042918,0.38229602218718445,1.0,1/10,1.12%,CD81
prerank,positive regulation of angiogenesis (GO:0045766),0.4639570703136726,1.3365435976012596,0.045174537987679675,0.38199815150297667,1.0,32/108,17.53%,S100A1;RAMP2;MDK;HSPB1;GRN;HMOX1;RHOB;CD34;PKM;ECM1;APLNR;ADAM12;BTG1;EMC10;HIPK2;TNFSF12;AQP1;KDR;GATA2;NINJ1;WNT5A;PDCD6;KLF4;TIE1;CTSH;RRAS;DLL1;GATA4;TWIST1;CDH5;PIK3CD;FLT1
prerank,positive regulation of lipid storage (GO:0010884),0.5633402297755059,1.3361836480913074,0.125,0.382439439873375,1.0,5/21,14.51%,C3;LPL;PLIN3;MSR1;EHD1
prerank,cellular metal ion homeostasis (GO:0006875),0.47047976151887133,1.335923310064556,0.035453597497393116,0.38265569829055146,1.0,29/102,18.56%,TPT1;CALR;MT3;CXCL12;SLC30A1;CCL19;SLC24A4;SLC24A2;ATP1A3;DRD5;ATP1B2;TMCO1;HTR2C;ATP13A2;CALCB;ATP2B1;ATP1A4;ATP1A1;SLC8A1;ATP1B1;EDN3;RYR2;CCL3;CAV1;CDH5;CCL8;KCNMA1;CCR2;ATP1B3
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.5753687626923422,1.3359155093388582,0.1008827238335435,0.3822017042274729,1.0,5/20,8.06%,C3;HSP90AB1;TXN;TXNIP;P2RX7
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.6269534991329729,1.3357316241447883,0.14709851551956815,0.3821712922290349,1.0,5/13,15.69%,CLU;MANF;NUPR1;WFS1;NR1H2
prerank,negative regulation of phagocytosis (GO:0050765),0.600284443849391,1.335695012502383,0.11139240506329114,0.3818039071418321,1.0,6/17,17.73%,RACK1;SIRPA;SYT11;HMGB1;CD300LF;CD300A
prerank,cellular response to leucine starvation (GO:1990253),-0.5399295952215497,-1.335481492317332,0.14726027397260275,0.5233189140195107,1.0,6/10,25.19%,EIF2AK4;RRAGB;SESN1;LARS1;SESN2;SESN3
prerank,regulation of actomyosin structure organization (GO:0110020),-0.5028972348031802,-1.3351965060698776,0.13120567375886524,0.5207880323284062,1.0,6/13,2.54%,ROCK2;AKAP13;ASAP3;ALMS1;SLC9A1;ROCK1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5998343414422775,1.3351916276705538,0.12433155080213903,0.3826107949642649,1.0,13/16,31.25%,TMEM50A;LEPROT;CHMP5;CHMP6;VPS28;CHMP7;VPS36;CHMP4C;LEPROTL1;SNF8;CHMP4A;CHMP4B;TMEM50B
prerank,neuron development (GO:0048666),0.4613332706217088,1.3349272510656585,0.023185483870967742,0.3827674410719475,1.0,68/141,27.38%,APOE;PLP1;NLGN1;BLOC1S4;CNTNAP2;NTRK2;GPM6B;CNTN4;TENM3;SH3GL2;GPRIN1;UHMK1;TENM2;STMN3;MANF;LGI1;ATP8A2;PQBP1;PRDM12;MAPT;STMN4;MAP2;CDK5R1;EPHA5;HMGB1;BLOC1S1;B4GALT6;TENM4;BLOC1S3;BLOC1S5;CLN5;PRMT1;STMN1;EHD1;GPRIN2;UGDH;CDK5;NCDN;TMEM108;ADCYAP1;GPM6A;ERCC6;ATCAY;MYT1L;RASGRF1;DCX;VAPA;IL6;POU4F1;MEF2C;SRRM4;HS6ST1;BLOC1S2;TBCD;APP;TBC1D24;AGER;SRF;RUNX1;TGFB2;ZFYVE27;LAMB1;NPY;STX3;XBP1;ALK;PPP1R9B;MYOC
prerank,regulation of histone methylation (GO:0031060),-0.49656889235753476,-1.334258567287839,0.1422924901185771,0.5198209991747119,1.0,3/13,5.81%,NSD1;JARID2;MTHFR
prerank,vesicle organization (GO:0016050),0.5001152985159754,1.3340343987890204,0.09465478841870824,0.38464854590023895,1.0,16/46,21.75%,CD34;CAV2;CHMP2B;SAR1A;CORO1A;SRGN;FNBP1L;SNX11;SORT1;SNX33;SQSTM1;CAV1;USP8;HOOK1;EXOC8;DNM1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.4642117777788489,-1.3337111746467747,0.15503875968992248,0.5180212745402163,1.0,6/16,14.04%,CREBBP;NAA40;KAT2B;NAA16;NAA15;NAA35
prerank,entry into host (GO:0044409),0.6194066952548405,1.333495626203555,0.14535666218034993,0.3855574585917259,1.0,4/13,13.20%,PPIA;CTNNB1;CCR5;CXCR4
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5657012690908289,1.3329588511032704,0.12953367875647667,0.3865267666891023,1.0,11/21,25.67%,BGN;BCAN;DCN;CHPF2;CHPF;UGDH;VCAN;CHSY3;CSGALNACT2;CHST9;CSPG5
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5902451740403741,1.3325934976548803,0.12129032258064516,0.38694853771763776,1.0,5/17,4.03%,VTN;MDK;S100A11;IGFBP5;PDGFB
prerank,protein localization to cilium (GO:0061512),-0.38355812413638574,-1.3322385526157303,0.08860759493670886,0.5182901438347509,1.0,11/32,14.25%,ZNF423;RABEP1;BBS9;INVS;ARL3;WDR35;TULP3;IFT140;IFT122;TULP2;WDR19
prerank,cellular response to gamma radiation (GO:0071480),0.5959107455491579,1.3320021666621475,0.13082901554404144,0.38797741998765956,1.0,4/17,12.19%,RPL26;CRYAB;TMEM109;HRAS
prerank,positive regulation of cytokine production (GO:0001819),0.4509420522424721,1.331953756946873,0.005005005005005005,0.3876448994668314,1.0,99/292,25.01%,RPS3;CD74;GAPDH;MBP;TYROBP;MDK;C3;LAPTM5;POLR2E;HMOX1;PARK7;SOD1;ATF4;CCL19;PDE4B;CYBA;CD34;AGT;S100A13;SLC7A5;NFAM1;POLR2F;TNF;LAMTOR5;PTPRC;FCER1G;SORL1;MIF;FLOT1;HSPA1B;CTNNB1;TIRAP;HYAL2;ISG15;CEBPB;PQBP1;CLEC6A;HSPD1;LPL;IL2;EGR1;LILRA5;HMGB1;WNT5A;CSF1R;PNP;AIF1;FLT4;C1QTNF4;POLR2K;IRF7;SLC11A1;HSPA1A;LILRB1;RIPK2;TLR6;F2RL1;MAPK11;G3BP1;TLR5;HPSE;TLR1;RASGRP1;GATA4;TWIST1;PIK3CD;ADAM17;NOS2;SYK;CD14;CCR2;CXCL17;TGFB1;CD86;NLRP3;SPHK2;IL6;TMEM106A;POLR3D;CRLF2;PYCARD;TMED10;POLR3K;DDIT3;POLR2H;LBP;IRF5;RFTN1;PAEP;CD276;IL12RB1;AGPAT2;RELA;CD28;APP;IL33;AGER;STOML2;TLR7
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5411590557778422,-1.331851493425828,0.14705882352941177,0.5161614655758128,1.0,1/10,0.19%,BMP6
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6184196817156377,1.331700915114292,0.15331491712707182,0.387773585919231,1.0,3/12,13.22%,RBP4;STRAP;SOX9
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5464028971215097,1.3314341277525896,0.10991636798088411,0.38796302401199795,1.0,3/29,4.25%,LAMP1;TYROBP;SPI1
prerank,positive regulation of hormone secretion (GO:0046887),0.5811326552291985,1.3307412736051587,0.1251646903820817,0.38926902383226386,1.0,6/17,18.81%,SPP1;RASL10B;VAMP8;EDN3;NMB;SOX11
prerank,regulation of programmed cell death (GO:0043067),0.45769910454482887,1.3304815760123225,0.017189079878665317,0.389468098552023,1.0,40/161,15.61%,TPT1;RPS3;CLU;CTSB;HSP90AA1;CALR;LGALS1;AKT1;NME1;TGM2;AGT;PINK1;IGFBP3;MAGED1;TNF;BEX2;PRDX2;RTN4;VCP;ALPK2;OMA1;NDRG1;BNIP3L;SGK1;CXCL10;TARDBP;GAS1;BAX;APEX1;ZBTB7A;PMAIP1;WFS1;ACTN1;PHLPP1;SOX9;NME2;GLS2;IKZF3;CDK5;LRP8
prerank,mononuclear cell differentiation (GO:1903131),0.5561582131259475,1.3302550131564213,0.11685116851168512,0.3895652768157222,1.0,11/24,20.00%,MT1G;TREM2;IKZF1;IRF8;CSF1R;TRPM2;LILRB1;GAS6;BATF3;FLT3;PDE1B
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.4659591898356623,-1.3295238518075934,0.140625,0.5189127348022449,1.0,7/17,13.72%,CACNA1C;ANK2;ATP1A2;TRPM4;KCNJ2;CACNA1G;CACNA1D
prerank,T cell proliferation (GO:0042098),0.6229459608924641,1.3294001008242888,0.14248704663212436,0.3912898800253635,1.0,5/13,15.86%,MSN;SLC11A1;DOCK8;LILRB1;RASGRP1
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.3891461965320492,-1.3293594974883278,0.08227848101265822,0.516202162687346,1.0,10/29,15.98%,TCF7L2;CREBBP;PYGO1;TLE1;BCL9L;ASH2L;TERT;KMT2D;TLE3;CDC73
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.6183108923996743,1.3293592080672503,0.13262599469496023,0.390908547434282,1.0,6/13,21.53%,BOLA2;GLRX5;LTO1;CIAO1;CIAO2A;CIAO2B
prerank,calcium ion homeostasis (GO:0055074),0.47047445892493134,1.3290088946795544,0.054223149113660066,0.39127698903903235,1.0,28/95,19.75%,TPT1;CALR;CXCL12;SLC30A1;CCL19;SLC24A4;SLC24A2;TMTC2;GRIN1;DRD5;TMCO1;HTR2C;ATP13A2;CALCB;ATP2B1;WFS1;SLC8A1;ATP1B1;EDN3;RYR2;CCL3;CAV1;CDH5;CCL8;SELENON;CCR2;SNCA;TFAP2B
prerank,rRNA transcription (GO:0009303),0.5873969280465092,1.3288604733790896,0.125810635538262,0.3911554108174493,1.0,3/17,4.78%,CAVIN1;ANG;GTF3C6
prerank,histone H4 deacetylation (GO:0070933),-0.5284738752661067,-1.3287769735840769,0.1644295302013423,0.5146028376025317,1.0,4/10,7.80%,HDAC4;HDAC8;SMARCAD1;RCOR1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4563483648850455,1.328511962745355,0.019114688128772636,0.3914906351414219,1.0,48/166,19.80%,RPL26;RPS4X;RPL5;CLU;EEF2;VIM;HSP90AA1;HSP90AB1;PARK7;AKT1;CCL19;KLF2;EIF3D;NPM1;RPS27L;TNF;NR1D1;PDGFB;MID1IP1;CTDNEP1;EIF3C;MFSD2A;MLXIPL;EGR1;STARD4;DDB1;PCIF1;PCNA;ZCCHC4;PRMT1;KLF4;DDAH1;TLR6;ABCB10;ARPP19;NR1H2;IGF2;CIRBP;YTHDF1;EIF4A3;DDAH2;PPARGC1A;CTC1;SNCA;EPM2AIP1;HGF;IL6;SLC25A37
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.6094070499707694,1.327784775897434,0.15657894736842104,0.3928091777313445,1.0,4/14,10.91%,MDK;MAPK3;RARRES2;CSF1R
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4549164413285039,-1.32729383480245,0.11688311688311688,0.5150295180085166,1.0,4/16,4.53%,PRKAG2;APPL2;LONP2;PPARA
prerank,regulation of actin filament polymerization (GO:0030833),-0.3283168688915871,-1.3270821031695936,0.09433962264150944,0.5125794140306317,1.0,17/69,11.23%,ARHGAP28;FCHSD2;FER;BAIAP2L1;ARFGEF1;SLIT2;PRKCE;BAIAP2;CARMIL1;NCKAP1;CDC42EP5;PLEKHG2;GBA2;KANK1;SNX9;ARHGAP18;NCK1
prerank,negative regulation of locomotion (GO:0040013),0.622884879275872,1.3267328408669723,0.11724137931034483,0.39507550450931295,1.0,4/12,8.73%,PIN1;DUSP3;FRMD5;SPOCK3
prerank,central nervous system neuron axonogenesis (GO:0021955),0.638272687141135,1.326451969520811,0.13502673796791445,0.395330301215106,1.0,5/12,16.00%,HSP90AA1;HSP90AB1;B4GALT6;SPTBN4;EPHB1
prerank,protein localization to organelle (GO:0033365),0.45839698511609683,1.3259778608943553,0.03480040941658137,0.3960729806125492,1.0,38/133,19.48%,RPL11;LAMP1;COL1A1;CALR;HMOX1;SEC61B;PRNP;WDR83OS;TMEM30A;GABARAPL2;TOLLIP;AUP1;SEC61G;SORL1;IFT20;YWHAE;CTDNEP1;RPA2;ISG15;CD68;YBX1;VAMP2;ARF6;ZBTB7A;DNAJA1;MSX1;SERP1;ARL1;EHD1;SGTA;TRAM1L1;LMNA;SCG3;LAMP2;PPP1R15A;SYS1;DDRGK1;VAPA
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5479071686938219,1.3258655027477695,0.12162162162162163,0.39588399950531666,1.0,5/25,14.82%,B2M;LAPTM5;SLC7A5;WNT5A;F2RL1
prerank,B cell proliferation (GO:0042100),0.5844092096837956,1.3257606128831514,0.1408083441981747,0.3956519246091458,1.0,5/17,20.51%,PTPRC;CD180;HSPD1;RASGRP1;MEF2C
prerank,negative regulation of vascular permeability (GO:0043116),0.6286385452971577,1.3254995553920834,0.1289437585733882,0.3958824495672616,1.0,3/12,5.53%,CLDN5;RAMP2;SH3GL2
prerank,cellular protein catabolic process (GO:0044257),0.4865583141061098,1.3254651561147026,0.08163265306122448,0.39549241553587583,1.0,11/59,9.46%,CTSB;CTSL;CTSZ;CTSS;LGMN;CHEK2;UBE2G2;AP2M1;BNIP3L;CLTC;AP2S1
prerank,copper ion transport (GO:0006825),0.6322641323567834,1.3251236360351994,0.14185393258426968,0.3958621419404597,1.0,3/11,5.75%,ATOX1;COX17;STEAP4
prerank,defense response to symbiont (GO:0140546),0.4701192757045541,1.324742272905351,0.0694300518134715,0.3963563159030188,1.0,34/92,25.49%,IFITM3;IFITM2;IFITM1;SHFL;RNASE1;PTPRC;SERINC3;NT5C3A;FLNA;ISG15;PQBP1;BNIP3L;AGBL4;IFIT1;PMAIP1;IRF7;BST2;LILRB1;PDE12;SERINC5;F2RL1;G3BP1;OAS3;IL6;DDIT4;EXOSC4;PYCARD;IFI27;RSAD2;ISG20;RELA;LYST;TLR7;IFIT3
prerank,nitric oxide biosynthetic process (GO:0006809),0.6081378470574377,1.324154421024456,0.13520749665327977,0.3974073850717113,1.0,5/13,17.79%,AKT1;CYB5R3;SPR;DDAH2;NOS2
prerank,peptidyl-asparagine modification (GO:0018196),0.5238596218978893,1.3241068676795167,0.1242603550295858,0.3970501138297549,1.0,13/31,18.35%,OST4;RPN1;RPN2;DAD1;DDOST;LMAN1;MGAT2;DPM3;MCFD2;ASGR2;DPM2;MAGT1;STT3A
prerank,aminoglycan metabolic process (GO:0006022),0.649258756836902,1.3239885541921574,0.14124293785310735,0.3968489372169904,1.0,6/10,25.59%,CLN6;B3GAT3;XYLT1;B3GAT1;GAL3ST3;CHST9
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.4611291333576963,1.323439467933043,0.039755351681957186,0.3978128542933096,1.0,60/124,28.98%,CALM1;PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;RAC1;FZD9;PSMD1;PSMC3;CTNNB1;PSMD6;SFRP5;PSMA7;AP2M1;PFN1;CLTC;PSMD5;AP2S1;WNT5A;PSMB9;PSMD13;GNAO1;PSMB3;PSMB11;SFRP4;RHOA;PSMB10;TIAM1;PSMB1;PRICKLE2;ARRB2;PSMB5;AGO1;ARHGEF19;SFRP1;PPP3CA;PSMA6;PSMA4;FZD1;FZD2;AP2A1;PPP3R1;PSMD9;PARD6A;WNT7A;PSMC1;PSMD4;PDE6G;CELSR3;FZD3;PSMB2;PSMD10;PSMC5;LEF1;VANGL2;FZD5;MAP3K7;CCDC88C
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5642044891719328,1.323431639663094,0.12484076433121019,0.3973550822399772,1.0,4/21,3.16%,MT3;MMP3;PARK7;PINK1
prerank,positive regulation of embryonic development (GO:0040019),0.5723583430077013,1.3227312222581387,0.11068211068211069,0.39863473746227546,1.0,4/19,10.64%,RACK1;CFL1;OTX2;TENM4
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5245176367879697,1.3226662539086416,0.12632821723730814,0.39832227600911,1.0,18/29,31.99%,APOE;SHISA7;GRIK2;SYNGR1;SYP;PPFIA3;NCDN;NSMF;APP;SHISA6;ZDHHC2;NETO1;CAMK2B;ACP4;DBN1;MCTP1;RAB3A;DRD2
prerank,regulation of cell motility (GO:2000145),0.4584593979853482,1.3225696008421202,0.044193216855087356,0.39807089236698556,1.0,24/121,10.91%,TMSB4X;TMSB10;CAVIN1;RHOB;AKT1;CCL19;SPOCK2;SERPINE2;NRG1;ERBB4;RAC1;PIN1;FLNA;FRMD5;ENPP2;PKN1;SGK1;ROBO4;SPOCK3;NTN1;CADM4;PHPT1;DOCK10;CSF1R
prerank,positive regulation of defense response (GO:0031349),0.47588449142100275,1.3222186137119312,0.060445387062566275,0.3985119200793266,1.0,34/89,26.22%,MDK;GRN;CYBA;AGT;TNF;S100A8;S100A9;DDT;HYAL2;LPL;FEM1A;CEBPA;IL2;SLC15A4;LILRA5;PLA2G7;NINJ1;WNT5A;TNFRSF1A;GPSM3;CCL3;CCR2;SNCA;MEF2C;NFKBIA;POLR3D;TNIP1;AKIRIN2;APP;IL33;TLR7;PDE2A;CX3CL1;TLR2
prerank,neural crest cell migration (GO:0001755),0.5161386295184729,1.3221574898127277,0.11431870669745958,0.39819725149630153,1.0,10/36,13.77%,ERBB4;SEMA3F;SEMA7A;SEMA4C;FN1;CORO1C;SEMA6D;SEMA4A;SOX8;SEMA4G
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5846724549305786,1.3217129211040552,0.14116094986807387,0.3988682871821453,1.0,8/16,27.23%,SCD5;FASN;SCD;ACAT1;SLC25A1;PPCS;ACLY;HSD17B8
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5472348847412232,1.3216202253062068,0.11858190709046455,0.3986474720959226,1.0,12/24,22.74%,CXCL12;NBL1;LGMN;CREB3;CXCL10;PLA2G7;HMGB1;AIF1;CCR2;CXCL17;CCN3;DUSP1
prerank,negative regulation of TOR signaling (GO:0032007),-0.36640327992751837,-1.3215523761855466,0.05732484076433121,0.5233929212906636,1.0,17/36,25.19%,RNF152;FNIP1;UBR1;UBR2;PRKAA2;SESN1;DEPTOR;ATM;SIRT1;TSC1;ITFG2;SPAAR;CASTOR2;SESN2;CASTOR1;KPTN;SESN3
prerank,negative regulation of catalytic activity (GO:0043086),0.5503904635617891,1.3215176587908661,0.13333333333333333,0.3984306420355468,1.0,11/24,19.83%,MT3;NES;ATP5IF1;HP;TIMP1;PLN;IFIT1;PHPT1;TMBIM1;CCAR2;NOTCH1
prerank,receptor metabolic process (GO:0043112),0.4881455925599518,1.3214905075801329,0.09734513274336283,0.3980392335676121,1.0,19/53,19.62%,CD81;RAMP2;LGMN;NSG1;ITGB2;FCER1G;DNM3;AP2M1;TFRC;CLTC;RAMP3;LILRB1;ARRB2;CAV1;SYK;RAB31;SNCA;GRK2;TGFB1
prerank,nitric oxide metabolic process (GO:0046209),0.6008559818653283,1.3211601129888981,0.13474240422721268,0.39845760025819504,1.0,5/14,17.79%,AKT1;CYB5R3;SPR;DDAH2;NOS2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4522582078315209,1.3209870330852256,0.008032128514056224,0.3984693076567035,1.0,65/214,19.83%,APOE;CD74;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;TNF;PTPRC;PDGFB;NTRK2;C5AR1;PIN1;SEMA7A;MIF;NDRG4;SIRPA;DUSP3;DDT;ATP6AP1;TIRAP;FN1;DUSP26;P2RY6;KDR;CCN2;HTR2C;P2RY1;HMGB1;CSF1R;RAMP3;FLT4;HRAS;CAMK2N1;TIMP3;PTPRR;FBXW7;YWHAZ;SPRY1;CNKSR3;BMP2;CCL2;NEK10;GAS6;RRAS;F2RL1;PDGFA;RASGRP1;EPHB1;ARRB2;DAB2IP;ADRA1A;CCL3;GATA4;ADCYAP1;CCL8;FAM83D;SYK;GPR183;PTPN6;TGFB1;SPRY3;NOTCH1
prerank,establishment of spindle localization (GO:0051293),0.601123340205179,1.3207476463191647,0.13550135501355012,0.39862331961128666,1.0,9/14,31.07%,CFL1;CLASP1;LLGL1;ZBED3;KPNB1;MAP4;CLASP2;ESPL1;DYNC1H1
prerank,metal ion transport (GO:0030001),0.4668174618935866,1.3204807333215391,0.07586933614330875,0.39882741277041106,1.0,24/86,18.45%,TPT1;RAMP2;MT3;SLC30A1;CACNA1A;GRIN3A;CCR5;SELENOK;SLC3A2;NIPAL4;RAMP3;TRPM2;CHRNA4;SLC11A1;TRPC1;SLC8A1;RYR2;CCL3;CACNG8;CAV1;PSEN2;MAGT1;CCL8;NIPA1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5571585789050263,1.32041855424496,0.12177121771217712,0.39802517947156013,1.0,9/23,15.33%,YWHAB;YWHAH;YWHAE;YWHAG;PMAIP1;YWHAQ;BBC3;YWHAZ;BAD
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5571585789050263,1.32041855424496,0.12177121771217712,0.39802517947156013,1.0,9/23,15.33%,YWHAB;YWHAH;YWHAE;YWHAG;PMAIP1;YWHAQ;BBC3;YWHAZ;BAD
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.6219263297138165,1.319597845159556,0.18041958041958042,0.39959446327731674,1.0,3/11,9.89%,AGT;ABCG1;PLA2G7
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.5710660225025223,1.3195858441240333,0.12923462986198245,0.39916200807606494,1.0,11/20,27.23%,SCD5;HSD17B4;FASN;SCD;SLC25A1;ACSL3;DGAT1;ACSL4;ACLY;FAR2;HSD17B8
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5536309061809777,1.319544833802677,0.13048933500627352,0.39880237334280855,1.0,4/22,8.48%,APOE;TIMP2;TNF;TIMP1
prerank,cellular potassium ion homeostasis (GO:0030007),0.6177323889004693,1.3190433334024032,0.13988919667590027,0.39964574403242853,1.0,7/13,18.56%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;KCNMA1;ATP1B3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5454385232156872,1.3190008737963683,0.12437810945273632,0.3992636439100489,1.0,2/23,4.25%,TMSB4X;SPI1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.4729173947998559,1.3189532713444543,0.07468879668049792,0.3989187824491874,1.0,22/82,17.04%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NPM1;TUBA4A;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;ATF5;CEP131;DCTN1;NEK10;SSNA1;HAUS2;DCTN2;CETN2;PRKAR2B
prerank,mesonephros development (GO:0001823),-0.5082253567094798,-1.3189081763710837,0.13310580204778158,0.5264838809450983,1.0,3/11,13.00%,ZBTB16;FGF1;BMP4
prerank,B cell receptor signaling pathway (GO:0050853),0.514240670389081,1.3187444353935398,0.12131919905771496,0.398958160227188,1.0,13/32,27.05%,NFAM1;PTPRC;BAX;CTLA4;VAV3;SH2B2;PIK3CD;SYK;MEF2C;RFTN1;PLEKHA1;BLNK;ITK
prerank,eosinophil migration (GO:0072677),0.6013523419313411,1.3187066082785186,0.14227086183310533,0.3981176441493288,1.0,8/14,32.78%,LGALS3;CCL2;CCL3;CCL8;SCG2;CX3CL1;CCL13;CCL5
prerank,eosinophil chemotaxis (GO:0048245),0.6013523419313411,1.3187066082785186,0.14227086183310533,0.3981176441493288,1.0,8/14,32.78%,LGALS3;CCL2;CCL3;CCL8;SCG2;CX3CL1;CCL13;CCL5
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5846561883991548,1.3183218102300487,0.14624505928853754,0.3986733028630191,1.0,4/16,9.80%,HMOX1;APLNR;JCAD;GATA2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5833263769873022,1.3174108897907657,0.13308457711442787,0.4005318168270429,1.0,6/19,13.04%,KLF2;TNF;SLCO1C1;PDGFB;WFS1;KLF4
prerank,epithelial cell migration (GO:0010631),-0.35779158281290663,-1.317211591087278,0.04918032786885246,0.5273124741359146,1.0,12/37,14.24%,ABL1;KANK2;ROCK1;NRP1;ADGRA2;STARD13;DPP4;PXN;FAP;KANK1;GIPC1;KIT
prerank,modulation of chemical synaptic transmission (GO:0050804),0.46101442166879525,1.3171770642386902,0.0550935550935551,0.4006548043915259,1.0,52/107,28.00%,NRG3;NLGN1;DLGAP2;GRM5;DLGAP1;TNF;GRID2;GRIK5;GRIK2;CACNA1A;LRRC4C;SYT1;LGI1;RIMS2;GRM8;RIMS1;TPRG1L;GRM7;DGKI;GRID1;GRM1;BEGAIN;SYN1;HCRT;ABR;CX3CR1;MAPK8IP2;CDK5;LRP8;CLSTN2;NPTXR;TMEM108;CLSTN1;GRM4;CACNG5;KCTD13;MEF2C;CLSTN3;STX1B;GRIK1;UNC13A;APP;NPTX1;AGER;CACNA1B;SLC4A8;ITGB1;KCNMB4;PSMC5;CPLX1;CHRNA7;HOMER1
prerank,negative regulation of apoptotic process (GO:0043066),0.4383244925695349,1.3170054480072197,0.0,0.4006366924608512,1.0,123/444,20.73%,APOE;TPT1;RPS27A;PTMA;ARHGDIA;CD74;UBC;UBB;GPX1;MDK;HSPB1;GRN;MT3;CFL1;PARK7;SOD1;RPL10;MAPK3;HSPA5;AKT1;LGMN;FOXQ1;TREM2;HIGD2A;CCND2;TMBIM6;UBE2Z;CRYAB;HNRNPK;PRDX5;NPM1;ANXA5;ARL6IP1;PINK1;TNF;LAMTOR5;HSP90B1;FZD9;PRDX2;GLO1;HCLS1;NTRK2;NAA38;BNIP2;MIF;HSPA1B;CTNNB1;YWHAE;FLNA;IL2RB;LTK;TMEM14A;BEX3;BAG1;TFRC;UBA52;BNIP3L;HSPD1;FMN2;AQP1;FAIM2;KDR;IL2;NUPR1;DHCR24;SET;HCK;TAF9;WNT5A;ATF5;DNAJA1;FLT4;WFS1;SOX8;KLF4;SOX9;HSPA1A;YWHAZ;NME2;CCL2;PTPRZ1;RIPK2;CTSH;GAS6;CAT;CX3CR1;MAPK8IP2;ARF4;TYRO3;DLL1;DDAH2;SQSTM1;ATAD3A;VHL;GATA4;CAV1;ASNS;PSEN2;PIM3;PCID2;PPARGC1A;CIAPIN1;SFRP1;AGAP2;ERBB3;MAZ;PRELID1;DDRGK1;RNF144B;HMGN5;QARS1;SNCA;HYPK;TFAP2B;HGF;IL6;NOTCH1;POU4F1;CITED2;MEF2C;CAPN3;NFKBIA;MYC
prerank,L-amino acid transport (GO:0015807),0.5364256729376221,1.3160948040251248,0.1242603550295858,0.4025157158588332,1.0,8/28,12.80%,SLC38A5;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC3A2;SLC25A22;SLC1A1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5010037196144244,-1.3158565867024565,0.125,0.5275329743051822,1.0,4/12,5.55%,FOXP1;DAB2;PIAS2;NCOR1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.6082733944983805,1.3158426522386315,0.13788487282463185,0.40273488023001003,1.0,8/13,32.98%,ELOVL1;ELOVL2;TECRL;ELOVL7;ELOVL6;HACD4;ELOVL4;ELOVL5
prerank,regulation of regulated secretory pathway (GO:1903305),0.5124441728285337,1.3152371361517836,0.12195121951219512,0.40376629894019833,1.0,17/34,23.65%,SYT1;RIMS2;RAB15;RIMS1;SYT12;SYT11;SYT6;SYT4;RAB3D;SYN1;SYT10;SYT2;DOC2A;PREPL;SYT3;UNC13D;SYT5
prerank,ovarian follicle development (GO:0001541),0.6203061760042594,1.3150835093438675,0.14627659574468085,0.4036818807944527,1.0,7/13,20.68%,SOD1;ANG;CEBPB;FOXL2;EIF2B5;INHBA;INHBB
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.40368404144273845,-1.3145891611934106,0.11904761904761904,0.5276869790162034,1.0,11/28,18.59%,PARP9;KMT5C;KMT5B;SHLD1;PARP3;MRNIP;CYREN;SMCHD1;KDM4D;SIRT7;SHLD2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.5480026720047788,1.3144560455597545,0.11097992916174734,0.4048363846616359,1.0,12/27,20.93%,MDK;ITGB2;TNF;SIRPA;HSPD1;THY1;RHOA;CCL2;SKAP1;CCR2;IL6;PYCARD
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.48227002744781144,1.3141320534414394,0.08562019758507135,0.40520512512297824,1.0,25/60,24.60%,HSP90AA1;HSP90AB1;MAPK3;CCT2;PDGFB;CTNNB1;CCT7;CCT8;PCNA;KLF4;RFC2;HNRNPA1;PARM1;PTGES3;HGF;MAPK15;DKC1;RFC4;MYC;MAP2K7;CCT4;GRHL2;NAF1;PNKP;CCT3
prerank,cholesterol homeostasis (GO:0042632),0.47318055735385833,1.3135586574256632,0.08842794759825327,0.40625799791591805,1.0,16/64,17.91%,APOE;NPC2;RALY;NR1D1;ABCG1;LIPG;LPL;CD24;MALL;ABCA2;EHD1;NR1H2;CAV1;HDAC9;SOAT2;CNBP
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.47377300731247035,1.3130596472208542,0.06991525423728813,0.40703722554506255,1.0,34/73,26.48%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;SPI1;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;GATA2;KITLG;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;LMO1;PSMA6;PSMA4;PUS7;PSMD9;PSMC1;TCF3;PSMD4;METTL3;METTL14;PSMB2;RUNX1;PSMD10
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.5485103507657911,1.313038766854105,0.14285714285714285,0.4066106163712173,1.0,9/24,21.46%,PRNP;ITGB2;ANK3;HRAS;MTCL1;MIEF2;MFF;FIS1;C2CD5
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5036098719525056,1.312372903128955,0.08886389201349831,0.4078019005104959,1.0,15/44,19.79%,GPX1;MT3;AKT1;ARL6IP1;TNF;LAMTOR5;YWHAE;BEX3;AQP1;DHCR24;KLF4;GAS6;PCID2;SNCA;HGF
prerank,calcineurin-mediated signaling (GO:0097720),-0.5341659766479702,-1.3115721926668205,0.1702127659574468,0.5289647768641633,1.0,6/10,16.80%,NFAT5;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.5341659766479702,-1.3115721926668205,0.1702127659574468,0.5289647768641633,1.0,6/10,16.80%,NFAT5;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,excitatory postsynaptic potential (GO:0060079),0.5781282762121445,1.3115289883075836,0.15374677002583978,0.40958330819879,1.0,10/19,22.68%,AKT1;GRID2;MPP2;GRIN1;GRIN2A;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5892954239249832,1.3114532479938552,0.16180371352785147,0.40883137564239624,1.0,5/15,12.92%,BLOC1S4;AP3B2;BLOC1S1;BLOC1S3;BLOC1S5
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5892954239249832,1.3114532479938552,0.16180371352785147,0.40883137564239624,1.0,5/15,12.92%,BLOC1S4;AP3B2;BLOC1S1;BLOC1S3;BLOC1S5
prerank,anion transmembrane transport (GO:0098656),0.47693926584025675,1.311343200272832,0.07494646680942184,0.40866564806095235,1.0,32/67,28.03%,SLC38A5;SLC25A5;LRRC8A;SLC7A5;SLC1A2;SLC25A4;SLC25A13;SLC25A29;SLC6A5;SLC25A11;SLC3A2;SLC25A22;SLC25A21;SLC1A1;SLC19A1;SLC25A19;SLC35A3;SLC25A1;SLC35A1;SLC25A18;SLC35B4;MFSD12;SLC35B1;SFXN1;SLC6A8;SLC25A14;ABCC5;SLC13A5;SLC6A9;SLC25A12;SLC35A2;SLC16A7
prerank,sterol homeostasis (GO:0055092),0.4721848792619498,1.3112566809012995,0.08724100327153762,0.40842943671441656,1.0,16/65,17.91%,APOE;NPC2;RALY;NR1D1;ABCG1;LIPG;LPL;CD24;MALL;ABCA2;EHD1;NR1H2;CAV1;HDAC9;SOAT2;CNBP
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5889690920339612,1.3111074665315776,0.1527027027027027,0.40833864459937974,1.0,4/16,6.42%,APOD;TREM2;SIRPA;CUEDC2
prerank,T cell receptor signaling pathway (GO:0050852),0.4531247132911725,1.3109942448568652,0.05273833671399594,0.4081762538799296,1.0,62/138,30.74%,PSMB4;PSME1;PDE4B;PSMB6;PSMB8;PSME2;PSMD2;PTPRC;BTN3A3;PSMD1;PSMC3;PSMD6;PSMA7;CD3D;PAK1;THY1;MOG;PSMD5;ICOSLG;PAK3;PSMB9;RBCK1;PSMD13;PSMB3;PSMB11;CTLA4;PSMB10;RIPK2;PSMB1;PSMB5;LCP2;SKAP1;PIK3CD;EIF2B5;PSMA6;SKP1;PSMA4;TRAT1;NFKBID;RFTN1;CD276;PSMD9;PSMC1;RELA;INPP5D;CD28;PSMD4;STOML2;PSMB2;PRKCQ;PSMD10;ITK;PSMC5;IKBKG;CD3E;MAP3K7;PSME3;TXK;EIF2B1;ZAP70;PSMC2;PSMD14
prerank,C4-dicarboxylate transport (GO:0015740),0.6067619481051304,1.31066829560088,0.14824797843665768,0.4085107815520211,1.0,10/14,30.27%,SLC1A2;SLC25A13;SLC25A11;SLC25A22;SLC1A1;SLC25A18;SLC25A14;SLC13A5;SLC25A12;SLC25A30
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4586336669118363,1.3105370430300378,0.05635245901639344,0.40837832337071844,1.0,35/109,20.10%,CALM1;PSMB4;MAPK3;PSME1;PSMB6;PSMB8;PSME2;PSMD2;RAC1;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;PAK1;PSMD5;JUN;PSMB9;PSMD13;PSMB3;PSMB11;VAV1;VAV3;PSMB10;MAPK10;PSMB1;PSMB5;LCP2;SYK;PPP3CA;PSMA6;TAB1;SKP1;SOS1;PSMA4
prerank,lipid homeostasis (GO:0055088),0.47898476739950135,1.3103312578561592,0.08852459016393442,0.4084333251837824,1.0,14/57,14.20%,APOE;RCN3;PNPLA2;TREM2;ORMDL3;ABCG1;LIPG;RBP1;CEBPA;MLXIPL;ATP13A2;ABHD8;FBXW7;ABCA2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6467744943690179,1.3102632326909422,0.15647226173541964,0.408150597814577,1.0,3/10,3.75%,PARK7;TXN;GPR37L1
prerank,positive regulation of gene expression (GO:0010628),0.43751558867252005,1.3098987959715953,0.001,0.40861105856241503,1.0,114/442,19.83%,ACTB;RPL26;RPL23;RPS3;ACTG1;RPL11;RPS4X;RPS7;RPL5;CD74;CLU;EEF2;VIM;CLDN5;GSN;GAPDH;TYROBP;RAMP2;ACTA2;MT3;POLR2E;PARK7;SOD1;MAPK3;ATF4;AKT1;TREM2;EIF3D;NPM1;CD34;RPS27L;AGT;ANK3;S100A13;NFAM1;GPER1;POLR2F;TNF;LAMTOR5;PDGFB;NTRK2;AMH;MIF;FLOT1;HSPA1B;POLR1B;MSN;MUSK;FN1;RIMS2;TFRC;EIF3C;RIMS1;CLEC6A;P2RX7;VSIR;EGR1;GATA2;ATP13A2;WNT5A;DEK;LRP3;TMEM119;PCIF1;WARS1;RAMP3;POU3F1;WBP2;ELAVL4;CAMK2N1;POLR2K;ZCCHC4;SFRP4;KLF4;SLC11A1;SOX9;HSPA1A;BMP2;GJA1;LILRB1;CTSH;GAS6;TLR6;IFNGR1;MAPK11;PF4;DNMT3B;CIRBP;YTHDF1;HEY1;EPB41L4B;EIF4A3;CCL3;DNAJA4;TWIST1;PDCD5;CDH5;PIK3CD;AGO1;PPARGC1A;ERCC6;MAP2K2;MAZ;TBP;SOX11;DDRGK1;ERP29;HMGN5;INHBA;TGFB1;SPHK2;POLR1H;IL6;NOTCH1
prerank,monocarboxylic acid transport (GO:0015718),-0.34151536138430266,-1.3094859272073869,0.06315789473684211,0.5313055128304917,1.0,12/51,13.51%,SLCO3A1;SLC6A13;SLC16A12;NCOA1;SLC6A12;SLC16A9;ABCG2;SLCO2A1;ABCB4;SLC16A6;SLC16A13;ATP8B1
prerank,negative regulation of catabolic process (GO:0009895),0.5034492916166812,1.3093065380157018,0.1046119235095613,0.4097123400213937,1.0,10/47,10.35%,CST3;APOC1;TNF;PIN1;BSCL2;FLNA;PDE3B;FMN2;NUPR1;ADGRB1
prerank,regulation of cytokine production (GO:0001817),0.4528453203256038,1.309179095677631,0.05252317198764161,0.40955735327738474,1.0,32/126,18.54%,GAPDH;GPNMB;SOD1;TREM2;AGT;S100A13;NFAM1;TNF;PLD3;PTPRC;BTN3A3;MIF;FLOT1;SIRPA;ISG15;CLEC6A;MOG;SYT11;BCL6B;ICOSLG;IRF8;SRGN;ATP2B1;IRF7;SLC11A1;TRIL;TRAF3;HDAC9;TRIM32;PIK3CD;NOS2;CCR2
prerank,ESCRT III complex disassembly (GO:1904903),0.6329903233270832,1.3088010738112388,0.17714285714285713,0.4095841295702005,1.0,6/10,24.89%,CHMP2B;CHMP5;CHMP1B;VPS4A;CHMP7;CHMP1A
prerank,ESCRT complex disassembly (GO:1904896),0.6329903233270832,1.3088010738112388,0.17714285714285713,0.4095841295702005,1.0,6/10,24.89%,CHMP2B;CHMP5;CHMP1B;VPS4A;CHMP7;CHMP1A
prerank,cellular response to reactive oxygen species (GO:0034614),0.4825414125437153,1.308741433547696,0.09769484083424808,0.4092681565575929,1.0,14/59,11.69%,RPS3;PARK7;RHOB;MAPK3;AKT1;PRDX5;ROMO1;SIRPA;TNFAIP3;AQP1;MAPT;NET1;JUN;TRPM2
prerank,cellular response to amyloid-beta (GO:1904646),0.508261564961209,1.3086596428533102,0.11929824561403508,0.40901508309589324,1.0,12/35,16.92%,LGMN;PRNP;TREM2;GRM5;CACNA1A;GRIN1;ATP1A3;GRIN2A;GJA1;TLR6;CDK5;VCAM1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.48262352483586657,1.3085507074799871,0.08533916849015317,0.4088334155957984,1.0,27/57,25.51%,NLGN1;DLGAP2;GRIA2;DLGAP1;DLG2;NEFL;SHISA7;GRIN1;GRIN2A;GRIA4;LYNX1;CRH;GRIA1;BEGAIN;LRRC7;MAPK8IP2;CACNG8;NPTXR;GRIN2B;CACNG5;MEF2C;GRIA3;APP;NPTX1;CACNG2;PRRT1;SHISA6
prerank,negative regulation by host of viral transcription (GO:0043922),0.6253356973619691,1.3082334169239793,0.14978601997146934,0.4091866490677715,1.0,9/12,34.14%,PSMC3;JUN;TARDBP;CCL3;TFAP4;REST;POU2F3;CCL5;HMGA2
prerank,regulation of T cell activation (GO:0050863),0.5090802010933175,1.3081316321885699,0.12072892938496584,0.4090030218344761,1.0,12/42,20.93%,LAPTM5;GPNMB;LGALS3;SIRPA;DUSP3;HSPD1;THY1;FGL1;CCL2;CCR2;PRELID1;PYCARD
prerank,regulation of NMDA receptor activity (GO:2000310),0.5189619115381585,1.30799090177405,0.12341407151095732,0.40886651000084023,1.0,16/32,21.26%,NLGN1;GRIA2;DLG2;NEFL;GRIN1;GRIN2A;GRIA4;CRH;GRIA1;CCL2;LRRC7;MAPK8IP2;GRIN2B;CCR2;MEF2C;GRIA3
prerank,intracellular protein transmembrane transport (GO:0065002),0.4998567962113131,1.3077808776416673,0.12371134020618557,0.4089668178398879,1.0,11/42,15.74%,SEC61B;HSPA5;ROMO1;SEC61G;DNLZ;HSPD1;TOMM40L;SEC61A1;TIMM50;TOMM20L;PEX6
prerank,positive regulation of biosynthetic process (GO:0009891),0.5069351644331694,1.3076235327791854,0.1067853170189099,0.4089000093146824,1.0,8/40,10.35%,APOE;VIM;AKT1;CYBA;GRIN1;HSD17B13;MLXIPL;ADGRB1
prerank,epithelial tube morphogenesis (GO:0060562),0.5163417233064306,1.3075230383332186,0.11793020457280386,0.4087489144349731,1.0,11/32,11.65%,RHOB;CSNK2B;RASIP1;ACVRL1;CTNNB1;HES1;COL4A1;PAK1;PODXL;CSF1R;SOX17
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5914977885958531,1.3071514482517124,0.1532567049808429,0.4092307165674191,1.0,5/17,14.80%,AKAP6;ANK3;VAMP2;KCNE4;KCNE5
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6438294081658149,1.3064900007859717,0.1713091922005571,0.4104286288803625,1.0,4/10,10.70%,MT3;HP;DRD5;AOC3
prerank,histone H4-K16 acetylation (GO:0043984),-0.4364885135942617,-1.3062239424989435,0.1415525114155251,0.536669679241514,1.0,6/19,17.90%,OGT;KAT7;KMT2A;KANSL3;JADE2;KAT8
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6052213601494176,1.305963502984893,0.16272965879265092,0.41135415275612097,1.0,6/12,20.33%,TRH;MAOA;ODC1;SMS;SRM;OAZ2
prerank,cell differentiation in hindbrain (GO:0021533),0.6339120632824522,1.304886769616674,0.15202231520223153,0.413657069542895,1.0,4/11,8.69%,GRID2;KNDC1;PROX1;FAIM2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.4626577949699897,1.3047168182152387,0.07045215562565721,0.4135908828013257,1.0,14/86,10.09%,APOE;RPS3;CLU;GPX1;RAC1;PFN1;NAV3;PAK1;PROX1;CLASP1;MAPT;CDK5R1;ARF6;HCK
prerank,neural crest cell development (GO:0014032),0.49616755801288437,1.3047120482949828,0.11986301369863013,0.41314418468373865,1.0,13/44,18.81%,NRG1;ERBB4;SEMA3F;SEMA7A;SEMA4C;CORO1C;SEMA6D;SEMA4A;PDCD6;SOX8;SEMA4G;ANXA6;SOX11
prerank,autophagosome organization (GO:1905037),0.4820557549685989,1.3045738169200725,0.11711711711711711,0.41306260079434887,1.0,12/50,15.20%,GABARAP;MAP1LC3B;MAP1LC3A;EMC6;GABARAPL2;GABARAPL1;ATG9A;ATP13A2;ULK3;VMP1;UBQLN2;ATG101
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.52789226807579,1.3038877420669488,0.14543269230769232,0.4143094803601987,1.0,12/30,19.55%,PTPRC;PPP2R1A;HYAL2;PTK6;THY1;CADM4;SRCIN1;DMTN;CAV1;CD300A;SFRP1;PTPN6
prerank,membrane organization (GO:0061024),0.43908792398277086,1.303760047771025,0.015045135406218655,0.414166771656325,1.0,54/227,17.11%,ACTB;MTCH1;RPS27A;ACTG1;HSPA8;UBC;UBB;ANK3;SGCZ;SYNGR2;SH3GL2;CHMP2B;CTDNEP1;DNM3;AP2M1;SYT1;MYADM;TFRC;UBA52;SAR1A;SYNGR1;CORO1C;AMPH;CD3D;RIMS1;CLTC;VAMP3;VAMP2;EPN1;AP2S1;WNT5A;CHMP5;CHMP6;FCHO1;ARPC3;FNBP1L;SERP1;VAMP8;GLTP;CHRM2;ARPC5;TIMM50;CCDC88A;ARPC4;SYP;SH3KBP1;CLTA;M6PR;SYT2;ARRB2;CHMP1B;NAPA;ARPC2;DNM1L
prerank,positive regulation of response to external stimulus (GO:0032103),0.45601634420652865,1.3032370376185884,0.04717948717948718,0.4150563958666271,1.0,49/128,26.22%,MDK;GRN;THBD;CCL19;TREM2;CYBA;AGT;TNF;PDGFB;S100A8;S100A9;LY86;DDT;CD180;RARRES2;HYAL2;LPL;FEM1A;CEBPA;IL2;SLC15A4;P2RY12;LILRA5;PLA2G7;NINJ1;WNT5A;AIF1;TNFRSF1A;F2RL1;GPSM3;CCL3;CCR2;STX4;SNCA;TGFB1;NFKBIA;POLR3D;PTN;PPM1F;TNIP1;AKIRIN2;APP;IL33;TLR7;PRKCA;PDE2A;CX3CL1;USF1;TLR2
prerank,regulation of exit from mitosis (GO:0007096),0.5081351794844033,1.3028718310670029,0.11589403973509933,0.4155590824405439,1.0,3/38,0.82%,RPS27A;UBC;UBB
prerank,myeloid dendritic cell activation (GO:0001773),0.6260641235461419,1.3027210554856827,0.14442916093535077,0.4154998568206335,1.0,5/12,20.93%,DOCK2;HMGB1;BATF3;BATF2;PYCARD
prerank,cell cycle checkpoint signaling (GO:0000075),-0.49377234571431455,-1.3026626257859675,0.16666666666666666,0.542529413243349,1.0,5/12,20.56%,WEE1;PRCC;CHFR;PLK2;ZWILCH
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6040285807579368,1.3025815715461664,0.16073781291172595,0.4154066167172778,1.0,3/13,8.76%,CD74;MIF;PTTG1IP
prerank,artery morphogenesis (GO:0048844),-0.3852988630728397,-1.302055967943847,0.0625,0.5411415295788655,1.0,12/30,17.71%,BMPR1A;NRP1;ADAMTS9;TGFBR1;SMAD7;PDGFRB;BMP4;LRP1;JAG1;HEY2;BMPR2;NF1
prerank,epithelial structure maintenance (GO:0010669),0.613304771682105,1.3018909481424987,0.17097701149425287,0.41670132112968883,1.0,2/11,7.26%,RBP4;STRAP
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5006133534953061,1.301698872839453,0.11281489594742607,0.4167528283505469,1.0,17/47,20.75%,TYROBP;SOD1;CYBA;ITGB2;AGT;PDGFB;ROMO1;GRIN1;MAPT;ADGRB1;DCXR;TLR6;F2RL1;SYK;CBR1;TGFB1;GADD45A
prerank,T cell homeostasis (GO:0043029),0.6355242030256684,1.3009121453608319,0.16216216216216217,0.41825698386974114,1.0,3/10,14.33%,AKT1;PMAIP1;ZC3H8
prerank,nucleotide-excision repair (GO:0006289),0.45298498262442083,1.3008637024256693,0.061076604554865424,0.4179221036689059,1.0,38/101,26.50%,RPS27A;UBC;UBB;POLR2E;COPS7A;POLR2D;COPS6;POLR2F;PARP1;RPA2;HMGN1;UBA52;XAB2;PRPF19;RBX1;DDB1;POLR2G;PCNA;POLR2K;RFC2;COPS8;POLD4;CETN2;BRCA2;ERCC6;RAD23A;RFC4;ERCC1;POLR2H;LIG1;PNKP;POLD1;RPA3;PPIE;XPC;GTF2H5;CCNH;ERCC2
prerank,Fc receptor signaling pathway (GO:0038093),0.4555258162260562,1.3005815276639345,0.053497942386831275,0.41823103596971134,1.0,35/110,20.10%,CALM1;PSMB4;MAPK3;PSME1;PSMB6;PSMB8;PSME2;PSMD2;RAC1;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;PAK1;PSMD5;JUN;PSMB9;PSMD13;PSMB3;PSMB11;VAV1;VAV3;PSMB10;MAPK10;PSMB1;PSMB5;LCP2;SYK;PPP3CA;PSMA6;TAB1;SKP1;SOS1;PSMA4
prerank,linoleic acid metabolic process (GO:0043651),0.5609423564369677,1.3005774999037334,0.16158940397350993,0.41779091331657064,1.0,4/17,11.01%,FADS1;ELOVL1;ELOVL2;GSTM2
prerank,neuron projection development (GO:0031175),0.4459117807147102,1.300004679489895,0.032388663967611336,0.41878334475789264,1.0,55/168,20.23%,APOE;UBB;PLP1;NBL1;NLGN1;BLOC1S4;CNTNAP2;PACSIN1;GPM6B;CNTN4;NEFH;SH3GL2;GPRIN1;UHMK1;STMN3;MANF;LGI1;PQBP1;PRDM12;KLK8;PAK1;SGK1;GRM7;MAPT;STMN4;MAP2;CDK5R1;HMGB1;PAK3;BLOC1S1;DOCK10;BLOC1S3;NYAP2;BLOC1S5;PRMT1;SHTN1;STMN1;EHD1;GPRIN2;CDK5;EPB41L3;EPHB1;NCDN;DAB2IP;TMEM108;ADCYAP1;GPM6A;ERCC6;ATCAY;CTNND2;RASGRF1;VAPA;IL6;CTTN;POU4F1
prerank,regulation of vasculature development (GO:1901342),0.5350802054651278,1.2994734782783535,0.13405797101449277,0.41967524409845924,1.0,10/26,20.70%,GPNMB;HMOX1;EMP2;CTNNB1;VASH1;RNH1;WARS1;SFRP1;IL6;PLXND1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5595052321503406,1.2994178350924346,0.15716096324461343,0.4193575479380612,1.0,8/20,13.35%,HSP90AA1;HSP90AB1;PINK1;EPAS1;HSPA1B;EGR1;DNAJB2;HSPA1A
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4638803813844647,1.2992487228642755,0.07231404958677685,0.4193160062428013,1.0,32/95,21.99%,VIM;PDE4B;NR1D1;SIRPA;TIRAP;TNFAIP3;CD180;CCR5;CXCL10;CD68;TICAM2;HMGB1;ZFP36;WNT5A;CHMP5;RHOA;CCL2;LILRB1;CX3CR1;PF4;DAB2IP;CD14;CD86;NLRP3;IL6;GIT1;MEF2C;SIRT2;SELENOS;PYCARD;NUGGC;LBP
prerank,cellular calcium ion homeostasis (GO:0006874),0.4500526965606641,1.2990255481539192,0.061224489795918366,0.4194200436838165,1.0,40/133,18.54%,TPT1;CALR;CXCL12;SLC30A1;SMDT1;CCL19;GPER1;SLC24A4;SLC24A2;FZD9;CAV2;YWHAE;DRD5;CALB1;TMCO1;KCTD17;PLN;SELENOK;HTR2C;ATP13A2;BAX;CALCB;ATP2B1;TRPC7;WFS1;TRPC1;SLC8A1;ATP1B1;EDN3;RYR2;CCL3;ADCY8;CAV1;HERPUD1;FKBP1B;HCRTR1;CDH5;CCL8;ANXA6;CCR2
prerank,neutrophil activation (GO:0042119),0.6167116744662835,1.2986773327363101,0.17355371900826447,0.4198555886866411,1.0,4/12,18.30%,TYROBP;FCER1G;F2RL1;SYK
prerank,regulation of DNA repair (GO:0006282),-0.3492885781082493,-1.2984837262197213,0.10377358490566038,0.5467905516844864,1.0,16/44,14.31%,EYA2;EGFR;EYA1;BABAM2;TRIP12;UBR5;KAT7;UIMC1;EYA4;PML;RNF8;PARG;EYA3;ERCC8;SIRT1;SMCHD1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.444107936836466,1.2983901979576173,0.0486322188449848,0.42013659983245777,1.0,69/163,30.74%,PSMB4;PSME1;PDE4B;PSMB6;PSMB8;PSME2;PSMD2;NFAM1;PTPRC;BTN3A3;PSMD1;PSMC3;PSMD6;PSMA7;CD3D;PAK1;THY1;MOG;PSMD5;ICOSLG;PAK3;PSMB9;RBCK1;PSMD13;PSMB3;PSMB11;CTLA4;VAV3;PSMB10;SH2B2;RIPK2;PSMB1;PSMB5;LCP2;SKAP1;PIK3CD;SYK;EIF2B5;PSMA6;SKP1;PSMA4;TRAT1;MEF2C;NFKBID;RFTN1;CD276;PSMD9;PSMC1;RELA;INPP5D;CD28;PSMD4;PLEKHA1;STOML2;BLNK;PSMB2;PRKCQ;PSMD10;ITK;PSMC5;IKBKG;CD3E;MAP3K7;PSME3;TXK;EIF2B1;ZAP70;PSMC2;PSMD14
prerank,positive regulation of cell motility (GO:2000147),0.4421226705783963,1.2983094338272485,0.022110552763819097,0.41989158196083287,1.0,62/205,19.83%,ACTG1;RACK1;CAVIN1;MDK;COL1A1;GRN;GPNMB;CD151;CXCL12;HSPA5;CCL19;SPOCK2;GPER1;RHOC;SEMA3F;PDGFB;SEMA7A;SEMA4C;MYADM;FAM107A;CXCL16;SEMA6D;PAK1;PODXL;KDR;VSIR;NTN1;LGR6;LAMC2;PHPT1;SEMA4A;CSF1R;PECAM1;ELP3;AIF1;HRAS;BMP2;SEMA4G;CTSH;SDCBP;TIAM1;F2RL1;MMP14;PDGFA;CCL3;TWIST1;CASS4;CAV1;PLAU;CDH5;TRIM32;PIK3CD;F10;FLT1;ADAM17;MAZ;PPP3CA;STX4;DDRGK1;TGFB1;HGF;NOTCH1
prerank,regulation of cell cycle phase transition (GO:1901987),0.46166603782233023,1.2982665240553044,0.07253886010362694,0.4195400247304837,1.0,44/91,31.11%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;DDB1;PSMB9;PSMD13;BUB3;PSMB3;PSMB11;FBXW7;FBXO5;PSMB10;NEK10;PSMB1;PSMB5;PSMA6;SKP1;PSMA4;TFAP4;FZR1;PSMD9;PSMC1;PSMD4;CDC20;XPC;PSMB2;PSMD10;ERCC2;CDKN1A;PSMC5;TRIM39;ATP2B4;PSME3;PSMC2;PSMD14;NEK11
prerank,T cell differentiation in thymus (GO:0033077),0.5918244847783085,1.298220605226901,0.16133333333333333,0.4192091504183738,1.0,3/14,4.80%,ZFP36L1;PTPRC;ZFP36L2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5179520588059491,1.2981334376535965,0.1388888888888889,0.418962785599086,1.0,4/33,4.13%,CD74;TNF;ZFP36L1;HCLS1
prerank,anion transport (GO:0006820),0.5141691588761654,1.2972693492785585,0.11458333333333333,0.4206829610006729,1.0,10/33,19.38%,TSPO;SLC17A8;LRRC8A;SLC26A4;SLC17A7;SLC17A6;SLC19A1;SLC4A2;VDAC2;SLCO1B1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.5245677457005847,1.2970882089071678,0.12949640287769784,0.420704149821591,1.0,11/29,24.12%,SCD5;ELOVL1;ELOVL2;FASN;SCD;ELOVL7;SLC25A1;ACSL3;ELOVL6;ACSL4;ACLY
prerank,regulation of protein localization to cell surface (GO:2000008),0.510323735214708,1.2969482601448465,0.12124711316397228,0.42058330177643655,1.0,7/33,7.88%,TYROBP;HSP90AB1;TNF;MAP1A;GPM6B;CTNNB1;LEPROT
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4831825031637967,1.2966500660635618,0.11547085201793722,0.4209236889749849,1.0,17/50,16.92%,RPS3;PARK7;UBXN1;AKT1;HSPA1B;TNFAIP3;BAG5;ISG15;ADGRB1;DNAJA1;VPS28;FBXO5;HSPA1A;IVNS1ABP;ARRB2;SQSTM1;CAV1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5512359136420039,1.2962441347129345,0.1558109833971903,0.4214800415162815,1.0,4/20,4.77%,PPIA;PPIB;FKBP1A;PIN1
prerank,regulation of exocytosis (GO:0017157),0.4836316195938566,1.295847105979504,0.1271282633371169,0.4220216711639476,1.0,18/46,22.06%,ATP6AP1;SYT1;RIMS2;RAB15;IL1RAPL1;CLASP1;RAB3C;VAMP2;CADPS;STXBP5L;RAB3D;CHMP6;HAP1;RAB26;STX4;SNCA;RAB27B;UNC13D
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4765294596594336,1.2952139467534949,0.10855263157894737,0.42318588607814417,1.0,20/54,22.08%,RACK1;LAPTM5;TNF;HSPA1B;TNFAIP3;SPPL2B;OTULIN;RBCK1;HSPA1A;CLIP3;TNFRSF1A;NLRP2B;GAS6;F2RL1;ADAM17;TRAIP;SYK;PYCARD;SPPL2A;PELI3
prerank,negative regulation of endocytosis (GO:0045806),0.5481461736949726,1.2947009017939344,0.13630731102850063,0.42409110738027767,1.0,11/24,19.56%,APOC1;RAC1;LGALS3;SYT11;ARF6;LILRB1;NR1H2;SNX33;CAV1;CD300A;UNC119
prerank,glutamate metabolic process (GO:0006536),0.5610352053268287,1.2944907029384558,0.168848167539267,0.42417177105541215,1.0,8/19,22.39%,OAT;GLUL;GLS2;GLS;GLUD1;GOT1;GAD1;MTHFS
prerank,negative regulation of interleukin-17 production (GO:0032700),0.6265502002372267,1.2944577421994057,0.1763046544428773,0.42380564068442944,1.0,2/10,8.99%,PRNP;VSIR
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.29725516217279746,-1.2943235507066864,0.0,0.554504708690352,1.0,33/108,13.87%,NXN;SULF1;WWOX;TRABD2B;WLS;DCDC2;LRRK2;VGLL4;MACF1;GPC3;SKI;KREMEN1;PTK7;PRKN;NFATC1;AXIN1;GRB10;TLE1;RSPO3;FGFR2;MDFIC;BTRC;ESR1;KANK1;TERT;PSEN1;ITGA3;NLK;CSNK2A1;RNF43;ZRANB1;LRP1;CBFB
prerank,myelination (GO:0042552),0.49687459011184776,1.294052830827133,0.12625698324022347,0.42440090107630635,1.0,16/46,15.71%,MBP;PLP1;MPZ;PLLP;PMP22;MAL;KLK6;GAL3ST1;B4GALT6;MYRF;CXCR4;MALL;BCAS1;NFASC;EPB41L3;DEGS1
prerank,regulation of cellular response to stress (GO:0080135),0.4496682510117813,1.2937345699832068,0.058151609553478714,0.4247880851087946,1.0,23/115,9.33%,HSPA8;HSP90AA1;HSP90AB1;HSBP1;CHCHD2;MAPK3;ATF4;CRYAB;NPM1;PINK1;IER3;HSPA1B;YWHAE;MANF;BAG5;RPA2;BAG1;USP51;CEBPB;VASH1;MAPT;NUPR1;HSPB8
prerank,defense response to virus (GO:0051607),0.4561683731423378,1.2936266427921692,0.07875647668393783,0.42462182449577884,1.0,32/100,22.44%,IFITM3;IFITM2;IFITM1;SHFL;RNASE1;PTPRC;SERINC3;NT5C3A;FLNA;ISG15;PQBP1;BNIP3L;AGBL4;CXCL10;IFIT1;PMAIP1;IRF7;BST2;LILRB1;PDE12;SERINC5;F2RL1;G3BP1;ATAD3A;OAS3;IL6;DDIT4;EXOSC4;PYCARD;IFI27;RSAD2;ISG20
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5524766433800284,1.2928990973506498,0.16272965879265092,0.4256653693797482,1.0,6/19,12.48%,POLR2E;TERF1;POLR2D;POLR2F;POLR2G;POLR2K
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5524766433800284,1.2928990973506498,0.16272965879265092,0.4256653693797482,1.0,6/19,12.48%,POLR2E;TERF1;POLR2D;POLR2F;POLR2G;POLR2K
prerank,positive regulation of cell population proliferation (GO:0008284),0.43413629098838663,1.2919569673668068,0.003003003003003003,0.42762286444471254,1.0,123/423,21.57%,RPL23;RPS9;RPS4X;RPS15A;CD74;S100A6;CLDN5;CD81;MDK;GRN;CALR;GNAI2;CAPNS1;HMOX1;LAMC1;TSPAN31;AKT1;RPS6;LGMN;S100B;SLC25A5;NRG1;NME1;CCND2;ERBB4;NPM1;AGT;COPS9;S100A13;NES;GPER1;COX17;TNF;EMP2;PTPRC;FZD9;PDGFB;ROMO1;HCLS1;NTRK2;C5AR1;MIF;SSR1;SERTAD1;HES1;MATK;FN1;RHOG;RNF187;PAK1;NAMPT;PROX1;TIMP1;AQP1;KDR;IL2;VIPR1;MLXIPL;LAMC2;HCK;WNT5A;KITLG;TMEM119;CSF1R;IL11;AIF1;CEP131;FLT4;HRAS;SOX8;PRMT1;FBXO5;SOX9;BST2;NME2;BMP2;GJA1;CTSH;SDCBP;GAS6;HNRNPU;TIAM1;BAD;FOLR2;HPSE;PDF;PDGFA;IGF2;EDN3;DLL1;ADRA1D;CCKBR;CIAO1;FLT1;ADAM17;TBRG4;DDR2;CNBP;SFRP1;ERBB3;MAZ;SOX11;STX4;DDRGK1;HMGN5;RTKN2;PTPN6;TGFB1;CD86;TOX;TFAP2B;IL6;NOTCH1;FLT3;MAPK15;THPO;MEF2C;MYC;CRLF2;CRLF1;ID2;MEIS2;PTN
prerank,neuron projection organization (GO:0106027),0.5904264208047415,1.291839675290532,0.17053206002728513,0.42749441651298964,1.0,6/15,14.38%,LGMN;PRNP;MAP1A;ATP1A3;DCTN1;ARF1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.632921571577743,1.2918368529108608,0.18565400843881857,0.42705080942949547,1.0,4/10,16.13%,PTPRC;LILRB1;CX3CR1;ARRB2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6324830943056589,1.29169426648738,0.1794871794871795,0.4269920059007638,1.0,3/11,10.38%,CD74;MIF;TAF9
prerank,chromatin organization (GO:0006325),-0.28193378350835663,-1.291388713996501,0.0,0.5592296735269695,1.0,37/132,15.23%,BAZ2B;BRWD1;SETD5;BAZ2A;SETD2;HDAC4;HMG20A;NUDT5;EHMT1;ARID1A;KDM5B;HDAC8;KAT2B;JARID2;MYSM1;SMARCAD1;SMARCE1;SMARCA5;CHD1;BAZ1B;ZBTB1;TOP1;CDAN1;ESR1;KDM5C;INO80;SETDB1;MCM3AP;KDM4C;PBRM1;LRWD1;SETD7;SIRT1;KDM4D;EZH1;RSF1;EZH2
prerank,microtubule-based transport (GO:0099111),-0.49573648364965894,-1.2910794644073618,0.19245283018867926,0.5570127065952636,1.0,8/12,30.12%,SPAG17;SPA17;DYNC1I2;DNAAF2;ROPN1L;CCDC40;ADCY10;DNAAF4
prerank,central nervous system development (GO:0007417),0.43488084940828375,1.2905577177220358,0.014098690835850957,0.4293930003988913,1.0,83/250,22.82%,APOD;C1QA;GSN;MBP;C3;BCAN;MARCKS;ASIC2;S100B;SLC2A1;NES;CNTNAP2;ADAM23;CNTN4;SCTR;NDRG4;ADGRL3;ABCB6;ECRG4;MAL;SH3GL2;GRIN1;SPOCK1;TAGLN3;COL4A1;NKX2-2;HAPLN2;TMX2;ADGRG1;PHGDH;UFC1;NRCAM;KLK6;GRIN2A;PROX1;MAST1;MOG;MFSD2A;SLC6A17;AATK;CDK5R1;DNAJC30;MARCKSL1;MYRF;ATP6AP2;DNER;HAP1;ELP3;SOX8;LSR;CLN5;CXCR4;SOX9;PTPRZ1;CAPG;ROBO2;CX3CR1;VCAN;CDK5;DSCAML1;IER3IP1;COX7B;DLL1;GLIS2;HSPG2;SCIN;EIF2B5;GRIN2B;SOX11;QARS1;DCX;RAB18;NNAT;DDIT4;MEIS2;SOX10;HAPLN4;GRIK1;ROGDI;POU6F2;GRHL2;SNTG2;ACAN
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.34474859185261364,-1.2898569842933254,0.058823529411764705,0.5569595662376509,1.0,13/56,10.54%,BMP6;LDLRAD4;RBPMS;SMAD6;ACVR1;BMPR1A;DAB2;BMPER;TGFBR1;PMEPA1;SMAD7;GDF1;SMAD4
prerank,negative regulation of protein kinase activity (GO:0006469),0.4592753138221609,1.2893683486172651,0.06979166666666667,0.4320029837513176,1.0,35/88,22.26%,PPIA;HSPB1;PARK7;AKT1;NPM1;CAMK2N2;PTPRC;SORL1;DUSP3;HYAL2;CDKN1C;DBNDD2;CORO1C;DUSP26;PTK6;THY1;YWHAG;RTRAF;WARS1;CAMK2N1;PTPRB;SRCIN1;SLC8A1;DAB2IP;CAV1;PRKRIP1;AKT1S1;TAB1;QARS1;SNCA;GADD45A;PYCARD;PTPRO;PPM1F;PTPN1
prerank,ventricular septum development (GO:0003281),-0.3657717285962179,-1.2893612300288393,0.10071942446043165,0.5552037040368965,1.0,11/37,10.54%,TGFBR3;HECTD1;ACVR1;BMPR1A;ROBO1;SLIT2;TGFBR1;MDM4;ZFPM2;SMAD7;SMAD4
prerank,negative regulation of protein catabolic process (GO:0042177),0.49604167927559556,1.2888480544840006,0.12386363636363637,0.43294180812073557,1.0,16/40,20.78%,CST3;TIMP2;PIN1;FLNA;NELL1;FMN2;TIMP1;ADGRB1;ATRAID;CTSA;TIMP3;DAB2IP;AGAP2;SNCA;TIMP4;SIRT2
prerank,positive regulation of double-strand break repair (GO:2000781),-0.34921626637860026,-1.2885485869094022,0.08163265306122448,0.5542597149657295,1.0,16/39,18.98%,ARID2;PARP9;KMT5C;SPIDR;KMT5B;SHLD1;PARP3;MMS19;MRNIP;FUS;FANCB;SMCHD1;KDM4D;MGMT;SHLD2;ZCWPW1
prerank,regulation of neutrophil migration (GO:1902622),0.6296650383649146,1.2883508612347763,0.19887955182072828,0.4337212582234861,1.0,5/10,25.50%,RAC1;RHOG;JAM3;RAC2;MPP1
prerank,atrial septum morphogenesis (GO:0060413),-0.49270757426568756,-1.288176864747129,0.16206896551724137,0.5522275849591473,1.0,2/10,1.46%,NOTCH2;ACVR1
prerank,"wound healing, spreading of cells (GO:0044319)",0.5398886801833827,1.2880653484205449,0.13784764207980654,0.43404269189637673,1.0,9/24,19.09%,CD151;RHOC;ACVRL1;FLNA;MRTFA;LCP1;RHOA;ADAM17;TMEFF2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.44389958195013945,-1.2880058227351534,0.15879828326180256,0.5498150246917045,1.0,4/17,7.75%,AKAP13;ADCY9;RAPGEF2;ADRA1B
prerank,anterior/posterior pattern specification (GO:0009952),-0.34893741747105644,-1.2878395438525205,0.05063291139240506,0.5473392290309159,1.0,19/53,16.55%,WLS;HOXB6;HOXB3;HOXA3;LRP5;SKI;HOXB4;HOXA5;HOXC4;TGFBR1;HOXB5;PCSK5;HOXC6;HOXA6;HOXC5;HEY2;SMAD2;BMPR2;ACVR2B
prerank,nitrogen compound transport (GO:0071705),0.43987374839603505,1.2878000751044203,0.05402650356778797,0.43435529037313847,1.0,31/141,16.22%,SLC38A5;RAMP2;RCN3;SLC18A1;LRP1B;SLC7A5;TXNIP;SLC1A4;TMEM30A;HSP90B1;ABCB6;CHMP2B;RD3;ARRDC1;SLC25A29;SCAMP3;SLC6A6;AQP1;SLC15A4;SLC6A2;VAMP2;SLC3A2;SLC48A1;RAMP3;SLC7A14;CMTM6;SLC11A1;ARRDC3;SCAMP2;SLC15A2;CHMP1B
prerank,negative regulation of transferase activity (GO:0051348),0.5225560460070184,1.2875459618821723,0.14891041162227603,0.4345826692960688,1.0,9/28,14.09%,PARK7;TERF1;BAG5;CDKN1C;MAPT;PHPT1;ZFP36;FBXO5;HNRNPU
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5863266489850335,1.2873601620009867,0.18265440210249673,0.43462637418779626,1.0,5/15,15.69%,C3;CTDNEP1;MFSD2A;FBXW7;NR1H2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.5848880774272194,1.2871375334704647,0.18337730870712401,0.4347137052720248,1.0,2/14,3.62%,PARK7;TNF
prerank,actomyosin structure organization (GO:0031032),-0.31195632914305454,-1.2869037180592207,0.08450704225352113,0.546805555747782,1.0,12/75,7.21%,ROCK2;SORBS1;PHACTR1;TMOD3;FRMD6;ROCK1;ACTN2;EPB41L5;EPB41L2;MYH9;CDC42BPB;MYH10
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.47338833239454203,1.286637005303584,0.10903083700440529,0.4355696844794921,1.0,14/59,14.11%,RPS27A;UBC;UBB;AKT1;TNF;PRDX4;UBA52;TICAM2;NKIRAS1;RBCK1;TBKBP1;TNFRSF1A;RIPK2;NKIRAS2
prerank,regulation of neuroinflammatory response (GO:0150077),0.5657244978592006,1.2865123752794536,0.16971279373368145,0.435461049378982,1.0,5/19,8.96%,MMP3;TREM2;TNF;NR1D1;NUPR1
prerank,regulation of ERAD pathway (GO:1904292),0.6157721699230752,1.286462030701395,0.17655172413793102,0.43514284550859417,1.0,5/11,21.59%,UBXN1;RNFT1;HERPUD1;TMEM259;USP13
prerank,positive regulation of secretion (GO:0051047),0.6301808976699964,1.2861419626382382,0.1871584699453552,0.43553401979360346,1.0,4/11,18.84%,TRH;AQP1;SCIN;ACSL3
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.4420002611707466,1.285764549471926,0.052845528455284556,0.43604574539667695,1.0,29/148,15.60%,RPL23;RPL11;RPS15;RPL37;RPL5;RPS20;AKT1;CSNK2B;MBD3;CHEK2;PIN1;RPA2;HIPK2;BRPF1;TTC5;SGK1;TAF10;CDK5R1;PIP4P1;TAF9;SSRP1;CCNG1;HEXIM1;RFC2;STK11;PRR5;L3MBTL1;MAPK11;CDK5
prerank,regulation of cation transmembrane transport (GO:1904062),0.5179048566530663,1.2852433307042357,0.1530120481927711,0.43695953019966477,1.0,8/29,15.15%,CD63;KCNIP4;DPP10;DPP6;FGF12;KCNN2;KCNE5;KCNIP1
prerank,histone deacetylation (GO:0016575),-0.3439765864370551,-1.2850920592106987,0.11009174311926606,0.5483412530524363,1.0,14/43,13.14%,PRDM5;MIDEAS;BAZ2A;HDAC4;PER2;MTA3;HDAC8;TBL1X;SMARCAD1;RCOR1;MIER1;TBL1XR1;RCOR3;SIRT1
prerank,negative chemotaxis (GO:0050919),0.5048271212903638,1.2850816661846398,0.1445221445221445,0.43696103572054906,1.0,14/33,17.34%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;NTN1;LGR6;UNC5C;SEMA4A;LRTM2;RHOA;SEMA4G;PDGFA;SLIT3;SLIT1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6359334689173977,1.2846610830600125,0.1731301939058172,0.4375947037061007,1.0,5/10,22.97%,ANK3;KCNE4;KCNE5;CAV1;KCNAB1
prerank,regulation of hormone secretion (GO:0046883),0.5799605094844351,1.2845246976132358,0.1830065359477124,0.4375069136605776,1.0,7/15,18.81%,VAMP3;SCG5;VAMP2;IL11;EDN3;NMB;SOX11
prerank,cellular response to cytokine stimulus (GO:0071345),0.43087463533650067,1.284517828034188,0.001,0.4370741973973964,1.0,119/416,21.10%,RPS3;RPS27A;HSPA8;MT1X;UBC;VIM;IFITM2;UBB;GAPDH;RPL13A;HSP90AA1;F13A1;CXCL12;MMP3;HMOX1;NDUFA13;MT2A;AKT1;CCL19;AQP4;AKAP6;ITGB2;IL5;POMC;GPER1;TNF;ZFP36L1;HSP90B1;NR1D1;HCLS1;JUNB;UBE2G2;ZFP36L2;SIRPA;IL2RB;CSF3R;HYAL2;S1PR1;CDC34;FN1;UBA52;CCND1;CCR5;IL1RAPL1;CEBPA;TIMP1;CXCL10;IL2;IFIT1;EGR1;HCK;ZFP36;WNT5A;COL1A2;IRF8;CSF1R;IL3RA;IL11;LCN2;AIF1;IL2RG;MAOA;SELPLG;VAV1;RHOA;CXCR4;SOX9;DOCK8;YWHAZ;TNFRSF1A;CCL2;ERBIN;PTPRZ1;RHOU;GAS6;HNRNPU;PDE12;RO60;NDN;IFNGR1;MAPK11;PF4;YBX3;LRP8;CSF2RB;SIGIRR;DAB2IP;CCL3;TWIST1;VCAM1;PIK3CD;NOS2;CCL8;SYK;SFRP1;SLA;CCR2;STX4;EPRS1;IL20RA;IFNGR2;MUC1;PTPN6;SOS1;TGFB1;CD86;CSF2RA;HGF;IL6;FLT3;IL10RB;PDE1B;POU4F1;IL1RAP;CDK9;MYC;CRLF2;PYCARD;CRLF1
prerank,supramolecular fiber organization (GO:0097435),0.4284991295662687,1.2844526725578553,0.013,0.43678510274726756,1.0,68/333,14.45%,CST3;RPS27A;GFAP;ALDOA;UBC;VIM;B2M;UBB;GSN;COL1A1;HSP90AB1;H3-3A;ITM2B;CD151;PPIB;TPPP3;RHOB;LUM;SERPINH1;MARCKS;TPM2;MFGE8;EMP2;RHOC;RAC1;ARHGAP25;FKBP1A;PLEC;NEFL;PIN1;SORL1;PSENEN;LOX;ELMO1;COL4A1;STMN3;MFAP4;RHOG;TTR;UBA52;CORO1C;P4HB;CALB1;CORO1A;COL3A1;MYO5A;COL6A1;MYO7B;MAPT;STMN4;LAMC2;KRT9;EPPK1;COL9A1;MYO1F;MARCKSL1;COL1A2;ACTN1;MYH11;DPT;DCTN1;RHOA;CLIP3;FLII;DES;STMN1;COL7A1;CCDC88A
prerank,primary miRNA processing (GO:0031053),-0.5267435099731019,-1.2839055348854675,0.18456375838926176,0.5486061531779782,1.0,5/10,14.87%,SMAD3;DROSHA;SMAD1;SMAD2;SRRT
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5683688636434707,1.2838415827861884,0.16010498687664043,0.437900287671172,1.0,5/18,7.61%,NRXN1;NLGN1;GRIN1;RIMS2;RIMS1
prerank,sphingolipid metabolic process (GO:0006665),0.4480326153804943,1.2837142944943574,0.07676348547717843,0.43777643584430354,1.0,37/108,24.01%,PSAP;GM2A;HEXB;SERINC1;HEXA;CERS2;ORMDL3;B4GALNT1;PPP2R1A;ELOVL1;ENPP2;ELOVL2;GAL3ST1;SMPD1;ELOVL7;CTSA;GLTP;SPTLC1;ABCA2;DEGS1;NEU1;ST6GALNAC3;CSNK1G2;FA2H;CLN8;SPTSSA;CERKL;VAPA;SPHK2;SGPP1;SGPL1;SGPP2;ASAH2;ELOVL6;ORMDL2;ALDH3B1;VAPB
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6313878890710359,1.2832433355171227,0.18067226890756302,0.438554630167338,1.0,2/10,8.88%,PRNP;PRKAR1A
prerank,aortic valve morphogenesis (GO:0003180),-0.3750372390867819,-1.2831988505951835,0.12413793103448276,0.5476885723921475,1.0,10/30,14.58%,ROCK2;SMAD6;ROBO1;ROCK1;SLIT2;NFATC1;ELN;BMP4;JAG1;HEY2
prerank,regulation of inflammatory response (GO:0050727),0.43741325064186437,1.2827041846247058,0.03535353535353535,0.439510389278528,1.0,31/190,10.49%,APOE;TMSB4X;MDK;GRN;MMP3;PARK7;AGT;GPER1;TNF;NR1D1;LRFN5;SEMA7A;S100A8;S100A9;SIRPA;DDT;TNFAIP3;HYAL2;LPL;FEM1A;CEBPA;OTULIN;IL2;BCL6B;VAMP3;VAMP2;LILRA5;PLA2G7;HCK;NINJ1;WNT5A
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4655786629288313,1.2824277611758914,0.09022556390977443,0.4397922293497729,1.0,31/70,26.48%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;GATA2;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;LMO1;PSMA6;PSMA4;PUS7;PSMD9;PSMC1;TCF3;PSMD4;METTL3;PSMB2;RUNX1;PSMD10
prerank,negative regulation of protein transport (GO:0051224),0.5336969024559262,1.282129587862915,0.14950980392156862,0.4401044546023027,1.0,6/25,21.90%,APOE;DPH3;RSC1A1;ERP29;RSAD2;PPM1F
prerank,neutral amino acid transport (GO:0015804),0.5241468604271816,1.2814746306559193,0.15587529976019185,0.44135103763595074,1.0,7/28,12.80%,SLC38A5;SLC7A5;SLC1A4;SLC6A6;SLC6A17;SLC3A2;SLC1A1
prerank,axonal transport (GO:0098930),0.4976546991297036,1.2814316917210904,0.14385964912280702,0.4410031045091831,1.0,10/36,13.03%,SOD1;BLOC1S4;NEFL;AP3B2;MAPT;BLOC1S1;BLOC1S3;HAP1;BLOC1S5;DCTN1
prerank,endoplasmic reticulum organization (GO:0007029),0.4714233969725771,1.2812174958874853,0.10543130990415335,0.4411179447995431,1.0,30/72,24.94%,HMOX1;SEC61B;PRNP;WDR83OS;LMAN2;SEC61G;RTN4;CAV2;REEP5;LMAN1;REEP6;VAMP2;REEP2;SERP1;SEC61A1;SHTN1;SGTA;TRAM1L1;DNM1L;LNPK;VAPA;RAB18;MAPK15;TMEM33;TRAM1;RTN3;CYB5A;VAPB;APP;ZBED3
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4768449284706951,1.2811691393679692,0.11693989071038251,0.44079583433649877,1.0,22/55,20.32%,BGN;HEXB;BCAN;LUM;FMOD;HEXA;HYAL2;DCN;GUSB;SDC4;GPC5;FUCA1;SGSH;NAGLU;HPSE;VCAN;HSPG2;SDC3;TGFB1;HPSE2;LYVE1;AGRN
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.44404958804926553,1.2810508622007666,0.06097560975609756,0.44066916406112094,1.0,40/121,19.83%,CD74;VTN;CD81;PRNP;TREM2;GRM5;ERBB4;IL5;AGT;TNF;PTPRC;PDGFB;HCLS1;ARL2BP;MIF;HES1;CLEC6A;ENPP2;PTK6;IL2;LILRA5;FCGR1A;CSF1R;IL11;PECAM1;DOK7;TNFRSF1A;SRCIN1;RIPK2;GAS6;LRP8;IGF2;CASS4;ERBB3;UNC119;TGFB1;EFNA1;HGF;IL6;FLT3
prerank,positive regulation of vascular permeability (GO:0043117),-0.49439000602563193,-1.2808830819054613,0.168,0.5504564510962303,1.0,2/12,6.05%,BMP6;ANGPT1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4216165022253852,-1.2805166535478476,0.16587677725118483,0.5485189250136443,1.0,4/20,7.75%,AKAP13;ADCY9;RAPGEF2;ADRA1B
prerank,RNA polyadenylation (GO:0043631),-0.39445492030414087,-1.280433538641445,0.09230769230769231,0.5432967683677092,1.0,12/26,21.34%,SCAF8;TENT4B;WDR33;CSTF3;TUT1;FIP1L1;PAPOLB;CDC73;CPSF1;TENT2;PCF11;CLP1
prerank,mRNA polyadenylation (GO:0006378),-0.39445492030414087,-1.280433538641445,0.09230769230769231,0.5432967683677092,1.0,12/26,21.34%,SCAF8;TENT4B;WDR33;CSTF3;TUT1;FIP1L1;PAPOLB;CDC73;CPSF1;TENT2;PCF11;CLP1
prerank,fatty acid elongation (GO:0030497),0.5842000993862381,1.279691432462202,0.16710526315789473,0.4438109156462376,1.0,7/13,32.98%,ELOVL1;ELOVL2;ELOVL7;ELOVL6;HACD4;ELOVL4;ELOVL5
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.459470591196794,1.2793767069427622,0.11571125265392782,0.4441574585708757,1.0,27/75,23.65%,APOE;AKT1;AGT;RASIP1;SORL1;UCHL1;RGS2;HYAL2;CDKN1C;CEBPA;PRKAR1A;SMPD1;PRKAR1B;HEXIM1;SPRY1;SLC8A1;DAB2IP;PRKAR2B;CD300A;SPRY3;GADD45A;TFAP4;PYCARD;PTPN1;MEN1;DUSP1;TESK1
prerank,regulation of astrocyte differentiation (GO:0048710),0.6036844561500487,1.2790456385549827,0.1825726141078838,0.4445746261652858,1.0,6/12,21.24%,SERPINE2;HES1;BMP2;IL6;NOTCH1;ID2
prerank,regulation of microtubule nucleation (GO:0010968),0.6280879469228161,1.2785713450719873,0.19280575539568345,0.44539177896486415,1.0,6/10,20.07%,HSPA1B;PAK1;ARHGEF7;DCTN1;HSPA1A;GIT1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.48113196632562594,1.2784309861385879,0.12874583795782463,0.4452590919266987,1.0,21/46,24.88%,NRXN1;NLGN1;GRM5;TNF;SYT1;GRM8;TPRG1L;GRM7;DGKI;GRM1;CCL2;MAPK8IP2;CDK5;CACNG8;GRM4;CCR2;CACNG5;MEF2C;GRIK1;UNC13A;CACNG2
prerank,mesoderm development (GO:0007498),0.563671300749736,1.278332430593934,0.14747736093143596,0.44505753583309865,1.0,9/18,32.17%,IKZF1;HCK;TIE1;IKZF3;GDF11;MESD;MEST;TCF15;BTK
prerank,cellular response to fatty acid (GO:0071398),-0.4949827208011161,-1.2776024581254215,0.16666666666666666,0.5476540131591562,1.0,2/12,4.81%,PID1;IRS1
prerank,negative regulation of cell death (GO:0060548),0.4570980992985063,1.2773254346110012,0.09394572025052192,0.4472195349139158,1.0,24/88,19.16%,CLU;GPNMB;MT3;PARK7;AKT1;CD34;PINK1;NENF;SORL1;HSPA1B;LRPAP1;BNIP3L;CCN2;ATP13A2;CHGA;TMEM109;WFS1;HSPA1A;PDE12;CDK5;GATA4;PPARGC1A;SOX11;SNCA
prerank,lymphocyte chemotaxis (GO:0048247),0.5018288941364738,1.2772754667821908,0.1478463329452852,0.4468921983868572,1.0,10/34,19.50%,CCL19;CXCL16;CXCL10;CCL2;GAS6;CCL3;PIK3CD;CCL8;CH25H;GPR183
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5031449615660776,1.277257414259397,0.14069767441860465,0.44647591917003926,1.0,14/36,20.75%,APOE;CSNK2B;TNF;ACVRL1;VASH1;DCN;HMGB1;ADGRB1;DAB2IP;DNAJA4;TGFB1;NOTCH1;MEF2C;GADD45A
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.5859800932722493,1.2769088441655818,0.19014084507042253,0.44691433357512245,1.0,2/12,2.13%,NBL1;AKT1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5255635481581469,1.2763737934904287,0.16826923076923078,0.4478638466306115,1.0,7/25,14.45%,AKT1;AGT;GPER1;RTN4;PTK6;HAP1;CCDC88A
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4174978012413859,-1.276133854516015,0.1794871794871795,0.5482315874465681,1.0,2/19,0.28%,BMP6;AFDN
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4662096445444906,1.2760100041221258,0.12052117263843648,0.44837948695773916,1.0,26/66,25.58%,TYROBP;HSPB1;CCL19;TNF;SIRPA;TNFAIP3;LPL;P2RX7;EGR1;LILRA5;WNT5A;NLRP2B;RIPK2;CX3CR1;TLR6;F2RL1;CCL3;NLRP3;IL6;TMEM106A;GIT1;PYCARD;CASP1;APP;AGER;CX3CL1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.6156614653414025,1.2756743113711773,0.1792717086834734,0.44876463036928815,1.0,4/12,17.21%,MDK;AKT1;FUT9;SKAP1
prerank,cell junction organization (GO:0034330),0.4597266105056246,1.2754119555105758,0.12208067940552017,0.4489873414597369,1.0,23/71,20.32%,ACTB;ACTG1;C1QA;GRM5;PIN1;LRP4;FLNA;PPFIA4;PPFIA2;MAPT;PAK3;VMP1;RHOA;CBLN2;ELFN1;PPFIA3;RAB39B;CTNND2;FBLIM1;SNCA;TGFB1;MARVELD2;AGRN
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5992556889149044,1.2749497623378803,0.1731301939058172,0.44975965166316845,1.0,5/12,18.56%,FXYD1;ANK3;ATP1B2;ATP1B1;ATP1B3
prerank,acute-phase response (GO:0006953),0.6033190286052494,1.2747780057111413,0.192722371967655,0.4497775392133243,1.0,5/12,21.99%,MBL2;CEBPB;SIGIRR;IL6;LBP
prerank,cellular response to interferon-gamma (GO:0071346),0.45695065682458136,1.2742976403189865,0.0899581589958159,0.4505152649652214,1.0,29/88,24.14%,B2M;GAPDH;RPL13A;MT2A;CCL19;AQP4;SIRPA;FCGR1A;HCK;WNT5A;IRF8;AIF1;IRF7;CCL2;PDE12;IFNGR1;CCL3;VCAM1;CCL8;NCAM1;OAS3;EPRS1;IFNGR2;IRF9;IRF5;TRIM68;IL12RB1;CAMK2G;CASP1
prerank,response to amino acid (GO:0043200),0.5137327647020238,1.2741023483936647,0.15338164251207728,0.4505957820631666,1.0,12/31,19.42%,TMBIM6;LAMTOR2;LAMTOR4;LAMTOR5;GRIN1;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF;GLRA3
prerank,regulation of osteoblast proliferation (GO:0033688),0.5629779645447033,1.274037485286162,0.17562254259501967,0.4503320330874177,1.0,9/17,18.46%,NELL1;TNN;TMEM119;ATRAID;SOX8;RHOA;BMP2;HPSE;SFRP1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5409694782649385,1.2740337431541207,0.1820480404551201,0.44988573541677745,1.0,6/20,8.47%,HSP90AB1;AKT1;CCND2;PDGFB;CCND1;PROX1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6291668051518522,1.2740219902635537,0.21023513139695713,0.44946465412866626,1.0,1/10,0.06%,CST3
prerank,regulation of endothelial cell migration (GO:0010594),0.45025131788082745,1.2739547232460224,0.1099476439790576,0.449197000164673,1.0,21/85,11.92%,APOE;SPARC;GRN;CALR;RHOB;AKT1;AGT;EMP2;RAC1;ACVRL1;EMC10;GLUL;VASH1;DCN;PROX1;KDR;ADGRB1;WNT5A;PDCD6;AAMP;FLT4
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.600989887010771,1.2738884170300755,0.17185385656292287,0.4489395910086319,1.0,7/13,29.96%,NAMPT;KDR;CCL2;SELENOS;IL33;TLR2;NOD2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.6018656120604933,1.2735082014980739,0.19573901464713714,0.4494741558965396,1.0,2/12,2.92%,ACADVL;APOC1
prerank,regulation of cell death (GO:0010941),0.4504540784421236,1.2732418870060334,0.09947643979057591,0.4497237484491739,1.0,19/94,14.17%,CLU;UBB;CTSZ;MT3;PARK7;DCC;CRYAB;HSPA1B;LRPAP1;HP;HPR;BNIP3L;CCN2;DHCR24;RAMP3;TMEM109;HSPA1A;RIPK2;PDE12
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4485454728725717,1.2722926163453168,0.11356466876971609,0.4517074800732918,1.0,23/88,16.47%,FTH1;FTL;HSPA8;BLOC1S4;SORL1;SH3GL2;SORCS1;RAB14;MYO5A;SCAMP3;CLVS1;CLTC;VAMP2;CLVS2;BLOC1S1;BLOC1S3;VAMP8;ARF1;SCAMP2;SORT1;CLTA;GOLGA7;NAPA
prerank,cellular response to UV (GO:0034644),0.4632908689315792,1.271723720271919,0.11312700106723586,0.45270475926150955,1.0,16/76,12.26%,RPL26;CRIP1;MMP3;ATF4;NPM1;COPS9;PARP1;HYAL2;MFAP4;TIMP1;AQP1;DDB1;MC1R;SMPD1;PCNA;NSMCE3
prerank,mammary gland epithelium development (GO:0061180),0.5882053443282032,1.2717129777716474,0.17227456258411844,0.45229926298686246,1.0,3/14,10.91%,AKT1;ERBB4;CSF1R
prerank,peptidyl-arginine modification (GO:0018195),0.5758766059435674,1.271697129239256,0.19920844327176782,0.4518926434699329,1.0,2/15,2.10%,PARK7;KRTCAP2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6267098824483394,1.271225787536928,0.20402298850574713,0.4526399445920528,1.0,5/10,21.99%,TIRAP;TICAM2;NINJ1;F2RL1;LBP
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4371849349190094,1.2705696072418113,0.055780933062880324,0.4538933590683399,1.0,41/159,17.22%,BSG;CLDN5;MPZ;NLGN1;ITGB2;UNC5D;CD84;GRID2;DSCAM;LRFN5;CNTN4;PCDHGB4;CDH20;ADGRL3;TENM3;TENM2;LRRC4C;SELL;CLDN11;KIRREL3;CDH18;IL1RAPL1;ROBO4;EMB;TENM4;FGFRL1;PECAM1;PTPRD;CADM3;CDH12;LRRC4B;ROBO2;DCHS1;CDH19;IGSF9;CDH24;CDH7;DSCAML1;CDH10;VCAM1;CDH5
prerank,positive regulation of dendritic spine development (GO:0060999),0.5481361043209344,1.269830866726266,0.17434620174346202,0.4553376943788449,1.0,2/20,2.47%,APOE;NLGN1
prerank,positive regulation of sodium ion transport (GO:0010765),0.6016131196280181,1.2698247235932105,0.21418826739427013,0.45490275982927963,1.0,4/12,15.51%,ANK3;SCN4B;CNKSR3;PRSS8
prerank,neuronal action potential (GO:0019228),0.5398786534911019,1.2697703068205526,0.15756035578144853,0.45459448875736835,1.0,10/22,27.59%,ANK3;GPER1;SCN1A;KCNA2;KCNA1;MYH14;SCN9A;KCNMB4;SCN8A;SCN2A
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.532819418163575,1.2693522425249977,0.18045112781954886,0.45524907806164133,1.0,7/22,13.70%,MDK;NES;TAFA1;FZD9;PROX1;GATA2;PTPRZ1
prerank,regulation of microtubule polymerization (GO:0031113),0.488876165736349,1.2690927776480994,0.1425233644859813,0.4554777916893497,1.0,16/40,19.16%,RPS3;RAC1;NAV3;PAK1;CLASP1;MAPT;TUBB4A;MAP2;CDK5R1;DCTN1;CLIP3;STMN1;ARL2;MAPRE3;CDH5;SNCA
prerank,regulation of axon regeneration (GO:0048679),0.6079374338441881,1.2689688665268932,0.18548387096774194,0.45533838209143607,1.0,3/12,7.82%,GRN;CERS2;KLK8
prerank,histone H3-K4 methylation (GO:0051568),-0.3848974076417095,-1.2687246220492545,0.11235955056179775,0.5637062135388622,1.0,15/26,21.77%,KMT2C;TET2;OGT;TET3;KMT2A;ASH2L;WDR82;KMT2D;SETD4;PRDM9;SETD1B;WDR5B;BEND3;KDM6A;CTR9
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6290731782129502,1.268421875111222,0.20441988950276244,0.45629830508083014,1.0,6/10,29.96%,NAMPT;KDR;CCL2;IL33;TLR2;NOD2
prerank,stress-activated MAPK cascade (GO:0051403),0.4661177799895051,1.268369473483942,0.13616557734204793,0.45598253293102237,1.0,15/61,19.58%,RPS27A;UBC;UBB;MAPK3;ZFP36L1;UBA52;ZFP36;SH2D3C;RIPK2;UBE2V1;MAPK10;MAPK11;MAP4K2;TAB1;SKP1
prerank,positive regulation of vasculature development (GO:1904018),0.4438211147107672,1.2681007932779969,0.09834368530020704,0.45618098467386003,1.0,27/94,17.53%,RAMP2;HSPB1;GRN;HMOX1;RHOB;CD34;ECM1;APLNR;ADAM12;BTG1;EMC10;HIPK2;TNFSF12;AQP1;KDR;GATA2;NINJ1;WNT5A;PDCD6;TIE1;CTSH;RRAS;GATA4;TWIST1;CDH5;PIK3CD;FLT1
prerank,negative regulation of kinase activity (GO:0033673),0.46741186397180357,1.2676813630548267,0.12364425162689804,0.4568940508495254,1.0,20/62,19.16%,PPIA;HSPB1;PARK7;AKT1;CAMK2N2;PTPRC;CDKN1C;DBNDD2;THY1;YWHAG;MAPT;RTRAF;WARS1;CAMK2N1;HNRNPU;PRKRIP1;AKT1S1;TAB1;QARS1;SNCA
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.360058727412089,-1.2675210278960274,0.12121212121212122,0.5639015481098044,1.0,10/29,15.49%,STRN3;KANK2;YAP1;AXIN1;CNOT1;UFL1;ESR1;KMT2D;CBFB;CARM1
prerank,phagosome maturation (GO:0090382),0.49074735682559406,1.2668661096974,0.13885647607934656,0.45862042208232956,1.0,18/35,32.58%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;RAB14;CORO1A;ATP6V0D2;RAB20;RAB31;ATP6V1A;ATP6V0A1;ATP6V0B;TCIRG1;MREG;RAB38;ATP6V0E1;RAB34;RAB39A
prerank,non-motile cilium assembly (GO:1905515),-0.3811362178267831,-1.2666775888936954,0.13812154696132597,0.5631261288895506,1.0,14/30,22.60%,PCM1;PIBF1;CEP290;IFT88;RPGRIP1L;CEP89;TMEM80;IFT122;C2CD3;IFT57;TBC1D32;RPGRIP1;GORAB;BBS10
prerank,renal absorption (GO:0070293),0.614360737597056,1.2661206800858908,0.2117310443490701,0.46008164880001157,1.0,5/10,19.90%,GSN;HYAL2;SGK1;SLC15A2;MAGED2
prerank,membrane assembly (GO:0071709),0.49848122389245586,1.2655946046694895,0.15466351829988192,0.46096185868379513,1.0,10/34,12.77%,NRXN1;NLGN1;S100A10;ANK3;EMP2;LRP4;FLOT1;IL1RAPL1;PTPRD;NRXN2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5980539364287375,1.2655469378478597,0.2163265306122449,0.46061677523593714,1.0,4/12,17.21%,TNF;FLOT1;THY1;SKAP1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.519148573361178,1.265502094655628,0.18541409147095178,0.46029514421412054,1.0,7/24,16.08%,TPPP3;PIN1;STMN3;MAPT;STMN4;STMN1;FGF13
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.45566596177134316,1.2652475836815984,0.12432432432432433,0.46053163584015594,1.0,17/72,17.04%,RPS27A;UBC;UBB;RNASE1;RNASE4;PARP1;RPA2;UBA52;PNRC2;RBX1;DDB1;EDC4;PCNA;RFC2;PDE12;POLD4;MUS81
prerank,bone morphogenesis (GO:0060349),-0.46775557588557903,-1.2650277295134624,0.19455252918287938,0.5646317254118761,1.0,4/14,8.34%,LRP5;SKI;LRP6;FGFR2
prerank,regulation of defense response (GO:0031347),0.4501810598925729,1.264641784130645,0.11739594450373532,0.46170159776019437,1.0,14/76,15.61%,APOE;TMSB4X;GRN;PARK7;TREM2;SEMA7A;TIRAP;BCL6B;HCK;WNT5A;ELMOD2;AKNA;TRAF3;LRP8
prerank,cellular response to lipopolysaccharide (GO:0071222),0.45052356270415145,1.2643224269782818,0.09362139917695474,0.4621311871624779,1.0,34/101,21.99%,VIM;PDE4B;TNF;NR1D1;SIRPA;TNFAIP3;CD180;CCR5;CXCL10;CD68;TICAM2;HMGB1;HCK;ZFP36;WNT5A;CHMP5;RHOA;CCL2;LILRB1;CX3CR1;PF4;DAB2IP;CCL3;CD14;TGFB1;CD86;NLRP3;IL6;GIT1;MEF2C;SELENOS;PYCARD;NUGGC;LBP
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.49848033288608756,-1.2639953371202632,0.18518518518518517,0.5646453560233944,1.0,3/10,9.95%,RARB;RARG;PPARG
prerank,cellular response to chemokine (GO:1990869),0.47615417744320804,1.263936295569158,0.1342434584755404,0.462688506284191,1.0,20/46,33.35%,CXCL12;CCL19;CXCL10;RHOA;DOCK8;CCL2;PF4;CCL3;CCL8;CCR2;DUSP1;CX3CL1;OXSR1;PPBP;CCL13;CCL14;GPR35;ACKR3;CCL5;LRCH1
prerank,negative regulation of cellular component organization (GO:0051129),0.4567885649497058,1.2634743643149027,0.10267379679144385,0.46347140231626843,1.0,19/74,19.09%,HSPA8;CLU;HSPA5;CRYAB;TNF;LGALS3;SORL1;HSPA1B;SYT11;SVIP;DNAJB2;HSPA1A;DNAJB1;LILRB1;SACS;SNX33;DNAJA4;NOP53;TMEFF2
prerank,neuron projection morphogenesis (GO:0048812),0.43528827326784614,1.2634608667054477,0.08223350253807106,0.46305923844863206,1.0,38/137,16.57%,ACTB;S100A6;UBB;NBL1;DCC;NLGN1;S100B;ANK3;CTNNA2;MAP1A;CNTNAP2;PACSIN1;CNTN4;LRP4;NEFH;CTNNB1;KLK8;PAK1;SGK1;NRCAM;MAP2;TNN;PAK3;ADGRB1;DOCK10;APBB1;NYAP2;TMEM106B;SHTN1;CCK;MAPK8IP2;SPTBN4;CDK5;EPB41L3;DSCAML1;EPHB1;DAB2IP;BRSK2
prerank,mitochondrion transport along microtubule (GO:0047497),0.5824911133975116,1.2631822158236388,0.19690576652601968,0.4633359666689582,1.0,3/13,8.71%,UBB;NEFL;MAPT
prerank,regulation of neurogenesis (GO:0050767),0.46659722302597584,1.2630919470007511,0.1423841059602649,0.4631206030652813,1.0,18/55,19.83%,B2M;SERPINF1;TGM2;GPER1;TNF;SORL1;CTNNB1;HES1;HES6;BHLHE41;SNW1;CX3CR1;HEY1;DLL1;TRIM32;SOX11;IL6;NOTCH1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5468658960974755,1.2629757320558301,0.17639429312581065,0.46300725952323557,1.0,10/20,19.75%,ATP6AP1;ATP1A3;ATP1B2;ATP1A4;ATP1A1;SLC8A1;ATP1B1;KCNMA1;ATP1B3;TFAP2B
prerank,regulation of protein localization (GO:0032880),0.4636685145675483,1.2625408412577177,0.14129244249726178,0.46369770765567025,1.0,16/58,18.27%,CTSD;RACK1;HSP90AA1;HSP90AB1;FKBP1A;PARP1;RAB14;SLC26A4;MAP2;CAMK1;FBXW7;MMD2;USP8;ADCYAP1;VPS4A;ATCAY
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5120951364103276,1.2623891843525328,0.17661388550548113,0.4636506896649587,1.0,7/29,9.38%,APOE;AKT1;MID1IP1;CTDNEP1;HSD17B13;MFSD2A;MLXIPL
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4526805869568226,-1.261813697467712,0.14339622641509434,0.567306882209993,1.0,7/15,10.33%,TNRC6B;TNRC6A;TNRC6C;CNOT1;TENT4B;CPEB3;CNOT7
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5220998739833002,1.2616369570625925,0.16180048661800486,0.46515808233700867,1.0,10/25,20.93%,PINK1;GPER1;BAX;PMAIP1;BBC3;BAD;MFF;DNM1L;PDCD5;PYCARD
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.56291810434699,1.261579279000499,0.19579500657030224,0.4648745255592199,1.0,5/15,19.80%,CST3;CLASP1;DDR2;TGFB1;IL6
prerank,regulation of cellular component organization (GO:0051128),0.43429425282669454,1.2615220096388144,0.07186234817813765,0.4645568759911376,1.0,30/135,14.26%,APOE;HSPA8;GFAP;HSP90AA1;PARK7;SNX17;NRG3;AGT;PINK1;LAMTOR2;TNF;LTBP4;PACSIN1;SPOCK1;BAG5;TFRC;FAM107A;KLK8;SGK1;WFDC1;CD22;NET1;AP2S1;WNT5A;ATF5;SSRP1;NCLN;STK11;HNRNPU;EGLN2
prerank,JNK cascade (GO:0007254),0.48647648935198023,1.2612111332375522,0.16917728852838934,0.46490391535216036,1.0,8/40,14.40%,RPS27A;UBC;UBB;UBA52;SH2D3C;RIPK2;UBE2V1;MAPK10
prerank,negative regulation of protein secretion (GO:0050709),0.4910130906660091,1.2609538774954498,0.1602787456445993,0.46514189359639185,1.0,10/38,23.21%,APOE;DPH3;CHGA;SFRP1;ERP29;INHBB;RSAD2;REST;CCN3;PSMD9
prerank,positive regulation of T cell cytokine production (GO:0002726),0.5418944280521962,1.2608051639999331,0.18813131313131312,0.46507135270816813,1.0,2/20,1.12%,B2M;CD81
prerank,post-translational protein modification (GO:0043687),0.4254174055793044,1.260744651819965,0.009,0.46478830995729875,1.0,65/332,14.16%,APOE;CST3;SPP1;PSMB4;ELOB;SPARCL1;C3;LGALS1;LAMC1;LAMB2;PSME1;PSMB6;CKAP4;PSMB8;PSME2;PNPLA2;COPS7A;PSMD2;IGFBP3;COPS6;IGFBP4;MFGE8;HSP90B1;FBXO15;IGFBP5;KLHL9;SHISA5;PSMD1;EPAS1;PDIA6;PSMC3;PSMD6;PSMA7;PENK;FN1;P4HB;FN3KRP;FBXL14;FEM1C;FEM1A;APLP2;UBE2M;TIMP1;VWA1;PSMD5;NEDD8;RBX1;FBXO27;DDB1;ICMT;PSMB9;PSMD13;FBXW5;PSMB3;WFS1;MXRA8;PSMB11;FBXO30;FBXW7;FBXO31;ASB13;PSMB10;SPSB3;GAS6;KBTBD7
prerank,ameboidal-type cell migration (GO:0001667),0.474183948296773,1.2603264714065838,0.13600891861761427,0.4654179695802637,1.0,16/51,22.36%,AKT1;ERBB4;SEMA3F;SEMA7A;SEMA4C;CORO1C;SEMA6D;PKN1;SEMA4A;SOX8;SEMA4G;AMOT;ANXA6;SGPL1;SOX10;CCN3
prerank,intracellular sterol transport (GO:0032366),0.5833448272054058,1.2599079915498144,0.20939597315436242,0.46602035738571324,1.0,4/13,9.50%,NPC2;ABCG1;TSPO2;STARD4
prerank,mucosal immune response (GO:0002385),0.571757688280152,1.2596025160557647,0.20079260237780713,0.4663593475183862,1.0,1/15,0.47%,RPL39
prerank,negative regulation of cellular metabolic process (GO:0031324),0.49178081867684814,1.2593339726637134,0.16534541336353342,0.46663265492426,1.0,7/37,15.63%,APOE;MT3;PINK1;LRPAP1;SDCBP;ABCA2;ANKRD13D
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.5860985246431603,1.259319186623436,0.17774762550881953,0.4662083922999484,1.0,7/15,20.79%,SEC61B;HSP90B1;AUP1;VCP;SYVN1;HERPUD1;SELENOS
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.557335107278609,1.2593134252500748,0.19206145966709348,0.4657747409036589,1.0,5/18,15.46%,ATF4;MAF1;FLNA;POLR2K;UBTF
prerank,negative regulation of cell communication (GO:0010648),0.5365012274649361,1.259178375756641,0.176696542893726,0.4657347052895629,1.0,9/21,22.26%,IGFBP3;PTK6;KIF26A;IL11;GLRA1;SRMS;ERBB3;BRAP;PTPN1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3130846523732794,-1.2589211183705438,0.05063291139240506,0.571714565837103,1.0,27/61,20.79%,EYA2;EGFR;EYA1;BABAM2;DHX36;OTUD4;UIMC1;EYA4;PML;RNF8;PARP3;PDGFRB;EYA3;SMOC2;ERCC8;SIRT1;SMCHD1;MECP2;RTEL1;TIGAR;ZCWPW1;WRN;FGF2;USP9X;SIRT6;ABRAXAS1;PRKD2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.5491780035474352,1.258907100863653,0.21216041397153945,0.46598165152940635,1.0,10/18,28.07%,MDK;HES1;TENM4;CXCR4;PTPRZ1;NOTCH1;PTN;SOX1;TMEM98;TNFRSF1B
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.48099008660601805,-1.2587823930477096,0.18439716312056736,0.5693671798802793,1.0,5/11,14.58%,BMPR1A;ZFPM2;BMP4;JAG1;HEY2
prerank,maintenance of protein location in nucleus (GO:0051457),0.5367664756168923,1.2586779896405749,0.19600499375780275,0.46613658964806814,1.0,10/20,24.56%,CHCHD10;PARK7;ARL2BP;HNRNPU;ARL2;SYNE1;RANGAP1;SKP1;SUN2;BARD1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5245975616996825,1.258586663466285,0.187871581450654,0.465936517027171,1.0,3/25,4.01%,RPS3;PDE4B;PTPRC
prerank,regulation of cell development (GO:0060284),0.49719127901432364,1.2585138621369734,0.1567251461988304,0.46568422213273414,1.0,11/36,17.06%,RPS19;GRN;AKT1;CTNNB1;HES1;HES6;BHLHE41;CX3CR1;HEY1;DLL1;HDAC9
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.45362098220216346,1.2584968338795337,0.11027837259100642,0.4652812017670465,1.0,13/73,8.71%,MTCH1;RACK1;LAPTM5;RPS27L;HSPE1;TNF;S100A8;S100A9;VCP;BEX3;DLC1;HSPD1;MAPT
prerank,embryonic organ morphogenesis (GO:0048562),-0.347859374592702,-1.2584014013379938,0.09917355371900827,0.5675393716246111,1.0,9/42,5.68%,FBN1;HOXB3;ACVR1;HOXA3;NIPBL;HOXB4;HOXC4;RARG;EFEMP1
prerank,secondary alcohol metabolic process (GO:1902652),0.48395972728999015,1.257927337352916,0.143348623853211,0.46637021887545577,1.0,10/42,23.54%,APOE;ABCG1;PIP4P1;CLN6;SOAT2;CLN8;CH25H;OSBPL1A;IDH3G;NSDHL
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5041887442474097,1.257223930211661,0.19786729857819904,0.46776084640883253,1.0,12/29,20.93%,AGT;GPER1;TNF;HYAL2;TNFSF12;PMAIP1;CAV1;TNFRSF12A;SFRP1;LTBR;INHBA;PYCARD
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5109471206417577,1.257214981788651,0.18106508875739644,0.46733861649469816,1.0,10/27,21.33%,CALM1;FKBP1A;YWHAE;AHNAK;PLN;JPH4;FKBP1B;SELENON;CALM2;CACNB4
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.49337696859410884,-1.2570840636431264,0.2027491408934708,0.568114181049242,1.0,5/11,10.00%,ATF7IP;RESF1;TASOR;SETDB1;PPHLN1
prerank,sensory perception (GO:0007600),0.47703240931331287,1.2570546315078441,0.16347237880496054,0.46731948491228276,1.0,14/45,22.88%,C5AR1;PCDH15;PENK;PRDM12;P2RX7;PDYN;TMEM150C;KCNA2;CHRNA4;CCL2;CCR2;NTSR2;SCN9A;USH2A
prerank,vasculature development (GO:0001944),0.5577184972037699,1.256644401065401,0.17608409986859397,0.4679619943556462,1.0,7/16,17.22%,SOX18;ACVRL1;APLNR;FLT4;FBXW7;STK11;CDH5
prerank,negative regulation of cell division (GO:0051782),0.6069790001636866,1.2565140821885135,0.2041958041958042,0.46785338461605425,1.0,6/11,29.26%,TXNIP;VPS4A;MYC;BLM;CHMP4C;AURKB
prerank,regulation of sodium ion transport (GO:0002028),0.5001410243017932,1.2564515771689193,0.17437722419928825,0.46755997059328314,1.0,11/34,15.51%,NKAIN2;ANK3;YWHAH;NKAIN3;P2RX7;SCN4B;FGF12;ATP1A1;CNKSR3;SPTBN4;PRSS8
prerank,positive regulation of cellular protein localization (GO:1903829),0.45774262888846623,1.2564373324871876,0.11397849462365592,0.4671783528464073,1.0,13/69,9.18%,TYROBP;HSP90AB1;PARK7;AKT1;TNF;LAMTOR5;MAP1A;ORMDL3;RTN4;TFRC;MAPT;SYT11;GPR137B
prerank,positive regulation of intracellular protein transport (GO:0090316),0.43106551245573443,1.255248284450773,0.06889564336372847,0.4699284581410213,1.0,38/144,15.38%,CD81;PRNP;TOMM7;OAZ1;ITGB2;PINK1;ANK3;RAN;TMEM30A;YWHAB;HCLS1;UBL5;YWHAH;SORL1;PRR5L;YWHAE;FLNA;HYAL2;SAR1A;TRIM28;LEPROT;YWHAG;VAMP2;CAMK1;CEP131;PMAIP1;HRAS;B3GAT3;FBXW7;YWHAQ;BBC3;YWHAZ;MTCL1;RHOU;GAS6;MIEF2;BAD;MFF
prerank,negative regulation of signaling (GO:0023057),0.5156732084042319,1.2547423958401032,0.17515527950310558,0.4708221234705692,1.0,11/25,22.46%,IGFBP3;PTK6;KIF26A;IL11;GLRA1;SRMS;ERBB3;BRAP;TRAT1;PTPN1;AP1AR
prerank,actin nucleation (GO:0045010),0.54422577659227,1.254533147230636,0.19318181818181818,0.4709321448653268,1.0,10/21,22.09%,MAGEL2;IQGAP2;ARPC1B;ARPC3;ARPC5;ARPC5L;ARPC4;ARPC2;SCIN;SPIRE1
prerank,regulation of protein catabolic process (GO:0042176),0.44104075347704025,1.2543817881611377,0.11844863731656184,0.47087605114004377,1.0,31/99,20.78%,EEF1A1;GFAP;NDUFA13;OAZ1;TNF;CHEK2;PIN1;SORL1;FLNA;EEF1A2;TNFAIP3;VCP;FMN2;TNFSF12;ATP13A2;DDB1;ADGRB1;WNT5A;CHMP6;CTSA;VPS28;ODC1;EGLN2;RAB26;DAB2IP;TRIM32;FAM83D;AGAP2;HECW1;OAZ2;SIRT2
prerank,purine nucleotide catabolic process (GO:0006195),0.5903287060368846,1.2543109048830348,0.21438263229308005,0.4706379171172283,1.0,6/13,22.66%,GPX1;HINT1;DNPH1;PNP;NT5C;GDA
prerank,positive regulation of cell cycle (GO:0045787),0.4577842419338338,1.2535838671676967,0.14410480349344978,0.47205438053000315,1.0,21/62,21.52%,RPS15A;CALR;AKT1;LGMN;CCND2;PDGFB;DUSP3;CCND1;PTK6;PROX1;NUPR1;MAPRE3;NUDT16;ASNS;TRIM32;ADAM17;USP22;RAD23A;CITED2;MEIS2;FOXA1
prerank,negative regulation of developmental process (GO:0051093),0.45248938944445116,1.253306834969111,0.12646121147715197,0.47237190944803414,1.0,24/69,19.83%,CST3;DCC;VAT1;PINK1;SPI1;MIF;SFRP5;ALPK2;GRIN3A;TFRC;OMA1;VASH1;THY1;MAPT;SOX9;BMP2;GAS6;HEY1;DLL1;BCL11A;SFRP1;TGFB1;SPRY3;NOTCH1
prerank,protein import (GO:0017038),0.4446660146960685,1.2521291484630561,0.11752360965372508,0.47502011604035954,1.0,18/84,18.67%,APOE;CLU;HSP90AA1;AKT1;RAN;PXMP2;FAM53C;PTTG1IP;GDAP1;IPO4;NUP85;NUP88;SNX33;SPRN;EIF4ENIF1;LAMP2;SYK;NUP50
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.45396094737435433,-1.2516932193650356,0.16115702479338842,0.5792679210303485,1.0,6/15,9.62%,GPC3;WNT5B;RNF213;RSPO3;NPHP3;SPEF1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.43438540836126965,1.2514528394565294,0.10871794871794872,0.4764221537582674,1.0,38/107,21.69%,HSPA5;ATF4;RCN3;PPP1R15B;HSP90B1;FLOT1;VCP;PDIA3;CEBPB;P4HB;UFC1;TMCO1;SELENOK;JUN;BAX;SYVN1;WFS1;BBC3;UBXN6;ERO1A;DAB2IP;BRSK2;HERPUD1;BCAP31;PPP1R15A;RASGRF1;EIF2B5;DNAJC10;DDRGK1;DNAJB9;PDIA4;TMEM259;TMEM33;SELENOS;BAK1;DDIT3;ATP2A2;HYOU1
prerank,negative regulation of protein modification process (GO:0031400),0.45063254398128455,1.2514496145964253,0.12736842105263158,0.47598415118856147,1.0,18/79,11.37%,PPIA;DBI;PARK7;FKBP8;PRNP;FXYD1;IGFBP3;PPP1R15B;YWHAB;SIRPA;PRR5L;SH3GL2;MYADM;CORO1C;MAPT;CADM4;TARDBP;WARS1
prerank,positive regulation of cell killing (GO:0031343),0.5951392288285916,1.2514291375359368,0.18356164383561643,0.47559134222828453,1.0,5/13,18.30%,CYBA;RAC1;WNT5A;NOS2;SYK
prerank,rRNA pseudouridine synthesis (GO:0031118),0.626219106836742,1.2512457735149236,0.21212121212121213,0.47565346631816685,1.0,6/10,22.81%,NOP10;NHP2;GAR1;DKC1;RPUSD4;NAF1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.3087790747442748,-1.251212072355587,0.09090909090909091,0.577878635215939,1.0,17/59,13.98%,ROCK2;ACVR1;LRRK2;ROCK1;CAMK2D;PDPK1;TGFBR1;CDC42BPB;DYRK1A;HIPK3;TBK1;NLK;CSNK2A1;CSNK2A2;PRKD1;MARK2;GSK3B
prerank,Golgi to lysosome transport (GO:0090160),0.6096466023877283,1.2509401238163351,0.20110957004160887,0.47599388753058147,1.0,2/11,1.39%,LAMP1;LAPTM5
prerank,negative regulation of programmed cell death (GO:0043069),0.41683848888368485,1.2508816573120367,0.02,0.4757051197248696,1.0,92/355,20.73%,TPT1;RPS27A;PTMA;ARHGDIA;CD74;UBC;GPX4;UBB;HSPB1;LAPTM5;MT3;CFL1;PARK7;RPL10;HSPA5;AKT1;TREM2;HIGD2A;CCND2;TMBIM6;UBE2Z;CRYAB;HNRNPK;PRDX5;NPM1;ANXA5;ARL6IP1;HSP90B1;PRDX2;GLO1;NAA38;BNIP2;MIF;HSPA1B;CTNNB1;FLNA;IL2RB;LTK;TMEM14A;BAG1;TFRC;UBA52;BNIP3L;HSPD1;FMN2;AQP1;FAIM2;KDR;IL2;NUPR1;DHCR24;HCK;TAF9;WNT5A;ATF5;DNAJA1;FLT4;WFS1;SOX8;SOX9;HSPA1A;YWHAZ;NME2;RIPK2;CTSH;GAS6;CAT;ARF4;DDAH2;SQSTM1;ATAD3A;VHL;ASNS;PSEN2;PIM3;PCID2;CIAPIN1;SFRP1;PRELID1;DDRGK1;RNF144B;HMGN5;SNCA;HYPK;TFAP2B;HGF;IL6;POU4F1;CITED2;CAPN3;NFKBIA;MYC
prerank,regulation of lipid biosynthetic process (GO:0046890),0.49850864465555633,1.25085112182484,0.1686182669789227,0.4753401973761569,1.0,7/32,9.38%,APOE;C3;AKT1;GPER1;MID1IP1;HSD17B13;MLXIPL
prerank,mRNA metabolic process (GO:0016071),0.441227168946628,1.2508448876371432,0.11064278187565858,0.4749110512422596,1.0,36/90,25.32%,SNRPG;AURKAIP1;RNASE4;LSM6;ZFP36L2;SNRPE;HSPA1B;SNRPF;SRSF9;HNRNPA0;ZFP36;RNH1;PRPF8;SRSF2;SUPT4H1;SF3A2;SF3B2;HSPA1A;NONO;SNRPB;SF3A3;NUDT16;SLBP;NANOS2;TBRG4;PPARGC1A;SNRPD3;SF3A1;SRSF1;SRRM4;PCBP2;ALKBH5;LSM5;METTL3;PNPT1;PRKACA
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6099154244189536,1.2507721402213787,0.20874471086036672,0.4746718240051186,1.0,2/10,1.54%,VTN;MT3
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.47736993470167144,1.2506113611580825,0.16608996539792387,0.4746399820411182,1.0,15/42,22.36%,LARS2;GARS1;SARS2;SARS1;KARS1;AARS2;WARS1;NARS1;CARS1;TARS3;PPA1;EPRS1;QARS1;AIMP2;YARS2
prerank,membrane raft organization (GO:0031579),0.5666417525204928,1.2503073834611447,0.20918367346938777,0.47500911363278747,1.0,4/15,6.15%,S100A10;EMP2;FLOT1;MYADM
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.48981563990412663,1.2498904534969137,0.1697674418604651,0.4756604565912393,1.0,8/35,10.38%,ARHGDIA;SEMA3F;RAC1;SEMA7A;FLNA;SEMA4C;SEMA6D;SEMA4A
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.4491643841832341,1.2497982566320431,0.13763440860215054,0.4754707699713863,1.0,24/72,24.07%,CD74;RACK1;HSP90AB1;TNF;PTPRC;TNFAIP3;SPPL2B;OTULIN;CD24;RBCK1;CDC37;CLIP3;TNFRSF1A;GAS6;IFNGR1;SIGIRR;SYK;IFNGR2;PTPN6;PYCARD;SPPL2A;PTPN1;AGPAT2;SOCS3
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5880484585170276,1.2494314351588813,0.21933621933621933,0.475987812264908,1.0,3/12,10.56%,HSPA5;KDELR1;RER1
prerank,engulfment of apoptotic cell (GO:0043652),0.5662279503021357,1.2490765455552442,0.22476446837146702,0.4764895702620928,1.0,6/15,19.95%,RAC1;RHOG;XKR4;ADGRB1;RAC2;XKR6
prerank,synapse assembly (GO:0007416),0.4516246707633872,1.2488311201558082,0.12271259418729817,0.4766629184281844,1.0,24/67,20.70%,NRXN1;SPOCK2;NLGN1;GRID2;DSCAM;ADGRL3;DNM3;GABRA2;KIRREL3;NRCAM;WNT5A;DNER;GABRB3;NRXN2;CDK5;ACHE;FGF13;GABRB2;PCDHB14;GPM6A;LRRTM3;POU4F1;FZD1;PLXND1
prerank,peptidyl-threonine modification (GO:0018210),-0.3032406631477867,-1.2486591666116895,0.06153846153846154,0.581758645317114,1.0,19/66,13.98%,ROCK2;ACVR1;LRRK2;ROCK1;CAMK2D;GALNT11;PDPK1;TGFBR1;CDC42BPB;DYRK1A;HIPK3;GALNT1;TBK1;NLK;CSNK2A1;CSNK2A2;PRKD1;MARK2;GSK3B
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4659691731613455,-1.2480989114861702,0.18992248062015504,0.5806215831964782,1.0,8/12,30.57%,MAD1L1;CENPC;CENPE;NDC80;MIS12;NUF2;RMDN1;KIF2C
prerank,negative regulation of nervous system development (GO:0051961),0.552209717840307,1.247899664410389,0.2159383033419023,0.47861757062030735,1.0,10/17,26.22%,B2M;TNF;SORL1;ROBO2;SLIT1;IL6;NOTCH1;REST;WNT7A;TLR2
prerank,regulation of apoptotic process (GO:0042981),0.4135397194376472,1.2478300816985195,0.002,0.4783751266932152,1.0,190/676,21.18%,TPT1;RPS3;MTCH1;RPS27A;CTSD;PTMA;PPIA;ARHGDIA;CD74;CLU;CTSB;UBC;RACK1;UBB;HSP90AA1;HSPB1;CALR;LGALS1;MT3;CFL1;PARK7;SOD1;RPL10;RHOB;HSPA5;ATF4;AKT1;RPS6;NME1;HIGD2A;CCND2;TMBIM6;UBE2Z;CRYAB;HNRNPK;TGM2;PRDX5;NPM1;ANXA5;ARL6IP1;AGT;PINK1;IGFBP3;GPER1;MAGED1;TNF;GRID2;BEX2;HSP90B1;FZD9;PRDX2;GLO1;NAA38;RTN4;BNIP2;MIF;HSPA1B;PSENEN;CTNNB1;FLNA;IL2RB;VCP;ALPK2;LTK;TMEM14A;BAG1;TFRC;OMA1;UBA52;NDRG1;BNIP3L;HSPD1;ARHGEF4;SGK1;FOXL2;FMN2;CXCL10;AQP1;FAIM2;KDR;IL2;CSRNP3;NUPR1;RRP1B;DHCR24;NET1;TRIM2;JUN;HMGB1;ARHGEF7;HCK;TARDBP;SMPD1;TAF9;GAS1;WNT5A;BAX;APBB1;APEX1;ZBTB7A;ATF5;DNAJA1;PMAIP1;FLT4;PNMA2;WFS1;TCTN3;ACTN1;SOX8;PHLPP1;CTLA4;VAV1;SFRP4;SOX9;VAV3;HSPA1A;CLIP3;YWHAZ;MCF2L;NME2;BMP2;NLRP2B;LILRB1;WNT10B;RIPK2;CTSH;SPTLC1;GAS6;EGLN2;GLS2;ABR;CAT;IKZF3;TIAM1;BAD;CDK5;LRP8;IER3IP1;ARF4;DAB2IP;DDAH2;SQSTM1;ATAD3A;VHL;ASNS;PSEN2;DNM1L;PIM3;PDCD5;PCID2;ANP32A;KCNMA1;TNFRSF12A;SCIN;ARHGEF19;APH1B;CIAPIN1;GRM4;CCAR2;SFRP1;NOP53;AKT1S1;PRELID1;DDRGK1;RNF144B;NSMF;ANP32E;HMGN5;SNCA;HYPK;PTPN6;SOS1;SPHK2;TFAP2B;ING5;HGF;IL6;FLT3;KLF11;OSGIN1;CITED2;MEF2C;CAPN3;NFKBIA;MYC;GADD45A;TFAP4;PYCARD;BAK1;HSPA9
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5149732918958049,1.247603932666165,0.19578686493184635,0.4785453694991863,1.0,11/25,25.58%,AKAP6;GPER1;APLNR;THY1;CXCL10;RAMP3;TRPC1;SNCA;CAPN3;F2RL3;CX3CL1
prerank,L-serine metabolic process (GO:0006563),0.6232462056659602,1.2472679915939442,0.1935483870967742,0.47897204434983826,1.0,5/10,20.62%,SERINC3;SDS;PHGDH;SERINC5;SHMT2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4602206071018874,1.2468186423536995,0.15292841648590022,0.4797248067273323,1.0,20/57,22.09%,CHCHD10;PARK7;TREM2;PINK1;GPER1;DCN;KDR;BAX;PMAIP1;BBC3;MIEF2;BAD;MFF;DNM1L;PDCD5;PPARGC1A;PYCARD;FIS1;BAK1;SPIRE1
prerank,regulation of biosynthetic process (GO:0009889),0.6016853958445858,1.2465384124530414,0.2206703910614525,0.4800561834433981,1.0,3/11,19.74%,MID1IP1;SNCA;SPHK2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.39913865704508733,-1.2464889301466808,0.12365591397849462,0.5818207730036554,1.0,11/22,15.98%,SCAF8;BRD4;KAT7;CCNT1;CDK12;TCERG1;CCNK;CDK13;ELL;THOC5;CDC73
prerank,dendritic cell migration (GO:0036336),0.5698689995156478,1.2463531023299232,0.21100917431192662,0.4800935746639876,1.0,7/16,19.50%,CCL19;CCR5;HMGB1;TRPM2;CXCR4;CCR2;GPR183
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4273978487200046,1.2454669350765,0.06484295845997974,0.4820298907772227,1.0,42/161,16.92%,APOE;IGFBP6;PFDN5;PSMB4;MDK;PSME1;PSMB6;PSMB8;PSME2;PSMD2;IGFBP4;PSMD1;LRP4;TLE5;PSMC3;PSMD6;ANKRD6;SFRP5;PSMA7;PSMD5;JADE1;RBX1;TNN;WNT5A;PSMB9;PSMD13;PSMB3;SOX17;PSMB11;SFRP4;IGFBP2;SOX9;PSMB10;BMP2;AMER2;STK11;PSMB1;TMEM131L;PSMB5;DACT3;DAB2IP;CAV1
prerank,pseudouridine synthesis (GO:0001522),0.5925254717490587,1.2452501781567624,0.21370967741935484,0.48219940483769214,1.0,7/13,20.38%,NOP10;NHP2;TRUB2;PUSL1;GAR1;DKC1;PUS7
prerank,positive regulation of hydrolase activity (GO:0051345),0.4292175004157955,1.245143557021579,0.0826530612244898,0.48205209765562307,1.0,35/137,18.67%,RPS3;PSAP;RACK1;CALM1;NDUFA13;CCL19;RCN3;S100A10;CALM3;TGM2;PINK1;RHOC;PIN1;CAV2;THY1;NET1;RGS10;ARHGEF7;MTMR9;DOCK10;HRAS;RHOA;DOCK8;BMP2;CCL2;MTCL1;CTSH;F2RL1;RASGRP1;CCL3;ADCYAP1;CCL8;RASGRF1;SFRP1;CALM2
prerank,positive regulation of lipid localization (GO:1905954),0.6049584996827624,1.2450068021358616,0.22094691535150646,0.4819697212292088,1.0,2/11,7.81%,C3;LPL
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5473932081271611,1.2449840126495717,0.21352785145888595,0.4815874907891318,1.0,10/18,27.64%,TREM2;TNF;CCT2;CCT7;CCT8;DKC1;CCT4;CCT3;CHP1;CORO2B
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6097090242678912,1.244785917058949,0.22558459422283356,0.4816966670266992,1.0,6/10,20.78%,JUN;HSPA1A;DNAJB1;VHL;CITED2;SIRT2
prerank,mesenchymal cell differentiation (GO:0048762),-0.31703233465686315,-1.2447852864369386,0.11827956989247312,0.5834441502049771,1.0,11/51,8.47%,ROCK2;RANBP3L;TGFBR3;FBXL17;ROCK1;LRP6;LIMS1;DLG5;TGFBR1;FGFR2;LOXL3
prerank,regulation of cellular component size (GO:0032535),0.4976549205415613,1.2444063355449664,0.19785458879618595,0.4822252387745501,1.0,9/30,13.25%,PPP1CA;LAMTOR4;LAMTOR5;RAC1;AP2M1;MSN;ATP13A2;VAV1;VAV3
prerank,regulation of cardiac muscle contraction (GO:0055117),0.4903657973755514,1.2443389016096618,0.17969661610268378,0.4819461953538381,1.0,12/34,18.67%,CALM1;PDE4B;CALM3;RGS2;PLN;CHGA;SLC8A1;ATP1B1;RYR2;ADRA1A;SRI;CALM2
prerank,response to acidic pH (GO:0010447),0.5768178517469824,1.244205364512401,0.22628726287262874,0.4818501816329584,1.0,2/13,2.18%,CTSS;LGMN
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3961644039374001,-1.243872070535232,0.16831683168316833,0.5829903581593544,1.0,7/22,10.54%,ROCK2;SLC9A1;ROCK1;CAMK2D;MEF2A;IGF1;SMAD4
prerank,presynapse assembly (GO:0099054),0.5531613580169993,1.243733594034632,0.2204724409448819,0.48265291092705387,1.0,8/16,23.39%,NLGN1;LRP4;IL1RAPL1;WNT5A;PTPRD;LRRTM3;FZD1;WNT7A
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5285637288346243,1.243324805390819,0.1952141057934509,0.4833001570769838,1.0,5/22,9.38%,APOE;AKT1;EEF1A2;HSD17B13;MLXIPL
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5953722185194524,1.2430875088458404,0.2145922746781116,0.48344324013474416,1.0,4/10,22.63%,FBXW7;NCF1;ADAM17;TGFA
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6012124895237804,1.2423944747466016,0.21010638297872342,0.4848652411212672,1.0,3/12,4.28%,APOE;PRNP;FKBP1A
prerank,protein polymerization (GO:0051258),0.4561127989313748,1.2422678851190911,0.1575492341356674,0.4847696534631946,1.0,11/55,13.06%,GPX4;GSN;TPPP3;RAC1;MID1IP1;ANG;PIN1;FAM107A;MAPT;AIF1;MSRB1
prerank,cell projection assembly (GO:0030031),0.5304716407701715,1.241751452104938,0.20854922279792745,0.4856792428603529,1.0,10/22,17.97%,GSN;RAC1;NEFH;RHOG;RHOV;CAPG;RHOU;PDGFA;RAC2;SCIN
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5695802133773525,1.2410505862662655,0.20861372812920592,0.48705506626812317,1.0,5/14,14.86%,AK4;AK3;NME2;SMPDL3A;CMPK2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5743456481198925,1.2407229508858497,0.22888283378746593,0.48748999454413755,1.0,5/12,21.77%,BASP1;PODXL;CD24;PROM1;PTPRO
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6298490699327844,1.240561627240332,0.23154848046309695,0.48745273191600247,1.0,4/10,14.04%,CXCL12;CCL19;LILRB1;GAS6
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5374103206980906,1.2402426303444418,0.1979301423027167,0.48785331362262835,1.0,6/18,16.42%,HSP90AA1;MSN;NELL1;PTTG1IP;ATRAID;DAB2IP
prerank,lipid droplet formation (GO:0140042),0.6044461383571705,1.2396161333023379,0.201949860724234,0.48906246400173203,1.0,3/10,5.26%,AUP1;CDS1;BSCL2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.33659642615380564,-1.2393266718101568,0.11304347826086956,0.5922009020301541,1.0,8/45,5.68%,EGFR;PLCE1;GAREM1;BRAF;GAB1;SLC30A10;PDPK1;EFEMP1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5231648829966766,1.2387754427270985,0.22069825436408977,0.4909489108561764,1.0,10/21,18.67%,CALM1;CALM3;AKAP6;GSTO1;GSTM2;SLC8A1;RYR2;FKBP1B;SRI;CALM2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.4988554507635354,1.23873793617721,0.18470588235294116,0.4906132523451782,1.0,8/32,9.38%,TMSB4X;TREM2;PINK1;ENO1;VCP;P2RX7;NUPR1;MLXIPL
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4256684580881976,1.2386300169793985,0.08638211382113821,0.49048541572930227,1.0,40/149,20.93%,RPS3;RPS27A;PPIA;CLU;UBC;UBB;NPM1;AGT;TNF;LAMTOR5;S100A8;S100A9;FLOT1;HSPA1B;TIRAP;TFRC;UBA52;WNT5A;RBCK1;ZBTB7A;RHEBL1;HSPA1A;RIPK2;UBE2V1;CX3CR1;TLR6;CAV1;TRIM32;TERF2IP;PSMA6;DDRGK1;TAB1;TRIM13;RTKN2;NLRP3;IL6;IL1RAP;CAPN3;NFKBIA;PYCARD
prerank,glycerophospholipid catabolic process (GO:0046475),0.5056360796339893,1.2385934336622328,0.18193069306930693,0.4901420761034456,1.0,12/27,27.18%,PRDX6;ENPP2;PLA2G7;PLA2G4F;GDE1;GPCPD1;GDPD1;ENPP6;ABHD16A;GDPD3;ABHD12;PLA2G6
prerank,ephrin receptor signaling pathway (GO:0048013),0.44542722273155655,1.2381939344278137,0.15058324496288442,0.4907475495809332,1.0,30/82,20.07%,ACTB;ACTG1;ANKS1B;RAC1;PSENEN;GRIN1;AP2M1;PAK1;AP2S1;CDK5R1;ARPC1B;EPHA5;ARHGEF7;PAK3;ARPC3;HRAS;ARPC5;RHOA;VAV3;SDCBP;TIAM1;ARPC4;EPHB1;PSEN2;ARPC2;EFNB1;APH1B;GRIN2B;EFNA1;GIT1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.5042047853239217,-1.23805989856329,0.20634920634920634,0.5927850016799636,1.0,3/10,15.98%,DHX36;CPEB3;CDC73
prerank,positive regulation of transferase activity (GO:0051347),0.42938283051711185,1.237522595331226,0.08188331627430911,0.4920761268525757,1.0,48/142,22.81%,CD74;RPS2;DBI;HSP90AA1;HSP90AB1;MAPK3;TREM2;SERINC1;ERBB4;PINK1;CCT2;NTRK2;PIN1;SORL1;CTNNB1;LTK;MUSK;KDR;EPHA5;CSF1R;FLT4;PCNA;FBXW7;KLF4;RFC2;TIE1;ARRDC3;SERINC5;PARM1;PTGES3;IGF2;EPHB1;TYRO3;FLT1;DDR2;ERBB3;EPM2AIP1;TGFB1;FLT3;MAPK15;DKC1;RFC4;MAGEC2;MYC;MAP2K7;CCT4;GRHL2;NAF1
prerank,Golgi ribbon formation (GO:0090161),-0.45197274295082146,-1.2375214783521737,0.22878228782287824,0.5914358604954424,1.0,6/13,16.70%,VTI1A;STX16;GOLGA2;OPTN;MYO18A;TRIP11
prerank,regulation of cell size (GO:0008361),0.5118019723914693,1.2367607202894604,0.2064676616915423,0.4937068389216628,1.0,7/23,13.25%,LAMTOR4;LAMTOR5;RAC1;MSN;VAV1;RHOA;VAV3
prerank,regulation of stem cell differentiation (GO:2000736),0.4369887811405127,1.2364112740874282,0.1259181532004197,0.4941558171806223,1.0,37/89,26.48%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;ZFP36L2;PSMC3;PSMD6;HES1;PSMA7;PSMD5;GATA2;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;HNRNPU;PSMB1;PSMB5;LMO1;PSMA6;ESRRB;NOTCH1;PSMA4;PUS7;PTN;PSMD9;PSMC1;TCF3;PSMD4;METTL3;PSMB2;RUNX1;PSMD10
prerank,cellular response to inorganic substance (GO:0071241),0.5264577801447704,1.236175390117945,0.19974874371859297,0.49435718228763725,1.0,5/21,12.26%,MT3;MMP3;AQP1;DDX11;NSMCE3
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.4153731384800551,1.2361521175917178,0.036,0.49397761719374517,1.0,92/348,20.73%,RPL23;RPS3;ACTG1;RPL11;RPS7;RPL5;CD74;CLU;CD63;CLDN5;GSN;TYROBP;RAMP2;LAPTM5;ACTA2;MT3;PARK7;MAPK3;ATF4;AKT1;KLF2;TREM2;CD34;ANK3;GPER1;TNF;LAMTOR5;PDGFB;NTRK2;AMH;HSPA1B;MSN;MUSK;FN1;RIMS2;TFRC;RIMS1;TRIM28;P2RX7;VSIR;VAMP3;EGR1;GATA2;ATP13A2;WNT5A;LRP3;TMEM119;WARS1;RAMP3;POU3F1;WFS1;CAMK2N1;SFRP4;KLF4;SLC11A1;SOX9;HSPA1A;BMP2;GJA1;LILRB1;CTSH;GAS6;TLR6;IFNGR1;MAPK11;PF4;DNMT3B;HEY1;ARRB2;EPB41L4B;CCL3;DNAJA4;TWIST1;PDCD5;CDH5;PIK3CD;AGO1;PPARGC1A;MAZ;SOX11;DDRGK1;ERP29;HMGN5;SNCA;INHBA;TGFB1;IL6;NOTCH1;POU4F1;CITED2;MEF2C;MYC
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.49519894998579683,-1.2360567320984754,0.22491349480968859,0.5923726853934307,1.0,4/10,16.16%,CAMK2D;PRKCE;HECW2;STK39
prerank,negative regulation of epithelial cell migration (GO:0010633),0.49385468800156823,1.2359623658328591,0.1952941176470588,0.49401972131483846,1.0,11/33,16.69%,APOE;ACVRL1;CORO1C;VASH1;DCN;EPPK1;ADGRB1;PTPRR;DAB2IP;DNAJA4;PFN2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5401426884227181,1.235121365718078,0.21309370988446727,0.4957856786264027,1.0,6/18,18.07%,ACTB;VAMP8;ABCA2;CDK5;MMP14;VPS4A
prerank,phagosome acidification (GO:0090383),0.49982475121854325,1.2350583893314586,0.18259803921568626,0.4954973255469536,1.0,9/26,24.08%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;ATP6V0D2;RAB20;ATP6V1A;ATP6V0A1;ATP6V0B
prerank,glycerolipid catabolic process (GO:0046503),0.5286821500833426,1.2349956891240563,0.1895424836601307,0.4951965527549131,1.0,9/19,25.18%,PRDX6;LYPLA2;PLA2G4F;GDE1;GPCPD1;GDPD1;ENPP6;GDPD3;ABHD12
prerank,regulation of cell growth (GO:0001558),0.42035723526675967,1.2349124984451443,0.06224899598393574,0.49497470071602623,1.0,68/204,21.22%,RACK1;H3-3A;MT3;NDUFA13;AKT1;NRG3;AKAP6;EIF4G2;AGT;LAMTOR2;CCDC85B;ADAM15;LTBP4;ACVRL1;ENO1;RTN4;S100A8;S100A9;HSPA1B;PPP2R1A;SPOCK1;HYAL2;BTG1;LGI1;TFRC;FAM107A;CXCL16;SGK1;DDX49;WFDC1;IL2;MFSD2A;JADE1;NET1;EXOSC2;DNPH1;KIF26A;APBB1;MSX1;SOX17;DNAJB2;BST2;HSPA1A;GJA1;STK11;SDCBP;EGLN2;MMP14;IL17RB;DACT3;ING1;ATAD3A;NDUFS3;TRIM32;SLIT3;ADAM17;CCAR2;SFRP1;EXOSC9;SCGB3A1;INHBA;TGFB1;SPHK2;OSGIN1;TMEM97;EXOSC4;RERG;PAK5
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5894016436046811,1.234439683830892,0.2217687074829932,0.49569132473981614,1.0,3/12,5.19%,APOD;NDRG4;IFT20
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.4391172270865729,1.234161719982669,0.13539445628997868,0.4959948037521693,1.0,31/78,27.64%,ACTB;AKT1;CCNI;CCND2;PDGFB;SERTAD1;CDKN1C;CCND1;CEBPA;PROX1;CDK5R1;CDC37;CCNG1;HEXIM1;CDK5R2;MAPRE3;ADAM17;CCNJL;CDC25A;GADD45A;TFAP4;MEN1;BLM;CDKN2B;CCNG2;CCNA2;HHEX;CCNH;PSMD10;CDKN1A;CNPPD1
prerank,regulation of angiogenesis (GO:0045765),0.4190476013185007,1.23336601221142,0.05917753259779338,0.49768863038318323,1.0,55/192,18.54%,SPARC;CLDN5;RAMP2;HSPB1;GRN;GPNMB;HMOX1;RHOB;SERPINF1;CD34;EMP2;ECM1;CTNNB1;TNFAIP3;APLNR;ADAM12;PDE3B;BTG1;EMC10;HIPK2;PGK1;GLUL;VASH1;DCN;CXCL10;TNFSF12;AQP1;KDR;SARS1;GATA2;ADGRB1;NINJ1;RNH1;WNT5A;ECSCR;STAB1;PDCD6;WARS1;KLF4;TIE1;CTSH;RRAS;PF4;DAB2IP;AMOT;GATA4;TWIST1;CDH5;PIK3CD;ADAMTS1;FLT1;AGO1;HSPG2;SFRP1;CCR2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.4217465969179369,-1.2325152873943912,0.16289592760180996,0.5990744472204412,1.0,8/19,14.41%,PARD3B;PARD3;DLG1;SYNJ2BP;PATJ;MARK2;CLIC4;PRKCI
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5575063094604003,1.2314399239708507,0.21550591327201052,0.5022523269855061,1.0,6/15,16.06%,SRP14;SEC61G;SPCS1;SEC61A1;SPCS2;RYR2
prerank,cartilage development (GO:0051216),-0.3293111704019248,-1.2311387543036398,0.12280701754385964,0.5999392485446032,1.0,20/49,23.81%,SULF1;NFIB;SOX5;ZBTB16;WNT5B;ATP7A;ITGB8;PKD1;CREB3L2;BMP4;TRIP11;RUNX2;GPLD1;SULF2;HOXD3;FGF2;WNT2B;COL11A2;TRPV4;HYAL3
prerank,chemokine-mediated signaling pathway (GO:0070098),0.4672990753370516,1.23052328000557,0.17997750281214847,0.5042000457766602,1.0,17/42,32.78%,CXCL12;CCL19;CXCL10;CCL2;PF4;CCL3;CCL8;CCR2;THPO;CX3CL1;OXSR1;PPBP;CCL13;CCL14;GPR35;ACKR3;CCL5
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4355416376183766,1.2305228403730624,0.15100316789862725,0.5037554962004631,1.0,19/76,21.63%,TMSB4X;SPI1;TNFAIP3;ADORA3;OTULIN;RBCK1;KLF4;NLRP2B;ERBIN;TRAF3;G3BP2;ARRB2;DAB2IP;TCEAL7;COMMD7;NLRP3;NFKBIA;PYCARD;DDIT3
prerank,negative regulation of cell adhesion (GO:0007162),0.44254315084143897,1.230053799462095,0.15196599362380447,0.5045727201392611,1.0,29/72,27.74%,ARHGDIA;MDK;PTPRC;ACVRL1;DSCAM;PDE3B;SPOCK1;ARHGDIB;PODXL;ARHGDIG;RHOA;JAM3;DMTN;ERBB3;LPXN;MUC1;TGFB1;NOTCH1;PLXND1;PTPRO;DUSP1;CD164;PLXNB2;TBCD;CX3CL1;PLXNB3;PLXNA3;CORO2B;ADAM22
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.33173028819375,-1.2297630938904445,0.13761467889908258,0.600846442801138,1.0,16/44,14.52%,ROCK2;ABL1;LPAR1;PPM1E;SORBS3;NRP1;ARHGEF10L;CARMIL1;TGFBR1;PXN;RAPGEF3;FERMT2;TPM1;NF2;WNT11;TGFB3
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.45753698304299656,1.229593012417656,0.2036613272311213,0.5053919240200423,1.0,11/48,13.07%,ACTB;POLR2E;ELOF1;POLR2F;SERTAD1;POLR1B;H1-0;DEK;WBP2;POLR2K;ZMIZ2
prerank,telomere maintenance via telomerase (GO:0007004),0.5002014338303379,1.2290456123709366,0.2162485065710872,0.5063310318799491,1.0,9/28,20.17%,HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2;PTGES3;GAR1;TERF2IP;DKC1
prerank,response to estradiol (GO:0032355),-0.352038081880611,-1.2284790475243252,0.11643835616438356,0.6015914559165202,1.0,7/31,9.46%,STRN3;EGFR;NRIP1;STAT5B;LCOR;STAT3;ESR1
prerank,lymphocyte migration (GO:0072676),0.48615402839079047,1.2278967911142686,0.19976635514018692,0.508893282391186,1.0,13/32,33.74%,CCL19;S1PR1;MSN;CCL2;CCL3;CCL8;MYO1G;CX3CL1;CCL13;ZAP70;CCL14;CCL5;ADAM8
prerank,B cell activation (GO:0042113),0.44457403435159704,1.2278122669386595,0.15254237288135594,0.5086675016992146,1.0,27/68,27.04%,SLC25A5;LYL1;NFAM1;PTPRC;HSPD1;CD22;IL11;ZBTB7A;CHRNA4;HDAC5;RASGRP1;VCAM1;HDAC9;PIK3CD;ADAM17;DNAJB9;GPR183;CD86;FLT3;MEF2C;BANK1;KLF6;TCF3;BLNK;ITGB1;HHEX;CEBPG
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4421783793927754,1.2276748504503625,0.17704918032786884,0.5086074653943933,1.0,21/73,21.65%,ACTB;GPX1;H3-3A;POLR2E;POLR2F;SPI1;POLR1B;CREBZF;DEK;WBP2;POLR2K;HDAC5;IGF2;KDM1B;DNMT3B;ERCC6;TBP;SPHK2;POLR1H;PHF1;POLR2H
prerank,regulation of dendrite extension (GO:1903859),0.5355111906271768,1.2272986818709894,0.23285899094437257,0.5091640631108697,1.0,11/18,25.72%,SYT1;RIMS2;RIMS1;SYT4;CPNE5;SYT2;CPNE6;SYT3;UNC13A;RNF157;SYT17
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.5952026395633813,1.2269676054509573,0.2157676348547718,0.5096005706795752,1.0,5/12,15.32%,SEC61B;HSPA5;SEC61G;SEC61A1;SGTA
prerank,positive regulation of secretion by cell (GO:1903532),0.4379663534924288,1.2268785468277508,0.15658747300215983,0.5093987634749696,1.0,25/70,22.06%,PPIA;TREM2;GPER1;ANG;ABCG1;ATP6AP1;CLASP1;ARF6;CADPS;ATP13A2;APBB1;BMP2;IER3IP1;ACHE;EDN3;DNM1L;NMB;SOX11;SNCA;GRK2;TGFB1;TMED10;RAB27B;STX1B;UNC13D
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.5819159077803626,1.2262399655535072,0.2222222222222222,0.5105732110509451,1.0,3/11,5.38%,NBL1;MIF;DDT
prerank,protein import into mitochondrial matrix (GO:0030150),0.5363069196002227,1.2261381251961598,0.21986754966887417,0.5104328522602641,1.0,5/18,14.21%,ROMO1;DNLZ;TOMM40L;TIMM50;TOMM20L
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.48328495380830566,1.2261059669809184,0.20473372781065088,0.5100816274404744,1.0,9/33,17.68%,AKT1;AGT;GPER1;PTK6;HAP1;FBXW7;CCDC88A;NCF1;ADAM17
prerank,alanine transport (GO:0032328),0.6081616859048189,1.225933639460321,0.23109843081312412,0.5100723960135666,1.0,3/10,9.26%,SLC1A4;SLC6A6;SLC6A17
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4753645709176406,1.2255356412347511,0.20410490307867732,0.510725878501386,1.0,15/38,26.34%,RACK1;AKT1;GPER1;SFRP5;HYAL2;PDCD6;PHLPP1;ARRB2;NOP53;THEM4;DDIT3;BANK1;PHLDA3;PLEKHA1;TRIB3
prerank,glucose import (GO:0046323),0.5673716180698085,1.2252314472958952,0.2345679012345679,0.5111338375012175,1.0,3/13,17.73%,SLC2A1;SORT1;SLC2A3
prerank,protein localization to nucleus (GO:0034504),0.42601884501373405,1.2250550557806703,0.13278008298755187,0.5111668026647473,1.0,25/102,19.58%,RPL11;CHCHD10;COL1A1;CALR;AKT1;RAN;ARL2BP;YWHAE;FAM53C;CTDNEP1;PTTG1IP;ZBTB7A;MSX1;IPO4;HNRNPU;NUP85;ARL2;NUP88;SPRN;EIF4ENIF1;LMNA;SYK;NOP53;NUP50;SKP1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4737223633341455,1.224528996341006,0.18141097424412095,0.512138402510355,1.0,10/39,14.04%,RAMP2;GPER1;TNF;TNFAIP3;KDR;GATA2;ECSCR;IL11;CCL2;GAS6
prerank,mitochondrion organization (GO:0007005),0.4157410051536528,1.2244345004671338,0.09625126646403243,0.5119621136746023,1.0,38/165,18.27%,CHCHD10;TSPO;ATP5F1B;ATP5F1D;CHCHD2;TIMM8B;TIMM13;PARK7;TOMM5;TOMM7;HIGD2A;PINK1;COX7A2L;SLC25A4;COX7A2;PARP1;CAV2;AIP;TIMM10B;DNM3;OMA1;BNIP3L;HSPD1;HIGD1B;BAX;HAP1;GDAP1;TMEM70;TIMM50;MIEF2;SPG7;MFF;ATAD3A;DNM1L;BCAP31;PPARGC1A;FMC1;ATCAY
prerank,somite development (GO:0061053),-0.48159341436687564,-1.2243654405063504,0.21333333333333335,0.6095436421482308,1.0,6/11,25.52%,SMO;MEOX2;LOXL3;PPP2R3A;PTCH1;MTHFD1
prerank,axonogenesis (GO:0007409),0.4159369301171538,1.224197906745026,0.06331658291457286,0.512151011918372,1.0,65/237,18.10%,ACTB;BSG;S100A6;HSP90AA1;HSP90AB1;CXCL12;MAPK3;DCC;NRXN1;S100B;ANK3;CTNNA2;UNC5D;LYPLA2;SEMA3F;MAP1A;DSCAM;CNTN4;SEMA7A;NEFH;SEMA4C;SHC3;LGI1;NRXN3;DAB1;OTX2;TNR;SEMA6D;NRCAM;ROBO4;EMB;LGR6;UNC5C;CDK5R1;KIF5A;EPHA5;PAK3;ADGRB1;SEMA4A;LRTM2;B4GALT6;WNT5A;APBB1;GFRA1;DOK5;CXCR4;SEMA4G;SHTN1;CCK;ROBO2;IGSF9;SH3KBP1;SPTBN4;CDK5;DSCAML1;GFRA2;EPHB1;BRSK2;SPTBN2;EFNB1;SLIT3;SLIT1;PIK3CD;NCAM1;KIF5C
prerank,response to ATP (GO:0033198),0.5386587933705557,1.223699606570829,0.23195876288659795,0.5130021962637237,1.0,4/18,9.44%,HSP90B1;P2RX7;P2RY12;P2RY1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.42747246747180384,1.2234983239573811,0.13285272914521112,0.5131393916363975,1.0,30/98,17.14%,CD81;AKT1;PRNP;TREM2;ITGB2;ANK3;GPER1;TNF;YWHAB;LGALS3;DPP10;YWHAH;YWHAE;RHOG;YWHAG;ARF6;ZDHHC5;RAMP3;PMAIP1;HRAS;YWHAQ;CLIP3;BBC3;YWHAZ;MTCL1;MIEF2;BAD;MFF;SQSTM1;PDCD5
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5238767886139861,1.2226085694837125,0.2245922208281054,0.5150296114868365,1.0,10/21,21.90%,RACK1;MLXIPL;CNKSR3;NLRP2B;INPP5J;DMTN;CAV1;DDIT4;GADD45A;PPM1F
prerank,positive regulation of dendrite extension (GO:1903861),0.5408341180117209,1.221993873329181,0.21944809461235218,0.5162119976123102,1.0,11/17,25.72%,SYT1;RIMS2;RIMS1;SYT4;CPNE5;SYT2;CPNE6;SYT3;UNC13A;RNF157;SYT17
prerank,regulation of T cell proliferation (GO:0042129),0.4542582497690059,1.2217762955733509,0.1682743837084673,0.5163678752307413,1.0,13/61,19.80%,GPNMB;CCL19;PTPRC;LGALS3;TFRC;CEBPB;SDC4;PNP;AIF1;LILRB1;VCAM1;CD86;IL6
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5879361725151252,1.2217062051157288,0.2301255230125523,0.5161009747868299,1.0,4/11,18.64%,NCL;PIH1D1;DDX11;NOP53
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5273548179274818,1.221173759325638,0.2255541069100391,0.5170800268917334,1.0,6/19,16.42%,CD63;DCN;CADM4;JCAD;DLL1;DAB2IP
prerank,regulation of interleukin-10 production (GO:0032653),0.4691430093676777,1.2209816487584468,0.19796380090497737,0.5171385127093704,1.0,15/44,24.85%,TYROBP;CD34;ISG15;HSPD1;VSIR;LILRA5;HMGB1;LILRB1;F2RL1;DLL1;SYK;IL6;PYCARD;CD28;AGER
prerank,cellular response to acid chemical (GO:0071229),0.49816021462990207,1.2207876967758235,0.20893719806763286,0.5172127844005208,1.0,10/27,19.03%,KLF2;LAMTOR2;LAMTOR4;LAMTOR5;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF
prerank,inflammatory response (GO:0006954),0.4162633620598901,1.2206324994327018,0.07336683417085427,0.5171733106874319,1.0,54/195,19.91%,CCL19;CYBA;ITGB2;PRDX5;NFAM1;TNF;TAC1;RAC1;C5AR1;S100A8;S100A9;CYBB;HP;HPR;ADORA3;CEBPB;CCR5;HNRNPA0;CXCL10;TACR1;CRH;SIGLEC1;HMGB1;TUSC2;AOC3;CSF1R;AIF1;SLC11A1;CXCR4;HDAC5;TNFRSF1A;BMP2;CCL2;RIPK2;KLRG1;TLR6;PF4;FOLR2;TLR5;TLR1;CCL3;ADCY8;HDAC9;PTGIR;PIK3CD;NOS2;HSPG2;CCL8;CD14;CCR2;TGFB1;NLRP3;IL6;IL10RB
prerank,cellular response to oxygen-containing compound (GO:1901701),0.4143924577542436,1.2203171932839731,0.04104104104104104,0.5175429096533591,1.0,68/291,16.43%,ACTB;RPS3;VIM;MT3;MMP3;NDUFA13;MAPK3;AKT1;PDE4B;AKAP6;TGM2;PRDX5;LAMTOR2;GPER1;LAMTOR4;LAMTOR5;ZFP36L1;HSP90B1;IGFBP5;NR1D1;PDGFB;ROMO1;SIRPA;TIRAP;TNFAIP3;CD180;VCP;LTK;DRD5;BRINP3;CCR5;LPL;PTK6;P2RX7;P2RY6;CXCL10;AQP1;MAPT;CD68;P2RY12;EGR1;P2RY1;TICAM2;JUN;HMGB1;ZFP36;WNT5A;CHMP5;BRINP1;RAMP3;GLRA2;GLRA1;SNW1;BRINP2;RHOA;SOX9;LAMTOR3;CCL2;LILRB1;WNT10B;CX3CR1;PF4;RRAGC;HCN1;DMTN;NCF1;DAB2IP;RRAGD
prerank,glial cell development (GO:0021782),0.5058089979148295,1.218641820386313,0.20930232558139536,0.5216389557028289,1.0,12/25,26.22%,MDK;MT3;S100A9;MYRF;MXRA8;DLL1;EIF2B5;SOX11;SOX10;APP;CSPG5;TLR2
prerank,mitotic recombination (GO:0006312),-0.4452505876873414,-1.2186124534971714,0.1950207468879668,0.6223747604484933,1.0,3/15,6.96%,NSMCE2;TEP1;MSH3
prerank,positive regulation of viral transcription (GO:0050434),0.4944154619022252,1.2184486798717806,0.23485784919653893,0.5216849409937345,1.0,10/25,21.65%,POLR2E;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;POLR2K;NELFE;CDK9;POLR2H
prerank,neuropeptide signaling pathway (GO:0007218),0.45251176170913693,1.218387009882443,0.17736670293797607,0.5214128116753369,1.0,16/58,19.42%,SORL1;CPE;PENK;SORCS1;SSTR4;PDYN;PPY;GLRA2;SORCS3;GLRA1;NTS;SORT1;HCRTR1;ADCYAP1;GPR149;GLRA3
prerank,regulation of endocytosis (GO:0030100),0.44789662130232943,1.2181720687614706,0.17780172413793102,0.5214822035597682,1.0,17/61,17.28%,APOE;CD151;CCL19;SNX17;LGALS3;PACSIN1;FLOT1;LRPAP1;SYT11;CD22;AP2S1;SMPD1;CLIP3;LILRB1;SNX33;DLL1;RAB5C
prerank,regulation of cellular respiration (GO:0043457),0.5448990290033641,1.2181656828354637,0.2378449408672799,0.5210503067781308,1.0,10/17,30.59%,VCP;NOS2;NOP53;PRELID1;IL10RB;SHMT2;PNPT1;IFNAR1;IDE;IFNLR1
prerank,regulation of embryonic development (GO:0045995),-0.3618919464665629,-1.2180631011029541,0.18791946308724833,0.621067392319062,1.0,11/34,10.24%,PHLDB2;TRIP12;DHX36;NIPBL;NIBAN2;EHMT1;WDPCP;INSR;TDG;NPHP3;NR2C2
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.30090048629804467,-1.2177734739137087,0.08571428571428572,0.6191990413521888,1.0,24/85,11.59%,AKAP13;NOTCH2;PLCE1;DENND4A;ARHGAP17;KANK2;DENND4C;MAPKAP1;OGT;EPS8;ARHGEF18;RAF1;SHOC2;STARD13;DENND1A;RAPGEF1;BCR;IGF1;KANK1;NGF;EPHB2;OPHN1;DENND3;MYO9B
prerank,regulation of potassium ion transport (GO:0043266),0.4877392567015707,1.2177159802964106,0.2119760479041916,0.5217468540477904,1.0,8/31,15.15%,CD63;KCNIP4;ANK3;DPP10;DPP6;KCNN2;KCNE5;KCNIP1
prerank,negative regulation of transmembrane transport (GO:0034763),0.5767782518388103,1.2173868650551007,0.24457308248914617,0.5222074030136381,1.0,2/10,12.58%,AKT1;RSC1A1
prerank,proteasome assembly (GO:0043248),0.5811411206276981,1.217204316443305,0.24492753623188407,0.5222493506454474,1.0,7/11,26.48%,POMP;PSMD5;PSMD13;OTUD6B;PSMD9;PSMD4;PSMD10
prerank,Notch signaling pathway (GO:0007219),-0.3035171312483032,-1.2170669602848128,0.08974358974358974,0.6181501662708594,1.0,17/59,15.09%,PBX1;GMDS;NOTCH2;ZNF423;CREBBP;MAML2;MIB1;GALNT11;KAT2B;MAML1;ITCH;PSEN1;RBPJ;DTX1;JAG1;HEY2;NLE1
prerank,regulation of cell killing (GO:0031341),0.542600145959572,1.2167987217720222,0.25190839694656486,0.5229041599260446,1.0,4/16,11.33%,CYBA;RAC1;WNT5A;IL11
prerank,regulation of catecholamine secretion (GO:0050433),0.49205759626619283,1.2167295697136964,0.2265717674970344,0.5226483397127724,1.0,15/29,25.72%,SYT1;SYT12;SYT11;SYT6;SYT4;CHGA;KCNA2;CHRNA4;SYT10;SYT2;SNCA;GRK2;SYT3;SYT5;SYT17
prerank,zinc ion transport (GO:0006829),0.5156863779716536,1.2164821718458392,0.22839506172839505,0.5228675824916852,1.0,5/21,11.69%,MT3;SLC30A1;SLC39A1;SLC39A7;TRPM2
prerank,positive regulation of protein polymerization (GO:0032273),0.44245732750399314,1.216219671320107,0.18369565217391304,0.5231409791026836,1.0,13/65,10.09%,RPS3;HSP90AA1;TPPP3;PINK1;RAC1;PFN1;NAV3;PAK1;CLASP1;MAPT;CDK5R1;ARF6;HCK
prerank,regulation of cellular component movement (GO:0051270),-0.31554155126261274,-1.2156624869180828,0.1111111111111111,0.6190837679265306,1.0,14/49,11.61%,ROCK2;TGFBR3;EGFR;ABL1;MEMO1;ROCK1;RAF1;TGFBR1;CDK6;SP100;ABL2;DIAPH1;ARHGAP18;ZSWIM4
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5999057588876348,1.2151453410815112,0.22549019607843138,0.5255914963373376,1.0,6/10,25.03%,HSPA5;ATF4;CCL2;HERPUD1;DDIT3;EIF2S1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.43564969478002336,1.2151265121339136,0.17037037037037037,0.5251957003220338,1.0,22/75,17.68%,MDK;HMOX1;AKT1;PDGFB;ANG;ECM1;APLNR;EMC10;PROX1;TNFSF12;KDR;JCAD;GATA2;HMGB1;WNT5A;PDCD6;FLT4;BMP2;IGF2;EGFL7;PIK3CD;ADAM17
prerank,response to UV-A (GO:0070141),0.552801991450029,1.214961612003333,0.24868421052631579,0.5251466845200761,1.0,4/14,8.48%,MMP3;AKT1;CCND1;TIMP1
prerank,regulation of mitotic cell cycle (GO:0007346),0.41554679636510145,1.214775134761174,0.09748743718592964,0.525203966191711,1.0,66/171,26.50%,PSMB4;PSME1;LGMN;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;PIN1;CAV2;DUSP3;PSMC3;PSMD6;PSMA7;BTG1;CDKN1C;BRINP3;PSMD5;DDB1;GAS1;PSMB9;PSMD13;BRINP1;BUB3;PSMB3;PSMB11;BRINP2;FBXO5;RNF40;PSMB10;SDCBP;HNRNPU;L3MBTL1;PSMB1;PSMB5;ASNS;PIM3;USP22;BTG4;PSMA6;SKP1;TGFB1;PSMA4;CDK9;DYNLT3;TFAP4;ASAH2;MEIS2;FOXA1;FZR1;CDK10;PSMD9;CCDC8;PSMC1;RCC1;INTS13;APP;PSMD4;CDC20;PRKCA;KIF20B;XPC;PSMB2;CDK11B;PSMD10;ERCC2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.45268810546759786,1.2140948064593087,0.19690265486725664,0.5265321726873916,1.0,19/54,27.02%,CD63;KCNIP4;AKAP6;DPP10;YWHAE;FLNA;KCNJ10;DPP6;KCNN2;KCNE5;KCNIP1;CAV1;KCNMA1;GABBR2;KCNJ3;KCNAB1;KCNJ6;KCNMB4;KCNN4
prerank,positive regulation of protein metabolic process (GO:0051247),0.4256526041509003,1.2136437025775724,0.15368852459016394,0.527342752305917,1.0,32/110,20.69%,APOE;CLU;NDUFA13;AKT1;KLF2;OAZ1;AGT;TNF;SORL1;TNFAIP3;VCP;TNFSF12;DDB1;WNT5A;WFS1;VPS28;PRMT1;KLF4;ABCA2;EGLN2;ABCB10;NR1H2;RASGRP1;DAB2IP;TRIM32;INHBA;TGFB1;CD86;SLC25A37;HECW1;OAZ2;NFKBIA
prerank,superoxide metabolic process (GO:0006801),0.4992346435855178,1.2136147866500584,0.19105199516324062,0.5269586469607321,1.0,6/29,9.77%,MT3;SOD1;CYBA;PRDX2;CYBB;PRDX1
prerank,regulation of acrosome reaction (GO:0060046),0.6017799643680084,1.2133457468457785,0.2601626016260163,0.527293199011573,1.0,2/10,11.99%,PRSS37;GLRA1
prerank,arachidonic acid metabolic process (GO:0019369),0.47737534140940135,1.2133130939748504,0.20594965675057209,0.526936021291643,1.0,3/35,1.19%,GPX4;PTGDS;GPX1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5595435120888052,1.212945027943581,0.2506493506493506,0.5274756449873255,1.0,4/15,10.38%,CD74;MIF;PTTG1IP;TAF9
prerank,B cell differentiation (GO:0030183),0.46566977128863596,1.212821265062052,0.17337807606263983,0.5273431858348099,1.0,20/46,27.04%,SLC25A5;LYL1;NFAM1;PTPRC;IL11;ZBTB7A;SYVN1;IRF2BP2;HDAC5;VCAM1;HDAC9;ADAM17;DNAJB9;FLT3;KLF6;TCF3;BLNK;ITGB1;HHEX;CEBPG
prerank,vacuolar acidification (GO:0007035),0.5233814118139881,1.2127294193881526,0.20395550061804696,0.5271365291239792,1.0,7/21,13.12%,GRN;ATP6V0E2;ATP6AP2;ATP6V0D2;CLN6;CLN5;SLC11A1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4730980090713884,1.2126218259218837,0.2036405005688282,0.5270094815867107,1.0,6/37,6.42%,APOD;TREM2;TNF;PLD3;SIRPA;CUEDC2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5145890518684091,1.21236944851946,0.22576687116564417,0.5272337152526141,1.0,5/23,16.13%,LAMP1;LILRB1;NCR1;RASGRP1;ARRB2
prerank,ear morphogenesis (GO:0042471),-0.39841759798597914,-1.211794762840896,0.203125,0.62665343360695,1.0,5/20,12.89%,NIPBL;FGFR2;EPHB2;ZIC1;SIX1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.35220176057945896,-1.2117851238331825,0.18055555555555555,0.6240429829751085,1.0,5/34,6.23%,AUTS2;PLCE1;FER;SLIT2;NCKAP1
prerank,protein insertion into membrane (GO:0051205),0.4871491455337529,1.211683233897092,0.21212121212121213,0.5285620958394033,1.0,12/32,22.12%,HMOX1;SEC61B;PRNP;WDR83OS;SEC61G;VAMP2;SERP1;SGTA;TRAM1L1;VAPA;TRAM1;CYB5A
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4306093416896353,1.2116443283844114,0.14842105263157895,0.5282222541343001,1.0,28/88,20.10%,PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;FBXL14;PSMD5;RBX1;FBXO27;PSMB9;PSMD13;FBXW5;PSMB3;PSMB11;FBXW7;FBXO31;PSMB10;PSMB1;PSMB5;PSMA6;FBXL16;SKP1;PSMA4
prerank,positive regulation of apoptotic process (GO:0043065),0.408490481180179,1.2115651306952249,0.04504504504504504,0.5280083974953084,1.0,91/293,22.30%,RPS3;MTCH1;RPS27A;CTSD;CLU;UBC;RACK1;UBB;GRN;SOD1;RHOB;ATF4;RPS6;PRNP;UBE2Z;TGM2;IGFBP3;GPER1;TNF;FZD9;TLE5;PSENEN;CTNNB1;BTG1;DLC1;OMA1;UBA52;BNIP3L;HSPD1;ARHGEF4;FOXL2;CSRNP3;NUPR1;RRP1B;NET1;CDK5R1;JUN;HMGB1;ARHGEF7;SMPD1;BAX;APBB1;DNAJA1;PMAIP1;PNMA2;TCTN3;CTLA4;VAV1;SFRP4;VAV3;CLIP3;MCF2L;BMP2;NLRP2B;LILRB1;WNT10B;ABR;TIAM1;BAD;CDK5;DAB2IP;SQSTM1;CCL3;BACE1;PSEN2;DNM1L;PDCD5;KCNMA1;TNFRSF12A;SCIN;ARHGEF19;APH1B;CCAR2;SFRP1;SNCA;SOS1;SPHK2;TFAP2B;ING5;IL6;KLF11;GADD45A;SIRT2;TFAP4;PYCARD;BAK1;FOXA1;DDIT3;SUDS3;IRF5;REST
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.3510018468167485,-1.210686150283879,0.11290322580645161,0.6244756309476056,1.0,15/32,27.20%,BABAM2;FOXN3;RINT1;UIMC1;TAOK3;MRNIP;ATM;CLSPN;TAOK1;CDC14B;ABRAXAS1;BRCC3;CDK1;PLK1;TICRR
prerank,response to muramyl dipeptide (GO:0032495),0.5705088347374084,1.2103294703350824,0.2722298221614227,0.5308731112938523,1.0,4/12,13.86%,VIM;CHMP5;ERBIN;RIPK2
prerank,carboxylic acid transport (GO:0046942),0.4453323875677958,1.2096439658800457,0.19058050383351588,0.5322557763913325,1.0,9/55,9.97%,PSAP;SLC38A5;SLC7A5;SLC1A4;SLC25A29;SLC6A6;SLC15A4;SLC6A17;SLC3A2
prerank,positive regulation of protein modification process (GO:0031401),0.4116305996730682,1.2094421293055047,0.07931726907630522,0.5323307064440653,1.0,43/203,14.04%,PPIA;CD74;RACK1;CALM1;HSP90AA1;C3;GPNMB;MT3;MAPK3;AKT1;TXN;CALM3;TREM2;CCND2;ERBB4;PINK1;GPER1;TNF;RAC1;NTRK2;PIN1;FLOT1;KNDC1;RARRES2;MUSK;TFRC;DLC1;CCND1;PAK1;KDR;P2RY1;CAMK1;SMPD1;TMEM119;CSF1R;PECAM1;SVIP;FLT4;HRAS;SOX9;CLIP3;BMP2;GAS6
prerank,membrane repolarization (GO:0086009),0.5464476647622578,1.2094236247243415,0.2359249329758713,0.5319298823413413,1.0,6/15,18.56%,ATP1B2;KCNE4;ATP1A1;KCNE5;ATP1B1;ATP1B3
prerank,positive regulation of JUN kinase activity (GO:0043507),0.49809201001381576,1.2092018909341202,0.2304878048780488,0.5320641607193437,1.0,5/23,16.42%,RPS3;TNF;PAK1;TLR6;DAB2IP
prerank,extracellular matrix organization (GO:0030198),0.40785557795375443,1.2091818038778168,0.057057057057057055,0.5316715216823044,1.0,45/276,8.70%,BSG;SPARC;VTN;GSN;CTSL;SPP1;BGN;COL1A1;CD151;CAPNS1;PPIB;CTSS;MMP3;BCAN;LAMC1;LAMB2;TMPRSS6;LUM;TIMP2;SERPINH1;A2M;SPOCK2;ITGB2;MMP27;ADAM15;PDGFB;PLEC;GPM6B;FLOT1;ADAMTS4;ADAM12;LOX;COL4A1;FN1;TTR;MMP21;APLP1;TNR;P4HB;COL3A1;LCP1;DCN;COL6A1;TIMP1;KDR
prerank,apical protein localization (GO:0045176),0.5965414288204131,1.2089157742308443,0.2627118644067797,0.531979859986058,1.0,2/10,5.44%,ACTB;MAL
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4220144199900566,1.2088544569939732,0.14169215086646278,0.531680974922157,1.0,29/117,19.80%,CD81;RAMP2;TREM2;POMC;SCTR;DRD5;CD163;RXFP1;PRKAR1A;VIPR1;CRH;KARS1;FCGR1A;HCK;MC1R;PRKAR1B;CALCB;RAMP3;ADCY4;MC5R;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;IL6
prerank,negative regulation of double-strand break repair (GO:2000780),-0.36584407672310193,-1.2086178295199896,0.17647058823529413,0.6272647503423012,1.0,11/30,18.59%,TRIP12;UBR5;SHLD1;RNF169;FBH1;CYREN;FANCB;SMCHD1;CGAS;RMI2;SHLD2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.47572173297292364,1.2084457977048537,0.2247596153846154,0.5322943179903462,1.0,15/32,27.62%,CAVIN1;POLR2E;MAPK3;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;CCNH;ERCC2;POLR1F
prerank,protein localization to mitochondrion (GO:0070585),0.5821213079186192,1.2081742622277127,0.2569060773480663,0.5325940991409659,1.0,4/11,11.49%,AKT1;PINK1;ISG15;DNAJA1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.5483457221424275,1.2076165921262918,0.23910171730515192,0.5336502784421451,1.0,4/16,15.69%,PNPLA2;CTDNEP1;MFSD2A;NR1H2
prerank,regulation of transposition (GO:0010528),-0.4482386416276001,-1.207597042776602,0.20155038759689922,0.6273052771730331,1.0,4/13,16.25%,UBR2;MYBL1;TEX15;SIRT7
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.469824520713973,1.2073137695941996,0.2037037037037037,0.5340653411205128,1.0,9/38,18.82%,GPX1;HMOX1;LGALS3;TNFAIP3;FAIM2;PMAIP1;TMBIM1;SFRP1;STX4
prerank,response to calcium ion (GO:0051592),0.42336436256424015,1.2072875387299542,0.16615067079463364,0.5336886288922515,1.0,38/102,26.20%,CALM1;LGMN;NLGN1;CALM3;SLC25A13;SYT1;SYT12;SYT11;SYT6;SYT4;SMPD1;WNT5A;PDCD6;TRPM2;ALOX5AP;TRPC1;SYT10;CPNE5;SYT2;CPNE6;RYR2;DMTN;ADCY8;CAV1;KCNMA1;CALM2;PPP3CA;CPNE4;D2HGDH;MEF2C;CAPN3;SYT3;SYT5;ECT2;ITPR3;SYT17;CPNE3;KCNMB4
prerank,regulation of protein phosphorylation (GO:0001932),0.4101958309527032,1.20722468391808,0.05911823647294589,0.533412351675722,1.0,62/256,15.86%,PPIA;CD74;RACK1;HSP90AA1;C3;HSPB1;GPNMB;MT3;PARK7;SOD1;MAPK3;ATF4;AKT1;FKBP8;PRNP;TREM2;ITGB2;CCND2;GRM5;ERBB4;NPM1;PINK1;IGFBP3;GPER1;PPP1R15B;TNF;RAC1;NTRK2;PIN1;FLOT1;SIRPA;KNDC1;PRR5L;SH3GL2;RARRES2;MYADM;MUSK;FN1;TFRC;CORO1C;CCND1;CEBPB;PAK1;KDR;P2RY1;CADM4;TARDBP;TMEM119;CSF1R;WARS1;PECAM1;FLT4;HRAS;SOX9;CLIP3;BMP2;GAS6;CCDC88A;SPTBN4;PDGFA;IGF2;RASGRP1
prerank,regulation of actin nucleation (GO:0051125),0.5652316649248185,1.2065402544288044,0.2763888888888889,0.5348117854176953,1.0,4/12,17.97%,GSN;CORO1A;ARF1;SCIN
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.42706535928292255,1.2064368882897423,0.1689545934530095,0.5346017329039009,1.0,29/77,22.35%,CLU;GPX1;PARK7;NDUFA13;AKT1;SLC25A5;TMBIM6;PINK1;TNF;FZD9;LGALS3;GHITM;TMEM14A;PIH1D1;ACAA2;HSPA1A;CX3CR1;MAPK8IP2;GATA4;HERPUD1;NDUFS3;MAZ;PRELID1;QARS1;RTKN2;HGF;ASAH2;PELI3;SCG2
prerank,positive regulation of cell migration (GO:0030335),0.4081061022354102,1.206283498904517,0.06806806806806807,0.5345710789797983,1.0,73/253,19.83%,ACTG1;RACK1;VTN;MDK;COL1A1;GRN;GPNMB;CD151;CXCL12;S100A11;HSPA5;GPER1;RHOC;SEMA3F;PTPRC;PDGFB;RTN4;SEMA7A;SEMA4C;MYADM;PFN1;FN1;FAM107A;CXCL16;SEMA6D;ENPP2;PAK1;PODXL;CLASP1;KDR;VSIR;LGR6;LAMC2;ARHGEF7;SEMA4A;CSF1R;PECAM1;ELP3;AIF1;HRAS;FBXO5;SOX9;BMP2;SEMA4G;SHTN1;CTSH;SDCBP;TIAM1;F2RL1;MMP14;PDGFA;DMTN;DAB2IP;CCL3;CASS4;CAV1;PLAU;CDH5;TRIM32;PIK3CD;F10;FLT1;ADAM17;DDR2;CCR2;MAZ;PPP3CA;STX4;DDRGK1;NSMF;TGFB1;HGF;NOTCH1
prerank,nucleotide catabolic process (GO:0009166),0.5475714691091549,1.2048238750460314,0.2683578104138852,0.5380463273197983,1.0,5/16,11.59%,GPX1;VCP;DNPH1;NUDT3;PNP
prerank,regulation of microtubule-based process (GO:0032886),-0.3399901608223769,-1.2047622371647357,0.18120805369127516,0.6322439814215829,1.0,9/36,13.98%,PHLDB2;EPHA3;MACF1;MEMO1;ROCK1;PRKAA2;DIAPH1;MARK2;GSK3B
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5778344767772108,1.2043368111401267,0.25359477124183005,0.5388729847991037,1.0,4/12,14.49%,CYBA;GRIN1;ADGRB1;TLR6
prerank,ureteric bud development (GO:0001657),-0.42211759074768723,-1.203721149896878,0.2420091324200913,0.6324378219829249,1.0,6/17,13.33%,GPC3;SLIT2;FGFR2;SIX1;BMP4;WNT11
prerank,plasma membrane invagination (GO:0099024),0.48362016260022467,1.2037063700575215,0.19904648390941598,0.5400987417382342,1.0,9/29,16.17%,GSN;ITGB2;ARHGAP25;ELMO1;FCGR1A;AIF1;MSR1;RHOA;SNX33
prerank,chromatin assembly or disassembly (GO:0006333),-0.4571581039461503,-1.203365595754367,0.23985239852398524,0.6307308686104834,1.0,4/11,15.79%,HDAC8;NOC2L;CDAN1;TP53
prerank,regulation of lymphocyte migration (GO:2000401),0.582066494887461,1.2032094653501786,0.2579250720461095,0.5409871634402077,1.0,2/10,6.25%,AKT1;MSN
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4689877225672267,-1.2030249934973596,0.250936329588015,0.6290519171401472,1.0,5/12,10.00%,ATF7IP;RESF1;TASOR;SETDB1;PPHLN1
prerank,camera-type eye morphogenesis (GO:0048593),-0.48201413387659553,-1.2028772797031424,0.23344947735191637,0.6268936549592398,1.0,3/10,3.28%,SHROOM2;SKI;LRP6
prerank,nucleosome disassembly (GO:0006337),-0.4340202932258931,-1.2027692187039403,0.1984732824427481,0.6220851723649543,1.0,3/14,6.59%,ARID2;ARID1A;SMARCE1
prerank,chromatin disassembly (GO:0031498),-0.4340202932258931,-1.2027692187039403,0.1984732824427481,0.6220851723649543,1.0,3/14,6.59%,ARID2;ARID1A;SMARCE1
prerank,regulation of cellular protein localization (GO:1903827),0.4559651151871847,1.2023014107714438,0.20927601809954752,0.542928804366917,1.0,13/45,11.18%,HSP90AA1;HSP90AB1;MAP1A;PIN1;PARP1;CTNNB1;VCP;LCP1;MAPT;MAP2;ATP13A2;SUMO3;GPC5
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.4872780077312303,-1.2022599131222689,0.22297297297297297,0.6209138614472435,1.0,4/11,14.94%,CLK2;SIK1;C1QTNF3;CRY1
prerank,neuron projection fasciculation (GO:0106030),0.6009211487101713,1.2019496165318264,0.25611510791366904,0.5434163530126511,1.0,4/10,9.55%,CNTN4;RTN4;NRCAM;CDK5R1
prerank,regulation of dopamine secretion (GO:0014059),0.5007798062991536,1.2015904375420785,0.24179829890643986,0.5438927213052391,1.0,13/25,25.72%,SYT1;SYT12;SYT11;SYT6;SYT4;KCNA2;CHRNA4;SYT10;SYT2;SNCA;SYT3;SYT5;SYT17
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4198747932348381,1.2010558778653238,0.1592554291623578,0.5449083057504155,1.0,32/100,21.01%,RPL11;CLU;RACK1;GABARAP;ELOB;HSP90AB1;PARK7;UBXN1;MAP1A;HSPA1B;VCP;BAG5;FOXF2;USP5;CEBPA;RBX1;XPO1;TAF9;SUMO2;DNAJB2;HSPA1A;SDCBP;HSPBP1;HERPUD1;CCAR2;NOP53;DDRGK1;RNF144B;RAD23A;DESI1;SIRT2;STUB1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.4323554571458663,1.2007766253887697,0.19002123142250532,0.5452248630794845,1.0,20/76,16.67%,GRM5;TGM2;AGT;C5AR1;GNA11;DRD5;P2RY6;TACR1;HTR2C;P2RY12;P2RY1;GRM1;GPR18;CHRM2;GRPR;CX3CR1;F2RL1;ADRA1A;ADRA1D;CCKBR
prerank,kidney development (GO:0001822),-0.2909945074031511,-1.200746033526843,0.11594202898550725,0.6224062602208373,1.0,17/65,13.00%,SULF1;KANK2;ZBTB16;NIPBL;GLI2;AGTR1;TGFBR1;PYGO1;ARL3;CEP290;PCSK5;IFT88;NPHP3;PKD1;GREB1L;SIX1;BMP4
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.43805083264740036,1.2007072628768884,0.17984832069339113,0.5449611750108584,1.0,13/66,9.22%,PARK7;AKT1;RAN;CCT2;LAMTOR5;HCLS1;ORMDL3;FLNA;HYAL2;TFRC;CCT7;TRIM28;CCT8
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.43106628705411404,1.2006274501211838,0.1783840503672613,0.5447345205354491,1.0,28/86,19.80%,CD74;VTN;CD81;PRNP;TREM2;ITGB2;IL5;AGT;PTPRC;PDGFB;HCLS1;MIF;CLEC6A;ENPP2;CADM4;IL11;PECAM1;RIPK2;LRP8;PDGFA;IGF2;DMTN;SFRP1;PTPN6;TGFB1;EFNA1;HGF;IL6
prerank,positive regulation of growth (GO:0045927),0.4373548764843008,1.2004517110820807,0.18466522678185746,0.5447499239842377,1.0,23/64,22.21%,H3-3A;AKT1;AKAP6;EIF4G2;S100A8;S100A9;LGI1;CXCL16;DDX49;IL2;MFSD2A;EXOSC2;DNPH1;WFS1;SDCBP;MMP14;TRIM32;ADAM17;SFRP1;EXOSC9;EXOSC4;PPM1F;RFTN1
prerank,regulation of cell differentiation (GO:0045595),0.4113167640433482,1.2002888598903765,0.14343434343434344,0.5447478260666274,1.0,36/148,16.50%,MDK;HSP90AB1;UQCC2;ATF4;SPOCK2;NLGN1;TNF;EMP2;ZFP36L1;NR1D1;LTBP4;LGALS3;MCRIP1;YWHAH;PPP2R1A;PLEKHB1;LTK;FADS1;CEBPB;KLK6;SLC6A6;CLASP1;YWHAG;CCN2;BCL6B;CD24;CDK5R1;CAMK1;KLF4;PLEKHB2;TIAM1;IGF2;EDN3;HEY1;DLL1;VHL
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5769330979505048,1.2001930120007183,0.2716927453769559,0.5445592074438256,1.0,9/12,25.44%,TUBB4A;MAP2;ARHGEF7;CLIP3;STMN1;CDH5;SNCA;TBCD;MAPRE1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5113726753064396,1.1997204682242701,0.255,0.5453416158657506,1.0,5/22,15.46%,ATF4;NCL;PIH1D1;DDX11;UBTF
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.46624558199685545,1.1992231466577037,0.22482435597189696,0.5462471562239906,1.0,9/34,19.83%,MT1G;RAMP2;HSPB1;KDR;GAS1;FLT4;DAB2IP;FLT1;NOTCH1
prerank,negative regulation of complement activation (GO:0045916),0.58613849408177,1.199035128422929,0.2507418397626113,0.5463158945365006,1.0,2/10,8.49%,A2M;SERPING1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5887124584661093,1.1987216656191864,0.27994227994227994,0.5462459278717591,1.0,2/10,16.24%,REEP6;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5887124584661093,1.1987216656191864,0.27994227994227994,0.5462459278717591,1.0,2/10,16.24%,REEP6;CNGB1
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.2931073656854619,-1.198173215871504,0.11290322580645161,0.6263936618746888,1.0,18/76,13.15%,FCHSD2;FER;ABL1;BAIAP2L1;BCAS3;PRKCE;SORBS3;NRP1;BAIAP2;NTRK3;CARMIL1;NCKAP1;CDC42EP5;SNX9;NCK1;SYNPO2;KATNBL1;NUMA1
prerank,negative regulation of chemotaxis (GO:0050922),0.47456114350108985,1.1980864762972978,0.22365339578454332,0.5475284858423596,1.0,9/31,14.22%,SEMA3F;SEMA7A;DUSP3;SEMA4C;SEMA6D;SEMA4A;AIF1;SEMA4G;ROBO2
prerank,Notch signaling involved in heart development (GO:0061314),-0.4685775579246567,-1.197988983612271,0.23776223776223776,0.6244337797815855,1.0,5/11,14.58%,NOTCH2;GALNT11;RBPJ;JAG1;HEY2
prerank,protein ADP-ribosylation (GO:0006471),-0.3663873509230176,-1.1973448401129316,0.18888888888888888,0.623484270590192,1.0,9/28,15.12%,PARP4;PARP9;PARP12;PARP16;PARP3;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,negative regulation of cellular senescence (GO:2000773),-0.4524058716697916,-1.1973134576439493,0.212,0.6211009783910716,1.0,7/13,13.14%,MAP3K3;SLC30A10;CDK6;ZKSCAN3;TERT;TERF2;SIRT1
prerank,carnitine shuttle (GO:0006853),-0.4660994703358443,-1.196994214733693,0.2195945945945946,0.6195080951429048,1.0,3/11,11.99%,PRKAG2;PRKAA2;CPT2
prerank,ventricular septum morphogenesis (GO:0060412),-0.3606716117918646,-1.1966678729669413,0.1702127659574468,0.6179232363942417,1.0,12/27,16.38%,TGFBR3;ACVR1;BMPR1A;ROBO1;SLIT2;TGFBR1;ZFPM2;SMAD7;SMAD4;BMP4;HEY2;BMPR2
prerank,regulation of ruffle assembly (GO:1900027),0.5019997946728822,1.1965784299301228,0.24688279301745636,0.5512862521908318,1.0,7/23,16.92%,NLGN1;PFN1;P2RY12;DEF8;HRAS;PFN2;CAV1
prerank,vasoconstriction (GO:0042310),0.5819490324531983,1.196256745354799,0.2633802816901408,0.5517157162992589,1.0,3/11,15.92%,ACTA2;SLC8A1;EDN3
prerank,negative regulation of cell migration (GO:0030336),0.41330026340418186,1.1961306285557185,0.13238289205702647,0.5515945167664972,1.0,29/137,9.99%,CD74;CLDN5;IFITM1;CALR;HMOX1;RHOB;IGFBP3;ADAM15;IGFBP5;RAC1;ACVRL1;DNAI3;MIF;NDRG4;DUSP3;HYAL2;ARHGDIB;DLC1;ADORA3;ADGRG1;CORO1C;NAV3;ATP1B2;COL3A1;THY1;TIMP1;CLASP1;TNN;EPPK1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5652904584841689,1.1958771713043161,0.27475592747559274,0.5518458961061291,1.0,5/12,21.26%,FLOT1;PQBP1;IFIT1;CAV1;RALB
prerank,positive regulation of protein kinase activity (GO:0045860),0.4138097613815861,1.1958339755553984,0.13043478260869565,0.5515186882461947,1.0,44/148,19.71%,CLU;CALM1;HSP90AA1;HSP90AB1;CCL19;PRNP;CALM3;GRM5;AGT;TNF;EMP2;PTPRC;PDGFB;PAK1;EGR1;LILRA5;CAMK1;FCGR1A;PAK3;PIH1D1;CSF1R;DOK7;RHOA;SLC11A1;SRCIN1;STK11;GAS6;MMD2;CCDC88A;LRP8;MAPRE3;LCP2;DAB2IP;CASS4;ADCYAP1;DDR2;CAMKK1;MAP2K2;AGAP2;ERBB3;CALM2;SNCA;UNC119;EFNA1
prerank,metal ion homeostasis (GO:0055065),0.4561835154454117,1.1954610605006644,0.22935779816513763,0.5520377480337287,1.0,12/40,19.75%,MT3;ANK3;TMTC2;GRIN1;SLC12A5;WFS1;SLC8A1;KCNA1;CAV1;SELENON;SNCA;TFAP2B
prerank,glycolipid biosynthetic process (GO:0009247),-0.3254017736391321,-1.1953607936034205,0.15942028985507245,0.6187499812579093,1.0,17/38,19.42%,LARGE1;ST3GAL4;A4GALT;PGAP2;PIGM;ST3GAL5;PIGN;ST3GAL2;GBGT1;PGAP3;PIGO;PIGF;DPM1;PIGU;PIGW;PIGL;ST6GALNAC5
prerank,positive regulation of protein transport (GO:0051222),0.4313763314622279,1.1953043508355006,0.1849096705632306,0.552018777718948,1.0,22/67,20.96%,PPIA;RACK1;TREM2;OAZ1;TNF;ANG;PRR5L;ABCG1;VAMP2;ARF6;ATP13A2;APBB1;CEP131;VPS28;B3GAT3;IER3IP1;ACHE;DNM1L;ACSL3;TGFB1;OAZ2;TMED10
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5512087933446151,1.1952427093332711,0.2895104895104895,0.5517424468617241,1.0,8/14,22.26%,HSPA5;BAX;DAB2IP;DDRGK1;DNAJB9;TMEM33;BAK1;PTPN1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5676165580197332,1.1952354403934933,0.2646657571623465,0.5513120960642871,1.0,6/12,24.81%,TREM2;TNF;NUPR1;CCL3;IL6;IL33
prerank,positive regulation of chromatin organization (GO:1905269),0.5630521215738349,1.1950509515540988,0.2783216783216783,0.5513736709563871,1.0,2/12,2.97%,H3-3A;TERF1
prerank,negative regulation of defense response (GO:0031348),0.43240767212160314,1.1949671160586122,0.16844349680170576,0.5511705501454285,1.0,22/77,25.29%,APOE;GPER1;NR1D1;LRFN5;SIRPA;TNFAIP3;FEM1A;OTULIN;KLF4;TNFRSF1A;TYRO3;FNDC4;CDH5;CXCL17;NLRP3;SIRT2;SELENOS;CCN3;PCBP2;C1QBP;TEK;MFHAS1
prerank,positive regulation of immune effector process (GO:0002699),0.4912413204452959,1.194720368391092,0.225,0.5514136098094229,1.0,4/27,8.83%,RPS19;CD81;PTPRC;IL2
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5413339671421664,1.194708039039594,0.2716688227684347,0.5509997608855981,1.0,4/16,16.23%,TYROBP;VSIR;LILRB1;DLL1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5872059656895591,1.1943311241603014,0.26474622770919065,0.5515729036136622,1.0,4/10,16.16%,PTPRC;TLE5;KLF4;SIGIRR
prerank,positive regulation of T cell activation (GO:0050870),0.440327601165436,1.1940896719009924,0.19597457627118645,0.551743264419693,1.0,17/62,20.93%,CD81;MDK;CCL19;PTPRC;SIRPA;TFRC;HSPD1;THY1;PNP;AIF1;DOCK8;CCL2;VCAM1;CCR2;CD86;IL6;PYCARD
prerank,stem cell development (GO:0048864),0.5321726303681231,1.1933060487887084,0.2554278416347382,0.5534711577583382,1.0,10/16,32.30%,NRG1;PTPRC;PDCD6;SOX8;SOX11;WNT7A;NOLC1;SHH;KBTBD8;CDH2
prerank,DNA duplex unwinding (GO:0032508),0.4439978243440046,1.1930279036737153,0.22160970231532526,0.5537994268022598,1.0,8/50,11.80%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1;DDX11
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4797827110825211,1.1928772195291224,0.24228028503562946,0.5537628630354245,1.0,9/29,14.55%,RPS2;PARK7;PINK1;PIN1;BAG5;FEM1A;FBXW7;FBXO5;ARRDC3
prerank,negative regulation of response to wounding (GO:1903035),0.5197640316614777,1.192833347717618,0.24688279301745636,0.553430013385509,1.0,4/19,9.99%,MDK;CERS2;KLK8;EPPK1
prerank,negative regulation of hydrolase activity (GO:0051346),0.4480310932523126,1.191462300329951,0.2154696132596685,0.5566486504403635,1.0,12/49,16.42%,CST3;ECM1;ATP5IF1;CSTB;TMED2;RRP1B;MAP2;NEIL1;PPP1R35;HRAS;ARL2;DAB2IP
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5357785631557176,1.1911027309736997,0.26225165562913905,0.5571371786645917,1.0,7/17,20.79%,SEC61B;HSP90B1;AUP1;VCP;SYVN1;HERPUD1;SELENOS
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4333932403953615,1.1905359094694417,0.19957761351636746,0.5582386941137383,1.0,23/73,19.80%,HSP90AA1;HSP90AB1;PARK7;AKT1;TXN;PINK1;TNF;HCLS1;MIF;TFRC;PAK1;CAMK1;IL11;RAMP3;SH2D3C;RIPK2;GAS6;PFN2;CAV1;TERF2IP;SNCA;TGFB1;IL6
prerank,protein autophosphorylation (GO:0046777),-0.23625385273966276,-1.1904522525456998,0.0,0.6292007807724596,1.0,36/157,12.61%,GRK5;EGFR;FER;ABL1;DAPK1;LRRK2;CAMK2D;SIK2;MAP3K13;MAP3K3;CLK2;SMG1;EIF2AK4;PDPK1;EPHA4;STK24;INSR;CDK12;MARK3;EIF2AK3;DYRK1A;MAPKAPK3;SIK1;TAOK3;FGFR2;AAK1;STK10;NEK6;RIPK1;PDGFRB;SLK;PTK2;DAPK2;ULK2;ATM;PRKD1
prerank,tRNA aminoacylation (GO:0043039),0.4633133553556681,1.1902584115025372,0.23798358733880423,0.5585406441011431,1.0,13/37,22.36%,LARS2;GARS1;SARS2;SARS1;KARS1;WARS1;NARS1;CARS1;PPA1;EPRS1;QARS1;AIMP2;YARS2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.5173048965569276,1.1898056871568827,0.24645161290322581,0.5593479914253203,1.0,7/20,20.23%,PARK7;LAMTOR5;H1-0;TWIST1;DDRGK1;TGFB1;POU4F1
prerank,secretory granule organization (GO:0033363),0.5779210763928785,1.1892655401860104,0.25697503671071953,0.5603258964279891,1.0,6/10,24.63%,BLOC1S1;SRGN;BLOC1S3;BLOC1S2;LYST;F2RL3
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.35888930634332344,-1.1890947178483204,0.20279720279720279,0.6302733269815951,1.0,9/30,10.23%,GOLGA4;VAMP5;MACF1;SPTBN1;BLZF1;RAB10;GGA2;OPTN;KIF13A
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3054914623145868,-1.1882276485858907,0.14285714285714285,0.6301056784152917,1.0,15/56,10.96%,EGFR;FER;ABL1;EPHA3;EPHA4;EFEMP1;INSR;DYRK1A;FGFR2;ABI1;PDGFRB;ABL2;TPST1;EPHB2;PTK2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5059942719277258,1.1879992281176992,0.2503097893432466,0.5633279474682185,1.0,4/22,12.78%,MDK;IL2;VSIR;CTLA4
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.506179663522693,1.187837667938024,0.25857843137254904,0.5633257873120627,1.0,7/21,18.31%,YWHAB;FKBP1A;PPP1R1B;YWHAE;ARPP19;FKBP1B;PPP1R15A
prerank,nervous system development (GO:0007399),0.3929815522998459,1.1877073820704345,0.032,0.5632657130684796,1.0,133/429,22.91%,GSN;SCD5;MBP;MDK;ITM2B;BCAN;LSAMP;MPZ;NBL1;MARCKS;ASIC2;NRXN1;SPOCK2;NLGN1;S100B;SLC2A1;NRG1;ERBB4;NES;KCNQ2;FZD9;MOBP;ADAM23;PMP22;DSCAM;GPM6B;CNTN4;ADGRL3;ECRG4;MAL;RBFOX3;SH3GL2;HES1;SPOCK1;TAGLN3;STMN3;DNM3;HAPLN2;NINJ2;FN1;LGI1;APLP1;LY6H;LRCH4;CRMP1;NAV3;NELL1;PRDM12;KIRREL3;NRCAM;KLK6;PROX1;MOG;NDUFS2;FGF11;MARCKSL1;ADGRB1;NINJ1;SMPD1;DNER;ADGRB2;HAP1;FGF12;CHRM3;ELP3;POU3F1;IRF2BPL;GFRA1;SOX8;CHRM2;NRXN2;CLN5;DCTN1;NRSN2;CXCR4;ST8SIA4;PTPRZ1;CAPG;ROBO2;SPG7;RBFOX1;NAGLU;DCHS1;NFASC;PRPS1;VCAN;CDK5;DSCAML1;COX7B;ACHE;GMFB;CPNE6;GFRA2;EPHB1;TYRO3;FGF13;DOC2A;PRX;PPP2R5D;GLIS2;CLN8;SCIN;PCDHB14;GPM6A;ERCC6;APBA2;MYT1L;ERBB3;FABP7;INHBA;DCX;UNC119;TGFB1;POU4F1;GDF11;MEF2C;PLXND1;BTBD6;SRRM4;SOX10;PTN;HAPLN4;IGF2BP3;SDHA;GRIK1;ROGDI;POU6F2;GRHL2;GDA;CHRNA3;SNTG2;ACAN;DPYSL2
prerank,regulation of neuron projection development (GO:0010975),0.40382933247607977,1.1875567639609483,0.14014014014014015,0.5632188519373504,1.0,30/163,10.49%,APOE;ITM2C;MDK;MT3;CFL1;DCC;AKT1;CTNNA2;NTRK2;CAMK1D;S100A9;CSMD3;NDRG4;KNDC1;TENM3;SPOCK1;LTK;BAG5;LRRC4C;CRMP1;ATP1B2;PAK1;PTK6;IL1RAPL1;PPFIA2;MFSD2A;CDK5R1;CAMK1;PAK3;WNT5A
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.4692404743899585,1.1875380626561916,0.24413145539906103,0.5628174025568731,1.0,10/33,20.17%,HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2;PTGES3;GAR1;CTC1;TERF2IP;DKC1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.39020882680441527,-1.1867420528258,0.2222222222222222,0.6313987804838666,1.0,8/21,15.44%,SMO;DCDC2;TTC23;DLG5;GAS8;EVC;UCHL5;KIF7
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4776069304274293,1.186534223568178,0.2439903846153846,0.5645597757163109,1.0,10/29,24.12%,DBI;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5;ACLY
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4776069304274293,1.186534223568178,0.2439903846153846,0.5645597757163109,1.0,10/29,24.12%,DBI;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5;ACLY
prerank,negative regulation of angiogenesis (GO:0016525),0.4247781323151894,1.1861480112877338,0.18248175182481752,0.5651681404787687,1.0,24/84,18.54%,SPARC;CLDN5;KLF2;SERPINF1;TNF;CTNNB1;PDE3B;PGK1;VASH1;DCN;CXCL10;EPN1;SARS1;ADGRB1;ECSCR;STAB1;KLF4;PF4;DAB2IP;AMOT;ADAMTS1;AGO1;HSPG2;CCR2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4710782742923285,1.185935072588161,0.22894424673784106,0.5653128666568079,1.0,14/31,25.72%,SYT1;SYT12;SYT11;SYT6;SYT4;SYT10;CBARP;SYT2;DOC2A;DOC2B;SYT3;REST;SYT5;SYT17
prerank,embryonic digestive tract development (GO:0048566),-0.4059257639597975,-1.185801324791775,0.2077922077922078,0.6312848621559862,1.0,6/18,8.34%,RARB;GLI3;NIPBL;GLI2;PCSK5;FGFR2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5854768930727567,1.1855470976658733,0.269774011299435,0.565904312709133,1.0,5/10,16.95%,FKBP1A;YWHAE;PLN;CBARP;FKBP1B
prerank,regulation of centrosome cycle (GO:0046605),0.5045614814314392,1.185467343932864,0.23954372623574144,0.5656668564434787,1.0,7/21,16.22%,NPM1;CHMP2B;CHMP5;FBXW5;ATF5;CEP131;CHMP1B
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4422488872617734,1.1852463789220142,0.23420479302832245,0.5658798517143608,1.0,15/52,15.33%,TOMM7;PINK1;YWHAB;UBL5;YWHAH;YWHAE;LEPROT;YWHAG;PMAIP1;FBXW7;YWHAQ;BBC3;YWHAZ;RHOU;BAD
prerank,sulfur amino acid catabolic process (GO:0000098),0.5823095404995059,1.1849764109962075,0.2873900293255132,0.5661545673459927,1.0,4/10,23.82%,MPST;TXN2;TST;ADO
prerank,cellular response to oxygen levels (GO:0071453),0.5891787679537346,1.1846265658445614,0.3,0.5666753497390263,1.0,3/10,8.93%,ATP6V1G1;ATP6AP1;NDUFS2
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.3224112271213987,-1.184326459411991,0.16216216216216217,0.6327201676617658,1.0,12/44,10.33%,ROCK2;FTO;TNRC6B;ROCK1;TNRC6A;DHX36;TNRC6C;CNOT1;YTHDF3;CPEB3;MOV10;CNOT7
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4223827535455986,1.1837483878494761,0.19091847265221878,0.568634135555853,1.0,31/93,20.43%,RACK1;HSP90AA1;HSP90AB1;PARK7;AKT1;TXN;PINK1;TNF;HCLS1;MIF;TFRC;PAK1;MLXIPL;CAMK1;IL11;RAMP3;SH2D3C;CNKSR3;NLRP2B;RIPK2;INPP5J;GAS6;SPTBN4;DMTN;PFN2;CAV1;TERF2IP;SNCA;TGFB1;IL6;DDIT4
prerank,steroid metabolic process (GO:0008202),0.4246018762318549,1.1836818208938575,0.2106951871657754,0.5683687124385243,1.0,10/72,12.96%,TSPO;LGMN;SCP2;RDH5;LSS;HSD17B4;DHCR24;FDX2;GC;HSD3B2
prerank,regulation of wound healing (GO:0061041),0.4518001727112295,1.1835002603570308,0.24284077892325315,0.568396212408607,1.0,11/42,17.95%,ACTG1;VTN;TNFAIP3;CADM4;EPPK1;HRAS;F2RL1;DMTN;CAV1;PLAU;TNFRSF12A
prerank,regulation of dendrite development (GO:0050773),0.45758869970857635,1.183424564858333,0.2488425925925926,0.5681626820652894,1.0,18/37,27.98%,DCC;ADGRB3;PACSIN1;CAMK1D;CSMD3;KNDC1;MFSD2A;LRP8;DAB2IP;BCL11A;NSMF;HECW1;PTN;CHRNA3;VLDLR;RAP2A;ALK;LZTS1
prerank,snRNA metabolic process (GO:0016073),-0.4114349902377312,-1.1831142455302532,0.2543859649122807,0.6334686458132158,1.0,7/17,18.35%,INTS8;INTS6;ZCCHC8;TUT1;MTREX;INTS3;INTS11
prerank,cellular sodium ion homeostasis (GO:0006883),0.5374707591587489,1.1828935629571424,0.2635135135135135,0.5691579387314107,1.0,7/15,18.56%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;SLC8A1;ATP1B1;ATP1B3
prerank,endoderm development (GO:0007492),0.5511942534450551,1.182670322045851,0.2724867724867725,0.5693272331605184,1.0,5/13,22.74%,LAMC1;SOX17;GATA4;DUSP2;DUSP1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.394449156714344,1.182646357169013,0.037,0.5689359280819606,1.0,138/509,20.57%,RPL23;RPS3;RPS15;RPL37;CD74;RPS20;RACK1;GAPDH;HSP90AA1;HSP90AB1;LAPTM5;LGALS1;HMOX1;PARK7;CCL19;TXN;NLGN1;S100B;TREM2;NRG1;TGM2;ERBB4;AGT;PINK1;S100A13;LAMTOR2;GPER1;LAMTOR4;TNF;RHOC;GPR37L1;LAMTOR5;EEF1D;RAC1;PTPRC;PDGFB;HCLS1;FKBP1A;SHISA5;NTRK2;ECM1;RTN4;SCTR;S100A8;S100A9;MIF;CAV2;FLNA;TIRAP;FN1;TFRC;RHOG;EPOR;TMEM101;CLEC6A;DCN;KDR;NUPR1;P2RY12;TICAM2;JCAD;LILRA5;TMEM9B;HMGB1;MC1R;WNT5A;KITLG;RBCK1;BAX;IL11;RAMP3;PMAIP1;FLT4;C1QTNF4;HRAS;VAV1;RHOA;SOX9;BST2;RUNDC3A;HEXIM1;BBC3;LAMTOR3;TNFRSF1A;BMP2;GJA1;RIPK2;GAS6;UBE2V1;CX3CR1;TLR6;F2RL1;RRAGC;BAD;HPSE;GDF15;PDGFA;IGF2;NCF1;DAB2IP;RRAGD;ADRA1A;ADRA1D;CCL3;CASS4;CAV1;DNM1L;BCAP31;TRIM32;PIK3CD;F10;FLT1;RAC2;S100A4;TERF2IP;GRM4;CD14;ERBB3;MAZ;LTBR;KLB;SOX11;TRIM13;RTKN2;VAPA;PTPN6;TGFB1;CD86;SPHK2;HGF;IL6;TMEM106A;FLT3;THEM4;THPO;TRAT1;CANT1;GOLT1B
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5281033858964712,1.1825535585388511,0.26913265306122447,0.5687650866001898,1.0,3/17,8.76%,CD74;MIF;PTTG1IP
prerank,autophagosome assembly (GO:0000045),0.43584085116585203,1.1825317345147421,0.2283464566929134,0.5683786360548023,1.0,7/52,5.61%,GABARAP;MAP1LC3B;MAP1LC3A;EMC6;GABARAPL2;GABARAPL1;ATG9A
prerank,polyamine metabolic process (GO:0006595),0.551006222207124,1.1823544835469055,0.26605504587155965,0.5683816724069537,1.0,5/13,20.33%,ODC1;SMOX;SMS;SRM;OAZ2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.556086094893719,1.182066228584119,0.2878179384203481,0.5687118072153736,1.0,6/13,16.37%,NELFCD;SUPT4H1;HEXIM1;HNRNPU;RECQL5;NELFE
prerank,polyol biosynthetic process (GO:0046173),-0.40717868785587163,-1.1819612156405015,0.2320675105485232,0.6340474319837028,1.0,6/16,19.83%,ITPKB;ACER3;IP6K2;PPIP5K1;CYP27A1;FGF2
prerank,secondary palate development (GO:0062009),-0.43029560231421976,-1.1818264857878673,0.24583333333333332,0.6320805073089346,1.0,5/14,14.85%,TGFBR3;SMAD4;WNT11;TGFB3;SMAD2
prerank,protein-DNA complex disassembly (GO:0032986),0.530680516122559,1.1816867174868826,0.26420079260237783,0.5693417311066256,1.0,1/16,0.13%,RPL23
prerank,cellular response to ionizing radiation (GO:0071479),0.4481339178117255,1.1814727032395,0.2376237623762376,0.5694819192094218,1.0,8/47,12.19%,RPL26;RHOB;CRYAB;EEF1D;NUCKS1;NET1;TMEM109;HRAS
prerank,import into nucleus (GO:0051170),0.4251732976734848,1.1813382353938708,0.20317460317460317,0.5693901966285183,1.0,19/73,18.98%,SNRPG;AKT1;GEMIN7;RAN;SNRPD2;SNRPE;FAM53C;SNRPF;PTTG1IP;IPO4;NUP85;SNRPB;HNRNPA1;NUP88;SPRN;EIF4ENIF1;SYK;NUP50;SNRPD3
prerank,regulation of small molecule metabolic process (GO:0062012),0.47860253287800536,1.1811221942036874,0.2542372881355932,0.5695566082504478,1.0,4/28,10.32%,APOE;ACADVL;NCOR2;BCKDK
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.5375057161013203,1.180888119812575,0.2693333333333333,0.5697855070080362,1.0,5/14,14.86%,AK4;AK3;PNP;NME2;CMPK2
prerank,ERAD pathway (GO:0036503),0.4183551500028434,1.1803516367244793,0.21976866456361724,0.5708117449815971,1.0,25/83,22.02%,SEC61B;HSPA5;RCN3;HSP90B1;AUP1;UBE2G2;VCP;FBXO27;SEL1L2;SYVN1;WFS1;DNAJB2;MAN1B1;UBQLN2;SGTA;UBXN6;BRSK2;HERPUD1;DNAJC10;DNAJB9;TRIM13;SELENOS;STUB1;USP13;AMFR
prerank,endothelial cell proliferation (GO:0001935),0.5215021528045872,1.1801284411499429,0.26187419768934533,0.5709660945486462,1.0,3/17,4.06%,HMOX1;CD34;ACVRL1
prerank,negative regulation of B cell proliferation (GO:0030889),0.5621727554963477,1.1800951975692358,0.2810368349249659,0.5706080894280516,1.0,4/11,24.38%,TYROBP;CTLA4;CD300A;TNFRSF13B
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5686075039244595,1.1796327112994995,0.2971014492753623,0.5713403937981288,1.0,5/11,23.77%,PCBP1;PCBP4;ZNF445;IGF2BP3;PCBP2
prerank,embryonic heart tube development (GO:0035050),0.5350110621454756,1.1794704286571147,0.2569906790945406,0.5713200193799213,1.0,6/14,20.44%,SOX18;NDRG4;HES1;SOX17;RYR2;CITED2
prerank,female gonad development (GO:0008585),0.5157332085521451,1.1790346130580962,0.27715355805243447,0.5720348334671079,1.0,9/19,25.24%,SOD1;ANG;CEBPB;FOXL2;EIF2B5;INHBA;INHBB;COL9A3;INHA
prerank,Golgi organization (GO:0007030),-0.26890397446482517,-1.1782004261029828,0.037037037037037035,0.6392016854601644,1.0,38/112,17.47%,LRRK2;BCAS3;ARFGEF1;ARHGAP21;CSNK1A1;USP6NL;VTI1A;RAB30;GORASP2;RAB2A;BLZF1;STX16;GOLGB1;HUWE1;UBXN2B;GOLGA2;GBF1;DYNC2H1;BET1;OPTN;GOLGA5;GOLGA8B;UBXN2A;MYO18A;PLEKHM2;PRKD1;RAB43;OBSL1;TRAPPC11;ATP8B1;NPLOC4;SEC16A;FBXW8;GOLPH3L;SEC16B;TRIP11;ATL2;LMAN2L
prerank,regulation of establishment of protein localization (GO:0070201),0.549478079603302,1.1778287924179272,0.2821917808219178,0.5748515483727282,1.0,2/13,2.59%,CTSD;TREM2
prerank,RNA destabilization (GO:0050779),-0.39898543455895563,-1.1773463313424244,0.2079646017699115,0.6389245311512249,1.0,4/18,5.76%,ROCK2;FTO;ROCK1;YTHDF3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4517043983066996,1.1769880389663825,0.23298731257208766,0.5767405546060986,1.0,9/39,11.31%,FXYD5;FXYD1;ANK3;YWHAH;FGF14;SCN4B;FGF11;FXYD7;FGF12
prerank,negative regulation of response to external stimulus (GO:0032102),0.415533506541707,1.1769069106672596,0.1892450879007239,0.576511118012554,1.0,31/105,25.99%,APOE;CERS2;CTNNA2;GPER1;GRID2;NR1D1;LRFN5;SIRPA;DUSP3;TNFAIP3;KLK8;FEM1A;OTULIN;EPPK1;KLF4;TNFRSF1A;TYRO3;SIGIRR;FNDC4;CDH5;CXCL17;NLRP3;SIRT2;SELENOS;CCN3;PCBP2;C1QBP;TEK;MFHAS1;TRIB1;CRK
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.4121181063752102,-1.1767311211332285,0.2222222222222222,0.6381902359592312,1.0,10/15,28.67%,ANAPC1;ANAPC7;NEK6;HECW2;CDC27;CENPE;TPR;RIOK2;PLK1;UBE2C
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4586530671241745,1.1760284769948113,0.2562574493444577,0.5784041703392198,1.0,11/33,22.39%,OAT;PYCR2;GLUL;DDAH1;GLS2;GLS;DDAH2;GLUD1;GOT1;ALDH4A1;MTHFS
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.41490973117962393,-1.175975598955436,0.21011673151750973,0.6376859151311752,1.0,5/17,8.09%,BMP6;SASH1;CARD16;TRIM5;LY96
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.40199140046326437,1.1759371474061422,0.14400805639476336,0.5781947902928615,1.0,49/173,21.08%,CTSZ;DYNLL2;DYNLL1;USE1;ANK3;LMAN2;DCTN3;ERGIC3;KDELR1;TMED7;LMAN1;F9;TRAPPC2L;SAR1A;TRAPPC5;TMED2;TRAPPC1;CAPZA2;YKT6;TEX261;ARFGAP2;TICAM2;TMED3;TMED9;PDCD6;GRIA1;TMED1;BET1L;DCTN1;YIF1B;GAS6;COL7A1;MCFD2;DCTN2;SPTBN4;IER3IP1;ARF4;NAPA;SPTBN2;BCAP31;F10;CTSC;TRAPPC3;VAPA;YIF1A;GOLT1A;COPB2;TMED10;COPG1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.4277179838353629,1.1757756072771086,0.2257360959651036,0.5781909533762444,1.0,21/69,22.02%,SEC61B;HSPA5;HSP90B1;AUP1;UBE2G2;VCP;FBXO27;SEL1L2;SYVN1;WFS1;DNAJB2;MAN1B1;UBQLN2;SGTA;HERPUD1;DNAJC10;DNAJB9;TRIM13;SELENOS;STUB1;AMFR
prerank,hippo signaling (GO:0035329),-0.36134661168426563,-1.1757669231249561,0.18452380952380953,0.6358769932421852,1.0,7/26,12.85%,TEAD1;STK3;YAP1;TEAD2;SAV1;LATS2;CASP3
prerank,regulation of telomerase activity (GO:0051972),0.44517702840439555,1.1753978091740904,0.23615819209039549,0.5787566542650141,1.0,20/45,26.18%,HSP90AA1;HSP90AB1;MAPK3;TERF1;CCT2;CTNNB1;KLF4;PARM1;PTGES3;MAPK15;DKC1;MYC;MAP2K7;MEN1;CCT4;GRHL2;NAF1;PNKP;PIF1;PRKCQ
prerank,regulation of protein transport (GO:0051223),0.4846149631428029,1.17483293989871,0.2682634730538922,0.5798606627091469,1.0,6/27,11.49%,HSPA8;TNF;LCP1;ATP13A2;STXBP5L;DNAJA1
prerank,regulation of myoblast fusion (GO:1901739),0.5756560525502011,1.1746855162427055,0.2855191256830601,0.579826408645373,1.0,6/11,18.91%,FLOT1;CD53;ADGRB1;EHD1;EHD2;SCGB3A1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3051706337917326,-1.1746468451194898,0.18181818181818182,0.6364025082522187,1.0,17/51,14.52%,ROCK2;ABL1;LPAR1;PPM1E;SORBS3;NRP1;ARHGEF10L;CARMIL1;TGFBR1;PXN;RAPGEF3;FERMT2;TPM1;NF2;SYNPO2;WNT11;TGFB3
prerank,response to muscle stretch (GO:0035994),0.532801616820531,1.1743206236096513,0.2857142857142857,0.5803454904704702,1.0,4/15,16.06%,GSN;CTNNB1;SLC8A1;RYR2
prerank,negative regulation of translation (GO:0017148),0.4188451204776805,1.1742993269862207,0.21047120418848167,0.5799565202971577,1.0,9/87,4.66%,MRPL13;RPS3;RACK1;GAPDH;RPL13A;CALR;IGFBP5;NCL;MEX3D
prerank,chromosome organization (GO:0051276),0.40922347171456286,1.174170012070805,0.2053388090349076,0.5798827588175176,1.0,19/99,14.83%,RPS27A;UBC;UBB;H3-3A;COPS7A;HDAC11;COPS6;PARP1;NUCKS1;HMGN1;UBA52;RBX1;DDB1;SUPT4H1;FAM50A;ZBTB7A;HDAC5;L3MBTL1;COPS8
prerank,microtubule anchoring at centrosome (GO:0034454),-0.47119358788335197,-1.1737375374818022,0.2842809364548495,0.6365722488639206,1.0,5/10,18.29%,NIN;NINL;PCM1;CCDC120;CEP19
prerank,C21-steroid hormone metabolic process (GO:0008207),0.5058576008579808,1.1734238009655027,0.26898326898326896,0.5814487466435848,1.0,4/20,17.71%,TSPO;FDX2;HSD3B2;STARD3NL
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5628566519334002,1.1730733317432345,0.27853260869565216,0.5819478691806576,1.0,4/12,12.98%,GRN;ATP6AP2;CLN6;CLN5
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4259371301721812,1.172119507761358,0.23315508021390374,0.584088554069455,1.0,11/66,9.99%,APOE;SPARC;B2M;ATP5F1A;MAGED1;ATP5IF1;CAV2;CDKN1C;VASH1;NUPR1;EPPK1
prerank,diterpenoid metabolic process (GO:0016101),0.43619611391982666,1.1710935658718018,0.23710208562019758,0.5863746058046473,1.0,16/55,20.32%,APOE;RBP4;RARRES2;TTR;RDH5;RBP1;LPL;SDC4;GPC5;AKR1B10;LRP8;LRAT;HSPG2;BCO2;SDC3;AGRN
prerank,integrated stress response signaling (GO:0140467),0.5355022136585121,1.1709524992153386,0.2845849802371542,0.5863229484909096,1.0,7/14,25.03%,HSPA5;ATF4;OMA1;CCL2;HERPUD1;DDIT3;EIF2S1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5698289050985523,1.170384871406695,0.301460823373174,0.587314021607543,1.0,5/10,31.99%,CTNNB1;CX3CR1;FZD3;CX3CL1;DRD2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.48012664992735243,1.1699094895241906,0.279126213592233,0.5881515650008091,1.0,8/24,22.58%,RPS3;ACVRL1;H1-0;SUB1;TERF2IP;ERCC1;BLM;DACH1
prerank,cellular response to organic cyclic compound (GO:0071407),0.4024125847168631,1.1695609289039324,0.1656441717791411,0.588658839472469,1.0,37/141,18.46%,ACTB;SPP1;GABRB1;AKAP6;TGM2;GPER1;TNF;ZFP36L1;HSP90B1;IGFBP5;PDGFB;CTNNB1;MSN;ATP1A3;DRD5;P2RX7;P2RY6;AQP1;P2RY12;EGR1;P2RY1;GNAI1;RAMP3;TRPM2;GABRB3;ATP1A1;SLC1A1;CCL2;PDE12;HCN1;DMTN;CCL3;GABRB2;ADCY8;HCN3;NCOA4;SFRP1
prerank,regulation of phospholipase C activity (GO:1900274),-0.4280173196790612,-1.1694047262472262,0.27230046948356806,0.6459362061298044,1.0,8/15,20.52%,ABL1;NTRK3;ESR1;PDGFRB;ABL2;KIT;FGF2;PDGFRA
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.46362056264664586,1.1691808847664227,0.26157407407407407,0.5892453028047324,1.0,11/35,12.19%,ARHGDIA;MDK;HCLS1;ARHGDIB;IQGAP2;ESAM;PHPT1;HCK;CSF1R;TRPM2;HRAS
prerank,peripheral nervous system development (GO:0007422),0.496907880025384,1.1690460106706648,0.2814070351758794,0.589176116241273,1.0,10/23,26.21%,ASIC2;PMP22;ADGRB1;ADGRB2;SOX8;NFASC;ERBB3;SOX10;GPC1;SCN8A
prerank,positive regulation of MAPK cascade (GO:0043410),0.39799022666957645,1.1688418329845607,0.12537612838515547,0.589297028177952,1.0,65/245,19.83%,APOE;CD74;LAPTM5;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;TNF;GPR37L1;PTPRC;PDGFB;NTRK2;C5AR1;SEMA7A;MIF;NDRG4;CAV2;DDT;ATP6AP1;TIRAP;SEMA4C;P2RY6;KDR;CCN2;HTR2C;CD24;P2RY1;JCAD;LILRA5;HMGB1;CSF1R;IL11;RAMP3;FLT4;HRAS;FBXW7;BMP2;CCL2;NEK10;GAS6;F2RL1;GDF15;PDGFA;IGF2;RASGRP1;EDN3;ARRB2;DAB2IP;ADRA1A;ADRA1D;CCL3;GATA4;FLT1;ADCYAP1;CCL8;GRM4;GPR183;TGFB1;IL6;TMEM106A;NOTCH1;FLT3
prerank,blood vessel morphogenesis (GO:0048514),0.43433226330331787,1.1685932393244016,0.24671052631578946,0.5894953204313836,1.0,18/54,19.62%,RAMP2;SOX18;ID1;RASIP1;APLNR;LOX;HES1;COL4A1;PROX1;KDR;SOX17;FLT4;SLC1A1;EGFL7;CAV1;FLT1;SYK;TGFB1
prerank,negative regulation of ossification (GO:0030279),0.4886823357006638,1.1683487229183585,0.27805486284289277,0.5897257893502978,1.0,9/23,20.51%,MDK;ECM1;LRP4;SRGN;SOX9;CCL3;SFRP1;NOTCH1;MEF2C
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.2586369949884826,-1.167885879356003,0.16666666666666666,0.6476793800315537,1.0,44/138,18.44%,TEAD1;NOTCH2;NR3C2;RARB;CREBBP;MAML2;NR6A1;MNAT1;THRB;TAF15;PPARA;RARG;YAP1;KAT2B;NCOR1;TBL1X;NR1D2;MAML1;TBL1XR1;TEAD2;ESR1;PPARG;NR2C2;GTF2E2;MED26;RBPJ;TAF2;POLR2A;AR;NR2F1;GTF2H4;POLR2B;CDK7;POLR2J;GTF2A2;ESRRA;NR3C1;TAF8;ERCC3;TAF4B;NR5A2;GTF2H2;TAF7;MED23
prerank,extracellular matrix assembly (GO:0085029),0.49718209614828823,1.1677619147045373,0.27328431372549017,0.590936159471027,1.0,8/23,20.15%,RAMP2;LAMB2;GPM6B;MFAP4;MYH11;GAS6;TGFB1;QSOX1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.4164628300545575,1.1670432647441824,0.2330198537095089,0.5924586629747092,1.0,17/80,14.55%,UBB;RPS2;LAPTM5;PINK1;FKBP1A;PIN1;FAM107A;CENPX;PTTG1IP;RBX1;PDCD6;WFS1;NSMCE3;FBXW7;RIPK2;HSPBP1;ARRDC3
prerank,regulation of protein modification process (GO:0031399),0.4385612621950361,1.1670111968521857,0.2535832414553473,0.5921038123515607,1.0,16/50,18.64%,HSPB1;MT3;PPIB;GRM5;PIN1;FN1;CORO1C;CADM4;WARS1;ABCA2;CCDC88A;IGF2;ASPSCR1;CDH5;CCAR2;NOP53
prerank,midbody abscission (GO:0061952),0.5132271552309731,1.1668174340818591,0.2831168831168831,0.5921490977371243,1.0,10/17,31.00%,CHMP2B;CHMP5;CHMP6;CHMP1B;VPS4A;CHMP7;CHMP1A;CHMP4C;CHMP4A;CHMP4B
prerank,cation transmembrane transport (GO:0098655),0.4455156290532703,1.1665437343987048,0.2517162471395881,0.5924649229416287,1.0,11/44,15.84%,SLC38A5;ASIC2;SLC7A5;SLC25A29;SLC6A5;ATP13A2;SLC3A2;TRPM2;ABCC8;SLC25A19;ATP1B1
prerank,I-kappaB phosphorylation (GO:0007252),0.5752752108885126,1.1663762776304918,0.3021897810218978,0.5924760657094987,1.0,5/10,28.75%,PRDX4;DAB2IP;TLR7;TLR2;MAP3K7
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.4492600499656494,-1.1651089816673996,0.2779783393501805,0.6528201462619138,1.0,5/11,24.20%,CAMK2D;SESTD1;NOS1AP;NOS1;CACNB1
prerank,DNA double-strand break processing (GO:0000729),-0.3989628477374958,-1.165091348381097,0.2727272727272727,0.6505044001865995,1.0,5/18,12.57%,SMARCAD1;RBBP8;SLX4;RNF138;ATM
prerank,stress granule assembly (GO:0034063),0.5027828616269918,1.1647115513227588,0.2767052767052767,0.596546781470152,1.0,7/20,15.94%,RPS23;MAPT;ATXN2L;CSDE1;G3BP1;CIRBP;YTHDF1
prerank,regulation of gastrulation (GO:0010470),0.5339958302782172,1.16471105769643,0.2963464140730717,0.5960962694762424,1.0,4/14,10.64%,RACK1;OTX2;CLASP1;TENM4
prerank,placenta development (GO:0001890),0.5523657241599198,1.1646213439497757,0.2859097127222982,0.5959022994559012,1.0,2/12,4.47%,SOD1;ANG
prerank,regulation of kinase activity (GO:0043549),0.4128764182338932,1.1644845852608023,0.22717842323651452,0.5958441482886864,1.0,22/89,18.55%,EEF1A1;CD74;SOD1;TREM2;ERBB4;EMP2;NTRK2;LTK;CDKN1C;MUSK;KDR;MAPT;EPHA5;CSF1R;FLT4;TIE1;HNRNPU;EPHB1;TYRO3;FLT1;DDR2;ERBB3
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.46926145158366217,1.1643231820499755,0.29594272076372313,0.5958248819176827,1.0,7/28,16.42%,GABARAP;TNF;SPI1;BAX;TNFRSF1A;SORT1;DAB2IP
prerank,cellular response to catecholamine stimulus (GO:0071870),0.48988278724734147,1.1640977255023182,0.2720677146311971,0.595952669515447,1.0,6/23,6.81%,MAPK3;ATF4;PDE4B;TGM2;DRD5;APLP1
prerank,purine ribonucleotide transport (GO:0015868),0.5207039687783365,1.1640130358587506,0.31065468549422337,0.5957250393447865,1.0,3/16,13.83%,LRRC8A;SLC25A4;SLC19A1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.44046759472367536,1.1639888494915465,0.2663706992230855,0.5953509485043196,1.0,15/46,22.80%,GPER1;PTPRC;PIN1;SIRPA;DUSP3;DUSP26;CAMK2N1;TIMP3;PTPRR;SPRY1;CNKSR3;DAB2IP;SPRY3;PTPN1;TNIP1
prerank,muscle contraction (GO:0006936),0.40305622750541753,1.1634392142123755,0.1924643584521385,0.5963151734372151,1.0,23/126,16.58%,MYL6;ALDOA;VIM;CALM1;MYL9;ACTA2;MYL12A;FXYD1;TPM2;CRYAB;MYL1;MYL12B;P2RX6;GNAO1;MYL6B;GLRA1;MYH11;TNNI1;DES;TMOD1;SLC8A1;ADRA1A;DTNA
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5537378182252306,1.1632742696218534,0.30180806675938804,0.5963284423708575,1.0,2/11,5.76%,AUP1;VCP
prerank,positive regulation of protein processing (GO:0010954),0.5066691463907547,1.163206512537768,0.2794307891332471,0.5960589482389449,1.0,3/19,8.57%,GSN;ENO1;CLEC3B
prerank,positive regulation of programmed cell death (GO:0043068),0.39312819755673833,1.1630791673855863,0.0871743486973948,0.5959602510742408,1.0,80/272,22.30%,MTCH1;RPS27A;CTSD;CLU;UBC;RACK1;UBB;LAPTM5;SOD1;RHOB;ATF4;RPS6;UBE2Z;TGM2;IGFBP3;GPER1;TNF;FZD9;PSENEN;CTNNB1;OMA1;UBA52;BNIP3L;HSPD1;ARHGEF4;FOXL2;CSRNP3;RRP1B;NET1;JUN;HMGB1;ARHGEF7;SMPD1;BAX;APBB1;DNAJA1;PMAIP1;PNMA2;TCTN3;CTLA4;VAV1;SFRP4;VAV3;CLIP3;MCF2L;BMP2;NLRP2B;LILRB1;WNT10B;ABR;TIAM1;BAD;DAB2IP;SQSTM1;PSEN2;DNM1L;PDCD5;NOS2;KCNMA1;TNFRSF12A;SCIN;ARHGEF19;APH1B;SYK;CCAR2;SFRP1;SNCA;SOS1;SPHK2;ING5;IL6;KLF11;GADD45A;TFAP4;PYCARD;BAK1;FOXA1;SUDS3;IRF5;REST
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.40445713307020364,1.162276743159526,0.21338912133891214,0.5976982301367553,1.0,40/104,27.64%,ACTB;CALM1;AKT1;CCNI;CALM3;CCND2;SERTAD1;CCND1;THY1;CDK5R1;CAMK1;PIH1D1;CSF1R;CDC37;CCNG1;RHOA;CDK5R2;SLC8A1;DAB2IP;CCNJL;CDC25A;MAP2K2;CALM2;SNCA;GADD45A;PYCARD;RALB;INCENP;BLM;CDKN2B;TESK1;HGS;CCNG2;CCNA2;TRIB1;TRIB3;CCNH;SNF8;CDKN1A;CNPPD1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.4924000274996088,1.1622492299348302,0.2769423558897243,0.5973265239520721,1.0,5/20,13.65%,GSN;GPER1;ECSCR;SFRP4;CCL2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.47750877741283326,1.1615160328829783,0.2786683107274969,0.5988712499867632,1.0,9/26,21.50%,AKT1;CYB5R3;SPR;SPTLC1;ABCA2;DDAH2;NOS2;SPHK2;ASAH2
prerank,sodium ion homeostasis (GO:0055078),0.49436750707454513,1.1613994818754236,0.28241335044929394,0.5987678393376463,1.0,8/21,19.75%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;SLC8A1;ATP1B1;ATP1B3;TFAP2B
prerank,regulation of inclusion body assembly (GO:0090083),0.5590238290046341,1.160973240661431,0.2956521739130435,0.5995416514087457,1.0,8/11,20.99%,HSPA1B;BAG5;DNAJB2;HSPA1A;DNAJB1;SACS;DNAJA4;HSPA2
prerank,regulation of cholesterol storage (GO:0010885),0.5323397139379251,1.1609489880186772,0.2751677852348993,0.5991667790815964,1.0,6/15,15.69%,TREM2;ABCG1;LPL;MSR1;EHD1;NR1H2
prerank,regulation of cellular localization (GO:0060341),0.44077068333129804,1.160941872552376,0.26174496644295303,0.5987374148985932,1.0,10/46,9.74%,GSN;HSP90AA1;HSP90AB1;PINK1;NR1D1;PARP1;REEP5;REEP6;MAP2;EPHA5
prerank,long-chain fatty acid metabolic process (GO:0001676),0.420555704469774,1.160734175569782,0.24518201284796573,0.598860246219945,1.0,17/64,23.63%,GPX4;GPX1;SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4;GSTM2;ACOT1;ACOT4;FAAH;LTC4S;ACSL3;ASAH2;ELOVL6;ACSL4;CYP2E1
prerank,anterior/posterior axis specification (GO:0009948),-0.42197068919958886,-1.160672474396722,0.26907630522088355,0.6598926444376213,1.0,3/15,8.51%,WLS;SKI;TASOR
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.48721925100047525,1.1606004743126421,0.27631578947368424,0.5988085826021831,1.0,10/24,24.91%,RAMP2;TNFAIP3;KDR;GATA2;IL11;GAS6;CDH5;SCG2;PAK4;TEK
prerank,regulation of translational initiation (GO:0006446),0.4250654940136119,1.1603428019523268,0.23060344827586207,0.5990460944955097,1.0,19/63,20.86%,HSPB1;EIF1;ATF4;EIF4G2;POLR2D;NPM1;EIF1B;PPP1R15B;UHMK1;CEBPB;MIF4GD;POLR2G;EIF3B;CSDE1;YTHDF1;EIF2B5;EIF4H;KLHL25;EIF5B
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5769735830444005,1.1597479577130552,0.29898403483309144,0.6001730131042805,1.0,1/10,1.89%,MAPK3
prerank,regulation of cell projection organization (GO:0031344),0.5410048121451212,1.1595943239472761,0.31309041835357626,0.6001536849016698,1.0,3/13,9.00%,CCL19;TREM2;MFSD2A
prerank,acute inflammatory response (GO:0002526),0.4782798184433744,1.1593482419184877,0.29615861214374223,0.6003449566311899,1.0,4/23,7.24%,MBL2;HP;HPR;CEBPB
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5781034248922394,1.158977465034163,0.3137535816618911,0.6008911991918371,1.0,2/10,13.71%,CD24;LILRB1
prerank,protein transport (GO:0015031),0.3849465779218965,1.158938230562576,0.098,0.6005545529261306,1.0,93/332,22.59%,APOE;CD74;CLU;RAMP2;ATP6V0C;LAPTM5;RCN3;SNX17;ATP6V1F;NPM1;ANK3;LRP1B;TXNIP;CANX;OLFM2;HSP90B1;ARF5;ATP6V1G1;YWHAH;ATP6V0E2;ABCG1;ATP6AP1;CHMP2B;TMED7;TFRC;RD3;ARRDC1;SAR1A;RAB14;RAB15;SCAMP3;TMED2;CLTC;ARL11;RAB3C;SCG5;VAMP2;ARF6;TICAM2;ARL4C;TMED3;RAB3D;TMED9;PDCD6;ATP6V0D2;CTSA;RAMP3;PPY;CMTM6;SGSM1;ARL4D;TMED1;ARL1;VMP1;SYNDIG1;ARF1;EHD1;ARRDC3;TBC1D22B;SCAMP2;UNC93B1;TVP23A;RAB26;GOLGA7;ARF4;SNX33;CHMP1B;RAB20;NAPA;TBC1D9;RAB5C;LAMP2;SYS1;STX4;RAB31;PREPL;ERP29;PDIA4;RAB18;UNC119;TBC1D10C;CTTN;RAB6B;COPB2;TMED10;COPG1;IFT27;STX1B;AP2A1;SCG2;RAB28;EVI5L;ATP6V1A
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.547396996979028,1.1585855699374952,0.30229419703103916,0.6010868780232723,1.0,6/13,19.74%,LAMP1;ITGB2;F2RL1;SYK;STX4;SPHK2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.2655697280419989,-1.1584394603919848,0.0625,0.6636387214379704,1.0,31/140,9.25%,ARHGAP29;AKAP13;ARHGAP28;ARHGAP6;ARHGAP20;PLCE1;ARHGAP10;RHOJ;CGNL1;SOS2;ARHGEF11;ARHGAP17;TIAM2;ARHGAP21;SLIT2;ITSN1;ARHGAP23;ARHGEF18;RHOT1;FGD4;STARD13;ARHGAP12;ARHGEF12;ARHGAP32;FAM13B;PLEKHG2;BCR;ARHGEF6;VAV2;SYDE2;ARHGAP31
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.4051837862893527,-1.1578766302607555,0.24369747899159663,0.6626160749411061,1.0,8/16,23.57%,PDK1;PRKN;FOXK2;FOXK1;SIRT1;RORA;MLYCD;RORC
prerank,positive regulation of cell growth (GO:0030307),0.4055531888116854,1.1577037542372555,0.21302998965873837,0.6029852251859391,1.0,30/96,18.62%,H3-3A;AKT1;AKAP6;EIF4G2;SEMA7A;S100A8;S100A9;SYT1;LGI1;RIMS2;CXCL16;RIMS1;DDX49;MAPT;IL2;MFSD2A;NTN1;EXOSC2;SYT4;DNPH1;SHTN1;SDCBP;CPNE5;MMP14;SYT2;CPNE6;TRIM32;ADAM17;SFRP1;EXOSC9
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5244651270586773,1.1574943200284196,0.3040103492884864,0.6031040001195125,1.0,1/16,0.70%,VIM
prerank,regulation of chromatin organization (GO:1902275),-0.4203462468830275,-1.157465138420001,0.25475285171102663,0.6612873653032706,1.0,5/14,11.24%,MLLT3;SETD5;TLK2;TLK1;PARG
prerank,positive regulation of protein phosphorylation (GO:0001934),0.38914662676284645,1.1573300980978083,0.092,0.6031113198304972,1.0,94/348,20.42%,PPIA;CD74;RACK1;CALM1;VTN;CD81;HSP90AA1;C3;HSP90AB1;GPNMB;MT3;PARK7;MAPK3;AKT1;CCL19;TXN;PRNP;CALM3;TREM2;CCND2;ERBB4;IL5;AGT;PINK1;CSNK2B;GPER1;TNF;RAC1;PTPRC;PDGFB;ACVRL1;HCLS1;NTRK2;PIN1;MIF;FLOT1;KNDC1;APLNR;RARRES2;MUSK;TFRC;LEFTY2;CCND1;CLEC6A;ENPP2;PAK1;KDR;P2RY1;CAMK1;TMEM119;CSF1R;IL11;PECAM1;RAMP3;FLT4;HRAS;SH2D3C;SOX9;CLIP3;BMP2;NEK10;RIPK2;LEFTY1;SDCBP;GAS6;MMD2;CX3CR1;GDF15;LRP8;PDGFA;IGF2;RASGRP1;MAPRE3;LCP2;PFN2;CAV1;ADCYAP1;ADAM17;DDR2;CAMKK1;TERF2IP;AGAP2;CALM2;DDRGK1;ERP29;SNCA;INHBA;TGFB1;EFNA1;HGF;IL6;GDF11;THPO;CDK9
prerank,receptor recycling (GO:0001881),0.5727793205705296,1.1571855111871243,0.3118594436310395,0.6030698454772129,1.0,2/10,4.90%,NSG1;SORL1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.511793324894563,1.156900072662443,0.3062261753494282,0.6034019218596769,1.0,7/18,21.57%,MDK;CAMK1D;F2RL1;EDN3;ADAM17;IL6;PTN
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.5504201970431973,1.156787540688973,0.3226256983240223,0.6032607227642751,1.0,6/12,22.17%,CLTC;PF4;TMEFF2;TGFB1;SELENOS;AP2A1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4701162518245534,1.1567087194671044,0.28896882494004794,0.6030159393128268,1.0,7/27,19.64%,CD74;MIF;PTTG1IP;MSX1;PMAIP1;TWIST1;HIC1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.4124605871895121,-1.156706549324969,0.24553571428571427,0.6610549138299225,1.0,3/16,3.19%,SOX5;DHX36;HOXB4
prerank,positive regulation of protein catabolic process (GO:0045732),0.4084907443900231,1.155497247625696,0.24361702127659574,0.6058357948742814,1.0,18/84,17.31%,APOE;HSP90AA1;NDUFA13;OAZ1;TNF;SORL1;TNFAIP3;VCP;MSN;TNFSF12;PTTG1IP;DDB1;WNT5A;VPS28;EGLN2;SNX33;DAB2IP;TRIM32
prerank,vasculogenesis (GO:0001570),0.460356308786118,1.155302772195202,0.29337899543379,0.6059168333710218,1.0,10/32,19.83%,RAMP2;SOX18;RASIP1;APLNR;KDR;SOX17;EGFL7;CAV1;TGFB1;NOTCH1
prerank,sensory perception of pain (GO:0019233),0.4886277851999832,1.1550202676322618,0.3029197080291971,0.6062320202433849,1.0,7/21,21.14%,PRDM12;P2RX7;KCNA2;CHRNA4;CCL2;CCR2;SCN9A
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5593069382162954,1.1549807472258713,0.3081232492997199,0.6058929891970263,1.0,7/11,26.38%,LEPROT;VHL;CAV1;ADIPOR1;SOCS3;HGS;PTPRT
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.5027754550304311,1.154701028360591,0.3020833333333333,0.6061984587448661,1.0,6/18,20.73%,FTH1;DAB2IP;TRIM32;CD300A;SFRP1;MYC
prerank,negative regulation of cell growth (GO:0030308),0.4027540928644384,1.1545237177163756,0.2324159021406728,0.6062120028868017,1.0,40/121,22.36%,RACK1;MT3;NDUFA13;DCC;CCDC85B;ADAM15;ACVRL1;ENO1;RTN4;HSPA1B;PPP2R1A;HYAL2;BTG1;WFDC1;JADE1;MAP2;APBB1;MSX1;SOX17;DNAJB2;BST2;HSPA1A;GJA1;STK11;FGF13;DACT3;ING1;NDUFS3;SLIT3;CCAR2;SFRP1;SCGB3A1;INHBA;TGFB1;SPHK2;OSGIN1;RERG;MAG;CDA;CCN3
prerank,regulation of cholesterol transport (GO:0032374),0.5066542576183564,1.1544335718990686,0.30711610486891383,0.6059890988925702,1.0,6/20,15.69%,TSPO;APOC1;LIPG;OSBPL6;ABCA2;NR1H2
prerank,regulation of catabolic process (GO:0009894),0.5033096220002566,1.1542157328952747,0.29833546734955185,0.6061408292581019,1.0,9/18,26.73%,CHEK2;RARRES2;CHMP6;ODC1;FAM83D;HGS;ITGB1;ZDHHC2;SNF8
prerank,regulation of organelle assembly (GO:1902115),-0.2880153307498995,-1.1538232837261362,0.20270270270270271,0.6664408896041616,1.0,15/72,8.44%,ALMS1;DCDC2;CEP295;MTMR3;PDCD6IP;SENP6;TBC1D19;USP6NL;ATXN2;TBC1D12;STX18;TBC1D2B;RABGAP1;TBC1D9B;IFT88
prerank,inhibitory synapse assembly (GO:1904862),0.5625182252689358,1.153723277182695,0.31484049930651875,0.6070418250481571,1.0,5/11,16.56%,GABRA2;WNT5A;GABRB3;FGF13;GABRB2
prerank,striated muscle tissue development (GO:0014706),0.45962120179417193,1.1533497715192622,0.2853745541022592,0.6075499776484763,1.0,3/29,3.42%,MYL6;RBP4;SGCZ
prerank,regulation of interleukin-12 production (GO:0032655),0.4384906618899859,1.1532443256562468,0.27647714604236345,0.6073956215435653,1.0,10/47,14.84%,MDK;LAPTM5;CCL19;TIRAP;HSPD1;LILRA5;HMGB1;LILRB1;RIPK2;MAPK11
prerank,cellular lipid catabolic process (GO:0044242),0.4692494781181138,1.1531746308112638,0.3022432113341204,0.6071577669021945,1.0,12/27,32.34%,MT3;NUDT19;LIPG;ENPP2;PLBD2;FAAH;SIRT2;ABHD12;AOAH;PLBD1;ACOX1;CEL
prerank,dendritic spine organization (GO:0097061),0.47588846790826556,1.1530730265591207,0.26997578692493945,0.6070017961382127,1.0,8/26,18.37%,LGMN;PRNP;TREM2;PAK3;DOCK10;ARF1;EPHB1;CTNND2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.4943084317158272,1.1529946644799343,0.29699248120300753,0.6067688276091996,1.0,11/20,21.65%,TGM2;TMCO1;KCTD17;SELENOK;BAX;WFS1;HERPUD1;BCAP31;FIS1;BAK1;ATP2A2
prerank,sensory perception of sound (GO:0007605),0.4110634402091088,1.152987544490519,0.2278876170655567,0.6063478778745724,1.0,19/88,13.57%,COL1A1;TIMM8B;TIMM13;SOD1;HOMER2;LHFPL3;LHFPL4;PCDH15;MYO3A;SLC26A4;MYO7B;GRM7;NDUFB9;GRAP;TPRN;CRYM;WFS1;PAX3;PJVK
prerank,regulation of vasculogenesis (GO:2001212),0.5363463321898897,1.1524967120872607,0.31746031746031744,0.6071670094042316,1.0,5/14,16.05%,CD34;EMP2;KDR;RRAS;HEY1
prerank,response to fatty acid (GO:0070542),-0.38793326680781537,-1.1522105332538797,0.2511415525114155,0.6683702445765767,1.0,3/17,5.09%,PID1;IRS1;FOXO3
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.4411712852392697,1.1520730238080013,0.29021372328458944,0.6078880957010041,1.0,12/41,21.99%,CD34;POMC;SIRPA;TNFAIP3;SYT11;VSIR;MC1R;LILRB1;GAS6;PTPN6;SELENOS;LBP
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.35350452425679474,-1.151676217040345,0.25,0.6674412271260964,1.0,6/26,3.89%,ROCK2;ASAP3;ALMS1;SLC9A1;ROCK1;PRKN
prerank,protein N-linked glycosylation (GO:0006487),0.4184114654841354,1.1510422074878324,0.2532467532467532,0.6101997137003276,1.0,20/66,18.35%,OST4;KRTCAP2;TMEM258;RPN1;RPN2;DAD1;DDOST;LMAN1;PMM1;GAL3ST1;MGAT2;DPM3;MPDU1;MOGS;MCFD2;ASGR2;ALG3;DPM2;MAGT1;STT3A
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4540053533495647,1.150908193092525,0.28773584905660377,0.6101184487835948,1.0,4/33,7.84%,CALR;H3-3A;PARK7;PKN1
prerank,smooth muscle cell differentiation (GO:0051145),0.5553080842647953,1.1507992177277038,0.3204951856946355,0.6099448946206816,1.0,5/12,20.51%,MRTFA;APLNR;HEY1;TMEM204;MEF2C
prerank,ERBB2 signaling pathway (GO:0038128),0.46418260105362874,1.1502733879547116,0.2877526753864447,0.6109261988245774,1.0,11/31,21.01%,HSP90AA1;NRG1;ERBB4;MATK;PTK6;CDC37;PTPRR;ERBIN;ERBB3;SOS1;STUB1
prerank,regulation of centriole replication (GO:0046599),-0.3956872537541869,-1.1494205369188502,0.2409090909090909,0.6714526469829732,1.0,3/17,5.37%,ALMS1;CEP295;KAT2B
prerank,chondrocyte differentiation (GO:0002062),-0.3453909241634343,-1.1493574067184296,0.2037037037037037,0.6693041270849435,1.0,11/32,19.41%,SULF1;NFIB;SOX5;WNT5B;EIF2AK3;CREB3L2;BMP4;BMPR2;RUNX2;GPLD1;SULF2
prerank,RNA transport (GO:0050658),0.4173657636984623,1.148811611571871,0.26082251082251084,0.6144291519827307,1.0,23/71,22.27%,MAGOHB;MAGOH;DDX39B;ZFP36L1;FLOT1;SRSF9;YBX1;RTRAF;ZFP36;SRSF2;RBFOX1;HNRNPA1;THOC3;TST;EIF4A3;SLBP;KIF5C;U2AF1L4;RAE1;SRSF1;ALYREF;RFTN1;DHX38
prerank,transcription by RNA polymerase I (GO:0006360),0.44720767674944417,1.1483333142041736,0.28486293206197855,0.6152833053110601,1.0,15/34,27.62%,CAVIN1;POLR2E;MAPK3;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;CCNH;ERCC2;POLR1F
prerank,cardiac muscle contraction (GO:0060048),0.4569433606968369,1.1482524914316905,0.2789598108747045,0.6150389871960434,1.0,9/34,19.29%,GSN;SCN4B;GAA;TNNI1;KCNE5;SLC8A1;ATP1B1;RYR2;GRK2
prerank,regulation of osteoblast differentiation (GO:0045667),-0.2697282595042801,-1.147915611194427,0.1111111111111111,0.6708908910126339,1.0,27/82,16.55%,BMP6;RANBP3L;SMAD6;ACVR1;SMOC1;BMPR1A;CRIM1;SUFU;LRP5;SKI;YAP1;CDK6;IGF1;FGFR2;IL6R;PPARG;TRPM4;FERMT2;PTK2;ZHX3;PRKD1;BMP4;LIMD1;ACVR2A;WNT4;BMPR2;ACVR2B
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.4568476257372698,1.1478399769976522,0.28741092636579574,0.6157438633494388,1.0,7/31,15.74%,ROMO1;DNLZ;HSPD1;TOMM40L;TIMM50;TOMM20L;PEX6
prerank,sensory perception of mechanical stimulus (GO:0050954),0.41095266353495463,1.1476670446717863,0.22741433021806853,0.615778392816082,1.0,19/85,13.57%,COL1A1;TIMM8B;TIMM13;SOD1;HOMER2;LHFPL3;LHFPL4;PCDH15;MYO3A;SLC26A4;MYO7B;GRM7;NDUFB9;GRAP;TPRN;CRYM;WFS1;PAX3;PJVK
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.37732026325807233,-1.1474929167595547,0.28205128205128205,0.6696059679481925,1.0,9/20,19.01%,DICER1;DROSHA;ZC3H7A;ZC3H7B;TERT;PUM2;TARBP2;AGO2;AGO4
prerank,response to gamma radiation (GO:0010332),0.4851595825444877,1.1465518974249045,0.29606879606879605,0.6183941936355198,1.0,4/24,12.19%,RPL26;CRYAB;TMEM109;HRAS
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3119530691073435,-1.1464504137382532,0.23357664233576642,0.6701003318468118,1.0,11/39,15.24%,AFDN;EPHA7;FLOT2;DPP4;SMAD7;CDH1;PTK2;NF2;JAG1;MDGA1;SPINT2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.5437313021162112,1.1461972833920533,0.3108108108108108,0.6189120702256174,1.0,6/13,19.80%,MDK;ITGB2;TNF;RHOA;FUT9;IL6
prerank,nucleocytoplasmic transport (GO:0006913),0.44933234027684593,1.145597539542669,0.2958715596330275,0.6201664539656844,1.0,12/40,18.98%,SNRPG;GEMIN7;NPM1;SNRPD2;SNRPE;SNRPF;RBM15B;XPO1;SNRPB;HNRNPA1;ANP32A;SNRPD3
prerank,positive regulation of exocytosis (GO:0045921),0.444715542297028,1.1455199449587532,0.2829736211031175,0.6199196685293936,1.0,14/35,26.73%,ATP6AP1;RAB15;CLASP1;CADPS;ATP13A2;RAB3D;SDC4;SDCBP;VPS4A;SNCA;RAB27B;UNC13D;HGS;SNF8
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3458373173508399,-1.1447013216330921,0.22151898734177214,0.6725952682450763,1.0,14/26,32.15%,NSMCE2;ANAPC5;ANAPC7;NEK6;HECW2;CDC27;CENPE;ANAPC4;RIOK2;PLK1;UBE2C;RB1;CCNB1;CDC16
prerank,organic hydroxy compound transport (GO:0015850),0.438880550305859,1.144520142137752,0.29723502304147464,0.622256208252662,1.0,11/36,27.54%,NPC2;RBP4;SLCO1C1;SLC10A3;SLC16A1;SLC10A6;SLCO1B1;ABCC3;ABCG5;RALBP1;STRA6
prerank,cell projection organization (GO:0030030),0.46458018793163325,1.1444071862792573,0.28858218318695106,0.6221096701251094,1.0,12/30,17.97%,GSN;RAC1;NEFH;RHOG;ATP1B2;P2RY12;RHOV;CAPG;RHOU;PDGFA;RAC2;SCIN
prerank,blood circulation (GO:0008015),0.43497319394001305,1.1442134873155352,0.2639040348964013,0.6221855595134993,1.0,9/49,8.85%,GPX1;CXCL12;SOD1;SGCZ;CYB5R3;ACVRL1;SERPING1;CXCL10;PLN
prerank,negative regulation of reproductive process (GO:2000242),0.5079255300138497,1.144144811308874,0.3058064516129032,0.6219135909547759,1.0,5/17,13.64%,CALR;NPPC;ARHGDIB;TIMP1;GJA1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5400640603989492,1.1440783878757868,0.3242857142857143,0.6216517827517503,1.0,6/13,27.07%,UBE2G2;SVIP;BRSK2;BCAP31;OS9;UBE2J1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4324684981717527,-1.1438548950557552,0.2903225806451613,0.6725238238123304,1.0,6/13,10.33%,TNRC6B;TNRC6A;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,organophosphate catabolic process (GO:0046434),0.5495030085008252,1.1438402630013422,0.3215258855585831,0.621876359670918,1.0,3/11,14.15%,LIPG;ENPP2;PLBD2
prerank,regulation of trophoblast cell migration (GO:1901163),0.5173729288858149,1.143800402145552,0.3112033195020747,0.621531340106611,1.0,4/14,13.64%,CALR;ARHGDIB;TIMP1;GJA1
prerank,DNA biosynthetic process (GO:0071897),0.5152972461236154,1.1435801620628938,0.3278061224489796,0.6217104225030954,1.0,1/16,0.39%,PPIA
prerank,regulation of coagulation (GO:0050818),0.5569658990924891,1.143492575786049,0.33379310344827584,0.6215023910152108,1.0,5/11,20.37%,HS3ST5;PROCR;F2RL1;CAV1;FOXA2
prerank,protein secretion (GO:0009306),0.4191657265432091,1.1433811301621413,0.27502750275027504,0.6213426325911017,1.0,20/56,23.93%,PARK7;RCN3;PTPRN;CANX;OLFM2;RIMS2;RAB15;RAB3C;RAB3D;PPY;ARL4D;MAFA;TVP23A;ADCYAP1;PDIA4;PORCN;COPG1;SCG2;CAMK2G;MTTP
prerank,pore complex assembly (GO:0046931),-0.3915288856557604,-1.1433160235124737,0.28125,0.6716489613985638,1.0,6/19,11.15%,AFDN;ANO6;NUP98;PLEKHA7;AHCTF1;PDZD11
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.4947112249191793,1.1430409607369043,0.31865284974093266,0.6218098027754052,1.0,8/17,25.86%,NLGN1;RAB15;SYT4;RAB3D;SYT10;DOC2B;UNC13D;SLC4A8
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.4147384696772754,-1.1424382659232,0.28888888888888886,0.6717718024017756,1.0,7/14,23.23%,KMT5C;KMT5B;SHLD1;SHLD2;NECTIN2;HMCES;SHLD3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5545133089505665,1.1422298049038975,0.332378223495702,0.6234996461370279,1.0,5/11,20.78%,RAC1;PAK1;STMN1;HGF;SIRT2
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4017896270368104,-1.1421916659937923,0.25213675213675213,0.6700798793521379,1.0,4/15,11.86%,EGFR;FER;PTPN12;RBPJ
prerank,positive regulation of innate immune response (GO:0045089),0.46614433883276835,1.1418242407758081,0.2914691943127962,0.6241227903306399,1.0,4/30,10.49%,RPS19;SPI1;SLC15A4;WNT5A
prerank,cell-substrate junction assembly (GO:0007044),0.4540210424218818,1.1416015500727226,0.2980997624703088,0.624281226545448,1.0,9/33,12.23%,CD151;LAMC1;PLEC;FN1;DLC1;THY1;LAMC2;ARHGEF7;ACTN1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.37751833544244306,-1.1415418535944968,0.26976744186046514,0.6695350833134858,1.0,7/19,11.86%,TGFBR3;BMPR1A;VGLL4;TGFBR1;ZFPM2;FGFR2;RBPJ
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5238981078640756,1.1413487930234243,0.3046979865771812,0.6245558274854001,1.0,9/15,28.27%,ARL6IP1;RTN4;REEP2;LNPK;RAB18;TMEM33;RTN3;ZFYVE27;REEP1
prerank,regulation of cell migration (GO:0030334),0.38267756473222386,1.141155431882852,0.108,0.6246521128929219,1.0,99/382,20.44%,TMSB4X;ACTG1;CD74;TMSB10;RACK1;CLDN5;IFITM1;MDK;COL1A1;GRN;GPNMB;CD151;CXCL12;RHOB;HSPA5;AKT1;SERPINE2;ERBB4;CTNNA2;GPER1;ADAM15;RHOC;SEMA3F;IGFBP5;RAC1;PDGFB;ACVRL1;DNAI3;SEMA7A;SORL1;MIF;DUSP3;PRR5L;FLNA;SEMA4C;MYADM;FRMD5;DLC1;FAM107A;ADORA3;CORO1C;NAV3;CXCL16;SEMA6D;ENPP2;PAK1;SGK1;THY1;ROBO4;PODXL;KDR;VSIR;LGR6;LAMC2;EPPK1;SEMA4A;DOCK10;CSF1R;PECAM1;ELP3;AIF1;HRAS;RHOA;BST2;SRCIN1;BMP2;SEMA4G;CTSH;SDCBP;IGSF10;TIAM1;F2RL1;SLURP1;MMP14;PDGFA;CCL3;AMOT;CASS4;CAV1;PLAU;CDH5;TRIM32;PIK3CD;F10;FLT1;LMNA;ADAM17;SFRP1;MAZ;PPP3CA;STX4;DDRGK1;TMEFF2;TGFB1;HGF;NOTCH1;MAPK15;OSGIN1;CITED2
prerank,protein destabilization (GO:0031648),0.45477538553921415,1.1410454444384965,0.28983833718244806,0.6245158108924002,1.0,4/32,4.00%,SERF2;GSN;PRNP;NR1D1
prerank,response to interleukin-6 (GO:0070741),-0.4535704645180757,-1.1410262563222713,0.29225352112676056,0.6685627989312835,1.0,3/10,6.45%,PID1;PTGIS;NFKB1
prerank,negative regulation of DNA replication (GO:0008156),0.5273480441135139,1.1408415730372676,0.33102493074792244,0.6245843346640799,1.0,3/13,7.31%,S100A11;TERF1;GMNN
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4335307194523901,1.1404912197264285,0.30812641083521447,0.6250575872876984,1.0,12/43,21.99%,CD34;POMC;SIRPA;TNFAIP3;SYT11;VSIR;MC1R;LILRB1;GAS6;PTPN6;SELENOS;LBP
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5024430722943034,1.1398826596971465,0.3337612323491656,0.6262432858604842,1.0,4/18,3.62%,PARK7;AGT;RFK;TNF
prerank,cellular response to interleukin-6 (GO:0071354),-0.34525703479829606,-1.139422693224114,0.27167630057803466,0.6706012486972922,1.0,15/26,22.53%,PID1;FER;PTGIS;YAP1;NFKB1;STAT3;IL6R;SMAD4;ST3GAL6;JAK1;SBNO2;PTPN11;CBL;CTR9;SRC
prerank,negative regulation of gene expression (GO:0010629),0.3824790957128449,1.1393399348606092,0.139,0.6272651836546606,1.0,55/302,13.57%,APOE;MRPL13;RPS3;RPS13;RACK1;CLDN5;GAPDH;RPL13A;RPS26;CALR;H3-3A;GPNMB;PARK7;LGMN;CNPY2;TMBIM6;CD34;PINK1;SLC7A5;GPER1;TNF;IGFBP5;PDGFB;ACVRL1;SPI1;LSM6;NCL;ZFP36L2;MIF;HSPA1B;TLE5;SH3GL2;APLNR;MYADM;NCOR2;CREBZF;KDR;MAPT;YBX1;SYT11;GATA2;ZFP36;TARDBP;RNH1;LRP3;SRGN;PCIF1;ATP2B1;MSR1;HRAS;FBXW7;KLF4;SLC11A1;HSPA1A;BMP2
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.3253174969878919,-1.1390943845375336,0.2463768115942029,0.6692648185687117,1.0,9/34,14.46%,NSMCE2;LRP5;ANAPC5;INSR;ANAPC7;IGF1;PDGFRB;PHIP;CDC27
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.45580041179524083,1.1390513914886478,0.2948717948717949,0.6275886887708413,1.0,14/33,26.89%,AKT1;ZFP36L1;LTK;PIK3C2G;NYAP2;TYRO3;PIK3CD;ERBB3;SIRT2;NYAP1;C1QBP;PIK3R5;PLEKHA1;HTR2B
prerank,positive regulation of catalytic activity (GO:0043085),0.4438401041573453,1.1389387470711914,0.2967667436489607,0.6274825698740975,1.0,11/37,18.82%,MT3;SOD1;MAPK3;YWHAB;MID1IP1;PSENEN;B3GAT3;IGF2;CAV1;PSEN2;STX4
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.399675063572691,1.1386325011917653,0.22974358974358974,0.6278557131497005,1.0,31/122,19.82%,RPL26;RPS4X;RPL5;EEF2;VIM;AKT1;CCL19;EIF3D;NPM1;RPS27L;PDGFB;EIF3C;NAMPT;KDR;PCIF1;PCNA;ZCCHC4;PRMT1;KLF4;CCL2;ABCB10;IGF2;CIRBP;YTHDF1;EIF4A3;CTC1;EPM2AIP1;HGF;IL6;SLC25A37;TMEM106A
prerank,cellular response to amino acid starvation (GO:0034198),0.41072505729235026,1.1384554731206336,0.26765015806111697,0.6279084580890611,1.0,10/71,7.24%,ATP6V0C;MAPK3;ATF4;ATP6V1F;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;ATP6V0E2;CEBPB
prerank,proteasomal protein catabolic process (GO:0010498),0.3871795884073485,1.138328669050683,0.17251755265797392,0.6278119618320585,1.0,60/201,21.81%,PSMB4;UBXN1;PSME1;RCN3;PSMB6;PSMB8;PSME2;PSMD2;KCTD10;NR1D1;PSMD1;UCHL1;PSMC3;CTNNB1;PSMD6;VCP;PSMA7;CDC34;RNF187;KCTD2;FEM1C;NHLRC1;PRPF19;KCTD17;PSMD5;TRIM9;RBX1;TNFAIP1;TRIM2;DDB1;PSMB9;RBCK1;PSMD13;FBXW5;SYVN1;PSMB3;PMAIP1;ZSWIM8;PSMB11;FBXW7;PSMB10;SPSB3;KBTBD7;PSMB1;ARRB2;PSMB5;UBXN6;ENC1;BRSK2;PSMA6;TRIM13;KCTD13;RAD23A;HECW1;PSMA4;SIRT2;STUB1;IFI27;DDIT3;UBXN11
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5385992184434717,1.1379004060602331,0.3403068340306834,0.6285529529712037,1.0,2/12,2.26%,CALR;KLF2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4370621078842186,1.1378243597648172,0.3011111111111111,0.6283078683100702,1.0,15/45,23.87%,B2M;MT2A;FCGR1A;HCK;IRF8;IRF7;IFNGR1;VCAM1;NCAM1;OAS3;IFNGR2;IRF9;IRF5;TRIM68;CAMK2G
prerank,membrane depolarization (GO:0051899),0.4517629037920563,1.1376372714388214,0.3002336448598131,0.6283608302159117,1.0,15/32,29.44%,SCN1A;YWHAH;ATP5IF1;CACNA1A;P2RX7;CHRNA4;CAV1;SCN9A;CACNB4;CACNA1E;CACNG2;CACNA1B;SCN8A;SCN2A;SCN1B
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4384259142384679,1.137496375547687,0.30216647662485746,0.6282978745691282,1.0,11/39,21.90%,MBP;FXYD5;AKT1;MYADM;PODXL;KLF4;BMP2;AKNA;TGFB1;NOTCH1;PPM1F
prerank,response to exogenous dsRNA (GO:0043330),0.5026144619307015,1.1371309669382996,0.327720207253886,0.6288720351980469,1.0,7/18,22.21%,FLOT1;PQBP1;IFIT1;SLC3A2;CAV1;RALB;RFTN1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.40128478828370023,1.1370714668777728,0.27582644628099173,0.6285849786767,1.0,21/94,17.61%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;TUBA4A;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;TCTN3;DCTN1;SSNA1;HAUS2;DCTN2;CETN2;PRKAR2B;TCTN1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.46695252964321715,1.137065468364292,0.3202453987730061,0.6281560530471353,1.0,6/26,13.22%,EEF1A1;ZFP36L1;ZFP36L2;DUSP3;ZFP36;SOX9
prerank,positive regulation of cell adhesion (GO:0045785),0.4076253989610148,1.1364899231224563,0.2648305084745763,0.629236277155034,1.0,19/74,18.82%,MDK;CXCL12;TGM2;TNF;RAC1;PDGFB;FRMD5;ADGRG1;DUSP26;P4HB;P2RY12;MAGI1;FBLN2;ARL2;EPB41L4B;TMEM102;SYK;PPP3CA;STX4
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.336296314207857,-1.1361685237970633,0.24864864864864866,0.6750869527708137,1.0,7/26,7.11%,LGR4;APPL2;OTUD4;BIRC2;FLOT2;IRAK3;BIRC3
prerank,regulation of lymphocyte proliferation (GO:0050670),0.5088547023846639,1.1360800365484742,0.32219251336898397,0.6299324739810176,1.0,5/16,19.39%,LGALS3;CD22;IKZF3;SOX11;LST1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.38118036187288745,1.135840453138816,0.17369477911646586,0.6301471648528365,1.0,91/241,28.63%,HSPA8;PCBP1;SNRPG;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;HNRNPK;POLR2D;DDX39B;POLR2F;SYF2;RALY;SNRPD2;LSM6;LSM4;LSM8;UBL5;PUF60;SNRPE;SNRPA;SNRPF;ZMAT2;SRSF9;PQBP1;XAB2;HNRNPA0;CD2BP2;RBM15B;PRPF19;YBX1;PRPF8;POLR2G;SRSF2;SF3A2;PABPC1;RBM4B;SNW1;POLR2K;SF3B2;NONO;HNRNPU;SNRPB;HNRNPA1;CPSF2;SF3A3;PRPF31;PDCD7;EIF4A3;SF3B6;LSM7;TXNL4A;U2AF1L4;SNRPD3;SF3A1;SRSF1;ALYREF;HNRNPA3;SNRNP35;BUD31;DHX35;SNRNP200;CDC5L;HNRNPF;SNU13;CPSF4;POLR2H;HNRNPH2;DHX38;SNRPB2;PPWD1;PCBP2;ELAVL1;LSM5;METTL3;METTL14;PRPF40B;PPIE;DNAJC8;HNRNPC;SART1;SYMPK;USP39;WBP4;CHERP;LSM2;DHX15;PHF5A;DHX9;SNRPN
prerank,histone deubiquitination (GO:0016578),-0.3837414738383265,-1.1353962818181658,0.3088235294117647,0.6748612085699834,1.0,5/18,8.91%,USP3;USP49;UIMC1;USP16;USP36
prerank,regulation of developmental growth (GO:0048638),0.46214634133149085,1.135315818590222,0.29794933655006034,0.6311548191563665,1.0,6/29,9.99%,APOE;SOD1;MUSK;NRCAM;MFSD2A;EPPK1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.40651467142655096,-1.1352275277118857,0.27510917030567683,0.6731226532038032,1.0,6/16,8.31%,ROCK2;SLC9A1;ROCK1;CAMK2D;MEF2A;IGF1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.39837193662183834,1.1349841562315774,0.26068821689259647,0.631621225166344,1.0,22/92,14.70%,SPARC;GRN;CALR;RHOB;AKT1;AGT;RAC1;RTN4;EMC10;PFN1;ENPP2;PROX1;CLASP1;KDR;ARF6;WNT5A;PDCD6;AAMP;FLT4;SOX9;CTSH;RRAS
prerank,pentose-phosphate shunt (GO:0006098),0.540923275606379,1.134737936375393,0.32821229050279327,0.6318778699774763,1.0,5/11,17.87%,TALDO1;PGLS;RPIA;PGD;TKT
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.2811879039977785,-1.1343951780072732,0.20253164556962025,0.6730671577124255,1.0,11/61,10.34%,AUTS2;AKAP13;NOTCH2;ROBO1;LPAR1;SHOC2;RAPGEF1;IGF1;ALS2;NGF;MAP4K4
prerank,negative regulation of transport (GO:0051051),0.4295986213406311,1.1342172562151926,0.2869757174392936,0.6327964265380178,1.0,15/51,21.90%,RACK1;NRG1;CRYAB;LGALS3;SIRPA;SYT11;RSC1A1;BST2;LILRB1;NR1H2;SNX33;ERBB3;SNCA;TRAT1;PPM1F
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.5164017774296501,1.1341263586522274,0.3403416557161629,0.6321549060476369,1.0,3/14,19.38%,HMOX1;BLVRA;SLCO1B1
prerank,heme catabolic process (GO:0042167),0.5164017774296501,1.1341263586522274,0.3403416557161629,0.6321549060476369,1.0,3/14,19.38%,HMOX1;BLVRA;SLCO1B1
prerank,presynaptic endocytosis (GO:0140238),0.47108427594907787,1.1340168297296969,0.29024390243902437,0.6320124355816045,1.0,9/24,19.16%,NLGN1;CANX;PACSIN1;SYT1;AMPH;VAMP2;CDK5;SYT2;SNCA
prerank,chloride transmembrane transport (GO:1902476),0.42310283921377584,1.1334836327520565,0.30192962542565266,0.6330118123292083,1.0,13/48,19.42%,GABRB1;LRRC8A;GABRG3;GABRA2;SLC12A5;GLRA2;GABRA3;GABRB3;GLRA1;SLC1A1;GABRB2;ANO4;GLRA3
prerank,regulation of chromosome organization (GO:0033044),-0.3636935300053906,-1.1334779206461818,0.23711340206185566,0.673264001403289,1.0,6/22,11.49%,SMG6;SMG1;HDAC8;WAPL;YLPM1;TERF2
prerank,negative regulation of cell population proliferation (GO:0008285),0.3806426662097581,1.1331342244966796,0.14,0.6334597147051171,1.0,101/351,23.15%,FTH1;IGFBP6;B2M;APOD;IFITM1;GPNMB;HMOX1;S100A11;TREM2;NME1;ERBB4;RBP4;NPM1;IGFBP3;CSNK2B;GPER1;MAGED1;IGFBP5;ACVRL1;ANG;NDRG4;HSPA1B;CTNNB1;ST18;TNFAIP3;HES1;SFRP5;BTG1;CDKN1C;DLC1;ADORA3;SSTR4;ADGRG1;ATP8A2;NELL1;PAK1;CEBPA;PROX1;NUPR1;TNN;CGREF1;GATA2;EPPK1;ZBTB49;ADGRB1;WNT5A;THAP12;CTBP1;WARS1;ATF5;ATRAID;AIF1;HRAS;DNAJB2;CAMK2N1;SFRP4;KLF4;SOX9;HSPA1A;DDAH1;BMP2;STK11;COPS8;SLURP1;DLL1;DAB2IP;ADRA1A;VHL;PDCD5;PTGIR;TRIM32;ADAMTS1;LMNA;CD300A;SCIN;SFRP1;FABP7;BTG4;SOX11;INHBA;PTPN6;TGFB1;TFAP2B;ING5;IL6;NOTCH1;KLF11;MYC;SIRT2;RERG;TFAP4;SST;PTPRU;SSTR2;REST;MEN1;CCN3;TMEM127;CDK10;CD164;CDKN2B
prerank,negative regulation of protein phosphorylation (GO:0001933),0.389683204458002,1.1331314560897043,0.2288306451612903,0.6330224678074707,1.0,45/150,19.62%,PPIA;RACK1;CALM1;HSPB1;PARK7;AKT1;FKBP8;PRNP;CALM3;IGFBP3;PPP1R15B;CAMK2N2;PTPRC;SIRPA;PRR5L;SH3GL2;MYADM;DBNDD2;CORO1C;THY1;YWHAG;MLXIPL;CADM4;RTRAF;TARDBP;WARS1;CAMK2N1;CNKSR3;NLRP2B;INPP5J;DMTN;DAB2IP;TWIST1;CAV1;PRKRIP1;TERF2IP;SFRP1;CALM2;AKT1S1;DNAJC10;TAB1;QARS1;SNCA;PTPN6;TGFB1
prerank,L-glutamate transmembrane transport (GO:0015813),0.5605108925227933,1.1327912487046805,0.3309659090909091,0.6334927661383409,1.0,5/10,19.26%,SLC1A2;SLC25A13;SLC25A22;SLC1A1;SLC25A18
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5241698489568931,1.1326393794088294,0.33964817320703655,0.6334493560658302,1.0,7/14,20.79%,PARK7;TMBIM6;CREB3;SYVN1;HSPA1A;HERPUD1;SELENOS
prerank,rRNA 3'-end processing (GO:0031125),0.5535742925411735,1.1321980799131974,0.3376251788268956,0.6341993974975021,1.0,2/10,9.98%,RPS21;EXOSC2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.43868990773371286,1.1316107220486926,0.29911699779249445,0.6353471782844973,1.0,21/48,32.46%,PDE4B;SLC7A5;ISG15;HSPD1;SLC11A1;LILRB1;F2RL1;RASGRP1;CD14;CCR2;PYCARD;CD276;IL12RB1;TLR7;CEBPG;IL12RB2;ZFPM1;FZD5;TXK;TRIM27;CYRIB
prerank,sterol transport (GO:0015918),0.4863045609600888,1.1315925845379826,0.33877038895859474,0.6349540427585872,1.0,5/19,25.77%,NPC2;MSR1;CAV1;NPC1;ABCG5
prerank,negative regulation of response to stimulus (GO:0048585),0.4135496517389896,1.1315742998515674,0.29988974641675853,0.6345540297729099,1.0,20/60,20.37%,CLU;CD34;IGFBP3;TLE5;COL3A1;PTK6;THY1;YBX1;KIF26A;WFS1;FBXO5;KLF4;DDAH1;NR1H2;TWIST1;PIM3;SRMS;ERBB3;BRAP;FOXA2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.5525061407427461,1.1315303181062892,0.3292349726775956,0.634246304615404,1.0,3/11,20.46%,TREM2;CCL3;TRAT1
prerank,hyaluronan catabolic process (GO:0030214),0.5044374497723514,1.1315224617408237,0.3,0.6338210523446477,1.0,4/18,8.47%,HEXB;HEXA;HYAL2;GUSB
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.40962484598005056,1.131327042577824,0.28450106157112526,0.6339365853328329,1.0,22/72,19.83%,TREM2;AGT;GPER1;TNF;PDGFB;HCLS1;NTRK2;FN1;EPOR;DCN;KDR;SOX9;F2RL1;PDGFA;NCF1;PIK3CD;FLT1;ERBB3;MAZ;PTPN6;HGF;FLT3
prerank,positive regulation of TOR signaling (GO:0032008),0.43209243753872467,1.131002207787534,0.3035509736540664,0.634361580273805,1.0,12/40,16.43%,TREM2;LAMTOR2;LAMTOR4;LAMTOR5;GPR137B;PIP4P1;PIH1D1;GPR137C;LAMTOR3;GAS6;RRAGC;RRAGD
prerank,ether lipid biosynthetic process (GO:0008611),-0.45864135086599933,-1.1308038779803669,0.2956810631229236,0.678073852834104,1.0,4/10,16.13%,PLA2G4A;FAR1;PEX7;PLA2G4C
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4126680545684446,1.1305410849933173,0.2956989247311828,0.6351835072490294,1.0,20/70,27.18%,DBI;CHKB;CSNK2B;PLAAT3;ENPP2;MFSD2A;PLA2G7;PLA2G4F;CHAT;NR1H2;ACHE;SLC44A5;STARD10;LPCAT2;SLC44A2;PLA2G3;ABCA3;SLC44A1;MBOAT7;PLA2G6
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.32400333565002104,-1.1305336119842335,0.225,0.6765343713477502,1.0,9/31,11.86%,TGFBR3;BMPR1A;TGFBR1;ZFPM2;FGFR2;SMAD7;SMAD4;TPM1;RBPJ
prerank,T cell activation (GO:0042110),0.4136396015655512,1.1305118476292766,0.28299894403379094,0.6348165899757147,1.0,11/69,9.92%,CD74;MDK;CCL19;PTPRC;FKBP1A;DDOST;MSN;HSPD1;LCP1;IL2;ICOSLG
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5179628454969616,1.130508368924317,0.32309746328437916,0.6343809964598932,1.0,6/15,28.23%,YWHAE;KCNN2;ATP1A1;ATP1B1;KCNJ3;KCNQ1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3981412783826999,1.1301117355577492,0.27637130801687765,0.6349662735183864,1.0,28/85,21.59%,CLU;RACK1;GABARAP;ELOB;TREM2;HSPA1B;PSMC3;VCP;USP5;CEBPA;NUPR1;RBX1;ECSCR;SUMO2;DNAJB2;FBXW7;HSPA1A;RNFT1;HSPBP1;DAB2IP;NOP53;DDRGK1;RNF144B;RAD23A;TMEM259;SIRT2;STUB1;USP13
prerank,cellular response to glucose starvation (GO:0042149),-0.302766604425242,-1.1300802175797262,0.216,0.675481613425801,1.0,12/41,15.79%,PRKAG2;SIK2;MTMR3;FOXO3;EIF2AK3;PRKAA2;SIK1;SESN1;NUAK1;PRKAG1;ITFG2;TP53
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4424034800040552,1.130050473923401,0.30751445086705204,0.6346740518141782,1.0,5/36,5.21%,PPIA;TREM2;PINK1;SIRPA;DUSP3
prerank,purine nucleotide metabolic process (GO:0006163),0.4704117889109412,1.1297100864189675,0.3148831488314883,0.635152409838887,1.0,11/24,24.95%,GPX1;GART;DNPH1;PNP;PRPS1L1;PRPS1;GUK1;NT5C;GDA;PRPSAP1;ADSL
prerank,regulation of autophagy (GO:0010506),0.380654056217065,1.129506925073227,0.20402010050251257,0.6352315534979812,1.0,42/216,15.60%,EEF1A1;PSAP;GFAP;GAPDH;ATP6V0C;HSPB1;CAPNS1;MT3;AKT1;TREM2;EIF4G2;PINK1;LAMTOR2;LAMTOR4;RASIP1;LAMTOR5;TMEM59;ORMDL3;ATP6V1G1;UCHL1;ATP6V0E2;EEF1A2;DEPP1;DCN;MAPT;NUPR1;GPR137B;CDK5R1;ATP13A2;HMGB1;MTMR9;ATP6V0D2;CTSA;SVIP;FBXW7;LAMTOR3;UBQLN2;STK11;RRAGC;ATG101;BAD;CDK5
prerank,intracellular cholesterol transport (GO:0032367),0.5112823538600946,1.1291534235988037,0.34210526315789475,0.6357262702844765,1.0,4/15,9.50%,NPC2;ABCG1;TSPO2;STARD4
prerank,ncRNA transcription (GO:0098781),0.5243330190754698,1.1289506928981692,0.33245033112582784,0.6358136048980654,1.0,2/13,4.47%,CAVIN1;ANG
prerank,cyclooxygenase pathway (GO:0019371),0.5565643858726961,1.1288374176095002,0.3426183844011142,0.6356768873276655,1.0,5/10,22.93%,PTGDS;HPGDS;PTGES3;CBR1;TBXAS1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5546906460581865,1.1284999146704575,0.3455056179775281,0.6361088199322201,1.0,6/10,32.98%,MID1IP1;MLXIPL;NR1H2;ABCD2;NR1H3;ELOVL5
prerank,regulation of secretion by cell (GO:1903530),0.4162041030183824,1.1284877982267736,0.29295154185022027,0.6357004014208774,1.0,23/54,27.88%,SYT1;RIMS2;RAB15;RIMS1;RAB3C;VAMP3;SCG5;VAMP2;STXBP5L;RAB3D;HAP1;VAMP8;SYN1;HCRT;RAB26;STX4;MEF2C;LLGL1;ARFIP1;KCNMB4;RAB8A;LGI3;CPLX1
prerank,regulation of protein kinase B signaling (GO:0051896),0.3828330962931783,1.1278244348210265,0.21263791374122368,0.6370529528466466,1.0,68/193,25.91%,RACK1;HSP90AA1;HSP90AB1;PARK7;AKT1;CCL19;RCN3;TXN;NRG1;ERBB4;PINK1;GPER1;TNF;RAC1;PDGFB;HCLS1;NTRK2;RTN4;SFRP5;HYAL2;RHOG;P2RY12;MC1R;KITLG;PDCD6;RAMP3;PHLPP1;VAV1;GAS6;CX3CR1;RRAS;HPSE;GDF15;PDGFA;IGF2;ARRB2;CCL3;GATA4;CASS4;PIK3CD;F10;RAC2;ERBB3;MAZ;KLB;NOP53;TGFB1;CD86;HGF;FLT3;THEM4;THPO;TRAT1;DDIT3;BANK1;TGFA;MYDGF;PHLDA3;C1QBP;CD28;PIK3R5;PLEKHA1;TEK;MFHAS1;FGF22;CX3CL1;FGFR3;ITGB1
prerank,peptide metabolic process (GO:0006518),0.4054639178656343,1.1269965047177117,0.2822410147991543,0.6388656096219878,1.0,19/75,18.55%,GPX1;SOD1;GSTM1;CPXM1;CPD;CPE;SPCS1;GSTM5;AEBP1;GSTM2;CPXM2;CLN5;HPGDS;SPCS2;DNPEP;GLRX2;BACE1;PSEN2;SEC11C
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.2967353766578551,-1.1268094998411644,0.25882352941176473,0.681911256251165,1.0,16/53,14.31%,EYA2;EGFR;EYA1;BABAM2;PLA2R1;UIMC1;EYA4;RNF8;FBH1;FXR2;EYA3;ATM;ERCC8;SIRT1;BCLAF1;SMCHD1
prerank,import into cell (GO:0098657),0.4349124017760033,1.1265629481710677,0.2992036405005688,0.6395946026369376,1.0,10/41,15.07%,TREM2;SNAP25;LRRC8A;SLC7A5;GLUL;TSPO2;SLC6A6;SLC29A1;SLC19A1;SLC29A2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.4266741993460687,-1.1264932269531047,0.3111888111888112,0.6805370990584831,1.0,5/12,18.29%,NIN;NINL;PCM1;CCDC120;CEP19
prerank,positive regulation of developmental process (GO:0051094),0.38558035194912355,1.1264123697915844,0.23766364551863042,0.6395716848938845,1.0,40/164,17.55%,APOE;MDK;HSP90AB1;CFL1;NRXN1;NLGN1;PINK1;TNF;PDGFB;PACSIN1;RTN4;SORL1;TFRC;OTX2;CORO1C;CEBPB;ENPP2;DCN;SLC6A6;BASP1;CLASP1;KDR;CCN2;CAMK1;ARHGEF7;WNT5A;TMEM119;SOX8;FBXO5;SOX9;BMP2;GJA1;MIEF2;MFF;LRP8;EDN3;DAB2IP;VHL;DNM1L;LMNA
prerank,cellular component maintenance (GO:0043954),0.5338055291503712,1.1263914481381818,0.33469945355191255,0.639186905938025,1.0,2/12,2.59%,PRNP;TREM2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4711634194958898,1.1263263452303653,0.3337515683814304,0.6389236458326422,1.0,9/22,30.18%,RPS21;EXOSC2;EXOSC9;FTSJ3;ERI1;NOP14;PES1;NOL9;URB1
prerank,aortic valve development (GO:0003176),-0.3232194630385018,-1.1263163230680548,0.27611940298507465,0.678810435200229,1.0,6/34,4.70%,ROCK2;SMAD6;ROBO1;ROCK1;SLIT2;NFATC1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.44427540715365677,1.1262258195633978,0.3200962695547533,0.6387557459120549,1.0,14/30,27.62%,CAVIN1;POLR2E;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;CCNH;ERCC2;POLR1F
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5307470920995726,1.1260207049717794,0.3475177304964539,0.6388682322816538,1.0,6/12,22.30%,ZFP36L2;HES1;HNRNPU;ESRRB;NOTCH1;REST
prerank,carnitine metabolic process (GO:0009437),-0.4273123841400489,-1.126006557156552,0.2899628252788104,0.6775874774393594,1.0,8/12,28.84%,TMLHE;CPT1C;CPT2;ACADM;SHMT1;BBOX1;ALDH9A1;CPT1A
prerank,response to chemokine (GO:1990868),0.5141534018324484,1.1256963028970504,0.33655172413793105,0.6393209011545692,1.0,5/13,26.60%,CXCL12;RHOA;DOCK8;DUSP1;OXSR1
prerank,intracellular pH reduction (GO:0051452),0.4388053836782126,1.1248846241609,0.2998833138856476,0.6411128141432985,1.0,10/33,24.08%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;ATP6V0D2;SLC11A1;RAB20;ATP6V1A;ATP6V0A1;ATP6V0B
prerank,rRNA modification (GO:0000154),0.48944466376263657,1.1246729209162762,0.3316645807259074,0.6412201474015939,1.0,9/21,24.85%,TRMT112;NOP10;FBL;NHP2;ZCCHC4;GAR1;DKC1;FTSJ3;THUMPD1
prerank,mitochondrial membrane organization (GO:0007006),0.4456423559303687,1.124630234661997,0.3113207547169811,0.6408923572918236,1.0,11/32,21.18%,SLC25A5;MICOS13;SLC25A4;GHITM;PMAIP1;TIMM50;SPG7;BAD;APOO;BAK1;HSPA9
prerank,regulation of protein kinase A signaling (GO:0010738),0.4843104840893355,1.124271888634859,0.3125,0.6414032787892182,1.0,6/20,11.56%,AKAP6;MIF;PRKAR1A;MC1R;PRKAR1B;RAMP3
prerank,autonomic nervous system development (GO:0048483),0.5051655969257912,1.123871295215369,0.3268983268983269,0.642039785788749,1.0,7/17,21.53%,FN1;KIF26A;PHOX2A;SOX8;SOX11;TFAP2B;SOX10
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5247081378219824,1.123789680924049,0.34579439252336447,0.6418277318494312,1.0,2/13,1.76%,APOD;PARK7
prerank,regulation of dephosphorylation (GO:0035303),-0.40350521875033246,-1.1235165050836582,0.29831932773109243,0.6819197539795763,1.0,4/15,11.86%,SMG6;MTMR3;SMG7;PPP1R16A
prerank,actin crosslink formation (GO:0051764),-0.4292733318399367,-1.1230812366131389,0.3,0.6809393743532537,1.0,4/12,4.63%,DPYSL3;BAIAP2L1;BAIAP2;EPS8
prerank,regulation of multicellular organismal development (GO:2000026),-0.36034301017110937,-1.1226739966158816,0.2751322751322751,0.6799616184973135,1.0,7/25,8.81%,TRIP12;DHX36;NIPBL;EHMT1;MYSM1;INSR;TDG
prerank,peptide catabolic process (GO:0043171),-0.3508244094133166,-1.1224504917151779,0.2647058823529412,0.6783840404062862,1.0,3/23,6.22%,CPQ;NPEPPS;ANPEP
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3842631182435291,1.1223235798143212,0.26509723643807576,0.645357673852158,1.0,44/136,27.04%,TMSB4X;ID3;PRNP;ID1;SPI1;FLNA;TNFAIP3;HES1;SFRP5;ADORA3;HES6;OTULIN;PROX1;NUPR1;RBCK1;WFS1;SFRP4;KLF4;NLRP2B;ERBIN;FOXS1;GAS6;TRAF3;ARRB2;SIGIRR;DAB2IP;TCEAL7;GLIS2;COMMD7;NLRP3;FOXA2;NFKBIA;PYCARD;ID2;DDIT3;MEN1;RNF2;PAXIP1;TRIB1;TRIM37;PIM1;PSMD10;CHP1;CEBPG
prerank,response to purine-containing compound (GO:0014074),0.4926719218278991,1.1215881443600442,0.3536269430051813,0.6468921565469162,1.0,5/17,16.06%,P2RX7;P2RY6;P2RY1;TRPM2;RYR2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.49272924509679017,1.12145946180417,0.34017971758664955,0.6467860315689351,1.0,8/16,18.67%,CALM1;CALM3;GSTO1;GSTM2;SLC8A1;RYR2;FKBP1B;CALM2
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.374368558218118,-1.1213793531473326,0.28378378378378377,0.6790955169299508,1.0,6/20,16.06%,CLK2;NCOR1;SIK1;C1QTNF3;CRY1;WNT4
prerank,protein depolymerization (GO:0051261),0.4472863078790791,1.1211521271775076,0.3321256038647343,0.6471669902936906,1.0,7/27,14.18%,GSN;CFL1;STMN3;STMN4;MICAL1;DSTN;STMN1
prerank,regulation of protein localization to nucleus (GO:1900180),0.428994380004307,1.1210754206019338,0.31053811659192826,0.6469337382217092,1.0,9/43,11.13%,PARK7;AKT1;LAMTOR5;ORMDL3;PIN1;TFRC;GLUL;ATP13A2;SUMO3
prerank,positive regulation of DNA binding (GO:0043388),0.4528279050799949,1.120955483292384,0.331002331002331,0.6468231948682923,1.0,11/31,20.78%,PARK7;TXN;NME1;HES1;EDF1;HMGB1;H1-0;TWIST1;TGFB1;POU4F1;SIRT2
prerank,positive regulation of DNA recombination (GO:0045911),-0.33993350241867504,-1.1208924587474611,0.27319587628865977,0.678150908924029,1.0,12/27,19.45%,ARID2;KMT5C;KMT5B;SHLD1;MMS19;MRNIP;FUS;FANCB;PRDM9;SHLD2;ZCWPW1;HMCES
prerank,histone H4-K8 acetylation (GO:0043982),-0.41054385714664926,-1.1206143030487696,0.2975206611570248,0.674541569872608,1.0,5/15,17.90%,OGT;KAT7;KANSL3;JADE2;KAT8
prerank,histone H4-K5 acetylation (GO:0043981),-0.41054385714664926,-1.1206143030487696,0.2975206611570248,0.674541569872608,1.0,5/15,17.90%,OGT;KAT7;KANSL3;JADE2;KAT8
prerank,positive regulation of collagen metabolic process (GO:0010714),0.5012529338122269,1.118977738898919,0.3393085787451985,0.6517195898255695,1.0,2/17,8.99%,VIM;VSIR
prerank,lymphocyte proliferation (GO:0046651),0.47560462062314646,1.1186181604115242,0.3366093366093366,0.6522486280407442,1.0,6/22,20.51%,PTPRC;MSN;HSPD1;RASGRP1;FLT3;MEF2C
prerank,sodium ion export across plasma membrane (GO:0036376),0.5237271137575302,1.1186032285465084,0.32833787465940056,0.6518543057723052,1.0,6/13,18.56%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;ATP1B3
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5408435021553393,1.1185797601669143,0.3604336043360434,0.6514782356240424,1.0,3/12,13.29%,MAPK3;CSF1R;BST2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.528360684504328,1.1184800347041282,0.3462566844919786,0.6513184316264944,1.0,3/12,17.71%,TSPO;FDX2;STARD3NL
prerank,icosanoid biosynthetic process (GO:0046456),0.5534631408612357,1.118268644667596,0.3653566229985444,0.6514596515630112,1.0,4/10,17.18%,FADS1;MGST3;ALOX5AP;LTC4S
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5165388316215945,1.1180510543347704,0.347949080622348,0.6515993709654859,1.0,8/13,28.08%,CADM4;PDCD6;DAB2IP;PTPN1;CNMD;HGS;HHEX;MMRN2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.40363767968413633,1.1180216361491166,0.28827877507919747,0.6512434675213572,1.0,21/75,18.54%,SPARC;CLDN5;SERPINF1;CTNNB1;PDE3B;PGK1;VASH1;DCN;CXCL10;SARS1;ADGRB1;ECSCR;STAB1;KLF4;PF4;DAB2IP;AMOT;ADAMTS1;AGO1;HSPG2;CCR2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.47697452852775,1.1177483937867,0.34394904458598724,0.6515283387856221,1.0,6/22,19.60%,LGMN;VKORC1;RBP1;GC;LRAT;CBR1
prerank,mRNA stabilization (GO:0048255),0.43176095833638317,1.1176235150481002,0.31839080459770114,0.651439627020662,1.0,12/40,17.50%,TIRAP;HNRNPA0;YBX1;ZFP36;TARDBP;PABPC1;ELAVL4;SLC11A1;HNRNPU;YBX3;CIRBP;EIF4ENIF1
prerank,long-chain fatty acid transport (GO:0015909),0.45308783424564797,1.1173504570060924,0.3157262905162065,0.6517011223285066,1.0,4/30,9.00%,APOE;MID1IP1;FABP5;MFSD2A
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4333855471053076,1.1171980620370454,0.32429378531073444,0.6516613668583704,1.0,17/42,25.58%,EMP2;RAC1;PDGFB;SPOCK1;MYADM;CORO1C;THY1;RHOA;FBLN2;ARL2;DMTN;RAC2;NOTCH1;PTPRO;PPM1F;TBCD;CX3CL1
prerank,negative regulation of phosphorylation (GO:0042326),0.39942459149909826,1.11682047513933,0.2900523560209424,0.6522191441984148,1.0,18/85,11.37%,PPIA;PARK7;DYNLL1;FKBP8;PRNP;IGFBP3;PPP1R15B;SIRPA;PRR5L;SH3GL2;MYADM;CDKN1C;CORO1C;MAPT;NUPR1;CADM4;TARDBP;WARS1
prerank,covalent chromatin modification (GO:0016569),0.5153954281450552,1.1166306535893957,0.3333333333333333,0.6522996828886071,1.0,2/14,1.76%,MT3;PARK7
prerank,retinoid metabolic process (GO:0001523),0.4034175128447149,1.1165554988107416,0.30319148936170215,0.65206809572102,1.0,17/71,20.32%,APOE;RBP4;RARRES2;TTR;RDH5;RBP1;LPL;SDC4;GPC5;AKR1B10;DHRS13;LRP8;LRAT;HSPG2;BCO2;SDC3;AGRN
prerank,positive regulation of viral process (GO:0048524),0.4054504010026968,1.1161723752544084,0.3067685589519651,0.6526713459313149,1.0,20/60,24.21%,PPIA;POLR2E;POLR2D;POLR2F;IFIT1;NELFCD;DDB1;POLR2G;SUPT4H1;PABPC1;POLR2K;PDE12;TYRO3;NELFE;VPS4A;RAD23A;CDK9;POLR2H;VAPB;CD28
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.44391891953298823,1.1161677999250625,0.32479627473806755,0.6522433630586743,1.0,5/31,12.96%,SCP2;PYCR2;GPHN;LSS;HSD3B2
prerank,negative regulation of T cell differentiation (GO:0045581),0.5488574987627612,1.1160783304009312,0.359612724757953,0.6520252809794016,1.0,3/10,14.33%,MDK;CTLA4;ZC3H8
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3749835173781896,1.11575827865723,0.178,0.6524246573125144,1.0,72/308,19.80%,APOE;RPS19;GAPDH;MDK;COL1A1;PPIB;CFL1;SOD1;GATM;NLGN1;TREM2;AGT;S100A13;NFAM1;UCP2;TNF;PDGFB;ENO1;FABP5;EPAS1;RTN4;SORL1;MIF;FLOT1;BSCL2;CTNNB1;LRPAP1;TFRC;OMA1;OTX2;CEBPB;CLEC6A;IL2;CRH;WNT5A;TMEM119;SCD;HAP1;LCN2;KDM6B;MFAP2;VAMP8;SOX8;HCRT;THRA;FBXO5;SLC11A1;CXCR4;SOX9;NME2;BMP2;GJA1;SDCBP;GAS6;TIAM1;F2RL1;BAD;ACHE;ADRA1A;ADRA1D;TWIST1;CAV1;PIK3CD;ADCYAP1;PPARGC1A;SYK;CCR2;SOX11;INHBA;TGFB1;ESRRB;IL6
prerank,response to ionizing radiation (GO:0010212),-0.2739893520297149,-1.1156506581696122,0.20689655172413793,0.6855975743753379,1.0,22/70,17.75%,EYA1;BABAM2;DCUN1D3;COP1;CLK2;BRAT1;SPIDR;UIMC1;RNF8;NHEJ1;INO80;MRNIP;EYA3;ATM;USP28;TNKS1BP1;SIRT1;KDM4D;TP53;INIP;MAPK14;INTS3
prerank,oxoacid metabolic process (GO:0043436),0.4624938337018104,1.1154453610419786,0.34688995215311,0.652790389097924,1.0,5/27,9.05%,AGXT;MIF;SULT4A1;BPNT2;GRHPR
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.511884945913537,1.115334378196176,0.3307291666666667,0.6526307689030285,1.0,1/16,1.02%,LAMP1
prerank,response to amino acid starvation (GO:1990928),0.40176732129899617,1.1149091947192915,0.30809674027339645,0.653331068816455,1.0,10/72,7.24%,ATP6V0C;MAPK3;ATF4;ATP6V1F;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;ATP6V0E2;CEBPB
prerank,positive regulation of GTPase activity (GO:0043547),-0.24734016699234979,-1.114853725879877,0.0,0.6855311433575031,1.0,52/188,15.43%,ARHGAP29;AFDN;SIPA1L1;DOCK11;ASAP3;RSU1;BCAS3;ARHGAP42;RAPGEF2;TIAM2;SGSM2;USP6NL;TBC1D12;NTRK3;RALGAPB;LIMS1;DOCK7;RAPGEF6;SIPA1L3;TBC1D2B;CCL25;RABGAP1;RAPGEF1;TBC1D9B;BCR;TBC1D4;PKP4;SYDE2;BCAR3;PICALM;PIP5K1A;ALS2;SNX9;RAPGEF3;MAP4K4;TBCK;FERMT2;TBC1D8B;RALGAPA1;SIPA1;RIC1;DVL3;WNT11;TSC1;RAP1GDS1;GSK3B;NGEF;LARS1;RGS16;EZH2;GMIP;NDEL1
prerank,cellular component assembly (GO:0022607),0.3744945551964112,1.1147843128731967,0.20904522613065327,0.6532283170294239,1.0,64/253,20.88%,ACTB;ACTG1;CD74;GSN;CHCHD10;ELOB;LAMC1;NLGN1;SLC2A1;ARL6IP1;ANK3;RAC1;SYCP2;TAPBP;GPM6B;RTN4;NEFH;PPP2R1A;FLNA;ADD2;HES1;IL2RB;RHOG;FAM107A;OTX2;RIMS1;LCP1;MYO7B;CAPZA2;VAMP3;VAMP2;RHOV;EPPK1;MICAL1;WNT5A;AIF1;VMP1;RHOA;SOX9;YWHAZ;MAGI1;TSPAN4;CAPG;RHOU;GAS6;SPG7;PDGFA;YTHDF1;DMTN;DNM1L;RAC2;PPARGC1A;SCIN;FBLIM1;EPRS1;DCX;LPXN;TGFB1;LRRTM3;QSOX1;IL1RAP;FZD1;CAPN3;TFAP4
prerank,Rac protein signal transduction (GO:0016601),0.48851002759016604,1.1147835330797318,0.34827144686299616,0.6527967824243651,1.0,6/18,17.64%,RAC1;ELMO1;RHOG;AIF1;TIAM1;RAC2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.41989722800509277,-1.1147532817767971,0.2968197879858657,0.6836937242390253,1.0,7/13,19.61%,NR3C2;ESR1;AR;BMP4;PLPP1;NR3C1;MED1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.5601910838550962,1.1146667310499543,0.3595505617977528,0.6526841713855798,1.0,4/10,19.16%,APOD;NDRG4;PTGIR;SNCA
prerank,cellular amide metabolic process (GO:0043603),0.3909816760973107,1.1145314346944888,0.2815734989648033,0.6525878759202065,1.0,32/102,24.09%,DBI;ATF4;CPXM1;CPD;ORMDL3;PPP2R1A;CPE;PLAAT3;SMPD1;AEBP1;CPXM2;OXSM;ACOT1;ACOT7;SLC19A1;ABCA2;GLYAT;DNPEP;FOLR2;NAAA;NIT1;ACOT4;CLN8;THEM4;SHMT2;SGPL1;ASAH2;ACSM5;MTHFS;ORMDL2;CPZ;THOP1
prerank,second-messenger-mediated signaling (GO:0019932),0.3959407937746333,1.114513421218428,0.31104033970276007,0.6521976940315131,1.0,18/82,18.54%,APOE;RCAN3;AGT;PPP2R1A;CCR5;P2RY12;CHRM3;CXCR4;DDAH1;MAFA;CX3CR1;NUDT4;EDN3;RYR2;DDAH2;CCL3;NOS2;CCR2
prerank,apoptotic nuclear changes (GO:0030262),0.46085357082180817,1.1144079920821377,0.34652278177458035,0.6520379208308834,1.0,5/24,10.46%,GPER1;ENDOG;FOXL2;HMGB1;H1-0
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.43202162505983,1.1143239175450053,0.32142857142857145,0.651838350001552,1.0,13/39,23.21%,LRRC8A;TRH;RBP4;GPER1;CRH;RASL10B;BAD;DOC2B;ADCYAP1;GLUD1;NNAT;ACSL4;PSMD9
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.460734425696239,1.1140725928239747,0.34624697336561744,0.652087248174335,1.0,9/25,19.56%,APOC1;RAC1;LRPAP1;ARF6;UBQLN2;SDCBP;ABCA2;ANKRD13D;UNC119
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3481021543374386,-1.113976752890362,0.2698412698412698,0.6836902404824916,1.0,7/22,10.08%,NTRK3;PDPK1;AGTR1;FGFR2;ESR1;PDGFRB;ABL2
prerank,potassium ion homeostasis (GO:0055075),0.4666139508790595,1.1135724306504922,0.34125,0.653010574403453,1.0,9/23,19.75%,ATP1A3;ATP1B2;SLC12A5;ATP1A4;ATP1A1;ATP1B1;KCNMA1;ATP1B3;TFAP2B
prerank,establishment of protein localization to membrane (GO:0090150),-0.2718525211184131,-1.1134066230319966,0.2222222222222222,0.6831505340040621,1.0,9/66,6.91%,AFDN;PARD3;EGFR;SYNE3;BRAF;SEC63;ZDHHC1;GORASP2;RAB10
prerank,ketone body metabolic process (GO:1902224),-0.44938002391514137,-1.1129596069313457,0.3125,0.6821674956871904,1.0,8/10,29.71%,ACSS3;BDH2;HMGCS2;BDH1;AACS;HMGCLL1;HMGCL;OXCT1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.40212588792472964,1.1129000917039311,0.30495689655172414,0.6543397082535548,1.0,10/63,13.02%,RPL26;RPS27L;CHEK2;PCBP4;RPA2;CCND1;BAX;PCNA;PRMT1;FBXO31
prerank,synaptic vesicle exocytosis (GO:0016079),0.4301865711894962,1.1126095461062973,0.32825322391559203,0.6546772006172983,1.0,22/40,31.93%,SNAP25;DNAJC5;SYT1;RIMS2;RIMS1;VAMP2;SYT10;CDK5;SYT2;DOC2B;STX4;SNCA;STX1B;UNC13A;SYT5;STX3;PIP5K1C;CPLX1;PCLO;SNPH;SYT7;RAB3A
prerank,regulation of Rho protein signal transduction (GO:0035023),0.39996147812337346,1.1125139239517146,0.32119914346895073,0.6544804004295384,1.0,12/72,11.02%,APOE;ARHGDIA;KCTD10;RASIP1;RAC1;ARHGDIB;DLC1;ADGRG1;COL3A1;NET1;TNFAIP1;GPR18
prerank,neuron projection regeneration (GO:0031102),0.5396166694657479,1.1119939128532894,0.36615811373092927,0.6554588271827232,1.0,7/10,40.13%,GAP43;PTN;DHFR;NREP;MTR;OMG;RTN4RL1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4355646663714495,1.1116838547451828,0.3310104529616725,0.655818031945644,1.0,15/35,26.37%,ERBB4;TNF;PTPRC;HES1;LEPROT;VHL;CAV1;IL6;NOTCH1;IL10RB;ADIPOR1;SOCS3;HGS;DOT1L;OCIAD2
prerank,response to histamine (GO:0034776),0.5375633038928938,1.1116708397055954,0.3492063492063492,0.6554244431143509,1.0,3/10,16.56%,GABRB1;GABRB3;GABRB2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.514445270274831,1.111541353275653,0.3602080624187256,0.6553303069753424,1.0,4/13,17.68%,MDK;HMGB1;IGF2;ADAM17
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.49559513297126356,1.1110747088429207,0.35117493472584854,0.6561575001468674,1.0,4/15,14.86%,ENTPD3;AK4;NME2;CMPK2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.37928945390806074,1.1107922247792905,0.25251509054325955,0.6564999191075855,1.0,50/186,20.10%,APOE;IGFBP6;PFDN5;RACK1;PSMB4;MDK;PSME1;PSMB6;PSMB8;PSME2;PSMD2;IGFBP4;PSMD1;LRP4;TLE5;PSMC3;PSMD6;ANKRD6;SFRP5;ALPK2;PSMA7;PSMD5;JADE1;RBX1;WNT5A;PSMB9;PSMD13;PSMB3;SOX17;PSMB11;SFRP4;IGFBP2;SOX9;PSMB10;BMP2;AMER2;STK11;PSMB1;TMEM131L;PSMB5;DACT3;DAB2IP;CAV1;APCDD1;SFRP1;NOTUM;PSMA6;HIC1;HECW1;PSMA4
prerank,myeloid leukocyte differentiation (GO:0002573),0.40496331888982073,1.110712508976573,0.3246753246753247,0.6562804175928075,1.0,18/65,20.25%,MT1G;TYROBP;CCL19;TREM2;GLO1;SPI1;PARP1;CEBPA;DEK;CSF1R;F2RL1;OSTM1;BATF3;OSCAR;PIK3CD;GPR183;PDE1B;BATF2
prerank,positive regulation of vacuole organization (GO:0044090),0.5481948965861779,1.1106328166966453,0.3651026392961877,0.6560765606793147,1.0,1/10,1.33%,GRN
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.3563729970905608,-1.1104064579390578,0.2727272727272727,0.6870213385336004,1.0,5/20,6.23%,ROCK2;FMNL2;ROCK1;DLG1;NCKAP1
prerank,negative regulation of cell cycle (GO:0045786),0.401860883327216,1.1102990965339068,0.3108535300316122,0.6565219339031093,1.0,17/73,13.71%,RHOB;NPPC;GPER1;BTG1;CDKN1C;BRINP3;GMNN;CEBPA;NUPR1;GAS1;BRINP1;CAMK2N1;BRINP2;HEXIM1;BMP2;NLRP2B;LILRB1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2896033838888583,-1.1101388276721962,0.24,0.6856409662607043,1.0,13/52,12.55%,CELF2;RBM5;RBFOX2;RBM25;MBNL2;YTHDC1;THRAP3;TRA2B;WTAP;RBM4;FXR2;HNRNPL;DDX17
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.44915113056896516,1.1100852675122852,0.336996336996337,0.6566402170821133,1.0,12/28,21.63%,ATF4;CEBPB;SELENOK;BAX;BBC3;ERO1A;DAB2IP;BRSK2;PPP1R15A;DNAJC10;BAK1;DDIT3
prerank,cGMP biosynthetic process (GO:0006182),0.557564609688765,1.1100283702783842,0.3546511627906977,0.6563675647867355,1.0,1/10,2.38%,NPPC
prerank,regulation of organelle organization (GO:0033043),0.38930493654604775,1.1099747207239568,0.30809128630705396,0.6560793185219832,1.0,21/80,17.11%,MAPK3;ARL6IP1;PINK1;S100A8;S100A9;STMN3;MSN;LMAN1;SAR1A;SURF4;MYO5A;MAPT;SYT11;ATP13A2;TMED9;PJVK;MIEF2;PDE4DIP;MFF;SQSTM1;DNM1L
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.435614784092913,1.1099397926813146,0.33613445378151263,0.655739798440846,1.0,10/35,17.62%,APOE;AKAP6;RIMS2;AQP1;HTR2C;EPHA5;SOX9;NUDT4;CAP1;ADCYAP1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4431068589313826,1.1098897906345073,0.3384253819036428,0.6554313134879609,1.0,12/34,18.37%,TREM2;NR1D1;TNFAIP3;TICAM2;NLRP2B;TLR6;F2RL1;CD300LF;TYRO3;DAB2IP;CD300A;CD14
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.5427729777475372,1.1093448918952185,0.36637931034482757,0.6564529805108049,1.0,5/10,19.02%,C3;TREM2;F2RL1;CD300A;RAB31
prerank,regulation of viral life cycle (GO:1903900),0.46982534752112737,1.1092626713551552,0.35135135135135137,0.6562341696303499,1.0,4/21,18.07%,PPIA;HS3ST5;TYRO3;VPS4A
prerank,regulation of stem cell proliferation (GO:0072091),0.5064845734048186,1.1091612664428443,0.35159235668789807,0.6560754312881195,1.0,5/17,18.81%,ZFP36L1;PTPRC;GJA1;HNRNPU;SOX11
prerank,regulation of cell population proliferation (GO:0042127),0.36967298320056813,1.1089927247016467,0.094,0.6560846993773377,1.0,207/691,25.92%,FTH1;RPL23;RPS9;RPS4X;RPS15A;CLU;IGFBP6;CLDN5;IFITM1;TSPO;CD81;CALR;GPNMB;GNAI2;CAPNS1;JUND;S100A11;TSPAN31;AKT1;RPS6;LGMN;S100B;SLC25A5;NRG1;NME1;CCND2;ERBB4;NPM1;AGT;COPS9;IGFBP3;S100A13;CSNK2B;GPER1;COX17;EMP2;ZFP36L1;PDGFB;ACVRL1;ROMO1;HCLS1;NTRK2;JUNB;HSPA1B;SSR1;CTNNB1;ST18;ECRG4;SERTAD1;HES1;SFRP5;LTK;EID2;BTG1;MATK;FN1;TFRC;RHOG;RNF187;DLC1;ADORA3;SSTR4;ADGRG1;ATP8A2;PAK1;SGK1;NAMPT;CEBPA;PROX1;TIMP1;CXCL10;KDR;IL2;NUPR1;BCL6B;VIPR1;MLXIPL;CADM4;LAMC2;CGREF1;JUN;HCK;ZBTB49;ADGRB1;KITLG;CSF1R;THAP12;CTBP1;IL11;WARS1;ATF5;AIF1;CEP131;FLT4;HRAS;DNAJB2;CAMK2N1;SFRP4;PRMT1;FBXO5;KLF4;RHOA;SOX9;HSPA1A;DDAH1;BMP2;CTSH;STK11;SDCBP;CCDC88A;TIAM1;COPS8;PF4;SLURP1;FOLR2;PDF;PDGFA;IGF2;EDN3;DLL1;IER5;DAB2IP;ADRA1A;ADRA1D;VHL;JAG2;CCKBR;PDCD5;CIAO1;ADAMTS1;FLT1;LMNA;ADAM17;TBRG4;CNBP;SCIN;SFRP1;ERBB3;MAZ;FABP7;BTG4;SOX11;STX4;SCGB3A1;DDRGK1;HMGN5;INHBA;RTKN2;PTPN6;TGFB1;CD86;TFAP2B;ING5;IL6;NOTCH1;FLT3;KLF11;MAPK15;THPO;OSGIN1;MYC;SIRT2;CRLF2;RERG;TFAP4;SST;CRLF1;ID2;MEIS2;PTN;PTPRU;TNFRSF9;SSTR2;REST;MEN1;TMEM127;TGFA;CDK10;TSHR;CD164;CDKN2B;PRLR;DUSP15;FABP3;RELA;OSR2;RNF126;NAP1L1;APP;TNFRSF11A;FOXM1;COL18A1;HGS;WDR6;BOK;DOT1L;BAP1;TRAPPC14;INHA;FGF22;IFIT3;KIF20B;CX3CL1;FGFR3;PTHLH;UBE2A;FKTN
prerank,detection of visible light (GO:0009584),0.49307379405466506,1.1088692580598454,0.34675324675324676,0.6559929611180849,1.0,3/16,16.24%,GNA11;REEP6;CNGB1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4211253225154632,1.108498324797208,0.3287981859410431,0.6564808861296123,1.0,4/42,6.16%,ACTB;VPS72;MBD3;ZNHIT1
prerank,ion homeostasis (GO:0050801),-0.31913668599726547,-1.10848594538187,0.30128205128205127,0.6880778880119928,1.0,20/30,34.11%,SLC4A10;CAMK2D;FHL1;WNK4;KLHL3;SLC4A3;HCN4;RANGRF;NEDD4L;SLC4A9;SLC4A11;SLC4A5;SLC4A4;AP3D1;SLC4A7;SLC30A2;SLC30A8;WNK1;SLC30A3;RHAG
prerank,telomere maintenance via recombination (GO:0000722),-0.4420863128077511,-1.1083508263182205,0.3111111111111111,0.6862927625030042,1.0,2/11,3.00%,NSMCE2;TEP1
prerank,negative regulation of heart contraction (GO:0045822),0.5370673549279394,1.107719314815284,0.35774647887323946,0.6580890744156123,1.0,5/11,19.29%,PLN;SPTBN4;FKBP1B;SRI;GRK2
prerank,regulation of protein kinase activity (GO:0045859),0.38829202495750176,1.106972444623574,0.2968270214943705,0.6595861231158019,1.0,29/106,19.16%,PPIA;HSPB1;PARK7;SOD1;AKT1;CCL19;TNF;CAMK2N2;PTPRC;C5AR1;DBNDD2;THY1;YWHAG;RTRAF;WARS1;CAMK2N1;GAS6;MMD2;MAPRE3;LCP2;PRKRIP1;ADCYAP1;DDR2;CAMKK1;AGAP2;AKT1S1;TAB1;QARS1;SNCA
prerank,zinc ion transmembrane transport (GO:0071577),0.46587293768306137,1.1068516104369632,0.36790123456790125,0.6594910704726532,1.0,5/22,11.69%,SLC30A1;SLC39A1;SLC39A10;SLC39A7;TRPM2
prerank,regulation of neuron differentiation (GO:0045664),0.3994906629172555,1.1065132517548422,0.3146186440677966,0.6599659415075325,1.0,30/76,25.15%,CALR;NBL1;NLGN1;CNTN4;YWHAH;HES1;LTK;BRINP3;NRCAM;YWHAG;CDK5R1;BRINP1;BRINP2;RHOA;BMP2;MMD2;TIAM1;PCP4;HEY1;DLL1;BEND6;TRIM32;SOX11;MEF2C;ADRA2B;ID2;REST;TCF3;ECT2;NEPRO
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5343856724800267,1.105624670497129,0.3677069199457259,0.6618783148050067,1.0,5/11,28.23%,YWHAE;ATP1A1;ATP1B1;KCNJ3;KCNQ1
prerank,iron-sulfur cluster assembly (GO:0016226),0.457826627154396,1.1056148080745878,0.34278668310727495,0.6614746631805909,1.0,8/24,21.53%,BOLA2;GLRX5;ISCU;CIAO1;CIAPIN1;HSPA9;CIAO2A;CIAO2B
prerank,histone H4 acetylation (GO:0043967),-0.29902229729744345,-1.1054159337173903,0.22807017543859648,0.6920483203504534,1.0,11/47,13.31%,ZZZ3;OGT;EPC1;NAA40;KAT7;KMT2A;ATF2;EP400;KANSL3;BRD8;JADE2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.38686619355231044,1.1051302627817572,0.30785123966942146,0.6623422347009398,1.0,26/110,17.62%,RAMP2;GPER1;ADGRB3;ADGRL3;S1PR5;S1PR1;DRD5;GPR6;ADGRG1;RXFP1;CXCL10;MC1R;ADGRB1;CALCB;ADGRB2;RAMP3;ADCY4;PF4;MC5R;ADGRL4;ADRA1A;ADRA1D;ADCY8;ADGRE1;PTGIR;ADCYAP1
prerank,synaptic vesicle localization (GO:0097479),0.5136852478340772,1.1047999632483405,0.3626373626373626,0.6627975948556564,1.0,5/13,18.10%,NLGN1;KIF5A;SYNDIG1;CDK5;KIF5C
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3926123740866409,1.1046732620632085,0.3125,0.6627008238287205,1.0,26/87,18.15%,ARHGDIA;MDK;RHOB;RHOC;RAC1;GPM6B;ARHGDIB;IQGAP2;RHOG;DLC1;FAM107A;ESAM;CORO1A;PAK1;EPHA5;PAK3;PHPT1;CSF1R;TRPM2;RHOA;BST2;CCDC88A;PDGFA;DMTN;RAC2;ARHGEF19
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5440920443570603,1.104534018635788,0.34738372093023256,0.6626432783703112,1.0,1/10,2.47%,SERPINE2
prerank,mitotic cytokinesis (GO:0000281),-0.29899315021538686,-1.1042830448133532,0.24509803921568626,0.6930037342423315,1.0,9/47,7.25%,ROCK2;SON;ROCK1;SPTBN1;PDCD6IP;TTC19;ARL3;MYH10;KLHDC8B
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5034302509672453,1.1028295847497216,0.35517693315858456,0.6667251649566556,1.0,1/17,1.02%,LAMP1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.507713235318755,1.1028232663745823,0.36585365853658536,0.6663130106561729,1.0,5/13,15.46%,SHISA7;GRIK2;SYNGR1;SYP;PPFIA3
prerank,regulation of heart contraction (GO:0008016),0.3918849504025548,1.1024117278257146,0.31374606505771246,0.6669745405367106,1.0,24/90,18.67%,CALM1;S100A1;NPPC;CALM3;FXYD1;AGT;ATP1A3;ADORA3;ATP1B2;PLN;FXYD7;ATP2B1;ATP1A4;ATP1A1;DES;TRPC1;KCNE5;SLC8A1;ATP1B1;RYR2;FKBP1B;SRI;ATP1B3;CALM2
prerank,hepaticobiliary system development (GO:0061008),-0.3649284473720224,-1.1020349071421274,0.30198019801980197,0.697254882306736,1.0,5/20,7.82%,TGFBR3;COBL;NIPBL;ARID5B;MET
prerank,regulation of sequestering of triglyceride (GO:0010889),0.49493189962761747,1.1016895992082034,0.36774193548387096,0.668425871533271,1.0,4/15,11.01%,PNPLA2;TREM2;LPL;PLIN3
prerank,response to tumor necrosis factor (GO:0034612),0.3892507694883037,1.1015702867039687,0.3301787592008412,0.6683050854754026,1.0,19/91,18.46%,RPS3;AKT1;CCL19;GPER1;ZFP36L1;NR1D1;ZFP36L2;HYAL2;CXCL16;ZFP36;SMPD1;CCL2;ERBIN;YBX3;DAB2IP;CCL3;TRIM32;CCL8;SFRP1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.4334560064410541,1.101149517854099,0.35046728971962615,0.668981629118987,1.0,13/35,25.21%,PARP1;RPA2;NEIL1;APEX1;PCNA;RFC2;POLD4;RFC4;POLG;LIG1;PNKP;POLD1;RPA3
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.45267833817738595,1.100792848412222,0.36009732360097324,0.6694815175953617,1.0,5/25,7.46%,CTSS;NDUFA4;ANK3;COX17;ATP1B2
prerank,neuromuscular process controlling balance (GO:0050885),0.5181959200024047,1.1007601565651097,0.35278154681139756,0.6691268986901913,1.0,2/12,6.06%,NRXN1;PCDH15
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3948473462982228,1.1007206635946645,0.3344017094017094,0.6688009519804201,1.0,6/76,4.25%,TMSB4X;RPS3;LAPTM5;CCL19;TNF;SPI1
prerank,spinal cord development (GO:0021510),-0.411584441501241,-1.1005084000000682,0.3167259786476868,0.699451939715175,1.0,6/12,20.78%,GLI2;VIT;LOXL3;PKD1;NF1;PKD2
prerank,clathrin coat assembly (GO:0048268),0.49644301275068387,1.1004108795237568,0.3584905660377358,0.6691878329266533,1.0,6/15,15.34%,NSG1;CLTC;AP2S1;FCHO1;NSG2;CLTA
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4641440351397811,1.1003145846376472,0.3656441717791411,0.6690019019370261,1.0,2/22,7.73%,B2M;HSPD1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5189974167210177,1.1003037680660537,0.37986577181208053,0.668598446934791,1.0,3/13,8.70%,CTNNB1;COL4A1;KDR
prerank,regulation of cell junction assembly (GO:1901888),-0.3403460988796998,-1.099690480504326,0.30864197530864196,0.6996544755410515,1.0,5/27,2.54%,ROCK2;PDLIM5;SETD5;RAPGEF2;ROCK1
prerank,telomere organization (GO:0032200),0.42038026950282636,1.0996874180057832,0.33793103448275863,0.6697882912320754,1.0,15/43,25.21%,H3-3A;TERF1;LTO1;PARP1;RPA2;APEX1;PCNA;PTGES3;POLD4;CTC1;TERF2IP;BLM;POLD1;DOT1L;RPA3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.43974642356069865,1.0992802543475364,0.3563218390804598,0.6704341438790018,1.0,9/33,14.04%,RAMP2;MDK;TNFAIP3;KDR;NUPR1;GATA2;IL11;WFS1;GAS6
prerank,regulation of protein polymerization (GO:0032271),0.4338785040571205,1.099135362345348,0.34679334916864607,0.6703946584209814,1.0,12/35,16.69%,HSP90AA1;TPPP3;HCLS1;PFN1;ESAM;MAPT;COTL1;MAP2;PAK3;ARL2;MAPRE3;PFN2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.40480703454063577,1.0986979495501923,0.3379978471474704,0.6711354084024291,1.0,13/59,15.73%,BSG;CD84;DSCAM;CNTN4;TENM3;KIRREL3;ROBO4;EMB;PECAM1;CADM3;ROBO2;IGSF9;DSCAML1
prerank,thyroid hormone generation (GO:0006590),-0.43903116959413924,-1.0986196199364293,0.30656934306569344,0.7004528520102242,1.0,1/10,0.43%,CPQ
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.42802627589987097,1.0984137964403733,0.345475910693302,0.6714441969463218,1.0,10/37,16.92%,NLGN1;GRID2;TENM3;TENM2;IL1RAPL1;TENM4;PTPRD;CADM3;DCHS1;VCAM1
prerank,regulation of MAPK cascade (GO:0043408),0.38133962290693946,1.0983310676978102,0.2782258064516129,0.6712059146293256,1.0,52/157,21.22%,CD74;LAPTM5;MAPK3;PEBP1;GPER1;GPR37L1;PTPRC;PDGFB;NTRK2;CAV2;DUSP3;FN1;PAK1;P2RX7;KDR;CD24;JCAD;LILRA5;HMGB1;PAK3;ATP6AP2;IL11;FLT4;HRAS;PHLPP1;YWHAZ;BMP2;NEK10;RRAS;GDF15;PDGFA;IGF2;RASGRP1;EPHB1;DAB2IP;ADRA1A;ADRA1D;CAV1;FLT1;FAM83D;GRM4;MAP2K2;SYK;PTPN6;SPRY3;LBH;IL6;TMEM106A;FLT3;THPO;ADRA2B;PAK5
prerank,mitotic cytokinetic process (GO:1902410),0.46989023536536223,1.0979835737742316,0.36086404066073696,0.671674358135158,1.0,11/20,31.00%,CHMP2B;CHMP5;CHMP6;RHOA;CHMP1B;VPS4A;CHMP7;CHMP1A;CHMP4C;CHMP4A;CHMP4B
prerank,lipid translocation (GO:0034204),0.4722852419915675,1.0978271262635624,0.3645443196004994,0.6716584826311663,1.0,6/21,18.89%,TMEM30A;ATP8B4;ATP8A2;ATP8A1;ATP11B;RFT1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.40038673168461053,-1.0970170748318988,0.3345070422535211,0.7027669547331624,1.0,5/13,11.86%,TGFBR3;BMPR1A;ZFPM2;FGFR2;RBPJ
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5132429509746367,1.0966526077970276,0.36820652173913043,0.6743974897190372,1.0,6/13,26.38%,PTPRC;HES1;IL6;CRLF2;DOT1L;PTPRT
prerank,protein localization to cell periphery (GO:1990778),0.3751406520897412,1.0964309483783812,0.29591836734693877,0.6745527346730155,1.0,34/133,18.56%,BSG;CD81;RAMP2;KCNIP4;S100A10;ANK3;TNF;EMP2;DPP10;PACSIN1;FLOT1;FLNA;MYADM;RAB15;MYO5A;TMED2;DPP6;RAB3C;P2RY1;RAB3D;RAMP3;TNFRSF1A;MAP7;GAS6;EHD1;LIN7C;SPTBN4;EPB41L3;ATP1B1;FGF13;CAV1;CRB3;EHD2;ATP1B3
prerank,vitamin D metabolic process (GO:0042359),0.5091471144724494,1.0961666614763526,0.38651994497936726,0.6748537976972507,1.0,2/13,12.75%,LGMN;GC
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5133964428933926,1.0960248937098744,0.364,0.6747812836635229,1.0,2/13,6.14%,SULT4A1;BPNT2
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.42912955729052116,-1.095861638875286,0.35494880546075086,0.7039447210420061,1.0,6/10,20.11%,SETD2;EHMT1;SETD7;SETD4;SETD3;SETD6
prerank,regulation of mast cell activation (GO:0033003),0.5376272795294187,1.095522290606492,0.40193370165745856,0.6756465191443348,1.0,5/10,32.15%,CD84;CD300LF;CRLF2;MILR1;PLSCR1
prerank,nucleic acid-templated transcription (GO:0097659),0.420947000629561,1.09515152346849,0.35402298850574715,0.6762098720490954,1.0,8/42,15.05%,PTMA;POLR2E;POLR2D;POLR2F;XAB2;POLR2G;POLR2K;RRAGC
prerank,regulation of protein kinase C signaling (GO:0090036),0.5079100918191025,1.0950549128992704,0.3824324324324324,0.676012058614668,1.0,6/14,19.74%,MYADM;MC1R;WNT5A;FLT4;ADRA1A;SPHK2
prerank,nucleoside salvage (GO:0043174),0.5325564197635616,1.0949470722800525,0.3704225352112676,0.6758652857419525,1.0,7/10,31.51%,UCK1;UCKL1;CDA;UPP1;TK1;TK2;DCK
prerank,ion transport (GO:0006811),0.3825593242368317,1.0946243956146366,0.30832476875642345,0.6762900092331139,1.0,32/111,19.98%,TSPO;SLC17A8;GABRB1;SLC39A1;LRRC8A;SLC1A2;SLC24A4;SLC24A2;GRIN1;SLC12A5;CNGA3;TMEM63C;SLC26A4;SLC15A4;LASP1;SLC17A7;SLC17A6;KCNN2;GLRA1;ATP1A4;SLC25A22;CHRNA4;SLC1A1;SLC15A2;SLC8A1;CNGB1;SLC9A9;ATP11B;SLC4A2;VDAC2;SLC25A18;PKD2L1
prerank,hemopoiesis (GO:0030097),0.3886087250701648,1.0943362295287604,0.3228511530398323,0.6766090332436269,1.0,30/87,20.30%,ATF4;LYL1;CD34;GLRX5;PTPRC;PDGFB;ZFP36L2;TIRAP;SBDS;KIRREL3;CEBPA;KDR;WNT5A;KITLG;CSF1R;FLT4;ARMC6;SELPLG;WNT10B;RRAS;L3MBTL1;DLL1;FLT1;SFRP1;INHBA;RTKN2;TGFB1;TOX;FLT3;TPO
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.41064196002033926,-1.0938538100873152,0.313953488372093,0.7072119423170188,1.0,2/12,1.06%,NOTCH2;DOCK11
prerank,regulation of JUN kinase activity (GO:0043506),0.42891179706839766,1.0932786634007143,0.3516998827667057,0.6789911377787579,1.0,7/33,16.42%,RPS3;TNF;PAK1;DNAJA1;MAPK8IP1;TLR6;DAB2IP
prerank,motor neuron axon guidance (GO:0008045),0.5048762135113616,1.0932751941520573,0.36684782608695654,0.6785673083644419,1.0,6/15,17.64%,RAC1;RHOG;NTN1;LAMC2;SLIT1;RAC2
prerank,blood vessel endothelial cell migration (GO:0043534),0.46164569810036016,1.0930378909012495,0.3740831295843521,0.6787441252046371,1.0,5/22,8.70%,AKT1;SOX18;ID1;EMP2;KDR
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.44255875321710264,1.0920782667968505,0.36829268292682926,0.680785911013126,1.0,6/27,11.31%,FXYD5;FXYD1;YWHAH;SCN4B;FXYD7;FGF12
prerank,cardiac muscle cell contraction (GO:0086003),0.4715149088234279,1.0914474089141055,0.37786259541984735,0.681984663091433,1.0,5/19,12.14%,GSN;SCN1A;SCN4B;FGF12;ATP1A1
prerank,protein acetylation (GO:0006473),-0.32729141889660807,-1.0912453218674458,0.3136094674556213,0.7123376775237537,1.0,11/30,16.32%,CREBBP;NAA40;KAT2B;NAA16;NAA15;ESCO1;KAT6A;SIRT1;NAA35;SPHK1;FOXO1
prerank,cellular response to hormone stimulus (GO:0032870),0.39713016107329985,1.0907329674020916,0.34010695187165774,0.6834240652496876,1.0,17/69,19.03%,CTSB;CTSL;RAMP2;CTSS;GPER1;ZFP36L1;ATP1A3;RAMP3;WBP2;ATP1A1;CTSH;ROBO2;CAV1;SLIT3;NCOA4;SFRP1;NSMF
prerank,chloride transport (GO:0006821),0.3888675475114759,1.0905555016577935,0.35432230522945574,0.683479726662026,1.0,14/74,12.80%,GABRB1;FXYD1;LRRC8A;GABRG3;GABRA2;SLC12A5;TTYH1;GLRA2;GABRA3;GABRB3;GLRA1;CLIC1;TTYH3;SLC1A1
prerank,negative regulation of cellular process (GO:0048523),0.365754031374975,1.089840545770479,0.188,0.6848431167612964,1.0,141/521,22.76%,FTH1;ARHGDIA;CLU;IGFBP6;RACK1;IFITM1;MDK;GPNMB;MT3;PARK7;NDUFA13;RHOB;S100A11;TREM2;NME1;TMBIM6;CRYAB;ERBB4;NPM1;CD34;IGFBP3;TXNIP;CCDC85B;CSNK2B;GPER1;ADAM15;ACVRL1;ENO1;DSCAM;RTN4;MIF;HSPA1B;SIRPA;PPP2R1A;CTNNB1;ST18;PDE3B;SFRP5;HYAL2;BTG1;ARHGDIB;LRPAP1;DLC1;ADORA3;SSTR4;ADGRG1;ATP8A2;GMNN;BNIP3L;KLK8;CEBPA;PODXL;WFDC1;PROX1;CCN2;NUPR1;SYT11;VAMP3;JADE1;CGREF1;ARHGDIG;ZBTB49;ADGRB1;THAP12;BRINP1;CTBP1;APBB1;WARS1;ATF5;MSX1;SOX17;TMEM109;WFS1;VAMP8;HRAS;ACTN1;DNAJB2;CAMK2N1;SFRP4;FBXO5;KLF4;BST2;HSPA1A;DDAH1;BMP2;NLRP2B;GJA1;LILRB1;STK11;PDE12;COPS8;SLURP1;NR1H2;DLL1;DACT3;ING1;DAB2IP;ADRA1A;VHL;PDCD5;NDUFS3;SLIT3;ADAMTS1;LMNA;SCIN;ANXA6;CCAR2;SFRP1;ERBB3;FABP7;BTG4;SOX11;SCGB3A1;INHBA;LPXN;PTPN6;TGFB1;SPHK2;TFAP2B;ING5;IL6;NOTCH1;KLF11;OSGIN1;PLXND1;MYC;SIRT2;RERG;TFAP4;SST;PTPRU;TDRD9;SSTR2;CDA;REST;MEN1;CCN3;TMEM127;BLM;DUSP1;CDK10
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.43002788393361546,1.0894423893262464,0.3523809523809524,0.685515927682123,1.0,8/34,10.02%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;P4HB;ARHGEF7
prerank,negative regulation of interleukin-6 production (GO:0032715),0.4473588973318072,1.088752345825336,0.3533007334963325,0.686874455450732,1.0,7/27,20.79%,TNF;SIRPA;TNFAIP3;SYT11;GAS6;PTPN6;SELENOS
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.4066172496479856,-1.0886889963042437,0.31835205992509363,0.7173659441379455,1.0,6/13,13.00%,NFIB;PPARA;NFATC4;PPARG;NFATC3;BMP4
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.48030500176942037,1.0884456591258154,0.3671052631578947,0.6872214096835145,1.0,7/17,17.68%,AKT1;CCND2;PDGFB;CCND1;PROX1;MAPRE3;ADAM17
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4934944626280855,1.0880309520825195,0.38315217391304346,0.6878803880821425,1.0,2/14,10.14%,CHKB;PCYT2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.38044548904670744,1.0879107501606509,0.34183673469387754,0.6877667641638904,1.0,28/116,20.79%,RAMP2;TREM2;POMC;SCTR;DRD5;CD163;RXFP1;PRKAR1A;VIPR1;CRH;FCGR1A;HCK;MC1R;PRKAR1B;CALCB;RAMP3;ADCY4;MC5R;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;IL6;SELENOS
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5144624725712746,1.0873233024786675,0.392,0.6889162716124909,1.0,5/13,19.83%,SOX8;SOX9;DLL1;TGFB1;NOTCH1
prerank,positive regulation of neuron differentiation (GO:0045666),0.42375969998564567,1.0871553777830103,0.35912240184757505,0.6889387719871168,1.0,18/40,24.45%,NBL1;BRINP3;NRCAM;PROX1;BRINP1;BRINP2;RHOA;BMP2;MMD2;PCP4;BEND6;TRIM32;SOX11;MEF2C;ADRA2B;REST;TCF3;ECT2
prerank,regulation of AMPA receptor activity (GO:2000311),0.4561684421904123,1.0867111381341383,0.3768472906403941,0.6896795031926164,1.0,9/25,25.51%,NLGN1;SHISA7;MAPK8IP2;CACNG8;CACNG5;MEF2C;CACNG2;PRRT1;SHISA6
prerank,microtubule nucleation (GO:0007020),-0.37406293609732316,-1.0863621687138794,0.3380952380952381,0.7217747639907724,1.0,9/19,24.41%,AKAP9;GOLGA2;CCDC57;TUBGCP6;NDEL1;TUBGCP5;TPX2;TUBG1;SLAIN2
prerank,regulation of T cell chemotaxis (GO:0010819),0.520176757447387,1.086221427456643,0.3940677966101695,0.690534956455639,1.0,5/11,26.60%,CXCL10;WNT5A;ADAM17;CCR2;OXSR1
prerank,lysosome organization (GO:0007040),0.4221257145771814,1.08583952338407,0.3689655172413793,0.6910817190226353,1.0,8/36,13.27%,GRN;CORO1A;CLVS1;CLVS2;GAA;CLN6;CLN5;TMEM106B
prerank,negative regulation of lyase activity (GO:0051350),0.49360165025234615,1.0857382255610952,0.3641092327698309,0.6908876666357511,1.0,5/16,20.12%,GNAI2;RD3;PHPT1;CCR2;GABBR2
prerank,negative regulation of glycolytic process (GO:0045820),-0.4470274040166161,-1.0857295584272322,0.34868421052631576,0.7191964990773894,1.0,3/10,5.55%,HDAC4;PPARA;NCOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4470274040166161,-1.0857295584272322,0.34868421052631576,0.7191964990773894,1.0,3/10,5.55%,HDAC4;PPARA;NCOR1
prerank,protein localization to cell junction (GO:1902414),-0.34671790575561245,-1.085700610445376,0.3183856502242152,0.7172027048900232,1.0,11/22,22.36%,CGNL1;ARHGEF18;HEG1;DLG4;FERMT2;NECTIN1;NLGN2;JAK1;BSN;PAK2;MPP4
prerank,mRNA destabilization (GO:0061157),-0.29212126295509455,-1.0856352173071122,0.31297709923664124,0.715293378752306,1.0,10/38,10.38%,ROCK2;FTO;ROCK1;DHX36;CNOT1;YTHDF3;CPEB3;TUT7;MOV10;RC3H2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.441142886267321,1.0853811265261992,0.36687116564417177,0.6914078655332121,1.0,12/27,35.28%,CHKB;PLAAT3;PCYT2;NAAA;ETNPPL;PLA2G3;PLA2G6;CEPT1;PNPLA8;PISD;PLAAT1;PLA2G15
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.26997333262888396,-1.0852891030632874,0.2962962962962963,0.7141911330809703,1.0,17/67,10.96%,EGFR;FER;ABL1;GHR;EPHA3;IL15;EPHA4;EFEMP1;INSR;DYRK1A;PIBF1;FGFR2;ABI1;PDGFRB;ABL2;EPHB2;PTK2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.43080093041106915,1.0850111864271095,0.37334933973589435,0.6919701376771917,1.0,9/31,19.80%,RBP4;PTPRC;TFRC;IL2;VAMP3;STX4;DNAJB9;CD86;IL6
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.48604739690479526,1.0849089691850975,0.39487179487179486,0.6917960232027096,1.0,3/16,3.62%,MDK;ITGB2;TNF
prerank,oligodendrocyte development (GO:0014003),0.48501190037890995,1.0847447263115042,0.36610608020698576,0.6918074559234001,1.0,9/15,32.79%,PLP1;B4GALT6;MYRF;EIF2B5;SOX10;EIF2B1;B4GALT5;CNTNAP1;PRDM8
prerank,epithelial cell morphogenesis (GO:0003382),-0.37576196057370836,-1.0845583860983434,0.3231441048034934,0.7141129218036463,1.0,3/17,7.82%,COL22A1;SIPA1L3;MET
prerank,cell-matrix adhesion (GO:0007160),0.3809570512680758,1.0845439530845553,0.3470225872689938,0.6919023414902085,1.0,18/95,10.02%,CD63;VTN;ITGB2;CD34;ADAM15;EMP2;RAC1;TIMM10B;BCAM;FN1;DLC1;COL3A1;THY1;ZYX;PPFIA2;TNN;SIGLEC1;ARHGEF7
prerank,regulation of epithelial cell proliferation (GO:0050678),0.38704864492759533,1.0844628004294008,0.350418410041841,0.6916804969613654,1.0,21/85,16.42%,B2M;GPX1;GRN;LAMC1;NME1;MAGED1;ZFP36L1;NR1D1;ACVRL1;C5AR1;CDKN1C;NUPR1;EPPK1;ZFP36;HRAS;SOX9;NME2;TIE1;BAD;EPB41L4B;DAB2IP
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3817535528060635,-1.0843933241675119,0.34024896265560167,0.7124851525912549,1.0,8/16,26.65%,FOXD1;FGF1;SIX1;BMP4;FGF2;PKD2;GDNF;NPNT
prerank,positive chemotaxis (GO:0050918),0.47298939499350934,1.0840682146198584,0.35446313065976714,0.6922736925595602,1.0,3/17,7.66%,GPNMB;LGALS3;CORO1A
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3662092426385101,1.0839335715631357,0.2931726907630522,0.6921887167331319,1.0,60/234,21.63%,RPS3;RPS27A;PPIA;CLU;UBC;UBB;PARK7;AKT1;NPM1;AGT;NFAM1;TNF;BEX1;LAMTOR5;HCLS1;CAMK1D;S100A8;S100A9;FLOT1;HSPA1B;CTNNB1;TIRAP;HIPK2;TFRC;UBA52;EPHA5;WNT5A;RBCK1;ZBTB7A;RHEBL1;HDAC5;HSPA1A;RIPK2;UBE2V1;CX3CR1;TLR6;TSSK4;LRP8;ADCY8;CAV1;TRIM32;DDR2;PPARGC1A;TERF2IP;PSMA6;DDRGK1;TAB1;TRIM13;RTKN2;NLRP3;IL6;IL1RAP;FZD1;BUD31;CAPN3;NFKBIA;PYCARD;FZD2;FOXA1;DDIT3
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3723922430579867,1.083791241507417,0.32225579053373615,0.692106886006491,1.0,60/151,31.95%,APOE;CHKB;GSTM1;CERS2;CSNK2B;MGST1;GPHN;GSTO1;ELOVL1;ELOVL2;MFSD2A;GSTM5;GSTM2;MGST3;ELOVL7;CHAT;GCNT1;HPGDS;SPTLC1;DEGS1;ACHE;CSNK1G2;FA2H;AKR1A1;SPTSSA;INHBA;VAPA;SPHK2;ESD;SGPP1;SGPL1;SGPP2;SLC44A5;ELOVL6;STARD10;TNIP1;MOCS2;LPCAT2;ALDH3B1;VAPB;SLC44A2;ASL;INHA;SLC44A1;LCMT2;HACD4;SAMD8;GSTM4;ASS1;CERT1;ALAS2;CEPT1;ARG2;ALDH3A2;CERS6;B4GALT5;SPNS2;ELOVL4;PCSK1;ALAS1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3869783706334721,1.0837194608275709,0.3410526315789474,0.6918678561260337,1.0,25/78,19.62%,ACTB;AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;TMEM59;AP2M1;RHOG;CLTC;ARF6;ZDHHC5;RAMP3;VAMP8;RSC1A1;CLIP3;CDK5;MMP14;SQSTM1;TMBIM1;VPS4A;STX4;STAC3;TGFB1
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.3826380130831844,-1.0835283394740591,0.30962343096234307,0.7126938983473112,1.0,6/14,23.30%,SEC24D;SCAP;SEC24A;SEC24C;SEC31B;RAB1A
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.3225850583507172,-1.0833609624695923,0.2883435582822086,0.7110925836861315,1.0,6/31,8.34%,HOXB3;HOXA3;HOXB4;HOXC4;TGFBR1;FGFR2
prerank,cellular response to retinoic acid (GO:0071300),0.4219537228101933,1.0833436330103057,0.3777267508610792,0.6923963255691565,1.0,11/42,13.77%,NDUFA13;LTK;BRINP3;PTK6;AQP1;WNT5A;BRINP1;SNW1;BRINP2;SOX9;WNT10B
prerank,cellular response to calcium ion (GO:0071277),0.39216578921623946,1.0829292871171692,0.3450479233226837,0.6930806323141492,1.0,25/67,25.80%,LGMN;NLGN1;SYT1;SYT12;SYT11;SYT6;SYT4;SMPD1;WNT5A;TRPM2;ALOX5AP;SYT10;CPNE5;SYT2;CPNE6;DMTN;ADCY8;CPNE4;MEF2C;CAPN3;SYT3;SYT5;ECT2;SYT17;CPNE3
prerank,lipid transport (GO:0006869),0.3816041270055206,1.082871284115405,0.3405349794238683,0.692805069816215,1.0,20/97,20.19%,APOE;PLTP;GM2A;NPC2;SLCO1C1;SCP2;FABP5;ABCG1;MFSD2A;ATP8A1;SLC10A3;NME4;GLTP;ABCA2;MFSD2B;CLN8;SLC10A6;PRELID1;SLCO1B1;ABCC3
prerank,T cell mediated immunity (GO:0002456),0.5074004290865819,1.0824480188248449,0.3943472409152086,0.6934537343922702,1.0,5/13,25.44%,EMP2;BTN3A3;CTSH;MYO1G;GNL1
prerank,regulation of muscle contraction (GO:0006937),0.4404161024526013,1.0817177016083623,0.38564476885644766,0.694983119461657,1.0,8/26,18.36%,MYL9;ENO1;CHRM2;TNNI1;KCNA1;CAV1;SRI;ANXA6
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.414760503923724,-1.0812852279414518,0.32075471698113206,0.7144654670014967,1.0,4/11,15.79%,EGFR;RIPK1;BMP4;TP53
prerank,phospholipid metabolic process (GO:0006644),0.3916889336099766,1.0808383327085063,0.3647932131495228,0.6968343082639976,1.0,22/71,26.62%,GPX4;PLAAT3;FADS1;LIPG;ENPP2;LPL;PIP4P1;PCYT2;SMPD1;PLA2G4F;GDE1;PLBD2;ABCA2;CLN8;AGPAT5;PLPPR2;PGP;AGPAT2;PLA2G3;ABHD12;PLPPR4;GPAM
prerank,sensory perception of chemical stimulus (GO:0007606),0.4927990151335579,1.0807198203231396,0.3702239789196311,0.6967233829808303,1.0,3/15,14.70%,SLC24A4;C5AR1;SYT10
prerank,regulation of Notch signaling pathway (GO:0008593),-0.26987047859172164,-1.0805296658507437,0.29310344827586204,0.7143194119090291,1.0,19/76,14.41%,TSPAN5;EGFR;CREBBP;ZMIZ1;MAML2;NIBAN2;GALNT11;YAP1;KAT2B;STAT3;MAML1;SYNJ2BP;AAK1;CD46;RBPJ;DTX1;WWP2;JAG1;PRKCI
prerank,synaptic vesicle recycling (GO:0036465),0.4324000280905365,1.0804014280707912,0.38908659549228947,0.6971226377542411,1.0,18/31,33.16%,NLGN1;CANX;PACSIN1;SYT1;AMPH;VAMP2;CDK5;SYT2;SNCA;WNT7A;SYT5;TBC1D24;PIP5K1C;SYT7;RAB3A;SNCG;CEL;SNCB
prerank,regulation of macroautophagy (GO:0016241),0.37356062845486215,1.0802543706287913,0.345679012345679,0.6970775003931982,1.0,24/105,16.43%,GAPDH;ATP6V0C;CAPNS1;AKT1;PINK1;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;UCHL1;ATP6V0E2;BNIP3L;SCOC;DCN;KDR;CDK5R1;ATP13A2;ATP6V0D2;LAMTOR3;UBQLN2;RRAGC;ATG101;CDK5;RRAGD
prerank,transport across blood-brain barrier (GO:0150104),0.38007370468352,1.0801845917934627,0.36134453781512604,0.6968084973857354,1.0,22/83,15.75%,SLC38A5;SLC2A1;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;FABP5;TFRC;ATP1B2;SLC6A6;MFSD2A;SLC6A17;SLC29A1;LRP3;ATP8A1;ATP1A4;SLC1A1;SLC19A1;ABCA2;SLC29A2;SLC15A2;SLC16A1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.48098449456172576,1.079589201706407,0.3836150845253576,0.6979169060523143,1.0,5/17,16.92%,CEBPB;CD24;SOX9;DLL1;CAV1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.32393276154019485,-1.0791569964719583,0.3150684931506849,0.7159611598450909,1.0,8/29,10.54%,PLEKHH2;LIMA1;ARFGEF1;SLIT2;PRKN;ARPIN;KANK1;SMAD4
prerank,regulation of macromolecule metabolic process (GO:0060255),0.36699737662615295,1.0788636382675392,0.3272543059777102,0.6993771851591248,1.0,33/170,15.92%,APOE;CRIP1;PCBP1;HNRNPAB;TREM2;HNRNPK;ZFP36L1;PTPRC;TAPBP;PIN1;FLOT1;SIRPA;PCBP4;APLNR;ALPK2;RNF187;NELL1;PRDM12;PROX1;YBX1;TARDBP;MTMR9;ATRAID;KDM6B;AIF1;RO60;ARF1;SORT1;SLC8A1;DHH;YBX3;ATP1B1;EDN3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.2864002904086082,-1.0788419339444004,0.288,0.7148303529225115,1.0,15/42,18.59%,ARID2;SETD2;SPIDR;SHLD1;MMS19;PPP4R2;FBH1;MRNIP;FUS;FANCB;SMCHD1;CGAS;RTEL1;RMI2;SHLD2
prerank,odontogenesis (GO:0042476),-0.3011431544425145,-1.0783633855964565,0.3548387096774194,0.7141308401752766,1.0,6/35,8.34%,EDA;ANKRD11;GLI2;LRP6;BCOR;FGFR2
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.43740062609305114,1.0782831352888873,0.375,0.7004633434394937,1.0,10/28,16.28%,AKT1;ARRDC1;GATA2;ZBTB7A;FBXW7;MMP14;EGFL7;HEY1;DLL1;BEND6
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.36298419806056165,1.0780094359656072,0.3135678391959799,0.7007558367273086,1.0,53/208,20.93%,CD74;GAPDH;HSPB1;LGALS1;HMOX1;CCL19;S100B;TREM2;PINK1;S100A13;TNF;RHOC;LAMTOR5;EEF1D;NR1D1;FKBP1A;SHISA5;ECM1;FLNA;TIRAP;TNFAIP3;TFRC;TMEM101;CLEC6A;OTUD7A;TICAM2;TMEM9B;TRIM59;WNT5A;RBCK1;RHOA;BST2;TNFRSF1A;GJA1;RIPK2;UBE2V1;TLR6;F2RL1;TRAF3;DAB2IP;SQSTM1;TRIM32;S100A4;TERF2IP;LTBR;TRIM13;VAPA;SPHK2;TMEM106A;CANT1;GOLT1B;CAPN3;PYCARD
prerank,positive regulation of phosphorylation (GO:0042327),0.36576120229161446,1.0779152964300243,0.311,0.7005810550825256,1.0,50/240,16.08%,PPIA;CD74;RACK1;HSP90AA1;C3;GPNMB;MT3;MAPK3;AKT1;TREM2;CCND2;ERBB4;PINK1;GPER1;TNF;RAC1;NTRK2;ANG;DSCAM;PIN1;MIF;FLOT1;KNDC1;RARRES2;LTK;MUSK;TFRC;CCND1;PAK1;P2RX7;KDR;MLXIPL;P2RY1;EPHA5;TMEM119;CSF1R;PECAM1;FLT4;HRAS;SOX9;CLIP3;BMP2;TIE1;SDCBP;GAS6;PTGES3;IGF2;RASGRP1;EPHB1;TYRO3
prerank,hyaluronan metabolic process (GO:0030212),0.46151340513023925,1.0779085938705042,0.39636363636363636,0.7001611525142901,1.0,4/23,8.47%,HEXB;HEXA;HYAL2;GUSB
prerank,positive regulation of interleukin-10 production (GO:0032733),0.43642721704241927,1.0777400759171338,0.37545126353790614,0.7001816621436742,1.0,10/30,24.21%,CD34;ISG15;HSPD1;LILRA5;HMGB1;F2RL1;SYK;IL6;PYCARD;CD28
prerank,cholesterol biosynthetic process (GO:0006695),0.42846381445593146,1.0775543691532048,0.3825265643447462,0.700221364712645,1.0,12/31,28.73%,LSS;DHCR24;ACAA2;SC5D;PLPP6;FDPS;PMVK;NSDHL;ACLY;INSIG2;EBP;HMGCS1
prerank,amino acid import across plasma membrane (GO:0089718),0.44443840935882867,1.0772936254356977,0.3804755944931164,0.7004458801872587,1.0,8/24,12.80%,SLC7A5;SLC1A4;SLC1A2;TSPO2;SLC6A6;SLC6A5;SLC3A2;SLC1A1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.4306781059559599,1.0769659831685163,0.38652482269503546,0.7008278733249742,1.0,7/32,13.42%,PGAM1;RPL10;GRM5;METAP1;PCIF1;RBM4B;METTL18
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.47372517751000176,1.0767761122596213,0.3829787234042553,0.7009132612748326,1.0,5/19,17.11%,PARK7;PINK1;ATP13A2;FBXW7;DNM1L
prerank,macroautophagy (GO:0016236),0.3714360678371429,1.076555139453999,0.3631687242798354,0.7010362863661128,1.0,19/118,12.24%,GABARAP;DYNLL2;DYNLL1;TOMM6;TOMM5;TOMM7;MAP1LC3B;MAP1LC3A;PINK1;CSNK2B;GABARAPL2;GABARAPL1;CHMP2B;VCP;ATP13A2;CHMP6;ULK3;VAMP8;VPS28
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.38409029874228623,1.0748674162798093,0.3667017913593256,0.7049508499007247,1.0,15/80,10.88%,USE1;ARF5;LMAN2;TAPBP;ERGIC3;KDELR1;TMED7;SURF4;TMED2;ARFGAP2;KIF5A;TMED3;RER1;KIF26A;TMED9
prerank,miRNA metabolic process (GO:0010586),-0.34007564396195383,-1.0747311139469173,0.3273542600896861,0.7222785787214697,1.0,9/20,16.48%,TENT4B;DICER1;PARN;DROSHA;TUT7;DDX17;TUT4;TARBP2;AGO2
prerank,negative regulation of immune response (GO:0050777),0.3703878239810765,1.0746837136316745,0.35192697768762676,0.7050137907915833,1.0,35/154,19.80%,RAMP2;TREM2;POMC;LGALS3;SPI1;SCTR;TNFAIP3;DRD5;CD163;COL3A1;RXFP1;PRKAR1A;VIPR1;CRH;FCGR1A;HCK;MC1R;PRKAR1B;CALCB;RAMP3;LILRB1;ADCY4;MC5R;TYRO3;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;CD300A;SYK;CCR2;GPR83;IL6
prerank,muscle cell differentiation (GO:0042692),0.42905925884424095,1.074489432965853,0.3706293706293706,0.7050557247311238,1.0,8/32,20.51%,SGCZ;MRTFA;SEMA4C;MTLN;NINJ1;SYNE1;TMEM204;MEF2C
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.37980037936982763,1.074197647289709,0.3588667366211962,0.7053946205414978,1.0,20/87,13.91%,RPS27A;UBC;CLDN5;UBB;FMOD;ID1;ACVRL1;FKBP1A;EID2;LEFTY2;WFIKKN2;UBA52;COL3A1;ZYX;JUN;COL1A2;AMHR2;RHOA;ZMIZ2;LEFTY1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4656913071155053,1.0740290762454194,0.40717029449423814,0.7053872942652739,1.0,8/19,24.50%,RPS27L;HIPK2;TMEM109;SNW1;DDIT4;PYCARD;PHLDA3;DYRK2
prerank,histone H2A ubiquitination (GO:0033522),-0.3590304531001216,-1.0738679596993184,0.3448275862068966,0.7225927624834455,1.0,5/17,10.93%,BCOR;RNF8;UBR2;DDB2;CUL4B
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5120874427096166,1.0734467176288702,0.4037685060565276,0.7063785526353344,1.0,5/12,16.37%,NELFCD;HEXIM1;HNRNPU;RECQL5;NELFE
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4440030461810875,1.073446598138271,0.3890909090909091,0.705945318501514,1.0,11/26,20.93%,MBP;PSME1;PSME2;PSENEN;GRIN1;VSIR;APH1B;GRIN2B;PRELID1;EFNA1;PYCARD
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3607754398491899,1.073422041357565,0.29,0.7055692505587328,1.0,60/314,14.16%,RPS27A;UBC;UBB;PSMB4;SEC61B;UBXN1;HSPA5;PSME1;PSMB6;PSMB8;PSME2;PSMD2;KCTD10;HSP90B1;AUP1;PSMD1;UBE2G2;UCHL1;PSMC3;CTNNB1;ECRG4;PSMD6;VCP;PSMA7;CDC34;RNF187;UBA52;KCTD2;FBXL14;FEM1C;FEM1A;NHLRC1;KCTD17;PSMD5;TRIM9;RBX1;FBXO27;TNFAIP1;TRIM2;DDB1;PSMB9;SEL1L2;RBCK1;PSMD13;FBXW5;SYVN1;BUB3;PSMB3;WFS1;DNAJB2;MAN1B1;ZSWIM8;PSMB11;FBXW7;FBXO5;FBXO31;PSMB10;UBQLN2;SPSB3;KBTBD7
prerank,regulation of protein processing (GO:0070613),0.4671972973221178,1.0733788182141912,0.4025641025641026,0.7052407110263281,1.0,5/21,10.39%,SERPINE2;PRNP;TMEM59;PRSS37;GAS1
prerank,external encapsulating structure organization (GO:0045229),0.36372042383862807,1.0730222647734833,0.31093279839518556,0.7057771125230505,1.0,35/205,11.79%,BSG;SPARC;VTN;SPP1;BGN;COL1A1;MMP3;BCAN;LAMC1;LAMB2;LUM;SPOCK2;ITGB2;MMP27;ADAM15;HRNR;PDGFB;ADAMTS4;ADAM12;LOX;COL4A1;FN1;TTR;MMP21;APLP1;TNR;COL3A1;DCN;COL6A1;KDR;LAMC2;COL9A1;COL1A2;PECAM1;MFAP2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.360046192625058,1.0729543757948745,0.29187562688064195,0.7055267996534875,1.0,84/264,26.21%,HSPA8;PCBP1;SNRPG;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;HNRNPK;POLR2D;DDX39B;POLR2F;SYF2;RALY;SNRPD2;LSM6;LSM4;LSM8;UBL5;PUF60;SNRPE;SNRPA;SNRPF;ZMAT2;SRSF9;STRAP;PQBP1;XAB2;HNRNPA0;CD2BP2;RBM15B;PRPF19;YBX1;PRPF8;POLR2G;SRSF2;SF3A2;PABPC1;RBM4B;SNW1;POLR2K;SF3B2;NONO;HNRNPU;SNRPB;HNRNPA1;CPSF2;SF3A3;PRPF31;PDCD7;EIF4A3;SF3B6;LSM7;TXNL4A;U2AF1L4;SNRPD3;SF3A1;SRSF1;ALYREF;HNRNPA3;SNRNP35;BUD31;DHX35;SNRNP200;CDC5L;HNRNPF;SNU13;CPSF4;POLR2H;HNRNPH2;DHX38;SNRPB2;PPWD1;PCBP2;ELAVL1;LSM5;METTL3;METTL14;PRPF40B;PPIE;CELF4;DNAJC8;HNRNPC;SART1
prerank,response to retinoic acid (GO:0032526),0.39485456138892927,1.0721219852140846,0.3745928338762215,0.7072582724759883,1.0,13/59,13.92%,NDUFA13;RBP4;LTK;BRINP3;PTK6;AQP1;WNT5A;BRINP1;SNW1;BRINP2;SOX9;WNT10B;CTSH
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.4091297153255358,1.072022960402861,0.3758465011286682,0.7070846200130406,1.0,10/45,12.51%,AURKAIP1;ZFP36L1;ZFP36L2;CTNNB1;BTG1;CDKN1C;BRINP3;GAS1;BRINP1;BRINP2
prerank,myelin assembly (GO:0032288),0.5331350490705944,1.071861835686952,0.425531914893617,0.7070650140994031,1.0,7/10,31.21%,PMP22;TENM4;ABCA2;EPB41L3;GPC1;CD9;CNTNAP1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.40419808308057653,-1.0718285823242348,0.377431906614786,0.726291824177928,1.0,4/12,16.20%,GMDS;FUT8;PARG;GFPT2
prerank,cellular response to starvation (GO:0009267),0.3688105766778024,1.0717115708409448,0.35454545454545455,0.7070199078273801,1.0,18/147,7.24%,HSPA8;GABARAP;ATP6V0C;MAPK3;HSPA5;ATF4;ATP6V1F;MAP1LC3B;MAP1LC3A;LAMTOR2;LAMTOR4;LAMTOR5;GABARAPL2;ATP6V1G1;GABARAPL1;ATP6V0E2;FADS1;CEBPB
prerank,cellular response to UV-A (GO:0071492),0.518591709962235,1.0715025638854347,0.38928067700987307,0.7071397737312303,1.0,2/11,8.48%,MMP3;TIMP1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5358281908783917,1.0713267133390576,0.41944847605224966,0.7071658205860446,1.0,3/10,16.42%,DCN;CADM4;DAB2IP
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.3343442034990354,-1.0709571324955602,0.33962264150943394,0.7266948989984328,1.0,5/25,6.67%,EXT1;B3GNT2;B3GALT1;HS2ST1;NDST1
prerank,NAD biosynthetic process (GO:0009435),-0.348644726321935,-1.070157411747794,0.35377358490566035,0.7268386222908082,1.0,8/20,20.38%,PTGIS;PARP9;PARP16;PARP10;NUDT12;NADSYN1;NMNAT2;NMNAT3
prerank,dopaminergic neuron differentiation (GO:0071542),0.4637996643110524,1.069618551674259,0.40547588005215124,0.7111989256014967,1.0,6/19,21.52%,CTNNB1;MANF;OTX2;PHOX2A;FOXA2;FOXA1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5103802652823195,1.069556823394363,0.39261285909712723,0.7109080361330161,1.0,2/11,9.39%,KLF2;EPN1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.414115189304299,1.0692298617966967,0.4053738317757009,0.7113045568594902,1.0,9/39,14.80%,FXYD5;FXYD1;YWHAH;YWHAE;SCN4B;FXYD7;FGF12;CHRM3;KCNE5
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4764465514241353,1.0691370112781649,0.42002600780234073,0.7111281013991502,1.0,3/18,13.59%,FCER1G;C5AR1;SH2B2
prerank,neuron differentiation (GO:0030182),0.36656025661458325,1.068914954125103,0.3393939393939394,0.7112934922900677,1.0,59/165,29.46%,ITM2C;NTRK2;PIN1;CTNNB1;TENM3;SPOCK1;TENM2;MANF;OTX2;ATP8A2;IL1RAPL1;CDK5R1;EPHA5;WNT5A;TENM4;PHOX2A;PTPRD;IRX3;WNT10B;UGDH;CDK5;MYEF2;OLIG1;BRSK2;FUT9;ERCC6;MYT1L;BTG4;SOX11;ACSL3;INHBA;FOXA2;DDIT4;MEF2C;FZD1;FZD2;ID2;FOXA1;HS6ST1;ACSL4;IER2;USH2A;WNT7A;OLIG2;SRF;FZD3;RORB;RUNX1;TGFB2;ERCC2;WNT2;XBP1;ALK;FZD5;MTPN;ATP2B2;TENM1;SNPH;IRX5
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.29670853932607777,-1.0687685068303918,0.32558139534883723,0.7287541324227843,1.0,7/39,13.19%,PI4KA;TTC7B;SMG1;ITPKB;IP6K2;PIP4K2C;SOCS5
prerank,RNA splicing (GO:0008380),0.3745702694140629,1.0687270884180564,0.3704474505723205,0.7113547189461583,1.0,25/95,18.98%,SNRPG;MAGOHB;MAGOH;DDX39B;SNRPD2;LSM6;LSM4;PPP2R1A;SNRPF;TARDBP;PRPF8;SRSF2;SF3B2;IVNS1ABP;NONO;SNRPB;RRAGC;SF3A3;CELF3;PDCD7;PPARGC1A;CCAR2;USB1;TXNL4A;SNRPD3
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5159151983350788,1.0685819732363255,0.42441054091539526,0.7112954420966363,1.0,6/11,32.78%,ANK3;SYK;PRKCA;PRKCQ;PLAUR;CCL5
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3304792611389064,-1.0685510638908535,0.3055555555555556,0.7273919879495063,1.0,3/24,6.23%,AUTS2;PLCE1;NCKAP1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.36381557464029307,1.0684889883632562,0.3637284701114488,0.7110940524143833,1.0,31/158,14.82%,CD74;GAPDH;LGALS1;HMOX1;CCL19;S100B;PINK1;S100A13;TNF;RHOC;LAMTOR5;EEF1D;FKBP1A;SHISA5;ECM1;FLNA;TIRAP;TFRC;TMEM101;CLEC6A;TICAM2;TMEM9B;RBCK1;RHOA;BST2;TNFRSF1A;GJA1;RIPK2;UBE2V1;TLR6;F2RL1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.39657685745268,-1.0683078229466263,0.3684210526315789,0.7260373691363019,1.0,2/13,3.48%,KCNK5;KCNT2
prerank,bone development (GO:0060348),0.41930571509597675,1.0678457583043948,0.39863325740318906,0.7123634208052421,1.0,6/39,6.83%,RPL13;PPIB;VKORC1;TGM2;PTPRC;SBDS
prerank,base conversion or substitution editing (GO:0016553),0.5190049551807616,1.0677109782656993,0.40425531914893614,0.712294800241179,1.0,4/11,24.80%,APOBEC2;NUDT16;APOBEC1;METTL3
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.4021835038269534,-1.0676976349649392,0.3882783882783883,0.7255911559041093,1.0,3/12,6.66%,DPYSL3;DPYD;CTPS2
prerank,regulation of neuron migration (GO:2001222),0.4472621035006926,1.067546430796234,0.38413878562577447,0.7122716086426849,1.0,12/26,25.58%,MDK;CTNNA2;ADGRG1;COL3A1;TNN;SHTN1;IGSF10;DAB2IP;NSMF;PLXNB2;KIF20B;CX3CL1
prerank,pancreas development (GO:0031016),-0.41764760011571533,-1.0674546886411116,0.3691275167785235,0.724252057939242,1.0,3/12,9.08%,TCF7L2;MET;NPHP3
prerank,positive regulation of neurogenesis (GO:0050769),0.38378914333873104,1.0670789649658656,0.36785329018338725,0.7130800621565921,1.0,25/68,26.82%,ARHGDIA;SERPINF1;TGM2;GPER1;NTRK2;CTNNB1;IL1RAPL1;SS18L2;PTPRD;SNW1;SOX8;RHOA;ROBO2;CX3CR1;TIAM1;TRIM32;SOX11;PLXND1;SS18L1;PLXNB2;NAP1L1;FZD3;CX3CL1;PLXNB3;PLXNA3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.4533632907030338,1.0665267979493842,0.4175824175824176,0.7140622276006943,1.0,6/23,17.36%,MDK;AGT;SOX8;SOX9;GJA1;PIK3CD
prerank,protein-containing complex subunit organization (GO:0043933),0.3685335275416175,1.066506366115762,0.36119711042311664,0.713679428474474,1.0,28/109,20.88%,CD74;CHCHD10;ELOB;LAMC1;SLC2A1;TAPBP;PPP2R1A;ADD2;HES1;IL2RB;OTX2;RIMS1;CAPZA2;VAMP3;VAMP2;SOX9;MAGI1;TSPAN4;CAPG;SPG7;DMTN;DNM1L;PPARGC1A;EPRS1;LPXN;IL1RAP;CAPN3;TFAP4
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.45990584702874604,1.066501807048389,0.39846743295019155,0.7132583195443929,1.0,6/21,17.38%,IGFBP5;PDGFB;P2RY6;JUN;GJA1;ADAMTS1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4511378390392034,1.066477294910313,0.41676942046855736,0.7128870386782802,1.0,7/22,19.28%,APOD;PARK7;LMAN1;GDI1;DMTN;RANGAP1;CABP1
prerank,protein localization to membrane (GO:0072657),0.35931840279344635,1.066253910861398,0.3548387096774194,0.7130583795566946,1.0,40/187,16.08%,BSG;CD81;RAMP2;KCNIP4;NRXN1;NLGN1;S100A10;ITGB2;ANK3;TNF;EMP2;DPP10;DLG2;PACSIN1;FLOT1;FLNA;CPE;MYADM;RAB15;MYO5A;TMED2;DPP6;THY1;RAB3C;P2RY1;ABHD17A;RAB3D;RAMP3;NRXN2;TNFRSF1A;MAP7;GAS6;EHD1;LRRC7;LIN7C;SPTBN4;FRMPD1;EPB41L3;ATP1B1;FGF13
prerank,protein localization to plasma membrane (GO:0072659),0.36574326122258066,1.0659508206697974,0.35845213849287166,0.7134247884622799,1.0,30/129,16.08%,BSG;CD81;RAMP2;KCNIP4;S100A10;ANK3;TNF;EMP2;DPP10;PACSIN1;FLOT1;FLNA;MYADM;RAB15;MYO5A;TMED2;DPP6;RAB3C;P2RY1;RAB3D;RAMP3;TNFRSF1A;MAP7;GAS6;CCDC88A;EHD1;SPTBN4;EPB41L3;ATP1B1;FGF13
prerank,response to lipopolysaccharide (GO:0032496),0.37152249979355045,1.065905849044964,0.3553299492385787,0.7131162021453946,1.0,39/138,21.99%,VIM;PDE4B;NR1D1;S100A8;S100A9;SIRPA;TIRAP;TNFAIP3;CD180;CCR5;HNRNPA0;CXCL10;CD68;TICAM2;HMGB1;ZFP36;WNT5A;CHMP5;RHOA;SLC11A1;CCL2;ERBIN;LILRB1;CX3CR1;PF4;DAB2IP;ADAM17;NOS2;CD14;SNCA;CD86;NLRP3;IL6;GIT1;MEF2C;SELENOS;PYCARD;NUGGC;LBP
prerank,cortical cytoskeleton organization (GO:0030865),0.40474019494944186,1.0651876773436924,0.3979706877113867,0.7145223435908266,1.0,14/41,17.64%,RHOB;NLGN1;TNF;RHOC;RAC1;RHOG;LCP1;ARF6;FMNL1;RHOA;EPB41L3;FHOD3;FMNL3;RAC2
prerank,mRNA splice site selection (GO:0006376),-0.3130925271781385,-1.0650084392248782,0.32727272727272727,0.7288832605791041,1.0,7/30,11.18%,CELF2;LUC7L2;SFSWAP;YTHDC1;KHDC4;PRPF39;SETX
prerank,negative regulation of cell development (GO:0010721),0.44381839150008645,1.0648573931767467,0.39627329192546584,0.7149568623010715,1.0,10/25,23.39%,B2M;TNF;SORL1;RFLNB;FBXW7;LILRB1;IL6;NOTCH1;REST;WNT7A
prerank,protein homotetramerization (GO:0051289),0.39569339145275684,1.0647415001531126,0.41511500547645125,0.7148403744050081,1.0,3/49,2.26%,ALDOA;B2M;AQP4
prerank,granulocyte differentiation (GO:0030851),0.4686914584438726,1.0645174438092893,0.40498034076015726,0.7149754241521552,1.0,3/18,10.53%,SPI1;CEBPA;DEK
prerank,TOR signaling (GO:0031929),0.43433106753148526,1.063568228986941,0.3919239904988123,0.7170717810538585,1.0,7/26,14.46%,AKT1;RPS6;PINK1;PRR5L;RHEBL1;CCDC88A;PRR5
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.41175931522362086,-1.0633017057772063,0.3423728813559322,0.7315712769211393,1.0,4/11,8.31%,GHR;IRS1;EIF2AK3;IGF1
prerank,neurotransmitter uptake (GO:0001504),0.4981787459583284,1.0628811910734302,0.41274238227146814,0.7184210893379452,1.0,4/12,15.07%,SNAP25;GLUL;SLC29A1;SLC29A2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.36046484264103884,-1.0619340951959633,0.34523809523809523,0.7332572684299977,1.0,9/16,16.69%,SMG6;DHX36;SLX4;TNKS2;TERF2;ATM;TINF2;PINX1;RTEL1
prerank,sensory perception of taste (GO:0050909),0.5242800599145596,1.0617165236191364,0.426367461430575,0.7210690110068618,1.0,5/10,32.75%,ASIC2;PKD2L1;TAS1R1;CD36;PKD1L3
prerank,sulfation (GO:0051923),-0.4276988393105767,-1.0615565263472508,0.36363636363636365,0.732292765931038,1.0,1/11,0.07%,UST
prerank,positive regulation of glucose metabolic process (GO:0010907),0.48320881363875784,1.0611495892063807,0.395128552097429,0.7221005106456392,1.0,5/14,17.90%,AKT1;DDB1;PMAIP1;ARPP19;PPARGC1A
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.41804974865602346,1.061094167699963,0.40731995277449823,0.7218157753228552,1.0,13/32,26.18%,MAPK3;CCT2;CTNNB1;CCT7;CCT8;HNRNPA1;MAPK15;MAP2K7;CCT4;NAF1;PNKP;CCT3;PRKCQ
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.3781169527582987,-1.0605936458672824,0.39923954372623577,0.7328899074509255,1.0,3/14,4.74%,ACTN2;ANK2;AKAP9
prerank,regulation of protein autophosphorylation (GO:0031952),0.417073756734517,1.0605776970177048,0.4070175438596491,0.722712768785944,1.0,4/36,4.03%,CALM1;GPNMB;CALM3;PDGFB
prerank,oogenesis (GO:0048477),0.4835063871218542,1.0602439816129985,0.41633199464524767,0.723149921133812,1.0,6/15,24.80%,MDK;FMN2;NANOS2;PTN;IHO1;METTL3
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.34720179555439423,-1.0597005246229165,0.386046511627907,0.733419145769134,1.0,4/18,2.54%,ROCK2;BCAS3;ARFGEF1;ROCK1
prerank,regulation of mitotic spindle organization (GO:0060236),0.41357791560969426,1.0596923302218824,0.3821805392731536,0.7241596603647598,1.0,11/35,19.20%,HSPA1B;CHMP2B;CLTC;GNAI1;TACC3;CHMP5;DCTN1;HSPA1A;HNRNPU;CHMP1B;RAE1
prerank,regulation of T cell cytokine production (GO:0002724),0.475240351642702,1.0595175171776463,0.399734395750332,0.7242098931580089,1.0,1/15,0.77%,B2M
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.41219604569015306,1.0594775752649195,0.3870601589103292,0.7238776745079936,1.0,15/41,29.17%,CTSS;AKAP6;ANK3;FLNA;KCNJ10;KCNN2;KCNE5;KCNMA1;GABBR2;KCNJ3;KCNJ6;KCNMB4;KCNN4;KCNQ1;STAC
prerank,cellular response to sterol (GO:0036315),-0.39960298233746294,-1.05941520749627,0.35793357933579334,0.732197858864745,1.0,3/13,4.45%,SMO;LRP6;GRAMD1C
prerank,macrophage differentiation (GO:0030225),-0.39405146410138003,-1.0594130270491597,0.3906810035842294,0.7302326482740412,1.0,5/13,13.89%,IL31RA;IL15;BMP4;SIRT1;CASP8
prerank,steroid hormone biosynthetic process (GO:0120178),0.42710250601177585,1.0588684749610355,0.40639810426540285,0.7250199081999876,1.0,6/29,21.16%,TSPO;HSD17B6;FDX2;HSD3B2;STARD3NL;HSD17B11
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3905578243469884,-1.05860980523599,0.362962962962963,0.7303614925439802,1.0,4/13,8.31%,SORBS1;IRS1;INSR;IGF1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.43459205462103945,1.0585832451985184,0.409035409035409,0.7253313172134837,1.0,5/26,7.61%,NRXN1;NLGN1;GRIN1;RIMS2;RIMS1
prerank,brain development (GO:0007420),0.3667183016478084,1.058491187709954,0.39263803680981596,0.7251336069085096,1.0,37/136,20.43%,APOD;CTNNA2;NES;CNTNAP2;CNTN4;SCTR;NDRG4;ADGRL3;ABCB6;GRIN1;COL4A1;NKX2-2;TMX2;ADGRG1;PHGDH;UFC1;GRIN2A;PROX1;MAST1;MFSD2A;SLC6A17;AATK;CDK5R1;DNAJC30;HAP1;CLN5;CXCR4;ROBO2;CX3CR1;DSCAML1;IER3IP1;HSPG2;GRIN2B;QARS1;RAB18;NNAT;DDIT4
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4636043533594959,1.0581370459936241,0.41229193341869397,0.7256411116991077,1.0,6/18,18.59%,NRXN1;NLGN1;CCL2;CACNG8;CCR2;CACNG5
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4702856037041678,1.0576301504267769,0.40688775510204084,0.726566920636985,1.0,5/17,17.06%,APOC1;LPL;SORT1;NR1H2;HDAC9
prerank,apoptotic DNA fragmentation (GO:0006309),0.47189161640377036,1.0573680781556043,0.42493638676844786,0.7268274422965538,1.0,4/16,10.46%,ENDOG;FOXL2;HMGB1;H1-0
prerank,inorganic cation transmembrane transport (GO:0098662),0.35534841839105225,1.0569167831500001,0.3517034068136273,0.7275778242624996,1.0,61/268,20.02%,ATP5MF;ATP6V0C;ATP5F1B;SLC30A1;ASIC2;ATP6V1F;SLC39A1;UCP2;SLC24A4;SLC24A2;SCN1A;KCNQ3;KCNQ2;FKBP1A;KCNC3;KCND2;CACNA1A;ATP6V0E2;KCNJ10;ATP1A3;SLC39A7;HVCN1;TMCO1;P2RX7;SLC6A6;SLC6A17;SLC6A2;SLC6A5;SCN4B;KCNC1;SLC6A16;KCNA2;TRPM2;TRPC7;KCNN2;ATP1A4;ATP1A1;SLC40A1;KCNK9;SLC11A1;KCNF1;SLC25A27;ABCC8;GAS6;TRPC1;SLC8A1;ATP1B1;KCNK3;KCNA1;HCN1;ORAI1;SLC9A9;LRRC55;HCN3;KCNK10;ATP1B3;KCNH7;KCNH8;KCNK13;PKD2L1;KCNQ5
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.4931461798162152,1.056842158258805,0.4233983286908078,0.7273307808034769,1.0,8/12,31.51%,UCK1;UCKL1;CDA;UPP1;TK1;TK2;CAD;DCK
prerank,axonal fasciculation (GO:0007413),0.5052382656332609,1.0567208742170948,0.4373297002724796,0.7272285379805217,1.0,4/12,9.55%,CNTN4;RTN4;NRCAM;CDK5R1
prerank,icosanoid metabolic process (GO:0006690),0.40204284486468705,1.056711786917615,0.38171428571428573,0.7268144694898921,1.0,7/40,17.18%,GPX4;GPX1;FADS1;DPEP2;ALOX5AP;FAAH;LTC4S
prerank,lipid biosynthetic process (GO:0008610),0.38026392717248675,1.0566316344568998,0.39213602550478216,0.7265856416563443,1.0,20/77,27.23%,SCD5;SCP2;FADS1;LIPG;LPL;LSS;PCYT2;OXSM;SCD;HSD3B2;CLN8;AGPAT5;PDSS1;NDUFAB1;ACSM5;PRLR;ACLY;GPAM;XBP1;HSD17B8
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.2792502907818353,-1.0565873252976803,0.3220338983050847,0.7338777367501716,1.0,10/43,11.10%,SMAD3;NFIB;TEAD1;PPARA;FOXO3;NFATC4;STAT3;PPARG;NFATC3;TERT
prerank,cellular defense response (GO:0006968),0.4104006949517847,1.0558646688444435,0.40660592255125283,0.7281013364328532,1.0,17/40,29.90%,TYROBP;CD5L;LGALS3BP;C5AR1;CCR5;KLRG1;CX3CR1;NCR1;NCF1;TRAT1;LBP;RELA;NCF2;ITGB1;ITK;TCIRG1;RAB23
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.3120068662414015,-1.0554964857778604,0.32967032967032966,0.7348956340424341,1.0,9/27,15.79%,FBXL17;PER2;PER3;PML;SIK1;RBM4;FBXL12;CRY1;TP53
prerank,mRNA processing (GO:0006397),0.35263989571712595,1.0553613084649955,0.3420260782347041,0.7289555412056291,1.0,97/287,26.59%,HSPA8;PCBP1;SNRPG;AURKAIP1;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;HNRNPK;POLR2D;DDX39B;POLR2F;SYF2;RALY;SNRPD2;LSM6;LSM4;LSM8;UBL5;PUF60;SNRPE;SNRPA;SNRPF;ZMAT2;SRSF9;PQBP1;XAB2;HNRNPA0;CD2BP2;RBM15B;PRPF19;YBX1;PRPF8;POLR2G;SRSF2;SUPT4H1;SF3A2;PABPC1;RBM4B;SNW1;POLR2K;CMTR1;SF3B2;NONO;HNRNPU;SNRPB;HNRNPA1;CPSF2;SF3A3;THOC3;PRPF31;PDCD7;EIF4A3;SF3B6;LSM7;TBRG4;PPARGC1A;TXNL4A;U2AF1L4;SNRPD3;SF3A1;SRSF1;ALYREF;HNRNPA3;SNRNP35;BUD31;DHX35;SRRM4;SNRNP200;CDC5L;HNRNPF;SNU13;CPSF4;POLR2H;RAMAC;HNRNPH2;DHX38;SNRPB2;PPWD1;PCBP2;ELAVL1;ALKBH5;LSM5;METTL3;METTL14;PRPF40B;PRKACA;PPIE;GTF2H5;DNAJC8;HNRNPC;SART1;RPRD1A;CCNH;ERCC2;SYMPK
prerank,positive regulation of lipid kinase activity (GO:0090218),0.42659241984665824,1.0551124234839393,0.41309523809523807,0.7291730637087166,1.0,5/29,9.20%,CD81;CCL19;PDGFB;EEF1A2;P2RY12
prerank,response to peptide hormone (GO:0043434),-0.28958242686357516,-1.0545523801956551,0.3684210526315789,0.7354807973162986,1.0,14/43,15.64%,ROCK2;TGFBR3;STAT5B;ROCK1;OGT;IRS1;EIF2B3;STAT3;STAT2;SIRT1;EIF2B2;TSC1;CRY1;STAT5A
prerank,positive regulation of type I interferon production (GO:0032481),0.3781304487165973,1.054386310689248,0.3976545842217484,0.7306246214539728,1.0,19/73,22.20%,GAPDH;HSP90AA1;POLR2E;POLR2F;FLOT1;CTNNB1;ISG15;PQBP1;HSPD1;POLR2K;IRF7;RIPK2;G3BP1;OAS3;CD14;POLR3D;POLR3K;POLR2H;IRF5
prerank,serine family amino acid biosynthetic process (GO:0009070),0.5026117112429427,1.0532942368701916,0.4092769440654843,0.7330127225136146,1.0,3/12,14.63%,SERINC3;PHGDH;SERINC5
prerank,regulation of response to biotic stimulus (GO:0002831),-0.3140478644599353,-1.0531965157109437,0.3655913978494624,0.7373867538243688,1.0,11/28,18.37%,FOXP1;APPL2;BIRC2;RNF135;TRIM5;BIRC3;CASP8;PTPN22;APPL1;CD55;DHX58
prerank,protein localization to synapse (GO:0035418),0.5061361285321447,1.0531628596047438,0.40782122905027934,0.7329116217307098,1.0,3/12,12.77%,NRXN1;NLGN1;NRXN2
prerank,regulation of synapse maturation (GO:0090128),0.5183238946828284,1.0531160218953795,0.409288824383164,0.7326059617989437,1.0,6/10,33.33%,NRXN1;YWHAZ;DAB2IP;CDC20;CAMK2B;RELN
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.47076233927195477,1.0530407022089068,0.43861892583120204,0.7319308363555705,1.0,5/16,7.08%,APOD;ACVRL1;DLC1;FAM107A;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.47076233927195477,1.0530407022089068,0.43861892583120204,0.7319308363555705,1.0,5/16,7.08%,APOD;ACVRL1;DLC1;FAM107A;CORO1C
prerank,regulation of protein secretion (GO:0050708),0.367150941637967,1.0527967660816175,0.3894628099173554,0.7321376624622236,1.0,30/119,22.21%,APOE;PPIA;UQCC2;MTNR1B;TREM2;SLC2A1;SNAP25;TNF;ANG;CACNA1A;ABCG1;ARF6;DPH3;ATP13A2;STXBP5L;APBB1;ABCC8;IER3IP1;ACHE;SLC2A2;DNM1L;NOS2;ERP29;TGFB1;TFAP2B;IL6;TMED10;RSAD2;KCNC2;LLGL1
prerank,regulation of focal adhesion assembly (GO:0051893),0.3950329926103286,1.052480727249383,0.4037199124726477,0.7325088617045892,1.0,13/54,8.70%,ACTG1;APOD;S100A10;RAC1;ACVRL1;GPM6B;DUSP3;DLC1;FAM107A;CORO1C;THY1;CLASP1;KDR
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.31452858345806656,-1.052464378856628,0.3696969696969697,0.7373412229562935,1.0,10/31,14.62%,PARD3B;PARD3;PDCD6IP;DLG1;SYNJ2BP;PDZD11;OPHN1;MARK2;PRKCI;MYO9A
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.39445341320906335,1.0524409625452542,0.3900789177001127,0.7321819866217251,1.0,9/47,10.02%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;CORO1C;P4HB;ARHGEF7
prerank,positive regulation of reproductive process (GO:2000243),0.4212576099007056,1.0523458460836401,0.4138755980861244,0.7319763803133597,1.0,8/31,23.84%,PGAM4;PRSS37;TACR1;GLRA1;INHBA;INHBB;SIRT2;C1QBP
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.39160755107957973,1.051785772390746,0.41169853768278963,0.7329413401081791,1.0,14/48,25.06%,CRIP1;RPS27L;CHEK2;HIPK2;BAX;TMEM109;SNW1;HIC1;DDIT4;PYCARD;BAK1;PHLDA3;DYRK2;BOK
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.47173696624656014,1.051546992249359,0.42463958060288337,0.7331223541607229,1.0,4/16,10.33%,ZFP36L1;ZFP36L2;ZFP36;TARDBP
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.35038136048543117,-1.0513542605400341,0.3755656108597285,0.7385587239968374,1.0,7/19,16.38%,SMAD6;ACVR1;BMPR1A;MDM4;SMAD4;HEY2;BMPR2
prerank,lipid oxidation (GO:0034440),0.49957300394094784,1.0512073269713278,0.43579234972677594,0.733580521426638,1.0,5/12,35.20%,PLA2G7;PPARGC1A;ADIPOR1;ACOX1;ADIPOR2
prerank,regulation of lipid storage (GO:0010883),0.4450396614400588,1.0509299284076121,0.4216417910447761,0.7338261025387223,1.0,7/22,20.69%,C3;TNF;LPL;ALKBH7;FBXW7;IL6;NFKBIA
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5187922486924205,1.050642222893139,0.42857142857142855,0.7341268023865974,1.0,4/10,27.07%,UBE2G2;SVIP;OS9;UBE2J1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.35966509551424886,1.0501620762557498,0.3876518218623482,0.734913538223124,1.0,36/142,17.62%,CD52;CHRNA9;GPER1;TAC1;FZD9;C5AR1;CAV2;CACNA1A;YWHAE;CCR5;CALB1;PLN;TACR1;CD24;P2RY1;HMGB1;WNT5A;CALCB;ATP2B1;TRPC7;CXCR4;TRPC1;CX3CR1;F2RL1;SLC8A1;RYR2;ADRA1A;ADRA1D;ADCY8;CCKBR;CAV1;FKBP1B;BCAP31;HCRTR1;PTGIR;ADCYAP1
prerank,histone ubiquitination (GO:0016574),-0.3359495048311265,-1.0498146047504482,0.35348837209302325,0.7405075058325387,1.0,11/21,29.44%,HUWE1;RNF8;UBR2;CDC73;UBE2E1;WAC;RNF20;CTR9;PHC1;UBE2U;LEO1
prerank,regulation of platelet aggregation (GO:0090330),0.47110687558588105,1.049378740361027,0.4365284974093264,0.7364747183609447,1.0,6/17,27.27%,SERPINE2;DMTN;SYK;PRKCA;PRKCQ;CD9
prerank,thymus development (GO:0048538),0.4965334239070802,1.0492757123679173,0.45609065155807366,0.7363251465007925,1.0,2/13,5.69%,SOD1;HES1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.41724230656890726,1.0492040755993608,0.39390243902439026,0.7360743128315176,1.0,11/32,22.68%,SLC30A1;GPER1;RIMS2;RIMS1;SYT11;SYN1;HCRT;PREPL;MEF2C;STX1B;CHRNA3
prerank,regulation of collagen biosynthetic process (GO:0032965),0.46309991449476445,1.0491905163017199,0.41845764854614415,0.7356802498233652,1.0,1/19,0.70%,VIM
prerank,nucleic acid metabolic process (GO:0090304),0.38126680765364845,1.0491350324352655,0.4114470842332613,0.7353822757903581,1.0,23/69,24.90%,PCBP1;POLR2E;HNRNPK;POLR2D;POLR2F;RAN;LSM8;HNRNPA0;POLR2G;POLR2K;HNRNPU;PDE12;HNRNPA1;RECQL5;WDR74;HNRNPA3;POLG;HNRNPF;POLR2H;HNRNPH2;PCBP2;METTL3;METTL14
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.40324027933025,-1.0491115823668353,0.42105263157894735,0.7403823617929297,1.0,5/12,14.55%,PARP12;PARP16;PARP3;TNKS2;PARP10
prerank,extracellular structure organization (GO:0043062),0.35546270027626264,1.048964115017751,0.3831494483450351,0.7353798954780452,1.0,34/204,11.79%,BSG;SPARC;VTN;SPP1;BGN;COL1A1;MMP3;BCAN;LAMC1;LAMB2;LUM;SPOCK2;ITGB2;MMP27;ADAM15;PDGFB;ADAMTS4;ADAM12;LOX;COL4A1;FN1;TTR;MMP21;APLP1;TNR;COL3A1;DCN;COL6A1;KDR;LAMC2;COL9A1;COL1A2;PECAM1;MFAP2
prerank,cellular response to lipid (GO:0071396),0.3612660525680557,1.0488074011500108,0.3845381526104418,0.7353434056870263,1.0,56/191,22.27%,VIM;SPP1;NDUFA13;PDE4B;GPER1;ADAM15;NR1D1;SIRPA;TNFAIP3;CD180;LTK;MSN;MGST1;ATP1A3;BRINP3;CCR5;LPL;PTK6;CXCL10;AQP1;CD68;TICAM2;HMGB1;GNAI1;ZFP36;WNT5A;CHMP5;BRINP1;RAMP3;ATP1A1;SNW1;BRINP2;RHOA;SOX9;CCL2;LILRB1;WNT10B;CX3CR1;PF4;DAB2IP;ADCY8;NCOA4;CD14;SFRP1;CD86;NLRP3;SPHK2;IL6;GIT1;POU4F1;MEF2C;SELENOS;PYCARD;NUGGC;LBP;SSTR2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.5038027619773661,1.048668079784455,0.4310850439882698,0.7352370694639182,1.0,6/10,35.65%,PIH1D1;TAF9;NAF1;RUVBL2;ZNHIT3;NUFIP1
prerank,Rho protein signal transduction (GO:0007266),0.3890386360952071,1.0476856331476525,0.42414174972314506,0.7373165974124362,1.0,13/53,14.04%,ARHGDIA;CFL1;RHOB;ARHGDIB;RHOG;ADGRG1;NTN1;RHOV;ARHGDIG;COL1A2;RHOA;SHTN1;RHOU
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2821363357285137,-1.0476644151862353,0.36607142857142855,0.7424295219668609,1.0,10/44,11.23%,FCHSD2;FER;BAIAP2L1;PRKCE;BAIAP2;CARMIL1;NCKAP1;CDC42EP5;SNX9;NCK1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4622736743683382,1.047497500286728,0.41130091984231276,0.7373885736208966,1.0,8/17,16.95%,ATP1A3;ATP1B2;ATP1A1;GJA1;SLC8A1;ATP1B1;RYR2;FKBP1B
prerank,glycine metabolic process (GO:0006544),0.4878788518710047,1.0474587819865813,0.4366576819407008,0.7370447022505502,1.0,7/12,34.93%,SDS;GLYAT;SHMT2;DLD;RIDA;GCAT;GCSH
prerank,protein sumoylation (GO:0016925),-0.27447680161907795,-1.0473018261444262,0.39805825242718446,0.7414490928170349,1.0,18/49,22.39%,EYA1;RANBP2;NSMCE2;PIAS1;PIAS2;NUP98;SAE1;TOPORS;TRPM4;STX1A;AAAS;NUP214;NUP35;NDC1;NUP62;TPR;NUP93;NUP160
prerank,regulation of receptor internalization (GO:0002090),0.41484032482776934,1.047186373674016,0.4188235294117647,0.7372754786277989,1.0,8/35,16.13%,CD63;FLOT1;LRPAP1;SFRP4;SDCBP;ARF1;ANKRD13D;ARRB2
prerank,cellular response to growth factor stimulus (GO:0071363),0.358346839099176,1.0471564486579525,0.3929292929292929,0.7369162117686258,1.0,27/151,13.65%,EEF1A1;MT1G;RACK1;RAMP2;HSPB1;AKT1;LGMN;ZFP36L1;PDGFB;ACVRL1;NTRK2;ZFP36L2;DUSP3;CTNNB1;HYAL2;CLEC3B;KDR;MAPT;ZFP36;GAS1;WNT5A;FLT4;AMHR2;KLF4;SOX9;BMP2;CCL2
prerank,cellular response to light stimulus (GO:0071482),0.3883208204743256,1.0467650454856285,0.43088552915766737,0.7374332982752755,1.0,9/66,12.26%,RPL26;ATF4;NPM1;COPS9;PARP1;AQP1;SMPD1;PCNA;NSMCE3
prerank,protein modification by small protein removal (GO:0070646),0.3535290343200271,1.0467563522739125,0.37737737737737737,0.7370330490071135,1.0,62/252,21.16%,ACTB;RPS27A;UBC;UBB;PSMB4;EIF3F;PSME1;PSMB6;PSMB8;PSME2;COPS7A;PSMD2;RCE1;COPS6;PSMD1;UCHL1;PSMC3;TNFAIP3;PSMD6;VCP;PSMA7;USP51;UBA52;USP5;ABRAXAS2;TAF10;PSMD5;NEDD8;OTUD7A;RNF128;PSMB9;PSMD13;PSMB3;USP29;PSMB11;RHOA;PSMB10;OTUD6B;COPS8;USP26;BABAM1;TRAF3;OTUB1;PSMB1;KDM1B;ARRB2;PSMB5;USP8;USP22;CDC25A;PSMA6;TAB1;RAD23A;DESI2;DESI1;NLRP3;WDR48;PSMA4;NFKBIA;MYC;ACTR5;CCP110
prerank,actin filament polymerization (GO:0030041),0.42107825038979346,1.0467163818000387,0.4418604651162791,0.7367158374209876,1.0,6/29,13.06%,GSN;RAC1;ANG;FAM107A;AIF1;MSRB1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.3995578994248573,-1.0466654370751922,0.37630662020905925,0.741280929447773,1.0,4/12,8.31%,SORBS1;IRS1;INSR;IGF1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.426976652597546,1.0465837719313138,0.4233128834355828,0.7366290419831536,1.0,8/27,16.49%,RNASE1;RNASE4;NHP2;POP7;RNASEH1;TOE1;PDE12;NUDT16
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.263488532246104,-1.0460610647498032,0.3888888888888889,0.7409715697378304,1.0,18/63,13.89%,WWOX;TCF7L2;ACVR1;BIRC6;CFLAR;ZMYND11;SH3RF1;TGFBR1;PML;IGF1;SP100;RIPK1;BCL2L12;AR;DEPTOR;BMP4;PHIP;CASP8
prerank,skeletal muscle tissue development (GO:0007519),0.41904876867342505,1.0458727292494805,0.43387470997679817,0.7379777470353001,1.0,8/32,20.77%,MYL6;CAV2;FOXL2;MYL6B;CAV1;SELENON;MEF2C;MYH14
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.36485451858286433,-1.0456504719580904,0.3902439024390244,0.7400999576106344,1.0,6/15,18.91%,LARGE1;OGA;MGAT3;RENBP;CHST3;NAGK
prerank,acidic amino acid transport (GO:0015800),0.46746767075574147,1.045586911444655,0.4370179948586118,0.7382928541458782,1.0,6/17,13.64%,SLC1A2;SLC25A13;SLC6A6;SLC25A22;SLC1A1;GJA1
prerank,carbohydrate transport (GO:0008643),0.5010025915522183,1.0452203938483984,0.42712842712842713,0.7387977429240321,1.0,3/11,16.67%,AQP1;SLC50A1;SLC2A2
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4358379704755307,1.045123593801692,0.4298245614035088,0.7385965929782933,1.0,12/24,34.10%,ITGB2;MSN;PECAM1;VCAM1;SYK;CERCAM;TNIP1;ITGB1;CCL5;SEMA4D;ITGAL;FERMT3
prerank,regulation of protein import into nucleus (GO:0042306),0.4097336204546157,1.0449197476140344,0.4182242990654206,0.7386831038785248,1.0,6/36,7.67%,APOD;RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,protein O-linked mannosylation (GO:0035269),-0.34777469363681457,-1.0448940878147541,0.4084507042253521,0.7402604782952137,1.0,3/18,1.56%,TMTC1;LARGE1;TMTC4
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3674035946985727,1.044831790267344,0.427536231884058,0.738471552280072,1.0,28/100,19.83%,MAPK3;TREM2;AGT;GPER1;IER3;TNF;PDGFB;HCLS1;NTRK2;FN1;EPOR;DCN;KDR;PIK3IP1;SOX9;F2RL1;PDGFA;NCF1;DAB2IP;TWIST1;PIK3CD;FLT1;ERBB3;MAZ;NOP53;PTPN6;HGF;FLT3
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.48072378718464914,1.044625952882869,0.42971887550200805,0.7385529689778677,1.0,4/13,17.39%,SYT1;SYT4;SYT10;DOC2B
prerank,negative regulation of synaptic transmission (GO:0050805),0.44179642763253474,1.044450531865269,0.4240102171136654,0.738583094459966,1.0,5/23,15.87%,SLC30A1;SLC24A2;SYT11;ARF1;ACHE
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.43192445791315287,1.0441069800107816,0.4236024844720497,0.7390691905780435,1.0,3/23,9.18%,CALM1;METAP1;METAP2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.37190436411282884,-1.0438114921932298,0.39357429718875503,0.7411543977925852,1.0,6/15,20.52%,NIPBL;TGFBR1;FGFR2;SIX1;MTHFD1L;PDGFRA
prerank,axonal transport of mitochondrion (GO:0019896),0.5015666186400642,1.043786289154601,0.4283667621776504,0.7394670592490715,1.0,3/11,11.30%,NEFL;MAPT;HAP1
prerank,protein deubiquitination (GO:0016579),0.352891922520257,1.0437685551555693,0.37975951903807614,0.7390832474696611,1.0,73/242,25.29%,ACTB;RPS27A;UBC;UBB;PSMB4;EIF3F;PSME1;PSMB6;PSMB8;PSME2;PSMD2;RCE1;PSMD1;UCHL1;PSMC3;TNFAIP3;PSMD6;VCP;PSMA7;USP51;UBA52;USP5;ABRAXAS2;OTULIN;TAF10;PSMD5;NEDD8;OTUD7A;RNF128;PSMB9;PSMD13;PSMB3;USP29;PSMB11;RHOA;PSMB10;OTUD6B;USP26;BABAM1;TRAF3;OTUB1;PSMB1;KDM1B;ARRB2;PSMB5;USP8;USP22;CDC25A;PSMA6;TAB1;RAD23A;DESI2;NLRP3;WDR48;PSMA4;SHMT2;NFKBIA;MYC;ACTR5;CCP110;USP13;SUDS3;TNIP1;PSMD9;PSMC1;BARD1;PSMD4;IL33;CDC20;HGS;BAP1;CCNA2;TAF9B
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3422186779972568,-1.0437613237005001,0.38860103626943004,0.7393487146367678,1.0,3/21,2.13%,ADCY9;ADCY1;ADCY5
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.4990319622669762,1.0435689183455235,0.4190871369294606,0.7391809135812125,1.0,3/11,10.02%,CORO1C;ENPP2;ARHGEF7
prerank,erythrocyte development (GO:0048821),0.5121208430186814,1.0434675032872671,0.4175977653631285,0.7390221012106352,1.0,5/10,31.95%,ZBTB7A;ABCB10;DMTN;ALAS2;ALAS1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.3878828701628443,1.0432972745385989,0.41073384446878425,0.7390170906999788,1.0,15/55,20.78%,MT3;AGT;PINK1;RAC1;PDGFB;ROMO1;DCXR;ARF4;RAC2;BCO2;SNCA;CBR1;SPHK2;GADD45A;SIRT2
prerank,vascular transport (GO:0010232),0.36896754991475345,1.0429346996696776,0.4201058201058201,0.7394474598261307,1.0,21/81,15.75%,SLC38A5;SLC2A1;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;TFRC;ATP1B2;SLC6A6;MFSD2A;SLC6A17;SLC29A1;LRP3;ATP8A1;ATP1A4;SLC1A1;SLC19A1;ABCA2;SLC29A2;SLC15A2;SLC16A1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.4515060438673765,1.0423691390406373,0.42297979797979796,0.7404838154428458,1.0,5/19,14.94%,GMPPB;PMM1;AMDHD2;NANS;UGDH
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4650143231651305,1.0415333758289542,0.4620253164556962,0.7422364848549882,1.0,2/16,2.92%,ACADVL;APOC1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.368721743892031,1.0414755143894152,0.42436974789915966,0.7419482754521902,1.0,24/78,21.01%,CLU;RACK1;GABARAP;ELOB;HSPA1B;VCP;USP5;CEBPA;RBX1;SUMO2;DNAJB2;HSPA1A;UBQLN2;HSPBP1;SGTA;CAV1;HERPUD1;BCAP31;NOP53;DDRGK1;RNF144B;RAD23A;SIRT2;STUB1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.43805109367833145,1.0411451824887106,0.42998760842627015,0.7423323582083465,1.0,9/20,18.67%,CALM1;CALM3;GSTO1;GSTM2;SLC8A1;ATP1B1;RYR2;FKBP1B;CALM2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4135411266165424,1.04074733021528,0.4209905660377358,0.7429601559918257,1.0,9/32,26.27%,CHKB;CSNK2B;MFSD2A;CHAT;ACHE;SLC44A5;STARD10;SLC44A2;SLC44A1
prerank,axon guidance (GO:0007411),0.35318828037576266,1.0405232164749771,0.40945674044265595,0.7431053393131751,1.0,53/201,18.10%,BSG;CXCL12;MAPK3;DCC;NRXN1;UNC5D;LYPLA2;SEMA3F;RAC1;DSCAM;CNTN4;SEMA7A;SEMA4C;SHC3;LGI1;NRXN3;RHOG;DAB1;OTX2;TNR;SEMA6D;ROBO4;NTN1;EMB;LGR6;UNC5C;CDK5R1;KIF5A;LAMC2;EPHA5;SEMA4A;LRTM2;WNT5A;GFRA1;DOK5;CXCR4;SEMA4G;ROBO2;IGSF9;SH3KBP1;SPTBN4;DSCAML1;GFRA2;EPHB1;GAP43;SPTBN2;EFNB1;SLIT3;SLIT1;PIK3CD;RAC2;NCAM1;KIF5C
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.22338976898216054,-1.040273372912799,0.3076923076923077,0.7467560996951593,1.0,51/166,18.44%,TEAD1;NOTCH2;NR3C2;RARB;CREBBP;MAML2;NR6A1;MNAT1;THRB;TAF15;PPARA;RARG;YAP1;KAT2B;NCOR1;TBL1X;NR1D2;TAF1D;SMARCA5;MAML1;TAF1A;GTF3C1;TBL1XR1;TEAD2;ESR1;PPARG;NR2C2;GTF2E2;MED26;RBPJ;TAF2;POLR2A;AR;NR2F1;GTF2H4;CRCP;POLR2B;CDK7;RSF1;POLR2J;GTF2A2;ESRRA;NR3C1;TAF8;ERCC3;TAF4B;NR5A2;RRN3;GTF2H2;TAF7;MED23
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4816924011167399,1.0400231905972939,0.44813829787234044,0.743988123999847,1.0,2/14,3.48%,PPP1CA;PPP1R15B
prerank,positive regulation of protein secretion (GO:0050714),0.37393529526883634,1.0397031301682724,0.434643995749203,0.7444075194819237,1.0,21/69,20.96%,PPIA;TREM2;LRRC8A;TRH;RBP4;GPER1;ANG;ABCG1;ARF6;ATP13A2;APBB1;F2RL1;BAD;IER3IP1;ACHE;DNM1L;DOC2B;GLUD1;TGFB1;NNAT;TMED10
prerank,regulation of MAP kinase activity (GO:0043405),0.3667035490974947,1.0392745314252483,0.4153686396677051,0.7450521914268105,1.0,22/92,19.83%,APOE;AGT;TNF;PDGFB;SORL1;UCHL1;RGS2;HYAL2;CD24;SMPD1;HRAS;SPRY1;NEK10;PDGFA;RASGRP1;EDN3;DAB2IP;FLT1;CD300A;TGFB1;SPRY3;FLT3
prerank,negative regulation of cell motility (GO:2000146),0.36343592251897255,1.0376789133515354,0.4247422680412371,0.7486549248888716,1.0,18/108,9.99%,CD74;CLDN5;IFITM1;RHOB;ADAM15;IGFBP5;ACVRL1;DNAI3;PIN1;MIF;DUSP3;FRMD5;DLC1;ADORA3;NAV3;THY1;SPOCK3;EPPK1
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.23934563221993627,-1.0376587413053049,0.2727272727272727,0.7524061163324627,1.0,42/153,14.78%,ROCK2;LRRK2;ROCK1;CAMK2D;PRKCE;MAP3K13;CSNK1A1;MARK1;SMG1;PDPK1;RICTOR;TLK2;TGFBR1;TLK1;MARK3;EIF2AK3;MAST2;DYRK1A;MAPKAPK3;TOP1;MAPK9;NEK6;HIPK3;RIPK1;PKD1;DMPK;MORC3;DGKQ;TBK1;STK38;LATS2;NLK;ULK2;CSNK2A1;CSNK2A2;ATM;PRKD1;SRPK2;MARK2;GSK3B;PRKCI;PRKCB
prerank,response to iron ion (GO:0010039),0.4821281086426552,1.037584811086513,0.44105409153952846,0.748447872812957,1.0,1/12,0.77%,B2M
prerank,negative regulation of hormone secretion (GO:0046888),0.5252578874458314,1.0372914766974335,0.44668587896253603,0.7487062664285058,1.0,2/10,13.64%,IL11;GJA1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.43120382246276784,1.037186195039707,0.42661691542288555,0.7481299568047816,1.0,10/23,23.15%,HSP90AB1;CDKN1C;HIPK2;SNW1;STK11;SDCBP;ADAM17;CITED2;MEN1;CDKN2B
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.43120382246276784,1.037186195039707,0.42661691542288555,0.7481299568047816,1.0,10/23,23.15%,HSP90AB1;CDKN1C;HIPK2;SNW1;STK11;SDCBP;ADAM17;CITED2;MEN1;CDKN2B
prerank,positive regulation of behavior (GO:0048520),0.5061677080836576,1.0370228195092666,0.47514619883040937,0.7480870005362793,1.0,6/10,27.54%,NLGN1;INSL5;CRH;MEF2C;SGIP1;STRA6
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.45360885168428844,1.0369597842528175,0.4287515762925599,0.7478009180709083,1.0,10/18,30.92%,BAX;PMAIP1;RNFT1;TMEM259;BAK1;USP13;DDIT3;BOK;XBP1;FCGR2B
prerank,regulation of monocyte differentiation (GO:0045655),0.48076758443291945,1.036917463085043,0.4316069057104914,0.7474768763972646,1.0,2/14,3.83%,CD74;ZFP36L1
prerank,regulation of fibroblast migration (GO:0010762),0.4423969162871283,1.0367516865745028,0.4467005076142132,0.7474914868971668,1.0,8/20,19.62%,RAC1;PRR5L;HYAL2;CORO1C;ARHGEF7;DMTN;DDR2;TGFB1
prerank,regulation of histone acetylation (GO:0035065),0.414121345172929,1.0366474658697866,0.42550655542312277,0.7473259516739121,1.0,9/33,19.16%,PARK7;MAPK3;SPI1;SET;CAMK1;CTBP1;HDAC5;PPARGC1A;SNCA
prerank,regulation of biomineral tissue development (GO:0070167),0.43430768308795,1.0364604350843556,0.44350961538461536,0.7473605730376074,1.0,12/26,19.83%,ECM1;S1PR1;CEBPB;FBXO5;SOX9;GAS6;HEY1;TWIST1;DDR2;NOTUM;TGFB1;NOTCH1
prerank,establishment of protein localization to organelle (GO:0072594),0.37099970499913243,1.0364230688105172,0.43130990415335463,0.747022575041272,1.0,16/72,18.67%,LAMP1;AKT1;PINK1;RAN;FAM53C;CD68;PTTG1IP;IPO4;NUP85;NUP88;RYR2;SPRN;EIF4ENIF1;LAMP2;SYK;NUP50
prerank,apoptotic process (GO:0006915),0.35162442956501216,1.0360984147052081,0.41282565130260523,0.7474070121856662,1.0,52/203,21.40%,PPIA;GAPDH;RHOB;DCC;AKT1;NSG1;ITGB2;RFK;ADAM15;IER3;RTN4;BNIP2;PARP1;PPP2R1A;MAL;SFRP5;ELMO1;DLC1;MAGEH1;HSPD1;TNFSF12;JADE1;DHCR24;TNFAIP1;BAX;PMAIP1;CXCR4;PAX3;BBC3;STK11;RRAGC;BAD;CDK5;GLRX2;ADRA1A;PRUNE2;TRAIP;ATCAY;PPP1R15A;CD14;ERBB3;NLRP3;PDE1B;DDIT4;CAPN3;NFKBIA;MYC;GADD45A;PYCARD;BAK1;PAK5;IFI27
prerank,positive regulation of heart contraction (GO:0045823),0.44659754051034056,1.0352282149471979,0.44387096774193546,0.749175117919747,1.0,8/19,28.23%,RGS2;CHGA;EDN3;RYR2;ADRA1A;ATP2A2;TGFB2;KCNQ1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.378080905843874,1.0349825096875755,0.42826321467098166,0.7493478780753203,1.0,15/68,16.78%,DBI;HINT1;RAN;SULT4A1;BPNT2;ADSS1;AK4;AK3;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;BAD;ACOT4
prerank,regulation of cell morphogenesis (GO:0022604),0.41828682243604265,1.0344268208422842,0.4452296819787986,0.750290416509264,1.0,2/30,1.58%,SPARC;CFL1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.35415986750406386,1.0343848291987534,0.42727272727272725,0.7499765544235619,1.0,50/182,20.51%,APOE;RACK1;CLDN5;HSP90AB1;PARK7;LGMN;CNPY2;CD34;PINK1;SLC7A5;GPER1;TNF;PDGFB;ACVRL1;SPI1;MIF;TLE5;SH3GL2;APLNR;MYADM;LRPAP1;KDR;MAPT;GATA2;TARDBP;LRP3;MSR1;HRAS;FBXW7;KLF4;BMP2;SDCBP;SUB1;ANKRD13D;CCL3;VHL;APOBEC1;NOS2;AGO1;MAP2K2;SFRP1;SOX11;DDRGK1;ERP29;TGFB1;NOTCH1;POU4F1;CITED2;TRAT1;MEF2C
prerank,regulation of protein localization to membrane (GO:1905475),0.4237625772636736,1.0343735251970774,0.4363411619283066,0.7495797395337688,1.0,2/28,0.88%,ACTB;GSN
prerank,regulation of ossification (GO:0030278),0.4052518296090377,1.0338575568848514,0.43902439024390244,0.750431762057684,1.0,15/36,21.57%,MDK;ECM1;LRP4;S1PR1;WNT5A;SOX9;BMP2;TWIST1;DDR2;SFRP1;NOTUM;SOX11;NOTCH1;MEF2C;PTN
prerank,response to hexose (GO:0009746),0.42113359390766947,1.0334762699825304,0.43899521531100477,0.7509857766831914,1.0,8/25,20.79%,PFKL;GYS2;LPL;VAMP2;MAFA;EIF2B5;KHK;SELENOS
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5062005253911419,1.0333127980941141,0.43447293447293445,0.7510082091212562,1.0,3/11,15.69%,CTDNEP1;MFSD2A;NR1H2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.24774286718301808,-1.0329815394460886,0.37735849056603776,0.7634051389497305,1.0,9/86,1.88%,BMP6;SULF1;RBPMS;ZNF423;ACVR1;BMPR1A;FOXD1;CREBBP;DAB2
prerank,positive regulation of chromosome organization (GO:2001252),-0.3715333208104443,-1.0329546924117397,0.4110169491525424,0.7615380202684238,1.0,4/15,20.69%,DHX36;PML;RTEL1;SIRT6
prerank,regulation of synapse assembly (GO:0051963),0.3884596807678096,1.032816479349468,0.41964285714285715,0.7518271440365621,1.0,22/46,24.54%,NRXN1;NLGN1;GRID2;LRFN5;LHFPL4;MUSK;IL1RAPL1;PTPRD;SYNDIG1;LRRC4B;ROBO2;EPHB1;CLSTN2;SLIT1;CLSTN1;SNCA;IL1RAP;MEF2C;CLSTN3;SLITRK3;WNT7A;APP
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.41417334068697864,1.0324813297335669,0.45552884615384615,0.7522495875622646,1.0,13/32,25.06%,HINT1;RPS27L;HIPK2;TMEM109;PMAIP1;SNW1;STK11;POU4F1;DDIT4;PYCARD;PHLDA3;DYRK2;BOK
prerank,carboxylic acid metabolic process (GO:0019752),0.40520717392769356,1.0320609859279604,0.4483985765124555,0.7528656472002562,1.0,12/33,22.93%,SLC2A1;AGXT;CYB5R3;MIF;GSTO1;GRHPR;GLYAT;ACOT4;SLC2A3;GLUD1;CYB5A;TBXAS1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.42193689815876934,1.0311079974273685,0.4317073170731707,0.7547855997952083,1.0,7/27,18.66%,AKT1;TREM2;CTNNA2;IL1RAPL1;CCDC88A;BRSK2;NCS1
prerank,protein dephosphorylation (GO:0006470),-0.2341481535417897,-1.0308196261017697,0.46153846153846156,0.7654994465432036,1.0,45/135,18.89%,EYA2;PTPN13;EYA1;PTPN21;PTPN9;PPP1R12A;PTPN14;PPM1E;TNS2;MTMR3;PPM1D;PTPN3;DUSP16;DUSP10;PPP4R1;EYA4;PPEF2;PPP2R5E;PTPN12;BTRC;PPP4R2;DAPP1;PTEN;DUSP7;FBXW11;NCK1;EYA3;PTPN2;PPP2CB;LHPP;RPAP2;PPP6C;PTPN22;DUSP11;PPP2R2A;PPP3CB;SSH1;PPP3CC;PPP2R1B;SDHAF2;PPTC7;PPP2R3A;CTTNBP2NL;PTPRK;PTPRM
prerank,calcium ion import across plasma membrane (GO:0098703),0.478250497256972,1.0306788686439652,0.4403292181069959,0.7553857951809071,1.0,5/14,28.95%,SLC24A2;TRPM2;SLC8A1;CACNA2D1;ATP2B4
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.42634093373044557,1.030437185291956,0.45305164319248825,0.7555659433174353,1.0,10/26,19.80%,C3;ATF4;SARS1;FLT4;HPSE;GATA4;CCR2;CXCL17;TGFB1;IL6
prerank,early endosome to Golgi transport (GO:0034498),0.4954098072221206,1.0297894746162766,0.45504840940525587,0.756738854405235,1.0,3/11,10.88%,LMAN1;SURF4;TMED9
prerank,electron transport chain (GO:0022900),0.46839914532937327,1.02953628026565,0.4412171507607192,0.7569196788679744,1.0,6/15,21.83%,ETFB;NDUFA5;SDHB;UQCRFS1;PPARGC1A;SDHA
prerank,histone H2B ubiquitination (GO:0033523),-0.4222196863307667,-1.0287676497430402,0.40728476821192056,0.7693686934999506,1.0,6/10,21.77%,RNF8;CDC73;UBE2E1;WAC;RNF20;CTR9
prerank,ganglion development (GO:0061548),0.5054957657975825,1.0285508520284903,0.46482758620689657,0.7589656247017011,1.0,3/11,9.53%,SEMA3F;CTNNB1;UNC5C
prerank,glycogen biosynthetic process (GO:0005978),0.497936993244524,1.0284132029019846,0.46802721088435373,0.7584407057494972,1.0,3/12,8.62%,NR1D1;GYS2;NHLRC1
prerank,glucan biosynthetic process (GO:0009250),0.497936993244524,1.0284132029019846,0.46802721088435373,0.7584407057494972,1.0,3/12,8.62%,NR1D1;GYS2;NHLRC1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5063510359481375,1.028390474002287,0.47413793103448276,0.7580780325579138,1.0,5/10,18.59%,DLGAP2;DLGAP1;BEGAIN;NPTXR;CACNG5
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3468404480140931,-1.0283421889701665,0.4088888888888889,0.7685912605486547,1.0,4/17,5.71%,ROBO1;SLIT2;NRP1;EFNB2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3944643911409704,1.028194767895222,0.45186862967157415,0.7581127050681763,1.0,11/41,18.54%,CCL19;SLC24A2;PTPRC;GRIN1;GRIN2A;HTR2C;TRPM2;SLC8A1;RYR2;ERO1A;GRIN2B
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.389410233835541,-1.0273453561393677,0.40441176470588236,0.7675777907150318,1.0,4/13,7.18%,STAT5B;IL15;IL15RA;STAT3
prerank,cellular response to interleukin-15 (GO:0071350),-0.389410233835541,-1.0273453561393677,0.40441176470588236,0.7675777907150318,1.0,4/13,7.18%,STAT5B;IL15;IL15RA;STAT3
prerank,dermatan sulfate metabolic process (GO:0030205),0.4797681494401644,1.026810256940288,0.453551912568306,0.7610975514072681,1.0,3/13,8.04%,BGN;BCAN;DCN
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4214832622133367,1.0264637434859885,0.45173267326732675,0.7615340741971492,1.0,11/24,28.08%,VTN;MT3;CADM4;PDCD6;DAB2IP;TMEM204;PTPN1;CNMD;HGS;HHEX;MMRN2
prerank,response to organonitrogen compound (GO:0010243),0.39801288936017815,1.0263943899818397,0.45875706214689266,0.7612861908394998,1.0,12/38,22.20%,RCN3;VCP;SYVN1;GLRA2;TRPM2;GLRA1;RRAGC;UBXN6;BRSK2;GLRA3;IL6;IRF5
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4168388082598483,1.0260269558568178,0.4323040380047506,0.7617450281326968,1.0,11/29,31.79%,DBI;PLAAT3;PLA2G4F;NR1H2;LPCAT2;PLA2G3;MBOAT7;PLA2G6;PLBD1;PNPLA8;NR1H3
prerank,synaptonemal complex assembly (GO:0007130),0.4650680160330685,1.025443527240958,0.4718019257221458,0.7623058799865903,1.0,1/15,4.19%,SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.4650680160330685,1.025443527240958,0.4718019257221458,0.7623058799865903,1.0,1/15,4.19%,SYCP2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4288202829466156,1.0252447229852193,0.46532156368221944,0.7623718073128772,1.0,8/24,22.69%,MT3;ACADVL;SLC25A13;MTLN;PPARGC1A;MYC;CYCS;COQ10A
prerank,protein tetramerization (GO:0051262),0.37213543059243553,1.0249306831324538,0.4573560767590618,0.762709805854739,1.0,13/67,20.62%,ALDOA;B2M;AQP4;KCNC3;GRIN1;KCNC1;TRPM2;GLS;HCN1;GRIN2B;SNCA;PKD2L1;SHMT2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.35121652876113013,1.0248185150212192,0.4402834008097166,0.7625534867461751,1.0,52/150,26.34%,HSP90AA1;HSP90AB1;PARK7;CCL19;TXN;NRG1;ERBB4;PINK1;TNF;RAC1;PDGFB;HCLS1;RTN4;RHOG;P2RY12;MC1R;KITLG;RAMP3;VAV1;GAS6;CX3CR1;HPSE;GDF15;PDGFA;IGF2;CCL3;CASS4;PIK3CD;F10;RAC2;ERBB3;MAZ;KLB;TGFB1;CD86;HGF;FLT3;THEM4;THPO;TRAT1;TGFA;MYDGF;C1QBP;CD28;PIK3R5;TEK;MFHAS1;FGF22;CX3CL1;FGFR3;ITGB1;TRIB3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.46763743469132724,1.0244679805971593,0.4453551912568306,0.7629959348111054,1.0,7/14,24.95%,RFK;ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,sodium ion import across plasma membrane (GO:0098719),-0.34620201457176303,-1.024440407081543,0.3949579831932773,0.7738848491650809,1.0,3/17,10.75%,SLC9A1;SLC9A2;TRPM4
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3670002810653451,1.0242659585526974,0.461038961038961,0.7630808893388761,1.0,24/68,26.59%,CAVIN1;SNRPG;POLR2E;POLR2F;SNRPE;POLR1B;SNRPF;POLR2K;SNRPB;CPSF2;UBTF;SLBP;MAZ;TBP;SNRPD3;POLR1H;POLR3K;CPSF4;POLR2H;POLR1G;GTF2H5;CCNH;ERCC2;SYMPK
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.48413567700021504,1.0242386393348801,0.46620689655172415,0.7627084826134249,1.0,3/12,8.04%,BGN;BCAN;DCN
prerank,mitochondrial genome maintenance (GO:0000002),0.49099780382121894,1.0241526645769359,0.4652482269503546,0.7624911814207721,1.0,5/11,25.82%,SLC25A4;PARP1;MPV17;LONP1;SLC25A36
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.44830925268349586,1.0239723718450093,0.4595300261096606,0.7625307087371286,1.0,7/17,20.78%,CALM1;CALM3;CADM4;DMTN;CALM2;DDIT4;SIRT2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.26831485763846036,-1.0234381466901152,0.42105263157894735,0.7746137629920173,1.0,15/56,15.87%,EGFR;UBE2E2;NSMCE2;BRD4;ANAPC5;ANAPC7;CDC25B;TFDP1;EIF4G1;ANKRD17;KLHL18;RAD51B;CCND3;CDC27;MECP2
prerank,activation of protein kinase A activity (GO:0034199),-0.3495435096392874,-1.023189533257287,0.3907563025210084,0.7734351066443477,1.0,3/16,2.13%,ADCY9;ADCY1;ADCY5
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.35892703914584523,1.0230561091388126,0.45359749739311783,0.7643782978533448,1.0,28/101,19.83%,CALM1;AKT1;CALM3;CCND2;TNF;PDGFB;CCND1;PROX1;CD24;CAMK1;PIH1D1;WNT5A;CSF1R;HRAS;RHOA;NEK10;PDGFA;RASGRP1;EDN3;MAPRE3;DAB2IP;FLT1;ADAM17;MAP2K2;CALM2;SNCA;TGFB1;FLT3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3127898246288651,-1.023000650840036,0.4427083333333333,0.7720894021528885,1.0,11/26,16.62%,SORBS1;OSBPL8;BRAF;IRS1;INSR;IGF1;CREBL2;PRKCI;OCLN;RHOQ;APPL1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.4764626856091398,1.02285979221579,0.45403899721448465,0.7644373173477773,1.0,7/12,23.65%,SYT1;RIMS2;RIMS1;SYT2;DOC2B;UNC13A;SYT5
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4217003546463139,1.0228071539503545,0.4627594627594628,0.764155632659025,1.0,4/25,11.56%,CNRIP1;TNF;CHMP6;RAMP3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.36689537390104643,-1.0227661756093236,0.424,0.7707701692317603,1.0,7/14,21.58%,ADAMTS12;EFEMP1;TGFBR1;CHADL;WNT9A;PTPN11;ADAMTS7
prerank,peptidyl-lysine modification (GO:0018205),-0.2382295398343413,-1.0227625753294254,0.45714285714285713,0.7688679634619933,1.0,28/99,18.49%,EYA1;PLOD2;RANBP2;NSMCE2;HDAC4;SENP6;PIAS1;PIAS2;LOXL1;NUP98;KAT2B;SAE1;ATP7A;SENP7;LOXL3;TOPORS;SENP1;TRPM4;ESCO1;STX1A;SIRT1;AAAS;SIRT7;NUP214;NUP35;NDC1;VCPKMT;METTL21A
prerank,calcium ion import (GO:0070509),-0.3037295000683955,-1.0227601671675568,0.4044943820224719,0.7669723376735017,1.0,8/28,14.04%,MCU;CACNA1C;MICU1;MICU2;TRPC4;CACNA1G;CACNA1D;AFG3L2
prerank,positive regulation of cell cycle process (GO:0090068),-0.2414765623462854,-1.022756036505043,0.275,0.7650916633377759,1.0,26/91,22.00%,SVIL;CEP295;LRP5;PRKCE;INSR;CDC14A;UBXN2B;IGF1;PKP4;CDC25B;CSPP1;PDGFRB;INO80;GIPC1;NUMA1;PHIP;DYNC1LI1;MAD2L1;CDC14B;RACGAP1;NUP62;KIF23;NDC80;PKN2;TPR;XRCC3
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.34660219467463826,1.0227407431700342,0.45326633165829144,0.7638910411960248,1.0,53/190,24.73%,TMSB4X;RACK1;NDUFA13;AKT1;TREM2;PINK1;PEBP1;GPER1;ARHGAP25;NR1D1;SPI1;DUSP3;TNFAIP3;APLNR;PDE3B;SFRP5;HYAL2;MYADM;CDC34;P2RX7;CD22;OTUD7A;TRIM59;PIK3IP1;PDCD6;PHLPP1;ARRB2;DAB2IP;TWIST1;CAV1;HERPUD1;NDUFS3;NOP53;AKT1S1;RTKN2;SPRY3;NLRP3;THEM4;DDIT4;PDE11A;PYCARD;DDIT3;BANK1;CCN3;TMEM127;DUSP1;TNIP1;ADIPOR1;PHLDA3;RNF157;RELA;EPM2A;PLEKHA1
prerank,positive regulation of interferon-beta production (GO:0032728),0.40663577547981866,1.022265812698563,0.4734982332155477,0.76465130646524,1.0,15/33,32.14%,HSP90AA1;FLOT1;ISG15;IRF7;RIPK2;OAS3;POLR3D;IRF5;TLR7;TLR2;TRIM56;DHX9;POLR3C;DDX3X;MAVS
prerank,centromere complex assembly (GO:0034508),-0.2788552430483654,-1.0218505252157228,0.43884892086330934,0.7658044472308851,1.0,17/36,25.89%,SMARCA5;POGZ;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPE;CENPU;CENPI;CENPH;MIS18BP1;MIS12;MIS18A;ITGB3BP;OIP5
prerank,epithelial cell-cell adhesion (GO:0090136),-0.41675220348527675,-1.0217642027142004,0.4057507987220447,0.7641509106686389,1.0,5/11,20.34%,VCL;PLEKHA7;KIT;THBS4;ITGB5
prerank,striated muscle contraction (GO:0006941),0.3792308021800202,1.021743490904714,0.44065934065934065,0.7655031752649221,1.0,12/53,20.77%,ALDOA;SCN4B;GAA;TNNI1;KCNE5;SLC8A1;ATP1B1;RYR2;DTNA;STAC3;GRK2;MYH14
prerank,regulation of DNA damage checkpoint (GO:2000001),0.49672085511308217,1.0212521704742847,0.4658119658119658,0.7663292388770868,1.0,2/10,6.11%,DDX39B;RPA2
prerank,positive regulation of transmembrane transport (GO:0034764),0.48103939889174796,1.0210155433480712,0.45582047685834504,0.7665133460742294,1.0,4/13,13.39%,C3;CA2;P2RX7;CLIP3
prerank,embryonic axis specification (GO:0000578),-0.374053701067836,-1.0207629160551674,0.44308943089430897,0.7651968424337156,1.0,3/15,8.51%,SMAD6;COBL;TASOR
prerank,regulation of nuclear division (GO:0051783),0.4411684665001021,1.020413938369437,0.45775535939470363,0.7675619232052789,1.0,8/20,29.27%,PIN1;CAV2;FBXO5;L3MBTL1;CCDC8;RCC1;KIF20B;MKI67
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.47475888533046234,1.0203468396263997,0.47233468286099867,0.7672914651841792,1.0,5/13,21.15%,LGMN;GRIN2A;RIPK2;BAD;BAK1
prerank,modulation by host of symbiont process (GO:0051851),0.4075934762208483,1.0202774792029534,0.4554913294797688,0.7670401779853689,1.0,11/31,22.30%,NUCKS1;AQP1;RRP1B;JUN;TARDBP;SNW1;CX3CR1;CCL3;TFAP4;SAP30BP;REST
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4392276324618914,1.0201734528367954,0.44923857868020306,0.7668845460041827,1.0,9/21,21.63%,PARK7;TMBIM6;CREB3;SYVN1;PMAIP1;HSPA1A;HERPUD1;SELENOS;DDIT3
prerank,positive regulation of wound healing (GO:0090303),0.3973508700459384,1.0200003401016038,0.4590542099192618,0.7669046536032342,1.0,2/36,0.88%,ACTG1;VTN
prerank,protein localization to chromosome (GO:0034502),-0.28493839266683296,-1.0199975137089492,0.40718562874251496,0.7655984296578063,1.0,9/34,16.82%,WAPL;PARP3;ESR1;MRNIP;TNKS2;TERF2;TINF2;PINX1;IFFO1
prerank,positive regulation of neuron projection development (GO:0010976),0.36543409306347907,1.0197729104446465,0.4582893347412883,0.7670447685142292,1.0,13/85,10.49%,APOE;MDK;PACSIN1;NTRK2;CAMK1D;S100A9;NDRG4;TENM3;LTK;ATP1B2;PTK6;CAMK1;WNT5A
prerank,organic anion transport (GO:0015711),0.3648476455506867,1.0197074943313107,0.48462354188759277,0.7667748093945576,1.0,26/76,28.26%,LRRC8A;CA2;SLCO1C1;SLC25A4;MGST1;AQP1;SLCO4C1;CA4;SLC19A1;SLC25A19;SLC35A3;SLC2A2;MFSD10;SLC4A2;SLC52A1;SLC35A1;SLCO1B1;SLC35B4;CYB5R1;CA3;SLC35B1;SLC4A8;ABCC5;SLC2A6;SLC35A2;CPTP
prerank,proteolysis (GO:0006508),0.345149745317506,1.0196328128489751,0.44488977955911824,0.7665347204644248,1.0,73/252,26.01%,CTSD;CTSB;CTSL;CTSZ;CTSS;MMP3;TMPRSS6;LGMN;CPXM1;CPD;PSENEN;PSMD6;CPE;SPPL2B;F9;SPCS1;VASH1;NEDD8;TINAGL1;PGPEP1L;METAP2;TMPRSS5;PCSK2;AEBP1;PLAT;CPXM2;SRGN;CTSA;ERMP1;PSMB11;LAP3;CTSH;SPG7;LRP8;MMP14;RNPEPL1;PSMB5;NAPSA;VHL;BACE1;PLAU;PSEN2;ADAM17;CTSC;APH1B;PSMA6;DESI2;DESI1;HGF;PGPEP1;CAPN3;FAM111A;ATG4D;SPPL2A;DPP7;CTSE;ACAN;ECE2;ST14;LONP1;PRCP;ERAP1;CPZ;CAPN11;FBXO2;THOP1;CASP1;FBXO3;PCSK6;APH1A;MMP2;MMP1;MMP24
prerank,regulation of striated muscle contraction (GO:0006942),0.41073807165690185,1.0196155838121874,0.45355850422195415,0.7661514238132889,1.0,7/27,19.29%,CALM1;CALM3;TNNI1;RYR2;SRI;CALM2;GRK2
prerank,regulation of water loss via skin (GO:0033561),0.462274991246008,1.0195849857519577,0.4559789750328515,0.7653700004137614,1.0,4/15,17.13%,HRNR;LSR;STMN1;FA2H
prerank,establishment of skin barrier (GO:0061436),0.462274991246008,1.0195849857519577,0.4559789750328515,0.7653700004137614,1.0,4/15,17.13%,HRNR;LSR;STMN1;FA2H
prerank,establishment of protein localization to extracellular region (GO:0035592),0.38996625926143447,1.019451469463468,0.4568469505178366,0.7652615802150741,1.0,13/39,23.93%,RCN3;CANX;OLFM2;RAB15;RAB3C;RAB3D;PPY;ARL4D;TVP23A;PDIA4;COPG1;SCG2;MTTP
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4060319507821008,1.0187015962729935,0.4591715976331361,0.7666808187513094,1.0,6/32,7.08%,APOD;ADAM15;ACVRL1;DLC1;FAM107A;CORO1C
prerank,protein maturation (GO:0051604),0.3587592967949566,1.0186793160306966,0.46233230134158926,0.7663113611043105,1.0,35/95,25.81%,BOLA2;CTSS;CPXM1;CPD;SORL1;PSENEN;CPE;PRSS37;HSPD1;METAP2;PCSK2;AEBP1;NAA10;CPXM2;SRGN;MMP14;BACE1;DNAJB11;PSEN2;CIAO1;ADAM17;APH1B;NNAT;LMF2;STUB1;CIAO2A;CIAO2B;NDUFAB1;TSPAN32;AANAT;ECE2;CPZ;PCSK6;APH1A;LIPT1
prerank,calcium ion transport (GO:0006816),0.35122077481943076,1.0186330414313012,0.46288659793814435,0.7660114005901563,1.0,26/113,17.83%,TPT1;RAMP2;SLC24A4;SLC24A2;FKBP1A;CACNA1A;GRIN3A;CCR5;TMCO1;P2RX7;SELENOK;SLC3A2;RAMP3;TRPM2;TRPC7;CHRNA4;GAS6;TRPC1;SLC8A1;RYR2;CCL3;ORAI1;CACNG8;CAV1;PSEN2;CCL8
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.38164846079815445,1.0186139310065292,0.44831460674157303,0.7656379026582569,1.0,11/48,11.99%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;P4HB;IL1RAPL1;ARHGEF7;SS18L2;PTPRD
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.4920863328993916,1.0178507438896247,0.4522111269614836,0.7670998109784253,1.0,2/11,13.71%,PTPRC;LILRB1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4764875981443636,1.0176562643741605,0.4772413793103448,0.7671757981342617,1.0,6/13,23.73%,BNIP3L;BAX;PMAIP1;BAD;VDAC2;BLOC1S2
prerank,protein targeting to membrane (GO:0006612),0.36009502057119874,1.0175396976693174,0.4619395203336809,0.767016033703683,1.0,31/83,31.00%,NACA;SSR2;ARL6IP1;SRP14;PXMP2;SSR1;ICMT;GDAP1;SEC61A1;GOLGA7B;YIF1B;SDCBP;SGTA;GOLGA7;NCF1;VPS37C;ZDHHC12;TRAM1;FIS1;NACAD;ZDHHC2;PEX11B;ARL6;SRP19;RTP3;ZDHHC14;SRPRA;ABCD2;ALDH3A2;CHMP4A;CHMP4B
prerank,regulation of viral release from host cell (GO:1902186),0.4236962479701055,1.0174482436730792,0.4510050251256281,0.766818524128185,1.0,6/21,19.05%,CHMP2B;TRIM28;DDB1;TRIM32;VPS4A;TRIM13
prerank,regulation of neuron projection arborization (GO:0150011),-0.37279940649774423,-1.0173554938256784,0.4251207729468599,0.771362951987546,1.0,6/15,14.62%,MACF1;MAP3K13;MOV10;DLG4;DVL3;MYO9A
prerank,negative regulation of cyclase activity (GO:0031280),0.4774863644053107,1.017214400258862,0.45861601085481685,0.7669618001894182,1.0,4/14,20.12%,GNAI2;RD3;CCR2;GABBR2
prerank,negative regulation of bone mineralization (GO:0030502),0.4685617900307276,1.0170782541219652,0.462059620596206,0.7668531007840265,1.0,4/13,16.48%,ECM1;RFLNB;SRGN;CCL3
prerank,defense response to tumor cell (GO:0002357),0.5024434029073636,1.0169458051412752,0.45584045584045585,0.7667471869896402,1.0,3/10,4.25%,LAPTM5;PRDX2;SPI1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.4615175473301113,1.016739552564701,0.442838370565046,0.7668065966783797,1.0,8/15,25.67%,BGN;BCAN;DCN;B3GAT3;VCAN;CSGALNACT2;CHST14;CSPG5
prerank,cardiac cell development (GO:0055006),0.4773991156595184,1.0165613478809523,0.46511627906976744,0.766811612505185,1.0,4/11,19.83%,ALPK2;MYH11;SLC8A1;NOTCH1
prerank,regulation of cell cycle (GO:0051726),0.34214870084625654,1.0165422039361636,0.476,0.7664402576539253,1.0,85/271,25.50%,RPL23;RPS15A;RACK1;HSP90AB1;CALR;JUND;RHOB;EIF4G2;GPER1;BEX2;PTPRC;FZD9;JUNB;MIF;UHMK1;HIPK2;USP51;SPATA22;CCND1;GMNN;PTK6;PROX1;NUPR1;DHCR24;MLXIPL;JUN;ZBTB49;TARDBP;BRINP1;CTBP1;APBB1;HRAS;CAMK2N1;FBXO5;SOX9;RNF40;BMP2;NLRP2B;LILRB1;STK11;SDCBP;HNRNPU;SND1;L3MBTL1;CDK5;DAB2IP;PIM3;TRIM32;TBRG4;CDC25A;PPP1R15A;SFRP1;NOP53;BTG4;INHBA;RAD23A;TGFB1;NOTCH1;MLF1;POU4F1;CDK9;CITED2;DYNLT3;MYC;GADD45A;SIRT2;TFAP4;ID2;ASAH2;MEN1;DUSP1;CDK10;CDKN2B;INTS13;BARD1;METTL3;FOXM1;CHMP1A;WDR6;BAP1;PNPT1;INHA;PRKACA;FBXL3;KIF20B
prerank,aminoglycan biosynthetic process (GO:0006023),-0.26792622140170025,-1.0158730544142318,0.4666666666666667,0.7736588072454782,1.0,9/49,6.67%,GPC6;EXT1;GPC4;GPC3;HS3ST3A1;B3GNT2;B3GALT1;HS2ST1;NDST1
prerank,aorta development (GO:0035904),-0.3723926155903864,-1.0157451344786363,0.424812030075188,0.772122154765459,1.0,6/14,13.71%,HECTD1;ROBO1;ADAMTS9;PDGFRB;LRP1;JAG1
prerank,regulation of glycogen metabolic process (GO:0070873),0.48142535817234444,1.01570900640268,0.48533333333333334,0.7681022698502733,1.0,3/12,20.78%,AKT1;PPP1R3D;KHK
prerank,amino acid transport (GO:0006865),0.3807860129707991,1.0156970048421226,0.45222222222222225,0.7677104078074215,1.0,8/49,11.61%,SLC38A5;SLC7A5;SLC1A4;SLC25A29;SLC6A6;SLC6A17;SLC3A2;SLC7A14
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3441753923696058,-1.0156564798137262,0.38073394495412843,0.7704580551065421,1.0,3/17,2.13%,ADCY9;ADCY1;ADCY5
prerank,response to UV (GO:0009411),0.3627297905695893,1.0154379010911876,0.4698544698544699,0.7679078395739034,1.0,32/95,26.50%,RPL26;GPX1;ATF4;AKT1;NPM1;COPS9;PARP1;MFAP4;CCND1;SDF4;AQP1;MC1R;SMPD1;PCNA;NSMCE3;CAT;CIRBP;TRIM32;CDC25A;ERCC6;CCAR2;MYC;BAK1;MAP2K7;MEN1;POLD1;RELA;METTL3;EIF2S1;USF1;UBE2A;ERCC2
prerank,lytic vacuole organization (GO:0080171),0.4030827785099887,1.015211360452301,0.4507042253521127,0.7680269723725812,1.0,7/32,13.27%,GRN;CLVS1;CLVS2;GAA;CLN6;CLN5;TMEM106B
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.43412299795740555,1.0151856581937604,0.4664179104477612,0.7676676480499829,1.0,4/20,13.57%,MT3;ATF4;CREB3;BMP2
prerank,cell differentiation in spinal cord (GO:0021515),0.497842068316214,1.0149441734409004,0.466484268125855,0.7678202093135339,1.0,1/10,3.10%,MDGA2
prerank,tight junction assembly (GO:0120192),0.3822800462615541,1.014835917413918,0.48734873487348734,0.7676236638981627,1.0,15/49,24.45%,ACTG1;CLDN5;RAMP2;CLDN11;ESAM;PECAM1;LSR;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;TBCD;ECT2
prerank,regulation of interferon-beta production (GO:0032648),0.3865180125727459,1.0148129776574408,0.4676503972758229,0.7672534887121584,1.0,20/46,32.14%,HSP90AA1;FLOT1;SIRPA;TIRAP;ISG15;IRF7;LILRB1;RIPK2;TRAF3;OAS3;POLR3D;PYCARD;IRF5;TLR7;TLR2;TRIM56;DHX9;POLR3C;DDX3X;MAVS
prerank,pre-miRNA processing (GO:0031054),-0.3709658855806115,-1.0147929807758396,0.4495798319327731,0.7709272470150127,1.0,8/14,19.01%,DICER1;DROSHA;TUT7;TUT4;TARBP2;AGO2;ADAR;AGO4
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5016428713627986,1.0147194094137486,0.4632768361581921,0.767061175568815,1.0,3/10,11.49%,TERF1;MAPT;DNAJA1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.41606362699983535,-1.0146241386660408,0.439873417721519,0.7695452038470534,1.0,3/10,15.55%,SMAD7;RC3H2;NFKBIZ
prerank,metal ion export (GO:0070839),0.4056537620986991,1.0144431106093883,0.4803804994054697,0.7673196218387797,1.0,10/31,18.56%,ATP1A3;ATP1B2;KCNE4;ATP1A4;ATP1A1;SLC40A1;SLC11A1;KCNE5;ATP1B1;ATP1B3
prerank,regulation of B cell apoptotic process (GO:0002902),-0.39120114329739397,-1.0138288689015145,0.42570281124497994,0.7699624139907922,1.0,3/12,8.07%,FOXP1;FNIP1;NOC2L
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3118799137454924,-1.0136939740525044,0.42134831460674155,0.7685047818911327,1.0,10/25,16.29%,SCAF8;SETD5;ZMYND11;KAT7;CCNT1;CCNK;ELL;THOC5;LDB1;WDR43
prerank,positive regulation of metabolic process (GO:0009893),0.3528980113114836,1.0132180400944268,0.4830421377183967,0.7699319588633102,1.0,31/103,24.12%,GATM;UCP2;TNF;FABP5;EPAS1;CAMK1D;BSCL2;OMA1;CEBPB;FASN;SCD;LCN2;KDM6B;MFAP2;HCRT;THRA;CXCR4;GJA1;ACHE;CAV1;ADCYAP1;PPARGC1A;SYK;CCR2;FABP4;ESRRG;ELOVL6;TSHR;ADIPOR1;PRLR;ACLY
prerank,positive regulation of TORC1 signaling (GO:1904263),0.44623846846987875,1.0126444050915295,0.469119579500657,0.7709035739606398,1.0,6/16,16.43%,LAMTOR5;GPR137B;PIP4P1;PIH1D1;GPR137C;RRAGD
prerank,negative regulation of lipid storage (GO:0010888),0.44085487813993285,1.0122324334370494,0.46455696202531643,0.7714787598915597,1.0,4/19,5.34%,PNPLA2;TREM2;TNF;ABCG1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.39081522554971493,1.012222298270134,0.4624413145539906,0.7710818088910474,1.0,10/36,25.91%,PARK7;FBXW7;CCL2;NCF1;ADAM17;CCR2;BUD31;ADRA2B;TGFA;ITGB1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.31100975232591566,-1.0120217068005484,0.4011627906976744,0.7713946146706997,1.0,10/25,16.29%,BRD4;ZMYND11;CDK12;TCERG1;RNF8;CDK13;ELL;LDB1;CDC73;WDR43
prerank,negative regulation of histone acetylation (GO:0035067),0.49180621651968964,1.011559911154569,0.4820936639118457,0.7723310482840413,1.0,4/11,19.16%,SPI1;SET;CTBP1;SNCA
prerank,keratan sulfate metabolic process (GO:0042339),0.41112389616880984,1.0111301738015062,0.4816568047337278,0.7730000337183867,1.0,6/31,10.44%,HEXB;LUM;FMOD;HEXA;CHST1;B4GALT6
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.47528599972095975,1.0105267874884816,0.49226441631504925,0.773213983518929,1.0,5/11,22.65%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.47528599972095975,1.0105267874884816,0.49226441631504925,0.773213983518929,1.0,5/11,22.65%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.47528599972095975,1.0105267874884816,0.49226441631504925,0.773213983518929,1.0,5/11,22.65%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.48752860184322533,1.0104047870697135,0.48582995951417,0.7730948811787132,1.0,5/12,26.18%,CLEC6A;SLC11A1;CCR2;IL12RB1;PRKCQ
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.26588315096936654,-1.0097955412106792,0.41,0.7757819057500591,1.0,12/52,10.38%,SAMD4A;CNOT4;PAN3;CNOT1;DCP1A;PARN;DDX6;TUT7;PATL1;CNOT10;CNOT7;RC3H2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4190380918900931,1.0097591697765576,0.4560975609756098,0.7742358113417116,1.0,7/23,16.92%,PTPRC;HYAL2;PTK6;THY1;CHMP6;SRCIN1;CAV1
prerank,intracellular protein transport (GO:0006886),0.33516938484268183,1.0096351460611561,0.45845845845845845,0.7741052382536128,1.0,78/304,22.57%,RPL11;CD74;GABARAP;CALR;LAPTM5;AKT1;SNX17;NLGN1;AKAP6;NPM1;RAN;ARF5;YWHAH;SORL1;FAM53C;TMED7;LMAN1;SAR1A;SURF4;RAB14;TMED2;CLTC;ARL11;PTTG1IP;SCG5;XPO1;ARF6;TICAM2;ARL4C;TMED3;TMED9;CDC37;PDCD6;HAP1;CTSA;SGSM1;ARL4D;TMED1;VPS28;ARL1;SYNDIG1;CLIP3;IPO4;ARF1;EHD1;NUP85;TBC1D22B;NUP88;UNC93B1;ARF4;RAB20;NAPA;TBC1D9;RAB5C;SPRN;EIF4ENIF1;LAMP2;SYK;NUP50;STX4;RAB31;ERP29;RAB18;TGFB1;DESI1;TBC1D10C;CTTN;RAB6B;COPB2;HEATR3;TMED10;C2CD5;IFT27;STX1B;AP2A1;RAB28;VPS36;EVI5L
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.44704010255098753,1.009444596428403,0.49224806201550386,0.774134620994645,1.0,6/18,22.73%,ELOVL1;ELOVL2;ELOVL7;ACSL3;ELOVL6;ACSL4
prerank,regulation of intracellular protein transport (GO:0033157),0.4035204835986957,1.0094224381924883,0.4799054373522459,0.7737646526187171,1.0,16/32,28.97%,OAZ1;PRR5L;UHMK1;LCP1;VAMP2;ATP13A2;CEP131;B3GAT3;TGFB1;OAZ2;IFI27;PTPN1;ICE1;KIF20B;PCNT;TENM1
prerank,regulation of cell communication (GO:0010646),0.39858270435962817,1.0089479994364727,0.508177570093458,0.7745225510709735,1.0,11/35,19.89%,MTCH1;KAZALD1;YWHAG;SCG5;NCLN;SLC8A1;GLRX2;RYR2;SRI;GRK2;IGFBPL1
prerank,autophagy of peroxisome (GO:0030242),0.4800524677123813,1.0089147454672254,0.49731182795698925,0.7741758666396489,1.0,3/12,16.45%,MAP1LC3B;PJVK;SQSTM1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4156823067290819,1.0086961338822609,0.47766749379652607,0.7742864555983663,1.0,4/26,4.15%,PRNP;AKAP6;TNF;HOMER2
prerank,purine-containing compound catabolic process (GO:0072523),0.476840435522486,1.0085935955794243,0.49247606019151846,0.7741148601740862,1.0,5/13,22.66%,GPX1;DNPH1;PNP;NT5C;GDA
prerank,secondary alcohol biosynthetic process (GO:1902653),0.4018557867455135,1.0084876879003373,0.4562647754137116,0.7739497381680166,1.0,11/30,28.73%,LSS;DHCR24;ACAA2;PLPP6;FDPS;PMVK;NSDHL;ACLY;INSIG2;EBP;HMGCS1
prerank,regulation of secretion (GO:0051046),0.4780082080064057,1.0078698757513576,0.4648648648648649,0.775031243043941,1.0,5/13,18.84%,NRG1;SGK1;SCIN;ERBB3;ACSL3
prerank,photoperiodism (GO:0009648),-0.3029474842979891,-1.007794732793081,0.41420118343195267,0.779574534985666,1.0,9/28,15.79%,FBXL17;PER2;PER3;PML;SIK1;RBM4;FBXL12;CRY1;TP53
prerank,development of primary male sexual characteristics (GO:0046546),0.39986172812283105,1.0070203882078783,0.48498845265588914,0.7765978519672628,1.0,13/34,28.62%,WNT5A;KITLG;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK
prerank,RNA catabolic process (GO:0006401),0.379167684510972,1.0065079652220743,0.48072562358276644,0.7773822267502964,1.0,15/46,25.17%,RNASEH2A;LSM6;ZFP36L2;HSPA1B;ZFP36;RNASEH1;RNH1;HSPA1A;SND1;NUDT16;NANOS2;ISG20;LSM5;METTL3;PNPT1
prerank,heterocycle biosynthetic process (GO:0018130),0.4669392066084945,1.0056614925648628,0.5115020297699594,0.7789798658393067,1.0,2/14,6.66%,PYCR2;GPHN
prerank,protein prenylation (GO:0018342),0.4960133073622786,1.0055728657213945,0.49022346368715086,0.7787488115545346,1.0,1/10,3.05%,RCE1
prerank,calcium ion transport into cytosol (GO:0060402),0.4306446662226859,1.00551307951854,0.4832298136645963,0.7784939799593563,1.0,10/21,25.32%,GRIN1;GRIN2A;TRPM2;JPH4;SLC8A1;RYR2;ADRA1A;GRIN2B;CACNA2D1;ITPR3
prerank,positive regulation of protein depolymerization (GO:1901881),0.4796756024107223,1.0050347345259105,0.49445983379501385,0.7792171785930115,1.0,6/11,34.37%,NES;F2RL1;WDR1;STMN2;KATNB1;SEMA5A
prerank,synaptic vesicle membrane organization (GO:0048499),0.43499063575467817,1.0050300141219988,0.4701397712833545,0.7788100194259346,1.0,6/17,21.91%,SNAP25;SYNGR2;SYNGR1;SYP;STX4;STX1B
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.35701715323812433,1.0048843262172444,0.48025613660619,0.7787286924329552,1.0,15/76,14.42%,CLU;RACK1;GABARAP;ELOB;LAPTM5;HSPA1B;VCP;USP5;CEBPA;RBX1;SUMO2;DNAJB2;FBXW7;HSPA1A;HSPBP1
prerank,phagolysosome assembly (GO:0001845),0.47030893420039666,1.0047664942816699,0.4646324549237171,0.7785890801071251,1.0,9/12,38.81%,RAB14;CORO1A;RAB20;SYT7;RAB34;RAB39A;ARL8B;RAB7A;RAB7B
prerank,positive regulation of protein acetylation (GO:1901985),-0.38766682743477665,-1.0047152289253263,0.4392857142857143,0.7858037462693114,1.0,4/12,10.31%,CEP295;PRKAA2;FAM161A;RAPGEF3
prerank,embryonic hemopoiesis (GO:0035162),0.47780408816615105,1.0047028649028462,0.4821192052980132,0.7783152241937953,1.0,3/12,10.54%,ATF4;KDR;KITLG
prerank,activation of adenylate cyclase activity (GO:0007190),-0.28241756438698074,-1.0046453434211784,0.4645669291338583,0.7841319332036207,1.0,6/35,7.84%,ADCY9;ADCY1;LGR4;ADCY5;RAF1;EDNRA
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4224533291897982,1.0046123016107307,0.46776232616940583,0.7781161117380165,1.0,8/23,28.26%,TNFAIP3;NLRP2B;GAS6;CX3CR1;NLRP3;GIT1;CX3CL1;CPTP
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.4214291559155927,1.0043926429807641,0.4802469135802469,0.7782564787162525,1.0,6/24,9.92%,NRG1;CTNNA2;OLFM2;BNIP2;CTNNB1;CAMK1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.27360457767283963,-1.0043648798801292,0.472,0.7830727036963987,1.0,5/45,1.88%,BMP6;RBPMS;ACVR1;BMPR1A;DAB2
prerank,positive regulation of JNK cascade (GO:0046330),0.3653582270572223,1.0043178136524369,0.4855614973262032,0.7780274473811897,1.0,25/70,25.29%,CCL19;TIRAP;ANKRD6;HIPK2;CCN2;HMGB1;FLT4;HRAS;MAPK8IP1;SDCBP;F2RL1;TRAF3;RASGRP1;NCF1;DAB2IP;MAP4K2;LTBR;GADD45A;PYCARD;UNC5CL;DUSP15;WNT7A;APP;AGER;MFHAS1
prerank,positive regulation of myelination (GO:0031643),-0.3894532037280535,-1.0042908785162463,0.41924398625429554,0.7814071403044386,1.0,2/11,5.53%,PARD3;DICER1
prerank,regulation of membrane repolarization (GO:0060306),0.46621602700295295,1.004186535850348,0.49595687331536387,0.7779338065596798,1.0,4/13,16.92%,AKAP6;YWHAE;KCNE5;CAV1
prerank,response to glucagon (GO:0033762),-0.3238493517562828,-1.0041830282587327,0.43414634146341463,0.7799179168925925,1.0,3/19,2.13%,ADCY9;ADCY1;ADCY5
prerank,multivesicular body assembly (GO:0036258),0.40368178109095254,1.0041682912594514,0.4696601941747573,0.7775659646702702,1.0,16/30,31.00%,CHMP2B;CHMP5;CHMP6;VPS28;CHMP1B;VPS4A;VPS37C;CHMP7;VPS36;CHMP1A;HGS;CHMP4C;SNF8;MVB12A;CHMP4A;CHMP4B
prerank,regulation of fibrinolysis (GO:0051917),0.4736385047333444,1.0040827846755849,0.48202396804260983,0.7773625939524925,1.0,1/13,1.93%,THBD
prerank,protein palmitoylation (GO:0018345),0.40892194316258335,1.0037296658901336,0.46953405017921146,0.7777795912067662,1.0,12/30,29.83%,GLUL;SELENOK;ZDHHC5;GOLGA7B;CLIP3;GOLGA7;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,inorganic ion transmembrane transport (GO:0098660),0.47265606677272654,1.0036880845892375,0.48243243243243245,0.7774699950253352,1.0,3/12,19.98%,ASIC2;ABCC8;PKD2L1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4211486132959424,1.0036812898113037,0.4731585518102372,0.777069491468468,1.0,6/21,17.87%,TALDO1;PGLS;RPIA;PGD;G6PC3;TKT
prerank,positive regulation of vasculogenesis (GO:2001214),0.4943222942164671,1.0028749786664564,0.47426981919332406,0.7786201474180054,1.0,3/10,14.70%,CD34;KDR;RRAS
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.34952088501378165,1.002380769297888,0.49743589743589745,0.7793587186087471,1.0,32/118,20.70%,SPARC;GPNMB;CFL1;HMOX1;EMP2;ADGRB3;KNDC1;CTNNB1;TNFAIP3;LRRC4C;PAK1;VASH1;PPFIA2;CLASP1;MAPT;CDK5R1;PAK3;RNH1;WARS1;FLT4;SRCIN1;ZMYM3;CDK5;DLL1;BRSK2;SFRP1;NSMF;TGFB1;IL6;HECW1;MEF2C;PLXND1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.42747203968325526,1.0023325953817035,0.4769038701622971,0.7790649852600234,1.0,6/22,21.33%,PDE4B;AHNAK;CBARP;SRI;STAC3;CACNB4
prerank,positive regulation of organelle organization (GO:0010638),0.3970252411119702,1.002215201893422,0.47511848341232227,0.7789438239995105,1.0,8/32,17.90%,TREM2;LMAN1;SURF4;P2RX7;TMED9;DOC2B;LNPK;PPARGC1A
prerank,activation of protein kinase activity (GO:0032147),0.3516591999203969,1.0020191856168932,0.5087179487179487,0.7790047821985545,1.0,24/106,14.83%,PPIA;MT3;PARK7;AKT1;TXN;NRG1;PINK1;EMP2;PDGFB;ANG;TIRAP;PAK1;PRKAR1A;PAK3;WNT5A;PRKAR1B;SLC11A1;STK11;GAS6;ADCY4;CCDC88A;PRR5;TLR6;COPS8
prerank,regulation of lipid metabolic process (GO:0019216),0.3542463115923264,1.001967589987713,0.48333333333333334,0.7787163575691443,1.0,14/88,11.59%,PSAP;NPC2;APOC1;CERS2;NR1D1;MID1IP1;RARRES2;NCOR2;EDF1;LSS;FASN;SIN3B;SCD;SC5D
prerank,fatty acid transmembrane transport (GO:1902001),-0.3314658796370239,-1.0017970138498202,0.42857142857142855,0.7845762624472238,1.0,4/19,11.99%,PRKAG2;ABCD3;PRKAA2;CPT2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3934047658254869,-1.0012400263132384,0.41830065359477125,0.7842340999387979,1.0,9/11,31.11%,GRK3;ADM;GTF2H2;SAG;ARRB1;ADRB2;DRD3;ADRB3;ARR3
prerank,glucose transmembrane transport (GO:1904659),0.4316314521735087,1.0011742730884836,0.4783748361730013,0.7802126344980055,1.0,9/18,36.97%,SLC2A1;SORT1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.38864879753008985,1.000806005008925,0.4875283446712018,0.7807012598060671,1.0,12/41,21.77%,MDK;ANK3;TNF;FLOT1;THY1;PODXL;MAGI1;SKAP1;FOXA2;CITED2;FOXA1;PTPRU
prerank,SNARE complex assembly (GO:0035493),0.48416807049041133,1.0003545565189755,0.49,0.7813781912259874,1.0,4/10,19.16%,VAMP3;VAMP2;VAMP8;SNCA
prerank,regulation of gluconeogenesis (GO:0006111),-0.3082790361918881,-1.0002731351880934,0.44808743169398907,0.7849852397253394,1.0,9/27,16.25%,CLK2;OGT;SIK1;C1QTNF3;DGKQ;PTPN2;SIRT1;CRY1;SIRT7
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4696868712734459,1.0002504764543811,0.47545582047685836,0.7811948250874974,1.0,6/12,24.95%,ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,protein phosphorylation (GO:0006468),-0.23516199367801985,-1.0,1.0,0.776742445102913,1.0,142/478,18.16%,PRKAG2;ROCK2;GRK5;TGFBR3;EGFR;FER;ABL1;STK3;ACVR1;BMPR1A;DAPK1;BIRC6;EPHA3;LRRK2;PDK1;ROCK1;SIK3;FAM20A;CAMK2D;BRAF;SIK2;PRKCE;MAP3K13;CSNK1A1;MAP3K3;GRK3;CLK2;MARK1;SMG1;EIF2AK4;PDPK1;RICTOR;EPHA4;TLK2;EFEMP1;CCNT1;TGFBR1;WNK4;STK24;SNRK;IRAK3;INSR;CDK12;TLK1;PPP4R1;CDK6;MARK3;NEK4;CDC42BPB;EIF2AK3;MAST2;DYRK1A;MAPKAPK3;TRIB2;TYK2;PRKAA2;BAZ1B;SIK1;TOP1;MAML1;BCR;TAOK3;FGFR2;AAK1;STK10;SMAD7;NEK7;CDC25B;MAPK9;FRK;NEK6;HIPK3;ABI1;NRK;RIPK1;PDGFRB;MAP4K3;ABL2;PKD1;DMPK;TESK2;MAP4K4;TBCK;SLK;GRK4;EPHB2;MORC3;DGKQ;PTK2;CDK13;TBK1;DAPK2;MAPK6;STK38;NEK3;LATS2;NUAK1;NLK;ULK2;CSNK2A1;CSNK2A2;ATM;PRKD1;BMP4;COQ8B;WNT11;SRPK2;MARK2;GTF2H4;GSK3B;PRKAG1;CDKL3;KIT;PRKCI;PRKCB;SMAD2;CRY1;CDK7;CLSPN;ACVR2A;ABI3;PASK;STK39;DCLK1;PPP3CB;BMPR2;ACVR2B;COQ8A;PKDCC;RYK;TAOK1;ULK1;STRADB;MAPK14;STK26;EPHA8;VRK3;ABI2;MAP3K5;STK16;JAK1;CDKL1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.22840046887860002,-1.0,1.0,0.776742445102913,1.0,334/1668,13.24%,ZBTB20;PBX1;NFIA;TSHZ2;FOXP1;BMP6;AUTS2;NFAT5;PRDM6;NSD1;SMAD3;FOXP2;NFIB;TEAD1;WWOX;WWC2;ZEB1;PID1;PHF21A;GLIS3;EGFR;HIVEP2;ZNF148;NR3C2;BAZ2B;MLLT10;ATXN1;DNMT3A;ARID1B;HOXB6;FHL2;RARB;PKNOX2;TCF4;TCF7L2;SMAD6;BRWD1;ABL1;KLF12;PRDM5;KDM3B;HOXB3;KMT2C;ZBTB7C;PRRX1;TCF12;ACVR1;ARNT;TSHZ3;KAT6B;SOX5;BMPR1A;FOXD1;TNRC6B;CREBBP;SLC9A1;ZMIZ1;GABPB2;MAML2;PBX3;KDM2A;ZHX2;NRIP1;STAT5B;DAB2;KANK2;BCAS3;MED13;CUX1;MXI1;SSBP2;ZBTB16;HLF;TET2;BBX;TRAK1;NR6A1;KDM7A;NCOA1;ZFP64;HOXA3;GLI3;FGF1;MIDEAS;ZIC4;BRD4;TNRC6A;SMURF2;SUFU;ZMYM5;CAMK2D;DHX36;NIPBL;PPP1R12A;LRP5;GLI2;ARNT2;JMJD1C;SKI;MGA;DPF3;ELF1;HDAC4;HOXB4;NFYC;ATF7;MNAT1;PER2;LRP6;THRB;NR2F2;CHD2;PIAS1;HOXA5;ZKSCAN2;PARP9;OGT;HIVEP3;PRKN;ASXL2;PIAS2;MCPH1;MED13L;PER3;MTA3;TET3;CRTC3;KLF3;URI1;NRF1;PPM1D;CREB5;TEF;ATAD2B;THRAP3;HOXC4;DCAF6;PPARA;OTUD7B;SSBP3;IL18;EPC1;ZFP90;RARG;YAP1;NFATC1;ELP4;ZNF292;TNRC6C;NFIX;FOXO3;ARID1A;KDM5B;CNOT1;HDAC8;DLG1;KAT7;NFATC4;FNIP1;MED15;KAT2B;SMAD9;KMT2A;TBX15;DICER1;NCOR1;ZNF182;KDM3A;CCNT1;TFCP2;MEOX2;MYSM1;FOXP4;TBL1X;LCOR;BCLAF3;SP1;FBXL19;BCOR;VGLL3;ASXL1;NFKB1;ZSCAN26;BCL9L;HOXB5;SMARCE1;NR1D2;MDM4;HDGFL3;HIF3A;CDK12;FOXK2;ZFPM2;ELF2;ARID4B;MTDH;CRLF3;TCERG1;SMARCA5;CHD1;STAT3;ZNF462;SMAD1;ZIC2;CPEB3;ZFP30;BAZ1B;ZBTB1;CCNL2;KCNIP3;CCNL1;ARID5B;ZFHX3;RCOR1;DNAJA3;MET;USP16;MAML1;POGZ;EBF4;RBBP8;NOC2L;ZBTB38;MEF2A;MYNN;SPEN;ZFHX4;JMY;IGF1;ZFX;FGFR2;STAT2;PRDM15;RBAK;MIER1;SMAD7;ZBTB26;EBF1;CREBRF;MYBL1;MOV10;TADA1;TBL1XR1;NFX1;TEAD2;FRK;PCGF5;TFDP1;ATF2;ESR1;CBX4;KLF8;DCAF1;SP4;SP100;RIPK1;INO80;PPARG;FOXK1;CCNK;ZFP91;SENP1;HOXC6;NR2C2;PKD1;IFRD1;PTEN;BCL2L12;ECD;ZKSCAN3;PPID;ZNF23;RGMA;SMAD4;ATF6;MED26;GMEB1;HOXA6;DGKQ;ETV6;ZIC1;CDK13;TBK1;NFATC3;SETX;BRD7;ELF4;NCK1;KDM4C;MZF1;YEATS2;ZHX3;CREB3L2;KMT2D;PSEN1;SAP130;RCOR3;PRRX2;RBPJ;KANSL3;ZBTB34;CAPRIN2;PHF20L1;BRD8;HOXC5;AR;AKAP8L;MKX;RNF14;SLTM;DDX17;ATM;IKZF2;TIAL1;ZNF507;PRKD1;KLF7;RREB1;SIX5;ARHGEF2;ZNF8;SIX1;KAT6A;ZKSCAN7;PHF8;HIVEP1;ZBTB8A;BMP4;DVL3;SIRT1;PPARGC1B;RPAP2;FUS;CXXC5
prerank,phosphorylation (GO:0016310),-0.272786873740128,-1.0,1.0,0.776742445102913,1.0,115/384,17.12%,PRKAG2;ROCK2;GRK5;EPHA7;FER;ABL1;STK3;ACVR1;BMPR1A;DAPK1;BIRC6;LRRK2;PDK1;PI4KA;ROCK1;SIK3;FAM20A;CAMK2D;BRAF;SIK2;PRKCE;MAP3K13;CSNK1A1;GRK3;CLK2;MARK1;EIF2AK4;PDPK1;TLK2;CCNT1;AGK;TGFBR1;WNK4;STK24;SNRK;IRAK3;INSR;CDK12;TLK1;PPP4R1;CDK6;MARK3;NEK4;CDC42BPB;EIF2AK3;MAST2;STAT3;DYRK1A;DGKA;TRIB2;TYK2;PRKAA2;SIK1;TOP1;MAML1;GK5;BCR;TAOK3;AAK1;STK10;NEK7;CDC25B;MAPK9;FRK;NEK6;HIPK3;NRK;FGGY;MAP4K3;DMPK;TESK2;MAP4K4;TBCK;GRK4;EPHB2;MORC3;DGKQ;CDK13;TBK1;DAPK2;MAPK6;STK38;NEK3;LATS2;NUAK1;NLK;CSNK2A1;ATM;PRKD1;COQ8B;WNT11;SRPK2;MARK2;GSK3B;PRKAG1;CDKL3;PRKCI;PRKCB;CDK7;SPHK1;LIMD1;ACVR2A;PANK2;PASK;STK39;DCLK1;PPP3CB;BMPR2;ACVR2B;COQ8A;RYK;TAOK1;ULK1;STRADB;STK26
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.2192712252876176,-1.0,1.0,0.776742445102913,1.0,374/1646,16.15%,ZBTB20;PBX1;NFIA;TSHZ2;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;NFIB;TEAD1;WWC2;ZEB1;MLLT3;GLIS3;EGFR;HIVEP2;BNC2;ZNF148;NR3C2;BAZ2B;ATXN1;RBFOX2;ARID1B;HOXB6;PKNOX2;TCF4;TCF7L2;SMAD6;BRWD1;ABL1;KLF12;PRDM5;ZNF423;SCMH1;KDM3B;HOXB3;ZBTB7C;PRRX1;TCF12;DENND4A;ACVR1;ARNT;SETD5;TSHZ3;KAT6B;SOX5;FOXD1;CREBBP;ZMIZ1;PBX3;KDM2A;ARHGEF11;ZHX2;STAT5B;VGLL4;MED13;CUX1;FOXN3;MXI1;SSBP2;ATF7IP;SNX6;ZBTB16;IL31RA;HLF;BBX;TRAK1;NR6A1;KDM7A;NCOA1;HOXA3;GLI3;BICRA;MIDEAS;ZIC4;BRD4;SMURF2;SUFU;WWP1;BAZ2A;CAMK2D;DHX36;NIPBL;LRP5;GLI2;ARNT2;JMJD1C;MGA;DPF3;USP47;ELF1;ZMYND11;HDAC4;HOXB4;NFYC;ATF7;MNAT1;CCAR1;PER2;LRP6;TAF15;NR2F2;CHD2;HMG20A;PIAS1;HOXA5;NFXL1;DKK3;ZKSCAN2;PARP9;OGT;YAF2;HIVEP3;CBFA2T2;NIBAN2;PRDM11;PIAS2;MED13L;MTA3;KLF3;URI1;NRF1;CREB5;TEF;THRAP3;HOXC4;PPARA;EPC1;ZFP90;YAP1;NFATC1;ELP4;EHMT1;ZNF292;NFIX;APBB2;AXIN1;FOXO3;ARID1A;KDM5B;KAT7;NFATC4;BICRAL;PHC3;LIMS1;L3MBTL3;SMAD9;KMT2A;TBX15;NCOR1;ZNF182;KDM3A;JARID2;EFEMP1;CCNT1;TFCP2;TGFBR1;MEOX2;FOXP4;TBL1X;LCOR;UIMC1;SP1;FBXL19;BCOR;TLE1;VGLL3;NFKB1;ZSCAN26;HOXB5;SMARCE1;INSR;NR1D2;MDM4;HDGFL3;HIF3A;FOXK2;ZFPM2;VSX1;ELF2;ARID4B;MTDH;CRLF3;NEK4;SMARCA5;CHD1;STAT3;NAA16;PML;DYRK1A;MBTD1;SMAD1;ZIC2;ZFP30;BAZ1B;CEP290;ZBTB1;CCNL2;CCNL1;ARID5B;ZFHX3;RCOR1;USP16;EBF4;RUNX1T1;RBBP8;ZBTB38;MEF2A;MYNN;SPEN;ZFHX4;JMY;IGF1;ZFX;MDFIC;BTAF1;STAT2;LOXL3;PRDM15;RBAK;MMS19;SMAD7;NSD3;ZBTB26;EBF1;CREBRF;MYBL1;TADA1;BTRC;TBL1XR1;NFX1;TEAD2;PCGF5;TFDP1;SPINDOC;ATF2;ESR1;CBX4;KLF8;PICALM;KDM5C;SP4;SP100;PPARG;FOXK1;CCNK;NAA15;ZFP91;HOXC6;ASCC1;NR2C2;IFRD1;CNOT7;PDCD4;ZKSCAN3;ZNF23;SMAD4;CDH1;ATF6;MED26;FBXW11;GMEB1;HOXA6;DGKQ;ETV6;ZIC1;NFATC3;TULP3;BRD7;ACTR8;DNM2;ELF4;KDM4C;MZF1;YEATS2;ZHX3;CREB3L2;KMT2D;PSEN1;ILF2;CD80;RCOR3;PRRX2;RBPJ;ZBTB34;NLK;PHF20L1;GPBP1;POLR2A;HOXC5;AR;QRICH1;MKX;RNF14;SLTM;DDX17;TASP1;IKZF2;TIAL1;KLF7;RREB1;SIX5;ZNF8;SIX1;KAT6A;ZKSCAN7;PHF8;HIVEP1;ZBTB8A;BMP4;APBB3;DVL3;SIRT1;PPARGC1B;FUS;WNT11;SCML4;NR2F1;ATP8B1;WWP2;HSF2;NFIC;ORC1;PCBD2;ZBTB21;PHIP;TGFB1I1;CBFB;BCLAF1;PBX4;CREBL2;RLF;KIT;TFCP2L1;NPAT;ZFP62;GMEB2;ZNF276;TGFB3;HEY2;PRKCB;EDRF1;SMAD2;SRRT;SOX13;CRY1;LDB1;RSF1;IRF2;GATAD2A;EZH2;NFYB;FOXN2;MLXIP;CARM1;MDM2;ZBTB46;STAT5A;LIMD1;BRWD3;FOXL1;GON4L;TP53;ZBTB6;ZNF483;MECP2;ING2;HOXA2;ESRRA;ZBTB5;WNT4;HINFP;NR3C1
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.1972243422655843,-1.0,1.0,0.776742445102913,1.0,86/336,17.26%,FOXP1;UBE2E2;ABL1;SUSD6;BABAM2;PDS5A;USP3;TRIP12;NIPBL;STXBP4;PARP4;USP47;MNAT1;UBR5;YAP1;KMT5C;BRAT1;UVRAG;TLK2;SPIDR;PDS5B;MSH3;UFL1;KMT5B;NEK4;PML;RNF8;ASH2L;BAZ1B;PARP3;ZBTB1;USP16;DDB2;RBBP8;ZBTB38;RNF169;TAOK3;ALKBH8;SLX4;MMS19;PSME4;TOPORS;ATF2;FBH1;INO80;CCNK;XPA;MRNIP;CUL4B;BCL2L11;SETX;CUL4A;PSEN1;RAD17;ATM;USP28;ERCC8;MTREX;SETD7;SIRT1;BCL2;RAD51B;GTF2H4;BOD1L1;CGAS;CRY1;TDP1;MGMT;TP53;FANCC;USP45;ALKBH3;ETAA1;HINFP;SIRT7;FOXO1;CEP63;BATF;RTEL1;TAOK1;INIP;FANCG;MAPK14;WAC;ERCC3;RMI2
prerank,cytoskeleton organization (GO:0007010),0.3448556170331045,0.9998555995499766,0.48290155440414506,0.7817264713989304,1.0,25/114,16.53%,APOE;MDK;CFL1;RHOB;CNN2;MAST3;RHOC;RAC1;PACSIN1;TNFAIP3;RHOG;THY1;MAST1;MICAL1;ARAP3;RHOA;CCL2;DES;RHOU;SH3KBP1;ZMYM3;EPB41L3;DMTN;CCL3;FMNL3
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.45867161488567953,0.9997588948361842,0.4979253112033195,0.7815307527588924,1.0,4/13,15.95%,CD2BP2;PRPF19;PRPF8;PRPF31
prerank,heterochromatin organization (GO:0070828),-0.361701879698651,-0.9997255069262059,0.43820224719101125,0.7756562592654865,1.0,5/14,14.88%,SETDB1;SETD7;SIRT1;SMCHD1;EZH1
prerank,skin development (GO:0043588),0.3646587553582852,0.9993577140131814,0.48759439050701187,0.782082764105406,1.0,15/65,17.13%,COL1A1;TXNIP;HRNR;ABCB6;COL3A1;DHCR24;KRT9;WNT5A;COL1A2;LSR;EVPL;STMN1;PDGFA;DLL1;FA2H
prerank,negative regulation of ATPase activity (GO:0032780),0.44120965042421045,0.9993006951000196,0.49866666666666665,0.781798047072442,1.0,3/16,8.94%,ATP5IF1;PLN;IFIT1
prerank,ceramide biosynthetic process (GO:0046513),0.3894895512583964,0.9988297801589746,0.48847926267281105,0.7824655578096652,1.0,12/40,21.50%,CERS2;B4GALNT1;SMPD1;B4GALT6;ST8SIA4;SPTLC1;DEGS1;ST6GALNAC3;FA2H;CLN8;SPTSSA;ASAH2
prerank,regulation of gene expression (GO:0010468),0.33040361302446697,0.9987626858773642,0.517,0.7822169199642343,1.0,175/903,18.57%,APOE;RPL23;RPS3;ACTG1;RPL11;CRIP1;RPS7;RPL5;CD74;CLU;PFDN5;RACK1;RPL6;CLDN5;GSN;CXXC1;PCBP1;TYROBP;RAMP2;GPX1;CALR;ACTA2;MT3;PARK7;MAPK3;HNRNPAB;ATF4;AKT1;LGMN;CNPY2;TREM2;SOX18;HINT1;HNRNPK;LYL1;CD34;PINK1;ANK3;SLC7A5;GPER1;MAGED1;TNF;DRAP1;LAMTOR5;ZFP36L1;PTPRC;PDGFB;ACVRL1;BTN3A3;HCLS1;SPI1;TAPBP;CHEK2;NTRK2;PIN1;AMH;MIF;HSPA1B;TLE5;SIRPA;PPP2R1A;PCBP4;SH3GL2;APLNR;AHNAK;ALPK2;MYADM;BTG1;MSN;MUSK;FADS1;FN1;RIMS2;TFRC;RNF187;TBX22;CEBPB;PQBP1;NELL1;HES6;RIMS1;PRDM12;EDF1;P2RX7;CEBPA;PROX1;KDR;MAPT;MOG;YBX1;VSIR;BCL6B;RRP1B;MLXIPL;MLX;EGR1;GATA2;ATP13A2;ICOSLG;TAF5L;TARDBP;WNT5A;HOXB7;LRP3;TMEM119;APBB1;SUPT4H1;WARS1;FAM50A;ATF5;ATRAID;KDM6B;RAMP3;POU3F1;SOX17;AIF1;MSR1;HRAS;CAMK2N1;FBXW7;SFRP4;KLF4;SLC11A1;SOX9;HDAC5;HSPA1A;METTL18;BMP2;GJA1;LILRB1;NONO;CTSH;GAS6;RO60;UBE2V1;MAFA;TLR6;IFNGR1;MAPK11;SORT1;PF4;SPIN4;SLC8A1;TRAF3;DHH;YBX3;GLRX2;IGF2;ATP1B1;DNMT3B;EDN3;HEY1;EPB41L4B;CCL3;VHL;DNAJA4;GATA4;TWIST1;PRX;PDCD5;CDH5;PIK3CD;NOS2;AGO1;BRCA2;PPARGC1A;CNBP;RLIM;MLF2;TERF2IP;ZNF22;MAP2K2;CCAR2;SFRP1;MAZ
prerank,O-glycan processing (GO:0016266),-0.25759066327849006,-0.9984343656638841,0.4578313253012048,0.7774656709547471,1.0,7/54,7.08%,GXYLT2;ST3GAL4;GALNT11;ST3GAL3;B3GNT2;ST6GAL1;GALNT12
prerank,histone mRNA metabolic process (GO:0008334),0.4061785496482898,0.9983903618293332,0.49823321554770317,0.7826846875493224,1.0,9/27,22.95%,SNRPG;SNRPE;SNRPF;SNRPB;CPSF2;SLBP;SNRPD3;EXOSC4;ERI1
prerank,regulation of signal transduction (GO:0009966),0.3416015033314254,0.9980346418342397,0.49748743718592964,0.7831257734315136,1.0,56/190,24.93%,MTCH1;PPIA;CLU;IGFBP6;CD63;RGS5;PRNP;TREM2;IGFBP3;IGFBP4;IGFBP5;PPP2R1A;NUCKS1;RGS2;OTX2;PTK6;KAZALD1;TIMP1;YWHAG;CD24;GAS1;RGS12;KIF26A;SNW1;NCLN;DOK5;IGFBP2;MAPK8IP2;UBTF;FRMPD1;GLRX2;DLL1;TMEM108;ADCYAP1;NCAM1;SRMS;TMEM204;ERBB3;RFNG;GRK2;TGFB1;BRAP;IGFBPL1;GIT1;RGS6;AMFR;LLGL1;PTPN1;FRRS1L;ZFAND2B;LFNG;TCF7L1;KCTD8;APP;ANKRD54;RGS4
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2768488814846642,-0.9978440328745852,0.4296875,0.777313712743657,1.0,8/34,12.15%,PTPN13;PTPN9;TNS2;DUSP16;DUSP10;PTPN12;DUSP7;PTPN2
prerank,phospholipid dephosphorylation (GO:0046839),-0.27922853982771223,-0.9978073423274728,0.48739495798319327,0.7756586994261024,1.0,18/37,24.51%,PLPP3;MTMR3;MTMR11;SACM1L;PTEN;PLPP5;EPHX2;MTMR10;PLPP1;PIP4P2;PLPP2;INPP5B;PLPPR1;TPTE;PLPPR3;MTMR1;MTMR7;SYNJ2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.4036058719540444,0.9975931784036831,0.495260663507109,0.7837557589675201,1.0,11/28,21.88%,MAP1A;STMN3;CLASP1;MAPT;STMN4;MAP2;STMN1;ARL2;MAPRE3;MAP1B;FKBP4
prerank,mammary gland development (GO:0030879),0.4269314971213456,0.997405717726476,0.4955640050697085,0.7838059952253809,1.0,2/21,2.95%,NRG1;ERBB4
prerank,protein glycosylation (GO:0006486),-0.22116039373651844,-0.997404741625989,0.47368421052631576,0.7750572993959648,1.0,23/125,10.32%,LARGE1;ST3GAL4;B4GALT1;MAN1C1;PLOD2;OGA;TET2;TRAK1;OGT;TET3;ST3GAL3;B3GNT2;PGM3;FUT8;B3GALT1;TUSC3;PMM2;GOLGA2;MGAT3;STT3B;ALG5;ENTPD5;GALNT1
prerank,regulation of p38MAPK cascade (GO:1900744),0.39328846144439683,0.9972484560723195,0.4871495327102804,0.7837403204682307,1.0,13/35,25.29%,TREM2;SPI1;EMC10;PHLPP1;PRMT1;BMP2;RASGRP1;NCF1;DAB2IP;GADD45A;DUSP1;AGER;MFHAS1
prerank,phospholipid translocation (GO:0045332),0.4063330607495324,0.9969500000504555,0.4859154929577465,0.7840379888406835,1.0,6/28,11.39%,TMEM30A;ATP8B4;ATP8A2;P2RX7;MFSD2A;ATP8A1
prerank,positive regulation of cartilage development (GO:0061036),0.44080834050918993,0.9966785439395641,0.48488664987405544,0.7842242162548813,1.0,4/17,13.57%,MDK;ACVRL1;SOX9;BMP2
prerank,intestinal lipid absorption (GO:0098856),-0.3749238906876321,-0.9962301077410829,0.4671280276816609,0.7764735099969631,1.0,1/11,1.15%,LIMA1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.34785991035650327,0.9961447545710711,0.48760330578512395,0.7850582290282002,1.0,24/112,13.91%,RPS27A;UBC;CLDN5;UBB;ID1;ZFP36L1;ACVRL1;FKBP1A;ZFP36L2;HYAL2;LEFTY2;WFIKKN2;UBA52;COL3A1;ZYX;CLEC3B;JUN;WNT5A;COL1A2;AMHR2;RHOA;ZMIZ2;SOX9;LEFTY1
prerank,regulation of interleukin-17 production (GO:0032660),0.4005739025323461,0.9960279740392026,0.49940968122786306,0.784905578032692,1.0,8/31,22.21%,PRNP;SLC7A5;IL2;VSIR;TGFB1;IL6;DDIT3;RFTN1
prerank,regulation of response to external stimulus (GO:0032101),0.34312506708163953,0.9960067389878237,0.5232678386763185,0.7845424346740242,1.0,21/121,16.92%,TMSB4X;CALM1;GRN;PARK7;TREM2;METAP1;SEMA7A;TIRAP;BCL6B;METAP2;P2RY12;HCK;WNT5A;ELMOD2;CXCR4;F2RL1;AKNA;TRAF3;LRP8;CNGB1;CAV1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.34704140164818575,-0.9959122969771249,0.5065502183406113,0.7755086537154791,1.0,7/16,15.47%,DPYSL3;TET2;DPYD;UPP2;UPB1;NT5C1A;NT5M
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.33382205027186057,0.9958875112800861,0.513,0.7844142344666408,1.0,90/390,18.64%,ACTB;ACTG1;ATP6V0C;HSP90AA1;COL1A1;POLR2E;MAPK3;AKT1;ATP6V1F;CYBA;NRG1;ERBB4;POLR2D;ANKS1B;POLR2F;RAC1;PDGFB;NTRK2;GRB14;ATP6V1G1;CAV2;PSENEN;ATP6V0E2;ATP6AP1;GRIN1;RARRES2;ELMO1;LTK;AP2M1;CYBB;SHC3;MUSK;RAB14;PAK1;NAMPT;PTK6;KDR;MPZL1;AP2S1;CDK5R1;ARPC1B;EPHA5;ARHGEF7;PAK3;HCK;POLR2G;FGFRL1;CSF1R;PLAT;HAP1;ARPC3;ATP6V0D2;AAMP;FLT4;HRAS;POLR2K;VAV1;ARPC5;RHOA;VAV3;SH2B2;TIE1;SDCBP;STMN1;TIAM1;HNRNPA1;MAPK11;ARPC4;SORT1;GDF15;PDGFA;IGF2;GFRA2;EPHB1;TYRO3;NCF1;LCP2;CASS4;PSEN2;ARPC2;EFNB1;FLT1;DDR2;APH1B;SRMS;SYK;SLA;GRIN2B;ERBB3;KLB
prerank,regulation of macrophage differentiation (GO:0045649),0.45426034617115846,0.9951760313913898,0.492,0.7856085163950514,1.0,6/15,25.31%,C1QC;PF4;INHBA;ID2;INHA;PRKCA
prerank,regulation of DNA binding (GO:0051101),0.38545213115992494,0.995164796602537,0.5112107623318386,0.7852261779426427,1.0,9/44,11.44%,TXN;NME1;CSNK2B;HES1;EDF1;JUN;HMGB1;SUMO3;ZBTB7A
prerank,myotube differentiation (GO:0014902),0.4447010392039851,0.9948860239794253,0.5096030729833547,0.7854315033262582,1.0,6/17,20.51%,PLD3;ADGRB3;ADAM12;SORT1;MYEF2;MEF2C
prerank,cell proliferation in forebrain (GO:0021846),-0.3999715893455381,-0.9945339911197787,0.4691780821917808,0.7774227420824792,1.0,4/10,15.42%,DOCK7;PCM1;NUMBL;NUMB
prerank,actin filament depolymerization (GO:0030042),0.4749304823408469,0.9943581438490475,0.48823529411764705,0.7862352944888471,1.0,4/11,13.03%,GSN;CFL1;MICAL1;DSTN
prerank,in utero embryonic development (GO:0001701),-0.3004846746076345,-0.9942900619520979,0.42592592592592593,0.7763417742904368,1.0,8/25,16.44%,ARNT2;FUT8;TGFBR1;FGFR2;PKD1;TGFB3;HINFP;MBNL1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.43504214955163756,0.9941100230064204,0.4987146529562982,0.7864077638161436,1.0,6/19,16.22%,HSPA1B;CHMP2B;CHMP5;HSPA1A;HNRNPU;CHMP1B
prerank,neuron projection extension (GO:1990138),0.3950515538187169,0.9938380525925178,0.4964705882352941,0.786628955785993,1.0,6/32,9.55%,HSP90AA1;HSP90AB1;SEMA3F;CTNNB1;SH3GL2;TNN
prerank,regulation of lipase activity (GO:0060191),0.46719977930564954,0.9937348567766358,0.4883720930232558,0.7864695825334879,1.0,5/13,24.88%,RHOC;LPL;RHOA;SNCA;PCSK6
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.40059316824885893,-0.9936076024285149,0.4243421052631579,0.7764898888344793,1.0,3/10,15.87%,DNMT3A;PCGF5;MECP2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.33704530055853366,0.9935727708128742,0.5366098294884654,0.7864228390222112,1.0,58/248,18.86%,APOE;IGFBP6;PFDN5;PSMB4;MDK;COL1A1;PPP1CA;PSME1;PSMB6;PSMB8;PSME2;PSMD2;IGFBP4;FZD9;PSMD1;PIN1;LRP4;TLE5;PSMC3;CTNNB1;PSMD6;ANKRD6;SFRP5;VCP;PSMA7;OTULIN;PSMD5;JADE1;RBX1;LGR6;WNT5A;PSMB9;ATP6AP2;PSMD13;GPC5;PSMB3;SOX17;PSMB11;SFRP4;IGFBP2;SOX9;PSMB10;BMP2;AMER2;STK11;PSMB1;TMEM131L;PSMB5;DACT3;DAB2IP;CAV1;USP8;CSNK1G2;CTNND2;CCAR2;SFRP1;NOTUM;PSMA6
prerank,coenzyme A metabolic process (GO:0015936),0.4476614343151653,0.9933961496633966,0.49794238683127573,0.7864173422095572,1.0,6/14,24.12%,ACAT1;ACOT7;COASY;PPCS;SLC25A16;ACLY
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3251488830011396,-0.9930454965440324,0.4790697674418605,0.7726755416596747,1.0,10/20,28.01%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3251488830011396,-0.9930454965440324,0.4790697674418605,0.7726755416596747,1.0,10/20,28.01%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3251488830011396,-0.9930454965440324,0.4790697674418605,0.7726755416596747,1.0,10/20,28.01%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,negative regulation of myotube differentiation (GO:0010832),0.4601875629906589,0.9929451510161751,0.48066298342541436,0.7870559264396232,1.0,6/12,27.21%,BHLHE41;TMEM119;HDAC5;NOTCH1;CCN3;XBP1
prerank,regulation of necroptotic process (GO:0060544),0.4107225346093523,0.9928890329989307,0.4736196319018405,0.7867711676022662,1.0,7/23,15.56%,HSP90AA1;FZD9;SLC25A4;FLOT1;CDC37;SDCBP;YBX3
prerank,calcium ion import into cytosol (GO:1902656),0.45383664147445774,0.9928505114946125,0.46883468834688347,0.7864542068195121,1.0,5/15,28.95%,SLC24A2;TRPM2;SLC8A1;CACNA2D1;ATP2B4
prerank,negative regulation of cell differentiation (GO:0045596),-0.22403121889113023,-0.9924212319487479,0.5555555555555556,0.7724667868730825,1.0,38/181,14.07%,LDLRAD4;RANBP3L;SMAD3;COL5A2;EGFR;ADAMTS12;SMAD6;COL5A1;CRIM1;ZBTB16;SUFU;LRP5;SKI;EIF2AK4;PPARA;YAP1;ADGRV1;EFEMP1;TGFBR1;ASXL1;ZFPM2;CDK6;TRIB2;RUNX1T1;SMAD7;NPHP3;PPARG;PTEN;PDCD4;TRPM4;FERMT2;ENPP1;TRIO;BMP4;SIRT1;DTX1;JAG1;CHADL
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.38181414413350134,0.9923359179007448,0.5033860045146726,0.7871963242992651,1.0,9/43,13.64%,HMOX1;AKT1;TNF;IGFBP5;PDGFB;P2RY6;JUN;AIF1;GJA1
prerank,stress fiber assembly (GO:0043149),-0.34733591720978774,-0.9923138879675112,0.4493927125506073,0.7692944244195616,1.0,2/15,0.87%,SORBS1;PHACTR1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.34733591720978774,-0.9923138879675112,0.4493927125506073,0.7692944244195616,1.0,2/15,0.87%,SORBS1;PHACTR1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4897559304189299,0.9922937485420713,0.5077138849929874,0.7868815018360482,1.0,5/11,24.84%,RPS27L;HIPK2;MUC1;TFAP4;FOXM1
prerank,catecholamine biosynthetic process (GO:0042423),-0.3829274719318736,-0.9922731027121667,0.45985401459854014,0.767709951012646,1.0,1/11,2.05%,MOXD1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3500386363496858,0.9922577505031221,0.5167714884696016,0.7865512909534669,1.0,27/90,23.25%,GATM;UCP2;FABP5;EPAS1;BSCL2;OMA1;CEBPB;SCD;LCN2;KDM6B;MFAP2;HCRT;THRA;CXCR4;GJA1;ACHE;CAV1;ADCYAP1;PPARGC1A;SYK;CCR2;FABP4;ESRRG;ELOVL6;TSHR;ADIPOR1;PRLR
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3724258050842417,0.992016975182065,0.4872080088987764,0.786273796137961,1.0,23/51,31.19%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;CC2D1B;NUP85;RANGAP1;LMNA;VPS4A;CHMP7;SIRT2;RCC1;KPNB1;VRK1;CHMP4C;NUP188;NUP205;PPP2CA;NUP43;CHMP4A;CHMP4B;SEH1L
prerank,mitotic nuclear membrane organization (GO:0101024),0.3724258050842417,0.992016975182065,0.4872080088987764,0.786273796137961,1.0,23/51,31.19%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;CC2D1B;NUP85;RANGAP1;LMNA;VPS4A;CHMP7;SIRT2;RCC1;KPNB1;VRK1;CHMP4C;NUP188;NUP205;PPP2CA;NUP43;CHMP4A;CHMP4B;SEH1L
prerank,actin filament organization (GO:0007015),0.3389252692951056,0.9917990211152015,0.524822695035461,0.7863488925779869,1.0,34/151,17.97%,ALDOA;GSN;RHOB;MARCKS;TPM2;EMP2;RHOC;RAC1;ARHGAP25;FLNA;ELMO1;RFLNB;RHOG;CORO1C;CORO1A;MYO5A;LCP1;PROX1;MYO7B;MYO1F;MARCKSL1;AIF1;ACTN1;DSTN;RHOA;FLII;CAPG;ARPC4;TMOD1;DMTN;FHOD3;CASS4;RAC2;SCIN
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3416559752955209,0.9914309338671021,0.5199182839632278,0.7868150178314334,1.0,31/140,18.54%,CD52;CHRNA9;GPER1;TAC1;C5AR1;CACNA1A;GRIN1;CCR5;P2RX7;TACR1;HTR2C;CD24;P2RY1;HMGB1;GRM1;GPR18;JPH4;CXCR4;CX3CR1;F2RL1;SLC8A1;RYR2;ADRA1A;ADRA1D;ADCY8;CCKBR;CAV1;BCAP31;PTGIR;ADCYAP1;CCR2
prerank,regulation of cell division (GO:0051302),0.35490964952738124,0.990653054946775,0.5148305084745762,0.7882232749523362,1.0,16/72,21.16%,RACK1;CALM1;CALM3;TXNIP;KLHL9;PIN1;CDK2AP2;DLL1;INSC;CETN2;CALM2;ESRRB;GIT1;MYC;SIRT2;CCP110
prerank,cellular response to increased oxygen levels (GO:0036295),0.4825262084036292,0.9905697281768265,0.517426273458445,0.7880045925256873,1.0,4/11,22.59%,ATP6V1G1;ATP6AP1;CAV1;ATP6V1A
prerank,regulation of extracellular matrix organization (GO:1903053),0.4440411249360972,0.9902538658614012,0.5019973368841545,0.788357989815351,1.0,8/15,29.37%,AGT;AEBP1;TIE1;DDR2;NOTCH1;EFEMP2;RUNX1;DDR1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3618951365902195,0.9902522706572504,0.5141304347826087,0.7879521445992548,1.0,15/59,22.46%,PARK7;GATM;SCP2;LIPG;SDS;LPL;HSD17B4;OXSM;OSBPL6;OSBPL3;CH25H;GAMT;NDUFAB1;ACSM5;OSBPL1A
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.43414905385687935,0.9900792010025936,0.4981179422835634,0.78792369067092,1.0,7/18,20.51%,MDK;HMGB1;CCL2;IGF2;FLT1;ADAM17;MEF2C
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3165154416342023,-0.990011143012259,0.4611872146118721,0.7719863898850614,1.0,4/18,9.46%,EGFR;NRIP1;LCOR;ESR1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3403766789961112,0.9899242877014551,0.4984520123839009,0.7878806392739064,1.0,44/117,32.31%,BSG;CKB;GATM;AGXT;GLO1;SCP2;LDHA;CKMT1A;LPL;GRHPR;FASN;ALKBH7;ACOT1;ACOT7;GLYAT;NAAA;SLC16A1;ACOT4;FA2H;BCO2;ACSL3;GAMT;THEM4;SGPL1;ALDH4A1;MTHFS;ACSL4;SLC6A8;NPC1;LDHB;GPAM;GGT5;CYP4B1;AOAH;ADH1A;PNPLA8;DLD;GNPAT;PDHB;DLAT;AASDHPPT;CD36;PDHA1;PCCB
prerank,regulation of myoblast differentiation (GO:0045661),0.3944793224349821,0.9898332806383943,0.49311926605504586,0.7876848844827891,1.0,10/32,20.51%,LRRC8A;IGFBP3;ZFP36L1;BTG1;SOX8;SOX9;DLL1;TGFB1;NOTCH1;MEF2C
prerank,vesicle transport along actin filament (GO:0030050),0.426788044103776,0.9894090534875902,0.49934810951760106,0.7882526770552182,1.0,4/19,11.41%,MYO5A;MYO7B;MYO1F;FNBP1L
prerank,cochlea morphogenesis (GO:0090103),0.4819834968959149,0.9894090117009876,0.4986111111111111,0.7878434077524896,1.0,2/10,13.22%,MYO3A;SOX9
prerank,protein mannosylation (GO:0035268),-0.31508299203898105,-0.9893519743696854,0.4888888888888889,0.7720405565010506,1.0,3/22,1.56%,TMTC1;LARGE1;TMTC4
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.32002118186482836,-0.9892716418044013,0.46464646464646464,0.7705307831460763,1.0,5/21,10.89%,CGNL1;SLIT2;MAPKAP1;ARHGAP12;EPHB2
prerank,aminoglycan catabolic process (GO:0006026),0.3983080940425397,0.989206163703857,0.5005834305717619,0.7878900809176728,1.0,13/28,20.32%,HYAL2;OVGP1;GUSB;SDC4;GPC5;FUCA1;SGSH;NAGLU;HPSE;HSPG2;SDC3;HPSE2;AGRN
prerank,neural tube closure (GO:0001843),-0.2920015140815072,-0.9891252915160529,0.4513888888888889,0.7692229922928568,1.0,8/34,13.26%,COBL;SKI;LRP6;MTHFR;LMO4;IFT122;DVL3;CELSR1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3656162727943475,0.9891238327138286,0.5191256830601093,0.7876861751118529,1.0,16/52,19.25%,RACK1;AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;RHOG;ARF6;ZDHHC5;RAMP3;CLIP3;SQSTM1;STX4;ACSL3;STAC3
prerank,ganglioside biosynthetic process (GO:0001574),0.45081273986041775,0.9890551423038723,0.49097938144329895,0.7874372275821689,1.0,4/15,16.27%,B4GALNT1;B4GALT6;ST8SIA4;ST6GALNAC3
prerank,receptor catabolic process (GO:0032801),0.4111981712750378,0.9889085382499855,0.5073529411764706,0.7873614159460055,1.0,9/24,25.00%,LGMN;AP2M1;CLTC;AP2S1;CLTA;TGFB1;AP2A1;VLDLR;GPRASP1
prerank,proteoglycan metabolic process (GO:0006029),-0.30455059820968966,-0.9878448443090496,0.4262295081967213,0.7708671940441134,1.0,8/26,19.41%,SULF1;ADAMTS12;IGF1;CHST11;FOXL1;BMPR2;B3GALT6;SULF2
prerank,insulin receptor signaling pathway (GO:0008286),0.35790788379974825,0.9876007735964271,0.5112299465240642,0.7900055930839541,1.0,10/69,7.92%,ATP6V0C;AKT1;ATP6V1F;GRB14;ATP6V1G1;CAV2;ATP6V0E2;ATP6AP1;RARRES2;NAMPT
prerank,positive regulation of histone methylation (GO:0031062),-0.30521468737047147,-0.9874216360136816,0.45,0.7703224075326427,1.0,6/24,13.14%,AUTS2;OGT;KMT2A;JARID2;SMAD4;SIRT1
prerank,regulation of type I interferon production (GO:0032479),0.34878340754607057,0.986970442182223,0.5230125523012552,0.7910576001620141,1.0,30/84,30.00%,GAPDH;POLR2E;POLR2F;PIN1;CTNNB1;TIRAP;TNFAIP3;ISG15;PQBP1;IRF8;POLR2K;IRF7;G3BP1;TRAF3;TRIM32;CD14;POLR3D;POLR3K;POLR2H;IRF5;PCBP2;RELA;NLRP4;TRIM56;DHX9;XRCC6;TRIM25;ACOD1;POLR3C;POLR3E
prerank,neurogenesis (GO:0022008),0.3799578400225514,0.9868139626554882,0.5203073545554336,0.7910076307224453,1.0,17/43,26.61%,SPOCK1;PRDM12;MAPT;NDUFS2;HAP1;CLN5;CXCR4;DCHS1;EPHB1;ERCC6;BTBD6;ROGDI;METTL3;METTL14;TGFB2;NTN5;WNT2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.39967179527899044,0.9867881816341237,0.4800483675937122,0.7906547992993317,1.0,5/28,7.67%,RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3440295709869645,0.9859051386625027,0.5474974463738509,0.7923454418239926,1.0,41/113,27.21%,MDK;GRN;LAMC1;AKT1;NME1;PTPRN;PDGFB;ANG;C5AR1;ECM1;RTN4;EMC10;PROX1;TNFSF12;KDR;WNT5A;PDCD6;FLT4;HRAS;SOX9;NME2;BMP2;BAD;EGFL7;PIK3CD;SFRP1;SOX11;MYC;PTN;SCG2;TGFA;MYDGF;WNT7A;AGGF1;OSR2;TEK;PRKCA;PLXNB3;LAMB1;HTR2B;XBP1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.486966034529794,0.9858199044965001,0.4928571428571429,0.7921250474437367,1.0,7/10,34.21%,SYNGR1;SYP;APP;NETO1;CAMK2B;DRD2;NPTN
prerank,response to cytokine (GO:0034097),0.338422246744925,0.9855097434170218,0.5361139369277721,0.7924501820680228,1.0,37/141,21.94%,IFITM3;CD74;IFITM2;IFITM1;TIMP2;AKAP6;SHFL;HCLS1;TLE5;DDOST;ISG15;CXCL16;COL3A1;IL1RAPL1;TIMP1;SMPD1;TAF9;CSF1R;TIMP3;RHOA;SLC11A1;CXCR4;BST2;SIGIRR;TMEM102;TRIM32;SNCA;PTPN6;FLT3;POU4F1;FOXA2;CDK9;TIMP4;SHMT2;ASAH2;MAP2K7;PTPN5
prerank,response to growth factor (GO:0070848),0.37796363103961084,0.985402994039887,0.5011467889908257,0.7922684978599445,1.0,5/41,5.33%,RACK1;AKT1;PDGFB;ACVRL1;CTNNB1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4357985265397895,0.9851398037027821,0.4987012987012987,0.792469668934203,1.0,8/18,19.75%,CLU;TNF;ABCG1;GSAP;ABCA2;IFNGR1;EFNA1;LRRTM3
prerank,regulation of lymphocyte activation (GO:0051249),0.4609437386051912,0.9847711223256606,0.5075034106412005,0.7929486112702494,1.0,2/12,14.58%,DCAF15;IKZF3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.30143118554044546,-0.9847568494467687,0.4782608695652174,0.7755721408709629,1.0,8/30,11.96%,TGFBR3;SMAD3;SMURF2;DKK3;SMAD7;SMAD4;LATS2;ITGA3
prerank,inorganic anion transmembrane transport (GO:0098661),0.3564670228018072,0.98470780371036,0.5350109409190372,0.7926810019893762,1.0,14/63,19.42%,GABRB1;LRRC8A;GABRG3;GABRA2;SLC12A5;SLC25A11;GLRA2;GABRA3;GABRB3;GLRA1;SLC1A1;GABRB2;ANO4;GLRA3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.45803887572891505,0.9844127158302255,0.4947089947089947,0.7929500740827433,1.0,3/14,18.54%,CD81;SYK;CCR2
prerank,sterol metabolic process (GO:0016125),0.35848871674262395,0.9842649744128281,0.5065217391304347,0.7928958934964034,1.0,9/60,18.07%,APOE;ABCG1;PIP4P1;FDX2;SC5D;CLN6;SOAT2;CLN8;CH25H
prerank,T cell differentiation (GO:0030217),0.38002788751949235,0.9840360486541702,0.5274599542334096,0.7929949410460242,1.0,9/40,17.68%,ZFP36L1;PTPRC;FCER1G;SPI1;ZFP36L2;IL2;JAG2;PIK3CD;ADAM17
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.48244860253335187,0.9838422992616447,0.5085714285714286,0.7930255680858455,1.0,3/10,19.51%,PDE3B;JAM3;MUC1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.33682196397818315,0.9838354757900385,0.5584677419354839,0.7926330049807904,1.0,56/199,22.66%,RPS19;MDK;GRN;CALR;GPNMB;ATF4;ID1;TNF;NR1D1;SPI1;LRP4;RGS2;ALPK2;ARHGDIB;LRPAP1;CORO1C;TIMP1;SYT11;HS3ST5;PROCR;SRGN;ATP2B1;PTPRR;SLC11A1;SOX9;SPRY1;BMP2;GJA1;WNT10B;STK11;GAS6;ARRDC3;IFNGR1;GDF15;NR1H2;PLCL2;HEY1;DAB2IP;PFN2;HDAC9;ADAM17;BRCA2;SFRP1;IP6K1;VASN;TGFB1;EFNA1;NOTCH1;FOXA2;MEF2C;TWSG1;FOXA1;DDIT3;PTPRO;GRHL2;PAEP
prerank,muscle cell development (GO:0055001),0.3941161995300815,0.9834235691359307,0.4935064935064935,0.7931639432202447,1.0,6/30,15.41%,RAMP2;SGCZ;HES1;ALPK2;MYH11;SLC8A1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4308141508024763,0.9833885015711318,0.5058365758754864,0.7928324569451242,1.0,5/18,18.88%,ZFP36L1;ZFP36L2;IKZF3;CCR2;PRELID1
prerank,protein deacetylation (GO:0006476),-0.2646045328402476,-0.982709872954305,0.43478260869565216,0.779485697558506,1.0,11/41,13.14%,PRDM5;MIDEAS;BAZ2A;HDAC4;MTA3;TBL1X;RCOR1;MIER1;TBL1XR1;RCOR3;SIRT1
prerank,respiratory tube development (GO:0030323),-0.30355962847662293,-0.9825170465573814,0.4024390243902439,0.7783237647625746,1.0,8/28,13.00%,FGF1;GLI2;PCSK5;FGFR2;LOXL3;NPHP3;ITGA3;BMP4
prerank,amyloid precursor protein catabolic process (GO:0042987),0.46156371821446135,0.9813489988994885,0.52,0.7970647880151797,1.0,6/14,18.16%,PSENEN;ABCG1;BACE1;PSEN2;ADAM17;APH1B
prerank,embryonic digit morphogenesis (GO:0042733),-0.32747509263463515,-0.9809114713439552,0.48444444444444446,0.7808845231303713,1.0,3/18,5.87%,CREBBP;GLI3;WDPCP
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.39131545499879394,-0.9796019938496778,0.4407894736842105,0.7827065809397266,1.0,5/10,18.91%,ST6GAL1;GNE;RENBP;NPL;NAGK
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3443020065084925,0.97913035918711,0.5324947589098532,0.8017349647911708,1.0,19/95,13.96%,RPS27A;UBC;UBB;HSP90AB1;LTBP4;FKBP1A;PIN1;EID2;CDKN1C;HIPK2;WFIKKN2;UBA52;STRAP;ZBTB7A;SNW1;HSPA1A;SPRY1;STK11;SDCBP
prerank,positive regulation of developmental growth (GO:0048639),0.3720229318270243,0.9789177231937465,0.5225522552255225,0.8018276350057292,1.0,20/49,26.46%,PPIB;SEMA7A;SYT1;RIMS2;RIMS1;MAPT;NTN1;SYT4;SHTN1;CPNE5;SYT2;CPNE6;DLL1;AGRN;SYT3;UNC13A;TWF2;RNF157;SYT17;ZFYVE27
prerank,smooth muscle contraction (GO:0006939),-0.33808600038140557,-0.9784279311577823,0.44360902255639095,0.7841294429474305,1.0,4/14,7.84%,ROCK2;ROCK1;MYLK;EDNRA
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.42483944584140915,0.9782891756221155,0.5059288537549407,0.8028215652386165,1.0,4/19,14.33%,MAF1;PRDX5;CEBPA;ZC3H8
prerank,endoderm formation (GO:0001706),0.38356023525724836,0.9781287547114412,0.5185614849187935,0.8027794930918272,1.0,9/35,19.19%,VTN;ITGB2;FN1;COL6A1;SOX17;COL7A1;MMP14;DUSP2;INHBA
prerank,epidermis development (GO:0008544),0.3649741952044212,0.9780756614883009,0.4955947136563877,0.8024823249502497,1.0,17/56,30.30%,GJB5;FABP5;YBX1;CCN2;LAMC2;KRT9;EVPL;COL7A1;DLL1;ATP2A2;GRHL2;PLOD1;PTHLH;ATP2C1;POU2F3;ALDH3A2;EMP1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.39558976944925184,-0.977824097047731,0.4691780821917808,0.7841414199070061,1.0,4/10,21.22%,SEC14L1;NPLOC4;DHX58;GPATCH3
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4142126040726582,0.9776252637765793,0.5131414267834794,0.8030879132588506,1.0,4/22,4.70%,TNF;LGALS3;FKBP1A;PPP1R1B
prerank,regulation of actin filament-based movement (GO:1903115),0.4850208611246855,0.9771569188635918,0.5123287671232877,0.8037474282702941,1.0,3/10,17.92%,PDE4B;PLN;SRI
prerank,peptidyl-glutamic acid modification (GO:0018200),0.4091908511862704,0.9770312024540688,0.5161676646706587,0.8035875074147327,1.0,7/24,19.37%,VKORC1;PARP1;AGBL4;NAA10;TTLL7;TTLL10;TTLL5
prerank,monocyte differentiation (GO:0030224),0.47254397954161176,0.976992657000785,0.5041782729805014,0.8032657654131771,1.0,1/10,0.43%,MT1G
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.44220277020022875,0.9769039462540529,0.5240641711229946,0.8030711007049018,1.0,7/14,31.63%,SCP2;HSD17B4;CRAT;EHHADH;ACOX3;DECR2;ACOX1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.4236280126705592,0.976415046803753,0.5006134969325153,0.8037678774220567,1.0,13/18,38.70%,PCNA;RFC4;GINS3;LIG1;POLE3;MCM7;POLD3;GINS1;RFC3;LIG3;POLD2;MCM4;MCM3
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.40869574369315753,0.9760672040167963,0.5138539042821159,0.8041775656994112,1.0,7/22,20.81%,ERBB4;TNF;HES1;IL6;NOTCH1;IL10RB;CRLF2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4920291526871501,0.9756519510176307,0.5229226361031518,0.804680269546098,1.0,5/10,24.84%,RPS27L;HIPK2;MUC1;TFAP4;FOXM1
prerank,male gonad development (GO:0008584),0.38876594407294374,0.9756310432823749,0.52,0.8043172856719295,1.0,13/34,28.62%,WNT5A;KITLG;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK
prerank,regulation of calcium ion transport (GO:0051924),0.36130006371864315,0.9755804698209002,0.5163755458515283,0.804013933686937,1.0,13/54,17.92%,CD84;HOMER2;CTNNB1;PLN;LILRA5;ATP2B1;WFS1;LILRB1;EPB41;CCL3;ORAI1;SARAF;SRI
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3484123593720819,-0.9754984997131557,0.49107142857142855,0.7885643871189585,1.0,3/16,3.81%,FER;ABL1;NRP1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.4288940246370918,0.9748210057813286,0.5025906735751295,0.8053368114078815,1.0,4/18,9.80%,HMOX1;KDR;JCAD;GATA2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.24573536925677797,-0.9747313066975637,0.5942028985507246,0.7889042497885634,1.0,11/58,13.19%,BABAM2;KDM2A;NSMCE2;UVRAG;MDC1;UIMC1;RNF8;NHEJ1;ATM;ERCC8;CYREN
prerank,positive regulation of insulin secretion (GO:0032024),0.3829662403175116,0.9746344673143735,0.5155350978135789,0.8053721806902251,1.0,14/36,27.18%,LRRC8A;TRH;RBP4;GPER1;BAD;ADCY8;DOC2B;GLUD1;STX4;NNAT;ACSL4;PSMD9;TM7SF3;PLA2G6
prerank,regulation of store-operated calcium entry (GO:2001256),0.47764944219253547,0.9745877600389191,0.5,0.805064317180699,1.0,2/10,4.15%,CD84;HOMER2
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3355109604859687,-0.9740560479845546,0.44396551724137934,0.7891133325034481,1.0,8/17,21.77%,CCNT1;CPEB3;VIRMA;ZC3H14;CPSF6;ZC3H3;RNF20;CTR9
prerank,cardiolipin metabolic process (GO:0032048),-0.3677326050596697,-0.9739834141280382,0.4581818181818182,0.787609808148141,1.0,6/13,26.98%,PLA2G4A;CRLS1;PLSCR3;HADHB;PLA2G5;PGS1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.37667951885499323,-0.9739361978597585,0.4962962962962963,0.7860519534530416,1.0,8/12,21.36%,PTPN14;RBM4;BMP4;AAAS;SIRT7;NUP214;KHDRBS1;TPR
prerank,long-term synaptic potentiation (GO:0060291),0.41293350192969946,0.9737258155186226,0.5185659411011524,0.8065625628369308,1.0,6/21,18.82%,SLC24A2;MPP2;GRIN2A;VAMP2;GRIN2B;STX4
prerank,negative regulation of cholesterol transport (GO:0032375),0.4775382934722046,0.973588392465354,0.5205091937765205,0.8064351909532578,1.0,4/10,30.81%,APOC1;ABCA2;ABCG5;SHH
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3520077787678827,0.973148792548677,0.5306781485468245,0.8069967432058817,1.0,9/65,7.26%,RPS27A;UBC;UBB;FKBP1A;PIN1;EID2;WFIKKN2;UBA52;STRAP
prerank,transcription by RNA polymerase II (GO:0006366),-0.23248948583133772,-0.9730289528210383,1.0,0.7868500769271112,1.0,95/305,18.44%,TEAD1;NOTCH2;MLLT3;GLIS3;NR3C2;RARB;PRRX1;SCAF8;SOX5;CREBBP;MAML2;INTS8;NR6A1;SETD2;MNAT1;THRB;TAF15;AFF4;PPARA;RARG;YAP1;ELP4;NFIX;INTS6;KAT2B;NCOR1;CCNT1;TFCP2;TBL1X;WDR33;SP1;NFKB1;NR1D2;CDK12;RNGTT;ZBTB1;MAML1;TAF1A;CSTF3;TBL1XR1;NFX1;TEAD2;PABPN1;TFDP1;ESR1;IWS1;TRIM24;PPARG;CCNK;PIR;NR2C2;GTF2E2;MED26;CDK13;SETX;PMF1;RBPJ;TAF2;POLR2A;ELL;AR;PHAX;RREB1;RPAP2;NR2F1;DTX1;NFIC;FIP1L1;CBFB;GTF2H4;GMEB2;POLR2B;SRRT;CDK7;POLR2J;GTF2A2;CDC73;ESRRA;ADRM1;NR3C1;RTF1;TRIP11;TAF8;ICE2;ERCC3;RPRD2;CPSF1;TAF4B;INTS3;SNAPC3;NR5A2;GTF2H2;TAF7;INTS11;MED23
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.4744669675153419,0.9723788634895317,0.5287049399198932,0.8083012860006938,1.0,2/11,4.85%,ARL6IP1;RTN4
prerank,superoxide anion generation (GO:0042554),0.4554721643998729,0.972368698313429,0.5251700680272109,0.8079159893425194,1.0,3/13,16.12%,CYBA;CYBB;NCF1
prerank,negative regulation of organelle assembly (GO:1902116),-0.2739104092856079,-0.9721456705494839,0.5323741007194245,0.7876061015627202,1.0,7/35,10.54%,LRRK2;NBDY;YAP1;KAT2B;SCFD1;CEP97;SMAD4
prerank,regulation of neuroblast proliferation (GO:1902692),0.44288007259554607,0.9720522028261825,0.5223499361430396,0.8082227635420371,1.0,6/15,25.58%,TAFA1;CTNNB1;CX3CR1;PTN;FZD3;CX3CL1
prerank,striated muscle cell differentiation (GO:0051146),0.4414860300866922,0.9714539348118085,0.5071335927367056,0.8091124597505502,1.0,7/16,15.71%,NRG1;PLD3;MTLN;KDM6B;BMP2;SORT1;MYEF2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.2359490503703202,-0.9711896427733553,0.5595238095238095,0.7885279191842058,1.0,19/67,18.16%,PLD1;FER;DCDC2;TBC1D19;USP6NL;TBC1D2B;RABGAP1;TBC1D9B;IFT88;SDCCAG8;FXR2;IFT140;ATP8B1;MYO10;ABITRAM;SGSM3;DYNC2LI1;FMR1;CDKL1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.35287739288239134,0.9711101089387068,0.5269978401727862,0.809498858135758,1.0,18/67,18.46%,MDK;CALR;S100A10;EMP2;RAC1;PDGFB;FLNA;MYADM;FN1;P4HB;ARHGEF7;FBLN2;ARL2;DMTN;CCL28;CASS4;SKAP1;SFRP1
prerank,synaptic vesicle endocytosis (GO:0048488),0.3828811778179033,0.9710505447135173,0.5286549707602339,0.8092339943557681,1.0,8/33,9.35%,NLGN1;CANX;PACSIN1;SNAP91;DNM3;SYT1;AMPH;VAMP2
prerank,cilium organization (GO:0044782),-0.1983568283491612,-0.9708639812339535,0.3333333333333333,0.7876486270785272,1.0,78/209,26.83%,PARVA;DCDC2;ASAP1;CC2D2A;EXOC4;CYS1;GALNT11;BBS9;ATP6V0D1;EXOC2;WDPCP;ARL3;PCM1;TTLL3;CCDC66;CDC14A;PIBF1;CEP290;OFD1;DZIP1L;CCDC57;GBF1;FAM161A;IFT88;DYNC2H1;NPHP3;ABLIM1;CFAP44;PKD1;CEP89;WDR35;CEP162;PDE6D;IFT140;INTU;IFT122;WDR11;WDR19;CLUAP1;DYNC2I2;CEP78;AVIL;TCTN2;TTC17;RFX3;CEP41;CEP19;POC1B;CFAP70;RAB8B;RTTN;RFX2;CDC14B;CPLANE2;PKD2;TMEM138;IFT80;IFT81;RAB1A;TMEM231;FOXJ1;CFAP61;RILPL2;CCDC65;MNS1;RILPL1;RAB3IP;ABCC4;PTPDC1;TEKT2;MAK;IFT52;CFAP43;BBS5;CFAP52;EXOC1;MKKS;KIF3B
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.40979575691722575,0.9706343304022522,0.5235732009925558,0.8097543660649752,1.0,8/23,22.73%,ELOVL1;ELOVL2;ELOVL7;ACOT7;ACSL3;DGAT1;ELOVL6;ACSL4
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.36896226766872464,-0.9705845636487568,0.45724907063197023,0.785095089872074,1.0,5/11,24.51%,PTEN;IMPA2;INPP1;INPP5B;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.36896226766872464,-0.9705845636487568,0.45724907063197023,0.785095089872074,1.0,5/11,24.51%,PTEN;IMPA2;INPP1;INPP5B;SYNJ2
prerank,positive regulation of lyase activity (GO:0051349),0.44400263425576947,0.9705450545202213,0.5191040843214756,0.8095475030085352,1.0,5/14,17.79%,PARK7;DRD5;ISCU;ORAI1;NOS2
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.4020481213228188,-0.9703052218506277,0.49122807017543857,0.7841112479105247,1.0,2/10,5.62%,ACTN2;CARMIL1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.4585887308076847,0.9702901845718809,0.532345013477089,0.809680984589848,1.0,4/11,26.18%,CLEC6A;NFKBID;IL12RB1;PRKCQ
prerank,modulation by host of viral genome replication (GO:0044827),0.44811411580382565,0.9698833462017047,0.5321477428180574,0.8101817273721948,1.0,5/13,21.40%,PPIB;NUCKS1;CCL8;VAPA;IFI27
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.28581848654775105,-0.969514656546965,0.5058139534883721,0.7845863888206472,1.0,13/27,22.50%,SMG6;PARP4;NIBAN2;PDGFRB;TERF2;SMOC2;ATM;PINX1;BMPR2;FGF2;PRKD2;TOM1L1;TNKS
prerank,cytoplasmic translational initiation (GO:0002183),0.4269349414801412,0.9693795886133394,0.5208333333333334,0.8109395016228931,1.0,5/17,20.49%,EIF3D;EIF3I;EIF4A1;EIF4H;EIF3M
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.39578372149082663,0.9692593681424684,0.5338983050847458,0.8107950970848357,1.0,9/26,25.31%,LGMN;DUSP3;HES1;ASNS;USP22;MEIS2;FOXA1;APP;PRKCA
prerank,visual system development (GO:0150063),0.3784153927176744,0.9690613014342597,0.5310668229777257,0.8108548013473778,1.0,7/37,13.15%,C1QA;C3;RBP4;HIPK2;SALL2;BLOC1S3;MAB21L1
prerank,skeletal muscle organ development (GO:0060538),0.40323741148925024,0.9686586978435829,0.5175332527206772,0.811395008321221,1.0,7/26,20.77%,MYL6;FOXL2;BASP1;MYL6B;CAV1;MEF2C;MYH14
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4134780984392037,0.9683150887692215,0.5147247119078106,0.8117524129608024,1.0,6/22,17.34%,AKT1;NTRK2;SH3GL2;MAPT;EHD1;TMEM108
prerank,positive regulation of filopodium assembly (GO:0051491),-0.2987609018254277,-0.967924401031065,0.5251396648044693,0.7869762223939823,1.0,5/24,7.48%,DPYSL3;DOCK11;BCAS3;NRP1;PALM
prerank,regulation of ATP metabolic process (GO:1903578),0.35636616785017045,0.9672381225707768,0.5342763873775843,0.8137035346664805,1.0,15/54,21.01%,UQCC2;PGAM1;PINK1;COX7A2L;COX7A2;ATP5IF1;AK4;ZBTB7A;NUP85;NUP88;NUP50;RAE1;SPHK2;SHMT2;FIS1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3504201651964282,0.9671147110089213,0.5339074273412271,0.8135546854937957,1.0,18/67,17.53%,HSP90AA1;HSPB1;CYBA;RAC1;ELMO1;CYBB;KDR;CLEC14A;PDCD6;AAMP;FLT4;VAV1;RHOA;VAV3;MAPK11;NCF1;DAB2IP;FLT1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.4286944249776562,0.9670410589451494,0.5463917525773195,0.8133249963119346,1.0,4/17,15.33%,BTG1;SFRP4;SOX9;BAD
prerank,cytosolic calcium ion transport (GO:0060401),-0.2965741599900425,-0.9661783164149135,0.5094339622641509,0.7899508161209414,1.0,6/28,8.36%,MCU;CACNA1C;MICU1;MICU2;SLC35G1;JPH1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.24689978056929315,-0.9660383932170252,0.45454545454545453,0.7886683069744569,1.0,13/62,8.98%,KMT2C;CNOT4;TNRC6B;CREBBP;ZBTB16;TNRC6A;HOXA5;TNRC6C;KAT2B;KMT2A;CDK6;ASH2L;MOV10
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4527223061020633,0.965873410077581,0.5331452750352609,0.8155522926284412,1.0,5/12,19.80%,TNF;NCOR2;LIN28B;TGFB1;IL6
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3733624443721818,0.9658661266758849,0.5333333333333333,0.8151600137471093,1.0,13/40,28.03%,SLC38A5;SLC7A5;SLC25A11;SLC25A21;SLC19A1;SLC16A1;SLC38A10;SLC7A10;SLC25A14;SLC7A6;SLC38A3;ABCC5;SLC16A7
prerank,positive regulation of intracellular transport (GO:0032388),0.3742069142148768,0.9658625975133095,0.5374149659863946,0.8147578986637728,1.0,18/38,31.07%,OAZ1;SORL1;PRR5L;MLC1;VAMP2;CEP131;B3GAT3;STK11;EHD1;EHD2;OAZ2;ICE1;KIF20B;PCNT;PGAP1;TENM1;SPAG5;DYNC1H1
prerank,focal adhesion assembly (GO:0048041),-0.32100031738273344,-0.965842243867161,0.48633879781420764,0.7875498577022534,1.0,6/21,10.81%,SORBS1;ACTN2;BCR;PIP5K1A;TESK2;FERMT2
prerank,regulation of cell adhesion (GO:0030155),0.33411181917234917,0.9657523711769126,0.5725971370143149,0.814612302182111,1.0,28/129,19.71%,ARHGDIA;MDK;CXCL12;TGM2;TNF;ACVRL1;DSCAM;PPP2R1A;PDE3B;MYADM;ARHGDIB;FRMD5;ADGRG1;DUSP26;P4HB;PODXL;ARHGDIG;CXCR4;DLL1;EPB41L4B;TMEM102;PLAU;RAC2;ERBB3;PPP3CA;STX4;LPXN;EFNA1
prerank,cellular protein localization (GO:0034613),0.3223118801716723,0.9657242406638461,0.613,0.8142692653749036,1.0,74/285,22.57%,CD74;CD63;LAPTM5;SNX17;ID1;NPM1;LAMTOR2;GRID2;EMP2;CNTNAP2;ARF5;PACSIN1;YWHAH;CTNNB1;FLNA;ATG9A;CPE;TMED7;SAR1A;RAB14;ESAM;TMED2;CLTC;ARL11;PRPF19;SCG5;ARF6;TICAM2;ABHD17A;ARL4C;TMED3;WNT5A;TMED9;PDCD6;CTSA;SGSM1;ARL4D;TMED1;ARL1;SYNDIG1;LAMTOR3;GJA1;ARF1;EHD1;JAM3;TBC1D22B;RRAGC;UNC93B1;EPB41L3;ARF4;RAB20;RRAGD;NAPA;AMOT;TBC1D9;RAB5C;WDR45;STX4;RAB31;ERP29;RAB18;HPS6;TBC1D10C;CTTN;CAPN3;RAB6B;COPB2;TMED10;IFT27;PTPRU;STX1B;AP2A1;RAB28;EVI5L
prerank,regulation of cardiac conduction (GO:1903779),0.36286643479511904,0.9653291220117319,0.5494994438264739,0.8147466801740428,1.0,15/54,18.56%,NPPC;FXYD1;AGT;ATP1A3;ATP1B2;FXYD7;ATP2B1;ATP1A4;ATP1A1;TRPC1;SLC8A1;ATP1B1;RYR2;FKBP1B;ATP1B3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.35248116430126286,-0.9650113254093401,0.49321266968325794,0.7881476921303525,1.0,6/15,15.77%,PIEZO2;ADGRV1;COL11A1;TMEM120A;KIT;PDZD7
prerank,regulation of axonogenesis (GO:0050770),0.3617829773968641,0.964745129977881,0.5487122060470325,0.815600890649961,1.0,13/51,16.57%,ARHGDIA;NTRK2;RTN4;LRP4;LRRC4C;PAK1;THY1;PAK3;GDI1;RHOA;ROBO2;TIAM1;BRSK2
prerank,lamellipodium assembly (GO:0030032),0.39384230485173355,0.9642644103410634,0.5207823960880196,0.8162350886853984,1.0,7/26,16.10%,RAC1;S1PR1;ARHGEF4;P2RY12;ARHGEF7;CCDC88A;DMTN
prerank,snRNA processing (GO:0016180),-0.339739436778542,-0.9641066475952266,0.4827586206896552,0.7888846062241237,1.0,5/16,18.35%,INTS8;INTS6;TUT1;INTS3;INTS11
prerank,alpha-amino acid metabolic process (GO:1901605),0.36231788210056914,0.9636450400438706,0.5308924485125858,0.8171518095966644,1.0,12/45,20.56%,OAT;SLC25A13;PYCR2;GLUL;DDAH1;GLS2;GLS;DDAH2;ASNS;NAT8L;GLUD1;GOT1
prerank,organophosphate ester transport (GO:0015748),0.40651589950616523,0.9628637185656768,0.5213032581453634,0.8184671367454011,1.0,3/24,4.20%,PLTP;NPC2;SCP2
prerank,diacylglycerol metabolic process (GO:0046339),0.4082623355491479,0.9625668415584482,0.53875,0.8187156369307751,1.0,10/23,23.40%,PNPLA2;ANG;DGKH;LIPE;DGKI;MOGAT2;DGAT1;DGKK;DGKB;MOGAT1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.342188284934835,0.961991077964264,0.5651260504201681,0.8195788213966669,1.0,30/93,25.29%,CCL19;SPI1;TIRAP;ANKRD6;SEMA4C;EMC10;HIPK2;CCN2;HMGB1;FLT4;HRAS;MAPK8IP1;PRMT1;BMP2;SDCBP;F2RL1;TRAF3;RASGRP1;NCF1;DAB2IP;MAP4K2;LTBR;GADD45A;PYCARD;UNC5CL;DUSP15;WNT7A;APP;AGER;MFHAS1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3468087785479605,-0.9619511743972772,0.4807692307692308,0.7928510366972245,1.0,5/14,14.71%,TNKS2;TERT;TERF2;TINF2;PINX1
prerank,mesenchymal cell development (GO:0014031),0.4195377609917134,0.961935921099194,0.5202614379084968,0.8192991418456405,1.0,13/18,39.89%,NRG1;PDCD6;SOX8;SOX11;NOTCH1;NOLC1;KBTBD8;CDH2;TBX20;KLHL12;TCOF1;FOXC1;SNAI2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.3345369430283032,-0.9616005591758724,0.5041666666666667,0.7920315771074502,1.0,6/16,11.86%,TGFBR3;BMPR1A;ZFPM2;IGF1;FGFR2;RBPJ
prerank,cAMP-mediated signaling (GO:0019933),-0.30233407113102223,-0.9609573137736193,0.48186528497409326,0.792092403672317,1.0,7/24,10.95%,ADCY1;PDE7B;RAPGEF2;KSR1;PDE7A;RAPGEF3;DGKQ
prerank,regulation of actin filament-based process (GO:0032970),0.3493517537915271,0.9606783362364979,0.5682062298603652,0.8216877635966262,1.0,20/70,18.15%,RHOB;CNN2;RHOC;RAC1;GPM6B;IQGAP2;RHOG;DLC1;FAM107A;CORO1A;PAK1;EPHA5;PAK3;RHOA;BST2;CCDC88A;PDGFA;DMTN;RAC2;ARHGEF19
prerank,negative regulation of protein polymerization (GO:0032272),0.39564266845922963,0.9604904475406166,0.5321212121212121,0.8217288433882125,1.0,14/27,25.44%,MYADM;PFN1;TUBB4A;MAP2;CLIP3;STMN1;PFN2;CDH5;SNCA;SSH2;TWF1;TWF2;TBCD;MAPRE1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4472222323626258,0.9604201942657437,0.5499316005471956,0.8214548015859097,1.0,3/12,14.20%,RAN;SEC14L2;ABCA2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.36424776520243096,-0.9603213888457516,0.5111111111111111,0.7921155424361637,1.0,8/12,28.67%,GOLGA2;BTRC;PTEN;CDC14B;GORASP1;RAB1A;PLK1;UBE2C
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.4270099046692857,0.9602549712377041,0.526246719160105,0.8214117835030156,1.0,7/16,37.59%,PTPRC;LILRB1;IL12RB1;AGER;CYRIB;STX7;FADD
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3738378066935152,0.9600159236673314,0.5423925667828107,0.8215530264669314,1.0,6/37,12.20%,DYNLL2;DYNLL1;IFT20;DYNLRB1;CEP131;DYNLRB2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.41172073356883404,0.9599627915253103,0.5463786531130876,0.8212422700045209,1.0,9/21,25.47%,HINT1;NUDT3;ACAT1;PNP;NUDT4;NUDT16;NUDT10;NUDT11;PDE2A
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4567290801478151,0.9596424391801629,0.5319444444444444,0.8215467210629964,1.0,7/12,27.21%,BAX;DAB2IP;TMEM33;BAK1;PTPN1;BOK;XBP1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.40826185778572716,0.9596235203450262,0.5329192546583851,0.8211773766984913,1.0,8/22,19.75%,CLU;TNF;ABCG1;GSAP;ABCA2;IFNGR1;EFNA1;LRRTM3
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.4175201763165927,0.9594060053221029,0.5440414507772021,0.8212533109507311,1.0,7/19,28.26%,TNFAIP3;NLRP2B;CX3CR1;NLRP3;GIT1;CX3CL1;CPTP
prerank,transcription by RNA polymerase III (GO:0006383),0.39215376469422,0.9593292196441345,0.5505481120584653,0.8210108450474414,1.0,10/27,26.94%,GTF3C6;POLR2K;IVNS1ABP;RO60;ZC3H8;TBP;GTF3A;POLR3K;ICE1;GTF3C2
prerank,calcium import into the mitochondrion (GO:0036444),-0.38230400755865757,-0.9586046944709566,0.49508196721311476,0.7949406825729378,1.0,3/10,6.22%,MCU;MICU1;MICU2
prerank,cellular glucose homeostasis (GO:0001678),0.37065022669907705,0.9585810428101335,0.5407239819004525,0.8222779823946382,1.0,5/41,5.78%,RACK1;LRRC8A;GPER1;NR1D1;NUCKS1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3912899556375928,0.9585211993984221,0.5429262394195888,0.8220010383732801,1.0,6/28,10.03%,CXCL12;HCLS1;PFN1;ESAM;COTL1;PAK3
prerank,positive regulation of cell projection organization (GO:0031346),0.33247043323629677,0.9579867329086466,0.6039094650205762,0.8227853157085047,1.0,20/115,14.81%,APOE;ARHGDIA;MDK;NTRK2;CAMK1D;S100A9;NDRG4;TENM3;LTK;ATP1B2;PTK6;IL1RAPL1;CAMK1;WNT5A;SS18L2;PTPRD;RHOA;ROBO2;TIAM1;LRRC7
prerank,histone acetylation (GO:0016573),-0.23349956275203287,-0.957803767203606,0.6031746031746031,0.7954076508547749,1.0,16/69,13.31%,KAT6B;CREBBP;ZZZ3;EPC1;NAA40;KAT7;KAT2B;TADA1;BRPF3;ATF2;EP400;YEATS2;PHF20L1;BRD8;KAT6A;JADE2
prerank,cation transport (GO:0006812),0.3274429234542376,0.9577557495231448,0.5889447236180905,0.8228655584324398,1.0,30/167,16.24%,SLC38A5;SLC39A1;SCN1A;GRIN1;KCNJ10;SLC25A29;SGK1;CNGA3;SLC6A6;TMEM63C;AQP1;SLC6A17;SCN4B;SLC3A2;KCNC1;KCNA2;TRPM2;KCNN2;ATP1A4;KCNK9;SLC1A1;KCNF1;ABCC8;NDUFA9;SLC8A1;ATP1B1;KCNK3;KCNA1;FGF13;CNGB1
prerank,cGMP metabolic process (GO:0046068),0.45805236158523627,0.9574485647196406,0.5459533607681756,0.8231237336750007,1.0,1/12,2.38%,NPPC
prerank,positive regulation of kinase activity (GO:0033674),0.33768712177903054,0.9573061423805026,0.5940390544707091,0.8230070510435792,1.0,28/107,18.55%,CD74;CCL19;TREM2;ERBB4;TNF;PTPRC;NTRK2;EEF1A2;LTK;MUSK;KDR;MAPT;EPHA5;CSF1R;FLT4;TIE1;GAS6;MMD2;MAPRE3;EPHB1;TYRO3;LCP2;FLT1;ADCYAP1;DDR2;CAMKK1;AGAP2;ERBB3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.4580822019890315,0.9569822781517261,0.5264623955431755,0.8233057544458234,1.0,5/11,35.15%,PKD2L1;LPO;RTP3;PKD1L3;RTP4
prerank,negative regulation of leukocyte migration (GO:0002686),0.4714389718532561,0.956933435483927,0.5557122708039492,0.8230108692269692,1.0,1/10,1.74%,HMOX1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.43921282582295773,0.9567698763054708,0.5356662180349933,0.8230072536301624,1.0,4/14,11.69%,IGFBP3;IGFBP5;NDRG4;AIF1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2546947469216093,-0.9566394318850374,0.5259259259259259,0.79674014300659,1.0,11/46,20.97%,PLD1;PLA2G4A;DGKA;DGKQ;DDHD2;AGPAT4;GPAT3;ABHD5;GPD1;PNPLA3;PLD2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.41047613926121324,0.9564636048832635,0.5429292929292929,0.8232599207942339,1.0,5/19,13.04%,TLE5;CD24;TAF9;WNT5A;KLF4
prerank,response to organic cyclic compound (GO:0014070),0.3575219106459734,0.9563885167936415,0.5456521739130434,0.8230105862619969,1.0,14/52,21.52%,SPP1;TNF;IGFBP5;CTNNB1;TRPM2;PMAIP1;SLC1A1;PAQR7;CCL2;ABCA2;CCL3;SFRP1;TGFB1;FOXA1
prerank,cellular response to glucose stimulus (GO:0071333),0.3869925685980327,0.9558850058642766,0.5312117503059975,0.8236719720632294,1.0,7/30,16.59%,RACK1;PTPRN;GPER1;MLXIPL;PTPRN2;GAS6;ADCY8
prerank,potassium ion transmembrane transport (GO:0071805),0.331468436299534,0.9558829128945464,0.6055327868852459,0.823270770054433,1.0,34/135,20.02%,SLC24A4;SLC24A2;KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;ATP1A3;ATP1B2;SLC12A5;KCNC1;KCNE4;KCNA2;KCNN2;ATP1A4;ATP1A1;KCNK9;KCNF1;ABCC8;KCNE5;ATP1B1;KCNK3;KCNA1;HCN1;SLC9A9;LRRC55;HCN3;KCNK10;ATP1B3;KCNH7;KCNH8;KCNK13;PKD2L1;KCNQ5
prerank,pharyngeal system development (GO:0060037),-0.33868391219254207,-0.9557960313699376,0.5523012552301255,0.7973500763126026,1.0,10/15,32.53%,BMPR1A;TGFBR1;BMP4;BMPR2;BMP5;PTCH1;BMP7;GATA3;SIX4;ISL1
prerank,sulfur compound biosynthetic process (GO:0044272),0.3333209561642116,0.9553767800592562,0.5777548918640577,0.8239653814144999,1.0,30/104,23.67%,BGN;BCAN;LUM;FMOD;GSTM1;MPST;MGST1;GSTO1;DCN;CHST1;B4GALT6;GSTM5;GSTM2;MGST3;CHPF2;CHPF;HPGDS;UGDH;VCAN;MAT2A;B3GNT3;AKR1A1;CHSY3;ESD;OPLAH;CSGALNACT2;ACAN;PRELP;B4GALT3;CHST14
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.40211721638551523,0.9550074901187225,0.5374064837905237,0.8243404668021509,1.0,8/22,25.29%,SPI1;EMC10;PRMT1;BMP2;NCF1;GADD45A;AGER;MFHAS1
prerank,sensory perception of smell (GO:0007608),0.4682715584696235,0.954529836345508,0.5491803278688525,0.8249620896335005,1.0,2/11,14.70%,SLC24A4;SYT10
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.3111640191627897,-0.954403403112177,0.5693069306930693,0.7977119254052072,1.0,6/21,13.34%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.3111640191627897,-0.954403403112177,0.5693069306930693,0.7977119254052072,1.0,6/21,13.34%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.4556018990168676,0.9541938120724205,0.5560283687943263,0.8252899217397949,1.0,3/11,13.77%,CD34;WNT5A;WNT10B
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.4401629184204712,0.9534731890283401,0.5374331550802139,0.8264286498273441,1.0,4/13,19.67%,SOD1;CLPTM1;ZC3H8;TOX
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.4654950200508186,0.953444514763033,0.5408450704225352,0.826076488637767,1.0,5/10,32.78%,WNT5A;ADAM17;CCR2;OXSR1;CCL5
prerank,regulation of T cell differentiation (GO:0045580),0.3750575978781253,0.9529345063485272,0.5464037122969838,0.8267987079604933,1.0,7/33,18.88%,MDK;SOD1;CLPTM1;IL2;CTLA4;CCR2;PRELID1
prerank,P-body assembly (GO:0033962),-0.3659167368238979,-0.95282747420254,0.5119453924914675,0.8003253396297532,1.0,4/12,8.44%,ATXN2;LSM14A;DDX6;PATL1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.34176916919039274,0.9525457071346245,0.5839572192513369,0.8272414583150759,1.0,9/72,13.00%,RPL26;RPS27L;CHEK2;PCBP4;HIPK2;NDRG1;BAX;PCNA;PRMT1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.340428135238675,-0.9520982090215142,0.5266903914590747,0.8005754904763523,1.0,5/14,13.98%,ARID2;MMS19;MRNIP;FUS;FANCB
prerank,regulation of multicellular organism growth (GO:0040014),0.440936901504773,0.9513132052006682,0.5501955671447197,0.8294771572850234,1.0,3/15,9.00%,PPIB;SOD1;MFSD2A
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4055631004620927,0.9512403542941376,0.5486725663716814,0.8292166999737617,1.0,5/21,8.49%,ACTG1;GPM6B;DUSP3;CORO1C;CLASP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3943511069172237,0.950426278376477,0.5473300970873787,0.8305898818159115,1.0,7/26,19.74%,PARK7;CYBA;GRIN1;ADGRB1;TLR6;SNCA;SPHK2
prerank,positive regulation of cell differentiation (GO:0045597),0.3239280788524386,0.9501450124393992,0.6305220883534136,0.8308017105103142,1.0,54/237,16.79%,IFITM1;MDK;COL1A1;HSP90AB1;NBL1;AKT1;LRRC8A;CD34;AGT;CTNNA2;IGFBP3;ZFP36L1;ACVRL1;CDS1;DNAI3;BNIP2;CTNNB1;ATP6AP1;RARRES2;BTG1;BRINP3;CEBPB;NELL1;LPL;NRCAM;SLC6A6;KDR;CCN2;CAMK1;ZFP36;KITLG;LRP3;TMEM119;BRINP1;ATRAID;MSR1;BRINP2;BLOC1S5;FBXO5;RHOA;SOX9;BMP2;GJA1;SDCBP;MMD2;TIAM1;PCP4;RRAS;MAPK11;PF4;EDN3;BEND6;VHL;TWIST1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.31404166198933703,-0.9498978249930438,0.536036036036036,0.8045326646348789,1.0,3/20,3.17%,CAMK2D;ACTN2;PRKCE
prerank,meiosis I (GO:0007127),-0.29387653595102686,-0.9492856750841161,0.5248618784530387,0.8043262483674546,1.0,18/23,43.03%,MYBL1;BCL2L11;ING2;ZCWPW1;ZSCAN21;SGO1;SYCP3;MEIOB;FOXJ3;SLC25A31;BRDT;MOV10L1;MEIKIN;CCNA1;DNMT3L;MEI1;MEIOC;BTBD18
prerank,positive regulation of macroautophagy (GO:0016239),0.35899025675714125,0.9490947943503543,0.5672316384180791,0.8326765368432086,1.0,8/48,9.33%,SLC25A5;PINK1;SLC25A4;BNIP3L;SCOC;DCN;KDR;HSPB8
prerank,synaptic membrane adhesion (GO:0099560),-0.3434565383478636,-0.9490392365652374,0.5393700787401575,0.8033884399578558,1.0,2/14,1.96%,GPC6;GPC4
prerank,ERBB signaling pathway (GO:0038127),0.34297614539479143,0.9488523344072793,0.5795698924731183,0.832791949729594,1.0,17/64,21.01%,HSP90AA1;AKT1;NRG1;ERBB4;SHC3;MATK;PTK6;CDC37;AAMP;PTPRR;SOX9;ERBIN;ADAM17;ERBB3;SOS1;TGFB1;STUB1
prerank,determination of heart left/right asymmetry (GO:0061371),0.3611176721072725,0.9486945470668015,0.5757575757575758,0.8326984228760279,1.0,14/42,28.41%,SOX18;NDRG4;APLNR;MMP21;TBX22;SOX17;DLL1;GATA4;NOTCH1;MEF2C;SRF;TBX2;ENG;VANGL2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.44220790602433074,0.9477996616506401,0.5396383866481224,0.8342457783895187,1.0,4/13,13.07%,ELOF1;SPI1;SERTAD1;ZMIZ2
prerank,negative regulation of signal transduction (GO:0009968),0.32116166160619697,0.9476036613685809,0.644,0.8342271909690657,1.0,64/249,19.68%,RACK1;APOD;CALR;DCC;AKT1;LGMN;TMBIM6;AGT;IGFBP3;TNF;IGFBP5;PTPRC;YWHAB;GRB14;NDRG4;TNFAIP3;SFRP5;VCP;RGS2;LRPAP1;ARRDC1;LEPROT;PTK6;DCN;NTN1;CADM4;GATA2;SMPD1;KIF26A;ULK3;PDCD6;ZBTB7A;FBXW7;SFRP4;SPRY1;BMP2;NLRP2B;CX3CR1;MAPK8IP2;GDF15;MMP14;EGFL7;HEY1;TYRO3;SIGIRR;DLL1;BEND6;DACT3;DAB2IP;GATA4;GLIS2;PTGIR;APCDD1;TMBIM1;SRMS;SFRP1;ERBB3;MAZ;NOTUM;QARS1;SNCA;SPRY3;HIC1;BRAP
prerank,protein export from nucleus (GO:0006611),-0.2796439016658165,-0.9473383256401793,0.5823529411764706,0.8064027441341598,1.0,12/27,17.08%,RANBP3L;DUSP16;SMURF1;NUTF2;PKD1;RANBP17;XPO4;XPO7;CCHCR1;CSE1L;NUP214;STRADB
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.378094161265018,0.9472808482294203,0.5799522673031027,0.8345373134584058,1.0,18/32,33.65%,MID1IP1;NAV3;CLASP1;TUBB4A;MAP2;CLIP3;STMN1;FGF13;CDH5;SNCA;FKBP4;TBCD;MAPRE1;CAMSAP3;CLASP2;STMN2;KATNB1;APC
prerank,neuron apoptotic process (GO:0051402),0.41070770519759997,0.9471958938663868,0.5585241730279898,0.8343163556843378,1.0,1/19,0.90%,GAPDH
prerank,regulation of ion transmembrane transport (GO:0034765),0.3759293906089271,0.9471838954478571,0.5562060889929742,0.8339361742998421,1.0,6/33,14.80%,AKAP6;YWHAE;KCNJ10;P2RX7;CHRM3;KCNE5
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.31470523678340884,-0.9467440223886852,0.5270935960591133,0.8062530811997337,1.0,2/21,3.66%,OSBPL8;PLA2G4A
prerank,response to interleukin-1 (GO:0070555),0.3435877486568387,0.9465062024575154,0.6010526315789474,0.8349977357138565,1.0,21/73,25.58%,CCL19;NR1D1;TLE5;SIRPA;HYAL2;SMPD1;TAF9;SOX9;CCL2;MAPK11;DAB2IP;CCL3;CCL8;SFRP1;SNCA;PYCARD;RELA;APP;TNFRSF11A;PRKCA;CX3CL1
prerank,positive regulation of translational initiation (GO:0045948),0.40928487847511497,0.9456322038651065,0.555699481865285,0.8364645283347111,1.0,5/18,18.44%,POLR2D;UHMK1;POLR2G;YTHDF1;EIF2B5
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33921879317527737,0.9455312373003625,0.5778947368421052,0.836257275681243,1.0,22/75,24.93%,CALM1;RGS5;C3;GPER1;METAP1;YWHAB;RGS2;KLK6;METAP2;RGS12;RAMP3;SYP;FRMPD1;CNGB1;ADCYAP1;GIT1;PPEF1;RGS6;RNF157;KCTD8;PDE6G;RGS4
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3773679266461057,0.9447604197663115,0.5662211421628189,0.8370973219715133,1.0,6/31,12.54%,POLR2E;POLR2D;POLR2F;POLR2G;POLR2K;CMTR1
prerank,7-methylguanosine RNA capping (GO:0009452),0.3773679266461057,0.9447604197663115,0.5662211421628189,0.8370973219715133,1.0,6/31,12.54%,POLR2E;POLR2D;POLR2F;POLR2G;POLR2K;CMTR1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.32113920092729764,0.9447491455370027,0.6424974823766365,0.8367150042064975,1.0,55/198,26.89%,ALDOA;GPX4;CALM1;ALDOC;PPP1CA;MAPK3;AKT1;PFKL;PTPRC;TOLLIP;DUSP3;PLAAT3;PGK1;DUSP28;LPL;PAK1;PIP4P1;BCKDK;NUDT3;PLA2G4F;PTPRD;GDE1;PTPRB;INPP5J;NUDT4;PPA1;CDK5;G6PC3;PIK3CD;CLN8;NT5C;PPP3CA;IP6K1;CERKL;NUDT10;PLPPR2;TGFB1;SPHK2;PGP;PLCH1;DUSP23;DUSP12;DUSP15;PNKP;AGPAT2;INPP5D;NUDT11;ACP2;PLA2G3;PLPPR4;TNK2;DUSP8;GPD2;INPP4B;HTR2B
prerank,protein modification process (GO:0036211),0.3380536827726227,0.9447190754964941,0.5823591923485654,0.8363694728386996,1.0,15/76,13.69%,RPN1;RPN2;UBL5;PARP1;LOX;CPE;CDC34;UBA52;UBE2M;NEDD8;ICMT;PLAT;CHRM3;SERP1;ST8SIA4
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3691309826544587,0.9444730421093946,0.5600461893764435,0.8365220031848367,1.0,10/35,19.63%,KCTD10;RASIP1;STMN3;DLC1;TNFAIP1;SPRY1;STMN1;DAB2IP;KCTD13;SPRY3
prerank,nucleoside catabolic process (GO:0009164),-0.3683812425366347,-0.9442166003463089,0.5371621621621622,0.8111033431317134,1.0,6/11,15.47%,DPYD;UPP2;UPB1;DERA;NT5C1A;NT5M
prerank,cellular response to cAMP (GO:0071320),0.37615119124403007,0.9439757831047385,0.5727810650887574,0.8371591114776292,1.0,11/30,28.23%,AKAP6;ZFP36L1;IGFBP5;AQP1;HCN1;DMTN;HCN3;AANAT;PDE2A;RAP1B;KCNQ1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.32458426666230783,0.9434512338697189,0.5892494929006086,0.8379339578236095,1.0,23/128,13.91%,RPS27A;UBC;CLDN5;UBB;MAPK3;ID1;ACVRL1;FKBP1A;AMH;EID2;LEFTY2;WFIKKN2;UBA52;COL3A1;ZYX;JUN;SLC33A1;COL1A2;AMHR2;RHOA;ZMIZ2;BMP2;LEFTY1
prerank,positive regulation of nervous system process (GO:0031646),0.40969127401399785,0.94341645419709,0.5568783068783069,0.8375913377575069,1.0,5/18,12.46%,RIMS2;RIMS1;MYRF;TENM4;HCRT
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4173673929492825,0.9433271502024326,0.5548302872062664,0.8373773679744836,1.0,7/16,19.48%,HSPA5;GABARAPL2;RYR2;BCAP31;PPP1R15A;DDRGK1;VAPA
prerank,double-strand break repair via break-induced replication (GO:0000727),0.44938898294646445,0.9429474680689433,0.5489130434782609,0.8377921481476476,1.0,5/12,27.80%,MCM5;MUS81;CDC45;MCM7;MCM2
prerank,osteoclast differentiation (GO:0030316),0.3975417998535629,0.9429302639650214,0.5573366214549939,0.8374218187222531,1.0,7/22,19.50%,TYROBP;TREM2;GLO1;CSF1R;OSTM1;OSCAR;GPR183
prerank,regulation of nervous system development (GO:0051960),0.3685811579404984,0.9428956689079762,0.5643678160919541,0.8370739891309367,1.0,11/37,21.57%,CTNNB1;HES1;HES6;BHLHE41;TENM4;PTPRZ1;CX3CR1;HEY1;DLL1;SIRT2;PTN
prerank,potassium ion import across plasma membrane (GO:1990573),0.363462073326788,0.9427147199135735,0.5558139534883721,0.8370438418021204,1.0,9/41,18.56%,KCNJ10;ATP1A3;ATP1B2;SLC12A5;ATP1A4;ATP1A1;KCNK9;ATP1B1;ATP1B3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.36167436468480263,0.9426688093000337,0.5831485587583148,0.8367257109097087,1.0,13/47,20.73%,PPIA;MAPK3;SEMA4C;PHLPP1;MAPK8IP1;F2RL1;MAPK8IP2;RASGRP1;EPHB1;DAB2IP;MAP2K2;QARS1;MYC
prerank,multivesicular body organization (GO:0036257),0.3799193745391164,0.9425675459863677,0.5443499392466585,0.836540065629983,1.0,16/31,31.00%,CHMP2B;CHMP5;CHMP6;VPS28;CHMP1B;VPS4A;VPS37C;CHMP7;VPS36;CHMP1A;HGS;CHMP4C;SNF8;MVB12A;CHMP4A;CHMP4B
prerank,negative regulation of centrosome duplication (GO:0010826),0.4485681997782554,0.9423473268940399,0.5473537604456824,0.8366169456685413,1.0,1/11,3.02%,NPM1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.36370445748056224,-0.9423104952243997,0.5208333333333334,0.8126651666316894,1.0,5/11,19.01%,TNRC6A;TNRC6C;RBM4;AGO2;AGO4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.36370445748056224,-0.9423104952243997,0.5208333333333334,0.8126651666316894,1.0,5/11,19.01%,TNRC6A;TNRC6C;RBM4;AGO2;AGO4
prerank,oligodendrocyte differentiation (GO:0048709),0.40531701346098065,0.9422853582706904,0.5593008739076155,0.8363568148742146,1.0,7/19,21.53%,MYRF;SOX8;SOX9;PTPRZ1;CDK5;EIF2B5;SOX10
prerank,regulation of mast cell degranulation (GO:0043304),-0.3451961244610751,-0.9420396195122273,0.5020242914979757,0.8118372856178504,1.0,2/14,0.95%,GAB2;FER
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3046423875921348,-0.9417341593022568,0.5120481927710844,0.8110239657082534,1.0,9/24,19.44%,SORBS1;IRS1;INSR;IGF1;ENPP1;GSK3B;PASK;PPP1R3B;PPP1R3F
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.36845193584386016,-0.9416897322119518,0.5066666666666667,0.8095134841239291,1.0,3/10,13.29%,PARD3;PRKD3;PLPP1
prerank,cellular response to alcohol (GO:0097306),-0.24717706424561392,-0.9412067908014559,0.6074074074074074,0.8092338879146845,1.0,7/42,5.69%,ADCY1;SMO;ADCY5;LRP6;GRAMD1C;LARP1;SPIDR
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3237027715652415,0.9410073545397947,0.630346232179226,0.8387183182676435,1.0,16/132,9.90%,APOE;HSP90AA1;LAPTM5;PNPLA2;TNF;TMEM59;ORMDL3;PRR5L;MSN;LIN28B;DCN;P2RX7;MTLN;PTTG1IP;MLXIPL;HMGB1
prerank,peptidyl-lysine methylation (GO:0018022),-0.28265749747131097,-0.9407003807783704,0.5406976744186046,0.8088679097106061,1.0,14/26,27.44%,SMYD3;SETD2;EHMT1;SETD7;EHMT2;SETD4;SETD3;VCPKMT;METTL21A;SETD6;SMYD1;N6AMT1;SUV39H1;ETFBKMT
prerank,neuron migration (GO:0001764),0.35056382061217806,0.9406377555190336,0.5935412026726058,0.8390794702444341,1.0,18/48,20.51%,RAC1;NTRK2;ADGRL3;SPOCK1;NRCAM;TUBB2B;CDK5R1;DNER;ELP3;CCK;CDK5;FGF13;TUBB2A;GPM6A;DCX;MAP1B;DDIT4;MEF2C
prerank,protein homotrimerization (GO:0070207),0.4333466507496334,0.9405232132830333,0.5425101214574899,0.8385226571969232,1.0,4/14,13.19%,SLC1A2;MIF;STEAP4;ALOX5AP
prerank,protein trimerization (GO:0070206),0.4333466507496334,0.9405232132830333,0.5425101214574899,0.8385226571969232,1.0,4/14,13.19%,SLC1A2;MIF;STEAP4;ALOX5AP
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.34664738061651934,-0.9404547487517467,0.5179282868525896,0.807833986002897,1.0,2/13,3.02%,CACNA1C;ANK2
prerank,positive regulation of protein import (GO:1904591),0.37850847889899986,0.9403598804968677,0.5499398315282792,0.8384295918224417,1.0,5/30,7.67%,RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,regulation of establishment of cell polarity (GO:2000114),0.4221402199784762,0.9401723669881649,0.5712435233160622,0.8384317346661421,1.0,2/16,0.88%,RACK1;GSN
prerank,cellular senescence (GO:0090398),0.384103933988807,0.9400127351796628,0.5801169590643275,0.8383542581837383,1.0,5/27,12.19%,CALR;SPI1;ECRG4;ULK3;HRAS
prerank,endothelial cell development (GO:0001885),0.38744599338392327,0.9399214818469486,0.5748129675810474,0.8381322102567333,1.0,12/25,27.11%,SOX18;MYADM;MSN;ROBO4;PECAM1;F2RL1;MARVELD2;CNMD;COL18A1;PDE2A;STC1;RAP1B
prerank,purine nucleotide biosynthetic process (GO:0006164),0.4423279175083318,0.9398751723053298,0.5534246575342465,0.8378280288053916,1.0,6/12,27.95%,GART;PRPS1L1;PRPS1;PRPSAP1;ADSL;ADA
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2823303160080919,-0.9398527634024848,0.5614973262032086,0.8078252154061575,1.0,6/26,13.34%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4506214417318843,0.9395133859499846,0.5538461538461539,0.8381858786828764,1.0,4/11,15.56%,FZD9;SLC25A4;NUPR1;YBX3
prerank,regulation of intracellular pH (GO:0051453),-0.26915350448640496,-0.9394416300870163,0.5704225352112676,0.8072656743942118,1.0,6/34,7.13%,SLC9A1;SLC4A10;LRRK2;SLC9A2;NOX1;TM9SF4
prerank,primary neural tube formation (GO:0014020),-0.2859675582372426,-0.9391112916898936,0.5822784810126582,0.8065124642400907,1.0,7/30,13.26%,COBL;SKI;LRP6;MTHFR;LMO4;IFT122;CELSR1
prerank,canonical Wnt signaling pathway (GO:0060070),-0.23272436120238038,-0.9391052739601713,0.5846153846153846,0.8049514216111912,1.0,11/68,6.49%,TCF7L2;LRRK2;PLPP3;LRP5;LRP6;CSNK1A1;FZD6;RARG;AXIN1;WNT5B;BCL9L
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.4242343657284867,0.9383622407615525,0.5443708609271524,0.8402308203354313,1.0,3/14,13.65%,GPER1;ECSCR;CCL2
prerank,positive regulation of myoblast differentiation (GO:0045663),0.41895328327551384,0.9383001431033512,0.5806878306878307,0.8399442887056785,1.0,3/16,6.20%,LRRC8A;IGFBP3;BTG1
prerank,telomere capping (GO:0016233),0.4147675828853154,0.938295312721172,0.5700934579439252,0.8395478247890494,1.0,4/16,18.20%,TERF1;DCLRE1C;CTC1;TERF2IP
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.45127726043508476,0.9382886903625988,0.5779310344827586,0.839156410046169,1.0,3/12,13.22%,AGT;SOX8;SOX9
prerank,regulation of Rac protein signal transduction (GO:0035020),0.42520781105471084,0.937567924363473,0.5694087403598972,0.8402601488389962,1.0,6/16,18.42%,GABARAP;STMN3;CADM4;ARF6;KBTBD7;RASGRF1
prerank,positive regulation of catabolic process (GO:0009896),0.3417393789135022,0.9375244748336063,0.5918591859185919,0.8399606311313053,1.0,16/65,20.33%,NDUFA13;OAZ1;TNF;SORL1;TNFAIP3;VCP;TNFSF12;VSIR;DDB1;WNT5A;VPS28;EGLN2;DAB2IP;TRIM32;HECW1;OAZ2
prerank,gonad development (GO:0008406),0.3631515914294571,0.9368514796940102,0.5907553551296505,0.840974832383404,1.0,15/41,29.46%,BASP1;WNT5A;KITLG;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK;IRX5
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.29573048994127227,-0.93679277447288,0.5454545454545454,0.8089832005290655,1.0,11/23,24.51%,MTMR3;MTMR11;SACM1L;PTEN;MTMR10;PIP4P2;INPP5B;TPTE;MTMR1;MTMR7;SYNJ2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.38029245379844906,0.9363883834119004,0.5690276110444178,0.841554341482224,1.0,8/30,17.64%,TOMM7;PINK1;UBL5;LEPROT;FBXW7;RHOU;PDCD5;RAC2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3673918733997995,0.9361099836659715,0.5654205607476636,0.8417244633385214,1.0,18/35,32.97%,MAPK3;CCT2;CTNNB1;CCT7;CCT8;HNRNPA1;MAPK15;MAP2K7;CCT4;NAF1;PNKP;CCT3;PRKCQ;HNRNPA2B1;AURKB;PKIB;ACD;CCT6A
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4104252765731171,0.9359923389331184,0.57543391188251,0.8415653733006281,1.0,4/18,12.45%,NLGN1;RIMS2;RIMS1;SYN1
prerank,negative regulation of cell aging (GO:0090344),-0.33040583934191187,-0.9358856391494296,0.5511111111111111,0.8098219444598264,1.0,7/16,13.14%,MAP3K3;SLC30A10;CDK6;ZKSCAN3;TERT;TERF2;SIRT1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.46136884425828234,0.9353374918890037,0.5866302864938608,0.8425363874699652,1.0,1/10,1.79%,SOD1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3523558935091456,-0.9352678455225277,0.5428571428571428,0.8097365469911233,1.0,4/13,13.14%,SORBS1;IRS1;ECHDC3;SIRT1
prerank,serine family amino acid catabolic process (GO:0009071),0.4565136783166533,0.935123266049337,0.5753228120516499,0.8425597935902398,1.0,5/10,34.93%,SDS;SHMT2;DLD;THNSL2;GCSH
prerank,renal water homeostasis (GO:0003091),0.39452793236698236,0.9347205896950795,0.5698393077873919,0.8429805353639593,1.0,9/23,19.75%,AQP4;AQP1;PRKAR1A;PRKAR1B;WFS1;ADCY4;ADCY8;PRKAR2B;TFAP2B
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.3294063846221944,-0.9334065029139668,0.5258620689655172,0.8129906896891059,1.0,4/17,5.55%,PID1;HDAC4;PPARA;NCOR1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3448367322624092,0.9331377466785475,0.5911602209944752,0.845815932934289,1.0,19/51,26.18%,MAPK3;TERF1;CCT2;CTNNB1;CCT7;CCT8;HNRNPU;HNRNPA1;CTC1;MAPK15;MAP2K7;GNL3L;CCT4;NAF1;PNKP;CCT3;PIF1;HNRNPC;PRKCQ
prerank,cellular response to nutrient levels (GO:0031669),0.33875641387259353,0.9329033774686123,0.5859124866595518,0.8459134166496801,1.0,15/62,21.26%,HSPA8;MAP1LC3B;MAP1LC3A;FADS1;FAM107A;LPL;CD68;MFSD2A;RRAGC;RRAGD;LAMP2;SFRP1;WDR45;INHBB;RALB
prerank,response to sterol (GO:0036314),0.4466107687029924,0.9325036587907305,0.5680555555555555,0.8463964568918797,1.0,5/11,23.44%,CCR5;ABCA2;CCL3;TGFB1;PMVK
prerank,stabilization of membrane potential (GO:0030322),0.41952497148276924,0.9324593608169707,0.5838668373879642,0.8460914054955406,1.0,5/16,19.45%,CHCHD10;KCNK9;KCNK3;KCNK10;KCNK13
prerank,cardiac muscle cell differentiation (GO:0055007),0.39628335411648313,0.9321321093014358,0.5666666666666667,0.8464000355370066,1.0,7/21,15.41%,NRG1;ALPK2;KDM6B;MYH11;IRX3;BMP2;SLC8A1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.36895546767469567,-0.9318907943741874,0.5292207792207793,0.8152555374527702,1.0,4/11,6.07%,SLC30A10;PPARA;COA8;ABCB7
prerank,regulation of cytoskeleton organization (GO:0051493),0.3258848817305952,0.9316708418843113,0.6319587628865979,0.8469637117812083,1.0,20/108,10.03%,RHOB;MAPK3;RHOC;RAC1;GPM6B;S100A8;S100A9;STMN3;IQGAP2;RHOG;DLC1;FAM107A;CORO1A;PAK1;P2RX7;CLASP1;MAPT;CDK2AP2;EPHA5;PAK3
prerank,negative regulation of DNA recombination (GO:0045910),0.3509783212906071,0.9315718730098834,0.5926352128883774,0.8467681400039716,1.0,7/43,12.48%,POLR2E;TERF1;POLR2D;POLR2F;H1-0;POLR2G;POLR2K
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.42318560701528474,0.9315620888020707,0.5628342245989305,0.846384325485092,1.0,5/14,26.60%,WNT5A;CCL3;ADAM17;CCR2;OXSR1
prerank,positive regulation of receptor internalization (GO:0002092),0.3921804562478979,0.9314437006465814,0.5778894472361809,0.846225774054257,1.0,3/22,16.13%,CD63;SFRP4;ARRB2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.35109242993598266,0.9311323713002561,0.5863991081382386,0.8464480360746144,1.0,11/43,20.51%,SOX18;NDRG4;APLNR;HES1;TBX22;SOX17;RYR2;DLL1;GATA4;NOTCH1;MEF2C
prerank,negative regulation of developmental growth (GO:0048640),0.37679220020124016,0.9308938003877967,0.572429906542056,0.8465018055239952,1.0,6/30,16.08%,MT3;DCC;RTN4;MAP2;GDF15;FGF13
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.31157133079345184,-0.9307688013878032,0.5428571428571428,0.8165016790660007,1.0,7/18,15.79%,EGFR;NCOR1;ESR1;RIPK1;TERT;BMP4;TP53
prerank,fatty acid metabolic process (GO:0006631),0.3242452696789832,0.930645189053936,0.6392600205549845,0.8466146711753142,1.0,41/115,32.34%,GPX4;GPX1;NUDT19;LIPG;LPL;FASN;ALKBH7;OXSM;ACOT1;ACOT7;ALOX5AP;CRAT;NAAA;ACOT4;FA2H;FAAH;LTC4S;PPARGC1A;ACSL3;THEM4;SGPL1;NDUFAB1;ACSM5;ACSL4;ADIPOR1;ACLY;GPAM;PON2;XBP1;HSD17B8;ACAD9;GGT5;CYP4B1;ABCD2;AOAH;PNPLA8;GNPAT;ELOVL4;ACOX1;CD36;CEL
prerank,mRNA catabolic process (GO:0006402),0.3532006170633706,0.9302466194133809,0.6064073226544623,0.8470165595148369,1.0,15/44,25.17%,LSM6;ZFP36L2;HSPA1B;ZFP36;RNH1;HSPA1A;PDE12;NUDT16;NANOS2;AGO1;EXOSC9;EXOSC4;LSM5;METTL3;PNPT1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.37432800382240544,-0.9296885302987391,0.5296052631578947,0.817677286339011,1.0,5/10,31.51%,IL18;LGALS9;PRKCZ;GATA3;IL4
prerank,regulation of fat cell differentiation (GO:0045598),0.33603887560947965,0.9292132171004931,0.6159496327387198,0.8487365361518605,1.0,17/74,13.77%,AKT1;CCDC85B;GPER1;TNF;ZFP36L1;NR1D1;CDS1;ZFP36L2;RARRES2;CEBPB;LPL;GATA2;ZFP36;WNT5A;LRP3;BMP2;WNT10B
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3488702700176198,0.9291366497996515,0.601536772777168,0.8484961066078545,1.0,4/50,3.62%,RPS3;LAPTM5;CCL19;TNF
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.3712500657463443,0.928980855661459,0.5976878612716763,0.8484283984162838,1.0,12/30,20.13%,PTPRC;SBDS;KDR;CSF1R;FLT4;ARMC6;FLT1;SFRP1;INHBA;TGFB1;FLT3;MLF1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.42700666871131643,0.9288696405784165,0.5870445344129555,0.8482455067817377,1.0,3/15,14.67%,VCP;GSTO1;HNRNPA1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3284567217130273,0.9287949705879863,0.6067653276955602,0.8479872222720014,1.0,14/87,14.67%,POLR2E;MAPK3;POLR2D;POLR2F;ZFP36L1;ZFP36L2;HYAL2;RAB14;ZFP36;POLR2G;FGFRL1;POLR2K;CCL2;HNRNPA1
prerank,generation of neurons (GO:0048699),0.3157454194900303,0.9285783799297009,0.6733668341708543,0.8480207133672987,1.0,45/190,21.13%,ITM2C;TAFA1;RAC1;NTRK2;PIN1;ADGRL3;CTNNB1;HES1;SPOCK1;HES6;NRCAM;IL1RAPL1;MAPT;TUBB2B;CDK5R1;BHLHE41;WNT5A;DNER;ELP3;PTPRD;IRX3;WNT10B;CCK;CX3CR1;CDK5;MYEF2;HEY1;FGF13;DLL1;OLIG1;BRSK2;FUT9;TUBB2A;GPM6A;ERCC6;MYT1L;BTG4;SOX11;ACSL3;DCX;MAP1B;DDIT4;MEF2C;FZD1;FZD2
prerank,cardiac muscle tissue development (GO:0048738),-0.24699640955196897,-0.9285146463017775,0.5603448275862069,0.8188964986142451,1.0,13/50,14.58%,AKAP13;NOTCH2;BMPR1A;ADAMTS9;SMAD1;SIK1;MAML1;SMAD4;GJB6;BMP4;CACNA1G;NDUFV2;HEY2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3476955957390243,0.9282240869680947,0.6075388026607539,0.8483363579331982,1.0,9/49,13.49%,ERBB4;TNF;HCLS1;ARL2BP;HES1;PTK6;IL2;CSF1R;TNFRSF1A
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.34928758292897794,-0.9279363313410384,0.512,0.818761953719898,1.0,5/13,17.19%,PTGIS;PARP9;PARP16;PARP10;NUDT12
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.38717832190291296,0.9271443556357939,0.5651658767772512,0.8501401798109044,1.0,8/24,19.80%,C3;ATF4;FLT4;HPSE;GATA4;CXCL17;TGFB1;IL6
prerank,phosphatidylserine metabolic process (GO:0006658),0.3651002928178214,0.9269781882575608,0.5757931844888367,0.8500746440845192,1.0,8/32,25.18%,SERINC1;PLAAT3;PLA2G4F;PTDSS1;SERINC5;ABHD16A;PLA2G3;ABHD12
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.35790814169508345,-0.9268825608518042,0.5244755244755245,0.8198262704075783,1.0,6/11,30.10%,ITPKB;IP6K2;PPIP5K1;FGF2;ITPKA;IP6K3
prerank,positive regulation of organelle assembly (GO:1902117),0.3519976233450429,0.9262260004100483,0.6083995459704881,0.8511625084553764,1.0,10/44,15.70%,IL5;TNF;LCP1;KCTD17;SDC4;CAPG;SDCBP;CCDC88A;G3BP1;G3BP2
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2714405644644377,-0.9260944195405628,0.6214285714285714,0.8202102071704367,1.0,6/31,7.89%,BABAM2;OTUD4;OTUD7B;USP50;UIMC1;USP16
prerank,positive regulation of response to stimulus (GO:0048584),0.359230451826703,0.9259688849825141,0.6101499423298731,0.8512743625535639,1.0,9/40,21.60%,B2M;YPEL3;TAF9;WNT5A;NSMCE1;IER5;SELENON;MYC;RSAD2
prerank,sodium ion transport (GO:0006814),0.3259393829509234,0.925457175400661,0.6311389759665622,0.8519344493054495,1.0,21/85,21.14%,ASIC2;SLC24A4;SLC24A2;SCN1A;SGK1;SLC6A6;SLC6A17;SLC6A2;SLC6A5;SCN4B;SLC6A16;ATP1A4;NDUFA9;SLC8A1;ATP1B1;HCN1;FGF13;HCN3;ATP1B3;PKD2L1;SCN9A
prerank,cellular response to misfolded protein (GO:0071218),0.3935290638638347,0.9250828188329473,0.5736040609137056,0.8522978384071009,1.0,2/20,5.76%,AUP1;VCP
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.41237248861538134,0.9247060616935736,0.5833333333333334,0.8527026354767104,1.0,8/16,29.10%,PPP2R1A;LEPROT;VHL;CAV1;ADIPOR1;SOCS3;HGS;PPP2CA
prerank,substrate-dependent cell migration (GO:0006929),0.4295305138141605,0.9246595522061641,0.5668449197860963,0.8523971468245246,1.0,5/14,13.96%,PTPRC;P2RY12;NTN1;SHTN1;SDCBP
prerank,diol biosynthetic process (GO:0034312),0.42015989890754135,0.9240670599963234,0.5697050938337802,0.8532071779130717,1.0,6/15,21.50%,SPR;QDPR;SPTLC1;ABCA2;SPHK2;ASAH2
prerank,ceramide metabolic process (GO:0006672),0.35080881148179166,0.924059741633629,0.5993303571428571,0.8528211033105145,1.0,15/49,22.95%,CERS2;ORMDL3;PPP2R1A;SMPD1;CLN6;SPTLC1;ABCA2;DEGS1;ST6GALNAC3;FA2H;CLN8;SPTSSA;SGPL1;ASAH2;ORMDL2
prerank,tube closure (GO:0060606),-0.2817703502861284,-0.9238950911106107,0.610738255033557,0.8240763540642991,1.0,7/31,13.26%,COBL;SKI;LRP6;MTHFR;LMO4;IFT122;CELSR1
prerank,lymphocyte differentiation (GO:0030098),0.33666114537915626,0.923493083776796,0.6100966702470462,0.8535857487549351,1.0,25/68,28.03%,SLC25A5;LYL1;NFAM1;PTPRC;IL2;IKZF1;IL11;ZBTB7A;HDAC5;JAG2;VCAM1;HDAC9;PIK3CD;ADAM17;DNAJB9;TOX;FLT3;KLF6;LFNG;TCF3;BLNK;ITGB1;HHEX;CEBPG;DLL4
prerank,regulation of isotype switching (GO:0045191),-0.3354589060327247,-0.9232993852183912,0.5473684210526316,0.8239676468697509,1.0,4/14,7.65%,KMT5C;KMT5B;SHLD1;PARP3
prerank,replication fork processing (GO:0031297),0.359851668581785,0.9230318045842426,0.579610538373425,0.8541583422130775,1.0,11/38,22.54%,NUCKS1;CENPX;DDX11;PCNA;BRCA2;TRAIP;MMS22L;ALYREF;CDK9;FAM111A;BLM
prerank,cellular biogenic amine catabolic process (GO:0042402),0.45080255670363306,0.923000445177125,0.5774058577405857,0.8538217765802572,1.0,6/10,39.88%,SMOX;SLC44A1;DMGDH;SARDH;CHDH;COMT
prerank,cellular response to alkaloid (GO:0071312),0.4060382283587154,0.9223949274282521,0.599476439790576,0.8546292264405164,1.0,6/17,25.54%,TGM2;GSTM2;SLC8A1;RYR2;BLM;RAD51
prerank,lysosome localization (GO:0032418),0.3610920879914715,0.922194920384454,0.6133486766398158,0.854639223386594,1.0,11/37,23.73%,S100A13;PIP4P1;BLOC1S1;DEF8;CHGA;TMEM106B;PIK3CD;BORCS5;HPS6;BORCS6;BLOC1S2
prerank,regulation of RNA splicing (GO:0043484),0.33535874524887854,0.9221843719670011,0.620021528525296,0.8542636164070314,1.0,10/69,11.37%,RPS13;RPS26;TMBIM6;HNRNPK;QKI;AHNAK;PQBP1;RRP1B;KHDRBS3;FAM50A
prerank,membrane protein proteolysis (GO:0033619),0.3645649612288466,0.9218589420176128,0.6022598870056497,0.8545450264303123,1.0,15/37,26.18%,TMPRSS6;PSENEN;SPPL2B;CTSH;NAPSA;BACE1;PSEN2;ADAM17;APH1B;TGFB1;SPPL2A;ERAP1;RELA;APH1A;PRKCQ
prerank,nuclear membrane reassembly (GO:0031468),0.3434323340384176,0.9218509670917912,0.6026637069922308,0.8541597757093097,1.0,24/54,31.19%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;CC2D1B;NUP85;RANGAP1;LMNA;VPS4A;CHMP7;SIRT2;RCC1;KPNB1;VRK1;CHMP4C;NUP188;NUP205;PPP2CA;NSFL1C;NUP43;CHMP4A;CHMP4B;SEH1L
prerank,histone lysine methylation (GO:0034968),-0.2688632844098115,-0.9217248773642157,0.6289308176100629,0.8263697539372731,1.0,16/33,22.93%,PRDM5;SMYD3;KMT2A;ASH2L;SETDB1;WDR82;KMT2D;EHMT2;PRDM9;SETD1B;EZH2;WDR5B;SETD3;SETD6;KDM6A;SMYD1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.32099752183141284,-0.9213298338858668,0.5258620689655172,0.8257672080563819,1.0,4/16,10.54%,AUTS2;KMT2A;BCOR;SMAD4
prerank,regulation of cellular metabolic process (GO:0031323),0.34751188162109437,0.9212200761861928,0.6129398410896708,0.8550381629331755,1.0,16/45,27.01%,NPC2;PINK1;FLOT1;ABCG1;NCOR2;FASN;ABCA2;ARF1;ARF4;BCO2;STUB1;MPV17;ACLY;FOXM1;EIF6;MBOAT7
prerank,sodium ion transmembrane transport (GO:0035725),0.32872417381728813,0.9211280022091415,0.632762312633833,0.854844109277756,1.0,22/84,21.14%,ASIC2;SLC24A4;SLC24A2;SCN1A;ATP1A3;ATP1B2;SLC6A6;SLC6A17;SLC6A2;SLC6A5;SCN4B;SLC6A16;ATP1A4;ATP1A1;SLC8A1;ATP1B1;HCN1;SLC9A9;HCN3;ATP1B3;PKD2L1;SCN9A
prerank,regulation of intracellular signal transduction (GO:1902531),0.30684754891770777,0.9210030132086278,0.745,0.8546789529039025,1.0,102/420,20.93%,TMSB4X;RPL11;ARHGDIA;RPL5;HSPB1;RHOB;MAPK3;AKT1;RCN3;A2M;NLGN1;TREM2;AKAP6;CSNK2B;IER3;TNF;RHOC;MBD3;RAC1;ARHGAP25;CHEK2;NTRK2;PEX5L;PIN1;ARHGAP9;RPA2;ARHGDIB;HIPK2;RHOG;DLC1;BRPF1;TTC5;ARHGAP15;CLEC6A;ARHGEF4;PAK1;SGK1;TAF10;MAPT;PRKAR1A;SLC15A4;CD24;NET1;CDK5R1;RHOV;ARHGDIG;PIP4P1;ARHGEF7;PAK3;GNAI1;TAF9;WNT5A;PRKAR1B;ARAP3;ATP6AP2;SSRP1;TAGAP;PHLPP1;VAV1;CCNG1;RHOA;VAV3;MCF2L;RFC2;ARHGAP45;STK11;RHOU;DEPDC7;ABR;PRR5;TIAM1;RRAS;L3MBTL1;F2RL1;MAPK11;RRAGC;SLC15A2;TRAF3;CDK5;DAB2IP;SQSTM1;GATA4;PRKAR2B;RAC2;MTA2;ARHGEF19;FAM83D;NOP53;TBP;SOS1;SPHK2;LBH;ING5;CHD3;POU4F1;DDIT4;RFC4;ARHGAP33;CAPN3;NFKBIA;ARAP2;PYCARD
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.37601462021433385,0.9209079652218568,0.5794621026894865,0.8544620157894591,1.0,6/27,17.54%,NME1;AK4;NME4;NME2;GUK1;NME3
prerank,positive regulation of exosomal secretion (GO:1903543),0.4111271924007475,0.9202829714974528,0.563013698630137,0.85537367459839,1.0,6/15,26.73%,ATP13A2;SDC4;SDCBP;VPS4A;HGS;SNF8
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3207510491127511,0.9202585834309547,0.6690721649484536,0.8550291729632907,1.0,12/104,7.26%,RPS27A;UBC;UBB;NBL1;FKBP1A;PIN1;SORL1;EID2;HIPK2;WFIKKN2;UBA52;STRAP
prerank,cell-cell junction maintenance (GO:0045217),0.452991779695013,0.9201950025934968,0.5771349862258953,0.8547432264267076,1.0,4/11,23.28%,MYADM;CSF1R;F2RL1;PARD6A
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.39880112740257306,0.9198374682145771,0.5852417302798982,0.8550850666284744,1.0,12/18,33.17%,CLASP1;BMP2;IER3IP1;DDR2;TGFB1;IL6;COLGALT1;EFEMP2;RUNX1;CLASP2;FSCN1;RGCC
prerank,B cell homeostasis (GO:0001782),0.45194238194452735,0.9198098945457178,0.5783633841886269,0.8547370939451936,1.0,5/10,24.38%,TNFAIP3;DOCK10;MEF2C;PPP2R3C;TNFRSF13B
prerank,Golgi localization (GO:0051645),-0.3484679280055783,-0.9196735609130791,0.554006968641115,0.8283162350478647,1.0,2/11,5.29%,ARHGAP21;UVRAG
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4339800028123294,0.9194006704415577,0.5894886363636364,0.8547500445169725,1.0,2/12,4.15%,PRNP;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4339800028123294,0.9194006704415577,0.5894886363636364,0.8547500445169725,1.0,2/12,4.15%,PRNP;HOMER2
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.3309347555956083,-0.9193998564219388,0.6007751937984496,0.8274220354482108,1.0,5/15,12.75%,PRKCE;PPARA;IRS1;PPARG;ADM
prerank,cellular response to nitrogen compound (GO:1901699),-0.2917827639588587,-0.9190916146574984,0.5770925110132159,0.8266106053527896,1.0,2/20,5.69%,ROCK2;SPIDR
prerank,embryonic skeletal system development (GO:0048706),-0.26812326806570586,-0.9185220776870892,0.5797101449275363,0.8265690450058647,1.0,7/35,7.94%,SULF1;HOXB3;HOXA3;HOXB4;HOXC4;KIAA1217;PCSK5
prerank,inner dynein arm assembly (GO:0036159),0.4510908087175832,0.918319016604852,0.5829846582984658,0.8565295636139647,1.0,2/10,12.11%,DNAI3;DNAH1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3385795232451786,0.9179207471055798,0.5951327433628318,0.8569291983457291,1.0,12/51,18.15%,UBB;NBL1;CNTNAP2;PACSIN1;KLK8;PAK1;SGK1;NYAP2;SHTN1;EPB41L3;DAB2IP;GPM6A
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4480954953835836,0.9174851447451857,0.5818673883626523,0.8574055455923189,1.0,4/11,26.08%,VSIR;HMGB1;TWSG1;RUNX1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.40930218811278113,0.9173863343967451,0.5994694960212201,0.857200686844536,1.0,5/16,16.25%,PRDX6;NCL;SNW1;CIRBP;CELF3
prerank,regulation of insulin secretion (GO:0050796),0.32275415930458756,0.9171322929149525,0.6460905349794238,0.8573203850285472,1.0,32/101,23.25%,UQCC2;MTNR1B;SLC2A1;SNAP25;LRRC8A;TRH;RBP4;GPER1;TNF;NR1D1;CACNA1A;EPHA5;CHGA;ABCC8;BAD;BRSK2;SLC2A2;DOC2B;NOS2;GLUD1;SFRP1;TFAP2B;IL6;NNAT;FOXA2;INHBB;KCNC2;REST;CCN3;ACSL4;PSMD9;CACNA1E
prerank,negative regulation of interferon-beta production (GO:0032688),0.45837757194863554,0.9171106861944729,0.5997150997150997,0.8569649705755179,1.0,3/10,20.93%,SIRPA;LILRB1;PYCARD
prerank,positive regulation of dendrite development (GO:1900006),0.45149588751616765,0.9171080080535375,0.5961538461538461,0.8565709640711807,1.0,6/10,27.29%,PACSIN1;LRP8;DAB2IP;PTN;VLDLR;ALK
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3711256305562396,-0.9167859408795862,0.545774647887324,0.8293433004292826,1.0,2/10,2.23%,SOX5;ZBTB16
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3194227804751922,0.9165087610754301,0.6639427987742594,0.8573793270276349,1.0,34/129,20.10%,PSMB4;COL1A1;PSME1;PSMB6;PSMB8;PSME2;PSMD2;FZD9;PSMD1;PIN1;PSMC3;PSMD6;VCP;PSMA7;PSMD5;LGR6;PSMB9;ATP6AP2;PSMD13;GPC5;PSMB3;PSMB11;SFRP4;PSMB10;PSMB1;PSMB5;CAV1;USP8;CSNK1G2;CCAR2;SFRP1;PSMA6;TGFB1;PSMA4
prerank,cellular response to drug (GO:0035690),0.38114435507900557,0.9163859887282203,0.5935960591133005,0.8572025409927293,1.0,9/25,28.23%,PDE4B;TFRC;GAS6;MEF2C;MYC;PPM1F;REST;RAP2A;KCNQ1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.3940423904768946,0.916343598355435,0.5997425997425997,0.8568776738771998,1.0,5/18,14.18%,KCTD10;RASIP1;DLC1;TNFAIP1;STMN1
prerank,negative regulation of anoikis (GO:2000811),-0.3355211008372544,-0.9162482232777609,0.5787401574803149,0.8290769834455702,1.0,4/14,13.34%,ITGA5;TLE1;PTK2;BCL2
prerank,DNA modification (GO:0006304),0.3794923016715348,0.9160120598207901,0.6074074074074074,0.8571209698333513,1.0,6/22,20.65%,TERF1;PARP1;NEIL1;NEIL2;TERF2IP;EXOSC4
prerank,vesicle transport along microtubule (GO:0047496),-0.29221634433231947,-0.9157855992405148,0.5786802030456852,0.8286859954445018,1.0,6/23,15.43%,TRAK1;PAFAH1B1;KIF13A;FBXW11;CLN3;NDEL1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3898191023634208,0.915389550924951,0.5954198473282443,0.8579645983555338,1.0,4/21,9.12%,CD81;NFAM1;SLC39A10;CD22
prerank,membrane lipid catabolic process (GO:0046466),0.4529488013039952,0.9151716140058068,0.5955056179775281,0.857985103770492,1.0,4/10,24.98%,ENPP2;FUCA1;SGPL1;NAGA
prerank,C-terminal protein amino acid modification (GO:0018410),0.43618018670683767,0.9147863360008197,0.5894590846047156,0.858377319705906,1.0,2/11,10.48%,AGBL4;ICMT
prerank,regulation of sprouting angiogenesis (GO:1903670),0.35983977692483216,0.9145719104372306,0.5955967555040557,0.8584030252017936,1.0,7/33,16.23%,S100A1;KLF2;PKM;GLUL;EPN1;KLF4;DLL1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.2883020049955421,-0.9144240737671604,0.6045197740112994,0.8306329057495947,1.0,5/24,5.83%,ADAMTS12;SOX5;ZBTB16;EFEMP1;TGFBR1
prerank,regulation of mitochondrial fusion (GO:0010635),0.4431150204323301,0.9143649415342576,0.5916666666666667,0.8584237490100746,1.0,3/11,6.65%,VAT1;TFRC;OMA1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.2879886489640984,-0.9141539707245636,0.5958549222797928,0.8296908760369046,1.0,5/23,11.26%,TGFBR3;ADAMTS9;FGFR2;SMAD7;TPM1
prerank,body fluid secretion (GO:0007589),0.41551616042884654,0.9141463194350449,0.5774456521739131,0.8584318395799803,1.0,1/15,2.95%,ERBB4
prerank,macromolecule catabolic process (GO:0009057),0.3733416124676555,0.9139469655983933,0.6140979689366786,0.8584417237993507,1.0,7/26,20.66%,LGMN;USE1;CLN6;CLN5;CLN8;TGFB1;CAPN3
prerank,regulation of cytoplasmic transport (GO:1903649),0.4361313338724962,0.9138408118261402,0.5777166437414031,0.8582382602388213,1.0,1/11,1.89%,MAPK3
prerank,mismatch repair (GO:0006298),-0.27169032341045113,-0.9133445555864879,0.6040609137055838,0.8300803752266358,1.0,6/27,8.81%,ABL1;SETD2;MLH3;MLH1;MSH3;TDG
prerank,positive regulation of histone acetylation (GO:0035066),0.3778909660109653,0.9124806549215223,0.5844806007509387,0.8605637198156352,1.0,8/23,27.30%,MAPK3;PIH1D1;WBP2;PPARGC1A;MUC1;SPHK2;PAXIP1;RUVBL2
prerank,regulation of cell cycle process (GO:0010564),0.3183375603880617,0.912351749668785,0.6659751037344398,0.8604120718402396,1.0,25/104,24.45%,CALM1;CALM3;GPER1;KLHL9;PIN1;CAV2;CTNNB1;USP51;ATF5;FBXO5;SOX9;SND1;L3MBTL1;NUDT16;CETN2;SFRP1;CALM2;GIT1;CCP110;NUGGC;IHO1;CDKN2B;CCDC8;RCC1;ECT2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.33183692192298697,-0.9122593935559585,0.5465116279069767,0.8310667295432868,1.0,2/14,5.45%,MOXD1;DAGLA
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.39768738013938226,0.9122553210079628,0.5964240102171137,0.8601931460463589,1.0,9/20,27.95%,YWHAB;RGS2;APLP1;STMN1;SNCA;GRK2;RNF157;GPRASP1;ADA
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.33749802969055215,0.9121495760697533,0.6346578366445916,0.860029231259993,1.0,16/52,19.25%,AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;RHOG;ARF6;ZDHHC5;GNAI1;RAMP3;CLIP3;SQSTM1;EPB41;STX4;STAC3
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.44613965823223933,0.9121452934276124,0.6033057851239669,0.8596409484499076,1.0,4/11,18.63%,NT5C3A;SLC25A19;SLC19A3;SLC19A2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.37417934172159223,0.9121025181496923,0.6056166056166056,0.8593203497647005,1.0,3/25,3.39%,CALM1;CALM3;CTNNA3
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.4243470985355134,0.9118369005665221,0.5934844192634561,0.8594585415884942,1.0,4/13,21.85%,CPE;RYR2;NOTCH1;NPY5R
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.23868614973177568,-0.9117361057518479,0.7096774193548387,0.8307558654692164,1.0,14/48,17.63%,ADCY9;ADCY1;ADCY5;AMPD3;PANK1;ADCY7;PAPSS1;ADSS2;PAPSS2;SLC26A2;AMPD2;PANK2;GUCY2C;PANK4
prerank,positive regulation of mitochondrial fission (GO:0090141),0.40035165432558595,0.9116080085225933,0.6095617529880478,0.8595069222759171,1.0,8/18,22.09%,PINK1;DCN;KDR;MIEF2;MFF;DNM1L;FIS1;SPIRE1
prerank,regulation of bone mineralization (GO:0030500),0.33735246461790974,0.9114798083836686,0.6352683461117196,0.859337428395466,1.0,20/55,21.57%,FZD9;GPM6B;ECM1;S1PR1;ISG15;NELL1;P2RX7;TMEM119;SRGN;ATRAID;ATP2B1;BMP2;SLC8A1;CCL3;TWIST1;DDR2;NOTUM;TGFB1;MEF2C;PTN
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.33664313214622316,0.9112840554185827,0.6316939890710382,0.859308763892173,1.0,10/57,13.49%,ERBB4;TNF;HCLS1;ARL2BP;PPP2R1A;HES1;PTK6;IL2;CSF1R;TNFRSF1A
prerank,heart trabecula morphogenesis (GO:0061384),0.396448107078767,0.9108821426696543,0.5981432360742706,0.8596947846899057,1.0,4/18,5.95%,NRG1;RBP4;FKBP1A;S1PR1
prerank,nuclear membrane organization (GO:0071763),0.38483112969235533,0.910723993099326,0.6085825747724317,0.859607347565192,1.0,6/19,21.97%,GPER1;TARDBP;DCTN1;VPS4A;CHMP7;TMEM43
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4378213757701882,0.9101864358175459,0.595536959553696,0.860294410418413,1.0,4/10,19.71%,NELL1;ATRAID;DAB2IP;EFNA1
prerank,cellular response to insulin stimulus (GO:0032869),0.317753387371672,0.9099404099269053,0.6995926680244399,0.8603708911890211,1.0,29/124,21.46%,ATP6V0C;AKT1;ATP6V1F;ZFP36L1;PKM;GRB14;ATP6V1G1;PARP1;CAV2;ATP6V0E2;ATP6AP1;PDE3B;RARRES2;RAB15;MYO5A;NAMPT;VAMP2;ATP6V0D2;HDAC5;SH2B2;IGF2;HDAC9;RAB31;EPRS1;SOS1;GOT1;INHBB;SELENOS;C2CD5
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.3059956960773811,-0.9098666394093239,0.5895196506550219,0.8336330127835776,1.0,6/18,14.46%,SMAD3;ITGB8;SMAD4;LTBP1;CD46;LGALS9
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.3962005311630549,0.9097439731649801,0.6129837702871411,0.8603485210371324,1.0,6/19,21.99%,ITGB2;TIRAP;TICAM2;TRIL;CD14;LBP
prerank,dicarboxylic acid transport (GO:0006835),0.3737714119927991,0.9093332939027102,0.6262135922330098,0.8607264723996012,1.0,8/28,19.26%,SLC1A2;SLC25A13;SLC25A22;SLC1A1;GJA1;SLC19A1;FOLR2;SLC25A18
prerank,positive regulation of signal transduction (GO:0009967),0.3045482484138189,0.9091545091129306,0.7304609218436874,0.8606785052883944,1.0,34/238,11.30%,RPS3;CD74;CD63;VTN;ATP6V0C;C3;MT3;KLF2;NRXN1;NLGN1;TREM2;GPER1;EMP2;PTPRC;SORL1;LY86;CAV2;FLNA;TNFAIP3;CD180;GRIN1;RIMS2;RIMS1;CLEC6A;P2RY6;KLK6;LGR6;JCAD;PIH1D1;ZDHHC5;ATP6AP2;BAX;ULK3;HAP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4311814174467067,0.9091090544285384,0.596100278551532,0.8599692500956261,1.0,2/12,3.62%,AKAP6;TNF
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4311814174467067,0.9091090544285384,0.596100278551532,0.8599692500956261,1.0,2/12,3.62%,AKAP6;TNF
prerank,regulation of blood circulation (GO:1903522),0.3589167947727169,0.9089985826991626,0.6146682188591386,0.8597798874937364,1.0,7/34,14.80%,S100A1;FXYD1;AGT;ADORA3;PLN;DES;KCNE5
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.23037775805734287,-0.9087363399983858,0.631578947368421,0.8347671378619183,1.0,12/69,10.31%,GAB2;PLCE1;PITPNM2;PI4KA;OGT;IRS1;PLCD3;PLCL1;IGF1;PDGFRB;PTEN;NGF
prerank,nucleotide metabolic process (GO:0009117),0.3729344513864812,0.9086319175077858,0.6160493827160494,0.8601349448307686,1.0,6/23,17.53%,PARK7;AK4;PNP;NME2;CMPK2;GUK1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.36323829582746037,0.9082325242258935,0.6063569682151589,0.8605217543602135,1.0,8/29,24.80%,HSP90AB1;ISG15;WNT5A;CDC37;OAS3;PTPN6;PTPN1;METTL3
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3163323502645966,0.9078711682392093,0.6652849740932643,0.8608369561290902,1.0,17/91,12.17%,MAPK3;SNX17;PTPRC;PACSIN1;SYT1;RIMS2;RAB15;RAB3C;CD22;VAMP2;AP2S1;HCK;STXBP5L;RAB3D;GAS1;HAP1;BET1L
prerank,cellular response to mechanical stimulus (GO:0071260),0.3476463249932733,0.9077504718340076,0.6226415094339622,0.8606653478939921,1.0,14/46,25.47%,MAPK3;CNN2;AQP1;TMEM150C;SOX9;TNFRSF1A;BAD;TLR5;LTBR;GADD45A;BAK1;CASP1;TLR7;PDE2A
prerank,regulation of response to interferon-gamma (GO:0060330),0.41894671996047655,0.9076667791833251,0.613031914893617,0.8604209302235386,1.0,5/14,24.07%,HSP90AB1;CDC37;IFNGR1;IFNGR2;SOCS3
prerank,actin polymerization or depolymerization (GO:0008154),0.338288991357833,0.9074622580007429,0.6357466063348416,0.8604400085384754,1.0,11/50,13.88%,GSN;CFL1;RAC1;ANG;FAM107A;MICAL1;AIF1;DSTN;MSRB1;FLII;CAPG
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3841103152455135,0.9072670279119236,0.6020025031289111,0.8604008382741449,1.0,4/22,10.29%,MDK;ZFP36L1;EPPK1;ZFP36
prerank,regulation of oxidoreductase activity (GO:0051341),0.4172265863464859,0.9072558600475222,0.6051560379918589,0.8600293611157978,1.0,2/13,6.61%,MT3;HP
prerank,negative regulation of cell cycle process (GO:0010948),-0.231586708358242,-0.9069506947541686,0.6962025316455697,0.8374773028102583,1.0,15/61,15.23%,TOM1L2;MGA;YAF2;EPC1;EHMT1;PHC3;APAF1;WAPL;RBBP8;TFDP1;TERF2;BMP4;NME6;EHMT2;EZH2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3786910261108507,0.906804179624825,0.6206060606060606,0.8605180115967184,1.0,4/26,9.38%,ACADVL;APOC1;MID1IP1;MLXIPL
prerank,negative regulation of protein depolymerization (GO:1901880),-0.28141213313026037,-0.9063425630352963,0.5789473684210527,0.8373475584479819,1.0,6/24,12.83%,PLEKHH2;LIMA1;HDGFL3;CAMSAP1;SPEF1;ARHGEF2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.2777840161415037,-0.9062019540029437,0.6206896551724138,0.836095497975084,1.0,5/26,5.21%,ACTN2;ANK2;FHL1;AKAP9;DLG1
prerank,heart looping (GO:0001947),0.34905869185964894,0.905791488271253,0.6300904977375565,0.8620937743096719,1.0,13/39,28.41%,SOX18;NDRG4;APLNR;TBX22;SOX17;DLL1;GATA4;NOTCH1;MEF2C;SRF;TBX2;ENG;VANGL2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.4256798810540188,0.905630391242957,0.5923836389280677,0.8620077745215713,1.0,6/13,22.39%,GLUL;ACOT4;GLUD1;GOT1;GAD1;MTHFS
prerank,negative regulation of cell junction assembly (GO:1901889),0.3776722798259508,0.9054375800045967,0.60984393757503,0.8619688639446582,1.0,6/25,7.08%,APOD;TNF;ACVRL1;DLC1;FAM107A;CORO1C
prerank,aorta morphogenesis (GO:0035909),-0.3184294379792757,-0.9053172714106305,0.6289592760180995,0.8365656506141221,1.0,8/17,14.58%,BMPR1A;ADAMTS9;MYLK;PDGFRB;RBPJ;LRP1;JAG1;HEY2
prerank,sphingolipid catabolic process (GO:0030149),0.40973232043122987,0.9041599970381843,0.6057818659658344,0.8640755280230304,1.0,5/15,21.50%,ENPP2;SMPD1;SMPDL3A;SGPL1;ASAH2
prerank,sensory organ development (GO:0007423),-0.24157966500685213,-0.9038118659190272,0.6818181818181818,0.8385714975994938,1.0,4/51,2.83%,PBX1;SMOC1;PBX3;SHROOM2
prerank,clathrin-dependent endocytosis (GO:0072583),0.3690747539319589,0.9034033766463606,0.6323713927227101,0.8651279269383193,1.0,10/26,16.23%,CANX;SNAP91;AP2M1;CLTC;AP2S1;SIGLEC1;FCHO1;FNBP1L;CLTA;DLL1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.41730419204787733,0.9033194609564305,0.6173333333333333,0.864912704031852,1.0,2/14,7.09%,PCBP4;SRSF9
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.3254048661558123,-0.9029680087246669,0.5826446280991735,0.8389896689874244,1.0,1/14,0.29%,SULF1
prerank,regulation of neurotransmitter transport (GO:0051588),0.4033992877091655,0.9029582078125243,0.6162018592297477,0.8652196046469711,1.0,7/16,27.88%,FLOT1;RIMS1;SYN1;HCRT;MEF2C;KCNMB4;CPLX1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3155484201216846,0.9028820155887649,0.6777893639207507,0.8649589604081034,1.0,24/94,21.90%,CRIP1;ATF4;HINT1;CHEK2;HIPK2;CEBPB;SELENOK;CD24;BAX;PMAIP1;BBC3;STK11;BAD;ERO1A;DAB2IP;BRSK2;PPP1R15A;DNAJC10;HIC1;POU4F1;PYCARD;BAK1;DDIT3;PPM1F
prerank,nucleotide biosynthetic process (GO:0009165),0.39162648667178557,0.9028699714985965,0.610126582278481,0.8645870986849818,1.0,7/18,27.17%,GART;PNP;PRPS1L1;PRPS1;PRPSAP1;ADSL;RRM2B
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4073003286314376,0.9024272258103258,0.601360544217687,0.8650396147630152,1.0,3/14,9.00%,AKT1;MTLN;MFSD2A
prerank,regulation of osteoclast differentiation (GO:0045670),0.359102807589325,0.9023669693706611,0.616532721010333,0.8647692455289782,1.0,8/33,22.77%,TNF;CEBPB;GPR137B;PRXL2A;LILRB3;CCL3;POU4F1;MAFB
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.32044930334208177,-0.9023649412819321,0.5882352941176471,0.8388583515024419,1.0,5/15,18.71%,RICTOR;UBR3;RAI2;NR5A2;CELF1
prerank,regulation of axon guidance (GO:1902667),0.44935053135424097,0.9019762532317336,0.5980392156862745,0.8651360226249206,1.0,3/10,15.94%,TUBB2B;ZSWIM8;YTHDF1
prerank,pyroptosis (GO:0070269),0.403212940600296,0.9015079234655375,0.6048064085447263,0.8656834715049642,1.0,1/15,2.59%,TREM2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.28527033374872224,-0.9007249941272216,0.6494845360824743,0.8412033758117711,1.0,7/23,20.56%,WEE1;PRCC;PABIR1;CHFR;INTS3;PLK2;ZWILCH
prerank,peptidyl-methionine modification (GO:0018206),0.4340731597543488,0.9005641232591899,0.6063100137174211,0.8670962065431724,1.0,4/12,20.36%,METAP1;METAP2;PDF;NAA25
prerank,protein import into nucleus (GO:0006606),0.32714781291142925,0.8995853141413245,0.658669574700109,0.8686042522767681,1.0,12/66,18.67%,RPL23;AKT1;RAN;FAM53C;PTTG1IP;IPO4;NUP85;NUP88;SPRN;EIF4ENIF1;SYK;NUP50
prerank,metallo-sulfur cluster assembly (GO:0031163),0.37799027700225807,0.8995479238467688,0.6165413533834586,0.868282617451455,1.0,8/22,25.43%,GLRX5;ISCU;CIAO1;CIAPIN1;HSPA9;CIAO2A;CIAO2B;HSCB
prerank,tRNA methylation (GO:0030488),-0.25842270150677116,-0.8994123710396095,0.635036496350365,0.8428429409685665,1.0,10/34,14.17%,TRMT13;NSUN6;ALKBH8;THADA;TRMT5;THUMPD3;FTSJ1;TRMO;TRMT1L;PRORP
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3546612112712043,0.8988331568238025,0.624263839811543,0.8692727234811954,1.0,12/35,29.18%,SCD5;FASN;SCD;ACAT1;ALOX5AP;SLC25A1;LTC4S;ACLY;FAR2;HSD17B8;GGT5;GGT7
prerank,positive regulation of actin nucleation (GO:0051127),0.43545904670756413,0.89848855988636,0.6116788321167883,0.869518408760462,1.0,1/11,0.88%,GSN
prerank,hexose transmembrane transport (GO:0008645),0.37405059930590956,0.8982276302354343,0.6064516129032258,0.8696467578802608,1.0,4/21,17.73%,SLC2A1;SLC50A1;SLC2A2;SLC2A3
prerank,T-helper cell differentiation (GO:0042093),-0.31770203518124623,-0.8981805240588976,0.6033755274261603,0.8442453588933296,1.0,2/14,6.86%,FOXP1;ATP7A
prerank,neurotrophin signaling pathway (GO:0038179),-0.2861051895017074,-0.8979035562592219,0.645320197044335,0.8433409997906742,1.0,7/21,15.02%,RAPGEF2;FRS2;RAPGEF1;NGF;KIDINS220;CASP3;BDNF
prerank,neuromuscular synaptic transmission (GO:0007274),0.3941125211721908,0.8973084978502872,0.6175710594315246,0.8710054405119437,1.0,8/18,24.79%,ERC2;CHAT;DTNA;STAC3;RIMBP2;CHRNA3;SLC5A7;TBC1D24
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3315635754182967,0.8972620915601829,0.6402640264026402,0.8706966423086442,1.0,25/54,26.01%,HEXA;HYAL2;GUSB;HS3ST6;HS3ST5;SDC4;GPC5;FUCA1;CLN6;B3GAT3;SGSH;NAGLU;UGDH;XYLT1;HPSE;HSPG2;SDC3;HPSE2;HS3ST2;AGRN;HS6ST1;B3GAT1;CHST9;GPC1;HS6ST2
prerank,melanosome organization (GO:0032438),0.3611792305821489,0.8971182358227089,0.6227106227106227,0.8705670722484556,1.0,5/26,12.92%,BLOC1S4;ABCB6;BLOC1S1;BLOC1S3;BLOC1S5
prerank,nucleus organization (GO:0006997),0.333997401408809,0.897031397826171,0.6447661469933185,0.8703264319495505,1.0,17/47,31.19%,RPS19;CHMP2B;CTDNEP1;CHMP5;CHMP6;CHMP1B;SYNE1;VPS4A;CHMP7;SUN2;SPAG4;CHMP1A;CHMP4C;NUP205;CHMP4A;CHMP4B;SEH1L
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.35948561301177845,0.8966207783256868,0.6261682242990654,0.8707335051920658,1.0,13/30,34.69%,ELOVL1;ELOVL2;TECRL;ELOVL7;ACOT1;ACOT4;ELOVL6;HACD4;ABCD2;ELOVL4;ACOX1;ELOVL5;PEX2
prerank,cell-cell junction organization (GO:0045216),0.32406686313035543,0.8966180470947025,0.6708994708994709,0.8703472331930604,1.0,20/79,20.17%,CLDN5;GJA4;CADM2;ANG;CDH20;MYADM;CDH18;CSF1R;CADM3;CDH12;DCHS1;CDH19;F2RL1;CDH24;CDH7;CDH10;CDH5;CTNND2;TGFB1;MARVELD2
prerank,negative regulation of autophagy (GO:0010507),0.32950232080729924,0.8964260361188466,0.6491803278688525,0.8703418200045696,1.0,9/54,11.54%,MT3;AKT1;TREM2;EIF4G2;PINK1;RASIP1;NUPR1;MTMR9;CTSA
prerank,lamellipodium organization (GO:0097581),0.3582873779682408,0.8954433207039234,0.64,0.8717814296539677,1.0,9/29,21.77%,RAC1;S1PR1;ARHGEF4;P2RY12;ARHGEF7;CCDC88A;DMTN;CTTN;PTPRO
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.32369793902622895,-0.8951884568461553,0.6065573770491803,0.8468433888466634,1.0,6/15,10.33%,TNRC6B;DHX36;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.32369793902622895,-0.8951884568461553,0.6065573770491803,0.8468433888466634,1.0,6/15,10.33%,TNRC6B;DHX36;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.29904506081089344,0.895112683112596,0.855,0.872015661951806,1.0,112/497,20.88%,MRPL13;RPS3;HSPA8;PFDN5;RACK1;GAPDH;RPL13A;DBI;CALR;MT3;NDUFA13;TMPRSS6;S100A11;ID3;NRG1;SOX18;ID1;CRYAB;TERF1;EID1;CCDC85B;TNF;IGFBP5;NR1D1;PDGFB;ACVRL1;SPI1;ENO1;NCL;TLE5;CTNNB1;HES1;MAGEL2;EID2;CDKN1C;TBX22;NCOR2;GMNN;ARID4A;TRIM28;CREBZF;FOXL2;CEBPA;BASP1;PROX1;RBM15B;YBX1;IKZF1;MLXIPL;MLX;CDK5R1;SET;JUN;BHLHE41;WNT5A;CTBP1;PCIF1;ZBTB7A;ATF5;L3MBTL4;BCL7A;SNW1;SOX8;MAEL;THRA;KLF4;SOX9;YWHAQ;HDAC5;HEXIM1;BMP2;NONO;FOXS1;GAS6;ZC3H8;L3MBTL1;SAMD11;CDK5;NR1H2;HEY1;ENC1;EIF4A3;DAB2IP;TCEAL7;TWIST1;HDAC9;GLIS2;PAX9;EIF4ENIF1;NANOS2;COMMD7;RLIM;ZHX1;CCAR2;SFRP1;CIR1;EPRS1;QARS1;ZBTB14;TGFB1;TFAP2B;LBH;NOTCH1;BEND5;PUS7;CITED2;SAMD1;CAPN3;CBX3;SIRT2;SELENOS;TFAP4
prerank,cell part morphogenesis (GO:0032990),-0.32655264900545544,-0.8950670516281887,0.5817490494296578,0.8455805750692632,1.0,2/13,3.93%,PID1;PACSIN2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.37611972955915146,0.8947027438092193,0.6363636363636364,0.8723969464460595,1.0,6/24,9.56%,S100A10;RAC1;DUSP3;THY1;KDR;ARF6
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.27435356511865283,-0.8945640436876822,0.6062176165803109,0.8452265459954355,1.0,8/23,21.07%,PAFAH1B1;UBXN2B;FBXW11;NUMA1;NDEL1;MAD2L1;MISP;NDC80
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.35444373342438057,0.8943641089603481,0.6083832335329341,0.8726398889763125,1.0,9/32,19.83%,HMOX1;KDR;JCAD;GATA2;KLF4;RHOA;HDAC5;HDAC9;NOTCH1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.40053107738666943,0.8942025041293777,0.6002710027100271,0.8725414961267022,1.0,4/15,20.81%,NLGN1;HAP1;ADRA1A;ZDHHC12
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.33201020408869,0.8935308940640019,0.6540178571428571,0.8734428806584387,1.0,6/54,13.00%,RPL26;CHEK2;PCBP4;BAX;PCNA;PRMT1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.2966861642168641,-0.893218588615156,0.5895196506550219,0.8469486091922972,1.0,6/18,13.83%,OGA;ADAMTS9;NGLY1;STT3B;DERA;MANBA
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.24959221312310864,-0.8926811340062547,0.7070707070707071,0.8466464003711007,1.0,10/46,8.96%,ZNF423;ALDH1A1;LGR4;NPR3;IL15;DOCK7;NRDC;ADAMTS5;PLCL1;ACOT11
prerank,potassium ion transport (GO:0006813),0.31159607929676286,0.8920663504865686,0.7148717948717949,0.8757994340520909,1.0,29/120,20.02%,SLC24A4;SLC24A2;KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;AQP1;KCNC1;KCNA2;KCNN2;ATP1A4;KCNK9;KCNF1;ABCC8;KCNK3;KCNA1;HCN1;SLC9A9;LRRC55;HCN3;KCNMA1;KCNK10;ATP1B3;KCNH7;KCNH8;KCNK13;PKD2L1;KCNQ5
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3081475219094927,-0.8918825500610056,0.6529680365296804,0.8469557275401209,1.0,5/16,15.32%,TIPIN;RAD17;ORC1;NAE1;CLSPN
prerank,negative regulation of biosynthetic process (GO:0009890),0.3979942651185544,0.891593201004586,0.6246612466124661,0.8762957860714764,1.0,2/16,3.46%,PARK7;GPER1
prerank,urogenital system development (GO:0001655),0.4323911005138626,0.8915463016748838,0.6273972602739726,0.8759778100037577,1.0,8/11,40.53%,AMH;SOX9;OSR2;SHH;PAX2;EPHB3;LHX1;OSR1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3232751081424489,0.8913157027072657,0.684154175588865,0.8760052740775753,1.0,15/66,19.83%,RPS3;TNF;PDGFB;PAK1;CD24;HRAS;NEK10;TLR6;PDGFA;RASGRP1;EDN3;DAB2IP;FLT1;TGFB1;FLT3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.1932075826637064,-0.891239564746631,0.9090909090909091,0.8469247367985042,1.0,30/119,20.20%,PTPN13;PITPNM2;PI4KA;MTMR3;TTC7B;PLEKHA4;SMG1;PLEKHA2;PGAP2;ITPKB;PIP5K1A;VAC14;SACM1L;PIGM;PTEN;IP6K2;PIP4K2C;SOCS5;PLEKHA8;PIGN;PGAP3;PIGO;PIGF;DPM1;PIGU;PIGW;PLCG2;PIGL;FGF2;PIP4K2A
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.32441497487761467,0.8910125449237336,0.6609989373007439,0.8761619785954496,1.0,21/70,24.91%,LAMC1;LAMB2;ATF4;RAC1;SPI1;FN1;PROX1;VAMP3;ACTN1;RHOA;SRCIN1;TYRO3;TMEFF2;LPXN;EFNA1;MEF2C;GRHL2;USH2A;TBCD;METTL3;TEK
prerank,amino acid transmembrane transport (GO:0003333),0.34453386806805464,0.8908453875629745,0.6509539842873177,0.8760701677979171,1.0,14/45,25.98%,SLC38A5;SLC7A5;SLC25A13;TSPO2;SLC6A6;SLC3A2;SLC25A22;SLC38A10;SLC25A18;MFSD12;SLC7A10;SFXN1;SLC7A6;SLC38A3
prerank,organelle organization (GO:0006996),0.29645226442499917,0.890792480741216,0.8268268268268268,0.8757768626371863,1.0,83/388,21.22%,APOE;PPIA;CHCHD10;ATP5F1B;MDK;CHCHD2;CFL1;PARK7;PINK1;CNN2;MAST3;LMAN2;AUP1;PACSIN1;ATP8B4;PARP1;CAV2;BSCL2;TNFAIP3;CHMP2B;PLAAT3;BAG5;REEP5;TMED7;LMAN1;SAR1A;SURF4;TSPO2;RAB14;REEP6;HSD17B13;TMED2;THY1;CLASP1;MAST1;TICAM2;TMED3;ARHGEF7;MICAL1;ARAP3;CHMP5;CHMP6;TMED9;CHGA;FNBP1L;TMED1;ARL1;SEC61A1;VMP1;SNX11;CCL2;DES;RHOU;MIEF2;SORT1;SH3KBP1;ZMYM3;PEX6;YTHDF1;DMTN;CHMP1B;ATAD3A;CCL3;FMNL3;CAV1;DNM1L;SYNE1;LNPK;PPARGC1A;VPS4A;KIF5C;STX4;RAB31;VAPA;RAB18;HPS6;MAPK15;CFAP410;CHMP7;MYC;TMED10;CYCS;PAK5
prerank,regulation of glucose metabolic process (GO:0010906),-0.25443222535109655,-0.8897541405121238,0.64375,0.8488058964383934,1.0,14/34,24.10%,PDK1;OGT;PRKN;IRS1;FOXK2;FOXK1;DGKQ;SIRT1;SIRT7;GPLD1;RORA;MLYCD;RORC;SLC45A3
prerank,positive regulation of neuron migration (GO:2001224),0.4346462483944947,0.888955260646427,0.6149584487534626,0.8788589352741577,1.0,4/11,19.03%,MDK;SHTN1;DAB2IP;NSMF
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3717750592235819,0.8888973088050188,0.6409036860879905,0.8785694355172841,1.0,9/24,20.60%,TMEM59;AP2M1;CLTC;GDI1;RSC1A1;DMTN;TMBIM1;TGFB1;PPP2R5A
prerank,fatty acid beta-oxidation (GO:0006635),0.32995724915917024,0.8888079503434063,0.6838074398249453,0.8783289971521151,1.0,9/51,17.02%,ACADVL;SCP2;ETFB;MTLN;HSD17B4;ACAA2;ACAT1;CRAT;ECHS1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.3423747524273547,0.8886294893903638,0.6545866364665912,0.8782490497921928,1.0,15/40,21.57%,FZD9;GPM6B;ISG15;CEBPB;NELL1;P2RX7;TMEM119;ATRAID;ATP2B1;FBXO5;BMP2;SLC8A1;TGFB1;MEF2C;PTN
prerank,mitochondrial fission (GO:0000266),0.3911341638751136,0.888581813697493,0.6220779220779221,0.8779475888794063,1.0,7/16,23.28%,DNM3;GDAP1;MFF;DNM1L;FIS1;DNM1;MTFR1L
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3066925079663326,0.887097613737012,0.718052738336714,0.8803390405056826,1.0,23/128,17.04%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;DCTN1;SSNA1;HAUS2;DCTN2;ARPP19;BRSK2;CETN2;PRKAR2B
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.35746401544860207,0.8869123437790059,0.6414868105515588,0.8802891803703167,1.0,8/30,16.06%,SCN1A;SCN4B;KCNE4;FGF12;ATP1A1;GJA1;KCNE5;RYR2
prerank,positive regulation of cilium assembly (GO:0045724),0.38846143795864313,0.8865869278336804,0.637065637065637,0.8805084747029694,1.0,5/18,24.74%,KCTD17;HAP1;CCDC88A;CCP110;WRAP73
prerank,regulation of response to oxidative stress (GO:1902882),0.42275991938981594,0.8865450905526205,0.6151645207439199,0.8801982852211102,1.0,5/11,31.82%,PINK1;SELENON;HEBP2;GGT7;MCTP1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.3250034329037381,-0.8856022471293222,0.6258992805755396,0.8572321024044727,1.0,4/13,14.25%,PLXNA2;NRP1;NRP2;PLXNA4
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3866211250806097,0.8855955364719629,0.6411837237977805,0.8815754271789783,1.0,7/20,21.99%,TNF;HCK;CCL2;CCL3;CD14;TGFB1;LBP
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3394933884894296,-0.8855809578047207,0.5884615384615385,0.8557505753848471,1.0,3/11,14.46%,RAPGEF2;SIRT1;LGALS9
prerank,vesicle coating (GO:0006901),0.3294590331869933,0.8855219758931465,0.6677559912854031,0.8805396840977128,1.0,13/61,18.23%,CTSZ;LMAN1;TRAPPC2L;TRAPPC5;TMED2;TRAPPC1;PDCD6;GRIA1;COL7A1;MCFD2;NAPA;CTSC;TRAPPC3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3294590331869933,0.8855219758931465,0.6677559912854031,0.8805396840977128,1.0,13/61,18.23%,CTSZ;LMAN1;TRAPPC2L;TRAPPC5;TMED2;TRAPPC1;PDCD6;GRIA1;COL7A1;MCFD2;NAPA;CTSC;TRAPPC3
prerank,COPII vesicle coating (GO:0048208),0.3294590331869933,0.8855219758931465,0.6677559912854031,0.8805396840977128,1.0,13/61,18.23%,CTSZ;LMAN1;TRAPPC2L;TRAPPC5;TMED2;TRAPPC1;PDCD6;GRIA1;COL7A1;MCFD2;NAPA;CTSC;TRAPPC3
prerank,circulatory system development (GO:0072359),0.30830846138636614,0.885087016693924,0.7002053388090349,0.880953824268776,1.0,31/118,20.51%,CRIP1;RAMP2;PRICKLE4;SOX18;ERBB4;RBP4;PDGFB;ACVRL1;APLNR;FN1;COL3A1;FGF12;KDM6B;SOX17;FLT4;FBXW7;SOX9;BMP2;STK11;HEY1;HDAC9;CDH5;HSPG2;TCF25;ERBB3;TGFB1;NOTCH1;POU4F1;CACYBP;CITED2;MEF2C
prerank,response to glucose (GO:0009749),0.33443929559427116,0.8846207267955533,0.6591422121896162,0.8814516718888343,1.0,12/46,20.79%,RACK1;GPER1;PFKL;GYS2;LPL;VAMP2;GAS6;MAFA;ADCY8;EIF2B5;KHK;SELENOS
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.35770084901784766,-0.8836615164862375,0.6535714285714286,0.8585600947196743,1.0,5/10,16.48%,DICER1;DROSHA;TERT;TARBP2;AGO2
prerank,retinoic acid metabolic process (GO:0042573),-0.3208625083861033,-0.8831430260133007,0.6254545454545455,0.8582692944566792,1.0,1/14,2.29%,ALDH1A2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.23377429713610495,-0.88311913713855,0.7887323943661971,0.8568078450787947,1.0,13/60,10.73%,TCF7L2;TNRC6B;MED13;ATF7IP;TNRC6A;DHX36;PPM1D;TNRC6C;MED15;NFKB1;MOV10;PTEN;MED26
prerank,regulation of erythrocyte differentiation (GO:0045646),0.34859843764533976,0.8831128223297756,0.642018779342723,0.8838269788393776,1.0,13/35,24.60%,ZFP36L1;SPI1;HSPA1B;BRD1;ZFP36;PRMT1;HSPA1A;MAPK11;ABCB10;INHBA;HSPA9;MAFB;ANKRD54
prerank,histone H3 acetylation (GO:0043966),0.3410798204122244,0.8829998686564621,0.6597701149425287,0.8836320273601921,1.0,7/40,10.38%,SPI1;BRD1;BRPF1;TAF10;JADE1;TAF5L;TAF9
prerank,replicative senescence (GO:0090399),0.4163094793578186,0.8825953152759425,0.6376021798365122,0.8839804254716285,1.0,2/12,4.32%,ROMO1;CHEK2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4172887077001088,0.8825914213499638,0.6424731182795699,0.8835917674012937,1.0,1/13,1.46%,GNAI2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.4068202842743995,0.8823542534260024,0.6151761517615176,0.8836479870627286,1.0,4/15,19.62%,TNF;CUEDC2;LILRB1;TGFB1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.38627167396450135,0.8821516436282055,0.6230769230769231,0.8836458054831918,1.0,2/19,3.62%,CLDN5;TNF
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.4253854596713418,0.8819301746957185,0.6170798898071626,0.8836704122089998,1.0,2/11,6.25%,SORL1;MSN
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.40347433178487674,0.8818005030045607,0.6323337679269883,0.8835235542662716,1.0,3/15,13.22%,AGT;SOX8;SOX9
prerank,regulation of postsynapse organization (GO:0099175),0.3587245550260215,0.8814377603157132,0.6638554216867469,0.883829199956181,1.0,8/28,15.60%,CFL1;IL1RAPL1;PPFIA2;CDK5R1;ABHD17A;WNT5A;SRCIN1;CDK5
prerank,rRNA methylation (GO:0031167),0.3772202245125724,0.881389069267066,0.6579925650557621,0.8835322534220901,1.0,4/22,12.87%,TRMT112;EMG1;FBL;ZCCHC4
prerank,positive regulation of integrin activation (GO:0033625),0.4247851341704588,0.880452664844967,0.6379542395693136,0.8848407567254889,1.0,3/11,17.21%,RASIP1;P2RY12;SKAP1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3465237883309746,0.8798772850266042,0.648936170212766,0.885476477375874,1.0,9/33,21.55%,SNRPG;SNRPE;SNRPF;SNRPB;CPSF2;SLBP;MAZ;SNRPD3;CPSF4
prerank,leukotriene metabolic process (GO:0006691),0.37920228240707426,0.87980415545126,0.6288265306122449,0.8852209907874868,1.0,4/19,17.18%,DPEP2;MGST3;ALOX5AP;LTC4S
prerank,axoneme assembly (GO:0035082),-0.2521917265176403,-0.879566131764017,0.6993865030674846,0.8632338843149037,1.0,11/30,24.46%,DNAI4;TTLL3;SPEF1;GAS8;CCDC39;LRGUK;SPAG17;RP1;FOXJ1;CCDC65;DNAAF2
prerank,regulation of gene silencing by RNA (GO:0060966),0.3283746213537277,0.8795480973152199,0.6827354260089686,0.8848983977469548,1.0,11/50,19.20%,H3-3A;POLR2E;POLR2D;POLR2F;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;RAE1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3283746213537277,0.8795480973152199,0.6827354260089686,0.8848983977469548,1.0,11/50,19.20%,H3-3A;POLR2E;POLR2D;POLR2F;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;RAE1
prerank,organelle disassembly (GO:1903008),-0.2530535000075207,-0.8793001499735132,0.6848484848484848,0.8622635061712217,1.0,8/33,12.16%,UFL1;ATG2B;GOLGA2;RB1CC1;GBF1;ATG2A;KLC1;ULK2
prerank,cell cycle G2/M phase transition (GO:0044839),0.30341295851177774,0.879090952325531,0.7380710659898477,0.8853367419281833,1.0,23/129,17.04%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;DCTN1;SSNA1;HAUS2;DCTN2;ARPP19;BRSK2;CETN2;PRKAR2B
prerank,regulation of metal ion transport (GO:0010959),-0.3121706177194779,-0.8789030014164265,0.6284584980237155,0.8616403877563669,1.0,6/16,14.00%,ANK2;SLC30A10;DLG1;IL16;BCL2;STIM1
prerank,nuclear body organization (GO:0030575),-0.33829054510051504,-0.8788278127980959,0.5993265993265994,0.8602790638112539,1.0,4/12,13.74%,USP50;PML;SRPK2;AFF2
prerank,nuclear transport (GO:0051169),0.39457532692252495,0.8782616457644157,0.6553966189856957,0.8864616024595914,1.0,5/16,17.63%,NPM1;RBM15B;XPO1;BANF1;ANP32A
prerank,triglyceride biosynthetic process (GO:0019432),-0.3008066197187286,-0.877792678255758,0.6259842519685039,0.8611218513339819,1.0,8/18,26.64%,AGMO;MOGAT3;GPAT3;GK;PNPLA3;LPIN2;DGAT2;LPIN3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.4258337596596482,0.877361052890573,0.63268156424581,0.8876912289294986,1.0,6/10,35.98%,SIRT2;RCC2;ECT2;SPAG5;APC;KNSTRN
prerank,axon extension (GO:0048675),0.36946995466824406,0.8772815434798452,0.6329268292682927,0.8874337212803628,1.0,3/23,3.86%,HSP90AA1;HSP90AB1;SEMA3F
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.34433344104386887,0.8769350995300864,0.656140350877193,0.8876820229112259,1.0,8/38,14.04%,TOMM7;PINK1;UBL5;ATP5IF1;LMAN1;LEPROT;FBXW7;RHOU
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.33008880640527416,0.8766710844537794,0.6833890746934225,0.8878068782260354,1.0,7/45,13.42%,RPL10;GRM5;METAP1;MEX3D;PCIF1;RBM4B;METTL18
prerank,regulation of mitochondrion organization (GO:0010821),0.33095858448229065,0.8763369809043742,0.6804932735426009,0.888017457166373,1.0,12/47,17.90%,TREM2;PINK1;OMA1;MAPT;ATP13A2;FBXW7;MIEF2;MFF;SQSTM1;TMEM102;DNM1L;PPARGC1A
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.29314287666082994,-0.8762924927516532,0.6711111111111111,0.8628943925977375,1.0,3/17,6.27%,SULF1;SLIT2;CASK
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.34337798964698085,0.8762053625954052,0.6556064073226545,0.887873940700602,1.0,5/38,9.14%,GRN;CYBA;LY86;CD180;SLC15A4
prerank,protein-containing complex assembly (GO:0065003),0.2943667235846823,0.8759087868742773,0.812625250501002,0.8880354216171468,1.0,63/259,22.63%,CD74;CHCHD10;CTSZ;ELOB;CXCL12;LAMC1;SLC2A1;CSNK2B;TNF;TAPBP;PPP2R1A;CTNNB1;ADD2;HES1;IL2RB;AP2M1;FN1;LMAN1;OTX2;TRAPPC2L;TRAPPC5;RIMS1;TMED2;P2RX7;TRAPPC1;CAPZA2;VAMP3;RBX1;VAMP2;PDCD6;GRIA1;SOX9;TNFRSF1A;MAGI1;TSPAN4;CAPG;COL7A1;MCFD2;SPG7;TIAM1;PDE4DIP;BAD;DMTN;NAPA;ADCY8;RBBP5;DNM1L;PPARGC1A;CTSC;TRAPPC3;EPRS1;LPXN;SKP1;IL1RAP;CAPN3;MYC;TFAP4;TMED10;COL16A1;LLGL1;MEN1;BLM;TGFA
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.31345689672098365,0.8757433072002018,0.6813880126182965,0.8879438848493851,1.0,12/76,14.42%,UBB;LAPTM5;PINK1;FKBP1A;FAM107A;CENPX;PTTG1IP;WFS1;NSMCE3;FBXW7;RIPK2;HSPBP1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3876517468684788,0.8755792394832264,0.6607142857142857,0.8878549994184899,1.0,2/18,4.05%,COX17;COA3
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3533141863286755,0.8755390429407417,0.6541717049576784,0.8875332390591637,1.0,5/30,11.44%,H3-3A;PARK7;NCOR2;PKN1;ZBTB7A
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.23463901806629084,-0.8755212168130388,0.7614678899082569,0.8631261788709833,1.0,16/45,20.61%,EGFR;NFKB1;DYRK1A;RIPK1;HEATR1;SETX;POLR2A;BMP4;ZC3H18;DIMT1;TP53;SIRT7;WDR43;SUPV3L1;BUD23;RBM20
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.38341299300138726,0.8752955858498864,0.6447368421052632,0.8875811562134611,1.0,7/18,23.21%,CRH;CHGA;SFRP1;INHBB;REST;CCN3;PSMD9
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3172376318370847,0.8748655958434408,0.7024442082890542,0.8879434974630729,1.0,12/66,13.65%,GPNMB;PSME1;AKT1;PSME2;CCND2;FAM107A;CCND1;JADE1;CDK2AP2;AIF1;KLF4;CCL2
prerank,endodermal cell differentiation (GO:0035987),0.35120487280589213,0.8748331887504446,0.666267942583732,0.8876135705572745,1.0,6/31,15.63%,VTN;ITGB2;FN1;COL6A1;COL7A1;MMP14
prerank,glycerophospholipid metabolic process (GO:0006650),0.30985937982787304,0.8747326600146209,0.6914893617021277,0.8874023431769494,1.0,21/75,25.80%,SERINC1;PRDX6;PIGZ;PIGQ;DGKH;PLA2G7;PLA2G4F;CSF1R;GDE1;SERINC5;GPCPD1;CPNE6;DPM2;GDPD1;ENPP6;PGP;GDPD3;PLA2G3;ABHD12;ABCA3;CPNE3
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.33615655355877455,-0.8744210903460674,0.6666666666666666,0.8640587063563524,1.0,2/12,4.81%,SORBS1;IRS1
prerank,monoacylglycerol metabolic process (GO:0046462),0.4000392320369877,0.87394881008472,0.6196403872752421,0.8884180226809033,1.0,7/13,29.22%,MOGAT2;DGAT2L6;FAAH;DGAT1;ABHD16A;ABHD12;MGLL
prerank,heterotypic cell-cell adhesion (GO:0034113),0.3611959241356709,0.873609756527639,0.6436498150431565,0.8886157810567837,1.0,5/25,16.92%,ITGB2;CTNNA3;NINJ1;JAM3;VCAM1
prerank,microtubule depolymerization (GO:0007019),0.3813559978291911,0.8733881595518991,0.6423927178153446,0.8886157088722509,1.0,7/17,32.79%,STMN3;STMN4;STMN1;NCKAP5;CCSAP;STMN2;KATNB1
prerank,COPII-coated vesicle budding (GO:0090114),0.31976468793947366,0.8726509713072131,0.6884368308351178,0.8895552654351718,1.0,16/68,20.96%,CTSZ;LMAN1;TRAPPC2L;SAR1A;TRAPPC5;TMED2;TRAPPC1;PDCD6;GRIA1;COL7A1;MCFD2;NAPA;CTSC;TRAPPC3;VAPA;TMED10
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.3799371253555085,0.8721591652985107,0.6628930817610063,0.8900755713165498,1.0,9/20,25.46%,PSENEN;SPPL2B;PSEN2;ADAM17;APH1B;TGFB1;SPPL2A;RELA;APH1A
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4264079715387771,0.8717871079060333,0.6508795669824087,0.8902935704370198,1.0,1/10,1.76%,PARK7
prerank,chromosome condensation (GO:0030261),0.3408055114236242,0.8717658877820026,0.6766743648960739,0.8899454460553177,1.0,6/36,13.88%,CSNK2B;GPER1;SET;H1-0;BANF1;NCAPG
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.3798144508343576,0.8703209418432692,0.6441326530612245,0.8921061436523362,1.0,2/18,6.25%,MAPK3;MSN
prerank,cranial nerve development (GO:0021545),0.4226960496378701,0.8700017329198008,0.6386206896551724,0.8923055073399337,1.0,3/11,20.23%,TMEM126A;ERBB3;POU4F1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.31956692594121117,-0.8699849392929409,0.631578947368421,0.8721119687491878,1.0,1/14,0.51%,ZEB1
prerank,microtubule polymerization (GO:0046785),0.35236804645715325,0.8691352132305291,0.6501210653753027,0.8934593002585998,1.0,4/28,8.71%,TPPP3;PIN1;CLASP1;MAPT
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.36046117343834105,0.8689321346412097,0.6592317224287485,0.8934443417989029,1.0,2/23,2.56%,CALM1;CALM3
prerank,negative regulation of blood pressure (GO:0045776),0.40496013139486725,0.867923707850549,0.6582781456953642,0.8948530311091675,1.0,3/13,23.74%,GPR37L1;NOS2;PRCP
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3294777810479414,0.8678814532872238,0.6712328767123288,0.894539951843572,1.0,13/39,27.64%,ADAM15;SPOCK1;CORO1C;RHOA;DMTN;NOTCH1;PTPRO;AP1AR;RCC2;TBCD;CX3CL1;MYOC;CORO2B
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3887177329435346,0.8675601121367887,0.6444444444444445,0.8946855566762474,1.0,2/15,12.23%,IDO2;QDPR
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.24950018078990846,-0.8675465949160581,0.7027027027027027,0.8757530318739287,1.0,4/32,6.23%,AUTS2;PLCE1;CARMIL1;NCKAP1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.21185604197485497,-0.866995518994206,0.8461538461538461,0.8755646985484236,1.0,20/80,16.22%,SNX6;DENND2A;SGSM2;VPS54;VTI1A;SNX12;SPAG9;DENND5A;STX16;ANKFY1;GBF1;TBC1D23;RIC1;TRAPPC10;TMEM87B;SNX2;VPS50;WASHC1;SNX1;HEATR5B
prerank,regulation of cellular senescence (GO:2000772),0.3530724406134226,0.8665878868714444,0.6752336448598131,0.8960107420209092,1.0,5/28,13.01%,B2M;YPEL3;VASH1;YBX1;FBXO5
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3167792822710127,0.8662468651754004,0.7180851063829787,0.8962145777715985,1.0,13/65,16.42%,AKT1;AGT;GPER1;DUSP3;SH3GL2;PTK6;EPN1;ARHGEF7;HAP1;SPRY1;CCDC88A;SH3KBP1;DAB2IP
prerank,regulation of synapse organization (GO:0050807),0.35974952792451903,0.866199767705671,0.6493184634448576,0.8959078150647187,1.0,7/26,13.46%,CTNNA2;TNF;KLK8;IL1RAPL1;ABHD17A;WNT5A;YWHAZ
prerank,regulation of protein export from nucleus (GO:0046825),0.360406727535102,0.8655981365747717,0.6645885286783042,0.896570822042064,1.0,9/23,24.56%,PARK7;YWHAE;UHMK1;CAMK1;GAS6;RANGAP1;IFI27;ANP32B;BARD1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3642643361626127,0.8655763501561924,0.6566265060240963,0.89621499723756,1.0,9/22,27.12%,DYNLL1;CDKN1C;PRKRIP1;INHBA;CDA;CDKN2B;TESK1;INHA;CDKN1A
prerank,cardiac myofibril assembly (GO:0055003),-0.3148320390376627,-0.8652542336636946,0.66,0.8777938197127444,1.0,4/15,12.94%,NEBL;MEF2A;PDGFRB;OBSL1
prerank,positive regulation of axonogenesis (GO:0050772),0.3309732505506756,0.8650990573403,0.6852272727272727,0.8966565256684274,1.0,9/43,14.60%,ARHGDIA;NTRK2;SEMA7A;MAPT;NTN1;RHOA;SHTN1;ROBO2;TIAM1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.30866456429764255,0.8649739323957658,0.708994708994709,0.8964801351179081,1.0,18/75,24.70%,SLC24A2;KCNJ10;SLC39A10;ATP1A3;ATP1B2;SLC12A5;TRPM2;ATP1A4;ATP1A1;KCNK9;SLC8A1;ATP1B1;SLC9A9;ATP1B3;KCNJ3;CACNA2D1;SLC39A12;KCNJ6
prerank,negative regulation of receptor internalization (GO:0002091),0.41284503308385284,0.8644419162100423,0.6841379310344827,0.8970041415965685,1.0,4/12,15.63%,LRPAP1;UBQLN2;SDCBP;ANKRD13D
prerank,glycogen metabolic process (GO:0005977),0.35684228718978495,0.8641951656563682,0.6593673965936739,0.8970376499220937,1.0,5/27,10.21%,CALM1;NR1D1;GYS2;NHLRC1;GAA
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3446477289207719,-0.8638524393376152,0.6476510067114094,0.8792883196394569,1.0,2/10,10.37%,INO80;SSBP1
prerank,wound healing (GO:0042060),0.3196250420253753,0.86317471331457,0.7249190938511327,0.8984238642229654,1.0,18/62,18.71%,HMOX1;NRG1;PLEC;COL3A1;PAK1;SYT11;EPPK1;SMPD1;WNT5A;SLC11A1;EVPL;HPSE;PDGFA;EPB41L4B;GATA4;ANXA6;ERBB3;PPP3CA
prerank,determination of left/right symmetry (GO:0007368),-0.23755858197308347,-0.8630363878025619,0.7142857142857143,0.8796224654125391,1.0,20/36,32.89%,SMO;GALNT11;OFD1;NPHP3;CCDC39;RFX3;CFAP53;DAND5;PKD2;ODAD2;ODAD3;FOXJ1;ODAD4;MKKS;KIF3B;CCDC40;DNAAF4;STIL;PKD1L1;BBS7
prerank,neuron fate commitment (GO:0048663),0.40304572841547837,0.8629338606903644,0.6689655172413793,0.8984563016396853,1.0,7/14,30.81%,DLL1;MYT1L;POU4F1;ID2;DLL4;POU3F2;SHH
prerank,monocarboxylic acid catabolic process (GO:0072329),0.370032026095935,0.8628464494413093,0.667905824039653,0.8982068195802616,1.0,2/21,4.91%,AGXT;NUDT19
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3223107140704239,-0.8621075652766659,0.6428571428571429,0.8801277613424454,1.0,4/13,14.92%,RREB1;SIX1;SOX13;NAPEPLD
prerank,cognition (GO:0050890),0.3318840517271446,0.8619699784260484,0.7062857142857143,0.8993524564391686,1.0,13/42,20.91%,GRM5;SLC1A4;TNF;C5AR1;CHMP2B;FAM107A;MFSD2A;CHRNA4;MAGT1;CBR3;JAKMIP1;PTCHD1;GPR155
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.35839559622677714,0.861636327963035,0.6591760299625468,0.8995516612055154,1.0,8/23,26.37%,ERBB4;TNF;HES1;IL6;NOTCH1;IL10RB;PRLR;OCIAD2
prerank,response to peptide (GO:1901652),0.33763885377439873,0.8613737144682833,0.6817653890824622,0.8996050771491949,1.0,15/33,30.05%,MMP3;PRNP;CACNA1A;GNAI1;RAMP3;ERBIN;EIF2B5;IRF5;AGER;MMP2;CACNA1B;STAT4;CHRNA7;NOD2;EIF2B1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.297847542499899,0.8608564021489608,0.7797979797979798,0.9001254790522215,1.0,35/152,18.86%,PSMB4;ATP6V0C;COL1A1;PSME1;PSMB6;PSMB8;PSME2;PSMD2;FZD9;PSMD1;PIN1;PSMC3;TNFAIP3;PSMD6;VCP;PSMA7;PSMD5;LGR6;PSMB9;ATP6AP2;PSMD13;GPC5;PSMB3;PSMB11;SFRP4;PSMB10;BMP2;PSMB1;PSMB5;CAV1;USP8;CSNK1G2;CCAR2;SFRP1;PSMA6
prerank,modified amino acid transport (GO:0072337),0.39245248116996206,0.8606297795279371,0.6657824933687002,0.9001313679053988,1.0,4/15,15.35%,SLC1A4;MGST1;SLC19A1;FOLR2
prerank,phosphatidic acid metabolic process (GO:0046473),-0.22767489279544442,-0.8603585783854973,0.7575757575757576,0.8825350830594428,1.0,11/48,20.97%,PLD1;PLA2G4A;DGKA;DGKQ;DDHD2;AGPAT4;GPAT3;ABHD5;GPD1;PNPLA3;PLD2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.38385291296907686,0.8603527972398737,0.6714100905562742,0.9002017447321097,1.0,2/17,3.62%,CLDN5;TNF
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3332713161174938,0.8602915310191044,0.7022274325908558,0.8999210838902029,1.0,5/38,9.94%,TREM2;NR1D1;TNFAIP3;OTUD7A;TRIM59
prerank,regulation of spindle assembly (GO:0090169),0.3573272060753874,0.8597227878105759,0.6771463119709794,0.9005288877668229,1.0,12/25,31.07%,HSPA1B;CHMP2B;CHMP5;HSPA1A;HNRNPU;CHMP1B;CHMP1A;CHMP4C;CCSAP;SPAG5;CHMP4B;DYNC1H1
prerank,prostanoid metabolic process (GO:0006692),0.4008107511496539,0.8589570156184799,0.657496561210454,0.9015049378019414,1.0,2/13,13.30%,GSTM1;HPGDS
prerank,negative regulation of ion transport (GO:0043271),0.35421458354331764,0.8587806033525828,0.6718562874251497,0.9014189035569817,1.0,5/24,19.16%,GPM6B;PLN;SYT11;LILRB1;SNCA
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.40017739371106353,0.8587229720709271,0.6771978021978022,0.9007454891885122,1.0,4/12,23.00%,CORO1C;DMTN;AP1AR;RCC2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.40017739371106353,0.8587229720709271,0.6771978021978022,0.9007454891885122,1.0,4/12,23.00%,CORO1C;DMTN;AP1AR;RCC2
prerank,cellular response to amino acid stimulus (GO:0071230),0.340477975411112,0.8585142064321649,0.6866197183098591,0.9007044417965158,1.0,9/33,19.03%,LAMTOR2;LAMTOR4;LAMTOR5;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.34759451115529016,-0.8579525169867153,0.6283783783783784,0.8862805101726524,1.0,2/10,9.23%,ATP7A;THAP4
prerank,cellular response to organic substance (GO:0071310),0.29707149798423077,0.8579230230101327,0.7733333333333333,0.9013393113638354,1.0,30/116,20.42%,RACK1;RAMP2;PARK7;AKAP6;TNF;IGFBP5;PDGFB;ACVRL1;HCLS1;CTNNB1;IL1RAPL1;CLEC3B;CSF1R;RAMP3;AMHR2;SLC1A1;KLF4;RHOA;CXCR4;CCL2;ROBO2;SIGIRR;CCL3;SLIT3;SFRP1;PTPN6;TGFB1;FLT3;POU4F1;CDK9
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.4112541555073667,0.8573712994115628,0.6713681241184767,0.9014989758468148,1.0,4/11,18.30%,IL2RB;IL2;IL2RG;SYK
prerank,cellular response to interleukin-2 (GO:0071352),0.4112541555073667,0.8573712994115628,0.6713681241184767,0.9014989758468148,1.0,4/11,18.30%,IL2RB;IL2;IL2RG;SYK
prerank,smoothened signaling pathway (GO:0007224),-0.2505048719188928,-0.85728557528456,0.7468354430379747,0.8861465589726264,1.0,4/32,2.95%,SMO;CC2D2A;GLI3;GLI2
prerank,negative regulation of GTPase activity (GO:0034260),-0.28134884455184656,-0.8570308995410824,0.6978021978021978,0.885130229309443,1.0,3/22,2.28%,LRRK2;BCAS3;ARFGEF1
prerank,positive regulation by host of viral transcription (GO:0043923),0.39377112579242635,0.856627067423669,0.6438172043010753,0.9023873253660667,1.0,4/15,12.31%,NUCKS1;RRP1B;JUN;SNW1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.39248414484040883,0.856392077416961,0.6765799256505576,0.9024077186908802,1.0,3/16,7.42%,PUF60;SRSF9;PQBP1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.34136692558843257,0.8563458170073311,0.6922183507549361,0.9020873210754511,1.0,11/34,20.78%,CCDC85B;GPER1;TNF;ZFP36L2;GATA2;WNT5A;LRP3;WNT10B;TGFB1;IL6;SIRT2
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.38124560730664014,0.8560098344225257,0.6578249336870027,0.9022506966121485,1.0,3/16,13.40%,GPR37L1;KLK1;DDAH1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3063454460229592,0.8559419823808009,0.7376873661670236,0.9019750355781533,1.0,8/74,5.49%,GPX1;HMOX1;PARK7;AKT1;TNF;LGALS3;HSPA1B;TNFAIP3
prerank,respiratory chain complex IV assembly (GO:0008535),0.36722651228379566,0.8557170265554698,0.6766917293233082,0.901970036265794,1.0,2/21,4.05%,COX17;COA3
prerank,negative regulation of defense response to virus (GO:0050687),-0.3466516760500406,-0.8552919351250305,0.6357827476038339,0.887310733745998,1.0,3/10,15.68%,ITCH;ILRUN;TARBP2
prerank,positive regulation of ion transport (GO:0043270),0.32095550519997346,0.855099680466417,0.7005586592178771,0.90264122748042,1.0,11/48,16.63%,ANK3;P2RX7;LILRA5;SCN4B;ATP2B1;WFS1;VAMP8;CNKSR3;PRSS8;CCL3;ORAI1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3111133564718106,0.8550490029832958,0.7342733188720173,0.9023494428400818,1.0,20/70,26.35%,GABARAP;DCC;TNF;P2RX7;TNFSF12;BAX;TNFRSF1A;SORT1;BAD;SIVA1;DAB2IP;ERBB3;INHBA;TGFB1;BAK1;IFI27;BLOC1S2;BOK;FGFR3;TGFB2
prerank,regulation of pH (GO:0006885),0.4150055568966077,0.854853211572759,0.6903765690376569,0.9022911935490285,1.0,3/11,12.13%,ATP6AP1;SLC26A4;ATP1A4
prerank,atrioventricular valve development (GO:0003171),-0.30770074650979706,-0.8542527588811796,0.65625,0.8880613605548254,1.0,3/14,6.64%,ACVR1;BMPR1A;MDM4
prerank,protein hydroxylation (GO:0018126),-0.30494583405505893,-0.8530026681514487,0.6724890829694323,0.8890899653249554,1.0,2/15,5.93%,PLOD2;ASPH
prerank,gland development (GO:0048732),0.31559066562442606,0.8529703127050243,0.7369565217391304,0.9051114291745876,1.0,9/59,13.22%,MDK;SOD1;NRG1;HES1;MSN;CEBPA;PROX1;LSR;SOX9
prerank,regulation of microtubule depolymerization (GO:0031114),0.3478046415103896,0.8527151523906783,0.6747572815533981,0.905133911974182,1.0,4/25,8.49%,MAP1A;MID1IP1;NAV3;CLASP1
prerank,positive regulation of viral genome replication (GO:0045070),0.3454253240273025,0.8525872546072435,0.6750902527075813,0.9049463571056874,1.0,5/29,14.17%,PPIA;IFIT1;DDB1;PABPC1;PDE12
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.41225391676443623,0.8522213609486611,0.6629213483146067,0.9051679683821662,1.0,3/11,19.83%,RGS2;LMNA;NOTCH1
prerank,muscle tissue morphogenesis (GO:0060415),-0.2925715213159491,-0.8518158741431561,0.656,0.8902386921532673,1.0,4/16,14.58%,TGFBR3;MYLK;BMP4;HEY2
prerank,heart development (GO:0007507),0.29232902035079933,0.8517877871518277,0.7898989898989899,0.9055049457433478,1.0,35/150,20.51%,CRIP1;RAMP2;PRICKLE4;SOX18;ERBB4;RBP4;SGCZ;PDGFB;ACVRL1;FKBP1A;NDRG4;APLNR;ALPK2;FN1;DLC1;MMP21;COL3A1;FGF12;KDM6B;SOX17;SOX9;BMP2;LEFTY1;GATA4;HDAC9;CRELD1;SGCG;TCF25;ERBB3;TGFB1;NOTCH1;POU4F1;CACYBP;CITED2;MEF2C
prerank,myelination in peripheral nervous system (GO:0022011),-0.3238292343053444,-0.8517188077986272,0.6872586872586872,0.8889136094212912,1.0,3/13,5.53%,PARD3;SKI;DICER1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4084475355929099,0.8514416875527688,0.6507042253521127,0.9056919328994641,1.0,2/11,10.66%,CD34;ATP6AP2
prerank,protein homooligomerization (GO:0051260),0.2957368581455026,0.8510298149127085,0.7667009249743063,0.9059742096860651,1.0,18/114,16.59%,ALDOA;B2M;AQP4;SLC1A2;MPP2;MIF;STEAP4;ALAD;NINJ1;TRPM2;RS1;PRMT1;ALOX5AP;GLS;EHD1;G3BP2;HCN1;ADCY8
prerank,melanocyte differentiation (GO:0030318),-0.34436535627627424,-0.8506888912847003,0.6344827586206897,0.8895082423865778,1.0,4/11,17.80%,LRMDA;ENPP1;KIT;MITF
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.348097194910291,-0.8506410409941679,0.6594982078853047,0.8881043093575051,1.0,4/10,14.92%,DUSP10;HIPK3;PDCD4;PTPN22
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3616977377573951,0.8505177328465421,0.6645962732919255,0.9064266475485968,1.0,7/21,20.93%,MT3;GRIN1;BEX3;PSMB9;PCID2;GRIN2B;PYCARD
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4184970183734092,0.8505016717101669,0.6752136752136753,0.906065775194763,1.0,1/10,3.66%,PFKL
prerank,regulation of exosomal secretion (GO:1903541),0.3607291251111157,0.849725180078862,0.6606217616580311,0.9069977528363449,1.0,7/19,26.73%,ATP13A2;SDC4;CHMP6;SDCBP;VPS4A;HGS;SNF8
prerank,negative regulation of cellular component movement (GO:0051271),0.3837250897160423,0.8491852444827085,0.6764705882352942,0.9075319729048237,1.0,4/15,12.23%,PIN1;FRMD5;SPOCK3;ACTN1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.38615531798528596,0.8491098815627776,0.6693227091633466,0.9072655046612437,1.0,4/15,16.23%,S100A1;PKM;KLF4;DLL1
prerank,regulation of transferase activity (GO:0051338),0.3719122034576715,0.8489751178007839,0.6640211640211641,0.9070907280384274,1.0,3/17,8.00%,EMP2;BAG5;FEM1A
prerank,tyrosine metabolic process (GO:0006570),-0.33562347908389284,-0.8488797265556242,0.6386861313868614,0.890342356333708,1.0,3/11,25.76%,THAP4;GSTZ1;HGD
prerank,positive regulation of lipid catabolic process (GO:0050996),0.36646037619967897,0.8488373156993314,0.681877444589309,0.9069202568176943,1.0,3/19,16.79%,PNPLA2;MTLN;TWIST1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3888077800082482,0.8486135305175723,0.6689750692520776,0.9068832704084727,1.0,6/13,33.21%,CCL19;ABCA2;IL33;CHP1;ALG10B;RAMP1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.40858691573375916,0.8477615285020493,0.6637806637806638,0.9079050956657466,1.0,4/10,19.74%,CAMK1;PIH1D1;HDAC5;SPHK2
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3634711438718143,0.8476951105160003,0.6834804539722572,0.9076365476897434,1.0,5/20,13.96%,HSP90AA1;FLOT1;NUPR1;CDC37;SDCBP
prerank,mitotic nuclear division (GO:0140014),-0.20701171450718833,-0.8470976638057153,0.8181818181818182,0.8924675467624932,1.0,30/71,24.01%,EPS8;STAG1;LSM14A;KLHDC8B;PIBF1;GOLGA2;OFD1;INO80;CENPK;AAAS;NDEL1;KIF2A;DSN1;KLHL22;CCDC61;SMC4;MISP;KIF18B;TPX2;ABRAXAS1;CEP192;NUP62;ARHGEF10;NDC80;TUBG1;MIS12;MAP9;SGO1;SMC3;SMC1A
prerank,glucose homeostasis (GO:0042593),0.3024676573233158,0.8467437593778688,0.7465968586387435,0.9088451049117288,1.0,17/83,20.73%,PARK7;MTNR1B;RPS6;LRRC8A;RBP4;NR1D1;NUCKS1;CEBPA;MLXIPL;WFS1;STK11;BAD;ADCY8;PPARGC1A;TFAP2B;IL6;PYGL
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.3876506881764806,0.8463916143890855,0.6719787516600265,0.9090449677634851,1.0,4/15,17.90%,MID1IP1;MLXIPL;NR1H2;PPARGC1A
prerank,Golgi to endosome transport (GO:0006895),-0.2950714154093615,-0.8463290660785099,0.668141592920354,0.8925321769246934,1.0,4/16,10.36%,VPS13A;MON2;GBF1;KIF16B
prerank,organophosphate biosynthetic process (GO:0090407),0.32918892245478687,0.8457507758599667,0.7106184364060677,0.9096848567597928,1.0,8/37,18.77%,TPI1;FADS1;GPHN;PCYT2;PNPO;TKT;AGPAT5;IP6K1
prerank,acyl-CoA metabolic process (GO:0006637),0.33168905194263304,0.8448891540161704,0.7186400937866354,0.9107012312096144,1.0,8/35,22.16%,DBI;OXSM;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5
prerank,embryonic organ development (GO:0048568),0.31320757572650304,0.8448225927028662,0.7389428263214671,0.910415911034206,1.0,12/61,11.65%,RPL10;ATF4;SOX18;RBP4;NES;TNF;NDRG4;RARRES2;KDR;MFSD2A;KITLG;SOX17
prerank,positive regulation of cyclase activity (GO:0031281),0.38852814459082136,0.8447389980512309,0.6679586563307494,0.9101776127214923,1.0,4/14,17.79%,MAPK3;DRD5;ORAI1;NOS2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3323151577269897,0.8446495851973295,0.7111622554660529,0.9099424142702447,1.0,11/37,27.12%,GPER1;IGFBP5;PDGFB;P2RY6;JUN;GJA1;ADAMTS1;MEF2C;MMP2;EFEMP2;CDKN1A
prerank,glycoprotein metabolic process (GO:0009100),-0.2220263787346023,-0.84377424936114,0.7848101265822784,0.8963300904103895,1.0,8/53,9.38%,LARGE1;ST3GAL4;MAN1C1;OGA;ADAMTS9;FUT8;NGLY1;STT3B
prerank,regulation of JNK cascade (GO:0046328),0.29860800218747763,0.8429023979356784,0.7791537667698658,0.9124132811321312,1.0,33/101,25.92%,CCL19;PINK1;SIRPA;DUSP3;TIRAP;ANKRD6;HIPK2;CCN2;HMGB1;FLT4;HRAS;PHLPP1;MAPK8IP1;SDCBP;F2RL1;MAPK8IP2;TRAF3;RASGRP1;EPHB1;NCF1;DAB2IP;MAP4K2;LTBR;GADD45A;PYCARD;UNC5CL;MEN1;DUSP15;WNT7A;APP;AGER;MFHAS1;FKTN
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.29968645836801405,-0.8428566959131402,0.6458333333333334,0.8968720551098005,1.0,4/15,12.15%,YTHDF3;STAT2;CNOT7;PTPN2
prerank,regulation of chromatin binding (GO:0035561),-0.33607137046195373,-0.8422279903632816,0.643598615916955,0.896687407596799,1.0,4/10,14.55%,PARP9;WAPL;BTAF1;KDM4D
prerank,regulation of glucose transmembrane transport (GO:0010827),0.36432332362581094,0.842070214863272,0.6815718157181572,0.9133936647836456,1.0,4/18,13.39%,C3;SLC2A1;RSC1A1;CLIP3
prerank,DNA replication initiation (GO:0006270),0.33019689316338174,0.8415418256473393,0.7266591676040495,0.9138930027498516,1.0,5/37,12.36%,MCM5;RPA2;CDC34;GMNN;POLE4
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.35999398872040167,0.8410824133159603,0.6996245306633292,0.9142684027233428,1.0,6/21,21.13%,PPP1CA;CTNNB1;FRAT2;CAV1;FZD1;FZD2
prerank,cellular response to ketone (GO:1901655),0.3307071689668095,0.8410299515519188,0.7116279069767442,0.9139617687095495,1.0,9/35,19.74%,SPP1;ADAM15;MSN;AQP1;GNAI1;ADCY8;NCOA4;SFRP1;SPHK2
prerank,regulation of endocytic recycling (GO:2001135),0.4024679481617324,0.8408250104845049,0.6700581395348837,0.9139228474642809,1.0,4/11,24.90%,SORL1;EHD1;EHD2;PLA2G3
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.30668238770383,0.8403335170678256,0.7428571428571429,0.9143596395192722,1.0,10/62,12.48%,ELOB;POLR2E;ELOF1;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;SSRP1;POLR2K
prerank,RNA biosynthetic process (GO:0032774),-0.2470325951117931,-0.8399875864909722,0.7417218543046358,0.8998573601939981,1.0,8/31,19.87%,TTF1;SMARCA5;TERT;SETX;POLR2A;RSF1;TAF7;NCOA6
prerank,double-strand break repair (GO:0006302),-0.18898528578957519,-0.8397417690158543,1.0,0.8988170386439684,1.0,32/158,15.18%,EYA1;BABAM2;KDM2A;NSMCE2;DDX1;PARP9;MDC1;SPIDR;UIMC1;SMARCAD1;SMARCA5;RNF8;BAZ1B;PARP3;RBBP8;NHEJ1;SLX4;RNF138;ERCC5;FBH1;INO80;SETX;ACTR8;EYA3;ATM;TNKS1BP1;CYREN;RAD51B;KDM4D;PALB2;KPNA2;TDP1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4194896387065151,0.8396076183445548,0.6879334257975035,0.9151754527884536,1.0,4/10,26.61%,CTNNB1;WNT5A;FZD1;WNT2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.31008603103644694,-0.8394190185164485,0.6518218623481782,0.8979599977580226,1.0,4/14,14.97%,AUTS2;KMT2A;SMAD4;PRDM9
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.4011118478920733,0.8388713141837324,0.694406548431105,0.9159415198767549,1.0,4/11,20.65%,FBL;EXOSC2;DKC1;EXOSC4
prerank,ethanol metabolic process (GO:0006067),-0.31731022699145683,-0.8378096994724554,0.688212927756654,0.8997873544130546,1.0,1/12,1.38%,ALDH1A1
prerank,lipid phosphorylation (GO:0046834),0.41196413605813903,0.83760639817864,0.6789772727272727,0.9176360703622792,1.0,6/10,31.61%,DGKH;DGKI;DGKK;DGKB;DGKZ;DGKG
prerank,sodium-independent organic anion transport (GO:0043252),0.4256234515631801,0.837369223529127,0.672463768115942,0.9176319150407795,1.0,4/10,19.38%,SLCO1C1;SLCO4C1;MFSD10;SLCO1B1
prerank,cardiac muscle cell action potential (GO:0086001),0.3384002396251711,0.8370997692208443,0.7092024539877301,0.917667284829941,1.0,7/30,15.84%,SCN1A;YWHAE;SCN4B;FGF12;ATP1A1;SLC8A1;ATP1B1
prerank,Ras protein signal transduction (GO:0007265),0.2889254792887009,0.8370183092588495,0.8219735503560529,0.9174158031858641,1.0,28/137,15.86%,ARHGDIA;CFL1;PARK7;RHOB;RAC1;ELMO1;ARHGDIB;SHC3;RHOG;ADGRG1;TRIM28;NTN1;ARHGDIG;JUN;GRAP;COL1A2;RASGRP3;AIF1;GDI1;HRAS;RHOA;SHTN1;TIAM1;RRAS;MAPK11;G3BP1;G3BP2;RASGRP1
prerank,regulation of nervous system process (GO:0031644),0.3651709610191385,0.8361766769068048,0.712468193384224,0.918421160147308,1.0,9/18,24.78%,DLGAP2;DLGAP1;HTR2C;BEGAIN;NPTXR;TMEM108;CACNG5;APP;NPTX1
prerank,tRNA processing (GO:0008033),0.3106000327209686,0.8361323466742809,0.7391774891774892,0.918107898197902,1.0,19/61,26.36%,METTL1;ELAC2;SARS1;KARS1;RTRAF;AARS2;POP7;TSEN15;RTCB;CTU1;TSEN54;CPSF4;URM1;ADAT2;TRNT1;TRMT10C;THUMPD1;CTU2;LCMT2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3622292751142441,0.8359923266902658,0.6972833117723156,0.9179469663192146,1.0,7/18,27.21%,BHLHE41;TMEM119;HDAC5;BMP2;NOTCH1;CCN3;XBP1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.40855328996734236,0.8358377994835084,0.6785206258890469,0.9178071221429243,1.0,3/10,12.80%,PSMC3;HMGB1;THRA
prerank,negative regulation of histone modification (GO:0031057),0.3867849017017303,0.8356541751361583,0.6849865951742627,0.9177220111515313,1.0,5/14,19.74%,SET;CTBP1;TWIST1;SNCA;SPHK2
prerank,regulation of sequestering of calcium ion (GO:0051282),0.39362930099017834,0.8355483025744171,0.695054945054945,0.9175167063574086,1.0,4/12,18.36%,MTLN;RYR2;FKBP1B;ANXA6
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.38454064004737853,0.8354377670512334,0.711051930758988,0.9173103443860539,1.0,5/14,22.08%,NLRP2B;GAS6;F2RL1;TRAIP;PELI3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.3792136985582275,0.8352028795322193,0.6936339522546419,0.9172977319158172,1.0,4/15,14.95%,AGT;LPL;MSR1;PF4
prerank,reticulophagy (GO:0061709),-0.3243644440523319,-0.8349578890756161,0.6666666666666666,0.9038858118430313,1.0,6/12,16.79%,UFL1;ATG2B;RB1CC1;ATG2A;ULK2;ULK1
prerank,negative regulation of histone methylation (GO:0031061),-0.3317841647583074,-0.8345061217777949,0.668918918918919,0.903322236032923,1.0,2/10,6.24%,JARID2;BCOR
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.3595756895401563,0.834460941070244,0.686046511627907,0.918118954498794,1.0,5/20,22.39%,GATM;PTDSS1;GAMT;OPLAH;MTHFS
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.33107602279764065,0.8344226177023643,0.694090382387022,0.9178015519788189,1.0,7/33,13.04%,TNF;PDGFB;SPI1;EGR1;GATA2;JUN;KLF4
prerank,regulation of cilium assembly (GO:1902017),-0.21592615104715676,-0.8340481382094955,0.8478260869565217,0.9027191515279561,1.0,11/62,11.89%,DCDC2;TBC1D19;USP6NL;YAP1;TBC1D2B;RABGAP1;TBC1D9B;IFT88;CEP97;SDCCAG8;IFT140
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3039953470069445,0.8339743285201324,0.7593406593406593,0.9181438685867314,1.0,10/64,12.48%,ELOB;POLR2E;ELOF1;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;SSRP1;POLR2K
prerank,positive regulation of hemostasis (GO:1900048),-0.3432232405541163,-0.8338125563105164,0.6896551724137931,0.9002276039511327,1.0,1/10,1.37%,ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),-0.3432232405541163,-0.8338125563105164,0.6896551724137931,0.9002276039511327,1.0,1/10,1.37%,ST3GAL4
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.24970625524801254,-0.8337984811873852,0.7880794701986755,0.897300322870306,1.0,14/29,25.89%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;OIP5
prerank,CENP-A containing chromatin organization (GO:0061641),-0.24970625524801254,-0.8337984811873852,0.7880794701986755,0.897300322870306,1.0,14/29,25.89%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;OIP5
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3229365772981516,0.8337520489750806,0.7213114754098361,0.9181219182373073,1.0,7/39,11.41%,MYO5A;PPFIA2;MYO7B;SYT4;MYO1F;HAP1;FNBP1L
prerank,mitotic DNA replication (GO:1902969),0.406801004475332,0.8333055681278355,0.6744827586206896,0.9184392557183122,1.0,7/10,38.70%,GINS3;CDC45;LIG1;MCM2;GINS1;MCM4;MCM3
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.31721329657259195,0.833095777907665,0.7372013651877133,0.9184004270758391,1.0,14/43,20.51%,IFITM1;DNAI3;ATP6AP1;NELL1;LRP3;TMEM119;ATRAID;FBXO5;BMP2;DDR2;SOX11;HGF;IL6;MEF2C
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.40397086937849774,0.8330754036622916,0.6847360912981455,0.91804636448738,1.0,3/10,18.20%,APEX1;DCLRE1C;TERF2IP
prerank,skeletal system development (GO:0001501),0.2888382664869929,0.832927494330194,0.8238866396761133,0.91790023712444,1.0,23/148,15.76%,RPL13;COL1A1;PPIB;BCAN;VKORC1;TGM2;RBP4;ETS2;ADAMTS4;HYAL2;BPNT2;HAPLN2;RFLNB;PRDX1;WNT5A;COL1A2;SOX9;BMP2;GJA1;XYLT1;VCAN;MMP14;IGF2
prerank,negative regulation of mRNA processing (GO:0050686),0.37949130043481394,0.8328303894280309,0.6916010498687664,0.9176696605920609,1.0,2/15,7.09%,PCBP4;SRSF9
prerank,phosphatidylcholine catabolic process (GO:0034638),0.40910361816355006,0.8324469437073557,0.6897506925207756,0.9178684957970632,1.0,2/10,9.89%,ENPP2;PLA2G7
prerank,establishment of endothelial barrier (GO:0061028),0.3350770106501376,0.831379713104239,0.7193396226415094,0.9192081324172592,1.0,6/29,14.82%,SOX18;MYADM;MSN;ROBO4;PECAM1;F2RL1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.35091649982242146,0.831350265246209,0.7210460772104608,0.9188642679020519,1.0,6/23,20.51%,AKAP6;NRG1;PROX1;MMP14;TGFB1;MEF2C
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3260333820591219,0.8312281117396327,0.7032181168057211,0.9186765006443243,1.0,8/31,20.65%,LSM6;LSM4;EXOSC2;POLR2G;EDC4;LSM7;EXOSC9;EXOSC4
prerank,nucleosome assembly (GO:0006334),0.33732649106412815,0.8312104659674271,0.7287735849056604,0.9183135789352397,1.0,6/31,16.80%,H3-3A;NPM1;BRD2;SOX9;IPO4;NAP1L2
prerank,sister chromatid segregation (GO:0000819),-0.24700248649893441,-0.8310249552677094,0.7441860465116279,0.9013633562512233,1.0,19/31,34.21%,TOP2B;INO80;CENPK;DSN1;KLHL22;SMC4;KIF18B;NDC80;TUBG1;MIS12;SGO1;SMC1A;PLK1;TUBG2;CDCA8;RB1;KIFC1;KIF18A;CHAMP1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.35220267780450715,0.8307711196148907,0.7115869017632241,0.9186535469079533,1.0,8/20,24.95%,ADSS1;GART;AK4;AK3;IMPDH1;PAICS;IMPDH2;ADSL
prerank,nucleosome organization (GO:0034728),0.30962199009156377,0.8306403416213741,0.740983606557377,0.9184860654013078,1.0,8/55,13.22%,H3-3A;VPS72;NPM1;ZNHIT1;BRD2;SET;H1-0;SOX9
prerank,amino sugar biosynthetic process (GO:0046349),-0.3123343986159457,-0.8304650726201831,0.6857142857142857,0.9009108940340902,1.0,4/12,18.91%,PGM3;RENBP;GFPT2;NAGK
prerank,apical junction assembly (GO:0043297),0.30759136286089034,0.8304446182976258,0.7334058759521219,0.9184140068732815,1.0,15/53,24.45%,CLDN5;RAMP2;RHOC;CLDN11;ESAM;PECAM1;RHOA;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;TBCD;ECT2
prerank,N-terminal protein amino acid modification (GO:0031365),0.3835940775192032,0.8302696858396946,0.6975476839237057,0.9183208438508919,1.0,4/14,15.54%,METAP1;METAP2;NAA10;PDF
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.31513638438724134,0.8298939814123169,0.7391786903440621,0.9185467277810986,1.0,15/44,28.23%,AKAP6;FLNA;KCNJ10;ATP1B2;KCNN2;KCNE5;ATP1B1;KCNMA1;ATP1B3;GABBR2;KCNJ3;KCNJ6;KCNMB4;KCNN4;KCNQ1
prerank,barbed-end actin filament capping (GO:0051016),0.36152234962815954,0.8298099463703476,0.7001287001287001,0.9179088955677551,1.0,8/18,23.75%,GSN;ADD2;CAPZA2;FLII;CAPG;SCIN;TWF1;TWF2
prerank,actin filament capping (GO:0051693),0.36152234962815954,0.8298099463703476,0.7001287001287001,0.9179088955677551,1.0,8/18,23.75%,GSN;ADD2;CAPZA2;FLII;CAPG;SCIN;TWF1;TWF2
prerank,magnesium ion transport (GO:0015693),0.38894627895769346,0.8296607485721655,0.6916010498687664,0.9177518990853654,1.0,6/12,30.54%,NIPAL4;MAGT1;NIPA1;NIPAL1;NIPAL3;MMGT1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.34695855987813645,0.8294768357348816,0.7037037037037037,0.9176799228822815,1.0,7/24,18.36%,CCL19;PTPRC;HTR2C;TRPM2;RYR2;ERO1A;ANXA6
prerank,myeloid cell development (GO:0061515),-0.28510795776550124,-0.8293868656269787,0.7211538461538461,0.9017239749295617,1.0,1/18,0.16%,FOXP1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3395786557820866,-0.8291310656502283,0.678082191780822,0.9007508928951852,1.0,3/10,16.25%,OGT;DGKQ;SIRT7
prerank,collagen fibril organization (GO:0030199),0.2947740453234895,0.8289320592362557,0.7866242038216561,0.9181743719847887,1.0,14/88,10.73%,COL1A1;CD151;PPIB;LUM;SERPINH1;PLEC;LOX;COL4A1;P4HB;COL3A1;COL6A1;LAMC2;COL9A1;COL1A2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.3990627711572752,0.8288305528914997,0.6985915492957746,0.917959022463871,1.0,1/11,1.37%,H3-3A
prerank,mitochondrial fusion (GO:0008053),0.35973901389426727,0.8288233370809126,0.7119289340101523,0.9175901091313055,1.0,7/18,24.87%,BAX;GDAP1;MIEF2;SPG7;MFF;FIS1;STOML2
prerank,inorganic anion transport (GO:0015698),0.3055056111086809,0.8272913195237332,0.7519294377067255,0.9196163120016313,1.0,8/53,13.12%,FXYD1;TTYH1;SLC26A4;SLC25A11;GLRA1;CLIC1;TTYH3;SLC11A1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.22772073026682343,-0.827277790716101,0.8405797101449275,0.9027474308280931,1.0,8/38,13.72%,CACNA1C;CAMK2D;ANK2;AKAP9;TRPM4;KCNJ2;CACNA1G;CACNA1D
prerank,mitochondrial protein processing (GO:0034982),0.39483287784873444,0.8270120815418649,0.7053941908713693,0.9196405780333007,1.0,3/11,14.50%,OMA1;PMPCB;SPG7
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.39175136449234443,0.8268100189658271,0.6834924965893588,0.9195854146855634,1.0,7/13,27.91%,LGMN;SHISA7;SQSTM1;ADCY8;APP;ZDHHC2;CHRNA7
prerank,toxin transport (GO:1901998),-0.33247552096409744,-0.8267700336335798,0.6913183279742765,0.9023067590152282,1.0,10/10,66.78%,ANTXR2;RAB29;ANTXR1;ANTXRL;SLC22A1;SLC22A3;SLC22A2;ADAM10;RAB40B;SLC29A4
prerank,regulation of cell aging (GO:0090342),0.40002432378024744,0.8265889845738225,0.6840659340659341,0.9195707953373489,1.0,5/11,25.17%,MIF;VASH1;LMNA;FOXM1;PNPT1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.372085591046236,0.8265875394141292,0.6936114732724902,0.9191898348545917,1.0,5/15,20.43%,NTRK2;HAP1;SORT1;SOS1;DDIT4
prerank,gliogenesis (GO:0042063),-0.29157163486557913,-0.826379878176584,0.7125506072874493,0.9016200349838105,1.0,2/15,7.03%,NFIB;CDK6
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.41198347413609404,0.8263402376781195,0.7064606741573034,0.9191770113013766,1.0,3/10,19.16%,SET;CTBP1;SNCA
prerank,response to cAMP (GO:0051591),0.3208698449594448,0.8259113362299485,0.7222870478413069,0.9194659350735287,1.0,7/37,17.86%,AKAP6;ZFP36L1;IGFBP5;AQP1;HCN1;DMTN;HCN3
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3760174504591175,0.8259083185205525,0.6978319783197832,0.919086707612146,1.0,3/15,14.49%,TREM2;NLRP2B;TLR6
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.40027307544767976,0.8258024427978391,0.6954674220963173,0.918875916597394,1.0,3/10,19.16%,AKT1;PMAIP1;SNCA
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3428930504049024,0.8257572526444535,0.7182587666263603,0.9185614815688873,1.0,8/26,25.24%,C1QC;GPR137B;LILRB3;CCL3;INHBA;MYC;MAFB;INHA
prerank,regulation of cell-matrix adhesion (GO:0001952),0.2991649589551634,0.8257388602453568,0.7675675675675676,0.9182085436344612,1.0,8/64,8.49%,ACTG1;ADAM15;EMP2;GPM6B;DUSP3;CORO1C;THY1;CLASP1
prerank,ether lipid metabolic process (GO:0046485),-0.3037020217603747,-0.8247292771517232,0.6653543307086615,0.9033196728844506,1.0,4/14,10.71%,AGMO;PAFAH1B1;FAR1;PEX7
prerank,cellular amino acid catabolic process (GO:0009063),0.2890268412196022,0.824399523694344,0.7666666666666667,0.9198990800513784,1.0,19/87,21.47%,BCAT2;GLUL;SDS;BCKDK;IDO2;ACAT1;CRYM;QDPR;SLC25A21;DDAH1;GLS2;GLS;ECHS1;NOS2;GLUD1;GOT1;SHMT2;GAD1;ALDH4A1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3497689290025177,0.8242623324724099,0.7308641975308642,0.91972824470146,1.0,4/23,11.17%,RACK1;VCP;RFX4;ULK3
prerank,signal peptide processing (GO:0006465),0.39883663378948997,0.8239864364467379,0.7125171939477304,0.9197596024313869,1.0,4/11,18.55%,SPCS1;CLN5;SPCS2;SEC11C
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2762467683501451,0.8235047830275973,0.9169169169169169,0.9201464928274,1.0,93/341,24.93%,PSMB4;UBXN1;PSME1;PSMB6;PSMB8;PSME2;PSMD2;PINK1;KCTD10;TOLLIP;PSMD1;UBE2G2;UCHL1;PSMC3;CTNNB1;TNFAIP3;PSMD6;VCP;PSMA7;CDC34;RNF187;ARRDC1;KCTD2;FBXL14;FEM1C;FEM1A;UBAP1L;NHLRC1;KCTD17;PSMD5;TRIM9;NEDD8;RBX1;OTUD7A;TNFAIP1;TRIM2;DDB1;RNF128;PSMB9;RBCK1;PSMD13;FBXW5;SYVN1;BUB3;PSMB3;VPS28;ZSWIM8;PSMB11;FBXW7;RNF150;RNF40;PSMB10;UBQLN2;SPSB3;KBTBD7;PSMB1;ARRB2;PSMB5;RNF7;SQSTM1;HERPUD1;RNF149;TRIM32;RLIM;VPS4A;VPS37C;PSMA6;RNF144B;TRIM13;KCTD13;RAD23A;RNF11;HECW1;PSMA4;KLHL25;SIRT2;STUB1;IFI27;DDIT3;UBXN11;AMFR;ELOC;FZR1;PSMD9;ZFAND2B;PSMC1;PCBP2;PTTG1;RNF126;UBQLN4;PSMD4;UBA1;CDC20
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.26318448492817637,-0.8234947907234537,0.7692307692307693,0.9042866624339455,1.0,4/20,7.19%,MCU;MICU1;MICU2;SLC8B1
prerank,histone exchange (GO:0043486),0.32303589961163937,0.8234500200202126,0.7398843930635838,0.9198423877415528,1.0,4/37,7.87%,VPS72;NPM1;ZNHIT1;CENPX
prerank,pinocytosis (GO:0006907),0.4110240832544585,0.823321823021418,0.678082191780822,0.9196827351253521,1.0,4/10,23.89%,DOCK2;SNX33;PYCARD;SNX5
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.404229741879359,0.8229782648428372,0.707977207977208,0.919832431660597,1.0,5/10,31.45%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1
prerank,regulation of chromosome segregation (GO:0051983),-0.2872732383916352,-0.8225584404269295,0.7180616740088106,0.9046127695402862,1.0,5/16,17.26%,CSNK2A1;CSNK2A2;NUMA1;PUM2;RMI2
prerank,protein import into peroxisome matrix (GO:0016558),0.39291538129467884,0.8225029125501655,0.7219917012448133,0.9202005390527571,1.0,6/12,35.64%,PEX5L;PEX6;PEX1;PEX14;PEX2;PEX13
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3731390134364293,0.8218934242575773,0.7067567567567568,0.9207533953147464,1.0,2/16,3.62%,SHFL;TNF
prerank,cellular protein modification process (GO:0006464),0.27273704511523716,0.8217424556729513,0.992,0.9205843808892152,1.0,268/982,26.80%,APOE;CST3;SPP1;PSMB4;ELOB;SPARCL1;C3;F13A1;LGALS1;PPP1CA;MT3;PARK7;LAMC1;LAMB2;MAPK3;PSME1;AKT1;PSMB6;CKAP4;PSMB8;PSME2;PNPLA2;COPS7A;PSMD2;RPN1;TGM2;RCE1;PINK1;IGFBP3;COPS6;IGFBP4;MFGE8;HSP90B1;FBXO15;METAP1;IGFBP5;KLHL9;PTPRC;PDGFB;ACVRL1;CTDSP2;CHEK2;SHISA5;PSMD1;RPN2;EPAS1;UBL5;PARP1;PDIA6;DAD1;PSMC3;PPP2R1A;PSMD6;LOX;CPE;CTDNEP1;PSMA7;LTK;DDOST;CDC34;PENK;MATK;FN1;CDK8;HIPK2;UBA52;ISG15;BRD2;DUSP26;P4HB;FN3KRP;COL3A1;EPB42;PKN1;PAK1;SGK1;PTK6;FBXL14;FEM1C;FEM1A;APLP2;UBE2M;TIMP1;MAST1;VWA1;PSMD5;NEDD8;LIPE;RBX1;METAP2;FBXO27;HS3ST5;AATK;PTPRN2;CTDSP1;DDB1;CAMK1;PAK3;PHPT1;HCK;BCKDK;ICMT;PRKAR1B;PSMB9;PLAT;PSMD13;CTBP1;B3GNT9;FBXW5;CHRM3;PSMB3;SERP1;WFS1;PTPRD;MXRA8;PSMB11;MAP3K21;CDK19;PTPRR;AMHR2;CDKL4;FBXO30;FBXW7;FBXO31;PTPRB;ASB13;PSMB10;YWHAZ;BMP2;TIMM50;CCL2;ST8SIA4;PTPRZ1;CDC42BPA;SPSB3;NEK10;STK11;EVPL;GAS6;KBTBD7;MAPK10;COPS8;PIGS;TSSK6;TSSK4;ALG3;VCAN;PDF;CDK5;PSMB1;ARF4;GMFB;PSMB5;ERO1A;RNF7;VHL;BRSK2;FUT9;EVA1A;PDP2;RBBP5;CSNK1G2;PPP2R5D;PIM3;PIK3CD;SCG3;PPM1J;B3GNT3;DUSP2;SYK;PDP1;MAP4K2;STT3A;WDR45;NOTUM;PPP3CA;ST6GALNAC2;PSMA6;MKNK1;TAB1;SLC35A1;GRK2;ST8SIA5;FBXL16;PTPN6;SKP1;TGFB1;IL6;PSMA4;QSOX1;PORCN;PPEF1;KLHL25;NEK1;PRSS23;CDK9;SSH2;PPP2R5A;BTBD6;SIRT2;GAD1;PAK5;PTPRU;PTPRO;KCTD7;PPM1F;PTPN5;QPCT;ENGASE;PTPN1;ELOC;MEN1;SCG2;B3GALT5;DUSP12;DUSP1;CDK10;CDK18;PSMD9;PTPRE;CCDC8;MGAT1;NUS1;WSB2;TGM7;PSMC1;B3GALT2;FBXO2;SOCS3;SBF1;PAK4;NPC1;RCN1;DYRK2;APP;PSMD4;PPP1CB;DYRK1B;DNAJC3;BAP1;LMTK3;CCN1;PRKCA;PRKACA;PRRT1;VRK1;FBXL3;DUSP6;FBXO32;LIPT1;AGA;PSMB2;MACROD2;DUSP8;TRIB1;MAP3K9;PIM1;CDK11B;TGFB2;PTPRT;KLHL21;PSMD10;MTMR6;OXSR1;FAM20B;RAB8A;LAMB1;CUL2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.22616672795440357,-0.8211837966709868,0.8584070796460177,0.9058020993401654,1.0,4/41,5.01%,PRKAG2;RANBP2;OGT;NUP98
prerank,protein methylation (GO:0006479),-0.225337092619625,-0.8208279644463861,0.811965811965812,0.9049778742566779,1.0,12/40,18.49%,NSD1;EHMT1;NSD3;CAMKMT;EHMT2;EZH2;CARM1;PRMT6;METTL22;SETD3;VCPKMT;METTL21A
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3411443398510584,0.8201014900347033,0.7272727272727273,0.9227191299088642,1.0,3/28,5.20%,C3;RAC1;SIRPA
prerank,regulation of spindle organization (GO:0090224),0.3547272355904658,0.8187010644017092,0.7096354166666666,0.9244772384936726,1.0,5/18,19.20%,CLTC;GNAI1;TACC3;DCTN1;RAE1
prerank,melanosome transport (GO:0032402),0.3568457463216442,0.8184804559849953,0.7157490396927016,0.9240435480979216,1.0,7/18,31.24%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MLPH;MREG
prerank,pigment granule transport (GO:0051904),0.3568457463216442,0.8184804559849953,0.7157490396927016,0.9240435480979216,1.0,7/18,31.24%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MLPH;MREG
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3622284644567023,0.817827451256475,0.6894736842105263,0.9246295583319124,1.0,2/17,10.75%,PLAAT3;PLA2G4F
prerank,regulation of protein sumoylation (GO:0033233),0.3628525998090453,0.8175998676895542,0.7109677419354838,0.9246021615280646,1.0,3/17,9.42%,PARK7;CTNNB1;EGR1
prerank,chromatin remodeling at centromere (GO:0031055),-0.2381645643025645,-0.817059625825825,0.8413793103448276,0.9106166186633285,1.0,14/31,25.89%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;OIP5
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.3516432735230165,0.8167272632229363,0.7104591836734694,0.9255727801921394,1.0,1/18,0.78%,APOD
prerank,extracellular transport (GO:0006858),-0.3148280233324827,-0.8166158964090291,0.6925925925925925,0.9099900226719709,1.0,9/12,30.12%,WWP2;SPAG17;TSG101;SPA17;DNAAF2;ROPN1L;CCDC40;ADCY10;DNAAF4
prerank,indolalkylamine catabolic process (GO:0046218),0.39298803008907707,0.8159786859679637,0.6777777777777778,0.9263678497798703,1.0,1/10,11.15%,IDO2
prerank,regulation of integrin activation (GO:0033623),0.37099927763380985,0.8159037889828907,0.7131979695431472,0.9261106084905211,1.0,4/15,18.75%,RASIP1;JAM3;SKAP1;FBLIM1
prerank,bile acid and bile salt transport (GO:0015721),0.3443573331945449,0.8157725276393262,0.7221510883482715,0.9259284665220306,1.0,5/24,20.19%,SLCO1C1;SLC10A3;SLC10A6;SLCO1B1;ABCC3
prerank,programmed necrotic cell death (GO:0097300),0.35530211856881044,0.8156566506444761,0.6993630573248407,0.9257208557341238,1.0,9/18,36.89%,ALKBH7;TICAM2;DNM1L;CD14;PGAM5;MLKL;PPIF;IPMK;ITPK1
prerank,regulation of phosphorylation (GO:0042325),0.2844891642681406,0.815539633747957,0.8253319713993871,0.9255050134221334,1.0,26/120,19.20%,HSPB1;PGAM1;DYNLL1;GRM5;EMP2;ANG;DSCAM;PIN1;MIF;CDKN1C;FN1;CORO1C;CD24;CADM4;ZBTB7A;SDCBP;CCDC88A;NUP85;NUP88;PTGES3;CDH5;PRKRIP1;NOP53;NUP50;INHBA;RAE1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.32659763415767995,0.8154535929347991,0.7252747252747253,0.925258951458589,1.0,6/30,14.82%,RAC1;ADGRG1;COL3A1;NET1;GPR18;F2RL1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.34050142096196734,0.8151607055261748,0.7216117216117216,0.9253357345156008,1.0,4/23,10.46%,ENDOG;FOXL2;HMGB1;H1-0
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.28248980952155517,-0.815032321882325,0.7456896551724138,0.9114730863575572,1.0,5/17,16.76%,IL18;STAT3;CD46;JAG1;CD55
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3244305051917492,-0.814880495305894,0.7016393442622951,0.9103192318656224,1.0,5/10,15.47%,DPYD;UPP2;UPB1;NT5C1A;NT5M
prerank,activation of phospholipase C activity (GO:0007202),0.32884817535647604,0.8145494621387144,0.7417840375586855,0.925848061557963,1.0,5/29,9.20%,NTRK2;ANG;C5AR1;P2RY6;P2RY12
prerank,positive regulation of isotype switching (GO:0045830),-0.29568027074301817,-0.8124680909501342,0.758893280632411,0.9134763311700644,1.0,3/15,7.14%,KMT5C;KMT5B;SHLD1
prerank,negative regulation of nuclear division (GO:0051784),0.40052792889389094,0.8124609713971755,0.7111416781292985,0.9286537525587358,1.0,3/11,17.78%,AURKAIP1;FBXO5;NANOS2
prerank,DNA packaging (GO:0006323),0.3661155314018677,0.812187399100398,0.7189973614775725,0.9286871155539772,1.0,3/16,11.65%,H1-0;NAA10;BANF1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.30832191703710055,0.8115193514158263,0.7660044150110376,0.9293499048132491,1.0,9/47,14.09%,AKT1;ZFP36L1;CDS1;RARRES2;CEBPB;LPL;ZFP36;BMP2;HNRNPU
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.38567556572447864,0.81151787506032,0.7138964577656676,0.9289696085248059,1.0,3/13,9.48%,RAN;AK4;AK3
prerank,calcium-mediated signaling (GO:0019722),0.28671103816643523,0.8113879705556194,0.797071129707113,0.9287886351918982,1.0,23/93,18.71%,RCAN3;PRNP;GRM5;PTPRC;CCR5;P2RX7;KDR;P2RY12;CHRM3;TRPM2;CXCR4;CX3CR1;NUDT4;SLC8A1;ATP1B1;RYR2;DMTN;CCL3;VCAM1;FKBP1B;BCAP31;CCR2;PPP3CA
prerank,acylglycerol biosynthetic process (GO:0046463),-0.2562344268253612,-0.811253133622801,0.7924528301886793,0.9142844585826819,1.0,3/23,3.66%,PLCE1;AGMO;PLA2G4A
prerank,regulation of gene silencing by miRNA (GO:0060964),0.29570346455084295,0.8112429085311375,0.7889009793253536,0.928614189090808,1.0,13/62,19.62%,H3-3A;POLR2E;POLR2D;POLR2F;ZFP36;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;RAE1;TGFB1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.30394444594155967,-0.8109568494154024,0.7379310344827587,0.9133997599277016,1.0,4/13,11.29%,FBN1;LTBP1;CD46;CHRDL1
prerank,glucan catabolic process (GO:0009251),0.36464242199880226,0.8108288987427436,0.6902536715620827,0.928879421191255,1.0,2/15,10.21%,CALM1;GAA
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3176235476153535,-0.8107071549364252,0.6892857142857143,0.9123749777593855,1.0,4/11,18.91%,PGM3;RENBP;GFPT2;NAGK
prerank,myofibril assembly (GO:0030239),-0.21636964167158385,-0.8104559097867292,0.8656716417910447,0.9113859498043014,1.0,7/42,14.75%,TMOD3;ACTN2;CFLAR;PDGFRB;TPM1;OBSL1;TNNT3
prerank,ruffle organization (GO:0031529),0.35998610202087705,0.8103571671923386,0.7245033112582782,0.9291942262797928,1.0,4/16,11.69%,RAC1;ARF6;CSF1R;AIF1
prerank,regulation of centrosome duplication (GO:0010824),0.32500173498445906,0.8102845573995916,0.7493917274939172,0.9289270564926103,1.0,6/29,16.22%,NPM1;CHMP2B;CHMP5;FBXW5;CEP131;CHMP1B
prerank,dendritic spine morphogenesis (GO:0060997),0.3718278964230646,0.8102513080644228,0.711436170212766,0.9285928439998149,1.0,5/15,23.39%,PAK3;DOCK10;EPHB1;CTNND2;WNT7A
prerank,mitotic cell cycle phase transition (GO:0044772),0.2749076396041969,0.8099745886795867,0.8906720160481444,0.9286209369416605,1.0,34/203,18.05%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;CCNI;CCND2;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CDC34;GPR132;CCND1;CLASP1;YWHAG;TUBB4A;TACC3;CEP131;USP29;CCNG1;DCTN1;SSNA1;HAUS2;USP26;DCTN2;ARPP19;BRSK2;CETN2;PRKAR2B;CCNJL;CDC25A
prerank,positive regulation of blood coagulation (GO:0030194),-0.28839501732428036,-0.8098386487369699,0.7656903765690377,0.9110455387826337,1.0,3/17,7.56%,ST3GAL4;ANO6;F3
prerank,cytoplasmic sequestering of protein (GO:0051220),0.37975482796208965,0.8088325068412047,0.7182320441988951,0.9299307083461041,1.0,2/13,5.39%,YWHAB;FLNA
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3558208677388199,0.8083991535956452,0.7244501940491591,0.9301689104995173,1.0,5/18,16.59%,CAMK1D;EPHA5;TSSK4;LRP8;ADCY8
prerank,early endosome to late endosome transport (GO:0045022),-0.2644963107841142,-0.8082609422758672,0.7577319587628866,0.9123749777593856,1.0,4/20,10.36%,STX8;EEA1;ANKRD27;KIF16B
prerank,plasma membrane tubulation (GO:0097320),0.3812831980993543,0.8080190638423833,0.7144754316069057,0.930358043728938,1.0,4/13,17.85%,PACSIN1;FNBP1L;SNX33;EHD2
prerank,establishment of epithelial cell polarity (GO:0090162),-0.271567755983217,-0.8077815449677838,0.7832512315270936,0.9117626809435945,1.0,5/19,14.62%,PARD3;SIPA1L3;OPHN1;MYO18A;MYO9A
prerank,response to molecule of bacterial origin (GO:0002237),0.2929701378288021,0.8077569041918343,0.793836344314559,0.9303381028015908,1.0,24/69,29.81%,C4B;S100A8;S100A9;TIRAP;TNFAIP3;HNRNPA0;CD24;SLC11A1;ERBIN;ADAM17;NOS2;CD14;SNCA;IL6;SIRT2;LBP;IRF5;TNFRSF11A;TRIB1;FZD5;GGT5;GGT7;IFNAR1;ACOD1
prerank,heterochromatin assembly (GO:0031507),0.34199736146003623,0.8073002719263328,0.7295918367346939,0.930649294811976,1.0,1/20,1.37%,H3-3A
prerank,RNA interference (GO:0016246),-0.278573148581816,-0.80624356895251,0.7838983050847458,0.9130975704630598,1.0,8/17,21.34%,DICER1;DROSHA;TERT;TARBP2;AGO2;CELF1;AGO4;CLP1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.30434781636858904,0.8058683093913815,0.7477477477477478,0.9324131361474869,1.0,7/46,9.92%,RAN;HCLS1;YWHAE;FLNA;HYAL2;TRIM28;CAMK1
prerank,regulation of mitochondrial fission (GO:0090140),0.33473535142275357,0.8056706281104953,0.7390761548064919,0.93232137029662,1.0,9/24,22.09%,PINK1;DCN;KDR;MAPT;MIEF2;MFF;DNM1L;FIS1;SPIRE1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.36266209752910655,0.8052033612076052,0.732824427480916,0.9326353351654231,1.0,5/17,20.29%,PTPRC;GJA1;HNRNPU;SOX11;THPO
prerank,"phototransduction, visible light (GO:0007603)",0.3691285574472047,0.8050684883491203,0.7235984354628422,0.9324460456751474,1.0,3/14,24.72%,GNA11;CNGB1;PDE6G
prerank,AMP metabolic process (GO:0046033),0.3679902672909262,0.8048859906266856,0.7207702888583218,0.9323547750504028,1.0,3/13,9.48%,ADSS1;AK4;AK3
prerank,cellular response to hexose stimulus (GO:0071331),0.3353021044355463,0.8043279500443267,0.7234848484848485,0.9328002261990495,1.0,2/23,3.46%,RACK1;GPER1
prerank,cellular response to fluid shear stress (GO:0071498),0.3835462076595299,0.8042396465441926,0.726530612244898,0.9325564686497757,1.0,3/12,20.51%,KLF2;KLF4;MEF2C
prerank,regulation of response to stress (GO:0080134),0.40147203224309647,0.8041805087354177,0.7303851640513552,0.932269775822347,1.0,2/10,16.59%,MLC1;ADCY8
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.3050951306802431,-0.8041758789208727,0.71875,0.9154674463225575,1.0,3/12,16.07%,IL18;CD80;IL17D
prerank,glial cell differentiation (GO:0010001),0.3256003003317361,0.8040229523785006,0.7453646477132262,0.9321360049512799,1.0,16/28,33.33%,MYRF;SOX8;SOX9;PTPRZ1;CDK5;EIF2B5;ERBB3;SOX11;SOX10;GPC1;MMP24;SHH;SOX4;CDH2;PAX2;RELN
prerank,protein localization to phagophore assembly site (GO:0034497),0.38679332924566395,0.8037327960603434,0.7253521126760564,0.9321680173396085,1.0,7/11,40.48%,ATG9A;WDR45;WIPI2;ATG13;PACS2;WIPI1;MFN2
prerank,primary alcohol metabolic process (GO:0034308),0.3325106093389043,0.803377775556259,0.7392373923739237,0.9323110668293213,1.0,9/25,30.72%,RBP4;GDE1;NAAA;LRAT;GDPD1;GDPD3;GPD2;ALDH3A2;ADH1A
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.34883297776351585,0.803327704797115,0.7343550446998723,0.9320122984648005,1.0,9/19,32.17%,MDK;GAS6;MMP14;SYK;PPP2R3C;XBP1;XRCC6;ZAP70;BTK
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3711507526941136,0.8032411837689445,0.7365038560411311,0.9317615588156073,1.0,5/14,21.55%,RTRAF;TSEN15;RTCB;TSEN54;CPSF4
prerank,DNA recombination (GO:0006310),0.31194028225088555,0.8032358960567291,0.7560975609756098,0.9313902266835831,1.0,9/37,25.54%,ENDOG;HMGB3;HMGB1;TSN;RECQL5;ERCC1;BLM;RPAIN;RAD51
prerank,bicellular tight junction assembly (GO:0070830),0.305642482124759,0.8028021541702954,0.7776536312849162,0.9316470044657784,1.0,13/46,24.45%,CLDN5;RAMP2;CLDN11;ESAM;PECAM1;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;TBCD;ECT2
prerank,glycerol metabolic process (GO:0006071),0.39630975560664505,0.802487013202579,0.7244897959183674,0.9317343590660555,1.0,4/10,27.51%,TPI1;PGP;GOT1;COQ2
prerank,filopodium assembly (GO:0046847),0.351184627781287,0.8024676151195176,0.7224489795918367,0.9313804448175985,1.0,2/16,7.74%,DNM3;ARHGEF4
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.33308188300019015,0.8022086450699535,0.7397769516728625,0.9313752189029909,1.0,8/25,20.23%,PARK7;H1-0;ZBTB7A;HEY1;TWIST1;SOX11;TGFB1;POU4F1
prerank,spliceosomal complex assembly (GO:0000245),0.30113747344776143,0.8018619249020975,0.765033407572383,0.9315070947484769,1.0,14/46,21.15%,SNRPG;DDX39B;SNRPD2;PUF60;SNRPE;SRSF9;PRPF19;SF3A2;SF3A3;CELF3;TXNL4A;SF3A1;SRSF1;SNRNP200
prerank,Wnt signaling pathway (GO:0016055),0.28598089254068787,0.8018412179931329,0.8237145855194123,0.9311580356310799,1.0,11/92,10.49%,RPS27A;UBC;UBB;FZD9;CTNNB1;CPE;SFRP5;UBA52;RBX1;CD24;WNT5A
prerank,regulation of DNA recombination (GO:0000018),-0.22384934282693025,-0.8014473428676775,0.8301886792452831,0.9189533006082422,1.0,10/32,20.69%,SETD2;SPIDR;SMARCAD1;MSH3;PPP4R2;KPNA2;RTEL1;SHLD2;ZCWPW1;SIRT6
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2239443963930355,-0.8014334507215658,0.8545454545454545,0.9175415122153875,1.0,4/41,5.01%,PRKAG2;RANBP2;OGT;NUP98
prerank,heart morphogenesis (GO:0003007),0.2970201994624309,0.8013973120521548,0.7574421168687983,0.9314308151974745,1.0,11/50,16.06%,ACVRL1;FKBP1A;HES1;ALPK2;DLC1;SOX17;SOX9;BMP2;LEFTY1;HEY1;RYR2
prerank,regulation of receptor recycling (GO:0001919),0.3589567427325156,0.8010575172068736,0.7256176853055917,0.9315640819063502,1.0,9/16,35.65%,VAMP3;RAMP3;SNCA;TRAT1;AP1AR;ECE1;ANXA2;LAMTOR1;NSF
prerank,regulation of vacuole organization (GO:0044088),0.3407245823871149,0.8008194500034286,0.7253164556962025,0.9315190668655469,1.0,4/20,16.18%,ENO1;IFT20;UBQLN2;ENO3
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.30983229154414144,0.8007946964565676,0.7777777777777778,0.9311768594192883,1.0,12/40,25.54%,NUCKS1;CENPX;DDX11;PCNA;TRAIP;MMS22L;ALYREF;CDK9;FAM111A;BLM;POLD1;RAD51
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3447878441721178,0.8005428179093979,0.7168597168597168,0.9311548317904874,1.0,5/20,25.06%,DCC;BAX;ERBB3;BAK1;BOK
prerank,defense response to protozoan (GO:0042832),0.37634869855773145,0.7992580374367919,0.7207702888583218,0.9326684392039084,1.0,4/12,24.06%,SLC11A1;PF4;BATF2;LYST
prerank,histone H2A monoubiquitination (GO:0035518),-0.2782164287254324,-0.7992491371364671,0.7795918367346939,0.9199361062120048,1.0,4/17,10.93%,BCOR;DDB2;PCGF5;CUL4B
prerank,male meiosis I (GO:0007141),-0.27361744339973404,-0.7984061691907752,0.7564102564102564,0.9199978858921535,1.0,12/16,43.03%,MYBL1;ING2;ZSCAN21;SYCP3;FOXJ3;SLC25A31;BRDT;MOV10L1;CCNA1;DNMT3L;MEIOC;BTBD18
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.34323636943791713,0.7983285549998592,0.7481203007518797,0.9336455949166061,1.0,9/21,26.18%,PSENEN;SPPL2B;BACE1;PSEN2;ADAM17;SPPL2A;ERAP1;APH1A;PRKCQ
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.36678852836940157,0.7981678358559724,0.7178807947019867,0.9334981650041296,1.0,6/14,32.72%,RASL10B;EDN3;CORIN;ENPEP;ECE1;ACE
prerank,regulation of phosphatase activity (GO:0010921),-0.25188513108268423,-0.7961925237283985,0.810126582278481,0.9223420664997312,1.0,8/24,17.34%,PPP6R3;URI1;PPP6R2;GPATCH2;SH3RF2;TSC1;ZCCHC9;SH2D4A
prerank,regulation of dendrite morphogenesis (GO:0048814),0.31283069485186316,0.7961184159705513,0.743801652892562,0.9360974072239837,1.0,10/32,22.68%,ADGRB3;YWHAH;KNDC1;IL1RAPL1;SS18L2;PTPRD;NSMF;HECW1;SS18L1;CHRNA3
prerank,protein polyubiquitination (GO:0000209),0.2668641990455018,0.7958474508113802,0.936,0.9361138316449465,1.0,43/297,13.37%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSMB8;PSME2;PSMD2;FBXO15;PSMD1;UBE2G2;ANAPC13;PSMC3;CTNNB1;DCAF15;TNFAIP3;PSMD6;UBE2Q1;PSMA7;MAGEL2;IRF2BP1;CDC34;RNF187;UBA52;FBXL14;NHLRC1;PRPF19;PSMD5;RBX1;FBXO27;TRIM2;PSMB9;RBCK1;PSMD13;FBXW5;SYVN1;PSMB3;PSMB11;FBXO30;FBXW7;FBXO31;PSMB10
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.3336331437675693,0.7958328635352084,0.7548543689320388,0.935758581755751,1.0,5/23,19.24%,HSP90AB1;CDC37;IFNGR1;NR1H2;IFNGR2
prerank,tRNA 5'-leader removal (GO:0001682),0.3668460605425742,0.7957969459075055,0.7433510638297872,0.9354337943978455,1.0,2/13,13.64%,POP7;POP4
prerank,neuromuscular process (GO:0050905),0.353586559985169,0.7953996375400922,0.7227979274611399,0.9356044171506166,1.0,3/16,16.01%,NRXN1;DCTN1;KCNA1
prerank,V(D)J recombination (GO:0033151),0.38416668849666563,0.7953470052483854,0.739612188365651,0.9352971834714643,1.0,3/11,24.14%,HMGB1;LIG1;TCF3
prerank,transcription preinitiation complex assembly (GO:0070897),-0.3005858582659048,-0.7950388929637869,0.7283018867924528,0.9227708710662419,1.0,7/12,34.25%,BDP1;GTF2A2;TAF7;TAF1;POLR1E;GTF2B;TAF7L
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3272741788114325,0.794449148741015,0.7435897435897436,0.9362803004729404,1.0,9/27,25.66%,CCL19;PDGFB;P2RY12;FLT1;AGAP2;TGFB1;FLT3;TEK;FGFR3
prerank,regulation of cellular pH (GO:0030641),0.3186200198621134,0.7936353630581068,0.7665876777251185,0.9370728647870484,1.0,3/29,5.39%,ATP5F1B;CA2;ATP6AP1
prerank,mesenchyme development (GO:0060485),-0.28513603697240636,-0.7935955965175532,0.7404255319148936,0.923832786421051,1.0,6/15,20.78%,TGFBR1;FGFR2;BMP4;WNT11;BMPR2;PKD2
prerank,protein monoubiquitination (GO:0006513),-0.22652592723076545,-0.793581989470897,0.8770491803278688,0.9224318828137755,1.0,9/36,18.77%,PRKN;UBE2R2;HUWE1;TOPORS;CDC73;UBE2E1;WAC;KLHL22;RNF20
prerank,positive regulation of telomere capping (GO:1904355),0.3493507752282668,0.7929751515317637,0.7558441558441559,0.9376383436150102,1.0,8/17,32.02%,MAPK3;MAPK15;MAP2K7;PNKP;PRKCQ;AURKB;HNRNPD;PKIB
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3807827611122389,0.7924932966861961,0.7185289957567186,0.9379355717618106,1.0,5/12,24.24%,TNF;NCOR2;TGFB1;ELAVL1;DND1
prerank,organelle assembly (GO:0070925),0.26322246486345524,0.7924192422167062,0.959,0.9376667053833934,1.0,68/384,20.66%,RPS23;RPS3;GABARAP;GSN;DYNLL2;DYNLL1;MAP1LC3B;NPM1;CD34;MAP1LC3A;EMC6;GABARAPL2;AUP1;CDS1;LSM4;IFT20;GABARAPL1;BSCL2;FLNA;ABCB6;CHMP2B;ATG9A;CORO1A;CNGA4;MAPT;CHMP5;CHMP6;FNBP1L;CEP131;FHDC1;TCTN3;VPS28;SAC3D1;VMP1;ANLN;ATXN2L;UBQLN2;FLII;EHD1;CSDE1;HAUS2;G3BP1;ATG101;TMOD1;ARF4;CIRBP;YTHDF1;MAPRE3;CHMP1B;CNGB1;TMEM17;E2F4;CCDC28B;EIF4ENIF1;TCTN1;EHD2;VPS4A;EXOC7;VPS37C;WDR45;NOTCH1;BBIP1;EXOC5;CFAP410;NEK1;CHMP7;CFAP54;CAPN3
prerank,positive regulation of bone mineralization (GO:0030501),0.31070276672404507,0.7922649328680637,0.7916181606519208,0.9375152435113157,1.0,13/35,21.57%,FZD9;GPM6B;ISG15;NELL1;P2RX7;TMEM119;ATRAID;ATP2B1;BMP2;SLC8A1;TGFB1;MEF2C;PTN
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.304002574818589,0.7919068081711048,0.7623873873873874,0.9376329368760076,1.0,8/39,16.42%,LGMN;DUSP3;SH3GL2;EPN1;ARHGEF7;SPRY1;SH3KBP1;DAB2IP
prerank,mRNA modification (GO:0016556),0.33316550394312683,0.7911348139340681,0.7579214195183777,0.9383551289313435,1.0,8/22,24.90%,PCIF1;CMTR1;TRUB2;DKC1;PUS7;TRMT10C;METTL3;METTL14
prerank,myoblast differentiation (GO:0045445),0.36366394879956876,0.790777029171801,0.7295514511873351,0.9384708291446938,1.0,2/14,4.70%,NRG1;EPAS1
prerank,chordate embryonic development (GO:0043009),0.29651752368691536,0.7904111639425867,0.8041125541125541,0.9386285561195669,1.0,10/55,15.76%,COL1A1;RBP4;FOXD3;PROX1;WNT5A;SOX8;PTPRR;BMP2;XYLT1;IGF2
prerank,sympathetic nervous system development (GO:0048485),0.36340218755580644,0.7903402774826017,0.7323568575233023,0.9383397878467722,1.0,4/15,19.75%,SEMA3F;CTNNB1;SOX11;TFAP2B
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.2582040363891508,-0.7903166057007781,0.815,0.9264926480095167,1.0,6/20,14.58%,TGFBR3;TGFBR1;PDCD4;RBPJ;BMP4;HEY2
prerank,positive regulation of ossification (GO:0045778),0.30620256297629156,0.790223696576439,0.7883295194508009,0.9381311369980339,1.0,15/39,21.57%,FZD9;GPM6B;ISG15;NELL1;P2RX7;WNT5A;TMEM119;ATRAID;ATP2B1;BMP2;SLC8A1;SOX11;TGFB1;MEF2C;PTN
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.334007751819331,0.7902176485080358,0.7691358024691358,0.9377613890150583,1.0,8/22,27.12%,CDKN1C;CEBPA;CAMK2N1;HEXIM1;TFAP4;MEN1;HHEX;CDKN1A
prerank,positive regulation of axon extension (GO:0045773),0.3358952018070478,0.7898864901314105,0.7557436517533253,0.937859573608327,1.0,5/22,13.83%,DSCAM;SEMA7A;MAPT;NTN1;SHTN1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.3613262893364364,0.7896231343843373,0.7506459948320413,0.9378514235159667,1.0,5/15,21.55%,RTRAF;TSEN15;RTCB;TSEN54;CPSF4
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.1753503564327577,-0.7895573554957429,0.9459459459459459,0.9263355569831885,1.0,25/109,20.26%,PTPN13;PITPNM2;PI4KA;MTMR3;PLA2G4A;PLEKHA4;PLEKHA2;MTMR11;PDGFRB;PIP5K1A;VAC14;SACM1L;PTEN;MTMR10;PIP4K2C;PLCD1;PIP4P2;PLEKHA8;PLA2G4C;PGAP3;PIGW;PLCG2;FGF2;PIP4K2A;INPP5B
prerank,regulation of DNA replication (GO:0006275),0.2966438538958515,0.7887661543572064,0.804851157662624,0.9386976547896908,1.0,9/49,14.45%,S100A11;TERF1;ACVRL1;PPP2R1A;NUCKS1;GMNN;PCNA;FBXO5;CCDC88A
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2632269787701488,0.7884553535010652,0.983,0.9387712338489199,1.0,114/476,23.39%,APOE;CD74;CXXC1;SPP1;COL1A1;ACTA2;MT3;HNRNPAB;ATF4;AKT1;KLF2;SOX18;ERBB4;NPM1;LYL1;AGT;ETS2;TNF;NR1D1;PDGFB;ACVRL1;CHEK2;YWHAH;CTNNB1;HES1;CDKN1C;HIPK2;RHOG;RNF187;OTX2;FOXF2;BRPF1;CEBPB;TRIM28;EDF1;FOXL2;SEC14L2;MLXIPL;EGR1;JUN;KARS1;MYRF;WNT5A;APBB1;NPAS3;ATF5;POU3F1;SOX17;WBP2;SOX8;IRF7;KLF4;SOX9;PAX3;NME2;BMP2;RAI1;ATMIN;UBE2V1;NUP85;MED30;NR1H2;MAPRE3;EBF3;HEY1;NCF1;ING1;VHL;GATA4;GLIS2;SKAP1;PCID2;MRPL12;USP22;BRCA2;PPARGC1A;CNBP;MAP2K2;SFRP1;MAZ;SOX11;HMGN5;INHBA;TGFB1;CD86;ESRRB;TFAP2B;LBH;ING5;IL6;NOTCH1;FOXA2;CITED2;MEF2C;FZD1;CAPN3;MYC;TFAP4;FZD2;ID2;SOX10;MAP2K7;ZXDC;DDIT3;SS18L1;ESRRG;REST;BLM;MAFB;KLF6;PSMD9;SFR1;SP3;WNT7A
prerank,negative regulation by host of viral process (GO:0044793),-0.32022049724276686,-0.7884453845492775,0.7492163009404389,0.9267495917341119,1.0,3/10,9.97%,PRKN;EIF2AK4;CCNK
prerank,glycogen catabolic process (GO:0005980),0.3528012233398409,0.7883105694865493,0.7192513368983957,0.9385998428733855,1.0,2/15,10.21%,CALM1;GAA
prerank,cellular polysaccharide catabolic process (GO:0044247),0.35005047110302334,0.7882184101044747,0.7172774869109948,0.9383508708392085,1.0,2/16,10.21%,CALM1;GAA
prerank,long-chain fatty acid import into cell (GO:0044539),0.38661150677613687,0.7878789759864905,0.7146974063400576,0.9384718896102557,1.0,1/10,2.60%,SLC2A1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.37591022642472116,0.7869750486449449,0.7424657534246575,0.9393911168820618,1.0,3/11,16.17%,GPM6B;LEPROT;SNX33
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3000996382228939,0.7869624216184518,0.7831858407079646,0.9390315113418559,1.0,11/46,19.71%,LAMC1;LAMB2;RAC1;FN1;VAMP3;RHOA;SRCIN1;TYRO3;TMEFF2;LPXN;EFNA1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.34245918710489703,0.7866412592440787,0.7760416666666666,0.9391137035835209,1.0,5/18,16.48%,GPR137B;FBXW7;LILRB1;LILRB3;CCL3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.30058388371901934,-0.7855968721004809,0.7451612903225806,0.9300023538215021,1.0,4/11,18.10%,STAT3;PUM2;LIMD1;FMR1
prerank,DNA metabolic process (GO:0006259),0.26624221251858216,0.7853018333744579,0.9469469469469469,0.9405783908671969,1.0,59/270,25.84%,RPS27A;UBC;UBB;PARK7;TERF1;NPM1;ENDOG;RAN;RNASEH2A;LTO1;PARP1;MCM5;HMGB3;VCP;RPA2;CDC34;UBA52;GMNN;TRIM28;DDB1;HMGB1;NEIL1;RNASEH1;APEX1;PCNA;NSMCE3;POLE4;CHRNA4;RFC2;TSN;PTGES3;RECQL5;GLRX2;POLD4;MUS81;CNBP;CTC1;TERF2IP;NOP53;RFC4;GADD45A;POLG;ERCC1;ZNF445;MEN1;BLM;CDC45;LIG1;LONP1;PNKP;POLD1;BARD1;ATRIP;DOT1L;RPAIN;RPA3;RAD51;XPC;UBE2A
prerank,regulation of peptide hormone secretion (GO:0090276),0.2877309346587372,0.7851650345693207,0.8118918918918919,0.940385048153293,1.0,13/67,19.80%,UQCC2;MTNR1B;SLC2A1;SNAP25;TNF;CACNA1A;HTR2C;RASL10B;ABCC8;SLC2A2;NOS2;TFAP2B;IL6
prerank,protein deacylation (GO:0035601),0.33005084165629195,0.785111362265706,0.7692307692307693,0.9400775458934651,1.0,5/23,20.78%,LYPLA2;ABHD17A;HDAC5;NOTUM;SIRT2
prerank,regulation of stem cell population maintenance (GO:2000036),0.3397190910518623,0.784114984779509,0.7535483870967742,0.9411000633302107,1.0,6/18,23.79%,TAF5L;ESRRB;MYC;PTN;REST;ELAVL1
prerank,dephosphorylation (GO:0016311),0.27072603645662,0.7839461100384975,0.891260162601626,0.9409609513263687,1.0,53/147,26.51%,PPP1CA;PTPRC;CTDSP2;DUSP3;PPP2R1A;CTDNEP1;DUSP28;DUSP26;PTPRN2;CTDSP1;PHPT1;PTPRD;PTPRR;PTPRB;TIMM50;PTPRZ1;STK11;PDP2;PPP2R5D;PPM1J;NT5C;DUSP2;PLPP6;PDP1;PPP3CA;TAB1;PLPPR2;PTPN6;PPEF1;PGP;SSH2;SGPP1;PPP2R5A;SGPP2;PTPRU;PTPRO;PPM1F;PTPN5;DUSP23;PTPN1;DUSP12;DUSP1;PTPRE;DUSP15;PNKP;SBF1;PPP1CB;ACP2;PLPPR4;DUSP6;DUSP8;PTPRT;MTMR6
prerank,histone H2A acetylation (GO:0043968),-0.27122333668553356,-0.7839178299481679,0.7738095238095238,0.931396226601311,1.0,4/16,12.20%,EPC1;NAA40;EP400;BRD8
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3208308474434033,0.783693860760328,0.7917675544794189,0.9409411590690011,1.0,6/27,15.69%,AGT;ABCG1;LPL;MSR1;PF4;NR1H2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3679812351691886,0.7829479165735714,0.7396694214876033,0.9415821854695635,1.0,2/12,4.03%,IGFBP5;PDGFB
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.2998913633364111,-0.7825817600186498,0.7454545454545455,0.9321406674075848,1.0,5/12,25.62%,BDH2;GGCT;GGT1;GCLC;MGST2
prerank,serine family amino acid metabolic process (GO:0009069),0.34915821759879084,0.7823925029778844,0.7637795275590551,0.9419755785124257,1.0,4/16,20.62%,SARS1;GLYAT;SEPSECS;SHMT2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.31302000824428566,0.7823686604244616,0.7743830787309048,0.9416368648201344,1.0,8/29,19.83%,TGM2;EPOR;VAV1;ERBIN;MMD2;RASGRP1;RASGRF1;NOTCH1
prerank,protein localization to centrosome (GO:0071539),-0.2722585315345383,-0.7822694799112948,0.7711864406779662,0.9312899449519859,1.0,6/17,20.76%,GOLGB1;PCM1;PIBF1;C2CD3;CCDC14;CEP192
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.31099185779413996,0.7821836513234247,0.7614571092831962,0.9415182965657644,1.0,10/31,26.34%,RPS2;PINK1;PIN1;FBXW7;ARRDC3;SKP1;MAGEC2;FZR1;CDC20;TRIB3
prerank,base-excision repair (GO:0006284),0.2937804682994175,0.781448389990625,0.7928730512249443,0.9421279428652577,1.0,15/48,25.21%,PARP1;RPA2;NEIL1;APEX1;PCNA;RFC2;POLD4;NEIL2;ERCC6;RFC4;POLG;LIG1;PNKP;POLD1;RPA3
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.27586347167142866,0.7814409115352345,0.8530020703933747,0.9417610003863918,1.0,35/95,26.32%,BGN;BCAN;LUM;FMOD;HEXA;DCN;HS3ST6;HS3ST5;CHST1;B4GALT6;SDC4;GPC5;CHPF2;B3GAT3;CHPF;UGDH;XYLT1;VCAN;HSPG2;B3GNT3;SDC3;CHSY3;HS3ST2;AGRN;CSGALNACT2;HS6ST1;ACAN;PRELP;B4GALT3;CHST14;CHST9;CSPG5;GPC1;HS6ST2;ABCC5
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2016782694642072,-0.7813062020016317,0.9014084507042254,0.9314834783892977,1.0,20/61,22.57%,ACVR1;MNAT1;CRLF3;CDK6;NASP;CUL4B;CUL4A;LATS2;PHF8;PPP6C;CDK7;HINFP;USP37;CUL5;PLK2;POLE;CACUL1;KHDRBS1;PIM2;RPS6KB1
prerank,liver development (GO:0001889),-0.23183704936096555,-0.7807361670411304,0.8364779874213837,0.9310028289042116,1.0,5/32,9.08%,TGFBR3;COBL;ARID5B;MET;NPHP3
prerank,sterol biosynthetic process (GO:0016126),0.30748794231009396,0.7803981931619413,0.7883040935672515,0.9428212558933449,1.0,13/33,28.73%,LSS;DHCR24;ACAA2;SC5D;CH25H;PLPP6;FDPS;PMVK;NSDHL;ACLY;INSIG2;EBP;HMGCS1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3197045068853495,0.780176238699694,0.7777777777777778,0.942751017192542,1.0,6/26,17.68%,AKT1;CCND2;CCND1;AIF1;ADAMTS1;ADAM17
prerank,chromatin assembly (GO:0031497),0.30336632423493093,0.7799619820069557,0.8022598870056498,0.9426573093150327,1.0,6/38,16.80%,H3-3A;NPM1;BRD2;H1-0;SOX9;NAP1L2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.32329366611031907,0.7793915521549191,0.7710109622411693,0.9430251230055385,1.0,12/25,31.51%,APRT;GART;PNP;PRPS1L1;PRPS1;PAICS;SHMT2;PRPSAP1;ADSL;ADA;DGUOK;DCK
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.30346592686480617,-0.7789067441733349,0.752542372881356,0.9325012551125443,1.0,2/11,5.71%,FRS2;EFNB2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.3585809938790406,0.7787346282922522,0.7597315436241611,0.9435621983575976,1.0,4/14,21.03%,CCL19;CD86;NLRP3;NFKBID
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.28286223085259304,-0.7783620571835939,0.7651821862348178,0.931933533209291,1.0,5/14,16.50%,GAB1;NRP1;VEGFB;VEGFC;VEGFD
prerank,establishment of vesicle localization (GO:0051650),0.3393853760756878,0.7782018374120089,0.7392996108949417,0.9439012411666494,1.0,7/18,31.26%,SYT11;KIF5A;CDK5;KIF5C;TESK1;IKBKG;SPG11
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.3042907177659102,-0.778129116472896,0.7612456747404844,0.9309089552013927,1.0,4/12,14.31%,YTHDC1;CDYL;PCGF5;SMCHD1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3385792620327823,0.7778453116762578,0.758800521512386,0.944019769690675,1.0,4/17,18.20%,TERF1;NEIL1;NEIL2;TERF2IP
prerank,negative regulation of insulin secretion (GO:0046676),0.34628447622983893,0.7776267478606224,0.759526938239159,0.9439311327434006,1.0,7/17,23.21%,CHGA;PIM3;SFRP1;INHBB;REST;CCN3;PSMD9
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3308058932336457,0.7775636877593615,0.774869109947644,0.9432621844156794,1.0,4/21,9.84%,PARP1;RPA2;RBX1;DDB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3308058932336457,0.7775636877593615,0.774869109947644,0.9432621844156794,1.0,4/21,9.84%,PARP1;RPA2;RBX1;DDB1
prerank,negative regulation of cellular protein localization (GO:1903828),0.3051006130674683,0.7774096106886661,0.7858796296296297,0.943100526351278,1.0,6/34,11.49%,MAP1A;SPI1;GPM6B;LEPROT;MAPT;DNAJA1
prerank,regulation of anoikis (GO:2000209),-0.2596078096551392,-0.7770860678922553,0.793859649122807,0.9311640350785668,1.0,5/19,13.34%,ITGA5;TLE1;SIK1;PTK2;BCL2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.25998477725177815,0.776916726472883,0.982,0.943366316977908,1.0,92/417,20.88%,HSPA8;PFDN5;CALR;MT3;NDUFA13;TMPRSS6;ID3;NRG1;SOX18;ID1;CRYAB;EID1;CCDC85B;TNF;NR1D1;PDGFB;SPI1;ENO1;TLE5;CTNNB1;HES1;MAGEL2;EID2;CDKN1C;TBX22;NCOR2;GMNN;ARID4A;TRIM28;CREBZF;FOXL2;CEBPA;BASP1;PROX1;RBM15B;IKZF1;MLXIPL;MLX;CDK5R1;SET;JUN;BHLHE41;WNT5A;CTBP1;ZBTB7A;ATF5;L3MBTL4;BCL7A;SNW1;SOX8;MAEL;THRA;KLF4;SOX9;YWHAQ;HDAC5;HEXIM1;BMP2;NONO;FOXS1;GAS6;ZC3H8;L3MBTL1;SAMD11;CDK5;NR1H2;HEY1;DAB2IP;TCEAL7;TWIST1;HDAC9;GLIS2;PAX9;COMMD7;RLIM;ZHX1;CCAR2;SFRP1;CIR1;QARS1;ZBTB14;TGFB1;TFAP2B;LBH;NOTCH1;BEND5;CITED2;SAMD1;CAPN3;CBX3;SIRT2;TFAP4
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.38519303177098907,0.7769106581443772,0.747887323943662,0.9430015415204899,1.0,4/10,22.89%,B3GAT3;XYLT1;CSGALNACT2;B3GAT1
prerank,mitochondrion distribution (GO:0048311),0.3678134730343908,0.7768031401920517,0.7847222222222222,0.9427810461982735,1.0,5/12,18.66%,MAPT;HAP1;DNM1L;ATCAY;ARMC1
prerank,tRNA wobble base modification (GO:0002097),0.3600514479422976,0.7767590614954365,0.7661623108665749,0.9424720618357534,1.0,6/14,24.99%,DPH3;ELP3;CTU1;URM1;ADAT2;CTU2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.34720638600231135,0.7766195216682614,0.7694267515923567,0.9422853299592291,1.0,7/17,33.61%,MPDU1;DOLK;ALG3;NUS1;DPAGT1;ALG6;ALG2
prerank,secretion (GO:0046903),-0.2815967084893793,-0.7764566351411083,0.78515625,0.9307567951005526,1.0,3/14,14.41%,SLC22A4;SLC22A6;PRKCI
prerank,regulation of defense response to virus (GO:0050688),0.3652965053192389,0.7762743295358668,0.7852161785216178,0.9423760316991067,1.0,7/14,30.59%,TNFAIP3;ELMOD2;TRAF3;PCBP2;C1QBP;DHX9;IFNLR1
prerank,regulation of muscle cell differentiation (GO:0051147),0.3120119134609653,0.7762665443450814,0.7990487514863258,0.9420142854077651,1.0,12/31,25.15%,CTNNA2;BNIP2;CTNNB1;CAMK1;MAPK11;IGF2;HDAC9;CDK9;MEF2C;ID2;TCF3;SRF
prerank,homocysteine metabolic process (GO:0050667),0.3785222477778294,0.7762105754427815,0.7693389592123769,0.9417095412775385,1.0,2/11,16.04%,MPST;TST
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.34087225263781346,0.776068052844654,0.7383798140770252,0.9415306838216205,1.0,6/17,28.15%,PODXL;P2RY12;SKAP1;SYK;TGFB2;CD3E
prerank,nuclear export (GO:0051168),0.2772362989190961,0.7753882970416263,0.8335123523093448,0.9420860170249387,1.0,17/80,20.12%,CALR;MAGOHB;MAGOH;DDX39B;RAN;SRSF9;XPO1;SRSF2;HNRNPA1;THOC3;EIF4A3;U2AF1L4;RAE1;TGFB1;DESI1;SRSF1;ALYREF
prerank,negative regulation of cilium assembly (GO:1902018),0.36281613247013605,0.7751905409012008,0.7440890125173852,0.941978346382827,1.0,7/12,29.65%,CCP110;EVI5L;CDK10;TESK1;TBC1D7;TCHP;MAP4
prerank,telomere maintenance (GO:0000723),0.2888179615303147,0.7745020200234279,0.8099447513812155,0.942544160655636,1.0,18/50,30.71%,TERF1;LTO1;PARP1;RPA2;APEX1;PCNA;PTGES3;POLD4;CTC1;TERF2IP;BLM;POLD1;RPA3;RAD51;XRCC6;DNA2;SMC6;POLD3
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.2922012025397312,0.7742189408500301,0.8085585585585585,0.9425415715261807,1.0,8/47,16.92%,ACADVL;APOC1;CD34;SIRPA;PROX1;FBXW7;ABCA2;CAV1
prerank,organic acid transport (GO:0015849),0.27377025292518165,0.7736472876098988,0.8525773195876288,0.9429251195489087,1.0,23/94,26.88%,SLC38A5;SLC1A4;SLCO1C1;SLC25A29;SLC6A6;MFSD2A;SLC25A11;SLC3A2;SLC10A3;SLC7A14;SLC19A1;FOLR2;SLC16A1;SLC10A6;SLCO1B1;ABCC3;SLC7A10;SLC25A14;SLC7A6;SFXN5;SLC43A2;SLC38A3;SLC13A5
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2890644566628042,0.77362171138811,0.8006681514476615,0.9425841695576478,1.0,12/48,19.80%,TREM2;PTPRC;ISG15;NLRP2B;GAS6;F2RL1;NR1H2;SIGIRR;SLIT3;TRAIP;OAS3;IL6
prerank,retinol metabolic process (GO:0042572),0.35636068804698773,0.7732667538133614,0.7422402159244265,0.9426847106563621,1.0,2/14,16.38%,RBP4;LRAT
prerank,neuromuscular junction development (GO:0007528),0.3223098072831673,0.772675539989918,0.7822277847309136,0.9431307562884869,1.0,6/24,13.03%,ANK3;LRP4;MUSK;GPHN;DOK7;DCTN1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.38031463424778145,0.772609140210182,0.7747489239598279,0.9428618894185553,1.0,1/11,3.53%,CANX
prerank,intestinal absorption (GO:0050892),0.356996695807274,0.77229794278039,0.7580645161290323,0.9429076395287772,1.0,7/13,42.47%,SLC2A2;KCNQ1;CD36;SLC26A6;F11R;UGCG;ADRA2A
prerank,protein O-linked glycosylation via serine (GO:0018242),0.3773768009673949,0.7721651522351762,0.7661623108665749,0.9427187865339998,1.0,5/10,36.37%,POGLUT3;GALNT13;GALNT2;POGLUT1;GALNT3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3070022918719939,0.7721085425075225,0.7817745803357314,0.9424279043199602,1.0,14/29,35.43%,LSM6;LSM4;EXOSC2;EDC4;LSM7;EXOSC9;EXOSC4;LSM5;LSM2;CNOT8;HBS1L;EXOSC3;CNOT6;DCPS
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.2864549233806228,-0.7717563897892434,0.7701149425287356,0.9365239067899386,1.0,4/12,14.92%,ELF1;ELF2;CBFB;PTPN22
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.20363942787845907,-0.771486796196341,0.9368421052631579,0.9354968566901131,1.0,16/48,22.39%,PRKAG2;RANBP2;OGT;NUP98;PRKAG1;AAAS;NUP214;NUP35;TIGAR;NDC1;JMJD8;NOA1;NUP62;TPR;NUP93;NUP160
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.2915644469685889,-0.7706763841690015,0.7455197132616488,0.9352142049610285,1.0,3/12,7.62%,SDK2;STAT3;CEP290
prerank,regulation of hemopoiesis (GO:1903706),-0.31144050252656946,-0.7705476933399709,0.8032786885245902,0.9339684634957159,1.0,5/10,16.07%,CREBBP;MYSM1;CBFB;PRKCB;IL17D
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.37273637334476584,0.7702208202972586,0.7583001328021248,0.9445614928357488,1.0,4/11,26.61%,CTNNB1;WNT5A;FZD1;WNT2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3206756396846413,0.7701846618797439,0.779126213592233,0.9442343050675438,1.0,3/24,7.89%,H3-3A;SPI1;CREBZF
prerank,positive regulation of histone modification (GO:0031058),0.30714131000920664,0.769722443725268,0.7952662721893491,0.9444900149921558,1.0,8/33,27.30%,MAPK3;APLNR;CTBP1;PPARGC1A;CDK9;SAP30BP;PAXIP1;RUVBL2
prerank,regulation of TORC1 signaling (GO:1903432),0.3034734220023962,0.7693508459669924,0.7875894988066826,0.9445924982764469,1.0,8/33,16.43%,LAMTOR5;GPR137B;PIP4P1;PIH1D1;GPR137C;STK11;RRAGC;RRAGD
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.36582480084616875,0.7693252434085668,0.7777777777777778,0.9442595952275505,1.0,3/11,13.07%,ELOF1;SERTAD1;ZMIZ2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.2789631743241772,-0.7685889835674127,0.8202247191011236,0.9355503561207578,1.0,6/14,18.79%,DPYD;UPP2;UPB1;NT5C1A;NT5M;DHODH
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3057457371210992,0.7683744463547632,0.7837209302325582,0.9451258572963893,1.0,6/31,13.65%,GPNMB;FAM107A;JADE1;CDK2AP2;KLF4;CCL2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.32566953539632343,0.7683713385926527,0.7774936061381074,0.9447603077763911,1.0,8/20,22.77%,ZFP36L1;ZFP36;PRMT1;PF4;HSPA9;MEIS2;HOXB8;MAFB
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.2427200221824162,-0.7674193177092977,0.8418079096045198,0.9358438088524232,1.0,9/23,24.20%,CAMK2D;ANK2;ATP1A2;DIAPH1;NOS1AP;NOS1;PTK2B;CASQ1;CACNB1
prerank,organic cation transport (GO:0015695),-0.25165558613193495,-0.767264387400054,0.827906976744186,0.9347055542561039,1.0,5/20,16.67%,SLC47A1;SLC22A4;SEC14L1;SLC25A26;SLC22A18
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.2672845875618585,-0.7672480756530135,0.8064516129032258,0.9333260463183637,1.0,3/15,8.50%,DAB2;SMAP1;AAK1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.24781880339229106,-0.7670689701359613,0.8215962441314554,0.9322308564496427,1.0,10/21,28.01%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.30173173276095644,0.767052300612618,0.7935409457900807,0.9461600659450348,1.0,6/33,13.65%,GPNMB;FAM107A;JADE1;CDK2AP2;KLF4;CCL2
prerank,amino sugar metabolic process (GO:0006040),-0.31070282205587785,-0.7659110716929437,0.7610921501706485,0.9324746394147418,1.0,4/10,23.70%,ST6GAL1;GNE;GFPT2;FN3K
prerank,renal system development (GO:0072001),0.282044100012123,0.7657526382732255,0.8122977346278317,0.947492242256013,1.0,8/52,11.96%,RBP4;AGT;LRP4;HYAL2;C1GALT1;PROX1;SOX17;WFS1
prerank,ncRNA metabolic process (GO:0034660),-0.2169430475189781,-0.7655414925191144,0.8461538461538461,0.9316207573856747,1.0,11/37,18.29%,TENT4B;DICER1;PARN;DROSHA;ZCCHC8;TUT7;DDX17;TUT4;TARBP2;AGO2;DTD2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.29937017751445577,0.7650291952783045,0.8095781071835804,0.9480965008688745,1.0,10/40,19.83%,MDK;COL1A1;CTNNB1;BMP2;SDCBP;TIAM1;TWIST1;TGFB1;IL6;NOTCH1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.20730566914414494,-0.7647441113901848,0.9611650485436893,0.9314752458044795,1.0,12/49,13.83%,OGA;PRKN;RNASE3;ADAMTS9;SIDT2;NGLY1;STT3B;RIPK1;DNASE1L1;DENND3;MTREX;MANBA
prerank,fat cell differentiation (GO:0045444),0.28263891198356667,0.7644457741381809,0.8322440087145969,0.948502125571948,1.0,16/57,20.68%,PSMB8;BSCL2;STEAP4;CEBPA;SDF4;CTBP1;IL11;ZBTB7A;ATF5;SOX8;KLF4;CLIP3;TRIM32;PPARGC1A;TFAP2B;INHBB
prerank,eye photoreceptor cell development (GO:0042462),-0.26523335879906773,-0.7644151237280441,0.7677165354330708,0.9305727528437545,1.0,3/15,9.42%,CEP290;RPGRIP1L;TOPORS
prerank,endocrine system development (GO:0035270),0.3313160446389313,0.7642117148657803,0.7830882352941176,0.9484365105169117,1.0,1/21,1.22%,MDK
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2752667801018809,0.7640957211692438,0.8738170347003155,0.9482101143938058,1.0,20/80,21.16%,CCL19;NLGN1;RAC1;TENM2;PFN1;P2RX7;KCTD17;P2RY12;DEF8;FNBP1L;HRAS;ANLN;CCDC88A;F2RL1;ARPC2;RAC2;GPM6A;AGRN;CDC42EP2;CCP110
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.30882474322537756,0.7639128589680435,0.7865707434052758,0.9480809636677987,1.0,11/27,31.99%,HTR2C;GRM1;GPR18;F2RL1;F2RL3;C3AR1;GPR17;OPRL1;F2RL2;GPR35;DRD2
prerank,membrane lipid biosynthetic process (GO:0046467),0.2827795627892702,0.763858095381928,0.8335170893054025,0.9477889330383755,1.0,27/58,32.98%,CERS2;ELOVL1;ELOVL2;ELOVL7;SPTLC1;DEGS1;SCCPDH;CSNK1G2;FA2H;SPTSSA;VAPA;SPHK2;SGPP1;SGPL1;SGPP2;ELOVL6;ALDH3B1;VAPB;HACD4;SAMD8;CERT1;ALDH3A2;CERS6;SPNS2;ELOVL4;ST8SIA6;ELOVL5
prerank,negative regulation of autophagosome assembly (GO:1902902),0.35470871704378326,0.7638533330016358,0.7606951871657754,0.9474247650209175,1.0,2/13,8.96%,PINK1;NUPR1
prerank,amino acid import (GO:0043090),0.32656051644831335,0.7638437184198367,0.7744845360824743,0.9470695921705943,1.0,4/21,12.80%,SLC7A5;TSPO2;SLC6A6;SLC1A1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.18224679120770293,-0.7636341175492074,1.0,0.9303173168065934,1.0,23/83,20.36%,ACVR1;BRD4;MNAT1;CRLF3;CDK6;NASP;TFDP1;CUL4B;CUL4A;LATS2;PHF8;ORC1;PPP6C;NPAT;CDK7;HINFP;USP37;CUL5;PLK2;POLE;CDK17;CACUL1;KHDRBS1
prerank,regulation of GTPase activity (GO:0043087),0.25974727928181257,0.7632309133399512,0.9203629032258065,0.9474926813392471,1.0,35/177,18.46%,RACK1;SOD1;CCL19;S100A10;TGM2;RASIP1;NTRK2;PIN1;CAV2;STMN3;ARHGAP9;ARHGAP15;TMED2;THY1;RRP1B;GPR137B;NET1;EPHA5;RGS10;ARHGEF7;DOCK10;HRAS;VAV1;VAV3;DOCK8;CCL2;F2RL1;ARL2;RASGRP1;DAB2IP;CCL3;ADCYAP1;CCL8;RASGRF1;SFRP1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.32836573105285094,0.7631507490676981,0.7752808988764045,0.9472331244315024,1.0,5/21,16.23%,CTSL;ZFP36L1;ZFP36;SFRP4;DLL1
prerank,protein import into peroxisome membrane (GO:0045046),0.32171731299880274,0.7629920799427726,0.8185185185185185,0.9470603974996801,1.0,10/22,35.64%,PXMP2;GDAP1;FIS1;PEX11B;ABCD2;ALDH3A2;PEX14;PEX2;ATAD1;PEX13
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3347368704569943,0.7628729816848576,0.7843631778058008,0.9468424286151366,1.0,2/19,6.14%,SULT4A1;BPNT2
prerank,organelle fission (GO:0048285),0.3152237287661733,0.7628722375558111,0.7876543209876543,0.9464734331246396,1.0,9/24,26.40%,DNM3;CORO1C;GDAP1;MFF;DNM1L;FIS1;DNM1;MTFR1L;PEX11B
prerank,protein ubiquitination (GO:0016567),0.2543266912955631,0.7627315448730192,0.988988988988989,0.9462845788648669,1.0,86/471,20.24%,RPS27A;UBC;RACK1;UBB;PSMB4;ELOB;PSME1;PSMB6;PSMB8;PSME2;PSMD2;UBE2Z;PINK1;KCTD10;FBXO15;KLHL9;PSMD1;EPAS1;UBE2G2;PSMC3;CTNNB1;DCAF15;PSMD6;VCP;UBE2Q1;PSMA7;IRF2BP1;CDC34;RNF187;UBA52;ISG15;ARRDC1;USP5;FBXL14;OTULIN;NHLRC1;PRPF19;PSMD5;NEDD8;RBX1;FBXO27;TNFAIP1;TRIM2;DDB1;PSMB9;RBCK1;PSMD13;KLHL7;FBXW5;SYVN1;PSMB3;PCNA;ZSWIM8;PSMB11;FBXO30;FBXW7;FBXO31;RNF40;PSMB10;RNFT1;UBE2V1;PSMB1;ARRB2;PSMB5;ENC1;RNF7;VHL;RNF181;RUSC1;TRIM32;USP22;RLIM;TRAIP;PSMA6;RNF208;RNF144B;TRIM13;KCTD13;FBXL16;RNF11;SKP1;BRAP;HECW1;UBE2QL1;PSMA4;KLHL25
prerank,genitalia development (GO:0048806),0.3599638594822972,0.7626347922262973,0.7644683714670256,0.9460233538918426,1.0,2/12,10.49%,FOXF2;WNT5A
prerank,regulation of lamellipodium organization (GO:1902743),-0.2772149376133862,-0.7626266783429921,0.8016877637130801,0.930408051309034,1.0,2/14,5.62%,FER;CARMIL1
prerank,respiratory system development (GO:0060541),0.3017655428903746,0.762612458690589,0.7938388625592417,0.9456838019205506,1.0,4/32,8.47%,RBP4;CEBPA;BASP1;PROX1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.1951940753368008,-0.7621016295729544,0.9493670886075949,0.929761379570225,1.0,15/57,17.11%,BABAM2;FOXN3;RINT1;MDC1;UIMC1;TAOK3;ATF2;MRNIP;TIPIN;RAD17;ATM;CLSPN;TP53;TAOK1;WAC
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.3421684212914146,0.7619079987408874,0.7839673913043478,0.9461970674034483,1.0,2/16,5.98%,PIGZ;PIGQ
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3150697417090146,0.7619014482914126,0.7940119760479042,0.9458354538937105,1.0,6/25,19.16%,ANG;DSCAM;MIF;SDCBP;PTGES3;SNCA
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.37243665714179675,0.7615835710341583,0.7841726618705036,0.9451536087190562,1.0,3/10,22.54%,TERF1;ERCC1;BLM
prerank,telomere maintenance via telomere trimming (GO:0090737),0.37243665714179675,0.7615835710341583,0.7841726618705036,0.9451536087190562,1.0,3/10,22.54%,TERF1;ERCC1;BLM
prerank,t-circle formation (GO:0090656),0.37243665714179675,0.7615835710341583,0.7841726618705036,0.9451536087190562,1.0,3/10,22.54%,TERF1;ERCC1;BLM
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.314795824918127,0.7615136499018147,0.7885085574572127,0.9448905197230353,1.0,6/26,16.32%,CCL19;PTPRC;HTR2C;TRPM2;RYR2;ERO1A
prerank,mitochondrion morphogenesis (GO:0070584),-0.29180898026588487,-0.7606251613328189,0.7781569965870307,0.9304975522551705,1.0,1/11,0.54%,PID1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.29735554003158016,-0.7604711613439838,0.7733812949640287,0.9293806711792476,1.0,3/12,10.75%,CACNA1C;DLG1;TRPM4
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2530848349334399,0.7604074967822114,0.999,0.9459473511972195,1.0,166/807,20.88%,RPL23;RPS27A;HSPA8;RPS14;PFDN5;UBC;UBB;CALR;MT3;HSBP1;VPS72;NDUFA13;RPL10;TMPRSS6;ATF4;KLF2;MAF1;ID3;NRG1;SOX18;ID1;CRYAB;PRDX5;EID1;CCDC85B;ETS2;TNF;DRAP1;NR1D1;PDGFB;SPI1;ENO1;PARP1;TLE5;CTNNB1;FLNA;HES1;TENM2;MAGEL2;IRF2BP1;EID2;CDKN1C;TBX22;NCOR2;UBA52;DUSP26;CCND1;CEBPB;GMNN;ARID4A;FOXD3;PRDM12;TRIM28;CREBZF;FOXL2;CBX6;CEBPA;BASP1;PROX1;NR2F6;RBM15B;BCL6B;IKZF1;MLXIPL;MLX;SARS1;CDK5R1;SET;SIN3B;JUN;HMGB1;BHLHE41;ZFP36;H1-0;WNT5A;IRF8;AEBP1;CTBP1;APBB1;SUPT4H1;ZBTB7A;ATF5;L3MBTL4;CRYM;IRF2BPL;WFS1;BCL7A;SNW1;SOX8;MAEL;THRA;IRX3;THAP11;IRF7;KLF4;SOX9;YWHAQ;IRF2BP2;HDAC5;HEXIM1;DNAJB1;BMP2;NONO;LEFTY1;SDCBP;FOXS1;GAS6;MIER2;HNRNPU;ZC3H8;IKZF5;L3MBTL1;SAMD11;CDK5;NR1H2;IGF2;KDM1B;DNMT3B;HEY1;DAB2IP;VHL;BATF3;TCEAL7;TWIST1;CAV1;HDAC9;GLIS2;PAX9;RIPPLY2;BCL11A;COMMD7;CNBP;MTA2;RLIM;TCF25;MYT1L;ZHX1;CCAR2;SFRP1;MAZ;NOP53;CIR1;SOX11;QARS1;SNCA;ZBTB14;MUC1;TGFB1;HIC1;EFNA1;TFAP2B;LBH;NOTCH1;KLF11;BEND5;CHD3;POU4F1;CITED2;MEF2C;SAMD1;CAPN3;MYC;CBX3;GADD45A;SIRT2;TFAP4
prerank,positive regulation of positive chemotaxis (GO:0050927),0.34362584372560806,0.7599263929606571,0.7799479166666666,0.946200548678175,1.0,3/15,14.82%,CXCL12;KDR;F2RL1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.30549469550305036,0.7591732183439746,0.8260869565217391,0.9467808713759039,1.0,8/34,19.83%,CCL19;PDGFB;P2RY12;PIK3IP1;DAB2IP;FLT1;TGFB1;FLT3
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3402916191149996,0.7589932521799482,0.7843137254901961,0.9466364026040621,1.0,2/15,4.28%,CSNK2B;FKBP1A
prerank,metanephros development (GO:0001656),-0.2239034566388701,-0.7587555906985125,0.8390804597701149,0.9304451364950873,1.0,10/26,24.98%,FOXD1;NIPBL;PKD1;SIX1;BMP4;NF1;PKD2;PTCH1;FGF10;GDNF
prerank,positive regulation of potassium ion transport (GO:0043268),0.29641437879247984,0.7586444657750385,0.8171296296296297,0.9467067076346949,1.0,12/38,28.23%,AKAP6;FLNA;KCNJ10;KCNN2;KCNE5;KCNMA1;GABBR2;KCNJ3;KCNJ6;KCNMB4;KCNN4;KCNQ1
prerank,regulation of mitotic nuclear division (GO:0007088),0.28300518237702166,0.7584806463222342,0.8342361863488624,0.9465439656163304,1.0,14/55,25.50%,AURKAIP1;PDGFB;PIN1;CAV2;FBXO5;L3MBTL1;IGF2;EDN3;TGFA;DUSP1;CCDC8;RCC1;CD28;KIF20B
prerank,endomembrane system organization (GO:0010256),0.2586080122539974,0.7584520932113806,0.9193548387096774,0.9462130589389242,1.0,35/178,18.07%,ANK3;LMAN2;ATP8B4;SYNGR2;CAV2;CHMP2B;CTDNEP1;BAG5;REEP5;TMED7;LMAN1;SYNGR1;SURF4;REEP6;TMED2;CLASP1;TICAM2;TMED3;ARHGEF7;TMED9;SRGN;SERP1;TMED1;ARL1;SEC61A1;VMP1;SYP;SNX33;SQSTM1;USP8;DNM1L;SYNE1;HOOK1;LNPK;VPS4A
prerank,bile acid biosynthetic process (GO:0006699),0.31380575533058663,0.7584017630941194,0.8134328358208955,0.9459098202353594,1.0,6/24,22.46%,SCP2;HSD17B4;OSBPL6;OSBPL3;CH25H;OSBPL1A
prerank,smooth muscle tissue development (GO:0048745),-0.30971961013584104,-0.7580930461573446,0.7885906040268457,0.9300005486180407,1.0,5/10,21.75%,SMO;MYLK;BMP4;NF1;PTCH1
prerank,keratinocyte differentiation (GO:0030216),-0.2298879820336426,-0.7579657938556739,0.8511904761904762,0.9288020661466428,1.0,7/29,14.09%,ADAM9;BCR;PIP5K1A;WNT16;CASP3;JAG1;CLIC4
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3239702161263395,0.7571104911512881,0.7972805933250927,0.9472043406252137,1.0,6/22,20.12%,GNAI2;DRD5;CAP1;ORAI1;CCR2;GABBR2
prerank,negative regulation of JNK cascade (GO:0046329),0.3046308169294429,0.7570137407100572,0.7923627684964201,0.9469692418213219,1.0,6/31,14.82%,PINK1;SIRPA;DUSP3;DNAJA1;MAPK8IP1;F2RL1
prerank,calcium ion transmembrane transport (GO:0070588),0.2660454676373138,0.756789152251779,0.8686974789915967,0.9468982295025627,1.0,18/86,16.63%,SMDT1;SLC24A4;SLC24A2;FKBP1A;CACNA1A;GRIN1;TMCO1;P2RX7;GRIN2A;PMPCB;ATP2B1;TRPM2;TRPC7;GAS6;TRPC1;SPG7;SLC8A1;ORAI1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.30640520372864416,0.7567281924675394,0.7912218268090154,0.9466079421913387,1.0,9/29,28.38%,FKBP1A;S1PR1;PROX1;BMP2;TGFB1;NOTCH1;TCAP;ZFPM1;ENG
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.3743236930431975,0.7558886175429479,0.7905308464849354,0.9473050445240686,1.0,5/11,26.35%,GPER1;GATA4;TGFB1;MEF2C;TGFB2
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3051717935701297,0.7548657472970824,0.8043217286914766,0.9482503648335024,1.0,8/29,24.24%,YBX1;PABPC1;SLC11A1;HNRNPU;CIRBP;EIF4ENIF1;ELAVL1;DND1
prerank,positive regulation of protein maturation (GO:1903319),-0.2967030315761544,-0.7545807691669217,0.8246753246753247,0.9322540005764626,1.0,4/11,24.06%,RHBDD1;CCBE1;BAG2;NLRC4
prerank,regulation of interleukin-1 production (GO:0032652),0.34545846251990997,0.7543769171250292,0.7825503355704698,0.948519377698299,1.0,4/15,20.96%,SIRPA;HMGB1;GAS6;TMED10
prerank,regulation of keratinocyte differentiation (GO:0045616),0.31284268934660914,0.7543409177642818,0.7785888077858881,0.9482012113876346,1.0,4/24,13.56%,CTSL;ZFP36L1;ZFP36;NME2
prerank,negative regulation of DNA binding (GO:0043392),-0.22482253560089832,-0.7542949907580729,0.873015873015873,0.9312983577318037,1.0,6/28,15.02%,SMO;PER2;SP100;ILRUN;HEY2;RSF1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.2301563377402578,-0.7541280468959545,0.8620689655172413,0.9301834449909059,1.0,3/26,4.96%,SNX6;CBLB;ERRFI1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3109588145580525,0.7539711453896335,0.8017348203221809,0.9483061361927281,1.0,3/25,6.65%,AUP1;VCP;OMA1
prerank,response to lipid (GO:0033993),0.2646354582714866,0.7536424200829049,0.8837448559670782,0.9483687118140373,1.0,16/105,14.20%,SPP1;RBP4;S100A8;S100A9;CTNNB1;ABCG1;TIRAP;HNRNPA0;GPX3;SCD;SLC11A1;SOX9;PAQR7;ERBIN;CTSH;ABCA2
prerank,isotype switching (GO:0045190),0.36765602697263927,0.7534307767003688,0.7875354107648725,0.948264474816271,1.0,1/10,7.73%,HSPD1
prerank,epithelial cell development (GO:0002064),0.3250065722786823,0.7528954903246677,0.8089171974522293,0.9485770684275969,1.0,1/20,1.48%,ACTA2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.33606526124641084,0.7527204632788305,0.7886944818304172,0.9484238868512677,1.0,4/17,15.96%,CTNNA2;DNAI3;ARF1;GMFB
prerank,microvillus organization (GO:0032528),0.35109976552273675,0.7526982843941061,0.7959459459459459,0.948083336677057,1.0,1/13,1.83%,FXYD5
prerank,cellular response to radiation (GO:0071478),0.29408306049823973,0.7523828397784033,0.821590909090909,0.9481044373901717,1.0,14/40,33.33%,RHOB;EEF1D;NET1;NSMCE3;GADD45A;BLM;ECT2;RAD51;RAD9A;CDKN1A;RHNO1;GRB2;CLOCK;SWI5
prerank,organonitrogen compound catabolic process (GO:1901565),0.27734319431509674,0.7518739927808761,0.8473282442748091,0.9483811582575299,1.0,15/57,23.87%,USE1;MPST;ENPP2;AMDHD2;PLA2G7;BCKDK;CLN6;CLN5;TXN2;TST;CLN8;CAPN3;SGPL1;ADO;ERAP1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.24862636511826985,0.7518063099142458,1.0,0.9481122696809134,1.0,245/1082,23.39%,APOE;RPS27A;CD74;UBC;UBB;CHCHD10;CXXC1;SPP1;CD81;PCBP1;COL1A1;ACTA2;MT3;CHCHD2;JUND;PARK7;MAPK3;TMPRSS6;HNRNPAB;ATF4;AKT1;KLF2;SOX18;PTPRN;ELOF1;ERBB4;NPM1;LYL1;POMC;AGT;DDX39B;GPER1;EIF5A;ETS2;TNF;BEX1;DRAP1;NR1D1;PDGFB;ACVRL1;HCLS1;SPI1;CHEK2;JUNB;GLMP;EPAS1;PIN1;YWHAH;PARP1;PSMC3;CTNNB1;ST18;MRTFA;GRIN1;SERTAD1;HES1;HYAL2;HMGN1;CDKN1C;CDK8;HIPK2;RHOG;RNF187;OTX2;UBA52;FOXF2;BRPF1;CEBPB;FOXD3;TRIM28;EDF1;SALL2;NAMPT;FOXL2;DCN;CEBPA;CREB3;CREB3L4;SEC14L2;PROX1;CXCL10;YBX1;CSRNP3;RRP1B;MLXIPL;MLX;EGR1;HOXD4;GATA2;JUN;KARS1;HMGB1;CAMK1;RTRAF;RFX4;ZBTB49;MC1R;TAF9;MYRF;H1-0;WNT5A;HOXB7;IRF8;PHOX2A;APBB1;NPAS3;SUPT4H1;APEX1;IL11;ATF5;KDM6B;SS18L2;POU3F1;SOX17;WBP2;PTOV1;IRF2BPL;HRAS;SNW1;SOX8;DBP;THRA;IRX3;IRF7;HOXD8;KLF4;ZMIZ2;SLC11A1;SOX9;PAX3;HDAC5;TNFRSF1A;NME2;BMP2;LILRB1;RAI1;ATMIN;LAGE3;RIPK2;HNRNPU;ZC3H8;UBE2V1;NUP85;MED30;F2RL1;PF4;AKNA;UBTF;NR1H2;IGF2;ARF4;KDM1B;BCL11B;MAPRE3;EBF3;HEY1;NCF1;DLL1;IER5;ING1;DAB2IP;SQSTM1;VHL;E2F4;GATA4;TWIST1;MED21;GLIS2;SKAP1;PCID2;MRPL12;ADCYAP1;USP22;AGO1;BRCA2;PPARGC1A;CNBP;ERCC6;LMO1;MAP2K2;TOX2;SFRP1;MAZ;PPP3CA;SOX11;DDRGK1;HMGN5;NRL;INHBA;TGFB1;CD86;NLRP3;ESRRB;TFAP2B;LBH;ING5;HGF;IL6;NOTCH1;ALYREF;POU4F1;AGRN;FOXA2;CDK9;CITED2;MEF2C;FZD1;CAPN3;NFKBIA;MYC;SIRT2;TFAP4;FZD2;CDC5L;ID2;FOSL2;MEIS2;FOXA1;SOX10;MAP2K7;ZXDC;DDIT3;CEBPZ;CKAP2;SS18L1;ESRRG;IRF5;REST;MEN1;BLM;GRHL2;SOX1;MAFB;TNIP1;IER2;KLF6;CSRNP1;PPP3R1;MYDGF;CDKN2B;PSMD9;AKIRIN2;SFR1;SP3;WNT7A
prerank,cardiac atrium morphogenesis (GO:0003209),0.33204329266441024,0.7516474755154872,0.7982233502538071,0.9479539676985109,1.0,8/16,28.38%,PROX1;BMP2;GATA4;NOTCH1;TGFB2;DLL4;ZFPM1;ENG
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3583763491188585,0.7516395503596173,0.7966339410939691,0.9475989693012558,1.0,8/12,37.86%,GLUD1;IDH3G;ACLY;IDH1;ASS1;IDH3A;IDH3B;SIRT4
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.31422212597849564,0.7505841880650728,0.8057644110275689,0.9485763542065604,1.0,7/25,19.19%,HSPA1B;BRD1;PRMT1;HSPA1A;MAPK11;ABCB10;INHBA
prerank,epithelial to mesenchymal transition (GO:0001837),0.28363646303032536,0.7502285119484455,0.8312849162011173,0.9486307397411562,1.0,14/47,19.83%,HNRNPAB;CTNNB1;FOXF2;TRIM28;WNT5A;SOX9;BMP2;AKNA;HEY1;S100A4;FAM83D;TGFB1;HGF;NOTCH1
prerank,membrane lipid metabolic process (GO:0006643),0.31195549202454514,0.7501874788627558,0.7873134328358209,0.9483172192540922,1.0,5/22,19.74%,SERINC1;GAL3ST1;SPTLC1;CERKL;SPHK2
prerank,positive regulation of mRNA processing (GO:0050685),0.31826167205328354,0.7499095733518879,0.8080808080808081,0.9483139731340574,1.0,5/21,16.25%,PRDX6;NCL;SNW1;CIRBP;CELF3
prerank,blood vessel diameter maintenance (GO:0097746),0.30144281603550116,0.7498342927563668,0.8178654292343387,0.9480413677560987,1.0,3/34,3.46%,KLF2;AGT;GPER1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3269873515125797,0.7497361688170677,0.8029739776951673,0.9477916575727618,1.0,7/20,20.60%,TMEM59;AP2M1;CLTC;RSC1A1;TMBIM1;TGFB1;PPP2R5A
prerank,phosphate ion homeostasis (GO:0055062),0.3757975778164551,0.7496030237410187,0.7757142857142857,0.9475923266020677,1.0,2/10,19.75%,SFRP4;TFAP2B
prerank,negative regulation of metabolic process (GO:0009892),0.281575754536534,0.748275267059698,0.8492849284928493,0.9488502663716757,1.0,14/54,21.63%,ATF4;ID1;APOC1;NR1D1;WNT10B;STK11;ARRDC3;NR1H2;PLCL2;ADAM17;IP6K1;NOTCH1;FIS1;DDIT3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3545713211941909,0.7479370912200275,0.7896174863387978,0.9488988290438696,1.0,6/13,33.61%,MPDU1;ALG3;ALG11;DPAGT1;ALG6;ALG2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.34162838856592387,0.7479055098604899,0.8027397260273973,0.9485786194464206,1.0,3/14,14.83%,TIRAP;TLR6;COPS8
prerank,regulation of innate immune response (GO:0045088),0.27363912487545433,0.7477519906602234,0.8377192982456141,0.9483971096724529,1.0,13/57,23.87%,HSP90AB1;TREM2;TIRAP;TNFAIP3;SLC15A4;CDC37;LRP8;TYRO3;PTPN6;POLR3D;PTPN1;AKIRIN2;ERAP1
prerank,dorsal/ventral pattern formation (GO:0009953),0.32408061892784384,0.7475906767057333,0.8012903225806451,0.9482231597798856,1.0,2/20,4.06%,NBL1;ACVRL1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3168317793217772,0.74694408149007,0.792191435768262,0.94866134182248,1.0,1/20,1.89%,MAPK3
prerank,regulation of histone deacetylation (GO:0031063),-0.2795497258406799,-0.7468128960435532,0.8195488721804511,0.9389654256972373,1.0,5/13,16.92%,CAMK2D;NIPBL;AKAP8L;ING2;PRMT6
prerank,tRNA metabolic process (GO:0006399),0.3297272380964624,0.7464812489344226,0.7964376590330788,0.9488763581148545,1.0,3/17,10.25%,SARS1;KARS1;POP7
prerank,regulation of vasoconstriction (GO:0019229),0.3085073661654487,0.74576871711458,0.8192771084337349,0.949379185678803,1.0,6/27,16.92%,AGT;CHRM3;ATP2B1;ADRA1A;ADRA1D;CAV1
prerank,actin filament-based transport (GO:0099515),0.31879955514949687,0.7451630058478684,0.795071335927367,0.9497738184444636,1.0,4/21,11.41%,MYO5A;MYO7B;MYO1F;FNBP1L
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2828031174163598,-0.7440572989816537,0.7786259541984732,0.941359412994383,1.0,2/13,8.04%,ADHFE1;DLST
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3507024655618623,0.743709426121265,0.7921896792189679,0.951176961273257,1.0,2/12,11.80%,CTNNB1;DDX11
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.2895564746379342,0.7434511626329956,0.8411967779056386,0.9511085962938415,1.0,8/37,15.98%,STMN3;FAM107A;CLASP1;MAPT;STMN4;CDK2AP2;STMN1;MAPRE3
prerank,"transcription, DNA-templated (GO:0006351)",0.2542887918956937,0.7430135063226451,0.9514661274014156,0.9512534376594882,1.0,38/207,21.65%,PTMA;ELOB;TSC22D1;POLR2E;ATF4;POLR2D;POLR2F;DRAP1;BTF3;GTF3C6;PARP1;XAB2;TAF10;NELFCD;TAF5L;TAF9;DEK;POLR2G;SUPT4H1;SSRP1;POLR2K;THRA;IVNS1ABP;RO60;RRAGC;UBTF;ARRB2;NELFE;MRPL12;ERCC6;TBP;KLF13;GTF3A;MLF1;CDK9;IRF9;POLR3K;POLR2H
prerank,response to prostaglandin E (GO:0034695),0.356131224955422,0.7428484807412943,0.7776261937244202,0.9510833681549502,1.0,1/10,2.25%,CCL19
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.22902891370545075,-0.7427160758777561,0.8944444444444445,0.9417900974256018,1.0,4/25,9.58%,SLIT2;YAP1;CEP97;KANK1
prerank,lung development (GO:0030324),0.29191866599042576,0.7420035811907472,0.8341232227488151,0.9517428385223102,1.0,4/33,8.47%,RCN3;RBP4;CEBPA;PROX1
prerank,spindle assembly (GO:0051225),0.26738555239323775,0.7418447738580118,0.8684782608695653,0.9515649497731808,1.0,11/67,19.21%,RPS3;CHEK2;FLNA;ABRAXAS2;CLASP1;SAC3D1;RHOA;HAUS2;MAPRE3;TOGARAM2;KIFC2
prerank,organelle fusion (GO:0048284),0.31375026825549607,0.7418087394260182,0.804726368159204,0.9512486357695347,1.0,7/22,21.01%,BAX;GDAP1;MIEF2;SPG7;MFF;STX4;FIS1
prerank,plasma membrane repair (GO:0001778),-0.2742573175186517,-0.741675666556328,0.8,0.9418258439544925,1.0,2/13,5.49%,MYOF;MYH9
prerank,protein neddylation (GO:0045116),0.3486041445643768,0.7416707611393369,0.76797829036635,0.9510614674761132,1.0,4/13,16.33%,UBE2M;NEDD8;RBX1;RNF7
prerank,proteoglycan biosynthetic process (GO:0030166),-0.21180920521489013,-0.7413950304244572,0.8910256410256411,0.9408347581250843,1.0,8/31,18.28%,EXT1;IGF1;CHST11;GLCE;EXT2;FOXL1;BMPR2;B3GALT6
prerank,response to insulin (GO:0032868),0.2661500755682313,0.7407496062117748,0.8869109947643979,0.951844736414282,1.0,26/80,27.21%,AKT1;ZFP36L1;PKM;PARP1;PDE3B;RAB15;MYO5A;VAMP2;HDAC5;SORT1;HDAC9;RAB31;EPRS1;EPM2AIP1;GOT1;INHBB;KHK;SELENOS;C2CD5;ZBED3;INSIG2;USF1;EIF6;TRIB3;RAB8A;XBP1
prerank,dendrite morphogenesis (GO:0048813),0.29436249584329416,0.7406049296313453,0.8471411901983664,0.9516515785575411,1.0,11/35,23.39%,CTNNA2;LRP4;MAP2;PAK3;DOCK10;TMEM106B;MAPK8IP2;EPHB1;CTNND2;PTN;WNT7A
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.2894893276695317,-0.7402303223977107,0.822463768115942,0.9410506673160669,1.0,6/11,17.79%,P4HTM;EGLN1;EGLN3;P4HA1;P4HA3;P4HA2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.2580801495697121,-0.7396689539996254,0.8801498127340824,0.9404290895773189,1.0,3/15,12.22%,GGACT;PRODH;HOGA1
prerank,mitotic sister chromatid segregation (GO:0000070),-0.16990110492514854,-0.7394480666089607,1.0,0.9393898383577782,1.0,29/98,23.17%,EML4;PDS5A;NIPBL;PDCD6IP;MCPH1;PDS5B;PIBF1;POGZ;INO80;CSNK2A1;CSNK2A2;CENPK;AKAP8L;PHF8;PINX1;DSN1;CENPE;KLHL22;SMC4;KIF18B;NUP62;KIF23;NDC80;NCAPD3;DIS3L2;KIF22;TUBG1;MIS12;SGO1
prerank,histone monoubiquitination (GO:0010390),-0.22900149962971775,-0.7391101052297775,0.9,0.9385152056280874,1.0,9/24,24.18%,BCOR;DDB2;CUL4B;CDC73;UBE2E1;WAC;RNF20;CTR9;RYBP
prerank,ncRNA 3'-end processing (GO:0043628),0.34770216014390376,0.738817359851908,0.7954545454545454,0.9534607684077271,1.0,7/14,32.23%,ELAC2;TOE1;ERI1;TRNT1;INTS12;INTS5;INTS6L
prerank,endocardial cushion development (GO:0003197),0.31468383987597726,0.7387323312467717,0.8067754077791719,0.9531904340396647,1.0,10/21,28.38%,ACVRL1;SOX9;BMP2;HEY1;GATA4;CRELD1;NOTCH1;TGFB2;TBX2;ENG
prerank,regulation of cartilage development (GO:0061035),0.32723225148209945,0.738562458586201,0.8067754077791719,0.9530404859843283,1.0,4/18,17.97%,MDK;SOX9;BMP2;SCIN
prerank,iron ion transmembrane transport (GO:0034755),0.3669512096129635,0.7382365755276727,0.786013986013986,0.9530697490610645,1.0,4/10,26.32%,ABCB6;SLC40A1;SLC25A37;ABCC5
prerank,vitamin transport (GO:0051180),0.2948924256143355,0.7381294053900921,0.8269230769230769,0.952835603374372,1.0,8/29,26.50%,GC;SLC19A1;FOLR2;SLC2A2;SLC19A2;SLC52A1;TCN2;SLC2A6
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.26317105442868177,0.7374708138977433,0.8818565400843882,0.9532589312440402,1.0,18/84,16.25%,MAGOH;HNRNPK;PRDX6;QKI;NCL;PUF60;RBFOX3;PCBP4;SRSF9;RBM15B;KHDRBS3;ZBTB7A;SNW1;HNRNPU;RBFOX1;HNRNPA1;CIRBP;CELF3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.28695018340288764,0.7365877237355798,0.841743119266055,0.95393334544218,1.0,7/39,13.78%,RASIP1;CTNNB1;COL4A1;PAK1;KDR;BMP2;TIE1
prerank,positive regulation of vasoconstriction (GO:0045907),0.34551801725997844,0.7364255694100085,0.7950138504155124,0.9537701536501578,1.0,3/13,16.92%,ADRA1A;ADRA1D;CAV1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2626953018373688,0.735922608883602,0.8603411513859275,0.9539870374923454,1.0,16/68,22.43%,SLC2A1;RFK;CYB5R3;GSTO1;SLC19A1;PNPO;SLC25A19;FOLR2;SLC19A3;SLC2A3;SLC19A2;SLC52A1;SHMT2;CYB5A;MTHFS;TCN2
prerank,regulation of epithelial cell migration (GO:0010632),0.2747303275180244,0.735418903271938,0.8484187568157033,0.9541927266668554,1.0,12/51,16.69%,EMP2;RTN4;PFN1;GLUL;CORO1C;ENPP2;CLASP1;PTPRR;SOX9;CTSH;DAB2IP;PFN2
prerank,regulation of hydrolase activity (GO:0051336),0.2645024781973239,0.7347434370713523,0.8722044728434505,0.9546279694876935,1.0,13/71,16.92%,SOD1;RASIP1;NTRK2;ATP5IF1;STMN3;ARHGAP9;ARHGAP15;GPR137B;EPHA5;VAV1;VAV3;DAB2IP;CAV1
prerank,fatty acid oxidation (GO:0019395),0.27285619137977996,0.7346846870960728,0.8740499457111836,0.9543310296855406,1.0,11/57,23.37%,ACADVL;SCP2;MTLN;HSD17B4;ACAA2;ACAT1;ECHS1;PPARGC1A;EHHADH;ADIPOR1;ILVBL
prerank,cardiocyte differentiation (GO:0035051),0.3661175050434339,0.7345190599037107,0.800561797752809,0.954164323701735,1.0,3/10,13.57%,NRG1;KDM6B;BMP2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.321926658795172,0.7337120288868121,0.8127388535031848,0.9547382207417988,1.0,4/19,8.70%,S100A10;RAC1;THY1;KDR
prerank,microvillus assembly (GO:0030033),0.3387550993629938,0.7332583368799634,0.8207547169811321,0.9549076396156209,1.0,1/14,1.83%,FXYD5
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.34193383826654977,0.7330696635500612,0.8002717391304348,0.9547618145935224,1.0,5/13,23.83%,B3GNT9;B3GNT3;B3GALT5;GAL3ST3;B3GALT2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3578785377093331,0.7329576415938208,0.8101788170563962,0.9545203907392511,1.0,4/11,20.73%,WNT5A;SOX9;PDGFA;MYC
prerank,regulation of cilium movement (GO:0003352),-0.2894175244790359,-0.7328789665725963,0.802547770700637,0.9449116519071726,1.0,10/10,71.08%,CCDC39;ODAD2;CCDC65;CFAP43;CCDC40;DNAAF1;CFAP298;DNAH11;DRC1;CFAP206
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.33183187023756594,0.7327948864091695,0.803921568627451,0.954365658219375,1.0,3/15,9.43%,MAPK3;KDR;AATK
prerank,arachidonic acid secretion (GO:0050482),-0.2918654280692945,-0.7325793613090974,0.8214285714285714,0.9425777077116685,1.0,10/10,70.84%,PLA2G5;ANXA1;BDKRB2;DRD3;PLA2G1B;DRD4;ACE;DRD2;PNPLA8;NMUR2
prerank,arachidonate transport (GO:1903963),-0.2918654280692945,-0.7325793613090974,0.8214285714285714,0.9425777077116685,1.0,10/10,70.84%,PLA2G5;ANXA1;BDKRB2;DRD3;PLA2G1B;DRD4;ACE;DRD2;PNPLA8;NMUR2
prerank,sphingolipid biosynthetic process (GO:0030148),0.2666323648468787,0.7325580098280141,0.8717672413793104,0.9542883581702581,1.0,22/71,24.01%,CERS2;ELOVL1;ELOVL2;SMPD1;B4GALT6;ELOVL7;SPTLC1;DEGS1;CSNK1G2;FA2H;CLN8;SPTSSA;ST8SIA5;VAPA;SPHK2;SGPP1;SGPL1;SGPP2;ASAH2;ELOVL6;ALDH3B1;VAPB
prerank,carbohydrate homeostasis (GO:0033500),0.2647423423453666,0.732268299274151,0.8776824034334764,0.9542660594158319,1.0,13/67,20.73%,PARK7;MTNR1B;RPS6;RBP4;CEBPA;MLXIPL;WFS1;STK11;BAD;ADCY8;TFAP2B;IL6;PYGL
prerank,fibrinolysis (GO:0042730),0.34441809100476795,0.7320973101714321,0.808454425363276,0.954105373628691,1.0,2/13,16.94%,PLAT;PLAU
prerank,DNA conformation change (GO:0071103),0.3196766762056742,0.7314668289179447,0.7953367875647669,0.9544908954829924,1.0,3/17,11.03%,HMGB3;HMGB1;NAA10
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.26062484448461976,0.7312921194574092,0.8844919786096257,0.9543350024409619,1.0,9/72,14.67%,POLR2E;MAPK3;POLR2D;POLR2F;RAB14;POLR2G;FGFRL1;POLR2K;HNRNPA1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3074247867804518,0.7303196666990965,0.8181818181818182,0.9551100189911604,1.0,3/21,8.49%,MID1IP1;NAV3;CLASP1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.27667546943890575,-0.7293792951447794,0.8265682656826568,0.9450466579362501,1.0,4/13,15.12%,CNOT1;MOV10;CNOT7;ZC3HAV1
prerank,endothelial cell migration (GO:0043542),0.2861546246040078,0.729126731612609,0.8406976744186047,0.9561177013723764,1.0,11/37,22.70%,SOX18;ID1;EMP2;TNFSF12;RHOA;CDH5;LPXN;PLXND1;SCG2;CCN3;LGALS8
prerank,lung epithelium development (GO:0060428),0.36317449067820723,0.7284834376290973,0.8311499272197962,0.9565033457914575,1.0,1/10,2.28%,RCN3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.28532264547435193,0.7283830074512921,0.8443670150987224,0.9562636365923393,1.0,8/33,18.91%,AKT1;CCND2;CCND1;AIF1;ADAMTS1;ADAM17;FAM83D;DDRGK1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3031858312433117,0.7279998804830943,0.8250904704463209,0.9563388954722983,1.0,4/26,10.44%,LUM;FMOD;CHST1;B4GALT6
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.24414111926337506,0.7276932505010512,0.989,0.9563443740389761,1.0,76/366,22.77%,PFDN5;RPL6;CXXC1;CALR;RPL10;ATF4;SOX18;HINT1;GRM5;LYL1;MAGED1;DRAP1;METAP1;ACVRL1;HCLS1;SPI1;CHEK2;PPP2R1A;NUCKS1;BTG1;FADS1;TBX22;CEBPB;GMNN;PQBP1;HES6;EDF1;CEBPA;YBX1;MLXIPL;MLX;TAF5L;HOXB7;APBB1;SUPT4H1;PCIF1;ATF5;SOX17;RBM4B;FBXO5;METTL18;BMP2;NONO;UBE2V1;MAFA;CCDC88A;SPIN4;PDGFA;GLRX2;IGF2;VHL;GATA4;BRCA2;PPARGC1A;CNBP;MLF2;TERF2IP;ZNF22;CCAR2;SOX11;HMGN5;HIC1;ESRRB;NOTCH1;MLF1;CHD3;MEF2C;PHF1;ACTR5;USP13;DDIT3;ESRRG;POU6F2;REST;SOX1;MAFB
prerank,regulation of lipid kinase activity (GO:0043550),0.353468528210583,0.7275703616887788,0.7895460797799174,0.9561338229344996,1.0,2/11,20.60%,EEF1A2;PPP2R5A
prerank,regulation of defense response to virus by host (GO:0050691),0.2866432375257128,0.7272752554184724,0.8416666666666667,0.9561313495470325,1.0,3/30,7.42%,HSP90AA1;TNFAIP3;PQBP1
prerank,small GTPase mediated signal transduction (GO:0007264),0.25484420470708596,0.7269634057320137,0.9085239085239085,0.9561325243558028,1.0,37/103,27.12%,PARK7;RAC1;SHC3;TRIM28;RGS19;NTN1;JUN;GRAP;RASGRP3;HRAS;RHEBL1;RUNDC3A;SHTN1;ABR;CCDC88A;TIAM1;RRAS;MAPK11;RRAGC;G3BP1;G3BP2;RASGRP1;USP8;RAB18;SOS1;BRAP;ARHGAP33;RERG;RALB;RAB42;CCNA2;TNK2;RGL2;KSR2;RALBP1;CHP1;CDKN1A
prerank,positive regulation of DNA repair (GO:0045739),0.27679828076901786,0.7268789303304946,0.8399122807017544,0.955875270173802,1.0,7/46,12.19%,RPS3;PARP1;TRIM28;FMN2;HMGB1;DDX11;PCNA
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.22423146491543072,-0.7266072833016102,0.8823529411764706,0.9469665869968391,1.0,2/26,1.37%,LARGE1;ST3GAL4
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.24291303355893512,-0.726486401673742,0.8407960199004975,0.9457665393181123,1.0,7/19,17.24%,CUX1;DHX36;CAPRIN2;OBSL1;CDKL3;FBXW8;CUX2
prerank,cardiac muscle cell development (GO:0055013),0.3159336173792998,0.7263310921698541,0.8237547892720306,0.9561443446775918,1.0,5/20,16.53%,ALPK2;MYH11;SORBS2;SLC8A1;FHOD3
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3175520293571527,0.7256147991773082,0.8233766233766234,0.9565905936387673,1.0,3/17,12.14%,GPER1;ATP1A3;ATP1A1
prerank,regulation of TOR signaling (GO:0032006),0.26109603647471014,0.7252565373752393,0.8870967741935484,0.9566250902210591,1.0,13/67,20.43%,TREM2;LAMTOR2;LAMTOR4;LAMTOR5;PIH1D1;PDCD6;LAMTOR3;GAS6;RRAGC;RRAGD;FAM83D;AKT1S1;DDIT4
prerank,regulation of keratinocyte migration (GO:0051547),0.3405576139706979,0.7249439374637829,0.803840877914952,0.9566409994882416,1.0,3/12,16.37%,ARF6;EPPK1;EPB41L4B
prerank,B cell activation involved in immune response (GO:0002312),0.3357425885034738,0.7249109388637133,0.8185538881309686,0.9563149125780604,1.0,4/13,33.30%,CD180;GPR183;FCGR2B;EXOSC3
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.31610368686649704,0.7247248716012608,0.8157894736842105,0.9561738179208977,1.0,7/20,20.60%,TMEM59;AP2M1;CLTC;RSC1A1;TMBIM1;TGFB1;PPP2R5A
prerank,lymphocyte mediated immunity (GO:0002449),0.34632172556199387,0.7247058696616419,0.8331053351573188,0.9558430609950063,1.0,1/12,4.11%,BTN3A3
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2907376054337384,0.7245462376197188,0.8329466357308585,0.9556611841935778,1.0,11/30,27.12%,TERF1;ACVRL1;HNRNPU;HNRNPA1;CTC1;GNL3L;MEN1;DACH1;PIF1;HNRNPC;CDKN1A
prerank,cell chemotaxis (GO:0060326),0.2636183891223325,0.724452599829703,0.8552631578947368,0.9554144186600273,1.0,15/60,26.18%,CXCL12;PDGFB;RHOG;CCR5;CXCR4;CX3CR1;EPHB1;ARRB2;CCL28;CCR2;HGF;CCN3;CX3CL1;PLXNB3;PRKCQ
prerank,protein complex oligomerization (GO:0051259),0.25549921741934206,0.7242608839806159,0.8915289256198347,0.9552793194185781,1.0,26/85,26.18%,LRRC8A;MPP2;KCNC3;ALAD;KCNC1;NINJ1;RS1;PRMT1;EHD1;UGDH;G3BP2;ADCY8;DNM1L;MAT2A;SNCA;GLRA3;SHMT2;PYCARD;KCNC2;BLM;ELAVL1;ECT2;STOML2;BOK;PNPT1;EHD3
prerank,carboxylic acid catabolic process (GO:0046395),0.3454831938921436,0.7239819018295446,0.808066759388039,0.9552379742875553,1.0,3/12,16.78%,AMDHD2;BCKDK;ACOT4
prerank,phagosome-lysosome fusion (GO:0090385),0.3476492757032268,0.7232790534865453,0.8109243697478992,0.9556818042828549,1.0,7/10,38.81%,RAB20;SYT7;RAB34;RAB39A;ARL8B;RAB7A;RAB7B
prerank,regulation of phosphate metabolic process (GO:0019220),0.321170554650622,0.7228856138924802,0.8352788586251622,0.9557607641176411,1.0,2/16,9.17%,PGAM1;CD24
prerank,positive regulation of RNA splicing (GO:0033120),0.2911999320666194,0.7223036707837085,0.8463414634146341,0.9560662830295635,1.0,6/29,16.25%,PRDX6;NCL;SNW1;HSPA1A;CIRBP;CELF3
prerank,peroxisomal membrane transport (GO:0015919),0.29299584650832433,0.7222338906793295,0.8362989323843416,0.9557825866909454,1.0,12/27,35.64%,PXMP2;GDAP1;PEX6;FIS1;PEX11B;PEX1;ABCD2;ALDH3A2;PEX14;PEX2;ATAD1;PEX13
prerank,bicarbonate transport (GO:0015701),0.29594444544657605,0.7222233263942844,0.8353808353808354,0.9554407690911012,1.0,6/25,21.11%,CA2;AQP1;CA4;SLC4A2;CYB5R1;CA3
prerank,adipose tissue development (GO:0060612),0.3429351290073494,0.7210338170888039,0.8111888111888111,0.9563921993431466,1.0,3/11,12.45%,NAMPT;PGRMC2;SOX8
prerank,modification-dependent protein catabolic process (GO:0019941),0.24442703678081634,0.7202105877168498,0.9515640766902119,0.956947201280288,1.0,24/193,13.52%,RPS27A;UBC;UBB;PINK1;KCTD10;TOLLIP;UBE2G2;CDC34;UBA52;ISG15;ARRDC1;FBXL14;FEM1C;FEM1A;NEDD8;RBX1;DDB1;RNF128;PSMD13;SYVN1;BUB3;RNF150;RNF40;UBQLN2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.24052701428685266,0.719731790866727,0.997,0.9571130950032176,1.0,117/572,21.63%,RPL23;RPS27A;RPS14;UBC;UBB;CALR;HSBP1;VPS72;RPL10;TMPRSS6;ATF4;KLF2;ID3;SOX18;ID1;EID1;ETS2;TNF;DRAP1;NR1D1;PDGFB;SPI1;ENO1;PARP1;TLE5;HES1;TENM2;IRF2BP1;TBX22;NCOR2;UBA52;DUSP26;CCND1;CEBPB;FOXD3;PRDM12;CBX6;PROX1;NR2F6;BCL6B;MLX;SARS1;SIN3B;JUN;HMGB1;BHLHE41;ZFP36;H1-0;IRF8;AEBP1;CTBP1;APBB1;SUPT4H1;ZBTB7A;CRYM;IRF2BPL;WFS1;SNW1;SOX8;THRA;IRX3;THAP11;IRF7;KLF4;SOX9;IRF2BP2;HDAC5;HSPA1A;HEXIM1;DNAJB1;BMP2;LEFTY1;SDCBP;MIER2;HNRNPU;IKZF5;NR1H2;IGF2;KDM1B;DNMT3B;HEY1;DAB2IP;VHL;BATF3;TWIST1;CAV1;HDAC9;GLIS2;RIPPLY2;BCL11A;CNBP;MTA2;TCF25;MYT1L;ZHX1;MAZ;NOP53;CIR1;SOX11;SNCA;HIC1;EFNA1;TFAP2B;NOTCH1;KLF11;CHD3;POU4F1;CITED2;MEF2C;MYC;GADD45A;SIRT2;ID2;IFI27;MEIS2;SOX10;DDIT3
prerank,brain morphogenesis (GO:0048854),0.3381653238784326,0.718963315364958,0.8127544097693351,0.9576211065016045,1.0,1/12,3.17%,CTNNA2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3120544285815561,0.718342088918545,0.8427109974424553,0.9579670849160399,1.0,4/21,14.80%,FLNA;SCN4B;KCNE4;KCNE5
prerank,GTP metabolic process (GO:0046039),0.32902872983450926,0.7183109288547029,0.8280839895013123,0.9576465464862101,1.0,3/15,9.48%,RAN;AK4;AK3
prerank,sphingosine metabolic process (GO:0006670),0.3201343635065431,0.7182975733197416,0.8141935483870968,0.9573092623698468,1.0,7/17,21.50%,SPTLC1;ABCA2;NAAA;SPHK2;SGPP1;SGPP2;ASAH2
prerank,negative regulation of telomere maintenance (GO:0032205),0.32150649779557144,0.7180490921150648,0.8190348525469169,0.9572514668927536,1.0,2/15,5.03%,TERF1;PARP1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.28985232816072937,-0.7178791192195203,0.8025078369905956,0.9544990925004434,1.0,2/10,6.06%,LRP6;ARHGAP12
prerank,negative regulation of type I interferon production (GO:0032480),0.2771999731323366,0.7173950658653805,0.868421052631579,0.9576512333020486,1.0,4/40,6.99%,PIN1;SIRPA;TNFAIP3;ISG15
prerank,negative regulation of biomineral tissue development (GO:0070168),0.3076355077311373,0.7171097987045381,0.8398486759142497,0.9576247579367538,1.0,8/21,19.83%,ECM1;SRGN;SOX9;GAS6;HEY1;CCL3;TGFB1;NOTCH1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2764034125003211,0.7165030103538762,0.8699654775604143,0.9579526426209215,1.0,10/40,22.50%,IER3;RPA2;USP51;MAPT;NSMCE1;FBXO5;UBE2V1;CDK9;MYC;RADX
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.27854584684785044,0.7149554662841542,0.869815668202765,0.9592714903262964,1.0,5/38,14.97%,H3-3A;NPM1;CENPX;IPO4;CENPL
prerank,methylguanosine-cap decapping (GO:0110156),0.3463600270029368,0.7144738558734197,0.8143459915611815,0.9594312159235546,1.0,2/10,11.14%,PNRC2;EDC4
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3531622861478379,0.7138544065863541,0.8246110325318247,0.9597425651526987,1.0,2/10,15.88%,PRDM12;DNMT3B
prerank,response to organophosphorus (GO:0046683),-0.24777976542326072,-0.713570684482692,0.8571428571428571,0.9580665971835423,1.0,6/16,26.40%,DGKQ;TRPC3;VGF;ABCC9;NDUFS4;TYMS
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.34772009783542723,0.7128756245743992,0.8152777777777778,0.9604503725173699,1.0,2/10,24.72%,CNGB1;PDE6G
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3264869665250046,0.712144121500182,0.8403819918144612,0.9608868098088945,1.0,6/14,28.08%,KLF4;RHOA;HDAC5;NOTCH1;DLL4;MMRN2
prerank,sphingosine biosynthetic process (GO:0046512),0.344425862358366,0.7121425988658634,0.8190743338008415,0.960175520758056,1.0,4/11,21.50%,SPTLC1;ABCA2;SPHK2;ASAH2
prerank,sphingoid biosynthetic process (GO:0046520),0.344425862358366,0.7121425988658634,0.8190743338008415,0.960175520758056,1.0,4/11,21.50%,SPTLC1;ABCA2;SPHK2;ASAH2
prerank,axonemal dynein complex assembly (GO:0070286),0.2904887303360941,0.7117131607024147,0.8604091456077015,0.9602741150972851,1.0,4/27,13.62%,DNAI3;DNAAF3;DNAH1;LRRC49
prerank,RNA processing (GO:0006396),0.2416444443159533,0.7116849501915066,0.9526686807653575,0.9599432365920629,1.0,42/176,21.40%,SNRPG;AURKAIP1;MAGOHB;MAGOH;HNRNPK;DDX39B;SNRPD2;LSM6;LSM4;PPP2R1A;SNRPF;SRSF9;LIN28B;HNRNPA0;TARDBP;PRPF8;SRSF2;SUPT4H1;SF3A2;ELAVL4;SF3B2;IVNS1ABP;NONO;MRPL44;HNRNPU;SNRPB;RRAGC;SF3A3;CELF3;PDCD7;APOBEC1;PPARGC1A;CCAR2;USB1;SNRPD3;SF3A1;SRSF1;DKC1;SNRNP35;TSEN54;SRRM4;HNRNPF
prerank,natural killer cell activation (GO:0030101),0.3009774128033418,0.7113758502424227,0.8376068376068376,0.9599167386458828,1.0,7/23,19.67%,PTPRC;IL2;PRDX1;NCR1;RASGRP1;PIK3CD;TOX
prerank,megakaryocyte differentiation (GO:0030219),0.3449970964433548,0.710436489196808,0.8162083936324168,0.9605611943657809,1.0,4/11,28.35%,IL11;THPO;CDKN2B;ZFPM1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2957684781936354,0.7102450681888964,0.8514357053682896,0.9604037268448791,1.0,8/22,28.21%,UBAP1L;VPS28;VPS4A;VPS37C;VPS36;RNF126;SNF8;MVB12A
prerank,positive regulation of interleukin-17 production (GO:0032740),0.303194618310281,0.7097604225598091,0.8442521631644005,0.9605810558886517,1.0,8/22,32.09%,SLC7A5;IL2;TGFB1;IL6;RFTN1;PRKCQ;NOD2;LY9
prerank,negative regulation of macroautophagy (GO:0016242),0.28862595174669226,0.7097256073094894,0.8260869565217391,0.9602603681461306,1.0,3/26,8.96%,AKT1;PINK1;NUPR1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3216259834103387,0.7096208905944691,0.8342318059299192,0.9600206551049961,1.0,3/15,16.49%,POP7;RNASEH1;NUDT16
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3061455834757796,0.708764599613196,0.8381430363864492,0.9605914232692638,1.0,7/21,15.48%,HS6ST3;HS3ST5;B3GAT3;SGSH;UGDH;XYLT1;HPSE
prerank,tRNA 5'-end processing (GO:0099116),0.316086732166923,0.7084549677577248,0.8265971316818774,0.960567981378034,1.0,5/15,33.63%,POP7;POP4;TRMT10C;POP5;HSD17B10
prerank,lipid modification (GO:0030258),0.27904655595654004,0.7068227552472904,0.8582949308755761,0.9619187971858617,1.0,17/37,32.81%,DGKH;DGKI;PLA2G7;PLPP6;PLPPR2;PORCN;SGPP1;DGKK;SGPP2;DGKB;CYP2E1;PLPPR4;MBOAT7;PLPP4;DGKZ;DGKG;PLPPR5
prerank,response to laminar fluid shear stress (GO:0034616),0.34801770391264975,0.7067236063668776,0.8412921348314607,0.9616666434189755,1.0,2/10,13.04%,KLF2;KLF4
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3047572622103141,0.7062375377580721,0.845088161209068,0.9618638215987796,1.0,7/19,26.02%,TERF1;HNRNPU;HNRNPA1;CTC1;GNL3L;PIF1;HNRNPC
prerank,purine-containing compound salvage (GO:0043101),-0.2666090238919472,-0.7060204704481937,0.8625954198473282,0.9648959567633888,1.0,4/12,16.37%,AMPD3;ADK;AMPD2;GMPR
prerank,plasma membrane organization (GO:0007009),0.2613158772458386,0.7051424567117405,0.8893662728249194,0.9626283447750391,1.0,15/61,18.82%,ANK3;PACSIN1;P2RX7;SYT11;SMPD1;FNBP1L;SERP1;CXCR4;EPB41L3;DEGS1;SNX33;FA2H;EHD2;ANXA6;STX4
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.23690389336712023,-0.7044549703848284,0.8851674641148325,0.9651385603149936,1.0,1/20,0.29%,SULF1
prerank,phosphate ion transmembrane transport (GO:0035435),0.3306047808657469,0.7042778940999862,0.8287671232876712,0.9631900867830094,1.0,8/12,40.03%,SLC25A11;SLC25A14;SLC25A30;SLC25A3;SLC37A2;XPR1;SLC20A1;SLC37A1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.24749086386256536,-0.7041412680450739,0.8681818181818182,0.9641224565626468,1.0,5/17,14.52%,PPARG;PTEN;PDCD4;TPM1;TGFB3
prerank,visual perception (GO:0007601),0.2523142316707916,0.7036615021596814,0.9258872651356994,0.9634773594314917,1.0,9/84,13.45%,COL1A1;OAT;SFRP5;RD3;GRM8;REEP6;WFS1;RS1;CRYBA1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.30077412395634623,0.7030839123208066,0.8453738910012675,0.9633923778680709,1.0,7/22,29.03%,GOLGA7B;CLIP3;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.30077412395634623,0.7030839123208066,0.8453738910012675,0.9633923778680709,1.0,7/22,29.03%,GOLGA7B;CLIP3;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.2535590582083087,0.7009478288295938,0.9084132055378061,0.9652317110754549,1.0,18/74,21.52%,MDK;COL1A1;MCRIP1;CTNNB1;CLASP1;SPRY1;BMP2;SDCBP;TIAM1;DAB2IP;TWIST1;SFRP1;VASN;TGFB1;EFNA1;IL6;FOXA2;FOXA1
prerank,renal filtration (GO:0097205),0.3412230769319565,0.6990286683562196,0.827538247566064,0.9668324773536433,1.0,3/10,11.16%,CD34;TMEM63C;MCAM
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.2861288655386548,0.6986373858723829,0.8757467144563919,0.9668861121459618,1.0,7/27,17.92%,PDE4B;CTNNA3;PLN;RYR2;FGF13;CAV1;SRI
prerank,inositol phosphate catabolic process (GO:0071545),0.3252784055487812,0.6986330792664461,0.8408488063660478,0.9665366725240416,1.0,2/12,13.87%,NUDT3;INPP5J
prerank,motile cilium assembly (GO:0044458),0.3365323134859299,0.6985359345583109,0.8291316526610645,0.9662909773026043,1.0,3/12,20.02%,DNAAF3;E2F4;BBOF1
prerank,positive regulation of autophagy (GO:0010508),0.2491637638952783,0.6980798230879063,0.9166666666666666,0.9663929094620034,1.0,12/81,15.33%,PARK7;PINK1;TMEM59;ORMDL3;BNIP3L;SCOC;DCN;KDR;HMGB1;SVIP;STK11;BAD
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.28370201545903034,0.6975534015082064,0.867699642431466,0.9665746428907123,1.0,7/31,15.61%,CFL1;NLGN1;PPFIA2;CDK5R1;SRCIN1;CDK5;LRP8
prerank,regulation of cellular catabolic process (GO:0031329),0.2554383906305188,0.697226201068253,0.9154774972557629,0.9665633983061722,1.0,6/62,9.18%,PSAP;HSPB1;DEPP1;MAPT;NUPR1;GPR137B
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.2644213902056674,0.6968834161605394,0.8929765886287625,0.9665585758923002,1.0,16/42,28.15%,S100A10;EMP2;RAC1;THY1;KDR;RRAS;CCL28;SKAP1;SFRP1;COL16A1;PPM1F;TEK;CX3CL1;EFEMP2;MYOC;CD3E
prerank,amide biosynthetic process (GO:0043604),0.2663568183451778,0.6963525593793463,0.8741573033707866,0.9667339929050767,1.0,15/47,31.57%,CERS2;SMPD1;SPTLC1;DEGS1;FA2H;CLN8;SPTSSA;ASAH2;AANAT;ASL;SAMD8;ASS1;ARG2;CERS6;PCSK1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3008790038368603,0.6959804203846127,0.8710089399744572,0.9667440662041769,1.0,5/21,23.00%,NPM1;CCND1;FBXO5;CDC25A;RCC2
prerank,glycoprotein catabolic process (GO:0006516),0.3104140117577133,0.6958594615132334,0.8229166666666666,0.9665117397136194,1.0,2/17,9.28%,CTSL;FBXO27
prerank,nucleoside phosphate catabolic process (GO:1901292),0.3261903380105181,0.6958419126986591,0.8422459893048129,0.9661742652768344,1.0,2/13,13.90%,ENTPD3;SMPDL3A
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2756726106320034,0.6953340595369315,0.8852071005917159,0.9663438751147735,1.0,9/33,20.29%,HSPA1B;BRD1;PRMT1;HSPA1A;MAPK11;ABCB10;SCIN;INHBA;THPO
prerank,cilium movement (GO:0003341),-0.18876929316186367,-0.6944386707885918,0.9693877551020408,0.9727165406468741,1.0,24/47,30.32%,DNAI4;SPEF1;CFAP251;GAS8;ODAD1;CCDC39;CFAP53;CFAP70;DNAAF5;ODAD2;SPAG17;ODAD3;CFAP61;SPA17;DNAAF2;ODAD4;TEKT2;ROPN1L;CCDC40;CCDC63;ADCY10;TEKT5;DNAAF4;TTC29
prerank,positive regulation of defense response to virus by host (GO:0002230),0.28202024594543246,0.6938131511725708,0.8646986469864698,0.967545861967042,1.0,3/24,13.71%,HSP90AA1;PQBP1;LILRB1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.3027768012915102,0.6928518421304841,0.8576923076923076,0.9682010516134097,1.0,3/18,8.22%,SPI1;ST18;CEBPA
prerank,mRNA 3'-end processing (GO:0031124),0.24815102093714744,0.6923077242648599,0.9132762312633833,0.9683835887332145,1.0,16/78,22.27%,MAGOHB;MAGOH;POLR2D;DDX39B;SRSF9;SRSF2;PABPC1;CPSF2;THOC3;EIF4A3;SLBP;U2AF1L4;SRSF1;ALYREF;CPSF4;DHX38
prerank,protein localization to cell surface (GO:0034394),0.2836347850456866,0.6920281884157705,0.8590686274509803,0.9683109916169303,1.0,9/26,25.95%,EMP2;CTNNB1;FLNA;ARF6;JAM3;PTPRU;UNC50;PRRT1;MESD
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.25475135213287037,-0.6919472090809841,0.8472222222222222,0.9737449887056754,1.0,2/13,13.87%,GLI3;CBFB
prerank,mesenchymal to epithelial transition (GO:0060231),0.3447778927029296,0.6918525521069298,0.8450704225352113,0.9681294552836246,1.0,1/10,8.24%,BASP1
prerank,mRNA methylation (GO:0080009),0.3084593623135211,0.6917701485061187,0.8290013679890561,0.9678586184897335,1.0,5/15,24.90%,PCIF1;CMTR1;TRMT10C;METTL3;METTL14
prerank,amyloid-beta metabolic process (GO:0050435),0.31398426845150673,0.690869322024012,0.8452535760728218,0.9684195472760364,1.0,8/16,32.72%,PSENEN;BACE1;PSEN2;APH1B;APH1A;IDE;NCSTN;ACE
prerank,cilium-dependent cell motility (GO:0060285),0.2895107461572044,0.6904660589788005,0.869837296620776,0.9684892516457083,1.0,3/22,12.15%,DNAI3;DNAH1;DNAH2
prerank,regulation of smooth muscle contraction (GO:0006940),0.2946376845862078,0.690358498803324,0.8641509433962264,0.9682384325942257,1.0,9/20,31.71%,CHRM3;ATP2B1;CHRM2;CAV1;CTTN;CHRNA3;SRF;NMUR2;NMU
prerank,regulation of protein acetylation (GO:1901983),0.3263014843208977,0.6900980395258565,0.8567415730337079,0.9681490376386283,1.0,2/12,9.92%,PARK7;CAMK1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.2464886850878359,-0.6896626787616728,0.9176954732510288,0.9744844271462123,1.0,4/15,12.39%,MDC1;ATF2;TIPIN;RAD17
prerank,bile acid metabolic process (GO:0008206),0.28076472974060157,0.6885144656351827,0.8890258939580764,0.9693665214409358,1.0,7/27,24.41%,SCP2;HSD17B4;OSBPL6;OSBPL3;CH25H;OSBPL1A;NPC1
prerank,sensory perception of light stimulus (GO:0050953),0.2454461453178106,0.6881983798152255,0.9370485036119711,0.9693217527147321,1.0,9/87,13.45%,COL1A1;OAT;SFRP5;PCDH15;RD3;GRM8;WFS1;RS1;CRYBA1
prerank,fatty acid catabolic process (GO:0009062),0.2486714512904793,0.6879732481300431,0.9172852598091198,0.9692009093718514,1.0,7/67,11.55%,ACADVL;SCP2;NUDT19;MTLN;HSD17B4;ACAA2;ACAT1
prerank,autophagy of nucleus (GO:0044804),-0.2472921157977181,-0.6876542814065844,0.875,0.9749828914974086,1.0,6/16,21.09%,ATG2B;RB1CC1;ATG2A;ULK2;ULK1;WDR45B
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.2624420302789542,0.6869273050956061,0.8818181818181818,0.9698593501169968,1.0,9/37,20.78%,CALM1;CALM3;CADM4;RIPK2;DMTN;CALM2;TGFB1;DDIT4;SIRT2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.2923621428170288,0.6860302250471226,0.8743781094527363,0.9703956277472897,1.0,2/21,2.94%,SMDT1;TGM2
prerank,regulation of phospholipid metabolic process (GO:1903725),0.33715130263585424,0.6853436493254881,0.8681626928471248,0.9706984917888096,1.0,2/10,10.39%,MFSD2A;MTMR9
prerank,actin filament network formation (GO:0051639),0.32917375467664234,0.6837660662924624,0.8593314763231198,0.9718434574301557,1.0,4/11,22.09%,LCP1;ACTN1;FHOD3;SPIRE1
prerank,myotube cell development (GO:0014904),-0.2781797215616872,-0.683236503789982,0.8519736842105263,0.977715466308013,1.0,3/10,12.89%,SKI;IGF1;SIX1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.26789278471810796,0.6828578593669711,0.9012925969447708,0.9723462719775083,1.0,7/33,19.71%,PDE3B;P2RY12;JAM3;PLAU;SYK;MUC1;EFNA1
prerank,cilium assembly (GO:0060271),0.2289245353494648,0.682650746468545,0.990990990990991,0.9721938616355068,1.0,49/296,21.16%,TUBB;GSN;TUBA1A;HSP90AA1;TUBB4B;DYNLL2;DYNLL1;TUBA4A;DCTN3;IFT20;PPP2R1A;YWHAE;FLNA;DNAAF3;DYNLRB1;CNGA4;CLASP1;YWHAG;TUBB4A;FNBP1L;CEP131;FHDC1;TCTN3;DYNLRB2;DCTN1;SSNA1;EHD1;HAUS2;DCTN2;ARF4;CNGB1;TMEM17;E2F4;CETN2;PRKAR2B;CCDC28B;TCTN1;EHD2;EXOC7;DCX;NOTCH1;BBIP1;EXOC5;BBOF1;CFAP410;NEK1;CFAP54;EXOC8;CCP110
prerank,oligosaccharide metabolic process (GO:0009311),0.2600361803320452,0.6824711692190769,0.9031531531531531,0.9720154339407877,1.0,15/46,26.40%,MAN2B2;MAN1B1;MPDU1;ST8SIA4;MAN2C1;ST6GAL2;NEU1;ST6GALNAC3;FUT9;ST8SIA5;B3GALT5;GAL3ST3;B3GALT2;NAGA;NEU3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.2995523791970831,0.6816598509980758,0.8761290322580645,0.9724533988283565,1.0,3/17,16.06%,KCNE4;KCNE5;RYR2
prerank,protein targeting to peroxisome (GO:0006625),-0.20286045572835049,-0.6814944196672977,0.9090909090909091,0.9779134222307339,1.0,3/29,4.05%,LONP2;ZFAND6;ABCD3
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.2512776871330669,-0.6808738150567867,0.8897338403041825,0.9770757699348196,1.0,7/13,31.36%,TUT1;FIP1L1;CPSF6;CPSF1;CSTF2T;CPSF7;CPSF4L
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.30826782324613783,0.6808519978299532,0.8727272727272727,0.9728709338561554,1.0,5/16,19.31%,B4GALNT1;B4GALT6;ST8SIA4;ST6GALNAC3;ST8SIA5
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.2407388676873601,0.6806579232721149,0.9369277721261444,0.9726871640989051,1.0,31/102,27.21%,AKT1;GPER1;ZFP36L1;PKM;PARP1;PDE3B;RAB15;MYO5A;PRKAR1A;VAMP2;PRKAR1B;HDAC5;ADCY4;ADCY8;CAV1;PRKAR2B;HDAC9;RAB31;EPRS1;GOT1;INHBB;SELENOS;C2CD5;TSHR;RELA;INSIG2;PRKACA;USF1;TRIB3;RAB8A;XBP1
prerank,folic acid metabolic process (GO:0046655),0.3032071050682138,0.6795590989919307,0.8543307086614174,0.9733772013144186,1.0,8/18,32.66%,SLC19A1;FOLR2;SHMT2;MTHFS;DHFR;MTHFD2L;ALDH1L1;MTRR
prerank,regulation of T cell mediated immunity (GO:0002709),0.3409182784721032,0.6794307748763385,0.8373408769448374,0.9731387523479409,1.0,4/10,28.07%,HMGB1;CCR2;AGER;TNFRSF1B
prerank,phospholipid biosynthetic process (GO:0008654),0.2647484776489094,0.6790315715371746,0.9078498293515358,0.9731675320205174,1.0,13/36,31.42%,FADS1;PCYT2;DOLK;CPNE6;AGPAT5;SPHK2;FDPS;NUS1;CPNE3;GPAM;SAMD8;DPAGT1;GNPAT
prerank,regulation of calcium-mediated signaling (GO:0050848),0.2825675956434367,0.6790041346150459,0.8817204301075269,0.9728395244335659,1.0,3/25,9.12%,TREM2;MAPT;CD22
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.25030152492186547,0.6789107492289858,0.9241603466955579,0.9725705489980785,1.0,23/59,28.06%,CTNNB1;CDK8;CCND1;CEBPB;TRIM28;JUN;BAX;CSF1R;THRA;SOX9;MED31;MED30;TWIST1;AGO1;IL6;RELA;CCNC;MED7;MED12;CDKN1A;MED16;LEF1;MED25
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.2672847605738835,0.6787931823013249,0.8954171562867215,0.9723337945979095,1.0,11/33,29.59%,PSME1;PSME2;FBXW7;FAM83D;DDRGK1;PTPN6;ID2;CDKN1A;TRIM39;ATP2B4;PSME3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.28380988603937085,0.6787850883660518,0.89,0.9719906151254705,1.0,8/24,26.02%,TERF1;PARP1;HNRNPU;HNRNPA1;CTC1;GNL3L;PIF1;HNRNPC
prerank,transport along microtubule (GO:0010970),0.312801925089394,0.6787317714592909,0.8475935828877005,0.9716835555812946,1.0,6/13,31.26%,CLIP3;BORCS5;COPG1;APP;CAMSAP3;SPG11
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.22782308392572298,0.6781480168552082,0.994,0.9718558808160414,1.0,71/327,24.14%,PFDN5;RPL6;CXXC1;CALR;ATF4;SOX18;HINT1;LYL1;MAGED1;DRAP1;RALY;ACVRL1;HCLS1;SPI1;CHEK2;PPP2R1A;BTG1;FADS1;TBX22;CEBPB;PQBP1;HES6;EDF1;CEBPA;YBX1;MLXIPL;MLX;TAF5L;HOXB7;APBB1;SUPT4H1;ATF5;SOX17;BMP2;NONO;UBE2V1;MAFA;SPIN4;GLRX2;IGF2;VHL;GATA4;BRCA2;PPARGC1A;CNBP;MLF2;TERF2IP;ZNF22;CCAR2;SOX11;HMGN5;HIC1;ESRRB;NOTCH1;MLF1;CHD3;MEF2C;PHF1;ACTR5;USP13;DDIT3;ESRRG;POU6F2;REST;SOX1;MAFB;TAF5;SP3;RELA;TCF7L1;TCF3
prerank,protein localization to Golgi apparatus (GO:0034067),-0.2071792450799151,-0.677426895198664,0.9144385026737968,0.978713715206549,1.0,7/27,16.61%,VPS13A;VPS13D;GBF1;OPTN;OBSL1;ARL5B;GBP5
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.249884540521954,0.6768333636031193,0.9242590559824369,0.9727298714914377,1.0,16/56,24.45%,RHOB;ANK3;RHOC;DCTN3;RHOA;ANLN;STMN1;SNX33;USP8;VPS4A;UNC119;CKAP2;INCENP;SPIRE1;RTKN;ECT2
prerank,positive regulation of heart rate (GO:0010460),0.29945455988933206,0.6763653787761642,0.8650385604113111,0.9728121127079336,1.0,5/17,21.65%,EDN3;RYR2;ADRA1A;ADRA1D;ATP2A2
prerank,membrane fusion (GO:0061025),0.2655680867030268,0.6757352745618485,0.903114186851211,0.9730505640528453,1.0,9/33,21.75%,DNM3;RIMS1;VAMP3;VAMP2;NAPA;DNM1L;GCA;VAPA;DNM1
prerank,signal transduction by p53 class mediator (GO:0072331),0.27163505910182445,0.6755410429178746,0.8887573964497042,0.9728883053279593,1.0,8/30,25.64%,HINT1;NDRG1;PMAIP1;STK11;POU4F1;PYCARD;BOK;PAXIP1
prerank,negative regulation of phosphatase activity (GO:0010923),0.27791276136036736,0.6753568879280422,0.8792682926829268,0.972699494568995,1.0,11/25,33.71%,FKBP1A;PPP1R1B;PPP1R35;FKBP1B;PPP1R15A;TGFB2;CHP1;PPP1R11;BOD1;PTPA;SEMA4D
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.32444937154541287,0.6746546925962906,0.8739495798319328,0.9729801731298994,1.0,3/12,16.42%,DCN;CADM4;DAB2IP
prerank,synaptic vesicle transport (GO:0048489),0.3260949215794925,0.6736099943884627,0.8673323823109843,0.9736123607078162,1.0,3/11,18.10%,KIF5A;CDK5;KIF5C
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.31729773559764823,0.6735952851090624,0.8580901856763926,0.9732731142163347,1.0,3/14,22.66%,CD84;RASGRP1;PAEP
prerank,nuclear pore organization (GO:0006999),-0.2501861079850696,-0.6734128425959869,0.8930041152263375,0.9808486978832486,1.0,6/14,21.53%,NUP98;AHCTF1;NUP35;NDC1;TPR;NUP93
prerank,chemical homeostasis (GO:0048878),0.24414615234859402,0.6733999219690503,0.9256830601092896,0.9730910950104983,1.0,8/61,12.89%,AQP4;PNPLA2;TREM2;RBP1;CEBPA;ATP13A2;ABHD8;FBXW7
prerank,aspartate family amino acid metabolic process (GO:0009066),0.29439719805860265,0.6729923011336945,0.8745148771021992,0.9731134205563817,1.0,8/18,28.89%,SLC25A13;SMS;ASNS;NAT8L;GOT1;ADI1;SLC25A12;ASS1
prerank,protein acylation (GO:0043543),0.26149562103429647,0.6722191674161554,0.8936170212765957,0.9734872842151202,1.0,12/38,29.83%,GLUL;SELENOK;ZDHHC5;NAA10;NAT9;ING5;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,establishment of spindle orientation (GO:0051294),-0.1985584768704135,-0.6718061708311853,0.9878048780487805,0.9809227079206282,1.0,9/28,21.07%,PAFAH1B1;UBXN2B;FBXW11;NUMA1;NDEL1;MAD2L1;MISP;LLGL2;NDC80
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.29769419469877106,0.6712873990126141,0.8725099601593626,0.9739599357465758,1.0,6/16,24.95%,ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,detection of mechanical stimulus (GO:0050982),-0.2212693464989143,-0.6709482693464135,0.943127962085308,0.9802181852329845,1.0,4/19,10.96%,PIEZO2;PIEZO1;PKD1;PTK2
prerank,RNA 3'-end processing (GO:0031123),0.24152287007390738,0.6708920919203087,0.92497320471597,0.9739693272606585,1.0,14/69,22.27%,MAGOHB;MAGOH;DDX39B;SRSF9;LIN28B;SRSF2;CPSF2;THOC3;EIF4A3;U2AF1L4;SRSF1;ALYREF;CPSF4;DHX38
prerank,neural crest cell differentiation (GO:0014033),0.2934335821285093,0.6702134326507623,0.8668373879641486,0.9742357964795222,1.0,9/18,32.30%,NRG1;PDCD6;SOX8;SOX11;MEF2C;HTR2B;NOLC1;KBTBD8;CDH2
prerank,DNA replication (GO:0006260),0.23548937889597807,0.6701763606690234,0.9570112589559877,0.9739160623412618,1.0,27/105,27.80%,PTMS;RNASEH2A;MCM5;RPA2;SET;RFC2;RECQL5;POLD4;ING5;RFC4;FAM111A;POLG;BLM;CDC45;PNKP;POLD1;NAP1L1;BARD1;ATRIP;RPAIN;RPA3;PIF1;RMI1;RAD9A;POLE3;MCM7;MCM2
prerank,mitotic spindle organization (GO:0007052),0.2301512895650381,0.6700051405061209,0.9717741935483871,0.9737070078185355,1.0,20/153,17.58%,RPS27;DYNLL2;DYNLL1;RAN;CHEK2;FLNA;VCP;SBDS;ABRAXAS2;CLASP1;XPO1;BUB3;RHOA;STMN1;NUP85;CENPL;DCTN2;RANGAP1;NUDC;TOGARAM2
prerank,acetyl-CoA metabolic process (GO:0006084),0.29310877099173127,0.6698057675575365,0.8455284552845529,0.9735424773052794,1.0,5/15,28.73%,ACAT1;PPCS;PMVK;ACLY;HMGCS1
prerank,endocytic recycling (GO:0032456),0.24942172017335512,0.6686285452425926,0.9347345132743363,0.9742547354561493,1.0,8/50,17.85%,SNX17;RAB14;ARF6;ARL4C;CMTM6;EHD1;DENND1C;EHD2
prerank,protein kinase A signaling (GO:0010737),0.3157828756091492,0.6676596396428561,0.8728813559322034,0.974794352210886,1.0,3/12,30.67%,LCP1;PRKACA;PRKACB
prerank,DNA damage checkpoint signaling (GO:0000077),0.2772014586068768,0.6676554457096645,0.8894230769230769,0.9744488158778932,1.0,11/28,33.84%,CHEK2;PRPF19;ERCC6;CDC5L;STK33;ATRIP;DOT1L;RAD9A;RHNO1;CLOCK;DONSON
prerank,cellular response to interleukin-4 (GO:0071353),-0.2722194325885011,-0.6658054318699419,0.9055944055944056,0.9831815679665533,1.0,10/10,72.80%,STAT6;JAK3;GATA3;TCF7;RUFY4;XCL1;DCSTAMP;SHPK;LEF1;XBP1
prerank,negative regulation of viral release from host cell (GO:1902187),0.30966021233661917,0.6657774795288328,0.8961218836565097,0.9757799641506633,1.0,3/13,19.05%,TRIM28;TRIM32;TRIM13
prerank,integrin-mediated signaling pathway (GO:0007229),0.2406750213371661,0.6654843069365728,0.9402347918890075,0.9756868303845078,1.0,11/73,13.68%,ITGB2;ADAM15;SEMA7A;FN1;ISG15;COL3A1;THY1;ZYX;HCK;NME2;ERBIN
prerank,mRNA transport (GO:0051028),0.23459804714789437,0.6653053627704133,0.954498448810755,0.9754780140138796,1.0,22/101,22.27%,MAGOHB;MAGOH;DDX39B;ZFP36L1;SRSF9;RBM15B;ZFP36;SRSF2;NUP85;NUP88;CPSF2;THOC3;EIF4A3;SLBP;KIF5C;U2AF1L4;NUP50;RAE1;SRSF1;ALYREF;CPSF4;DHX38
prerank,RNA modification (GO:0009451),0.24806682619327497,0.6645838884581224,0.9195148842337376,0.9757638947140064,1.0,16/54,29.12%,METTL1;NOP10;RBM15B;AARS2;CTU1;MEPCE;PUS7;FTSJ3;URM1;ADAT2;METTL3;THUMPD1;CTU2;LCMT2;NOP2;TRIT1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.24909559483240543,0.6644850157418507,0.9207248018120046,0.9755078192548264,1.0,8/44,18.07%,PARK7;SCP2;HSD17B4;SC5D;OSBPL6;PNPO;OSBPL3;CH25H
prerank,striated muscle cell development (GO:0055002),0.3002283922941757,0.6638739145028657,0.902834008097166,0.9757300992326642,1.0,7/14,35.67%,FLII;TMOD1;CAPN3;KLHL41;LMOD1;SDC1;LMOD3
prerank,regulation of cytokinesis (GO:0032465),0.23754371753880993,0.6632110278033304,0.945859872611465,0.9759567454961536,1.0,4/78,4.77%,CALM1;CALM3;KLHL9;PIN1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2850351237726335,0.6625916756432787,0.9012658227848102,0.9761557357105815,1.0,6/20,26.19%,CDKN1C;CEBPA;HEXIM1;TFAP4;MEN1;HHEX
prerank,sulfur compound transport (GO:0072348),0.26966383006851685,0.6624435040377826,0.893719806763285,0.975941286362561,1.0,6/27,18.63%,MGST1;SLC6A6;SLC26A4;SLC25A11;SLC25A19;SLC19A2
prerank,positive regulation of rRNA processing (GO:2000234),0.3320354994943409,0.6608249698181954,0.8920765027322405,0.9770064300201744,1.0,1/10,4.45%,TRMT112
prerank,icosanoid secretion (GO:0032309),0.3144628213360295,0.6606347116357408,0.8753462603878116,0.9768210315496455,1.0,5/12,32.72%,NOS2;NMUR2;PNPLA8;DRD2;ACE
prerank,regulation of Golgi organization (GO:1903358),0.2939941364185814,0.6601524034135297,0.8960709759188846,0.9768891072826987,1.0,4/17,18.29%,MAPK3;MYO5A;PDE4DIP;MAP2K2
prerank,leukotriene biosynthetic process (GO:0019370),0.305049838514582,0.6599754960406204,0.8821081830790569,0.9766750498943279,1.0,5/14,29.18%,MGST3;ALOX5AP;LTC4S;GGT5;GGT7
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.29408552105924635,0.6596905235847526,0.8855989232839838,0.9765566450778225,1.0,3/14,17.04%,PRKAR1A;PRKAR1B;PRKAR2B
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.23554523196685292,-0.6593458393447569,0.932806324110672,0.9870849326758933,1.0,13/13,76.47%,PVR;NECTIN2;IL12A;IL23A;IL12B;IL23R;XCL1;SLC22A13;MR1;FADD;STX7;CYRIB;IL12RB1
prerank,sulfur amino acid metabolic process (GO:0000096),0.274664590185119,0.6589119187805703,0.9041769041769042,0.9768545528991294,1.0,4/24,16.04%,MPST;SMS;TXN2;TST
prerank,xenobiotic transport (GO:0042908),0.2901554339344144,0.6580293619250321,0.8941326530612245,0.9772806455602769,1.0,6/17,26.32%,SLC7A5;GJA1;SLC15A2;ABCC3;ABCA3;ABCC5
prerank,positive regulation of phospholipase C activity (GO:0010863),0.2524213803444599,0.6576929687113285,0.9156492785793563,0.9772256334437855,1.0,9/40,19.63%,NTRK2;ANG;C5AR1;P2RY6;P2RY12;HRAS;ADRA1A;FLT1;CD86
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2919410031647158,0.6576831993984072,0.8841145833333334,0.9768831854198271,1.0,8/19,32.66%,SLC19A1;FOLR2;SHMT2;MTHFS;DHFR;MTHFD2L;ALDH1L1;MTRR
prerank,response to cholesterol (GO:0070723),0.2944929081649697,0.6570592992698119,0.8616438356164383,0.9770550635018734,1.0,7/17,23.44%,MLC1;CCR5;ABCA2;CCL3;TGFB1;GRAMD1A;PMVK
prerank,estrogen metabolic process (GO:0008210),0.29705161348444237,0.6567169921650814,0.8821954484605087,0.977000537467529,1.0,5/15,36.67%,HSD17B4;HSD17B11;HSD17B8;HSD17B10;CYP1B1
prerank,endodermal cell fate commitment (GO:0001711),-0.2646578488481526,-0.6561263519285546,0.9178571428571428,0.9882766064899382,1.0,4/10,21.77%,CDC73;RTF1;SOX2;CTR9
prerank,chromatin remodeling (GO:0006338),0.22750637802454657,0.6550979903044586,0.9592476489028213,0.9780327133665312,1.0,10/100,13.35%,ACTB;NPM1;MBD3;PAK1;NPM3;PIH1D1;ZBTB7A;KDM6B;SOX9;HDAC5
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.3121540829773424,0.6536063253294773,0.8715083798882681,0.9789180228171512,1.0,1/12,3.62%,TNF
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.23708560436249096,-0.6534647075767671,0.9212598425196851,0.9889293663680622,1.0,5/14,22.80%,TUT1;FIP1L1;CPSF6;CPSF1;CSTF2T
prerank,DNA geometric change (GO:0032392),0.27183918819390385,0.6529076658962367,0.8868832731648616,0.9791363525218726,1.0,9/24,29.52%,HMGB3;HMGB1;DDX11;RECQL5;BLM;PIF1;DHX9;HNRNPA2B1;DNA2
prerank,regulation of protein localization to centrosome (GO:1904779),-0.2629808254155764,-0.6526125080153217,0.8817891373801917,0.9882011406785222,1.0,3/10,20.82%,UBXN2B;GSK3B;NUP62
prerank,intracellular lipid transport (GO:0032365),0.2778186343966907,0.6523343619657157,0.9094387755102041,0.9792742471996857,1.0,2/21,4.25%,NPC2;MID1IP1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.29751920669269677,0.6523048158052871,0.8888888888888888,0.9789488729535344,1.0,3/15,19.80%,TNF;TLR6;IL6
prerank,response to ketone (GO:1901654),0.2643243257648339,0.6521003881922581,0.8904933814681107,0.978776567452141,1.0,6/24,19.62%,CCL19;WBP2;HSD3B2;CAV1;SLIT3;TGFB1
prerank,N-glycan processing (GO:0006491),-0.2240712811994787,-0.6509106210011943,0.9458128078817734,0.9880708505127664,1.0,2/18,5.57%,MAN1C1;FUT8
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.22300126235257983,-0.6507078505658828,0.9354838709677419,0.9868283084538325,1.0,3/17,9.30%,TAOK3;KLHDC10;MID1
prerank,ureteric bud morphogenesis (GO:0060675),-0.22908759827553815,-0.6504384682441104,0.9324894514767933,0.9856824608642061,1.0,7/16,26.65%,SIX1;BMP4;WNT11;FGF2;PKD2;GDNF;NPNT
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.2702902514741998,0.650308143106359,0.9062119366626066,0.9799033798129096,1.0,7/26,20.37%,NR1D1;EPHA5;BRSK2;ADCY8;PIM3;STX4;FOXA2
prerank,endocardial cushion morphogenesis (GO:0003203),0.28555024069377866,0.6501091887452759,0.8871794871794871,0.9797149622809315,1.0,8/18,28.38%,ACVRL1;SOX9;BMP2;HEY1;NOTCH1;TGFB2;TBX2;ENG
prerank,regulation of presynapse assembly (GO:1905606),0.283548181455465,0.6484746501362335,0.892998678996037,0.9803965046834816,1.0,8/18,24.54%,LRFN5;IL1RAPL1;PTPRD;LRRC4B;SNCA;SLITRK3;WNT7A;APP
prerank,regulation of presynapse organization (GO:0099174),0.283548181455465,0.6484746501362335,0.892998678996037,0.9803965046834816,1.0,8/18,24.54%,LRFN5;IL1RAPL1;PTPRD;LRRC4B;SNCA;SLITRK3;WNT7A;APP
prerank,cobalamin metabolic process (GO:0009235),-0.2244270015698587,-0.6480866901332285,0.9240506329113924,0.9860044324452976,1.0,17/17,77.59%,CUBN;MMADHC;MMAA;AMN;TCN1;ABCD4;ABCC1;CTRC;CBLIF;MMACHC;CD320;MMUT;MMAB;MTR;LMBRD1;MTRR;TCN2
prerank,RNA metabolic process (GO:0016070),0.22622446382879777,0.6478446018256743,0.9856850715746421,0.9805456883215617,1.0,24/127,17.86%,PCBP1;POLR2E;HNRNPK;POLR2D;DDX39B;POLR2F;RNASE1;RNASE4;RNASEH2A;LSM8;HNRNPA0;RNASEH1;POLR2G;ELAVL4;POLR2K;LAGE3;MRPL44;HNRNPU;SND1;HNRNPA1;APOBEC1;WDR74;AGO1;TBRG4
prerank,mesenchyme morphogenesis (GO:0072132),0.29099481090278334,0.6476994909072812,0.900398406374502,0.9803117642768715,1.0,8/17,28.38%,ACVRL1;SOX9;BMP2;HEY1;NOTCH1;TGFB2;TBX2;ENG
prerank,tRNA transport (GO:0051031),0.2554223841562408,0.6476707414745878,0.9181286549707602,0.9799814279640581,1.0,14/35,31.85%,RAN;YBX1;TOMM20L;NUP85;NUP88;NUP50;RAE1;NOL6;NUP188;NUP205;NUP210;NUP43;SEH1L;TOMM20
prerank,cellular response to estrogen stimulus (GO:0071391),-0.23468881610627437,-0.6474446017935752,0.9307359307359307,0.9851402873962292,1.0,3/14,12.34%,BCAS3;TRIM24;AR
prerank,RNA export from nucleus (GO:0006405),0.22841503672857832,0.6468258452004552,0.9689762150982419,0.9803261022870156,1.0,36/100,33.12%,MAGOHB;MAGOH;DDX39B;RAN;SRSF9;RBM15B;SRSF2;NUP85;HNRNPA1;NUP88;CPSF2;THOC3;EIF4A3;SLBP;U2AF1L4;NUP50;RAE1;SRSF1;ALYREF;CPSF4;DHX38;ALKBH5;HHEX;SYMPK;NUP188;NUP205;HNRNPA2B1;DDX25;NUP210;NUP43;SEH1L;XPO5;U2AF1;UPF1;POLDIP3;NXT1
prerank,regulation of mRNA processing (GO:0050684),0.26058297640273864,0.6459249708001227,0.9223529411764706,0.9807070675682692,1.0,3/32,4.14%,HNRNPK;ZFP36L1;QKI
prerank,protein alkylation (GO:0008213),0.27125609446522947,0.6456093492219444,0.9066834804539723,0.9806098628214444,1.0,5/22,23.69%,EEF1AKMT2;PRMT1;SNRPB;SNRPD3;ETF1
prerank,necroptotic process (GO:0070266),0.2862977820359575,0.6455383669055549,0.8737244897959183,0.98031708872562,1.0,7/16,36.89%,TICAM2;DNM1L;CD14;PGAM5;MLKL;IPMK;ITPK1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.31186443483099213,0.6445322735590483,0.8779472954230236,0.9807930257808191,1.0,1/11,3.83%,ZFP36L1
prerank,regulation of RNA metabolic process (GO:0051252),0.23783675703662308,0.6442610481147403,0.9513812154696133,0.9806814380617161,1.0,14/59,22.07%,PCBP1;PCBP4;AHNAK;PQBP1;RRP1B;FAM50A;METTL18;PRX;OAS3;SRRM4;HNRNPF;IGF2BP3;HNRNPLL;HNRNPH2
prerank,peroxisome organization (GO:0007031),-0.20125505407918526,-0.6439683207719162,0.9532163742690059,0.9862978706963562,1.0,7/25,16.72%,LONP2;ABCD3;ACOT8;PEX7;TMEM135;SEC16B;PEX11A
prerank,RNA methylation (GO:0001510),0.23661019948883288,0.6430275819470399,0.956953642384106,0.9812883418873338,1.0,15/60,26.45%,METTL1;TRMT112;FBL;RBM15B;PCIF1;CMTR1;ZCCHC4;MEPCE;FTSJ3;TRMT10C;METTL3;METTL14;WDR6;LCMT2;TYW3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.2922990747227816,0.6427351223615408,0.9037433155080213,0.981168059033937,1.0,3/14,19.40%,ENTPD3;NUDT16;NUDT9
prerank,regulation of cytoplasmic translation (GO:2000765),0.2991378125533724,0.6422636801199937,0.8811369509043928,0.9811792019568476,1.0,3/14,17.91%,PKM;YBX3;CNBP
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.22313824873651186,0.6419260740068513,0.9836734693877551,0.9811085360349708,1.0,26/138,18.55%,NPPC;ERBB4;NTRK2;LTK;SHC3;MUSK;PTK6;KDR;MPZL1;EPHA5;HCK;CSF1R;FLT4;PTPRD;TIE1;GFRA2;EPHB1;TYRO3;LCP2;CASS4;FLT1;DDR2;SRMS;SYK;SLA;ERBB3
prerank,response to steroid hormone (GO:0048545),0.2542922194639785,0.6415964930845743,0.9134045077105575,0.9810324229021476,1.0,7/31,19.62%,ATP1A3;WBP2;ATP1A1;PAQR7;ABCA2;CAV1;TGFB1
prerank,glycoprotein biosynthetic process (GO:0009101),0.23112328103186858,0.6414516854828644,0.9629629629629629,0.9808048986755687,1.0,24/79,26.63%,DAD1;DDOST;B3GNT9;SERP1;GCNT1;ST8SIA4;ALG3;XYLT1;FUT9;B3GNT3;ST6GALNAC2;ST8SIA5;TMEM106A;CANT1;CSGALNACT2;B3GALT5;TNIP1;MGAT1;NUS1;GAL3ST3;B3GALT2;NPC1;CHST9;FAM20B
prerank,regulation of phospholipase activity (GO:0010517),0.32083077773270463,0.641176976588385,0.890295358649789,0.9806702363744016,1.0,4/10,25.66%,RGS2;RASGRP1;SNCA;FGFR3
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.2782539114667884,0.6407780506946451,0.8975979772439949,0.9806238756244227,1.0,1/18,2.26%,AQP4
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.22327583234443715,0.6400748630346763,0.9795709908069459,0.980821487201068,1.0,34/125,31.19%,RPS27;DYNLL2;DYNLL1;RAN;SBDS;CLASP1;XPO1;TACC3;BUB3;STMN1;NUP85;CENPL;DCTN2;RANGAP1;NUDC;INCENP;RCC2;SUN2;RCC1;INTS13;CDC20;KPNB1;MAPRE1;B9D2;PCNT;CENPO;BIRC5;AURKB;MAP4;CLASP2;ESPL1;NUP43;DYNC1H1;SEH1L
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2353875166585434,-0.6396399716783595,0.9185185185185185,0.9879787970855609,1.0,3/14,15.90%,FOXO3;EARS2;MTERF2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.2959653702084551,0.6394678572189696,0.8940397350993378,0.9809465918794766,1.0,1/13,3.53%,CANX
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.2816851816656575,0.6394448055991945,0.910025706940874,0.980618701922534,1.0,5/19,15.31%,HS6ST3;HS3ST5;B3GAT3;UGDH;XYLT1
prerank,modulation by symbiont of entry into host (GO:0052372),0.28694681827220747,0.6386887990680536,0.8962868117797695,0.9808634025666545,1.0,9/16,37.56%,HS3ST5;CAV1;EXOC7;TRIM68;TRIM25;TRIM27;TRIM21;TRIM14;TRIM6
prerank,response to estrogen (GO:0043627),0.2581778611270429,0.6385325657768586,0.9217081850533808,0.9806406119310966,1.0,9/31,24.38%,CD24;WBP2;CAV1;RBBP5;NCOA4;SFRP1;CITED2;SFR1;KRT19
prerank,protein lipidation (GO:0006497),0.2367301924928806,0.6378249971813698,0.9370860927152318,0.9808323889023269,1.0,16/59,29.83%,PIGZ;PIGQ;GLUL;SELENOK;ZDHHC5;DPM3;DPM2;WDR45;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;PGAP4;WIPI2;ZDHHC14;ZDHHC16
prerank,tRNA wobble uridine modification (GO:0002098),0.2906339156106126,0.6372175819017317,0.8947368421052632,0.9809507639619555,1.0,5/14,24.99%,DPH3;ELP3;CTU1;URM1;CTU2
prerank,regulation of histone modification (GO:0031056),0.29880095995652456,0.6371198952621959,0.8856749311294766,0.980685397574919,1.0,1/13,1.76%,PARK7
prerank,response to progesterone (GO:0032570),0.27462074178347345,0.6361680249386179,0.9096858638743456,0.9810606771523395,1.0,8/18,33.52%,WBP2;CAV1;TGFB1;TGFB2;UBE3A;ACOD1;NR1H3;CATSPER2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.21147263047422016,0.6355064709381111,1.0,0.981199024776265,1.0,180/834,23.39%,RPS27A;UBC;UBB;CD81;PCBP1;CHCHD2;JUND;PARK7;MAPK3;TMPRSS6;ATF4;KLF2;SOX18;PTPRN;NPM1;POMC;GPER1;EIF5A;TNF;BEX1;DRAP1;NR1D1;PDGFB;ACVRL1;HCLS1;SPI1;JUNB;GLMP;EPAS1;PIN1;PARP1;PSMC3;CTNNB1;ST18;MRTFA;GRIN1;HES1;HYAL2;CDK8;HIPK2;OTX2;UBA52;FOXF2;CEBPB;FOXD3;SALL2;NAMPT;DCN;CEBPA;CREB3;CREB3L4;PROX1;CXCL10;YBX1;CSRNP3;RRP1B;MLXIPL;MLX;EGR1;HOXD4;GATA2;JUN;HMGB1;CAMK1;RTRAF;RFX4;ZBTB49;MC1R;TAF9;WNT5A;HOXB7;IRF8;PHOX2A;APBB1;SUPT4H1;APEX1;IL11;ATF5;KDM6B;SS18L2;SOX17;WBP2;PTOV1;IRF2BPL;HRAS;SNW1;SOX8;DBP;THRA;IRX3;IRF7;HOXD8;KLF4;ZMIZ2;SLC11A1;SOX9;PAX3;HDAC5;TNFRSF1A;NME2;BMP2;LILRB1;ATMIN;LAGE3;RIPK2;HNRNPU;MED30;F2RL1;PF4;SUB1;AKNA;NR1H2;IGF2;ARF4;KDM1B;BCL11B;HEY1;DLL1;IER5;MEPCE;DAB2IP;SQSTM1;E2F4;GATA4;TWIST1;MED21;GLIS2;SKAP1;ADCYAP1;AGO1;PPARGC1A;CNBP;LMO1;TOX2;PPP3CA;SOX11;DDRGK1;NRL;INHBA;MUC1;TGFB1;NLRP3;ESRRB;TFAP2B;HGF;IL6;NOTCH1;POU4F1;AGRN;FOXA2;CDK9;CITED2;MEF2C;NFKBIA;PLXND1;MYC;SIRT2;CDC5L;FOSL2;MEIS2;FOXA1;DDIT3;CEBPZ;CKAP2;SS18L1;IRF5;REST;MEN1;GRHL2;SOX1;TNIP1;IER2;KLF6;CSRNP1;PPP3R1;MYDGF;CDKN2B;AKIRIN2;SP3;WNT7A
prerank,artery development (GO:0060840),0.2663078076345205,0.6351982219200853,0.9057788944723618,0.9811047936021836,1.0,3/23,5.69%,ACVRL1;APLNR;HES1
prerank,sprouting angiogenesis (GO:0002040),0.23994654903388823,0.6343782508434673,0.937984496124031,0.9813793919207625,1.0,5/51,8.70%,RAMP2;AKT1;ACVRL1;OTULIN;KDR
prerank,protein K48-linked deubiquitination (GO:0071108),0.26664644824007205,0.6343115805892039,0.9175,0.981082569080914,1.0,5/23,16.97%,TNFAIP3;USP5;OTUD7A;OTUB1;USP8
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.23561923849477684,0.6340503224315451,0.9382022471910112,0.9809270042995535,1.0,10/49,20.51%,MYL9;H3-3A;PRMT1;L3MBTL1;PF4;RBBP5;AGO1;SCIN;THPO;MEF2C
prerank,mesoderm formation (GO:0001707),-0.21797799929721856,-0.633341808949028,0.9461883408071748,0.990877799981631,1.0,4/17,16.38%,ITGB4;ITGA3;SMAD2;BMPR2
prerank,Golgi inheritance (GO:0048313),-0.2451850861484436,-0.6332894028102398,0.9097222222222222,0.989546180425203,1.0,2/11,8.31%,GOLGA2;GBF1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.29957954034682543,0.63144686421036,0.8964088397790055,0.982514069223184,1.0,4/12,23.83%,B3GNT9;B3GNT3;B3GALT5;B3GALT2
prerank,tryptophan catabolic process (GO:0006569),0.3012464980229536,0.6311884182168445,0.8964088397790055,0.9823615230500702,1.0,1/11,11.15%,IDO2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.2877099576126673,0.629964960060031,0.9012016021361816,0.982898573982664,1.0,6/14,31.78%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1;FSCN1
prerank,digestive tract morphogenesis (GO:0048546),-0.23109089913092315,-0.6292393596900596,0.9108527131782945,0.9907148304294708,1.0,2/14,8.34%,NIPBL;FGFR2
prerank,regulation of myotube differentiation (GO:0010830),0.2576888267346166,0.6279043087545481,0.9205378973105135,0.9840351414028295,1.0,7/24,22.36%,BHLHE41;TMEM119;HDAC5;MMP14;HDAC9;NOTCH1;CCN3
prerank,establishment of melanosome localization (GO:0032401),0.27199166396181346,0.6277886052098961,0.9168797953964194,0.9837622165944719,1.0,7/19,31.24%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MLPH;MREG
prerank,regulation of autophagosome assembly (GO:2000785),0.24355452307484193,0.6254780277412705,0.9288214702450408,0.9850571776782575,1.0,4/33,13.52%,PINK1;IFT20;NUPR1;UBQLN2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.28461428184967374,0.6251777809510698,0.8988015978695073,0.9849217216876285,1.0,4/15,23.22%,PNP;SYK;CCR2;HSPH1
prerank,regulation of mRNA metabolic process (GO:1903311),-0.24952443673910335,-0.6249600656511437,0.9384057971014492,0.9919787512221282,1.0,3/11,13.47%,IWS1;SLTM;SRPK2
prerank,epidermal cell differentiation (GO:0009913),0.24064760632186763,0.6247746646771151,0.9521094640820981,0.98486060371515,1.0,4/41,13.98%,TXNIP;CTNNB1;WNT5A;EVPL
prerank,homeostasis of number of cells (GO:0048872),0.2963252268765424,0.6245710407366222,0.8943758573388203,0.9846619891913249,1.0,4/12,26.37%,CX3CR1;NOTCH1;CCN3;OCIAD2
prerank,RNA stabilization (GO:0043489),0.24577148445280717,0.6231416024589479,0.9383720930232559,0.9853102420102444,1.0,10/33,24.24%,YBX1;PABPC1;SLC11A1;HNRNPU;CIRBP;EIF4ENIF1;DKC1;NAF1;ELAVL1;DND1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.2912447222845168,0.6230165148243698,0.9067567567567567,0.9850564958330523,1.0,3/12,22.54%,GMNN;NUGGC;BLM
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.2919805117140658,0.6224917317231362,0.9134078212290503,0.9850715956076237,1.0,3/12,17.90%,MTLN;TWIST1;PPARGC1A
prerank,cellular response to hydroxyurea (GO:0072711),0.3035942496553562,0.6223932451225419,0.9120567375886525,0.9847898937067944,1.0,3/10,22.54%,DDX11;NSMCE3;BLM
prerank,cardiac ventricle morphogenesis (GO:0003208),0.23841756584130597,0.622386653175535,0.9427262313860252,0.9844502752466119,1.0,10/41,21.85%,FKBP1A;CPE;PROX1;HEY1;GATA4;SOX11;TGFB1;NOTCH1;MEF2C;NPY5R
prerank,transepithelial transport (GO:0070633),0.2760597171248925,0.6217956299222759,0.913563829787234,0.984528081577134,1.0,2/15,12.80%,SLC1A2;SLC1A1
prerank,regulation of myelination (GO:0031641),0.25922977122678975,0.6211702425671932,0.9269183922046285,0.9846272288373483,1.0,8/25,28.07%,KLK8;MYRF;TENM4;PTPRZ1;SIRT2;PTN;TMEM98;TNFRSF1B
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.26197960505205425,0.6211233185160864,0.9348370927318296,0.9843202755661064,1.0,7/23,34.41%,PLAAT3;PLA2G4F;PLA2G3;PLA2G6;PLBD1;PNPLA8;MBOAT1
prerank,peptidyl-serine modification (GO:0018209),0.21351257247463087,0.6208035847230126,0.9969635627530364,0.984201209880587,1.0,29/166,19.29%,AKT1;PNCK;PINK1;MAST3;PDGFB;CAMK1D;PARP1;UHMK1;HIPK2;PKN1;SGK1;MAST1;CDK5R1;CAMK1;NAA10;POGLUT3;ULK3;DCLK3;GAS6;SBK1;STK32C;CAMKV;HIPK4;CDK5;CSNK1G2;GALNT13;STK32A;MKNK1;GRK2
prerank,GPI anchor biosynthetic process (GO:0006506),0.2473655832817782,0.620339809683241,0.9307048984468339,0.984174504416561,1.0,5/30,16.40%,PIGZ;PIGQ;DPM3;PIGS;DPM2
prerank,phosphate ion transport (GO:0006817),0.27558060789295513,0.6201699791316985,0.912,0.9839487455013955,1.0,8/16,40.03%,SLC25A11;SLC25A14;SLC25A30;SLC25A3;SLC37A2;XPR1;SLC20A1;SLC37A1
prerank,organelle transport along microtubule (GO:0072384),0.24655269785198575,0.6194371589236859,0.9325301204819277,0.9841164032667272,1.0,3/31,11.30%,UBB;MAPT;HAP1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.26280508291829385,0.6189048201682918,0.9343629343629344,0.9841443179746041,1.0,3/19,12.73%,SDS;CRYM;SLC25A21
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.3056680789181684,0.6184111364835909,0.906030855539972,0.9841217350463872,1.0,6/10,34.10%,PODXL;SKAP1;ADA;CD3E;CCL5;FERMT3
prerank,regulation of filopodium assembly (GO:0051489),0.24092310094636904,0.6175930838964028,0.9568764568764568,0.9843257321949217,1.0,9/38,20.32%,NLGN1;TENM2;ARF6;FNBP1L;TRPM2;GAP43;DMTN;GPM6A;AGRN
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.2618516909001225,0.6175309912950564,0.917910447761194,0.9840200798131506,1.0,7/22,25.96%,PPP1CA;DUSP2;PDP1;PPM1F;DUSP1;DUSP6;DUSP8
prerank,nuclear membrane disassembly (GO:0051081),0.28425787318955575,0.6166454470419336,0.9055555555555556,0.9842611968040836,1.0,4/14,25.35%,CTDNEP1;DCTN1;PRKCA;VRK1
prerank,protein modification by small protein conjugation (GO:0032446),0.20630137784066532,0.6157913910839508,0.997997997997998,0.9844879367089022,1.0,56/361,19.85%,RPS27A;UBC;RACK1;UBB;ELOB;UBE2Z;PINK1;KCTD10;KLHL9;EPAS1;UBE2G2;DCAF15;VCP;CDC34;RNF187;UBA52;ISG15;ARRDC1;USP5;TRIM28;UFC1;UBE2M;OTULIN;NEDD8;RBX1;TNFAIP1;DDB1;SUMO2;SUMO3;KLHL7;FBXW5;SYVN1;PCNA;ZSWIM8;FBXW7;RNF40;NUP85;NUP88;ARRB2;ENC1;RNF7;VHL;RNF181;RANGAP1;TRIM32;BCL11A;RLIM;TRAIP;NUP50;DDRGK1;TRIM13;KCTD13;RAE1;SKP1;BRAP;HECW1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.2897507495028654,0.6156938147485614,0.9132231404958677,0.9842008096865449,1.0,3/12,20.69%,ABCG1;NR1H2;NFKBIA
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.223626244634628,0.6154812149067959,0.9754273504273504,0.9840007670535564,1.0,18/69,27.89%,POLR2E;POLR2D;POLR2F;TAF9;POLR2G;POLR2K;ZC3H8;TBP;CDK9;POLR2H;TAF5;INTS13;ELL2;ICE1;RPRD1A;POU2F2;INTS12;TAF13
prerank,branched-chain amino acid metabolic process (GO:0009081),0.26222567032748356,0.6151836787175605,0.9144654088050315,0.9835075194351972,1.0,4/20,17.02%,BCAT2;BCKDK;ACAT1;ECHS1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.26222567032748356,0.6151836787175605,0.9144654088050315,0.9835075194351972,1.0,4/20,17.02%,BCAT2;BCKDK;ACAT1;ECHS1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.22735125682127358,-0.6138001138583425,0.9496124031007752,0.9969965003535631,1.0,4/13,20.47%,ACTN2;STK39;NOS1;PTK2B
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.25856256544762285,0.6134617952049605,0.9228855721393034,0.9842754886537316,1.0,10/22,32.39%,PSMC3;MED30;SUB1;SRF;PAXIP1;MED12;PSMC5;MED16;PSMC2;MED4
prerank,cytosolic transport (GO:0016482),0.21210973081272996,0.6129363782531534,0.9845837615621789,0.9842735322884878,1.0,19/108,20.82%,LAMP1;LAPTM5;EMP2;MAGEL2;RAB14;CLTC;VAMP3;YKT6;BET1L;ARL1;CLN5;DCTN1;SORT1;HOOK1;SYS1;PREPL;SNX16;TBC1D10C;RAB6B
prerank,protein oxidation (GO:0018158),0.29740088657152697,0.6122770437163603,0.9070100143061517,0.984353923083997,1.0,1/11,5.66%,LOX
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.2460241436216547,-0.6121690218126743,0.9467084639498433,0.9965429882707144,1.0,2/10,13.87%,SH3RF1;CBFB
prerank,positive regulation of protein export from nucleus (GO:0046827),0.2756779198430993,0.611469268286709,0.9274193548387096,0.9845347928443235,1.0,3/15,14.04%,YWHAE;CAMK1;GAS6
prerank,photoreceptor cell development (GO:0042461),0.2795806809346366,0.6113892432870331,0.9210884353741496,0.9842511461989538,1.0,4/14,25.59%,MFSD2A;CDHR1;DCX;RORB
prerank,nuclear envelope organization (GO:0006998),0.25568678185155913,0.6111325317358224,0.9332493702770781,0.9840779385312894,1.0,5/20,24.05%,CTDNEP1;VPS4A;TMEM43;SUN2;SPAG4
prerank,inner ear morphogenesis (GO:0042472),-0.19582928549921516,-0.6101476239183388,0.9567567567567568,0.9962790784256257,1.0,4/22,12.89%,FGFR2;EPHB2;ZIC1;SIX1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.28519975534477204,0.6097218823251771,0.9289617486338798,0.9846331379058566,1.0,4/12,27.04%,SNAP25;STX4;STX1B;STX3
prerank,response to hydroxyurea (GO:0072710),-0.23710120001223867,-0.6089766031706306,0.931899641577061,0.9955650557211105,1.0,2/11,5.69%,KAT7;SPIDR
prerank,microtubule bundle formation (GO:0001578),-0.16643376069009053,-0.608778079093262,0.9921259842519685,0.9943360032856325,1.0,17/42,28.67%,NAV1;TTLL3;CCDC66;SPEF1;NUMA1;GAS8;AAAS;MAP1S;LRGUK;RP1;CAPN6;FOXJ1;NCKAP5L;PLK1;PSRC1;CCDC40;SPAST
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.237330438772433,0.6081536605430814,0.9497142857142857,0.9852913788699987,1.0,13/36,28.75%,CALM1;CTNNB1;WNT5A;GNAO1;AGO1;PPP3CA;FZD2;PPP3R1;PDE6G;FZD3;LEF1;FZD5;MAP3K7
prerank,snRNA transcription (GO:0009301),0.22096588315004756,0.6078502733856616,0.9818569903948773,0.9851533523030641,1.0,18/70,27.89%,POLR2E;POLR2D;POLR2F;TAF9;POLR2G;POLR2K;ZC3H8;TBP;CDK9;POLR2H;TAF5;INTS13;ELL2;ICE1;RPRD1A;POU2F2;INTS12;TAF13
prerank,protein heterooligomerization (GO:0051291),0.26540084720456525,0.6078028276107724,0.9352331606217616,0.9848423768763669,1.0,5/17,27.23%,GRIN1;MAT2A;GRIN2B;KCNC2;HSD17B8
prerank,polyol metabolic process (GO:0019751),0.229528243405622,0.607110601892869,0.9628378378378378,0.9849260491464722,1.0,10/46,26.55%,CALM1;NUDT3;INPP5J;NUDT4;IP6K1;NUDT10;PLCH1;INPP5D;NUDT11;INPP4B
prerank,regulation of acute inflammatory response (GO:0002673),-0.19731223310725948,-0.6068067750108298,0.9504504504504504,0.9939924535519481,1.0,18/18,80.30%,OSMR;KLKB1;PTGES;IL4;GSTP1;CREB3L3;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B;IL6ST;DNASE1L3;F12;C2CD4A;ADAM8;IL6;NLRP3
prerank,positive regulation of histone deacetylation (GO:0031065),0.28855926707338364,0.6063391385645257,0.927694406548431,0.9850608006169747,1.0,2/12,11.07%,APLNR;CTBP1
prerank,membrane depolarization during action potential (GO:0086010),0.24728487603706148,0.6057851942131793,0.9294554455445545,0.9850690051044438,1.0,4/26,15.41%,SCN1A;YWHAH;SCN4B;SLC8A1
prerank,sphingoid metabolic process (GO:0046519),0.2882793912229143,0.605560404727681,0.9289617486338798,0.9848731329192634,1.0,5/12,21.50%,NAAA;SPHK2;SGPP1;SGPP2;ASAH2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.20327743481500182,0.6054738098591291,0.9959839357429718,0.9845802694896699,1.0,42/259,20.52%,GSN;DYNLL2;DYNLL1;FXYD5;EMP3;EMP2;RAC1;PMP22;IFT20;FLNA;S1PR1;DNM3;ARHGEF4;P2RX7;CNGA4;P2RY12;NTN1;ARF6;ARHGEF7;FNBP1L;AIF1;CEP131;FHDC1;TCTN3;SHTN1;SDCBP;CCDC88A;EHD1;ARF4;DMTN;CNGB1;TMEM17;CCDC28B;TCTN1;EHD2;EXOC7;NOTCH1;BBIP1;EXOC5;CFAP410;NEK1;CFAP54
prerank,regulation of steroid biosynthetic process (GO:0050810),0.2917502312105309,0.6054711376726862,0.9168975069252078,0.9842405741078192,1.0,2/11,13.57%,EGR1;BMP2
prerank,lipoprotein transport (GO:0042953),-0.23654345796119836,-0.6047914856741459,0.948905109489051,0.9937272503612171,1.0,3/10,14.78%,PPARG;LRP1;PRKCB
prerank,female gamete generation (GO:0007292),0.2455013997724067,0.6035934112545627,0.955952380952381,0.985047359057004,1.0,2/29,8.25%,MDK;FMN2
prerank,cardiac ventricle development (GO:0003231),0.25838043675251543,0.6023759571529377,0.9359795134443022,0.9854255290494719,1.0,8/20,28.38%,HES1;HEY1;GATA4;NOTCH1;PDE2A;STRA6;DLL4;ENG
prerank,regulation of double-strand break repair (GO:2000779),0.23020891954077158,0.601843367920895,0.9456018518518519,0.9853923097326105,1.0,11/39,25.54%,RPA2;USP51;FMN2;DEK;DDX11;OTUB1;TWIST1;TERF2IP;SPIRE1;FOXM1;RAD51
prerank,DNA repair (GO:0006281),0.20236652024842194,0.599465817301044,1.0,0.9864582057555761,1.0,65/284,26.62%,RPS27A;UBC;UBB;PARK7;UBXN1;NPM1;CHEK2;RNASEH2A;PARP1;VCP;NUCKS1;RPA2;UBA52;TRIM28;CENPX;DDB1;MC1R;NEIL1;APBB1;APEX1;PCNA;NSMCE3;NSMCE1;CHRNA4;RFC2;TEX264;UBE2V1;BABAM1;RECQL5;POLD4;DCLRE1C;CETN2;MUS81;NEIL2;BRCA2;ERCC6;TRAIP;NOP53;RAD23A;WDR48;RFC4;GADD45A;FAM111A;ERCC1;ACTR5;MEN1;BLM;FAAP20;LIG1;PNKP;POLD1;ALKBH5;BARD1;ATRIP;DOT1L;BAP1;RPAIN;RPA3;RAD51;XPC;UBE2A;GTF2H5;ALKBH2;ERCC2;RAD9A
prerank,piRNA metabolic process (GO:0034587),0.2606561585343442,0.598714885129354,0.9261146496815287,0.9865725559120753,1.0,3/19,21.84%,ASZ1;MAEL;TDRD9
prerank,mitochondrial transcription (GO:0006390),-0.24252429468086795,-0.5984619916572822,0.964516129032258,0.9954464887459283,1.0,2/10,15.90%,FOXO3;MTERF2
prerank,melanosome localization (GO:0032400),0.2530926161994921,0.5978406833160147,0.9428571428571428,0.9867377874992598,1.0,7/21,31.24%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MLPH;MREG
prerank,inositol phosphate metabolic process (GO:0043647),0.2263328169594978,0.5968305792638253,0.9750849377123443,0.986955523524495,1.0,10/46,26.55%,CALM1;NUDT3;INPP5J;NUDT4;IP6K1;NUDT10;PLCH1;INPP5D;NUDT11;INPP4B
prerank,mRNA export from nucleus (GO:0006406),0.21050576730034087,0.5968059479789876,0.9865284974093265,0.9866283426688341,1.0,21/102,22.27%,MAGOHB;MAGOH;POLR2D;DDX39B;SRSF9;RBM15B;SRSF2;NUP85;NUP88;CPSF2;THOC3;EIF4A3;SLBP;PCID2;U2AF1L4;NUP50;RAE1;SRSF1;ALYREF;CPSF4;DHX38
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.24175709762837805,0.596206178739317,0.9686411149825784,0.9866473591286216,1.0,8/32,23.10%,PCNA;FBXO5;CDK5;ESRRB;KLF11;ID2;CDK18;CDC45
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.28517409905599284,0.5953622053604504,0.9204851752021563,0.9867698167182878,1.0,3/12,23.54%,SLC11A1;CCR2;IL12RB1
prerank,determination of bilateral symmetry (GO:0009855),0.24539230995987057,0.5932604387311862,0.9489671931956257,0.9875836549885872,1.0,5/24,20.44%,MMP21;LEFTY1;DLL1;NOTCH1;CITED2
prerank,endosome organization (GO:0007032),0.22661793671458072,0.5913458854267013,0.9749430523917996,0.9882978983534232,1.0,8/41,21.75%,CHMP2B;CORO1C;SNX33;SQSTM1;USP8;HOOK1;EXOC8;DNM1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2753748638003657,0.5905939670518727,0.9436038514442916,0.9883698260069811,1.0,3/13,17.80%,NEIL1;NEIL2;NT5C
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.2073914431295385,-0.5904523898301796,0.966804979253112,0.9976752412108106,1.0,4/16,15.41%,TOP2B;SLX4;HFM1;FANCM
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.22601935054024536,0.5904277082474445,0.9660249150622876,0.9881267541098092,1.0,8/43,16.42%,DUSP3;SH3GL2;EPN1;ARHGEF7;CHMP6;SPRY1;SH3KBP1;DAB2IP
prerank,DNA integrity checkpoint signaling (GO:0031570),0.23527456928056992,0.5900764370135222,0.9639115250291036,0.9879767647208394,1.0,14/36,35.52%,CHEK2;PRPF19;ERCC6;CDC5L;CDC45;ATRIP;DOT1L;RAD9A;DNA2;RHNO1;CLOCK;TIMELESS;DONSON;SETMAR
prerank,regulation of adaptive immune response (GO:0002819),-0.194257697109939,-0.5878796050240548,0.972972972972973,0.9974015052251469,1.0,3/18,13.14%,EIF2AK4;ADCY7;SIRT1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.2583750571127882,0.5872604763645176,0.9482758620689655,0.989135593191649,1.0,8/19,32.14%,HSPD1;IRF7;RIPK2;IRF5;TLR7;DHX9;DDX3X;MAVS
prerank,positive regulation of macrophage differentiation (GO:0045651),0.2828290942070016,0.5866459213235257,0.9365517241379311,0.9891156182975572,1.0,4/11,25.31%,PF4;TGFB1;ID2;PRKCA
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.2661513624274861,0.5866087212437697,0.9362549800796812,0.9887918250644361,1.0,6/17,29.44%,SCN4B;KCNE4;KCNE5;CACNA2D1;KCNQ1;SCN1B
prerank,skeletal muscle contraction (GO:0003009),0.24998782881244364,0.5859916838153154,0.9437340153452686,0.988763304284024,1.0,5/19,29.17%,TNNI1;STAC3;MYH14;TCAP;STAC
prerank,DNA strand elongation (GO:0022616),0.2579122465632252,0.5859487294184946,0.9438775510204082,0.9884428578793083,1.0,10/18,40.32%,RFC4;GINS3;MCM7;POLD3;GINS1;RFC3;POLD2;MCM4;MCM3;DCLRE1B
prerank,ncRNA catabolic process (GO:0034661),0.23522202671991257,0.585841175461015,0.9582338902147971,0.9881576532464559,1.0,7/28,20.65%,LIN28B;EXOSC2;SND1;NUDT16;EXOSC9;RBM7;EXOSC4
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.2920163764310304,0.5852713673264975,0.9296551724137931,0.9881170432566453,1.0,5/10,30.81%,SOX9;PDGFA;MYC;CHRD;SHH
prerank,polarized epithelial cell differentiation (GO:0030859),0.273826816899973,0.585049611232162,0.9379217273954116,0.9878944751517759,1.0,5/13,31.45%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1
prerank,quinone biosynthetic process (GO:1901663),-0.2098734629789748,-0.5846183171102325,0.9606986899563319,0.9975088620710169,1.0,7/14,26.16%,COQ10B;COQ8B;COQ9;COQ8A;PDSS2;COQ3;FDXR
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.26813258779107957,0.5842893538711068,0.9360544217687075,0.9879402805203206,1.0,1/14,3.16%,ANK3
prerank,UV-damage excision repair (GO:0070914),0.2746301170072389,0.5842362576156337,0.9471544715447154,0.987629327013733,1.0,5/12,25.70%,DDB1;MC1R;ERCC1;ACTR5;XPC
prerank,nuclear pore complex assembly (GO:0051292),0.28140944458094297,0.5836216182850585,0.935064935064935,0.9876155913143175,1.0,1/10,4.85%,RTN4
prerank,snRNA 3'-end processing (GO:0034472),0.25153999605915245,0.5827406552102504,0.9499374217772215,0.9876960616526561,1.0,9/19,33.30%,EXOSC2;TOE1;USB1;EXOSC9;EXOSC4;INTS12;INTS5;INTS6L;EXOSC3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.2175638613496415,-0.5822731580824205,0.974169741697417,0.997137669441957,1.0,5/13,22.00%,DYNC1LI1;MAD2L1;NDC80;TPR;XRCC3
prerank,protein polyglutamylation (GO:0018095),0.2805832278755215,0.5808576769368738,0.9409395973154362,0.9883045288562177,1.0,4/11,27.46%,TTLL7;TTLL5;TPGS1;TTLL1
prerank,cellular response to osmotic stress (GO:0071470),0.2491716744086092,0.5807636445214386,0.958594730238394,0.9880141669211351,1.0,8/21,32.82%,ZFP36L1;AQP1;YBX3;CAPN3;OXSR1;SCN2A;DDX3X;CAB39
prerank,glycerolipid metabolic process (GO:0046486),-0.22732049998601087,-0.5801464907541237,0.9568106312292359,0.9966430823874265,1.0,3/11,10.95%,DGKA;PIP5K1A;DGKQ
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.22776198256481683,-0.5775756923420704,0.9465648854961832,0.9963446031427496,1.0,1/11,2.82%,ACTN2
prerank,GPI anchor metabolic process (GO:0006505),0.2366476777701107,0.5771797762216735,0.9481481481481482,0.9893951887349388,1.0,4/26,16.40%,PIGZ;PIGQ;DPM3;DPM2
prerank,lipoprotein localization (GO:0044872),-0.22176968568046532,-0.5771606172136023,0.9586466165413534,0.9951509334028782,1.0,3/11,14.78%,PPARG;LRP1;PRKCB
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.2327656673010532,-0.5769822077318242,0.9471947194719472,0.9938992859107416,1.0,5/10,31.08%,NUMA1;MED1;NCOA3;PRKCH;VDR
prerank,mitotic spindle assembly (GO:0090307),0.216278080915419,0.5759337007631341,0.9649532710280374,0.989654431623962,1.0,7/42,19.21%,CHEK2;FLNA;ABRAXAS2;CLASP1;RHOA;TOGARAM2;KIFC2
prerank,positive regulation of nuclear division (GO:0051785),0.23696013506511124,0.5752342784201292,0.9667458432304038,0.9896470082731387,1.0,6/25,24.21%,PDGFB;IGF2;EDN3;SIRT2;TGFA;CD28
prerank,response to interleukin-4 (GO:0070670),0.2842706502636205,0.5746192501507549,0.9359534206695779,0.9895987335550355,1.0,10/10,71.59%,XBP1;LEF1;SHPK;DCSTAMP;XCL1;CITED1;RUFY4;TCF7;GATA3;JAK3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.2611163348862135,0.5738791366682866,0.9418132611637348,0.9896076049304462,1.0,2/15,13.56%,SFRP4;NME2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.2805975678611393,0.5737267712695139,0.9381153305203939,0.9893519149152076,1.0,2/10,16.37%,ARF6;EPB41L4B
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.2428170513012224,0.5727427392476724,0.9664179104477612,0.9894726898064147,1.0,8/21,27.61%,JUN;MED30;SUB1;TWIST1;SRF;PAXIP1;MED12;MED16
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.27158580608563687,0.5727259641113165,0.9417218543046357,0.9891425856505439,1.0,1/12,4.32%,CHEK2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.23525482426636488,0.5719284478562019,0.9555555555555556,0.989187081878336,1.0,9/26,30.76%,TNFAIP3;TYRO3;SIGIRR;SIRT2;PCBP2;C1QBP;TRIB1;ACOD1;TRAFD1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.2103673607108138,-0.571426104523554,0.9658119658119658,0.9947726992185169,1.0,5/15,20.76%,PCM1;PIBF1;C2CD3;CCDC14;CEP192
prerank,positive regulation of protein deacetylation (GO:0090312),0.26275127929948516,0.5707019865065058,0.9540540540540541,0.9894257979841902,1.0,2/14,11.07%,APLNR;CTBP1
prerank,steroid biosynthetic process (GO:0006694),0.21083739294616635,0.5706461544929861,0.9754189944134078,0.9891129481521637,1.0,12/56,25.22%,SCP2;LSS;HSD17B4;SC5D;OSBPL6;HSD3B2;OSBPL3;CH25H;OSBPL1A;PRLR;PMVK;INSIG2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.2513180712327797,0.5704403970833687,0.9479034307496823,0.9888649074650753,1.0,9/16,39.52%,RECQL5;BLM;RAD51;MCM7;MCM2;TWNK;RECQL;MCM4;PURA
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.2778728992452336,0.5689432408760877,0.9423076923076923,0.9891975344190805,1.0,3/11,22.54%,GMNN;FBXO5;BLM
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.22835779813034962,0.567514123916997,0.9637681159420289,0.9894981551942519,1.0,1/29,4.19%,SYCP2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.20032575680601344,0.5651181892556179,0.99375,0.99024498145803,1.0,33/96,33.12%,MAGOHB;MAGOH;DDX39B;SRSF9;RBM15B;SRSF2;NUP85;NUP88;CPSF2;THOC3;EIF4A3;SLBP;U2AF1L4;NUP50;RAE1;SRSF1;ALYREF;CPSF4;DHX38;ALKBH5;HHEX;SYMPK;NUP188;NUP205;HNRNPA2B1;DDX25;NUP210;NUP43;SEH1L;U2AF1;UPF1;POLDIP3;NXT1
prerank,regulation of rRNA processing (GO:2000232),0.25585959291753807,0.5633791466469432,0.9473684210526315,0.9906945645958141,1.0,3/16,16.49%,TRMT112;METTL18;NUDT16
prerank,ubiquinone metabolic process (GO:0006743),-0.1986381917457276,-0.5620373553791906,0.9592760180995475,0.9966170179798584,1.0,7/15,26.16%,COQ10B;COQ8B;COQ9;COQ8A;PDSS2;COQ3;FDXR
prerank,DNA catabolic process (GO:0006308),-0.22063600902940078,-0.5600947347608488,0.9669117647058824,0.9959732287092494,1.0,2/11,9.82%,FBH1;DNASE1L1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.27097763887794246,0.5600742888403,0.9548660084626234,0.9917612468752881,1.0,1/10,5.28%,PPP2R1A
prerank,negative regulation of dephosphorylation (GO:0035305),0.24551036477303723,0.5599802118170271,0.9582278481012658,0.9914592566349952,1.0,6/18,26.76%,YWHAB;PPP1R35;ARPP19;PPP1R15A;MFHAS1;CHP1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.25444021859432997,0.559578902595541,0.9475032010243278,0.9912883377701842,1.0,3/15,22.79%,SMOX;SRM;AANAT
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.1899645519134639,0.55908048685719,0.996969696969697,0.9911694012434603,1.0,48/172,32.15%,CHKB;CSNK2B;CDIPT;CDS1;RAB14;DGKH;MFSD2A;PIK3C2G;PCYT2;MTMR9;ABHD8;CHAT;INPP5J;PTDSS1;ARF1;ACHE;CPNE6;PIK3CD;AGPAT5;RAB4A;SLC44A5;DGKB;STARD10;LPCAT2;ETNPPL;AGPAT2;INPP5D;SBF1;SLC44A2;PIK3R5;PLEKHA1;CPNE3;SLC44A1;MTMR6;INPP4B;GPAM;MBOAT7;PIP5K1C;ARF3;CDS2;CEPT1;DGKZ;PITPNM3;GNPAT;DGKG;PISD;AGPAT1;PLSCR1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.2187309742519066,0.5589595389037774,0.978310502283105,0.9908798097553401,1.0,8/37,25.17%,RNASEH2A;ENTPD3;RNASEH1;SND1;NUDT16;NUDT9;ISG20;PNPT1
prerank,lysine catabolic process (GO:0006554),0.2611413028602976,0.5588746680811518,0.9575671852899575,0.9902421446016783,1.0,2/12,12.73%,CRYM;SLC25A21
prerank,lysine metabolic process (GO:0006553),0.2611413028602976,0.5588746680811518,0.9575671852899575,0.9902421446016783,1.0,2/12,12.73%,CRYM;SLC25A21
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.26339473392443946,0.5569602897307716,0.9427012278308322,0.9906839072161023,1.0,4/12,30.33%,ADCY8;STX4;PLA2G6;C2CD2L
prerank,regulation of urine volume (GO:0035809),0.2742899556372316,0.5568418918267606,0.9540389972144847,0.9903895979624716,1.0,2/10,19.75%,HYAL2;TFAP2B
prerank,protein heterotetramerization (GO:0051290),0.2573433135043709,0.5564734907304681,0.9547325102880658,0.9902085698347488,1.0,2/13,18.54%,GRIN1;GRIN2B
prerank,muscle tissue development (GO:0060537),-0.20658376507400675,-0.5551228812515918,0.975,0.9961922637405359,1.0,4/13,21.75%,SMO;BMP4;NF1;PTCH1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.24260336204612057,0.5548169348432664,0.9559014267185474,0.9905358621999187,1.0,10/18,37.22%,CBARP;KCNE5;CAV1;SLC43A2;COMMD1;PPIF;CAB39;BIN1;KCNH2;SLC43A1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2517776557091673,0.5522144117414567,0.9623655913978495,0.9912273132071316,1.0,3/15,18.91%,NPM1;FAM83D;DDRGK1
prerank,manganese ion transport (GO:0006828),0.2530609610416124,0.5521799755544773,0.9525101763907734,0.9909072008006371,1.0,3/14,14.35%,TRPC7;SLC11A1;TRPC1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.26553129478156745,0.5519045928160177,0.9511173184357542,0.9906785037350455,1.0,4/11,25.57%,DLC1;SIRT2;BOK;FZD3
prerank,regulation of DNA metabolic process (GO:0051052),0.20981071701066256,0.5508694213623627,0.9841986455981941,0.9907349824060839,1.0,12/44,23.24%,NUCKS1;UBE2V1;SUB1;PDGFA;KDM1B;TERF2IP;ALYREF;CDK9;MYC;RADX;GRHL2;MPV17
prerank,positive regulation of T cell differentiation (GO:0045582),0.21844326150737792,0.5504446908916288,0.9744186046511628,0.9905647339259236,1.0,3/36,11.59%,MDK;VSIR;PNP
prerank,mitotic chromosome condensation (GO:0007076),0.22546499772610262,0.5497742585084255,0.9658119658119658,0.9904656432652371,1.0,3/26,13.88%,CSNK2B;SET;NCAPG
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.2568104770716033,0.5496911467107847,0.9564625850340136,0.9901630998192771,1.0,2/13,15.08%,AMDHD2;SLC35A3
prerank,ncRNA export from nucleus (GO:0097064),0.21588694984057233,0.5491143884489809,0.9837209302325581,0.9900530374024717,1.0,12/36,31.19%,NPM1;RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP188;NUP205;NUP210;NUP43;SEH1L
prerank,positive regulation of transporter activity (GO:0032411),-0.19519453465108594,-0.5467225124524313,0.9811320754716981,0.9973876624064645,1.0,3/13,16.16%,KMT2A;TRPC6;STK39
prerank,negative regulation of interleukin-12 production (GO:0032695),0.25004892721380095,0.5463158411134429,0.9506008010680908,0.990734892543906,1.0,2/14,13.71%,LILRA5;LILRB1
prerank,sulfate transport (GO:0008272),0.24678366012455108,0.545756351843698,0.9669876203576341,0.9906069745070336,1.0,2/14,9.40%,SLC26A4;SLC25A11
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.2703001505758473,0.545065013340738,0.9661016949152542,0.9905257677972239,1.0,4/10,28.38%,CAV1;TESK1;CHP1;ENG
prerank,tryptophan metabolic process (GO:0006568),0.26014739210800997,0.5446773855265166,0.9536516853932584,0.9903261243023439,1.0,1/11,11.15%,IDO2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.22104872045991894,0.5440238005004858,0.9795918367346939,0.9902299739828013,1.0,8/29,26.86%,GABARAPL2;NAPA;TRAPPC3;RAB6B;COPB2;COPG1;COG8;COPE
prerank,homologous chromosome segregation (GO:0045143),-0.1803258615514848,-0.5410019312316539,0.9897435897435898,0.9975769186787996,1.0,7/20,25.82%,CENPC;PRDM9;SIRT7;ZCWPW1;SGO1;MAJIN;MEIOB
prerank,metanephric mesenchyme development (GO:0072075),0.2638218059363715,0.5406714438220132,0.9514563106796117,0.9910772454085414,1.0,1/10,8.24%,BASP1
prerank,endochondral bone morphogenesis (GO:0060350),-0.21537779847440514,-0.5399900736614984,0.9832214765100671,0.9965003810944973,1.0,3/11,16.38%,COL13A1;BMP4;BMPR2
prerank,alpha-amino acid catabolic process (GO:1901606),-0.15879049382899801,-0.5396118390181363,1.0,0.995285965418211,1.0,5/29,18.31%,DDO;PRODH;HOGA1;ACADSB;GSTZ1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.20128879141927047,0.5391138147819512,0.9876957494407159,0.9912688015756485,1.0,17/52,32.66%,MDH1;SLC19A1;FOLR2;ACOT4;D2HGDH;GOT1;SHMT2;SDHA;MTHFS;ACLY;IDH1;DHFR;ASS1;L2HGDH;MTHFD2L;ALDH1L1;MTRR
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.2582437072030762,0.5379418868081703,0.9628099173553719,0.9913235405562578,1.0,3/11,27.21%,PF4;TMEM106A;XBP1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.20904588653362816,-0.5374409199308748,0.986013986013986,0.9945145588879796,1.0,4/11,22.98%,RIPK1;CASP8;COLEC12;SCARA3
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.21311330715234264,-0.5365145649457188,0.9834437086092715,0.9934705037917707,1.0,5/10,26.40%,MTHFR;MTHFD1L;SHMT1;MTHFD1;TYMS
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.25235561333945195,0.5348155243886785,0.9495091164095372,0.9920132816256937,1.0,3/12,25.35%,CTDNEP1;PRKCA;VRK1
prerank,maturation of 5.8S rRNA (GO:0000460),0.23277875240465645,0.5336012916083378,0.9690860215053764,0.9920749386756932,1.0,8/17,34.07%,EXOSC4;FTSJ3;RRP15;EIF6;PES1;NOL9;URB1;LAS1L
prerank,exit from mitosis (GO:0010458),0.2499968416034697,0.5326984679466322,0.9547325102880658,0.99202816606271,1.0,4/12,31.00%,CLASP1;CHMP7;CLASP2;CHMP4B
prerank,cytoplasmic microtubule organization (GO:0031122),0.19521448483451753,0.5322968352633372,0.9934569247546347,0.9918095684906919,1.0,8/54,17.38%,STMN3;CLASP1;MAPT;DCTN1;RHOA;CLIP3;CCDC88A;HOOK1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.18638694528384664,-0.5306268155036814,0.9840637450199203,0.9935687298690111,1.0,1/17,3.66%,PLA2G4A
prerank,microtubule anchoring (GO:0034453),0.2501253317425143,0.527388507280264,0.9749303621169917,0.9929756511066266,1.0,6/12,36.81%,CLASP1;CAMSAP3;CLASP2;PEX14;GCC2;BICD2
prerank,glutathione biosynthetic process (GO:0006750),-0.2054484966417676,-0.5267256533785991,0.972972972972973,0.993118763855233,1.0,11/11,79.48%,GGCT;GGT1;GCLC;MGST2;GCLM;GSS;CHAC1;CNDP2;HAGH;CHAC2;OPLAH
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.24082355014829454,0.5227624908956445,0.9656992084432717,0.9939662624261786,1.0,2/14,15.40%,ZDHHC5;TLR5
prerank,regulation of telomere capping (GO:1904353),0.21785934162458725,0.5215679741905347,0.9800747198007472,0.9939627351896615,1.0,1/23,1.89%,MAPK3
prerank,mitotic metaphase plate congression (GO:0007080),0.19218072569712957,0.5200644516104713,0.9966960352422908,0.9940357059735456,1.0,15/51,31.19%,CHMP2B;CHMP5;CHMP6;DCTN2;CHMP1B;NUDC;VPS4A;CHMP7;CHMP1A;KPNB1;CHMP4C;CHMP4A;CHMP4B;BOD1;SEH1L
prerank,muscle cell migration (GO:0014812),0.2576495932094403,0.5187899089538766,0.9639769452449568,0.9940364060425226,1.0,2/10,11.40%,PLAT;AAMP
prerank,tetrapyrrole metabolic process (GO:0033013),0.22790565029922705,0.5180469688267733,0.98046875,0.99391198557431,1.0,1/18,5.42%,ABCB6
prerank,rRNA catabolic process (GO:0016075),0.22891100701197747,0.5176860940051535,0.9754204398447607,0.9936717150322804,1.0,7/16,36.20%,EXOSC2;EXOSC9;EXOSC4;TRIR;PELO;EXOSC3;DEDD2
prerank,response to X-ray (GO:0010165),0.23511714073177586,0.510524234994251,0.9796747967479674,0.995141626389711,1.0,4/14,28.84%,NUCKS1;BLM;IKBIP;XRCC6
prerank,ubiquinone biosynthetic process (GO:0006744),0.23025941265120498,0.5068310442912719,0.9794871794871794,0.9956908816426256,1.0,5/15,27.51%,COQ6;NDUFA9;PDSS1;COQ10A;COQ2
prerank,positive regulation of telomere maintenance (GO:0032206),0.2028237487473118,0.5051264397440616,0.992831541218638,0.995764428858037,1.0,11/31,32.02%,MAPK3;MAPK15;ERCC1;MAP2K7;NAF1;PNKP;PRKCQ;HNRNPA2B1;AURKB;HNRNPD;PKIB
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.20488856916521003,0.5033245934291325,0.982989064398542,0.9958421663684551,1.0,10/29,29.10%,SPRY1;DAB2IP;SFRP1;VASN;EFNA1;FOXA2;FOXA1;ADIPOR1;SPRY2;PPP2CA
prerank,double-strand break repair via homologous recombination (GO:0000724),0.17898423487922244,0.5031947232419517,1.0,0.9955351416635706,1.0,23/95,29.83%,SEM1;PARP1;MCM5;NUCKS1;RPA2;NSMCE1;RECQL5;MUS81;BRCA2;MMS22L;MORF4L1;AP5S1;BLM;CDC45;SFR1;RPA3;RAD51;RMI1;MCM7;MCM2;AP5Z1;SMC6;POLN
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.22288563211850254,0.5018633889286951,0.9737876802096985,0.9955014407612809,1.0,4/18,23.00%,CCND1;FBXO5;CDC25A;RCC2
prerank,outer dynein arm assembly (GO:0036158),-0.17880002573806023,-0.49924821937345937,1.0,0.9966267322261245,1.0,7/14,30.12%,ODAD1;DNAAF5;ODAD2;ODAD3;ODAD4;CCDC63;DNAAF4
prerank,recombinational repair (GO:0000725),0.18077985813999714,0.4981785376229174,1.0,0.9959567978400953,1.0,22/77,33.33%,SEM1;PARP1;NUCKS1;RPA2;NSMCE1;RECQL5;BRCA2;MMS22L;MORF4L1;AP5S1;BLM;SFR1;RPA3;RAD51;RMI1;AP5Z1;SMC6;POLN;PSMD14;RHNO1;RAD51C;SWI5
prerank,regulation of interferon-alpha production (GO:0032647),0.20982895396155285,0.49794180976019975,0.9783989834815756,0.99567316841885,1.0,8/23,32.14%,HSPD1;IRF7;RIPK2;IRF5;TLR7;DHX9;DDX3X;MAVS
prerank,positive regulation of immune system process (GO:0002684),-0.1737410523671983,-0.49659731393222845,0.9911894273127754,0.9956259328128747,1.0,16/16,82.65%,IL15;LGALS9;ANXA1;TNFRSF18;HCAR2;TNFSF18;PLA2G1B;ZP3;GPR151;NCKAP1L;VEGFA;MIA3;PIK3CB;TGFB2;RSAD2;PIK3CD
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.22182406366403673,0.4939915030495119,0.9782016348773842,0.996138906531702,1.0,10/16,40.21%,SRSF1;SNRNP200;SART1;WBP4;WBP11;CWC15;PSIP1;DCPS;SNRPC;NCBP2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.21376767557116413,0.49242533597255644,0.9775840597758406,0.9961008170411438,1.0,8/19,31.51%,APRT;PNP;CDA;POLD1;ADA;POLD3;DGUOK;DCK
prerank,establishment of mitotic spindle localization (GO:0040001),0.19790859559376733,0.4922475096759591,0.9903030303030304,0.9958005055474192,1.0,9/28,30.74%,CLASP1;DCTN1;GJA1;INSC;KPNB1;ITGB1;CLASP2;ESPL1;NSFL1C
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.23898051039607465,0.4798328555454191,0.9817671809256662,0.9973224222257471,1.0,4/10,34.07%,F2RL1;CDC42EP2;APC;CDC42EP3
prerank,regulation of pseudopodium assembly (GO:0031272),0.23898051039607465,0.4798328555454191,0.9817671809256662,0.9973224222257471,1.0,4/10,34.07%,F2RL1;CDC42EP2;APC;CDC42EP3
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.19042857895009319,0.4746698235836612,0.9940828402366864,0.9974662074967893,1.0,11/32,31.19%,RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP188;NUP205;NUP210;NUP43;SEH1L
prerank,tRNA export from nucleus (GO:0006409),0.19042857895009319,0.4746698235836612,0.9940828402366864,0.9974662074967893,1.0,11/32,31.19%,RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP188;NUP205;NUP210;NUP43;SEH1L
prerank,tRNA modification (GO:0006400),0.17277411712614543,0.47135736050520394,1.0,0.9976392106889335,1.0,13/62,26.45%,METTL1;TRMT112;AARS2;CTU1;PUSL1;PUS7;URM1;ADAT2;THUMPD1;CTU2;WDR6;LCMT2;TYW3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.19796827427900363,0.47135110769754596,0.996268656716418,0.9973055416949035,1.0,10/24,40.41%,PLA2G4F;PLA2G3;ABCA3;GPAM;CDS2;PNPLA8;PLA2G15;LPCAT1;LPGAT1;LPCAT4
prerank,phasic smooth muscle contraction (GO:0014821),0.23670259572532526,0.4703057286057103,0.9861111111111112,0.997118169160952,1.0,3/10,31.99%,EDN3;HTR2B;DRD2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.21948098190940407,0.46983818586149706,0.9933244325767691,0.9968562873848114,1.0,5/13,35.88%,UNC93B1;TLR7;IRAK2;PIK3AP1;MYD88
prerank,cellular response to pH (GO:0071467),0.20849178511567745,0.4647352285843833,0.9923954372623575,0.9972128677517302,1.0,4/17,26.76%,HVCN1;PKD2L1;GPR68;CHP1
prerank,monosaccharide transmembrane transport (GO:0015749),0.20576326750067803,0.46246683272222566,0.9904240766073872,0.9971771535294265,1.0,2/16,16.67%,SLC50A1;SLC2A2
prerank,sarcomere organization (GO:0045214),0.18840310371112648,0.4614838921203448,0.9901719901719902,0.9969576571071529,1.0,7/27,30.46%,CSRP1;FHOD3;CAPN3;KRT19;TCAP;WDR1;SYNPO2L
prerank,neural tube development (GO:0021915),0.20817601866497368,0.4557807684965581,0.9880636604774535,0.9973119018028547,1.0,4/15,22.58%,PROX1;SOX11;TGFB1;GRHL2
prerank,retinal metabolic process (GO:0042574),0.21402424041687892,0.4480004711930204,0.99302649930265,0.9978116902511733,1.0,2/12,18.40%,DHRS13;BCO2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.18421962541881265,0.44464005195978773,0.9975216852540273,0.9977939592888363,1.0,10/23,36.12%,SLC12A5;SLC26A4;TFAP2B;PDK2;SLC12A9;SLC12A6;SLC9A7;CLCN3;SLC12A2;KCNH2
prerank,signal transduction in response to DNA damage (GO:0042770),0.16830456378176237,0.44423906971617017,0.9978021978021978,0.9975013847664441,1.0,11/49,26.62%,CHEK2;NDRG1;PRPF19;ERCC6;GADD45A;CDC5L;STK33;ATRIP;DOT1L;PAXIP1;RAD9A
prerank,protein localization to kinetochore (GO:0034501),-0.16298594829781393,-0.44231766249101856,1.0,0.9987780156773841,1.0,8/14,34.21%,CENPT;TTK;ZWILCH;MIS12;CDK1;KNL1;SPDL1;CHAMP1
prerank,response to light stimulus (GO:0009416),0.1630239824799692,0.4365683558090757,1.0,0.9978575642962236,1.0,21/55,34.98%,MAPK10;CIRBP;TRIM32;ERCC6;CCAR2;MAP2K7;MEN1;AANAT;POLD1;USF1;UBE2A;ERCC2;FECH;DRD2;CLOCK;TYR;ERCC4;CDKN2D;CPT1B;GPR88;DTL
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.19045525902668775,0.43039045757286803,0.9986945169712794,0.9979980391040371,1.0,17/17,80.97%,BUB3;AURKB;BOD1;IK;CENPA;ZW10;MTBP;HASPIN;CTCF;CHAMP1;SPDL1;KNL1;RB1;CDK1;MIS12;ZWILCH;TTK
prerank,regulation of sensory perception of pain (GO:0051930),0.20746527455815617,0.4250831109680813,0.9914407988587732,0.9980206966929498,1.0,3/11,29.22%,CCL3;CCN3;MGLL
prerank,regulation of interleukin-13 production (GO:0032656),0.20048078086199095,0.4169061221561794,0.994413407821229,0.9981952941751895,1.0,3/13,27.84%,LILRA5;SPHK2;LEF1
prerank,protein localization to condensed chromosome (GO:1903083),0.1935144807375101,0.4092669669910607,0.9986376021798365,0.9982812182859241,1.0,1/12,11.48%,BUB3
